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Governance
The Laboratory is governed by a Board of Trustees of up to 35 members which meets three or four times
a year. Authority to act for the Board of Trustees between meetings is vested in the Executive Committee
of the Board of Trustees. The Executive Committee is composed of the Officers of the Board and any
other members who may be elected to the Executive Committee by the Board of Trustees. Additional
standing and ad hoc committees are appointed by the Board of Trustees to provide guidance and advice
in specific areas of the Laboratory's operations.
Representation on the Board of Trustees itself is divided between business and community leaders
and scientists from major educational and research institutions.
The Laboratory is chartered as an educational and research institution by the Board of Regents of the
Education Department of the State of New York. It is authorized to operate a graduate program under the
name “Cold Spring Harbor Laboratory, Watson School of Biological Sciences” and thereat to confer the
degrees of Doctor of Philosophy (Ph.D.), Master of Science (M.S.), and Doctor of Science (Sc.D.),
Honorary.
It is designated as a "public charity" under Section 501(c)(3) of the Internal Revenue Code.
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Martha Farish Gerry
(1918–2007)
Martha Farish Gerry counted among her greatest accomplishments her “four children, a happy marriage, and
Forego,” her three-time “Horse of the Year.” Martha is remembered by many as the owner and operator of
the Lazy F Ranch, one of the first woman members of the Jockey Club, and the woman who did the most
for horse racing (New York Turf Writers, 1974). At Cold Spring Harbor Laboratory, we fondly remember her
enthusiasm for biomedical research and education and her generosity that helped to keep those interests
alive. Her eyes were always bright with curiosity and wonder. We miss her visits to our laboratories, her enthu-
siasm for our graduate school, her insightful and direct comments at our board meetings, and her attendance
at our scientific lectures. Most of all, we miss her as a very enthusiastic friend who helped to guide this insti-
tution over many years.
Our friendship with Martha began in 1989 when she first met my predecessor, Jim Watson, who at the
time was Director of CSHL. Martha was modest about her knowledge of science and science education, but
her interest grew tremendously over her years of involvement here. Even though history was her major at
Vassar from 1936 to 1938, she became a knowledgeable advocate for science during the later years of her
life. In addition to what she so enthusiastically absorbed from participating in educational events at CSHL, I
understand from her family that she always did her homework in preparation for those events. I wasn’t sur-
prised to learn that she made sure to read up on the latest scientific research so that she could keep up in
conversations that she would regularly have with Jim and other researchers on campus. Scientists are life-
long learners, and in this aspect of science, Martha was not going to let her lack of formal training hold her
back.
Martha Farish Gerry was born to William Stamps Farish II and Libbie Rice Farish in Houston, Texas, on
October 20, 1918. Her father was the cofounder of Humble Oil and Refining (later Exxon Company, U.S.A.)
and the founder of the American Petroleum Institute. He moved his family to New York when he was named
Chairman of Jersey Standard. He was named President 4 years later. Martha’s career in horse racing began
unexpectedly when her father died of a heart attack at age 61, shortly after retiring and getting interested in
horse racing. At the age of 24, Martha took on the responsibility of four horses that her father had recently
purchased. You could say the rest is history. Martha owned and operated the Lazy F Ranch, which was orig-
inally owned by her father for over 60 years.
In addition to running the ranch and gracing the winner’s circle in 34 races with her most famous horse
Forego, Martha was recognized throughout the horse-racing world with many honors. Martha was
Chairwoman Emeritus of the Board of Trustees of the National Museum of Racing and Hall of Fame in
Saratoga, New York. Shortly before her unexpected death following heart surgery on September 17, she was
the first woman to be honored as an Exemplar of Racing by the Hall of Fame for her contributions to the sport.
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Martha helped to establish the Forego Fund for the Thoroughbred Retirement Foundation. Martha’s charita-
ble work did not stop there; the William Stamps Farish Fund broadly supports medical research, social ser-
vice needs, arts, and education. Martha herself was particularly involved with the Family & Children’s
Association, New York Presbyterian Hospital, and the United Hospital Fund.
In the CSHL community, Martha participated actively in the governance of the Laboratory. She was a
member of the CSHL Board of Trustees from 1991 until her death, serving as Secretary of the Board from
1997 to 2000. She was distinguished by her election as an Honorary Trustee in 2000. Board committees that
greatly benefited from her guidance included those overseeing the Banbury Program, the Dolan DNA
Learning Center, Buildings, and Development. She delighted, as did we, when the 2004 President’s Council
meeting brought together Martha’s love for science and horse racing by discussing the genetics of thor-
oughbreds. This meeting highlighted the fascinating history of the thoroughbred horse, the problems incurred
by its limited genetic outbreeding, and the precarious physical condition of today’s horses that limits increas-
es in performance while causing susceptibility to injury. It was at this meeting that I really saw Martha in her
element, for she was more knowledgeable than the “experts,” she was keen to see DNA biology have a role
in the sport, and she projected a dominant presence and spirit that all who attended noticed and admired.
Martha Farish married Edward H. Gerry (1914–2003), William Averell Harriman’s nephew, in 1939. They
had four children: William Gerry, Cornelia Corbett, Martha Townley, and Libbie Gerry. Both Martha and
Edward and the entire Farish family were generous supporters of many CSHL initiatives ranging from cancer
research projects to educational initiatives and campus infrastructure through the William Stamps Farish
Fund. Martha believed in CSHL’s commitment to discovery and innovation. Thanks to her belief in the fun-
damental mission of CSHL, we have the Farish Gerry Fellowship for a graduate student, the Edward and
Martha Gerry Fellowship for a graduate student, the Edward H. and Martha F. Gerry Faculty Lectureship, and
two Visiting Lectureship positions, one named in honor of Edward and one in honor of Martha, all as part of
the endowment for the Watson School of Biological Sciences.
More recently, Martha provided support for the Watson School Fund for Innovative Graduate Education,
CSHL’s Women’s Partnership for Science initiative, and the continuing CSHL Capital Campaign for the new
research buildings on our Hillside Campus expansion project.
Martha lived in New York in the summer, but she was a regular visitor to Saratoga, New York for the horse-
racing season there, to her stables in Kentucky, to her plantation in northern Florida, and to her beachside
home on Jupiter Island. Wherever she was, she kept in touch with the programs at Cold Spring Harbor
Laboratory and continued to do her homework. We are so grateful for her support and time that she shared
with us on Long Island as a neighbor in Mill Neck. In many ways, she will always be here. I often find myself
sitting in the Gerry Conference Room of the Marks Building, which we dedicated to Martha for her key role
in realizing the Marks Laboratory for brain imaging. I’m glad to see her name and picture on the wall, even
though I know it was never her goal to have things named after her. It is fitting that the picture is of Martha
with her famous horse Forego. It’s always a pleasure to be in her company in that room, where members of
the CSHL community will continue the conversations about science that she so vigorously supported and
where we teach the new class of Watson School students each year.
Bruce Stillman
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William Edward Murray, Esq.
(1926–2007)
William Edward Murray, Esq., of both Charleston, South Carolina, and New York City, deployed his high intel-
ligence, broad vision, and keen liking for innovative medical research to greatly broaden the scientific aspira-
tions of Cold Spring Harbor Laboratory for more than 20 years. Educated at The Citadel and the University of
South Carolina before serving as a Naval Lieutenant in the Pacific during World War II, Bill obtained his first law
training at the University of South Carolina. After moving north to Harvard, he earned a Master of Law (LL.M.),
being then inducted into Phi Beta Kappa. At New York University School of Law, he completed his legal train-
ing with a Doctor of Judicial Science (J.S.D.). In 1949, he commenced his career at the Chief Council’s Office
of the Internal Revenue Service, where he acquired an intimate awareness of the tax codes for estates and tri-
als, knowledge that he used to great profit in his subsequent career as one of New York City’s leading tax attor-
neys. At the same time, Bill became an impassioned investor in commercial real estate, founding in 1963 the
East Bay Company of Charleston, long serving as both its CEO and Chairman. The company has been instru-
mental in the revitalization of many historic sections of Charleston, a city that he so deeply loved.
Although I knew Bill largely through his desire to promote biomedical research, his philanthropic interests
were much broader, including many years on the Board of Marymount Manhattan College, where he long
served as its Chairman. In South Carolina, his interests were even more diverse, the Samuel Freeman
Charitable Trust making gifts to Allen College as well as the University of South Carolina, the College of
Charleston, and the Medical University of South Carolina in Charleston. Bill served as a trustee of Educational
TV of South Carolina, Director of the American Intercultural Student Exchange, and an impassioned supporter
of the East-West Institute that fostered exchanges between Eastern Europe and the United States.
I was first introduced to Bill when one of our trustees, Mary Lindsay, arranged for him to visit the Lab in
the fall of 1984. Mary’s unmarried first cousin, Samuel Freeman, had died in 1983, leaving Bill as the princi-
pal trustee of the Samuel Freeman Charitable Trust. In his will, Samuel Freeman expressed his wish that St.
Pauls School and cancer research be major beneficiaries of his fortune, which included the New Jersey Black
River and Western Railroad (a tourist railroad). Bill already was directing some of the Trust’s monies to the
Cancer Research Institute of New York, in particular allowing Sloan-Kettering’s highly intelligent Lloyd Old
work to develop vaccines against cancer. Mary, knowing that the Trust’s monies were not small, thought that
Bill would also help us to expand our cancer research program. Already, Freeman monies were allowing St.
Paul’s complete a new building for science, and I volunteered to see it in operation, a visit that occurred the
following February.
Never slow-moving, Bill immediately liked how we were progressing in our cancer research, and soon after
the end of our lunch at Robertson House, he made a commitment of $15,000 for equipment for monoclon-
al antibody research within our newly completed addition to James Laboratory (soon to be called Sambrook
Laboratory). We were then in the process of completing our new 360-seat auditorium, made possible by a
major gift from Oliver and Lorraine Grace. Long a friend of Oliver through their joint involvement with the vac-
cines effort of the Cancer Research Institute, Bill persuaded their respective trustees to use $350,000 of
Samuel Freeman Charitable Trust monies and $50,000 of Oliver S. and Jennie M. Donaldson Charitable Trust
x
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monies (for which he also was the principal trustee) to create the Samuel Freeman Computer Center in the
lower floor of Grace Auditorium. Through its six Sun workstations, the Lab now had a dedicated facility for
storing and retrieving DNA sequences as well as the use of X-ray and computer graphics techniques to solve
the structures of cancer-causing and DNA-binding proteins.
Soon after, the Lab commenced its largest ever fund-raising drive (Second Century Campaign) to build a
new dormitory (Dolan Hall) and a Neuroscience Building (Beckman) in the clearing above Grace Auditorium,
then occupied by the Page Motel and adjoining cabins. Not wanting its construction to be held up until suf-
ficient building funds were on hand, Bill, in 1987, arranged for the Samuel Freeman Charitable Trust to donate
$200,000, allowing our architects, Centerbrook of Essex, Connecticut, to expedite the preparation of the final
(construction) architectural drawings. Through that gift, the 1989 groundbreaking of the Neuroscience Center
occurred some 8 months sooner than it could have without Bill’s help.
The Samuel Freeman Charitable Trust returned to its focus on cancer research with a 1989 gift of $1 mil-
lion to bring into existence the Samuel Freeman Laboratory of Cancer Cell Biology. To be expended over 3
years, these monies permitted our highly innovative McClintock Lab cell biology effort to use monoclonal anti-
bodies against cytoskeletal proteins and two-dimensional electrophoresis gels to study how proteins coded
by oncogenes transform normal cells into their cancer equivalents. Freeman funds allowed our more than
motivated scientist, Bob Franza, to generate the most highly cited 1989 paper in all of cancer research. This
paper revealed how external growth signals lead to the emergence of highly specific DNA-binding proteins
that turn on the reading of genes, promoting cell growth and division. Two years later, the Oliver S. and Jennie
R. Donaldson Charitable Trust, following Bill’s wish, made a grant of $250,000 to our Moscow-born Grisha
Enikolopov to develop inhibitors of key molecular promotion of cancer cell growth.
Bill, by then, was also directly helping Soviet science, seeing that $50,000 of Freeman funds went to
Professor Gary Abelov’s Laboratory of Immunochemistry at the Cancer Research Institute in Moscow. Earlier,
his creation of an exchange program between Soviet and American immunologists led to his 1992 election
to the Russian Academy of Science. Freeman monies to the East-West Institute led not only to the exchange
of visits between South Carolina and Moscow, but to Bill’s increasingly frequent visits to the Soviet Union. His
visit to the pristine Lake Baykal in Siberia led to renovation monies that put again to sea “The Samuel
Freeman” marine research vessel.
After I became Cold Spring Harbor Laboratory’s President, Bill became a founding member of my
President’s Council, attending in May 1995 its meeting entitled The New Human Genetics: Implications for
Society. Bill joined our Board of Trustees at its annual 1995 meeting, serving for two 3-year terms. From then
on, as an Honorary Trustee, he continued to attend many of its meetings.
Bill’s ever-increasing interest in the neurosciences led to the Samuel Freeman Charitable Trust providing
us in 1997 with a $1 million grant toward the construction of the Samuel Freeman Building for Computational
Neuroscience. Dominating the entryway to its William E. Murray seminar room is a powerful life-size photo of
Bill in his office. Until a year before its dedication, Bill enjoyed fine health and the companionship of his loving
partner of 10 years, Helen Flynn. Then he suffered a slight stroke that, to our great relief, in no way kept Bill
from appearing characteristically animated at its dedication ceremony in May 2000. Sadly, this first sign of
mortality was a harbinger of further illnesses to come. All too soon, he began to show symptoms of
Parkinson’s disease that increasingly limited his freedom to move his affairs forward. My close neurobiologist
friend Rodolfo Llinas of New York University Medical Center was then starting to use high-power MEG imag-
ing techniques to study brain dysfunction. To let him examine the molar and premolar cortexes of Parkinson
victims, Bill deployed $100,000 of Freeman monies.
Increasingly, Bill and Helen were spending more and more of their time at their gracious Vendue Range
apartment on Charleston Harbor, as opposed to their more formal flat at the Carlyle in New York City. Helen’s
arthritis and Bill’s Parkinson’s rigidity were better tolerated during the warm days of Charleston, rather than
the cold days of New York. Bill’s last visit to the Lab occurred in September 2005, when he and his youngest
daughter Briana attended the dedication of our new Betty Livingston apartments at Upland Farms. The occa-
sion also allowed us to honor Bill’s 80th birthday on September 1 with an “80 Years of Distinction” booklet
that showed pictures of Bill at his vibrant best. In late September, we again were with him at a gracious birth-
day party with his daughters Elizabeth, Pamela, and Briana at the Metropolitan Museum of Art.
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At his funeral in Charleston, following his death on August 4, Liz and I remembered fondly the warmth and
innate sparkle of Bill that so enriched the 20 years we had with him in our lives. Over and over, he saw that
the Lab had the resources to bring my dreams to fruition. Although we never achieved our wish of sailing
around Lake Baykal with him and Helen on “The Samuel Freeman” or celebrating together the White Nights
of Saint Petersburg, they showed us Charleston at its best. I was privileged to receive the Honorary Degree
of the Medical College of Charleston in 1987 and Liz its Honorary Degree in 1992 from the College of
Charleston.
Cold Spring Harbor Laboratory will long cherish his memory.
James D. Watson
xii
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PRESIDENT’S REPORT
Science in the United States is at an important crossroad. Decisions taken in the next year or two are
certain to affect the health and welfare of every American citizen as well as the ability of this country to
continue to claim a leadership position in science and technology. Our challenges include improving the
quality of science education and teachers, rekindling interest in science among our young people, eas-
ing immigration of scientists and engineers from abroad who continue to bring an indispensable vitality
to U.S. research efforts, and most important restoring public support for basic science which has erod-
ed measurably in recent years. Each of these issues affects the viability of the research enterprise here at
Cold Spring Harbor Laboratory and at other leading scientific institutions across the country.
This year is a U.S. presidential election year and despite the importance of each of these issues, sci-
ence has for the most part flown below the radar of public discourse. The American people certainly sup-
port science and scientific research in general, yet science does not enter into the national debate as
much as it should. Not only Americans, but also all people in the world today face multiple threats to pub-
lic health and to the natural environment. It is scientific research that provides us with the means to cope
with these challenges, which are nothing short of existential. But science is not just a tool for addressing
specific challenges. As an approach to understanding nature, the world in which we live and life itself, it
steadily advances the frontiers of our knowledge and our capabilities and is thus a fundamental tool of
human progress.
No one disputes that the products of the scientific enterprise generate benefits for everyone. But
these accomplishments are often taken for granted. Nearly every American child and most adults now
use the Internet. But, because the online world has become “second nature,” we scarcely remember,
much less actively contemplate, the wise policies that led our government to consistently support the
computer science and physics research that made the Internet possible.
Major advances in physics, engineering, mathematics and computer science emerged from national
efforts to compete in the space race that began in the late 1950s. At that time, politicians and public pol-
icy leaders, in consultation with scientific advisors, effectively articulated national goals that embraced sci-
ence. Today, in the formulation of national policy, science has become an enterprise that is discussed
mainly in times of crisis and scientists are low on the list of policy advisors consulted. Preparedness is a
critical element for successful crisis management and it is therefore unfortunate that the societal com-
mitment to funding a scientific infrastructure that is prepared to meet the challenges of society has waned.
As pointed out in an important 2007 National Academy of Sciences report entitled Rising Above the
Gathering Storm: Energizing and Employing America for a Brighter Economic Future, the United States
is falling far behind its major competitors in supporting education and research in the physical sciences,
engineering and mathematics. If this “gathering storm” persists for much longer, the infrastructure for
these sciences will be irrevocably damaged. The National Academy report made some important rec-
ommendations to our nation’s leaders, but little has been done to implement them.
Although biology and medicine thus far have survived the reductions in federal government sup-
port that have cut deeply into the programs of their sister sciences, the fact remains that during the
past 5 years Federal support for biomedical research has been reduced. In that span, the budget of
the National Cancer Institute (NCI), for example, has not received any increase. In fact, it has been
severely reduced if we take the effect of inflation into account. If the President’s proposed budget for
2009 is implemented, the real purchasing power of NCI funding will have shrunk by 19% by the end
of next year, relative to its value in 2004. What does this mean? The NCI Director has warned that
the shrinkage threatens to make grants “meaningless,” impairing the ability of basic and clinical inves-
tigators to achieve their stated goals with allotted resources that are constantly eroding over time.
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The irony is breathtaking. This reduction in support comes at a time when real benefits in cancer
research are emerging from work performed during the last two decades. Data from the American
Cancer Society show that the cancer-related death rate per 100,000 Americans has been decreasing for
the last 10 years, particularly for lung, colorectal and breast cancer. Such advances are not serendipitous
but are rather the direct product of intensive basic and applied research over decades, made possible
only because of a societal consensus regarding the importance of keeping financial support robust.
This is not the time to cut back on research. Rather, it is the right time to invest. New technolo-
gies, such as RNA interference (RNAi), mouse models for human cancer that accurately reflect the
response that patients have to the illness, and genomic approaches to identifying new targets for
therapy and diagnosis—all so prominently applied at Cold Spring Harbor Laboratory, as described in
the pages of this report—are now being integrated into new strategies for cancer research and ther-
apy. We are also now combining tools developed for cancer research to begin to unravel the mys-
teries of the brain and neurological diseases such as autism, schizophrenia, and Alzheimer’s. At the
same time, basic research remains our priority because it is the source of our future advances in both
basic and applied research.
Reduction in funding not only limits what existing researchers can do, but it also discourages new
scientists from pursuing science as a career. Undergraduate and graduate students very rapidly
detect the anxious state of their professors when research funds become scarce. If a new genera-
tion of students in America is not thinking about a career in research, in short order the very fabric of
American science will be compromised.
During the past 5 years we have experienced belt-tightening as have nearly all scientists across
the country. Cold Spring Harbor Laboratory, however, has been able to survive and prosper due to
the generosity of private donors who value our commitment to conducting outstanding research and
education programs. Significant accomplishments in autism, schizophrenia, and cancer research
have been supported either entirely or substantially by philanthropy. We are profoundly grateful for
that support, but at the same time, we are obliged to raise a warning flag about public support for
research over the long run.
Public support of science is vitally important because it complements the philanthropic support that
enables great science to begin. For this reason, it is time to place science high on the list of public pri-
orities. CSHL is in a position to challenge investigators—both those who work here and those who
attend our meetings—to take an active role in public education and bring scientific discussion from lab-
oratories into classrooms and living rooms in our community and across the country. It must be part of
how we educate and train scientists today and in the future. We do this for our graduate students in the
Watson School of Biological Sciences. This should be only the beginning of our efforts in this direction.
CSHL is also in a position to empower teachers and students of all ages by providing technological
means with which they can enjoy easy access to real-time science. The Dolan DNA Learning Center
(DNALC) is the key to the success of such an initiative. Through the DNALC and our educational and
public affairs outreach, we must continue to broaden the population that we reach with our programs
and resources.
If we at CSHL take a more proactive role in fulfilling our responsibility to society by pursuing these
steps with fervor, we stand to succeed in continuing our own institution’s leadership role in research. We
will also be fulfilling our civic responsibility as scientists and citizens. If a concerted effort by scientists
and scientific institutions to draw the public into what each of us has personally experienced as the won-
der and promise of science is absent, we must ask: Can we realistically expect to overcome the nation-
al complacency that threatens the long-term stability of research activity in the United States?
CSHL has always been a leader and we have never shirked our responsibility to push science for-
ward. As we continue to fulfill our research and education missions, let us not forget the importance of
bringing the public along with us on our collective journey of discovery for the benefit of humankind.
2
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3HIGHLIGHTS OF THE YEAR
Research
Research performed at CSHL continues to have an extraordinary impact throughout the life
sciences, most especially in the areas in which we have chosen to concentrate: cancer biol-
ogy and genetics, neuroscience, genomics and bioinformatics, and plant genetics. A recent
study—Thomson Scientific’s Essential Science Indicators—placed CSHL in the top 1% of
research institutions most frequently cited by scientific research papers. CSHL’s scientists
collectively ranked in the top 3% of their peer group, a strong indication of their influence on
the entire field of molecular biology.
Such statistics are not the only measures of our effectiveness, but they speak unequivocal-
ly about the excellence of the research teams we have assembled on our small (although grow-
ing) campus. To convey more vividly the remarkable productivity of our programs, just a few of
the dozens of important findings reported by CSHL labs during the last year are reviewed here.
Spontaneous Mutations in Autism
This year, a group of CSHL researchers that included Michael Wigler, Jonathan Sebat, and
Lakshmi Muthuswamy published a landmark paper shedding light on the cau-
sation of autism. To the surprise of many, their work revealed that spontaneous
mutations in the genome—gene copy-number variations—are a major cause of
the disease. It has long been known that autism, like many other complex neu-
ropsychiatric illnesses, has a strong genetic component. Yet most prior genetic
studies have focused on families with more than one autistic child, perhaps
skewing our understanding of the importance of inheritance. With generous
support from the Simons Foundation, the CSHL team assembled genomic
samples from more than 1000 individuals in 264 different families. By charac-
terizing entire families—some with several autistic children and others with only
one—and comparing these with controls, the team could determine whether
specific sequences in a child’s genome were identical to those in their parents’ or whether their
genomes contained variants that reflected copying errors.
How common were copy-number variants (CNVs) in autistic children? The results were
striking: CNVs proved to be ten times more common in the group representing families with
only one autistic child. We now know that spontaneous mutations are a frequent cause of
autism, which we can continue to think of as a genetic disorder, although not necessarily an
inherited one. The team of investigators suspect that a higher-resolution analysis of the
genome will reveal that as many as half of the autism cases are caused by spontaneous
mutations. And they suggest that CNVs are likely to underlie other polygenetic disorders,
including schizophrenia. More recently, the Sebat group found tantalizing new evidence that
CNVs play a role in that devastating illness.
Pioneering the Small RNA Frontier
Work in Gregory Hannon’s lab continues to expand the frontiers of knowledge about small
RNAs and how they operate in complex networks to form RNA interference (RNAi) pathways.
M. Wigler
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4Greg and his team have been involved in this fast-changing area of research from
its inception at the beginning of the decade. With the advent of research by Greg,
Leemor Joshua-Tor, and other investigators on double-stranded RNAs and a pre-
viously unknown cellular machinery that “diced” and “sliced” them into short, sin-
gle-stranded microRNAs (miRNAs) and short interfering RNAs (siRNAs), a wholly
new class of RNA-based gene regulatory molecules came into view.
Greg’s most recent work extends knowledge at the basic science level,
while showing experimentally some of the applications that small RNA research
is likely to have in years to come. This year, the Hannon lab, in collaboration with
Senthil Muthuswamy’s team, demonstrated that by manipulating miRNAs, includ-
ing the tumor suppressor let-7, they could single out and repress stem-like cells
in mouse breast tissue that are widely thought to give rise to cancer. Another
team led by Greg, and including CSHL investigator Scott Lowe, identified a fam-
ily of miRNAs (called miR-34) that enable a critical tumor suppressor network
called the p53 pathway to fight cancer growth.
On the basic research front, Greg and colleagues have helped to reveal a
new major class of small RNAs, called Piwi-, or piRNAs, which, unlike their small
RNA “cousins,” do not appear to arise from double-stranded RNA precursors.
But like miRNA and siRNAs, piRNAs guide Argonaute proteins to silencing tar-
gets arrayed across the genome, via complementary base pairing. The Piwi clade
has been found in mammals and flies; its presence is tightly correlated with the
emergence of germ-line cells. Hannon has hypothesized in a recent paper that
piRNAs provide a glimpse into the ancestral functions of RNAi, their emergence
serving to counter the emergence—eons ago—of genomic parasites that threat-
ened the earliest self-replicating genomes.
Unmasking a “Master” Tumor Suppressor
Naturally occurring tumor suppressive mechanisms have been the focus of work at the
Laboratory for many years. This year, Alea Mills and colleagues solved a mystery in this area
that has befuddled cancer researchers for decades. It had been known since the 1970s that
the short arm of human chromosome 1 was often missing in many kinds of cancers, sug-
gesting that this region contained a “good gene” that prevented tumors from forming. Yet
attempts to pinpoint the gene by looking at human tumors turned up empty-handed.
Using an innovative method called chromosome engineering, Mills generated mice that
were missing large fragments of DNA identical to the suspect tumor suppressive region in
humans. Mice that lacked this region readily developed tumors, whereas mice
with an extra copy of this region had excessive tumor suppression that made the
cells stop dividing completely. Once they had pinpointed this powerful tumor sup-
pressive region, Mills and her team determined which of the 52 genes in the
region was responsible for preventing cancer.
They concluded that it was a gene called Chd5, the “master switch” of an
extensive tumor suppressor network. When Chd5 was deleted, the entire network
collapsed and prolific cancer resulted. Alea and her team have already found that
the gene is commonly deleted in an often fatal brain cancer called glioma, and
they are now investigating whether it is responsible for other kinds of human can-
cers. Future efforts will be focused on exploring anticancer therapies based on
modulation of Chd5 activity.
G. Hannon
S. Muthuswamy
A. Mills
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5Reversible Network Effects of Three Lung Cancer Genes
Cancer research that looks at one gene at a time is limited by the growing realization, made
possible by the work of Scott Lowe and others, that cancers are often caused by networks
of multiple interacting cancer genes. Mutations in these genes are widely thought to deter-
mine both response to treatment and clinical outcome in individual cases. This
year, Scott Powers and David Mu, with collaborators at Memorial Sloan-Kettering
Cancer Center, discovered that interactions of three adjacent genes found on
human chromosome 14 can set off a potentially lethal chain of events that results
in as many as one fifth of non-small-cell lung cancer cases. The genes—TTF1,
NKX2-8, and PAX9—work together to reactivate what appears to be a pattern of
gene expression normally present in the fetus, as lung tissue is being formed.
Scott and colleagues not only identified the mutation that triggers this abnormal
reactivation and demonstrated its causal role in human lung cancer, but also,
intriguingly, demonstrated in model systems that by turning these genes off, the
cancer can be stopped.
An Online Genome that Illustrates Genomic Variation
It is relevant to note that this year, CSHL launched a Web site enabling the general public to
understand visually, as perhaps never before, a key dimension of genetic variation—the level
of the single-nucleotide polymorphism, or SNP. With the online posting of Jim Watson’s
genome, it instantly became possible for anyone, using a plain Web browser, to view places
where Watson’s sequence is different from the “reference” human genome sequence pub-
lished by the Human Genome Project. Easy-to-use navigation tools facilitate the viewing of
genes and some of the common diseases associated with them.
Fixing an Editing Error to Treat a Neurodegenerative Disease
The process by which genes issue instructions to cells to produce specific proteins in spe-
cific amounts is intricate and usually very accurate. In a phase of this process called tran-
scription, itself a marvel of complexity and precision, a strand of RNA is generated, which, in
turn, is usually edited before leaving the nucleus to engage the ribosome, the cell’s protein
factory. Errors in the RNA editing process, called splicing, can lead to abnormal gene expres-
sion and in some cases serious disease.
Those suffering from spinal muscular atrophy (SMA), a neurodegenerative disease that is
often fatal in children, are the victims of a splicing error about which Adrian Krainer and col-
leagues have learned a great deal. This year, Adrian’s team published results of
work that holds genuine promise for SMA patients. The team looked closely at
how a mutated version of a gene called SNM2 is expressed in the illness. In a part
of the splicing process involving the precursor of the mature messenger RNA, the
team focused on a deleted segment, exon 7, that is linked with the mutated
gene’s abnormal expression pattern in SMA. Using a class of molecules called
antisense oligonucleotides, or ASOs, Adrian’s team, in collaboration with a team
at Isis Pharmaceuticals, was able to correct the splicing defect in cultured cells
gathered from individuals with SMA. They now intend to test this therapeutic
approach in mouse models.
Another phase of the Krainer lab’s work, which also has the potential to impact
therapeutics, yielded results this year. They established that a splicing factor
S. Powers
A. Krainer
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6called SF2/ASF, which they had previously described, can act to promote cancer. They
demonstrated how the SF2/ASF protein, when produced in excess, can cause variations in
the splicing patterns of many genes, one of which encodes a protein kinase that regulates
cell growth and protein synthesis. A novel variant of this kinase, S6K1, can both cause and
maintain cancer in cells.
An Inhibitory Neurotransmitter’s Surprising Role in Neural Plasticity
Josh Huang and his team have made substantial progress in recent years in their efforts to
characterize cellular and molecular mechanisms underlying the construction and plasticity of
GABAergic inhibitory circuits in the mammalian brain. A prominent feature of GABAergic con-
nectivity, which accounts for differential regulation of the input, integration,
and output of principal neurons, is the targeting of different classes of inhibito-
ry synapses to neuronal structures including spines, dendrites, somas, and
initial axonal segments. This year, they made significant progress on the
question of how GABAergic transmission is implicated in the regulation of
plasticity, demonstrating how an environmental input can modify GABAergic
neural circuitry.
This kind of work has direct implications in neurological and psychiatric ill-
ness such as autism and schizophrenia, which involve altered development
and function of GABAergic circuits. To the surprise of many in the field, Josh
and his team also discovered this year that the inhibitory neurotransmitter
GABA itself has a major role in plasticity. They revealed that it serves as a
trophic factor, with an impact on signaling that determines whether a synapse
will be stable and whether axons will grow or retract.
It is important to mention that the great technical expertise in mouse engineering that
makes possible the success of the Huang lab’s research program has been recognized by
the National Institutes of Health, which has awarded the group a major 5-year grant aimed
at the generation of advanced genetic tools for study of the GABAergic system. Because the
GABAergic network is very complex and heterogeneous, this will entail the generation of
approximately 20 distinct mouse lines for each characteristic cell type.
A Novel Plant Gene That Calibrates Growth to Light
In recent years, we have learned some surprising things about signaling in
plants, including the fact that individual proteins and RNAs can act as the
agents of mobile signaling. During 2007, David Jackson and his colleagues
discovered a gene whose role in development brings to light a signaling
mechanism that is scientifically intriguing and potentially of great commercial
value. The gene in question, called TILLERED1, encodes a transcription fac-
tor that controls the growth of branching in grasses, a process called tillering.
This gene, David reports, is particularly interesting because its transcription is
calibrated to the sensing of light by the plant. He speculates that sensors in
the leaves send signals, via a mechanism the lab is investigating, to the shoot
meristem, the compartment within the plant in which stem cells that govern
branching reside. Once understood, this signaling mechanism might be
mobilized to boost the yield of plants such as switchgrass that are currently
being used to make biofuels.
J. Huang
D. Jackson
001_030_LAR_Pres-High.qxd:001-024 Pres/High/COO  5/27/08  2:51 PM  Page 6
7A New Partnership with Industry to Help Feed a Hungry World
To help meet the pressing needs of agriculture at a moment when the world’s population is
soaring toward the $7 billion mark, plant scientists at CSHL have joined forces with their
counterparts at Pioneer Hi-Bred, the agricultural division of the DuPont Company. In an
agreement reached this year that is certain to benefit both organizations, their formidable sci-
entific acumen will be put to the challenge of helping farmers increase crop yields and grow
plants specifically engineered to endure environmental stresses while protecting themselves
from diseases and pests.
It is a partnership that departs in important ways from past agreements reached between
academic research institutions and the private sector, many of which have been quite nar-
rowly conceived. With thanks to John Maroney, Vice President, Technology Transfer, and his
staff who worked closely with CSHL scientists, the agreement between CSHL and Pioneer
encourages scientists in both organizations to communicate openly and share ideas, infor-
mation, and research results. Rather than a single project, the teams will collaborate on sev-
eral interrelated ventures over a 5-year period.
For Pioneer, it is a way to inject intellectual capital into an R&D enterprise that mostly focus-
es on applied work. For our plant scientists, it is a way to support a significant expansion of basic
research while keeping one foot solidly planted in the “actual world,” a world that sorely needs
innovative solutions if nutritional and energy requirements are to be met in the decades ahead.
Forging a Collaborative to Define the Big Questions in Plant Biology
Just as our campus has served in past years as the setting for historic meetings
at which plans were first sketched to sequence the human genome and the first
plant genome, so it will witness in the coming months the inaugural meeting of a
vitally important research collaborative that aims to define and address “grand
challenge questions” in plant biology. CSHL and four research universities, led by
the University of Arizona, will share a $50 million NSF grant over the next 5 years
to launch the iPlant Collaborative, which will focus attention on research questions
of global significance while at the same time orchestrating the development of an
all-encompassing computer- and Internet-based infrastructure that promises to
transform the way plant science is done.
Involving Rob Martienssen, Lincoln Stein, Doreen Ware, and Matt Vaughan of
CSHL, the initiative’s overarching objective is to bring plant science fully into the
21st century, as Rob has put the case, providing the technical and institutional
means by which sharing and mutidisciplinarity can fully replace the outmoded sin-
gle-investigator/single-institution research paradigm. It is a plan to provide plant
science and scientists with the means with which to meet the extraordinary chal-
lenges to agriculture of the years immediately ahead, implicit in the steady rise in
global populations, shrinking ecosystem diversity, and the prospect of significant
global climate change.
Cold Spring Harbor Laboratory Board of Trustees
The Board of Trustees welcomed two new members at the beginning of the year: CSHL
Association President Pien Bosch and American Express Executive Vice President and
General Counsel Louise Parent.
L. Stein
D. Ware
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8We mourned the passing of two Honorary Trustees and long-time friends, Martha Farish
Gerry and William E. Murray, Esq. Martha Gerry joined the Board of Trustees of the
Laboratory in 1991, serving as Secretary of the Board from 1997 to 2000, and thereafter as
an Honorary Trustee. Bill Murray was a member of the Board of Trustees of the Laboratory
from 1995, serving as a Trustee until November 2001, and thereafter as an Honorary Trustee.
Many thanks to trustees Jacob Goldfield, Jeff Hawkins, and Douglas Morris, who began
terms in 2000 and concluded their service this year. Mr. Goldfield, Managing Director, J.
Goldfield & Co., participated in the Finance and Investment Committee from 2001 to 2004,
the Investment Committee from 2004 to 2007, the Finance Committee in 2003 and 2005,
and the Research Committee from 2004 to 2007. As a Scientific Trustee, Jeff Hawkins,
cofounder of Numenta, Inc., served on the Research Committee from 2001 through 2007.
In recognition of his outstanding 40-year dedication to Cold Spring Harbor
Laboratory, the Board of Trustees appointed James D. Watson Chancellor
Emeritus and Oliver Grace Professor of Cancer Research Emeritus. Nobel lau-
reate for the 1953 codiscovery of the double helix structure of DNA, Jim served
as director of CSHL from 1968 to 1993, as president from 1994, and then as
chancellor from 2003 to 2007.
Under Jim’s leadership, CSHL rose to global prominence in cancer research
and pioneered a broad range of genetic and biological education programs,
including the doctoral program in the school that bears his name, the Watson
School of Biological Sciences. He and his wife Liz have made invaluable con-
tributions to this institution in so many ways, ranging from research and edu-
cation to philanthropy, campus architecture, and art. We look forward to the
Watsons’ continued participation and support in campus life.
With Pien Bosch as president, the Cold Spring Harbor Laboratory Association (CSHLA)
surpassed its 2007 fund-raising goal for the Annual Fund, raising nearly $1.3 million.
Successful events that were organized throughout the year by CSHLA, with able help of our
Development and Special Events Departments, included the Annual Meeting, the 9th Annual
Jazz at the Lab, the Dorcas Cummings Lecture, a Major Donor Party hosted by Connie and
Angelo Silveri, and the Women’s Partnership Luncheon. Five new directors were named to
the Association this year: Charles B. Goodwin, M.D., Lauryl Palatnick, David Peikon, Freddie
Staller, and Fifield Whitman.
Research and Education Management
CSHL continues to strengthen the management of our research and education
programs, which must evolve constantly to meet the challenges of contemporary
science and society. This year, we appointed a new Director of Research, David
L. Spector, who for the past two decades has focused his research at CSHL on
advancing the ability of biologists to see the processes of transcription and trans-
lation in living cells. In addition to continuing to run his own laboratory, David’s new
charge is to oversee the entire scientific program and staff of more than 400. To
support the Director of Research, we created the new position of Director of
Research Operations, to which we appointed Sydney Gary, who previously had
played a pivotal role as Assistant Director of the Banbury Center.
During the past year, the CSHL Grants Department has been transformed from a service
division to a proactive Office of Sponsored Programs (OSP). Under the leadership of Dr.
J.D. Watson
D.L. Spector
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9Walter Goldschmidts, OSP now actively promotes our research and educa-
tion mission by identifying and matching funding opportunities with CSHL
research expertise and needs. A new team approach to facilitating and man-
aging sponsored funding is accomplished by unprecedented collaboration
with CSHL investigators, the Director of Research, and other CSHL depart-
ments. We have improved support and grant-related counseling for new
investigators, enhanced budget monitoring and forecasting, and established
a CSHL grant application archive. Grant-writing workshops were hosted
throughout the year, and a new OSP intranet Web site with numerous
resources available for the CSHL community was launched.
The research management structure was further solidified by three out-
standing Program Chairs in our focal research areas: Gregory Hannon,
Bioinformatics/Genetics; Scott Lowe, Cancer and Molecular Biology; and
Roberto Malinow, Neuroscience.
We also welcomed CSHL professor Leemor Joshua-Tor to a new leader-
ship position as Dean of the Watson School for Biological Sciences (WSBS).
Leemor will fuse her award-winning research into the molecular basis of
nucleic acid regulatory processes with her expanded responsibilities, which
include the doctoral program, the postdoctoral program, joint undergraduate
Programs with Stony Brook University, the CSHL Summer Undergraduate
Research Program, and the Partners for the Future Program for high school
seniors. To provide additional support for the WSBS, the Assistant Dean posi-
tion was filled by appointment of the former Assistant Director of the Dolan
DNA Learning Center, Uwe Hilgert.
New Markets for CSHL Education Programs
CSHL’s program of scientific conferences and courses is one of the most recognized and
respected in the biological sciences. Every year, more than 8000 researchers from around the
world come to CSHL to participate in a wide range of meetings and courses. We are excited
about the progress that David Stewart, Executive Director, Meetings and Courses, and his
group have made over the last 2 years to bring a similar meetings and courses program to Asia.
At the end of 2007, we signed an agreement with the Suzhou Industrial Park (SIP), a new
high-technology project located west of Shanghai and proximal to the 2500-year-old city of
Suzhou. The largest cooperative project between the governments of China and Singapore,
the SIP has become one of the fastest growing and most competitive development zones in
China. Key to this success is the creation of a high-tech biotechnology and nanotechnology
research and education park. As part of the agreement, CSHL will develop and operate an
annual series of scientific conferences in a newly constructed complex within the SIP. We
plan to open this conference program in 2010.
This year, the Howard Hughes Medical Institute (HHMI), which has supported courses at
CSHL for more than 15 years, doubled its funding for the Lab’s postgraduate education to
$3 million during the next 4 years.
We are also pleased to be expanding our middle and high school education programs to
New York City. Partnering with the New York City Department of Education, the Dolan DNA
Learning Center (DNALC) was awarded a 5-year grant of $750,000 for precollege science
education from the HHMI. This will enable CSHL to open a DNA Lab in a Harlem public
S. Lowe
L. Joshua-Tor
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school, where we will train local teachers and give New York City students an opportunity to
participate in laboratory DNA experiments.
The HHMI-funded program will supplement an existing DNALC “footlocker” program
which currently provides training and footlockers full of lab equipment and supplies to 12,000
students in 60 school systems each year on Long Island. In addition, with leadership from
DNALC Executive Director David Micklos, the talented DNALC staff began distribution of the
world’s first integrated set of RNA interference (RNAi) experiments which use the same tech-
nology that won the Nobel Prize in 2006.
Congratulations to Banbury Center staff and its Executive Director Jan Witkowski—who
celebrated his 20-year anniversary with CSHL this year—for developing and executing 25
scientific meetings and nine courses on science and public policy. The breadth of topics cov-
ered at the Banbury Center is fantastic and this year was no exception. Highlights included
“Protecting the Public Trust in Immunization” and “Retreat from Reason,” which discussed
how to bring rationality to public discourse.
Hillside Campus Update
Groundbreaking on the Hillside Campus expansion project began in 2005, but this year, we
witnessed the most dramatic progress yet in this monumental capital project that will
increase our research capacity in cancer, neuroscience, and bioinformatics by nearly 40%.
At the beginning of the year, only the foundations for the six-building research complex were
in place. By year’s end, all of the internal piping and wiring were installed; the concrete super-
structure was complete, exterior block walls were erected, and the roof structure and sheath-
ing were in place, enclosing the buildings and ensuring that interior work continued through
the winter months.
All the work on building structures could readily be seen at a glance as it progressed. Much
less obvious was the enormous amount of work taking place inside the structures. Electricians
and steamfitters worked hard, installing electrical and mechanical systems, including the two
high-pressure boilers that will ultimately heat the six-building complex. These two areas were
The DNALC brings interactive Web-based resources to its hands-on
workshops and to teachers and students online
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by far the most complex components of the project, and the impressive progress made in
these areas is essential to the timely completion of the Hillside Campus.
The final touches were also put on the new chiller plant, and much of the underlying infra-
structure—drainage systems, electrical conduit and wiring, water and sewer piping—was
installed underground.
The Nassau County Chapter of the New York State Society of Professional Engineers pre-
sented CSHL with the Project of the Year Award for the engineering and innovative environ-
mental design of the storm water management system for the Hillside Campus. CSHL was
recognized for achieving a balance between development and the environment. The unique
and functional storm water management system not only is effective at protecting the sur-
rounding ecosystems, but also provides a visually pleasing backdrop for the Laboratory.
We thank Vice President and Chief Facilities Officer Art Brings and the Facilities
Department for all of these great results and the minimal disruption to our daily operations
and quality of life on campus as the work has proceeded.
Awards and Honors
CSHL Professor and HHMI Investigator Greg Hannon was honored by two
prestigious awards this year: The National Academy of Sciences 2007 Award
in Molecular Biology for his extraordinary scientific achievement in molecular
biology and The Memorial Sloan-Kettering Cancer Center’s 2007 Paul Marks
Prize for cancer research.
Two CSHL postdoctoral students from Greg’s laboratory received the pres-
tigious Pathway to Independence Award from the National Institutes of
Health. With this award, Jose Silva will be able to continue developing highly
efficient RNAi libraries. Alexei Aravin’s award was from the National Institute of
Child Health and Human Development. This is a new NIH program, providing
one of the few opportunities for postdoctoral fellows to receive both mentored
and independent research support.
Current construction of the Hillside Campus
G. Hannon
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James D. Watson became the first individual to have his genome sequenced. The
sequence was completed by collaboration between academic and industrial laboratories
using a new rapid DNA sequencing method. Such personalized genome sequences will
enable analysis of the details of human genome variation and will prompt needed public dis-
cussions about the use of such information.
Our new Dean of the Watson School of Biological Sciences, Leemor Joshua-Tor, was
awarded the first Dorothy Crowfoot Hodgkin Award from the Protein Society in recognition
of her exceptional contributions in protein science that have profoundly influenced our under-
standing of biology.
Lloyd Trotman, who recently joined our faculty, was named a 2007 Rita
Allen Foundation Scholar for his work on breast and colon cancer tumors. This
program identifies promising leaders in research focused on the development of
treatments and cures for cancer, cerebral palsy, or multiple sclerosis.
Lars Zender, a senior clinical postdoctoral fellow at CSHL, was awarded a
$40,000 grant for his seminal contributions in the field of cancer biology and
epigenomics. The grant was presented at the second annual “Cracking the Code
with the Bear” research symposium sponsored by the Bear Necessities Pediatric
Cancer Foundation in Chicago. In addition to Lars, CSHL postdoctoral fellows
Danielle Irvine and Julius Brennecke were also selected to present their cancer
research from a large pool of outstanding postdoctoral fellows across the country.
I was honored to receive the Curtin Medal for Excellence in Medical Research from the
John Curtin School of Medical Research at the Australian National University, where I
received my doctorate in 1979. In May, I also received an honorary degree and presented
the commencement address at the Long Island University graduation.
At the 2007 Watson School of Biological Sciences Commencement Convocation on April
22, we conferred the Degree of Doctor of Philosophy to Darren James Burgess, Beth Li-Ju
Chen, Catherine Yvonne Cormier, Claudia Edith Feierstein, Tomas Hromadka, Elizabeth
Proby Murchison, and Dougal G. R. Tervo. Jonathan See-Ming Kui received the Master of
Science degree. The Watson School awarded honorary degrees to Trustee Mary D. Lindsay,
former CSHL Director Joseph F. Sambrook, and Nobel Prize winner Sydney Brenner.
L. Trotman
Watson School Commencement Convocation. Former CSHL Director J.F.
Sambrook receives his honorary degree.
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CSHL was ranked among the most published and cited institutions by Thomson Scien-
tific’s Essential Science Indicators. In addition, Genes and Development, a publication of the
CSHL Press, ranked sixth in the category of journals that publish high-impact research in
molecular biology and genetics.
This fall, the CSHL Press published a groundbreaking textbook, Evolution by
Nicholas H. Barton, Derek E.G. Briggs, Jonathan A. Eisen, David B. Goldsetin,
and Nipam H. Patel., which for the first time integrates molecular biology,
genome science, and evolutionary biology. CSHL Press Executive Director
John Inglis and his staff of nearly 60 continue to innovate, most recently lever-
aging interactive digital technology. One excellent example of their effort to
keep pace with society’s increasing use of the Internet, editors at the Press
have supplemented the newly released undergraduate Evolution textbook with
a Web site (which even includes blogs) targeted for teachers and students who
have adopted the text.
For the sixth consecutive year, CSHL received the highest possible rating
from Charity Navigator for its financial organizational efficiency and capacity.
According to Trent Stamp, President of Charity Navigator, “with only 1% of the
charities rated receiving six consecutive four-star Charity Navigator evalua-
tions, Cold Spring Harbor Laboratory outperforms most charities in fiscal responsibility.”
The critical job of maintaining the highest standards of financial responsibility is ably per-
formed at CSHL by Lari Russo, Vice President, Finance and Comptroller, and her team.
These standards distinguish CSHL as an institution prepared to meet the expectations of
public and private donors who demand accountability, transparency, and quantifiable results
from their investments in nonprofit organizations.
Development
Under Charlie Prizzi, Vice President, Development, Cold Spring Harbor Laboratory’s fund-rais-
ing efforts saw much success in 2007. An additional $20 million was committed to the Hillside
Campus Campaign goal of $200 million. More than $40 million was raised in unrestricted and
program support. On behalf of CSHL, our Board of Trustees, and our Development
Department, I would like to acknowledge all those who helped us achieve our goals.
The Cold Spring Harbor Campaign
Capital, Endowment, and New Faculty and Laboratory Investment
We greatly appreciate the major donors who have generously contributed new gifts and
pledges of $100,000 or more to support the Laboratory’s Hillside Campus Campaign,
including Dr. and Mrs. Bayard D. Clarkson, Mr. and Mrs. John P. Cleary, Mr. and Mrs. John
H. Coleman, Mr. and Mrs. Norris Darrell, The Shelby Cullom Davis Foundation, the Estate of
Norman Dorf, Empire State Development Corporation (New York State), the William Stamps
Farish Fund, the Coleman Fung Foundation, Robert A. Gay, the Harrison Family Foundation,
Mary D. Lindsay, Mr. and Mrs. Robert D. Lindsay and Family, the Estate of Elisabeth Sloan
Livingston, Mr. and Mrs. David L. Luke III, Mr. and Mrs. Thomas D. McGrath, Jr., Mr. and Mrs.
Alan Seligson, The Seraph Foundation, Mr. and Mrs. Theodore R. Stanley, Cynthia R.
Stebbins, and the Roy J. Zuckerberg Family Foundation.
CSHL Press textbook Evolution
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Education Programs
New gifts and pledges of $100,000 or more to support the Watson School of Biological
Sciences, the Dolan DNA Learning Center, and other educational initiatives were gratefully
received from Edward A. Chernoff, the Annette Kade Charitable Trust, The Jerome L. Greene
Foundation, and the Doris M. and Peter S. Tilles Foundation.
Program Support
The Laboratory relies on private funding to maintain its innovative research programs. We
appreciate new gifts and pledges of $100,000 or more from Mr. and Mrs. Donald Everett
Axinn, The Mary K. Chapman Foundation, Kathryn Wasserman Davis, Dr. Leo A. Guthart, The
Thomas Hartman Foundation for Parkinson’s Research, Jo-Ellen and Ira Hazan, The Lita
Annenberg Hazen Foundation, Joan’s Legacy: The Joan Scarangello Foundation to Conquer
Lung Cancer, The G. Harold and Leila Y. Mathers Charitable Foundation, The Don Monti
Memorial Research Foundation, Manyu Ogale, V. Kann Rasmussen Foundation, The Sass
Foundation for Medical Research, The Simons Foundation, Mr. and Mrs. Theodore R.
Stanley, and the Swartz Foundation.
Breast Cancer Research Support
The Laboratory greatly appreciates the many individuals, foundations, and grassroots groups
who provide the funding, outreach, and public awareness essential to maintain our cutting-
edge breast cancer research. This year, CSHL was fortunate to receive support from Breast
Cancer Awareness Day in memory of Elizabeth McFarland, Breast Cancer Help, The Breast
Cancer Research Foundation, Clear Channel Enterprises/WALK 97.5, F.A.C.T. (Find A Cure
Today), the Joni Gladowsky Breast Cancer Foundation, Glen Cove Cares, Elaine Hayes
Special Effects Salon, Hearts for Cancer, Islip Breast Cancer Coalition, Long Beach Breast
Cancer Coalition, Long Island 2-Day Walk To Fight Breast Cancer, L.I.A.B.C. (Long Islanders
Against Breast Cancer), Manhasset Women’s Coalition Against Breast Cancer, Pam and
Pierre Omidyar, Sons of Italy, West Islip Youth Enrichment Services, and the Women’s
Insurance Network of Long Island.
The Robertson Research Fund
The Robertson Research Fund has been the primary in-house support for CSHL scientists
for more than three decades. In 2007, it supported research in the labs of Grigori Enikolopov,
Josh Huang, David Jackson, Leemor Joshua-Tor, Adrian Krainer, Rob Martienssen, Bill
Tansey, Marja Timmermans, and Anthony Zador. Start-up research support was also provid-
ed by the Fund to four new investigators: Hiroyasu Furukawa, Raffaella Sordella, Lloyd
Trotman, and Glenn Turner. In addition, the Robertson Research Fund continues to support
the annual CSHL In-House Symposium and programs for postdoctoral fellows, graduate stu-
dents, the laboratory seminar program, and faculty recruitment.
Library and Archives
We broke ground on a renovation and expansion project of the Carnegie Building that will
allow CSHL’s Library and Archives to serve our rapidly expanding campus and enable the
continued collection of important materials in the field of molecular biology, genetics, and
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biotechnology. The expansion is supported by CSHL donors, including corporate sponsor
Genentech and CSHL alumni scientist and friend Waclaw Szybalski, Ph.D., Professor
Emeritus of Oncology, University of Wisconsin-Madison.
The Archives completed a 2-year digitization project supported by the Josiah Macy, Jr.
Foundation. A new database now allows us to convert our archival materials into digital for-
mat and to provide access through a Web-based interface. The Archives Advisory
Committee, led by Nobel laureate and Chairman Rich Roberts, met for the second time since
its formation in 2006. The committee decided to host a scientific meeting at CSHL in 2008
on the subject of the history of biotechnology. The Sydney Brenner Scholarship, endowed
by Dr. Phillip Goulet, was awarded to noted scientist and biographer in history of science Jim
Schwartz for his proposed project on Hermann J. Muller.
This year, we were fortunate to acquire the collection of prominent scientist and longtime
CSHL Trustee Norton Zinder. The Medical Research Council donated to the Archives 136
notebooks of important research on C. elegans done by Sydney Brenner’s laboratory. Under
the leadership of Mila Pollock, the Library and Archives looks forward to organizing these
new collections, along with contributions from pioneering scientist Charles Weissmann.
The year 2007 also marked the debut of the Library’s CSHL Authors’ Publications
Database. The growing database of CSHL researchers currently contains more than 7500
citations from scientific journals spanning 1892 to the present.
Building Projects
It was another busy year for the CSHL Facilities Department, which undertook many simul-
taneous building projects during the year. The number, size, and ages of the Laboratory’s
facilities have necessitated a near-constant cycle of building and renovation.
Groundbreaking ceremony for the Library expansion. (Left to right) M. Pollock,
W. Szybalski, J. Watson, H. Anand, and B. Stillman
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As mentioned previously, the renovation and expansion of the Carnegie Building began in
2007. This project, scheduled with a very aggressive timetable, is slated for completion by
the end of 2008. Not only will the project provide much-needed space in the CSHL Library
and Archives, but it will also bring the historically significant structure up to current code and
will be completely accessible to those will disabilities. Moreover, it will serve as the home for
the new Genentech Center for the History of Molecular Biology and Biotechnology.
The Laboratory also undertook several projects to shore up the existing campus infra-
structure. The last remaining section of high-tension electrical main was replaced, complet-
ing a project begun last year. To anticipate future needs, a water main was reinforced and a
new gas main was connected to the campus. We also began a multiyear project to replace
all building management systems with high-efficiency systems to control the heating and air
conditioning. This project is anticipated to reduce power consumption in research buildings
by 25% and is expected to lower energy costs by as much as $500,000 per year.
Other small projects include the renovation of the Darrell House, a single-family property for-
merly owned by a longtime neighbor of the Laboratory, the late Ms. Susan Rose. This house
was renovated into faculty housing and is the last of three houses purchased by the Laboratory
that encircle a historic garden designed by Frederick Law Olmstead. The Laboratory also com-
pleted the renovations of the James library, updating the room to meet current needs, and
completed renovations in the James Laboratory. In 2007, the Laboratory renovated laborato-
ries in Beckman and Delbrück to accommodate newly arriving faculty. The Osterhout house—
formerly used as sabbatical housing—was converted to office space to accommodate library
staff while construction takes place in the Carnegie Building. The Laboratory also continued its
improvement of meeting facilities, building a reception office in Grace and renovating and
expanding the nearly 60-year-old restrooms in the Bush Auditorium.
Special Events
National DNA Day
We celebrated the 5th anniversary of the congressionally desig-
nated “National DNA Day” on April 25, featuring special laborato-
ry walking tours and festive signage on campus as well as
throughout the village of Cold Spring Harbor. In addition to collab-
oration with the National Institutes of Health, our local partners in
this celebration of DNA as part of our history and everyone’s future
were the Cold Spring Harbor Library and Environmental Center
and the Cold Spring Harbor Main Street Association.
Symposium
The 72nd annual Cold Spring Harbor Symposium celebrated the latest research on “Clocks
and Rhythms,” welcoming more than 300 researchers from around the world with wide-
ranging specialties in circadian clocks, aging, and developmental biology.
One of the traditional highlights of the Symposium is the Dorcas Cummings Memorial
Lecture, this year delivered by Charles A. Czeisler, Ph.D., M.D., the Baldino Professor of
Sleep Medicine and the Director of Sleep Medicine at Harvard Medical School, as well as the
Chief of the Division of Sleep Medicine at Brigham and Women’s Hospital, Boston.
CSHL celebrated National
DNA Day April 25
001_030_LAR_Pres-High.qxd:001-024 Pres/High/COO  5/27/08  2:51 PM  Page 16
17
Jazz at the Lab
The 9th annual Jazz at the Lab on April 14 featured the Dena DeRose Trio with special guest
Bob Merrill. The event raised more than $165,000 and was cochaired by CSHLA Directors
Suzanne and Michael DiMaio and Maria Brisbane, and Wallace Henderson.
Concert for a Cure for Cancer
Violin prodigy Jourdan Urbach performed a benefit concert and reception on September 30.
Proceeds benefited the Lustgarten Foundation for Pancreatic Cancer and CSHL.
Women’s Partnership for Science
Nearly 200 women attended the Women’s Partnership for Science
benefit luncheon, held at the home of Mr. and Mrs. Daniel P.
Davison on June 24, to learn about the most recent approaches to
personalized treatment for breast cancer. The talk was given in tan-
dem by CSHL investigator Mona Spector, Ph.D, and Jacqueline
Bromberg, MD, Ph.D., Memorial Sloan-Kettering Cancer Center.
Gavin Borden Visiting Fellows
The 13th Annual Gavin Borden Visiting Fellow Lecture, in memory
of the publisher of Molecular Biology of the Cell, was presented by
Dr. David Baker on October 29.
Groundbreaking for Library and Archives
On October 12, more than 100 friends celebrated the groundbreaking for the renovation and
expansion of the Carnegie Building, home to CSHL’s Library and Archives and the new
Genentech Center for the History of Molecular Biology and Biotechnology. At the podium,
with shovels in hand, I was joined by the Mayor of the Village of Laurel Hollow Harvinder
(Harry) Anand, Dr. Watson, Library benefactor Waclaw Szybalski, and Mila Pollock.
The Double Helix Medals Dinner
The Laboratory held its second Double Helix Medals Dinner on November 8 at the Mandarin
Oriental, New York. Medals were presented to David Koch for Corporate Leadership and
Richard Axel, M.D., and Michael Wigler, Ph.D., for Scientific Research. This special event,
which raised more than $3 million for CSHL, was cochaired by Ms. Jamie C. Nicholls and
Mr. Fran Biondi, Mr. and Mrs. Stephen M. Lessing, Dr. Arthur D. Levinson, Mr. and Mrs.
Robert D. Lindsay, Mr. Sean McManus, and Mr. and Mrs. David M.
Rubenstein.
Science Soirees
CSHL and The New York Public Library’s Science, Industry, and
Business Library (SIBL) sponsored a series to help nonscientists bet-
ter understand the scientific concepts fundamental to understanding
M. Spector and J. Bromberg
CSHL and New York Public Library
cohosted a public lecture series called
Science Soirées
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health and the well-being of society. According to CSHL researcher Partha Mitra, Crick-Clay
Professor of Biomathematics and series moderator, “The idea is to expose nonscientists to
fundamental scientific concepts that could affect their lives and provide them with a founda-
tion for informed decisions and further exploration.”
February 1
Tim Tully, Professor, Cold Spring Harbor Laboratory: The Future of Memory: The Biochemistry of
Memory and Its Future Enhancement.
March 12
Nicholas D. Schiff, Associate Professor and Associate Attending Neurologist, Weill Medical College of
Cornell University: Regaining Consciousness: Recovery from Severe Brain Injury.
April 9
Jeff Dangl, John N. Couch Distinguished Professor of Biology, The University of North Carolina at
Chapel Hill: Genetically Modified Foods: Revolutions in Plant Science and the Controversies They Spur.
May 1
Robert L. Kleinberg, Senior Research Scientist and Scientific Advisor, Schlumberger Research: Energy
Sources of the Future: The Arctic National Wildlife Refuge, Global Warming, and National Security.
June 11
Partha Mitra, Professor, Cold Spring Harbor Laboratory: Learning to Sing: Birdsong, Baby Talk, and the
Origins of Language.
CSHL Public Lecture Series
March 13
Don Axinn, What You Always Wanted to Know About Poets’ Lives, Their Odd Behavior, and Their
Creative Process but Were Afraid to Ask.
May 15
Gregory Hannon, HHMI Investigator and Professor, Cold Spring Harbor Laboratory: Recent Progress
in Cancer Research.
18
Double Helix Medals Dinner participants. (Left to right) E. Lauder, D. Koch,
A. Hayes-Dale, and J. Koch
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June 21
Portia Iversen, Cofounder of the Cure Autism Now Foundation and the Autism Genetic Resource
Exchange: An Evening About Autism.
September 25
Avner Hershlag, Director of North Shore Hospital’s Preimplantation Genetic Diagnosis program:
Custom-made Babies: Fact or Fiction?
October 23
Robert Malinow, Professor, Cold Spring Harbor Laboratory:
Recent Progress in Neuroscience Research.
Public Concerts
April 21
Chu-Fang Huang, piano
April 28
Yousun Chung and Teddy Robie, oboe and piano
May 5
The Parker String Quartet, violins, viola, and cello
May 19
Liza Ferschtman and Inon Barnatan, violin and piano
September 8
Wendy Warner and Irina Nuzova, cello-piano duo
September 29
Peter Orth, piano
October 13
Jean-Frederic Neuburger, piano
Exhibits
Photographer-in-Residence Max S. Gerber exhibited his work in a show titled “Faces of Science,” in
the Bush Auditorium from July 13 through July 29.
Laboratory Employees
New Staff
We welcomed Lloyd Trotman as an Assistant Professor in the CSHL Cancer Center, where
he will continue to research the role of PTEN “dosage” in breast and colon cancers. Lloyd
received his Ph.D. from the University of Zurich and did his postdoctoral fellowship at
Memorial Sloan-Kettering Cancer Center. At MSKCC, he and his colleagues found that
removal of only one copy of PTEN was sufficient to induce cancer in a mouse model of
prostate cancer and that removing both copies prevented the growth of cancer cells.
Dagnia Zeidlickis joined the CSHL staff as Vice President, Communications, with a mis-
sion to further our success in educating the general public about CSHL’s biomedical research
19
R. Malinow
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and education initiatives and accomplishments. Dagnia brings international experience in
public and government relations to the Public Affairs Department. Joining her later in the year
was Jim Bono, our new Director of Public Affairs. His media experience and understanding
of our private and public sector audiences locally and throughout the state will be an asset
to our institution.
Promotions
Congratulations to Anthony Zador who was promoted to Professor and Director
of the Swartz Center for Computational Neuroscience. We also commend Senthil
Muthuswamy who is now Associate Professor, Adam Kepecs who is Assistant
Professor, and Matthew Vaughn who was promoted to Research Assistant
Professor.
Departures
During the course of the year, several faculty members took on new challenges at other insti-
tutions. Lilian Clark, our former Dean of the Watson School of Biological Sciences, became
the Executive Director for Research Operations and Funding at Cancer Research U.K. I thank
Lilian for the enormous amount of work she did to help establish and eventually run the
Watson School. The success of the School is a reflection of her talent and capabilities.
Professor Tasuya Hirano moved to the Riken Discovery Research Institute in Japan. Two
CSHL researchers joined Howard Hughes Medical Institute’s Janelia Farm: Professor Karel
Svoboda, who continues his relationship with CSHL as an adjunct professor; and Associate
Professor Dmitri Chklovskii, who also continues here as an adjunct associate professor.
Similarly maintaining ties to CSHL, Professor Tim Tully remains an adjunct professor while
assuming the new role of Chief Scientific Officer at Dart Neuroscience, a company that he
cofounded. Wolfgang Lukowitz is now an adjunct assistant professor at CSHL, with a new
position as assistant professor at the University of Georgia in Athens. Michael Myers, who
was an assistant professor at CSHL, is now with the International Centre for Genetic
Engineering & Biotechnology in Italy.
Community Outreach
CSHL employees continue to actively participate in local and national community service
events, including Lab-wide Blood Drives in February, August, and December, the American
Cancer Society’s Daffodil Days in the spring, and both the John Theissen Children’s
Foundation Toy Drive and the Suffolk County Toy Drive in December. Every year, CSHL is
proud to sponsor the Cold Spring Harbor Library and Environmental Center kickoff festivities
for the children’s summer reading program.
We also continue to open the CSHL campus to guided walking tours, which are open to
the public most weekends from spring through the fall. Thanks to our specially trained team
of tour guides, who include CSHL students and postdocs, and the Meetings and Courses
team that administers this program. They open our doors to new friends and provide tour
participants with hands-on insight into the fantastic campus that we have built.
20
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Looking Forward
2007 was another remarkable year in the history of CSHL. Our research, education, and
administrative staff continue to surpass expectations. With Dill Ayres as our Chief Operating
Officer, this staff—now more than 1000 strong—put CSHL at the forefront of biomedical sci-
ence in so many respects. During this year, we have all worked hard to prepare for the
future—a future brimming with the potential of more breakthroughs. I appreciate all of the
efforts of our employees and thank Katie Raftery, Vice President, Human Resources, and her
Department for continuing to help make CSHL such a great place to work.
I often marvel at the fact that despite our long and rich history and despite our significant
growth, CSHL remains nimble in its ability not only to react, but also to anticipate change.
The world around us is changing fast in so many ways—the economy, the political climate,
the physical environment, societal norms. Evolution is a concept that we as scientists
embrace. We as an institution have also embraced this concept and are stronger for it.
Kudos to the Trustees, faculty, staff, and supporters for your help in making sure that CSHL
continues to stay ahead of the curve.
Bruce Stillman, Ph.D., F.R.S.
President
21
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CHIEF OPERATINGOFFICER’S REPORT
The year 2007 marked a period of steady progress across the full scope of Cold Spring Harbor
Laboratory’s operations, made possible by the effort and dedication of our faculty, students, and admin-
istrative staff.
The most outwardly visible indication of change is the ongoing construction of the new research build-
ings on our “Hillside Campus.” During the course of the year, the exterior of the buildings emerged on
the landscape at a rapid pace. At year end, all six buildings were up with roofs on and windows installed.
Given the magnitude of this project—100,000 square feet of new space under construction—it has been
remarkable how little disruption there has been to the quality of life on our main campus. This is a cred-
it to both the leadership of our own Facilities Department and the diligence of the general contractor. In
the coming year, we will see the exteriors and interiors of the buildings near completion, with some of the
space ready for occupancy by early 2009. The restoration and reforestation of the site will continue in
earnest next spring, resulting in what we are confident will be a handsome and architecturally consistent
addition to our beautiful campus. It is gratifying to be able to report that, as of year-end, the project is
progressing on time and on budget.
To support this expansion, CSHL announced in 2006 its largest ever capital campaign. The $200 mil-
lion campaign goal includes funds earmarked for construction costs, faculty recruitment and start-up,
and endowment. Thanks to the efforts of our Development Office, our Trustees, and the many generous
supporters of the Laboratory, we expect to reach the goal and complete the campaign by the end of
2008.
When the campus expansion was in the planning stage 6 years ago, there was little reason to assume
that federal funding for research would contract as it has. At the same time, certain areas of operating
expense such as energy, insurance, and health care have proven difficult to control while cutting-edge
research is becoming an increasingly expensive endeavor. Because we see no short-term change to this
altered environment, important initiatives have been undertaken in response and have generated positive
results. Management is exploring appropriate corporate research support agreements such as one
entered into this year with DuPont Pioneer to work in collaboration with our plant genetics group.
The effort to increase private support for research has also been very successful thanks, most
notably, to the Simons Foundation’s support of our autism program and to the Stanley Foundation sup-
port of a program for schizophrenia and cognitive disorders. To ensure that we are doing everything
possible to maximize our share of the federal pool of funds, Dr. Walter Goldschmidts joined the
Laboratory in 2006 from the National Institutes of Health as Executive Director of Sponsored Programs.
He is working very effectively with our new Director of Research Dr. David Spector and our investiga-
tors to both increase grant submissions and manage research budgets proactively.
In addition, the Administration continued to vigorously manage overhead and operational expenses.
Difficult decisions were made in 2007, the toughest of which was to freeze salaries and limit new admin-
istrative hires. We ask a great deal of our dedicated staff, and it was particularly painful to not offer rais-
es at a time when property taxes and fuel costs are increasing so dramatically in our geographic area.
For the fiscal year ended 12/31/07, the Laboratory operating budget reached $115.5 million—a 3.2%
increase over the prior year. Total assets were $639 million—an increase of 10%. Our objective each year
is to balance our operating budget after full depreciation expense, a $6.5 million item in 2007 or, at a min-
imum, to be cash-neutral after netting depreciation expense against spending on capital improvements.
Our ability to achieve the latter goal was greatly enhanced again this year by the success of our Cold
Spring Harbor Laboratory Association Annual Fund and the Double Helix Medals Gala in Manhattan,
which together raised nearly $4 million in unrestricted funds. As our sources of funding shifted toward
001_030_LAR_Pres-High.qxd:001-024 Pres/High/COO  5/27/08  2:51 PM  Page 22
23
001_030_LAR_Pres-High.qxd:001-024 Pres/High/COO  5/27/08  2:51 PM  Page 23
24
increased corporate and private support, we also relied more this year on internal funds by slightly
increasing what has historically been a conservative annual spending rate on our endowment.
The endowment fund achieved positive return on investment for the fifth consecutive year, surpassing
$300 million in year-end market value for the first time. Accounting for the effects of new endowment
gifts, annual spending, income, and appreciation, the fund has grown to this level from its establishment
in 1973 with an $8 million gift from the Charles Robertson family. Total return for the calendar year 2007
was 9.1%, well in excess of the S&P and other benchmark indices. Although these are certainly positive
results, the markets and the economy became very choppy in the last two months of the year and we
cannot necessarily assume positive returns in 2008.
We have our work cut out for ourselves in the coming year. A top priority will be to continue to be
proactive in developing private sources of funding for research and start-up expenses. The recruitment
of new investigators for the expanded campus and the planning for bringing the new buildings on line will
require continued energy and focus. Integration of new personnel and facilities is challenging and
demands careful planning and execution. Overhead will increase substantially so it is imperative that
expenses continue to be managed diligently.
Our talented and prominent Board of Trustees continues to provide valued leadership and support to
the Laboratory. We express our gratitude to three retiring Trustees in 2007—Jacob Goldfield, Jeff
Hawkins, and Doug Morris. Elected to the Board this year were Louise Parent and Cold Spring Harbor
Laboratory Association President Pien Bosch.
More than ever, this year, it is important to recognize the effort and dedication of our 1000 employees.
In a year where they have been asked to give more than they got, the Cold Spring Harbor Laboratory
staff is most deserving of our praise and gratitude.
Dill Ayres
Chief Operating Officer
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LONG-TERM SERVICE
The following employees celebrated milestone anniversaries in 2007:
35 years Terri Grodzicker
25 years Patricia Bird, Arthur Brings, David Micklos, Clifford Sutkevich
20 years Sadie Arana, Patricia Barker, Lisa Bianco, Joan Doxey, James Duffy,
Julie Ehrlich, John Inglis, Barbara Peters, Stanley Schwarz, Inez Sialiano,
Patricia Urena, Jan Witkowski
15 years Robert Collins, Gregory Hannon, Nancy Hodson, Randal Jones,
Richard McCombie, John Pisciotta, Simone Salghetti, Judith Smith,
Mary Smith, William Tansey, Leslie Wenzel, Curtis Williams, Barbara Zane,
Yi Zhong
(Top row) Jan Witkowski, Inez Sialiano, Stanley Schwarz, Lisa Bianco, Bruce Stillman, Patricia
Barker, John Inglis, Barbara Peters, Randal Jones, David Spector. (Bottom row) Judy Smith,
Sadie Arana, Simone Salghetti, Barbara Zane, Julie Ehrlich, Patricia Bird, Nancy Hodson
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CHANCELLOR’S REPORT
Schizophrenia remains a diagnosis that elicits fear and despair among individuals whose
lives it envelopes directly or indirectly. Approximately 1% of every human population, with no
known exception, lives with brains that inappropriately respond to their social milieu, domi-
nated by the “positive symptoms” of delusions, paranoia, voices, and visions that have no
basis in reality. Equally devastating is the fact that most schizophrenia victims have a dimin-
ished capacity to organize their thoughts and rationally plan their future courses of action.
These “negative symptoms” distinguish schizophrenia from its equally common relative bipo-
lar disease (manic depression). With both diseases, medicines, although far from perfect,
routinely bring most victims out of dangerous psychotic moments. For most who suffer from
bipolar disease, such antipsychotic and subsequent mood-stabilizing medicines, available
since the late 1950s, restore the capacity for almost normal life—either attending school or
holding rational, thought-demanding vocations. However, such medicines unfortunately have
no impact on the negative symptoms of most victims of schizophrenia. As they approach old
age and their families lose the ability to care for them, they all too often transition into the
homeless outcasts of human society.
At the heart of the despondency that schizophrenia evokes in those who care for its vic-
tims is our lack of knowledge of its ultimate underlying causes. No evidence exists for
causative infectious agents, and our most useful clues come from comparison of the inci-
dence of schizophrenia in identical versus fraternal twins. Its much higher concordance in
identical twins argues for inappropriate genetic instructions at the heart of much of serious
mental disease. Even this “fact,” however, is not easily accepted, with many believing that
mental disease results more from the stressful conditions of modern society than from the
possession of “bad” genes.
That such “nurture” as opposed to “nature” causation explanations remain prevalent
even today owes much to the failure of psychiatric geneticists to demonstrate the existence
of even one gene located at a precise chromosomal location that carries susceptibility for
schizophrenia and/or bipolar diseases. When successful gene mapping finally took off in the
mid-1980s and the causative genes for Huntington’s disease, cystic fibrosis, and breast
cancer were given precise locations on chromosomes 4, 7, and 17, no equivalent “eureka”
moments occurred for psychiatric diseases. Unclear then and still today was whether the
“bad” genes behind schizophrenia and bipolar disease are disease-causing only when
inherited from both parents (recessive genes) or whether a “bad” gene from only one par-
ent (dominant gene) is necessary. And although identical twins are much more likely to be
dually afflicted than fraternal twins (50% vs. 10%), why identical twins are not 100% con-
cordant remains mysterious.
Keeping psychiatric genetics moving in the unrewarding 1990s was the knowledge that
the Human Genome Project was on course and scheduled to be completed soon after the
beginning of the 21st century. With a completed human DNA sequence on hand, there
would be virtually infinite numbers of DNA sequence variants for use as genetic markers. It
is still too early to assess whether the long-sought nirvana of classical psychiatric genetics is
within its grasp. The Wellcome Trust’s first big associative study for manic depressive disease
was not reassuring. No one gene or small group of genes were discovered to be major play-
ers behind that illness’ disruptive cycling between manic and depressive behavior. Although
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we know now that several well-defined genes—neurogulin, disbindin, and DISC (disrupted in
schizophrenia)—contribute to schizophrenia in some families, none found so far seem to
affect more than a small percentage of victims.
The best way for psychiatric genetics to proceed may not be through further large-scale
genetic association studies, but by direct examination of the DNA of mentally ill individuals.
Within a decade, the science basis should exist for routinely examining the DNA of the men-
tally disturbed to determine which genes are at the root of their illness. Helping us to realize
this goal will be the ever-decreasing cost of DNA sequencing. Although the cost of estab-
lishing the first complete human genome was in the several $100 million range, subsequent
genomes come much cheaper. Craig Venter’s personal genome, generated in 2007 using
the same capillary sequence techniques that had generated the first (2003) genome, was
likely in the $10 million-plus range. Such mega costs, beyond the reach of almost all humans,
will soon be much reduced by use of several powerful new sequencing technologies. For my
personal genome of June 2007, using 454 Life Sciences technologies, Roche expended
slightly more than $1 million. During the next decade, the cost of personal genomes is likely
to fall to that of a Chevrolet-like economy automobile.
Until then, the most cost-effective way to discover the genes responsible for serious men-
tal illness will be the examination of individual human genomes for the presence of changes
(polymorphisms) in the copy number of the approximately 23,000 different human genes.
Normally, each of us has two copies of each of our genes (one each from our father and our
mother). During germ-cell formation, however, illegitimate genetic recombination events con-
tinually create mutant chromosomes lacking a specific gene or containing multiple copies of
the gene. Now, it seems likely that gene-copy-number changes, because of their much larg-
er sizes, are more likely individually to lead to diseases than the changes of one base pair to
another (e.g., AT→GC) along human chromosomes. Today, our best guess is that each
newly born individual contains 20–40 copy-number polymorphisms and some 300–400 sin-
gle-base-pair replacement insertions or deletions not present in either parent. At present, the
cost of finding all of an individual’s copy-number changes using DNA chips is 1000-fold less
expensive than using DNA sequencing to additionally find the many single-base-pair
changes not present in the parents’ DNA.
Before the human genome sequence was established, several microscopically visible
insertions and deletions (many million base pairs long) were shown to cause 1–2% of both
autism and schizophrenia. But because they invariably involved multiple numbers of genes,
the specific ones that cause autism or schizophrenia still remain unknown. More recently,
using new human-genome-dependent DNA chip technologies, Mike Wigler’s laboratory here
at Cold Spring Harbor has shown that duplications and deletions of much shorter lengths
are widely distributed over the 24 different human chromosomes. Through examining DNA
from some 500 affected children, Mike and Jonathan Sebat discovered that autism-associ-
ated copy-number variations create autism at multiple chromosome locations. To determine
the size of this universe of autism-causing genes, DNA from many thousands of such indi-
viduals must be examined. With the underlying “DNA chip” copy-number-finding technolo-
gy likely to remain near $1000 per human genome, and with the National Institutes of Health
effectively bankrupt, forthcoming large autistic gene searches will only be possible through
enlightened mega-philanthropic gifts such as those now coming to Cold Spring Harbor
Laboratory from Jim and Marilyn Simons.
Our success in discovering the DNA regions behind autism now encourages us to mount
a similar effort to determine the likely large universe of genes causing schizophrenia and
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bipolar disease. Already the first such search of some 500 victims’ DNA, funded by the
Lattner Foundation of Florida, has allowed CSHL investigators Jonathan Sebat and Sean
McCarthy to discover among victims of schizophrenia gene-copy variants not yet observed
in mentally healthy individuals. Most importantly, changes have already been observed in a
large number of genes, most of which code for proteins found in nerve cells. As with autism,
we will soon go on to examine the DNA of many thousands of schizophrenia and bipolar vic-
tims. The funds for much of this effort are already in hand thanks to the multiyear many-mil-
lion-dollar gifts from Ted and Vada Stanley.
Mike Wigler has gone on to conclude that most of the “bad” genes behind autism need
be present in only one copy in order to be expressed in boys. In contrast, most girls are
resistant to single copies, becoming carriers of autism—half of whose sons will be autistic.
Why most girls are resistant remains a total puzzle. We remain equally ignorant of how
schizophrenia runs in families. If one parent is schizophrenic, the probability of a child being
schizophrenic is only 10%. A possible explanation for this apparently low penetrance is that
many schizophrenia-predisposing genes must work in concert, say, in pairs, to be disease-
causing.
Alternatively, DNA changes that occur during embryonic development may either dimin-
ish or raise the probability that a disease-causing gene from a schizophrenic father or
mother expresses itself. “Epigenetic” chemical modification of the bases of DNA (e.g.,
methylation) occurring after birth are now frequently hypothesized to be at the heart of dis-
cordant-disease-pattern identical twins. Also to be seriously considered is whether much
hereditary schizophrenia, like hereditary cancer, is a two-hit phenomenon with an inherit-
ed nerve-cell-specific recessive gene coming from one parent, being complemented by a
second nerve-cell-specific mutation occurring early in embryonic development. According
to this hypothesis, lineage-specific clusters of malfunctioning neurons lead to mental insta-
bility by interrupting the function of key brain circuitry.
That so many different genes when changed in dosage or base-pair content lead to
autism, schizophrenia, or bipolar disease probably explains why these pernicious human
afflictions are so common. With several thousand different proteins likely underlying brain
function, its proper functioning can go wrong in so many ways. In contrast, the ability of
adults to digest lactose remains absent from most human populations because changes in
only several specific base pairs have the potential to generate lactase in adults. Whereas
most newly arising genes leading to autism are quietly selected out of the human gene pool,
this may not be true for genes leading to schizophrenia and bipolar disease, particularly if
most single copies act recessively and are not selected against.
Although full-blown schizophrenia and bipolar disease are not thought to be limited to
humans, it is not clear that we have observed sufficient numbers of chimpanzees or gorillas
in captivity to so diagnose them. Soon, the ever-lowering costs of DNA sequencing will allow
us to accurately measure the rates at which new mutations arise, not only in humans but also
in our close animal relatives. Conceivably, human success in colonizing so much of the
world’s environment has selected for a higher mutation rate than found in the chimpanzee,
whose life style may not have changed much over the past 5 million years. Although wildly
speculative, this way of reasoning explains why “the good God above” has let so much inher-
ent misery prevail today.
Arriving at an understanding of serious mental disease at the same advanced level that
we now comprehend cancer is likely to be a long arduous task requiring at least several
decades of sustained high-level science. As has been the case for cancer, an understand-
ing at the genetic level will be essential for any rational approach to better medicines.
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Fortunately, the tools—both physical and intellectual—are on hand for ultimate success at
the genetic level, but success will only prevail if we are able to expend large sums of money
over many years.
As soon as they are discovered, each of many human genes likely to cause schizophre-
nia, bipolar disease, and autism must be studied in appropriate mouse models. Happily,
there already exist several mouse models for the best known schizophrenia-associated
gene, DISC, whose identification arose from elegant chromosome observation made during
the past decade in David Porteous’ lab in Edinburgh. DISC is already being used to search
for new classes of antischizophrenic drugs.
Cold Spring Harbor Laboratory’s current capacity to be a major player in finding the genes
behind schizophrenia reflect the wisdom of its past Trustees in creating our Woodbury
Genome Center for high-technology science, a building whose machines and computers are
seemingly more conspicuous than its scientists. Our pursuit of mouse models for psychiatric
disorders will proceed in the buildings and animal facilities of our new Hillside Campus
scheduled to come on line about 1 year from now. Our decision to move ahead with this
major building endeavor so soon after 9/11 was much to our Trustees’ credit.
Forty years ago, I assumed the Directorship of this institution, believing that I could bring
it back to financial and intellectual vigor through focusing its research program on under-
standing cancer. Emphasizing cancer, I thought, would in no way diminish our long intellec-
tual commitment to pure science. To understand cancer cells, we would need to be simul-
taneously deeply knowledgeable about normal animal cells and understand how they
change through embryonic development. Today, in deciding to focus much of the Lab’s new
resources on the cognitive disorders of autism, schizophrenia, and bipolar disease, we must
understand the healthy brain and its extraordinary ability to perceive the outside world. In
many ways, we remain as ignorant of how our brain allows us to learn, remember, and think
as geneticists were about what the gene is and how it works before the Double Helix and
the Genetic Code came on the scene. Extraordinary new worlds of knowledge are out there
to be discovered.
I am now 10 days past 80. Focusing on making the important unknown known remains
my way to stay alive.
James D. Watson
Chancellor
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JOSEPH AND TITA MONTI
Cold Spring Harbor Laboratory is at the forefront of biomedical research and our dedicated investigators
continue to expand the boundaries of science. Financial support from friends makes this all possible. This
year, we mourned the passing of Joseph Monti and sadly remembered the loss of his beloved wife Tita
Monti just a year earlier. Together, they built the Don Monti Memorial Research Foundation in memory of
their son Don, who died of acute myeloblastic leukemia in 1972. CSHL was blessed by the generosity
of the Montis in 2006, when we formed an alliance to fund cancer research and established the Tita
Monti Cancer Research Laboratory, with the goal of funding better ways to help patients fight cancer.
In 2007, Joseph Monti died at the age of 88, after successful careers in the entertainment, restaurant,
hospitality, and real estate industries. But he was admired for so much more, including devotion to his
family, friends, and community. While most influential, he was a very gentle man who was loved by all
whom he touched. Mostly, he was a family man whose devotion to Tita, his children, and grandchildren
was apparent to all. He brought this same devotion to the family’s dream of alleviating the pain and suf-
fering caused by cancer. We express our deep condolences to their daughter Caroline Monti Saladino
who is the president of the Foundation, son Richard, and to their entire family and supporters. We appre-
ciate their continued inspiration. Through research, we will prevail over diseases and other causes of
human suffering.
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CANCER: GENE EXPRESSION AND PROLIFERATION
Gene Expression and Proliferation focuses on the regulation of gene expression, cell-division cycle con-
trol, and chromosome structure in normal and cancer cells.
Bruce Stillman’s lab studies the mechanism by which DNA is replicated within cells. Working with
yeast and human cells, Stillman and colleagues have identified many of the cellular proteins that func-
tion at the DNA replication fork during the S phase, the portion of the cell cycle when DNA synthesis
occurs. Among these are proteins that facilitate the assembly of chromatin, the “spools” around which
DNA wraps tightly for packing into the chromosomes. The lab has also focused on the means by which
chromatin assumes structural configurations that serve to propagate gene-expression information across
generations—an important aspect of epigenetics. The prime focus of current research is the mecha-
nism that initiates DNA replication in eukaryotic cells. At its heart is a protein that binds to “start” sites
on the chromosomes, called the origin recognition complex (ORC). Stillman has demonstrated that ORC
is also involved in the inheritance of centrosomes, the spatial control of DNA replication in the nucleus,
and the timing of chromosomal copying during S phase.
David L. Spector and colleagues study the spatial organization and regulation of gene expression.
Their in vivo approach is exemplified in a live-cell gene expression system that has made possible exam-
ination in real time of the recruitment of members of the gene expression and silencing machineries.
One of the lab’s current research foci is the distribution of polycomb proteins within the cell nucleus,
which are known to keep genes in a silent state. Spector’s team seeks to target them to segments of
DNA as a means of selectively silencing specific genes. The lab is also studying long noncoding RNA mol-
ecules retained in the cell nucleus. A small fraction of expressed RNAs actually encode for proteins.
Many of the other RNAs that are expressed are thought to perform yet undiscovered regulatory roles.
The lab is systematically screening and characterizing large, noncoding RNAs that sublocalize in the cell
nucleus with the ultimate goal of elucidating new mechanisms of regulating gene expression.
Leemor Joshua-Tor and her team are studying cell regulatory mechanisms, including protein com-
plexes involved in nucleic acid regulatory processes. They use X-ray crystallography to obtain three-
dimensional structures of individual proteins and atomic-level views of their interactions with other
molecules. Biochemistry and molecular biology tools enable them to study properties that can be cor-
related with protein structure and function. Joshua-Tor’s work on the helicase enzyme, which acts to
unwind DNA strands during the DNA self-replication process, reveals how single DNA strands pass
through structures called hexamer channels, and how DNA-binding hairpin structures collectively form
a spiral “staircase” that sequentially tracks the DNA backbone. The lab has also solved the structure of
a full-length protein called Argonaute, which they identified as Slicer, an enzyme that cleaves mRNA and
is central to the RNA interference machinery.
Understanding gene expression—the remarkable process by which genetic information encoded in
DNA is transcribed into strands of RNA, edited, and subsequently translated into proteins—is among the
fundamental pursuits of molecular biology. Adrian Krainer’s lab focuses on the posttranscriptional phase
of gene expression, in which precursor mRNA molecules are read by specialized protein and RNA com-
ponents, called splicing factors, that direct a molecular complex called the splicesosome to edit the
strand in extremely precise ways, preparatory to translation. The lab simultaneously probes mechanisms
of RNA splicing and ways in which they go awry in disease and the means by which faulty splicing can
be compensated for or corrected. They have obtained insights into the causation of certain cancers and
a potentially fatal neuromuscular disease called spinal muscular atrophy (SMA). Recently, they have stud-
ied pathways by which SF2/ASF, a splicing factor discovered in the lab, can transform cells. In SMA, they
focus on strategies to correct a flaw in the RNA-editing process called exon skipping that affects expres-
sion of the mutated SMN2 gene.
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Work in William Tansey’s lab follows from the intriguing observation, made by Tansey years ago, that
the destruction of transcription factors is tied to their ability to activate transcription. Transcription factors
are proteins that come into play when genes are expressed, involved early in the process by which genes
direct the cell to manufacture proteins. But why and how is this first step in the life of a protein function-
ally related to proteolysis, the very last step—the protein’s destruction by a molecular complex called the
proteosome? The key link, Tansey believes, is ubiquitin, a molecule with which proteins must be tagged
before they can enter the proteosome for destruction. Using a protein called Myc to study what happens
during ubiquitin-mediated proteolysis, the lab has found that it is targeted by ubiquitin in a manner con-
nected to its function. Overexpression of Myc is known to promote cancer. By “tagging” it with ubiquitin
for destruction, cells limit the chance that the potentially lethal protein will linger.
Cancer chemotherapy typically focuses on preventing metastatic spread, yet insights have been lack-
ing on how dormant metastatic lesions, after they have colonized distant organs, grow into large lethal
lesions. Vivek Mittal and colleagues are shedding new light on this progression to macrometastasis. They
study angiogenesis in the tumor microenvironment, which is composed of both malignant and nonma-
lignant cells. Among the latter are bone-marrow-derived endothelial progenitor cells, or EPCs, which,
Mittal has demonstrated, become involved selectively in tumor blood-vessel growth. Recently, Mittal’s
team has shown that progression from dormant to active metastasis is controlled by an angiogenic switch
turned on by bone-marrow-derived EPCs. Targeting the bone marrow compartment that gives rise to
these EPCs, perhaps in conjunction with chemotherapy, may prove to be an effective strategy in fight-
ing cancers in patients diagnosed after metastatic colonization has occurred.
Michael Myers seeks to understand how protein complexes regulate cellular behavior. Inside the cell,
the majority of proteins can be found in highly interactive networks. Their architecture and how they
change in response to the cellular environment are critical for the normal physiological functioning of the
cell. In fact, these networks are responsible for the robustness and adaptability of living cells. Perturba-
tions result in pathological conditions such as cancer and neurological disorders. Myers is using high-
throughput mass spectrometry to gain insights into protein interaction networks from a variety of normal
and pathological conditions.
Arne Stenlund and colleagues study the DNA replication properties of papillomaviruses, a large fam-
ily of viruses that induce cell proliferation at the site of infection. In most cases, the resulting tumors are
benign, but certain types of human papillomaviruses (HPVs) give rise to tumors that progress toward
malignancy, most notably cervical cancer. Stenlund’s group has obtained a detailed understanding of
processes required for initiation of DNA replication from the papillomaviruses, using this specific system
to gain a general biochemical understanding that is applicable in other systems. At the same time, they
pursue studies aimed at developing an effective small-molecule inhibitor of human papillomaviruses that
might someday be used by women who do not receive preventive anti-HPV vaccine or who are already
infected with HPV.
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We study the molecular basis of cell regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their interactions
with other molecules. Biochemistry and molecular biol-
ogy allow us to study properties that can be correlated
with protein structure and function. Our efforts largely
center on protein machines involved in nucleic acid reg-
ulatory processes.
DNA Translocation in a
Replicative Hexameric Helicase
E.J. Enemark
During DNA replication, two complementary DNA
strands are separated and each becomes a template for
the synthesis of a new complementary strand. Strand
separation is mediated by a helicase enzyme, a molec-
ular machine that uses the energy derived from ATP
hydrolysis to separate DNA strands while moving along
the DNA. Recently, we determined a crystal structure
of the replicative helicase E1 from papillomavirus
bound to single-stranded DNA and nucleotide mole-
cules at the ATP-binding sites.
Papillomaviruses are tumor viruses that cause benign
and cancerous lesions in their host. Replication of papil-
lomaviral DNA within a host cell requires the viral E1
protein, a multifunctional protein. E1 initially partici-
pates in recognizing a specific replication origin DNA
sequence as a dimer with E2, another viral protein. Sub-
sequently, further E1 molecules are assembled at the
replication origin until two hexamers are established.
These hexamers are the active helicases that operate
bidirectionally in the replication of the viral DNA. To
unwind DNA, helicases must separate the two strands
while moving along, or translocating, on the DNA. On
the basis of structures of the DNA-binding domain of
STRUCTURAL BIOLOGY OF NUCLEIC ACID REGULATORY
PROCESSES
L. Joshua-Tor C. Aksoy P.R. Kumar
J. Angiolillo T. Schalch
E. Enemark S. Smith
C. Faehnle N. Tolia
H. He
E1 bound to DNA that we determined a few years ago
in collaboration withArne Stenlund’s lab here at CSHL,
we suggested a mechanism for DNA strand separation.
However, the mechanism that couples the ATP cycle to
DNA translocation has been unclear.
The E1 hexameric helicase adopts a ring shape with
a prominent central channel. ATP-binding (and hydrol-
ysis) sites are located at the subunit interfaces, and mul-
tiple configurations are observed within the hexamer.
These have been assigned as ATP-type, ADP-type, and
apo-type. The configuration of the site for a given sub-
unit correlates with the relative height of its DNA-bind-
ing hairpin in the staircase arrangement. The subunits
that adopt an ATP-type configuration place their hair-
pins at the top of the staircase and the hairpins of apo-
type subunits occupy the bottom positions of the
staircase. The hairpins of the ADP-type subunits are
placed at intermediate positions.
A straightforward “coordinated escort” DNA-
translocation mechanism is inferred from the staircased
DNA binding and its correlation with the configuration
at the ATP-binding sites. Each DNA-binding hairpin
maintains continuous contact with one unique
nucleotide of single-stranded DNA and migrates down-
ward via ATP hydrolysis and subsequent ADP release
at the subunit interfaces.ATP hydrolysis occurs between
subunits located toward the top of the staircase, whereas
ADP release occurs between subunits located toward the
bottom of the staircase. The hairpin at the bottom of the
staircase releases its associated single-stranded DNA
phosphate to conclude its voyage through the hexam-
eric channel. Upon binding a new ATP molecule, this
subunit moves to the top of the staircase to pick up the
next available single-stranded DNA phosphate, initiat-
ing its escorted journey through the channel and repeat-
ing the process. For one full cycle of the hexamer, each
subunit hydrolyzes one ATP molecule, releases one
ADPmolecule, and translocates one nucleotide of DNA
through the interior channel. A full cycle, therefore,
translocates six nucleotides with associated hydrolysis
of six ATPs and release of six ADPs.
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Mechanisms of RNAi
N. Tolia, T. Schalch, C. Faehnle, C. Aksoy, S. Smith
[in collaboration with G.J. Hannon and R.A. Martienssen,
Cold Spring Harbor Laboratory; C. Mello, University of
Massachusetts; J. Partridge, St. Jude Children’s
Resesarch Hospital]
RNA interference (RNAi) has made an enormous impact
on biology in a very short period of time. Not only are we
still discovering new cellular pathways for the regulation
of gene expression that use these pathways, but RNAi
has also become an extraordinary useful and simple tool
for gene silencing. Almost from its beginnings, investi-
gators have used genetics, biochemistry, molecular biol-
ogy, and bioinformatics to study the mechanism of RNAi
and related pathways. We argued, however, that in order
to get a true mechanistic understanding of these path-
ways, we must understand how the components of the
RNAi machinery work at a molecular level. Therefore,
we embarked on structural and biochemical studies of
key proteins in the RNAi pathway.
During RNAi, long double-stranded RNA is processed
to yield short (~19–31 nucleotides) double-stranded
RNAs that trigger the RNAi response.These short RNAs
get incorporated into effector complexes called the RNA-
induced silencing complex (RISC), where in the mature
complexes a single-stranded RNA, the antisense strand
of the original double-stranded RNA, is retained in the
complex. This short interfering RNA (siRNAs or micro-
RNAs) then acts to guide the RISC complex to its target
through base complementarity. The best-characterized
pathway, and the one that is predominantly used for gene
knockdown technology, is a posttranscriptional gene
silencing (PTGS) pathway called “slicing.” Here, the
RISC complex is targeted to the mRNA and produces an
endonucleolytic cut in the mRNA target, thus preventing
gene expression from proceeding. Other RNAi silencing
pathways such as translational inhibition and transcrip-
tional gene silencing (TGS) are also mediated through
RISC complexes. In all cases, these complexes contain a
small single-stranded RNA and an Argonaute protein,
features that serve to define the RISC complex.
In solving the structure of a full-lengthArgonaute pro-
tein a couple of years ago, we showed that a characteris-
tic domain of these proteins, called the PIWI domain,
belongs to the RNase H family of proteins. This finding
was consistent with what was known about the bio-
chemistry of the “slicing” reaction (the endonucleolytic
cleavage of the mRNA by the RISC complex guided by
the siRNA). Mutating the key aspartates identified at the
active site to alanine in human Argonaute 2 abolished
slicing. We could also show that a large positively
charged groove along the protein could accommodate the
siRNA and target (mRNA) binding, with the scissile
phosphate at the active site. This was done by placing the
3′ end of the siRNA in a cleft of another characteristic
domain, called the PAZ domain, in accordance to our
previous results about 3′-end recognition by the PAZ
domain as well as results from other laboratories.
Since then, we were able to produce recombinant
humanArgonaute 2, the onlyArgonaute in human cells
able to carry out slicing, in an organism that lacks
RNAi, namely, Escherichia coli. Together with Greg
Hannon’s laboratory here at CSHL, we showed that all
that is needed to carry out slicing is an activeArgonaute
protein and an siRNA. This also enabled us to specifi-
cally examine what features of the effector step of RNAi
reside inArgonaute in combination with the siRNA and
what features must come from other components of
RISC or perhaps other steps in the pathway.
We have been examining several Argonaute family
members and found that the sole Argonaute protein in
Schizosaccharomyces pombe is an active slicer. Impor-
tantly, together with Rob Martienssen’s group here at
CSHL, we showed that slicing is required for TGS in S.
pombe.
We were also able to better define the active site of the
Argonautes, as there are some unique aspects different
from those of other RNase H enzymes. We have identi-
fied a third clade of theArgonaute family that is different
from theArgonauteArgonautes and the PiwiArgonautes,
whichwe named theGroup-3Argonautes.These appear to
be specific to worms—Caenorhabditis elegans and C.
briggsae—and consist predominantly of nonslicing Arg-
onautes, meaning that they do not have an intact catalytic
motif. Together with Craig Mello, we have shown that a
group of secondary Argonaute proteins in C. elegans
which act in a separate downstream silencing step belong
to the nonslicingArgonautes of this third clade. These act
following the initial trigger step that does require slicing,
carried out by the well-characterized primary Argonaute
RDE-1 in the exo-RNAi pathway or following the primary
Argonaute ERGO-1 in the endo-RNAi pathway in worms.
NADP Regulates the Yeast
GAL Induction System
P.R. Kumar [in collaboration with S.A. Johnston, Arizona State
University; R. Sternglanz, Stony Brook University]
Transcriptional regulation of the galactose metabolizing
genes in Saccharomyces cerevisiae depends on three core
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proteins: Gal4p; the transcriptional activator that binds
to upstream activating DNA sequences (UASGAL);
Gal80p, a repressor that binds to the carboxyl terminus of
Gal4p and inhibits transcription; and Gal3p, a cytoplas-
mic transducer which upon binding galactose and ATP
relieves Gal80p repression. The current model of induc-
tion relies on Gal3p sequestering Gal80p in the cyto-
plasm. However, the rapid induction of this system
implies that there is a missing factor. To understand the
molecular mechanism of theGAL regulatory system, we
have determined the structure of S. cerevisiae Gal80p
with the activation domain of Gal4p.
The crystal structures of Gal80p reveal a three-domain
architecture with an amino-terminal domain consisting
of a Rossmann fold, normally associated with binding of
NAD(P) cofactors. The carboxy-terminal domain con-
sists of a large β-sheet that forms an extensive dimer
interface with another monomer (Fig 1). A large cleft is
apparent between these two domains. A smaller third
domain, located between the amino- and carboxy-termi-
nal domains, consists of three small β-strands and a helix
that resemble a set of fingers at the entrance of the cleft.
Gal80p dimers form tetramers in both crystal forms.
When we soaked a crystal of Gal80pS0:P21 (a 21-amino-
acid peptide that contains the conserved region of the car-
boxy-terminal activation domain of Gal4p) with the
dinucleotide NAD, the structure revealed that NAD binds
to both monomers of Gal80p in the cleft formed by the
Rossmann fold. We were also able to observe extra den-
sity corresponding to the P21 peptide. The peptide
appears to interact with the nicotinamide portion of the
dinucleotide. NAD nestles between Gal80p and Gal4p,
making several key interactions with Gal80p.
In vitro pull-down assays of Gal80p with purified
recombinant GST-Gal4p containing the acidic activation
domain (AD), in the presence of NAD and NADH
showed no change in binding for either of these two din-
ucleotides. However, when NADP and NADPH were
used, a clear reduction in binding is observed with
increasing concentrations of NADP. Alterations in the
NAD(P)-binding site affect the initial rate ofGAL induc-
tion in vivo, but not overall final expression levels. It
appears that NAD might facilitate Gal80p binding to
Gal4p, since we could only identify Gal4p-AD with
NAD bound, and NADP destabilizes this interaction.The
mutations, affecting both NAD and NADP binding,
would therefore disrupt both the stabilizing effect of
NAD and destabilizing effect of NADP with a net result
of faster induction for the mutants compared to wild type.
Although we do not understand precisely how this
trigger for GAL regulation functions, nor the involve-
ment of NADP versus NAD, we speculate that switch-
ing the cell to a fermentable galactose medium causes a
change in NADP/NADPH or NADP/NAD ratios in the
cell, and Gal80p effectively senses the metabolic state of
the cell. NADP might be acting as a “second messen-
ger” in triggering the system.Alternatively, Gal80p may
function as an oxidoreductase enzyme, actively con-
verting NADPH to NADP in the presence of a substrate
causing it to disassociate from Gal4p.
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FIGURE 1 Two views of the Gal80pS0-Gal4AD-NAD dimer. (Gray
ribbons) Gal80p; the Gal4p-AD peptide and NAD in sticks. Dis-
ordered regions are shown as a dashed coil. The β-sheet regions
of the carboxy-terminal domains form an extensive dimeric inter-
face.
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MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE-MRNA SPLICING
RNA splicing is required for correct expression of most
eukaryotic protein-coding genes. The spliceosome
selects authentic splice sites with very high fidelity, rely-
ing on limited sequence information present throughout
introns and exons. In humans, about 75% of genes are
expressed via alternative splicing, giving rise to multi-
ple protein isoforms. The choice of alternative splice
sites is commonly regulated to alter gene expression,
either tissue-specifically or in response to a develop-
mental program or to signaling pathways. The fact that
multiple protein isoforms can be expressed from indi-
vidual genes demonstrates that the classical “one gene—
one enzyme” paradigm is no longer valid and provides
an explanation for the unexpectedly small number of
genes uncovered by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well as
RNA components that are part of small nuclear ribonu-
cleoprotein (snRNP) particles. The work in our lab
focuses on the identification and molecular characteri-
zation of protein factors and sequence elements that are
necessary for the catalysis and fidelity of splicing and/or
for the regulation of alternative splice site selection.We
are interested in how the spliceosome correctly identi-
fies the exons on pre-mRNA, and how certain point
mutations in either exon or intron sequences cause aber-
rant splicing, leading to various human genetic diseases.
Related areas of interest include the remodeling of
mRNP architecture as a consequence of splicing, which
influences downstream events, such as nonsense-medi-
ated mRNA decay (NMD); the role of alternative splic-
ing misregulation in cancer; and the development of
effective methods to correct defective splicing or mod-
ulate alternative splicing. A summary of some of our
recently published studies is provided below.
A SPLICING-FACTOR ONCOGENE
Alternative splicing has an important role in cancer,
partly by modulating the expression of many oncogenes
and tumor suppressors, and also because loss-of-
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function mutations that affect alternative splicing of var-
ious tumor suppressor genes account for some of the
inherited and sporadic susceptibility to cancer.We tested
the hypothesis that some of the factors that regulate
alternative splicing events are causally involved in can-
cer; this work was done in collaboration with David Mu
and Scott Lowe here at CSHL. We found that the splic-
ing factor SF2/ASF and its antagonist hnRNP A1 are
up-regulated in different sets of human tumors. In the
case of SF2/ASF, this is sometimes due to increased
copy number of its gene, SFRS1. SFRS1 resides on
chromosome 17q23, a region frequently amplified in
breast cancer. Using retroviral transduction, we showed
that slight overexpression of SF2/ASF is sufficient to
transform immortal rodent fibroblasts, which form
high-grade sarcomas in nude mice. The increased
expression of SF2/ASF modulates the sensitivity to
apoptotic stimuli and increases cell proliferation. In
addition, SF2/ASF overexpression results in activation
of downstream components of the PI3K/Akt/mTOR and
Ras/MAPK signaling pathways, i.e., phosphorylation of
S6K1 and eIF4E, respectively, bypassing upstream sig-
naling. As expected from its biochemical activities,
SF2/ASF overexpression affects alternative splicing of
transcripts frommany endogenous genes, including sev-
eral tumor suppressors and oncogenes. One of the key
targets is S6K1 pre-mRNA, resulting in increased
expression of an unusual isoform of this kinase with
oncogenic activity. shRNA-mediated down-regulation
of either SF2/ASF or the novel S6K1 isoform is suffi-
cient to reverse the transformed phenotype caused by
SF2/ASF overexpression in vitro and in vivo, indicat-
ing that SF2/ASF has a role in tumor maintenance.
These findings demonstrate that an alternative splicing
factor, SF2/ASF, can act as an oncoprotein by modulat-
ing alternative splicing of critical target genes and is a
potential target for cancer therapy.
ANTISENSE-CORRECTION OF SPLICING
DEFECT IN SMA
Spinal muscular atrophy (SMA) is a neurodegenerative
genetic disorder caused by the deletion or mutation of
38
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the survival-of-motor-neuron gene, SMN1. An SMN1
paralog, SMN2, differs by a C to T transition in exon 7
that causes substantial skipping of this exon, such that
SMN2 expresses only low levels of functional protein.
We continue to explore strategies to increase the extent
of exon 7 inclusion during splicing of SMN2 transcripts,
for eventual therapeutic use in SMA. One of our strate-
gies involves the use of antisense oligonucleotides
(ASOs), in collaboration with Frank Bennett (Isis Phar-
maceuticals). ASOs that target an exon or its flanking
splice sites typically promote exon skipping. However,
when we systematically tested a large number of ASOs
with a 2′-O-methoxy-ethyl ribose (MOE) backbone that
hybridize to different positions of SMN2 exon 7, we
identified several that promote greater exon inclusion,
others that promote exon skipping, and still others that
were neutral. This approach provides positional infor-
mation about presumptive exonic elements or secondary
structures with positive or negative effects on exon
inclusion. The ASOs are effective not only in cell-free
splicing assays, but also when transfected into cultured
cells, where they affect splicing of endogenous SMN
transcripts. The ASOs that promote exon 7 inclusion
increase full-length SMN protein levels, demonstrating
that they do not interfere with mRNA export or transla-
tion, despite hybridizing to an exon.
We then tested overlappingASOs complementary to
the flanking intronic regions, covering 60 nucleotides
upstream or downstream from exon 7. As with the
exonicASOs, we classified them into positive, negative,
and neutral with respect to their effects on exon 7 inclu-
sion. Several of the positive ASOs were very potent
when tested in cell-free splicing or in transfected cells,
defining silencer regions in both flanking introns. We
also tested them in transgenic mice that ubiquitously
express human SMN2 (Fig. 1).After intravenous admin-
istration, MOE ASOs are efficiently internalized by
cells in peripheral tissues, and they are imported into
the nucleus, where they can modulate gene expression.
We observed efficient correction of the splicing defect
in liver and kidney mRNA, and weaker correction in
skeletal muscle. There was no correction in spinal
cord—the tissue we need to target for SMA therapy—
because the ASOs do not cross the blood-brain barrier.
Therefore, in the future, we will explore methods for
direct administration to the central nervous system.
The above experiments show that ASO tiling is a
powerful method to map cis-acting elements that influ-
ence alternative splicing. To explore the mechanism of
action of the silencer element in intron 7—which was
first identified by Ravindra Singh and colleagues (Uni-
versity of Massachusetts Medical School,Worcester)—
we introduced point mutations and assayed splicing of
the resulting minigenes in transfected cells. Combined
with splicing-factor overexpression and biochemical
experiments, this analysis demonstrated that the intron
7 splicing silencer is recognized by the splicing repres-
sor hnRNPA1 and other closely related members of the
hnRNPA/B family.
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FIGURE 1 Correction of SMN2 splicing defect by antisense
oligonucleotide in transgenic mouse liver. (A) Diagram of the rele-
vant portion of human SMN2 pre-mRNA. The sequence at the 5′
end of intron 7 is shown. Two weak hnRNP A1 motifs that form an
intronic splicing silencer are underlined. The position where a com-
plementary antisense oligonucleotide (ASO 10–27) hybridizes to
the pre-mRNA is shown by a horizontal bar. (B) MOE oligonu-
cleotides were administered to hSMN2 transgenic mice via the tail
vein, twice a week, at 25 mg/kg. 00–00 is a random-sequence,
negative-control oligonucleotide. Each oligonucleotide, or saline,
was administered to eight mice, and the livers were harvested after
1, 2, 3, or 4 weeks of treatment (two mice each). Total RNA was
extracted and radioactive reverse-transcriptase polymerase chain
reaction (RT-PCR) carried out with a pair of hSMN2-specific
primers. Radiolabeled PCR products were analyzed by native
PAGE. The positions of the spliced mRNAs corresponding to exon
7 inclusion or skipping are indicated. (C) The gels shown in Bwere
quantitated on a phosphorimager. The histogram shows the
extent of exon 7 inclusion in response to each treatment.
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CHARACTERIZATION OF SPLICING FACTORS
Splice sites with weak matches to the consensus
sequences are common, although it is not clear how
such sites are efficiently utilized. Using an in vitro splic-
ing-complementation approach, we identified PUF60 as
a factor that promotes splicing of an intron with a weak
3′ splice site. PUF60 has homology with U2AF65, a gen-
eral splicing factor that facilitates 3′ splice site recogni-
tion at the early stages of spliceosome assembly. We
demonstrated that PUF60 can functionally substitute for
U2AF65 in vitro, but splicing is strongly stimulated by
the presence of both proteins. Reduction of either
PUF60 or U2AF65 in cells by RNA interference alters
the splicing pattern of certain endogenous transcripts,
consistent with the idea that regulation of PUF60 and
U2AF65 levels can dictate alternative splicing patterns.
Thus, it appears that recognition of 3′ splice sites
involves different U2AF-like molecules and that modu-
lation of these general splicing factors can have pro-
found effects on splicing.
We also characterized a protein phosphatase involved
in pre-mRNA splicing. Several kinases and phosphatases
participate in pre-mRNA splicing regulation, but their
precise roles and the identities of their cofactors and sub-
strates remain poorly understood.We showed previously
that the human Ser/Thr phosphatase PP2Cγ promotes
spliceosome assembly.We have now shown that PP2Cγ’s
distinctive acidic domain is essential for its activity in
splicing and interacts withYB-1, a spliceosome-associ-
ated factor. Moreover, PP2Cγ is a phosphoprotein in
vivo, and its acidic domain is phosphorylated under
splicing conditions in vitro. PP2Cγ phosphorylation
enhances its interaction withYB-1 and is reversed by the
phosphatase in cis. PP2Cγ knockdown leaves constitu-
tive splicing unaffected, but it inhibits cell proliferation
and affects alternative splicing of CD44 pre-mRNA, a
knownYB-1 target. This effect on splicing regulation is
mediated by PP2Cγ’s acidic domain, which is essential to
promote inclusion of CD44 exons v4 and v5 in vivo.We
proposed that PP2Cγ modulates alternative splicing of
specific pre-mRNAs coregulated byYB-1.
SR proteins are essential splicing factors with one or
two RNA-recognition motifs (RRMs) and a carboxy-ter-
minal Arg/Ser-rich (RS) domain. SR proteins bind to
exonic splicing enhancers (ESEs) via their RRM(s) and
are thought to promote splicing by antagonizing splic-
ing silencers, recruiting other components of the splic-
ing machinery through RS-RS domain interactions,
and/or promoting RNA base pairing through their RS
domains.We previously reported that the RS domain of
the SR protein SF2/ASF is dispensable for in vitro splic-
ing of some pre-mRNAs. In collaboration with
Gourisankar Ghosh (University of California, San
Diego), we have now extended these findings by iden-
tifying a short inhibitory domain in SF2/ASF; deletion
of this amino-terminal segment permits splicing in the
absence of this SR protein’s RS domain of an IgM pre-
mRNA substrate previously classified as RS-domain-
dependent. Splicing of this pre-mRNA with SF2/ASF
lacking its RS domain still requires an ESE, suggesting
that an SR protein RS domain is not always required for
ESE-dependent splicing activation. These data provide
additional evidence that the SF2/ASF RS domain is not
strictly required for constitutive splicing in vitro, con-
trary to prevailing models for how the domains of SR
proteins function to promote splicing.
SPLICE-SITE RECOGNITION, GENOMICS,
AND GENETICS
In collaboration with Michael Zhang’s group here at
CSHL, we characterized a novel class of splice sites
called dual-specificity splice sites. These splice sites can
be alternatively recognized as either 5′ or 3′ splice sites,
and they match a composite of canonical 5′ and 3′ splice
site consensus sequences, with a CAG|GURAG core.
The relative use of a dual site as a 5′ or 3′ splice site can
be accurately predicted by assuming competition for
specific binding between spliceosomal components
involved in recognition of 5′ and 3′ splice sites, respec-
tively. Dual-specificity splice sites exist in humans and
mice, and possibly in other vertebrate species, although
most sites are not conserved, suggesting that their evo-
lutionary origin is recent.
We continued to analyze the specificity of 5′ splice
site recognition and the relationship between 5′ splice
site mutations and genetic diseases. In many cases, muta-
tions can disrupt splicing even though they do not disrupt
the match to the splice site consensus. In collaboration
with Ravi Sachidanandam here at CSHL, we used com-
parative genomics, i.e., large-scale data sets of splice
sites from five different genomes, to identify pairwise
dependencies between individual nucleotides of the 5′
splice site as a conserved feature of the entire set of 5′
splice sites. These dependencies are also conserved in
human-mouse pairs of orthologous 5′ splice sites. Many
disease-associated mutations disrupt these dependencies,
as can some human single-nucleotide polymorphisms
(SNPs) that appear to alter splicing, suggesting that 5′
splice site SNPs have a role in complex diseases.
We participated in other related studies at the inter-
face among splicing, informatics, and human genetics.
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A collaborative study of NF1 splicing mutations from
neurofibromatosis type-1 patients with Katharina Wim-
mer (Universitat Wien) helped to derive predictive rules
for the outcome of mutations that disrupt 5′ splice sites.
A database of aberrant 5′ splice sites in human disease
genes was constructed and analyzed in collaboration with
IgorVore˘chovsky´ (University of Southampton School of
Medicine) and Emanuele Buratti (ICGEB, Trieste).
Another collaborative study with Dr. Brage Andresen
(Aarhus University Hospital) showed that a missense
mutation in exon 5 of the medium-chain acyl-CoA dehy-
drogenase (MCAD) gene that causes skipping of the exon
in the context of MCAD deficiency by inactivating an
ESE can be suppressed by an SNP that inactivates a
nearby exonic splicing silencer. This finding illustrates
that the phenotypic effects of splicing mutations need to
be assessed in the context of the relevant haplotype.
REMODELING OF SPLICED MRNP BY EIF4A3
Pre-mRNA splicing not only removes introns and joins
exons to generate spliced mRNA, but also results in
remodeling of the spliced mRNP, influencing various
downstream events, such as NMD (nonsense-mediated
decay). This remodeling includes the loading of an
exon–exon junction complex (EJC). To test whether
EJC assembly or EJC components are required for pre-
mRNA splicing, we immunodepleted the EJC core com-
ponent eIF4A3 from HeLa cell nuclear extract and
found that eIF4A3 is dispensable for pre-mRNA splic-
ing in vitro. However, we found that eIF4A3 is required
for the splicing-dependent loading of the Y14/Magoh
heterodimer onto mRNA. Surprisingly, the loading of
six other EJC components was not affected by eIF4A3
depletion, suggesting that their binding to mRNA
involves different or redundant pathways. Finally, we
found that the assembly of the EJC onto mRNA occurs
at the late stages of the splicing reaction and requires
the second-step splicing and mRNA-release factor
HRH1/hPrp22, a DExD/H-box type RNA helicase and
RNA-dependentATPase. The EJC-dependent and -inde-
pendent recruitment of RNA-binding proteins onto
mRNA suggests a role for the EJC in mRNP remodel-
ing involving interactions with other proteins already
bound to the pre-mRNA, which has implications for
NMD and other mRNA transactions.
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The microenvironment dictates the neoplastic potential
of a growing tumor. For example, it influences the pro-
liferation rate of the tumor, determines its metastatic
potential and location of metastatic disease, and, most
importantly, impacts the outcome of therapy. Therefore,
its not surprising that several drugs targeting various
components of the tumor microenvironment have suc-
cessfully made their way into clinical trials.
For instance,Avastin, a humanized monoclonal anti-
body targeting vascular endothelial growth factor
(VEGF), has been approved by the FDA and used in the
treatment of metastatic colorectal cancer in combina-
tion with standard chemotherapy. Similarly, other
antiangiogenic drugs such as combretastatin, which is a
vascular disruptive agent; VEGF-Trap-decoy receptors
that are VEGF antagonists; and R1 and R2 antibodies
that antagonize VEGF receptors are also in various
phases of clinical trials. The kinase inhibitor Gleevac
has also met FDA approval; it targets the pericyte com-
ponent of the microenvironment via its ability to block
the platelet-derived growth factor receptor (PDGF-R)
kinase. Inhibitors targeting other components of the
tumor microenvironment such as of fibroblasts and the
extracellular matrix (ECM) are also in the pipeline.
The bone marrow (BM) contributes significantly to
tumor progression.Although the BM-derived hematop-
oietic progenitor cells promote tumor angiogenesis via
the release of proangiogenic factors or by creating per-
missive conditions in the tumor microenvironment that
favor the growth of locally derived blood vessels, the
endothelial progenitor cells (EPCs) are believed to pro-
vide an alternative source of endothelial cells that lumi-
nally incorporate into nascent blood vessels as bona fide
endothelial cells. The BM also contributes in the initia-
tion of metastasis. Malignant primary tumors bookmark
sites in target organs by establishing viable premetasta-
tic niches comprising BM-derived VEGF-R1+ and
CD11b+ hematopoietic progenitor cells. These niches
provide permissive local microenvironments for recruit-
ing the incoming tumor cells, leading to the initiation
and establishment of micrometastases. The existence of
a BM reservoir of progenitor cells, and their selective
involvement in tumor neovascularization, metastasis ini-
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tiation, and progression has attracted considerable inter-
est because these cells represent novel targets for thera-
peutic intervention.
In my laboratory, we are using a multidisciplinary
approach to investigate the cellular and molecular mech-
anisms governing the contribution of hematopoietic
stem cells (HSCs) and EPCs in tumor growth, metasta-
sis initiation, and progression. In the last few years, we
have systematically addressed these issues by using a
powerful combination of mouse genetic models, func-
tional genomics, and BM transplantation (BMT)
approaches. Using this strategy, we demonstrated the
biological role of EPCs in angiogenesis-mediated tumor
growth and showed that ablation of one critical and spe-
cific component of the tumor microenvironment is a
feasible approach for preventing tumor growth.We have
extended our analysis of primary tumors toward eluci-
dating the progression of metastatic lesions and have
demonstrated that a second angiogenic switch underlies
the progression of avascular lung micrometastases to
vascular macrometastases. Importantly, ablation of
EPCs did not affect initial colonization by metastatic
cells but markedly impaired their progression into
macroscopic lesions as a consequence of reduced neo-
vascularization.
In the 2006 Annual Report, we had indicated our
progress in unraveling hierarchies of the endothelial lin-
eage in vivo, so that genome-wide analysis of gene
expression, microRNA expression, and epigenetics
could be performed. This analysis would determine how
the niche microenvironment regulates the balance
between cellular self-renewal and differentiation and,
importantly, how tumors influence migration of EPCs
out of the niche and how EPCs recruited to early tumors
differentiate into mature endothelial cells and luminally
incorporate into nascent neovessels. In this context, we
have already optimized fluorescence-activated cell sort-
ing (FACS) of specific populations, mRNA amplifica-
tions, and microarray hybridization.
Gene expression analysis has begun to reveal inter-
esting themes. For example, we have observed that
undifferentiated EPCs express more proangiogenic fac-
tors such as VEGF, PDGF, collagenase, and various
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chemokines; however, once they differentiate and incor-
porate into vessels, these proangiogenic factors are
down-regulated and negative regulators (TSP1, CD36,
angiopoietin) of angiogenesis are up-regulated. In addi-
tion, the involvement of neuronal guidance pathways
such as Netrin-Neogenin, EphrinB2-B4, Semaphorin-
Plexin D1, and Robo-Slit that have a role in vascular
patterning were also revealed in the gene expression
profiling analysis.
To understand the roles of these potential candidate
genes in vivo, we have investigated into EPC-specific
promoters that could be used to express transgenes in
EPCs in vivo. We have analyzed the promoters of these
genes (Id1, VEGF-R2, and VE-cadherin) for their abil-
ity to mark EPCs in vivo. The proximal promoters were
cloned into a lentivirus and used to drive two fluores-
cent markers (red and green fluorescent proteins). Of
these, the Id1 promoter was found to specifically mark
EPCs in the early BM, peripheral blood, and the tumor.
We have investigated whether the exquisite property of
the Id1 promoter to mark EPCs can be exploited for
cell-specific ablation or generating loss of EPC func-
tion. The Id1 promoter was used to drive a suicide gene,
herpes simplex virus thymidine kinase (HSV-TK).
Administration of ganciclovir specifically ablated EPCs
in TK BMTmice. EPC ablation impaired tumor growth
associated with reduced vessel density. In another pow-
erful approach, we have used RNA interference (RNAi)
for suppressing the expression of EPC-specific genes
(e.g., Id1 andVEGF-R2) in vivo. Suppression of Id1 or
VEGF-R2 in EPCs resulted in mobilization defects and
impaired angiogenesis-mediated growth of tumors. Col-
lectively, our results suggest that these promoters are
useful reagents to investigate EPC function in vivo.
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The completion of the human genome has ushered in a
new age of biological discovery. This accomplishment
has essentially identified all of the players governing
human biology. The important work of assigning func-
tions to this myriad of proteins has become one of the
principal tasks of modern biology.Although many func-
tions will be assigned using genetics or bioinformatics,
the majority of this functional characterization will be
performed by proteomics.
The goal of our laboratory is to understand how pro-
teins and protein complexes regulate cellular behavior.
In the environment of a cell, almost all of the proteins
can be found in a highly interactive network. These net-
works govern the complex cellular responses to both
normal and pathological stimuli. My laboratory is
focused on understanding the global architecture of this
network and how this network generates robustness
(error tolerance) and adaptability to the system and how
this network is altered to produce and survive complex
diseases, such as cancer.
Optimization of Protein Identification
R. Bish, O. Fregoso, D. Perkowski
Protein identification is the major tool of proteomics.
We have been optimizing mass spectrometry (MS) for
protein identification. MS has many advantages over
other techniques for protein identification, especially its
sensitivity. However, the improved sensitivity comes at
a price, as the sample preparation becomes increasingly
important to ensure success.We have optimized a num-
ber of parameters to increase this success rate.
One of the key steps of optimization is to minimize
the time and number of operations between the biolog-
ical sample and the mass spectrometer. Therefore, we
have developed a number of streamlined protocols for
coupling common purification techniques, principally
immunoprecipitation, to mass spectrometry (IP-MS).At
the heart of these techniques is the ability to digest the
sample directly from single-step affinity purifications.
This provides a decrease in the number of processing
steps and improves the recovery of the sample, as the
PROTEOMICS
M. Myers R. Bish
O. Fregoso
D. Perkowski
resulting peptides are more easily recovered than most
proteins. Immunoprecipitations are an ideal purification
strategy, because intact antibodies are resistant to pro-
teolysis. Using this protocol, we have been able to rap-
idly analyze complexes formed by a number of proteins
involved in signal transduction, the DNA-damage
response, and tumorigenesis. The increased sensitivity
of this approach has also resulted in a large increase in
the number of posttranslational modifications typically
identified per experiment.
Although the direct trypsinization of single-step
affinity purifications has many applications, it often can-
not be used for characterizing complex posttranslational
modifications that function in a scaffolding role. This is
due to the “contamination” of other proteins containing
the same/similar modifications. Therefore, we have
developed a tandem affinity purification scheme that
incorporates a denaturing step. The first nondenaturing
step is used to isolate the protein complex, and the pro-
tein complex is eluted from the affinity resin using a
strongly denaturing buffer.A second affinity step is then
used to purify the target protein away from noncovalently
bound proteins, as well as from proteins, which bind
nonspecifically during the first affinity step. As in the
single affinity step purification, the sample is recovered
from the second affinity step using proteolysis. This
denaturing tandem affinity purification (DTAP) has
proven to be ideally suited to characterizing ubiquitina-
tion and other complex posttranslational modifications.
Identification of an Ubiquitin-binding
Zinc Finger Involved in
DNA-damage Repair
R. Bish, O. Fregoso
DNA damage elicits a signaling cascade that results in
cell cycle arrest and recruitment of the DNA-repair
machinery to sites of DNA damage. Importantly, polyu-
biquitin chains have an important role in this recruit-
ment. In fact, BRCA1, a gene identified from hereditary
forms of breast cancer, is a critical factor for DNA repair
and it functions as an ubiquitin ligase. Interestingly,
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BRCA1 elaborates a specific form of polyubiquitin, K6-
linked chains. However, the substrates and effectors of
this chain are unclear. Therefore, we used IP-MS to iden-
tify potential BRCA1 effectors by identifying proteins
that are associated with K6-linked polyubiquitin chains.
This resulted in the identification of WHIP (Werner’s
helicase interacting protein).We have localized the ubiq-
uitin-binding domain ofWHIP to an amino-terminal zinc
finger. Importantly, four other human proteins (poly-
merase κ, polymerase η, Rad18, and UBZ1) contain
similar zinc finger domains, and we have demonstrated
that all five domains bind polyubiquitin.
Similarly to most ubiquitin-binding proteins, WHIP
is also ubiquitinated. Using DTAP, we have character-
ized the ubiquitination of WHIP and have found that it
contains a mixture of K48-, K63-, and K11-linked ubiq-
uitin chains, which is the first in vivo demonstration of
this type of mixed ubiquitination. Interestingly, the ubiq-
uitination of WHIP is responsive to DNA damage, as
UV irradiation results in the rapid increase of WHIP
polyubiquitination.
Importantly, the yeast homolog ofWHIP, MGS1, has
previously been implicated in having a role in DNA
repair following UV damage. Using IP-MS, we have
found WHIP to be in a larger network of DNA-repair
proteins, includingWerner’s helicase, ERCC1, ERCC4,
and the human RuvB homolog. Furthermore, WHIP-
GFP (green fluorescent protein) fusion proteins appear
to be localized to repair foci. Taken together, these data
indicate that WHIP has a role in DNA-damage repair.
Therefore, four of the five proteins containing ubiquitin-
binding domains similar to those of WHIP are now
known to be involved in DNA damage (WHIP, poly-
merase κ, polymerase η, and Rad18).
The restriction of a class of ubiquitin-binding domains
to a single cellular task is highly unusual. Therefore, we
are testing whether the remaining protein, UBZ1, also
has a role in DNA damage. In fact, IP-MS data indicate
that UBZ1 has a role in DNA-damage repair, as it is
found in a complex with ubiquitinated proliferating cell
nuclear antigen (PCNA), the completeWerner’s helicase
complex (WRN, Ku70, Ku80, and DNA-PK), and the
complete Bloom’s helicase complex (BLM,Topo 3a, and
BLAP75). Importantly, UBZ1 also undergoes ubiquiti-
nation in response to UV irradiation and is recruited to
repair foci. The ubiquitination of UBZ1 is also regulated
by UV irradiation, but unlikeWHIP, the polyubiquitina-
tion of UBZ1 decreases following UV irradiation. These
data indicate that, like WHIP, UBZ1 has a role in DNA-
damage repair. The molecular role of WHIP and UBZ1
in DNA-damage repair is currently being explored.
Genomic Tagging of Mammalian
Proteins in Somatic Cells
O. Fregoso
Both the single-affinity purification and denaturing tan-
dem-affinity purifications are highly flexible and can be
adapted to overexpressed and native proteins. However,
we have found that the use of epitope tags (FLAG, HA,
MAT, etc.) produce higher-quality mass spectra, largely
due to the uniformity and reproducibility of the affinity
resins. Unfortunately, in mammalian cells, this usually
requires the overexpression of the target protein, which
can lead to any number of artifacts. Genomic tagging
of proteins has proven to be a powerful tool in charac-
terizing protein complexes in yeast. However, this type
of genomic tagging has proven to be extremely difficult
in mammalian somatic cells.
Using adeno-associated virus (AAV), we have been
developing a strategy to epitope-tag proteins in the
mammalian genome. AAV can be used to direct the
site-specific integration of the epitope tag into the
genome. The targeting requires about 1 kb of flanking
homologous sequence. This tagging strategy relies on
infections at high multiplicity, and many nonhomolo-
gous integrants are expected to occur, which will be dif-
ficult to select against using current selection schemes.
Therefore, we have developed a novel selectable marker
for use in epitope tagging that uses an intein to couple
the marker to the translation, rather than the transcrip-
tion, of the targeted protein. This results in at least a
sixfold enrichment of targeted alleles over transcrip-
tion-coupled (IRES)-based strategies. In fact, transfec-
tion with a GFP-intein-puro construct, followed by
puromycin selection, results in more than 97% GFP-
positive cells. We are currently engineeringAAV to tar-
get members of the PARP (poly[ADP-ribose] poly-
merase) gene family.
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Most cellular processes can trace their beginnings to the
nucleus where a gene is activated, resulting in the pro-
duction of an RNA molecule that must get processed
and transported to the cytoplasm. Although much bio-
chemical information is available regarding many of the
factors involved in gene expression, the spatial and tem-
poral aspects of gene expression and the dynamics of
the nuclear domains that the gene expression machin-
ery occupies are less well-understood. During the past
year, we have focused on two main areas: (1) examining
the dynamics of gene expression/repression in living
cells and (2) characterizing the role of noncoding RNAs
in regulating gene expression.
The Dynamics of Gene
Expression/Repression
M. Hübner, R.I. Kumaran, J. Li, T. Nakamura, R. Thakar,
M. Yuan, R. Zhao
Much of our efforts during the past year relate to char-
acterizing the spatial and temporal aspects of gene
expression/repression. Our studies have utilized a cell
line (U2OS 2-6-3), previously developed in our labora-
tory, that contains a transgene stably integrated as a 200-
copy array in human chromosome 1p36 (Janicki et al.,
Cell 116: 683 [2004]). This cell system allows us to
directly visualize gene expression (DNA, RNA, protein)
within the context of a living cell. During the past year,
we have developed additional lines that also stably
express other proteins of interest, for example, the large
subunit of RNA polymerase II (RNA pol II LS) fused to
enhanced yellow fluorescent protein (EYFP) and lamin
B1 fused to mCherry (a mutant red fluorescent protein).
The stable expression of the aforementioned proteins
allows us to study the dynamics of gene expression dur-
ing the cell cycle. Using four-dimensional live-cell
microscopy, we have analyzed the specific timing of the
dissociation/association of the transcription machinery
with a specific genetic locus upon entry into and exit
frommitosis.We have found that RNA pol II LS starts to
leave the locus between 0 and 6 minutes before nuclear
CELL BIOLOGY OF THE NUCLEUS
D.L. Spector Y.-C.M. Chen R.I. Kumaran R. Thakar
Y. Fang J. Li J. Wilusz
S. Hearn T. Nakamura M. Yuan
M. Hübner H. Sunwoo R. Zhao
lamina disassembly. At the end of mitosis, RNA pol II
enters daughter nuclei between 2 and 6 minutes after
nuclear lamina reassembly. However, RNA pol II LS is
recruited to the genetic loci within the daughter nuclei
between 0 and 8 minutes postnuclear entry. Studies are
currently under way to determine whether other mem-
bers of the gene expression machinery (i.e., capping fac-
tors, pre-mRNA slicing factors, and polyadenylation
factors) are recruited to the locus in daughter nuclei con-
comitantly with RNA pol II or if they exhibit an ordered
recruitment of individual proteins or subcomplexes.
To address the effect of nuclear position on gene acti-
vation, we developed an inducible live-cell system in
which the position of the genetic locus can be targeted
from a more internal nuclear region to the nuclear
periphery in mammalian cells. Targeting was achieved
by the expression of a lamin B1 fusion protein. Inter-
estingly, the mechanism of targeting of the locus to the
nuclear periphery required one round of cell division
and nuclear reassembly. Once targeted, the locus
remained anchored to the nuclear periphery in inter-
phase as well as in daughter cells following passage
through a subsequent mitosis. Upon transcriptional
induction, components of the gene expression machin-
ery were recruited to the targeted locus, and nascent
transcripts were visualized at the nuclear periphery. The
kinetics of transcriptional induction at the nuclear lam-
ina was similar to that observed at an internal nuclear
region. This new cell system is a powerful tool to study
the dynamics of gene function at the nuclear periphery
during normal physiology and in disease states, such as
envelopathies, in living cells.
In addition to examining the role of the nuclear
periphery in gene activation/silencing, we have also
been interested in the silencing of endogenous genes by
polycomb (PcG) proteins. Polycomb proteins are asso-
ciated with regions of facultative heterochromatin, and
members of the PRC1 or maintenance complex are
present in PcG bodies. These bodies colocalize with
chromatin enriched in histone H3 di- and trimethylated
at lysine 27 (H3K27). We were interested in determin-
ing whether the induction of this histone mark at a spe-
cific chromosomal site triggers the de novo formation of
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a PcG body at that site. To induce H3K27 methylation
at the reporter locus, we targeted the PRC2 complex
member EZH2, which has previously been shown to
possess histone methyl transferase activity toward
H3K27, to the locus. We were able to show that this
fusion protein leads to efficient H3K27 trimethylation at
the locus. Importantly, this resulted in the colocalization
with the locus of theYFP-tagged PcG body marker pro-
tein Bmi1.A catalytically inactive EZH2 protein lacking
the SET domain, however, does not lead either to
H3K27 trimethylation or to PcG body formation at the
locus. We next investigated whether the PcG body per-
sists at the locus after removal of EZH2. To this end, we
used an EZH2 fusion protein containing the tetracy-
cline-inducible trans-activator (tTA)-binding protein.
This fusion protein allows us to remove EZH2 from the
locus within 2 minutes of doxycycline administration.
We found that the PcG body persists at the locus in the
absence of EZH2 for at least 8 hours.
We are currently investigating if the histone mark and
PcG body are inherited to the daughter cells during cell
division. We also wanted to determine if the newly
formed PcG body has an inhibitory effect on the tran-
scriptional inducibility of the locus. To this end, we
quantified in single cells the MS2-YFP signal at the
locus after induction with doxycycline. We found that
the tethering of EZH2 to the locus significantly inhib-
ited the transcriptional inducibility of the locus. In con-
clusion, we have developed several in vivo approaches
to examine the dynamics of gene expression/silencing in
living cells. Ongoing studies will elucidate the underly-
ing principles of these dynamics and how they can be
manipulated in vivo to regulate gene expression.
Identification and Characterization of
Nuclear Retained Noncoding RNAs
H. Sunwoo, J. Wilusz
Although it has been generally assumed that most
genetic information is expressed as and transacted by
proteins, recent evidence from genomic tiling arrays and
large-scale cDNA cloning projects suggests that the
majority of the transcriptional output of the mammalian
genome represents RNA that does not code for proteins.
These noncoding RNAs include microRNAs, Piwi-
interacting RNAs (piRNAs), and small nucleolar RNAs
(snoRNAs), as well as a significant number of longer
transcripts, most of whose functions are unknown.
These longer transcripts probably do not simply repre-
sent transcriptional “noise” because many have been
shown to exhibit cell-type-specific expression, local-
ization to specific subcellular compartments, and asso-
ciation with human diseases. Therefore, the big and
largely unanswered question that we are trying to
address is: What are the functions of these long non-
coding RNAs?
In collaboration with J. Mattick’s laboratory (Uni-
versity of Queensland, Brisbane, Australia) we have
examined noncoding RNAs (ncRNAs) whose expres-
sion levels change after mouse C2C12 myoblasts dif-
ferentiate into myotubes. RNA FISH (fluorescence in
situ hybridization) analysis of candidate clones revealed
one clone that showed an exclusive nuclear retention of
the ncRNA in a punctate distribution pattern. This pat-
tern corresponded to paraspeckles, a recently identified
nuclear domain whose function is unknown. Clone 22
encodes a 3.2-kb poly(A)+ RNA transcript that is
broadly expressed in adult mouse tissues and conserved
among mammals. Microarray data indicated that this
RNA is 4.6-fold more highly expressed in myotubes
than in myoblasts, suggesting its potential function dur-
ing differentiation. Interestingly, the same locus pro-
duces a longer 19-kb ncRNA by alternative 3′-end
formation in addition to the 3.2-kb transcript. This
longer ncRNA is also retained in the nucleus and local-
ized to paraspeckles where it is indistinguishable from
Clone 22. Ongoing studies are examining the mecha-
nism by which these ncRNAs are retained in the nucleus
and their potential function in myoblast differentiation.
MALAT1 is a long ncRNA that was originally iden-
tified as a transcript whose expression predicted metas-
tasis of non-small-cell lung tumors and was
subsequently shown to be overexpressed in many human
cancers (for review, see Prasanth and Spector 2007).We
have identified a highly conserved small (~60
nucleotide) ncRNA that originates from the MALAT1
locus and is broadly expressed in normal human tissues.
In contrast to the stable long MALAT1 transcript that
localizes to nuclear speckles, the approximately 60-
nucleotide RNA exclusively localizes to the cytoplasm
and has a short half-life (and thus we have named it
mascRNA, MALAT1-associated small cytoplasmic
RNA). mascRNA appears to represent a novel class of
small RNAs based on its size and because it does not
function as a microRNA precursor.
We propose that 3′-end processing of MALAT1 via
a previously uncharacterized mechanism generates the
mascRNA transcript. MALAT1 can generate two long
transcripts (~6.7 kb and ~7 kb in mouse) that differ in
the location of their 3′ ends. Cleavage/polyadenylation
can occur to yield the longer approximately 7-kb
MALAT1 isoform, but this isoform is expressed at a
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very low level in cells. Instead, MALAT1 3′-end for-
mation almost always occurs several hundred
nucleotides upstream of the polyadenylation signal (to
yield an ~6.7-kb isoform in mouse) via a mechanism
that is in stark contrast to classic cleavage/polyadenyla-
tion. A single cleavage event downstream from a
genomically encoded poly(A)-rich tract defines the 3′
end of the abundant approximately 6.7-kb MALAT1
transcript and the 5′ end of the mascRNA transcript.
This mechanism allows a short poly(A) tail-like moiety
to be present on the 3′ end of the abundant MALAT1
transcript. In support of this model, antisense oligonu-
cleotides complementary to the mascRNA region inhib-
ited MALAT1 upstream 3′-end processing (resulting in
an accumulation of the ~7-kb transcript) and reduced
mascRNA expression. Our findings reveal a novel 3′-
end processing mechanism by which a single locus can
yield both a stable nuclear retained ncRNA and a small
cytoplasmic ncRNA.
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The papillomaviruses are a group of viruses that infect
and transform the basal epithelium, inducing prolifer-
ation of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents one of the few
firmly established links between viral infections and
the development of cancer.
An impediment to the study of papillomaviruses has
been the inability to define simple in vitro cell culture
systems for analysis of the viral life cycle. These viruses
normally require specialized differentiating cells that
only with difficulty can be generated in cell culture.
However, for bovine papillomavirus (BPV-1), a con-
venient cell culture system exists where viral gene
expression, oncogenic transformation, and viral DNA
replication can be studied. Thus, BPV has become a use-
ful model for these aspects of the viral life cycle.
The DNA replication properties of the papillo-
maviruses show some unique and interesting character-
istics. As part of their normal life cycle, these viruses
can exist in a state of latency, which is characterized by
maintenance of the viral DNA as a multicopy plasmid in
infected cells. The copy number of the viral DNA is
tightly controlled and the viral DNA is stably inherited
under these conditions. Papillomaviruses therefore pro-
vide a unique opportunity to study plasmid replication
in mammalian cells. In addition, the viral DNA replica-
tion machinery represents one of the most promising
targets for antiviral therapy.
In previous years, we have reported the characteriza-
tion of the papillomavirus replicon and the identification
of the viral components that are required for viral DNA
replication. In recent years, we have directed our atten-
tion toward the biochemical events that are associated
with initiation of DNA replication. We are studying the
biochemical properties of the viral E1 and E2 proteins
and how these two proteins interact with the viral origin
of DNA replication and with the cellular replication
machinery to generate initiation complexes. Our studies
demonstrate that the E1 protein has all the characteristics
MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
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of an initiator protein, including ori recognition, DNA-
dependent ATPase activity, and DNA helicase activity.
The transcription factor E2, whose precise function has
remained more elusive, appears to serve largely as a
loading factor for E1. Through direct physical interac-
tions with both E1 and the ori, E2 provides sequence
specificity for the formation of the initiation complex.
We are currently attempting to elucidate how the E1
and E2 proteins orchestrate the precise biochemical
events that precede initiation of DNA replication at the
viral ori. These events include binding of the initiator to
the ori, the initial opening of the DNA duplex (melting),
and the assembly and loading of the E1 replicative heli-
case at the replication fork. Our studies so far indicate
that these activities are generated in an ordered process
that involves the sequential assembly of E1 molecules
on the ori. This sequential assembly generates different
complexes with different properties that in turn recog-
nize ori, destabilize the double helix, and function as the
replicative DNA helicase.
ADJACENT RESIDUES IN THE CONSERVED E1
INITIATOR β-HAIRPIN DEFINE DIFFERENT ROLES OF
THE β-HAIRPIN IN LOCAL ORI MELTING, HELICASE
LOADING, AND DNA HELICASE ACTIVITY
The mechanism through which local ori melting is
achieved is not understood for any replicon. As
reported previously, we have recently identified a spe-
cific form of the papillomavirus E1 initiator protein
that is associated with local ori melting. This form, a
double trimer (DT), is a required precursor for the dou-
ble hexameric (DH) helicase and forms in the presence
of ATP. On the basis of mutational analysis of the heli-
case domain of the E1 protein, a specific structural ele-
ment, a β-hairpin, is specifically required both for the
formation of the DT and for template melting. Muta-
tion of H507 at the tip of the β-hairpin to alanine results
in loss of both DT formation and ori melting.
To determine the specific role of this residue, we
substituted histidine with a wide range of residues,
including A, V, L, R, N, M, F, and Y and tested these
mutant E1 proteins for DNA replication in vivo and in
vitro. In vivo DNA replication assays demonstrated that
only H507F had significant replication activity. DNA
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replication assays in vitro, however, showed that both
H507F and H507Y had activity similar to that of the
wild-type protein, whereas the rest of the substitutions
lacked activity.
To determine at which step in initiation of DNA
replication the H507 has an essential role, we tested the
H507 substitutions in a variety of assays that we have
developed. By the electrophoretic mobility-shift assay
(EMSA), we determined that the wild-type E1, H507F,
and H507Y could form the DT complex. However, only
the wild-type E1 and H507F could form the double
hexameric (DH) helicase. Because of the location of
the β-hairpin on the inside surface of the hexameric
ring, we also tested all of the mutants for DNA helicase
activity. Although we could observe slight (about
twofold) differences in helicase activity of some H507
substitutions compared to wild-type E1, a helicase
defect is not responsible for the replication defect of
these substitutions because H507F, which is the only
mutant with wild-type replication activity, had among
the lowest activities. In contrast, mutation of the neigh-
boring residue, K506, resulted in complete loss of DNA
helicase activity, demonstrating that this particular
residue is required for the helicase.
These results provide a clear demonstration that the
β-hairpin is directly involved in both local ori melting
and helicase activity of E1 and that mutation of neigh-
boring residues distinguishes between these two activ-
ities. H507 is required specifically for local ori melting,
whereas the adjacent residue, K506, is required for both
local melting and DNA helicase activity. Consistent
with these results, an alignment of known SF3 helicases
demonstrates that K506 is well-conserved in both papo-
vavirus and parvovirus, in agreement with the impor-
tance of this residue for the helicase activity of these
proteins. In contrast, H507 is only conserved in the
papovavirus group. This distinction between the papo-
vavirus and parvovirus groups is consistent with the
fact that papovaviruses have double-stranded DNA
(dsDNA) genomes, whereas the parvoviruses have sin-
gle-stranded DNA (ssDNA) genomes and therefore do
not require a local ori melting activity.
These results now provide an explanation for how the
local melting activity and the helicase activity are
linked. In the DT, which initially melts the dsDNA, the
β-hairpin, and specifically H507, is involved in melting
the dsDNA, most likely through a direct interaction with
the DNA. As the DNA is melted, additional E1 mole-
cules are recruited to the complex, and as the helicase is
formed, K506 in the β-hairpin now contacts the ssDNA
in the helicase. This scheme provides an explanation for
the transition between the local ori melting activity and
the helicase activity and provides a novel mode of heli-
case loading in that the E1 helicase, in essence, loads
itself through the DT precursor, which melts the DNA
template.
ATP-DEPENDENT MINOR GROOVE RECOGNITION OF
T-A BASE PAIRS IS REQUIRED FOR TEMPLATE MELTING
BY THE E1 INITIATOR PROTEIN
Although local ori melting is an essential process in all
organisms, surprisingly, little information is available
about the process and the types of activities that perform
the melting. For many years, it has been known that in
prokaryotes, the protein DnaA is responsible for ori
melting, although the mechanism is not understood. In
eukaryotes, no activity has been identified that melts the
ori in preparation for DNA replication. Viral initiator
proteins such as the E1 protein from papillomaviruses
have long been known to be responsible for local ori
melting, as detected by oxidation of un-base-paired T
residues in the ori, although the mechanism is not
known. To define the local ori melting process, we have
examined this process in detail, including the sequence
dependence for local melting. We have determined that
local melting is not a single event but consists of several
events that happen in sequence. All of these events are
carried out by a double trimer (DT) of E1.
The helicase domain in the E1 protein specifically
recognizes a stretch of six T-A base pairs that flank the
E1-binding site. This recognition occurs in the minor
groove and results in local melting of the six T-A base
pairs.As expected from this result, the sixT-A base pairs
are also essential for formation of the double hexamer
(DH), for unwinding of the ori, and for DNA replica-
tion in vivo. In addition to melting of the six T-A base
pairs, which likely results from a direct interaction
between the E1 β-hairpin and the six T-A base pairs, the
six T-A base pairs also direct melting 5–6 base pairs
away from the T-A base pairs, toward the E1-binding
site. This melting is likely generated by interaction of
the oligomerization domain in E1 and the DNA (Fig. 1).
These events account for melting of about 15 base pairs
on each side of the E1-binding site. The E1-binding site
is clearly melted by a different mechanism, most likely
by the untwisting of the DNA by the two trimers.
Together, these data suggest a simple model for how E1
may be able to melt large regions of DNA using simple
means. One consequence of the dual interactions of
each E1 molecule with DNA is that each interaction
need only be responsible for melting of a few base pairs
because a total of 6 E1 molecules and 12 interactions
are involved in melting in the E1 DT.
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FIGURE 1 Model for how multiple E1 DNA interactions generate
large-scale melting. The E1 molecules in the DT bind in a helical
arrangement, wrapping around the DNA duplex. Each E1 mole-
cule contacts DNA in two positions, separated by one-half turn of
the helix. These contacts correspond to distal and proximal T-
dependent melting, respectively. Together, these six contacts
account for the approximately 15–18 base pairs of permanganate
reactivity observed in the left half of the ori. For clarity, only two of
the three staggered E1 molecules are shown.
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Research continues to focus on the mechanism of initi-
ation of DNA replication in cells from eukaryotes and
how specific states of gene expression are inherited
from one cell generation to the next. In rapidly prolifer-
ating cells, such as cancer cells, the process of dupli-
cating the cellular chromosomes begins soon after the
chromosomes are separated during mitosis. Previous
research has demonstrated that four proteins, the origin
recognition complex (ORC), Cdc6, Cdt1, and the
minichromosome maintenance (MCM) proteins, are
required for establishing a pre-replicative complex (pre-
RC) at sites along the chromosomes, many of which are
destined to become origins of DNA replication in the S
phase of the cell division cycle, the phase when DNA
synthesis occurs.
DEFINING ORIGINS OF DNA REPLICATION
During the last few years, much of our focus has been
on investigating the detailed interaction between ORC
and Cdc6, the very first step in the process of initiating
DNA replication. Although ORC binds to many sites in
the yeast genome, it does not solely determine the loca-
tion of origins because many ORC-binding sites are not
origins and ORC does not bind to all predicted origin
DNA sequences. Studies in past years have shown that
Cdc6 contributes to origin specificity and later cooper-
ates with ORC and Cdt1 to load the MCM proteins onto
the DNA, thereby creating competent pre-RCs for sub-
sequent initiation. ORC and Cdc6 combine to form a
ring-shaped complex that contains six AAA+ subunits.
ORC and Cdc6 ATPase mutants are defective in MCM
loading and ORC ATPase mutants have reduced activ-
ity in ORC–Cdc6–DNA complex formation.
Last year, the role of the Cdc6 ATPase on ORC–
Cdc6 complex stability was examined in the presence
or absence of specific DNA sequences. The Cdc6
ATPase was activated by ORC; it regulated ORC–Cdc6
complex stability, and Cdc6 ATPase activity was sup-
pressed by certain DNA sequences with the functional
origin DNA. Mutations in the conserved origin
sequences that are required for initiation of DNA repli-
cation induce Cdc6 ATPase activity and prevent stable
DNA REPLICATION AND CHROMATIN INHERITANCE
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N. Kara S.G. Prasanth P. Wendel
ORC–Cdc6 association with the DNA. By analyzing
ORC–Cdc6 complex stability on various DNAs, it was
demonstrated that specific DNA sequences control the
rate of Cdc6 ATPase, which in turn controls the rate of
Cdc6 dissociation from the ORC–Cdc6–DNA complex.
On the basis of these and previous data, a mechanism
was proposed explaining how Cdc6ATPase activity pro-
motes origin DNA sequence specificity: On DNA that
lacks origin activity, Cdc6 ATPase promotes dissocia-
tion of Cdc6 from the ORC bound to the DNA. Fur-
thermore, origin DNA down-regulates Cdc6 ATPase
activity, resulting in a stable ORC–Cdc6–DNA com-
plex, which can then promote MCM loading, a process
that requires Cdc6ATPase activity. This model for Cdc6
ATPase having a dual role in determining origin loca-
tion in the DNA has obvious relevance for origin speci-
ficity in higher eukaryotes.
THE STRUCTURE OF ORC
To determine in detail how the process of assembly of
the DNA replication apparatus occurs on chromosomes,
we began structural studies on ORC and the ORC–Cdc6
complex. Previous studies using single-particle recon-
struction of ORC from electron micrographs, in collab-
oration with Huilin Li’s group at Brookhaven National
Laboratory (BNL), have shown that ORC consists of a
multi-lobed complex that binds Cdc6 to form a ring-
shaped structure. In the past year, we devised a molec-
ular tagging procedure that attaches the Escherichia coli
maltose-binding protein (MBP) to either the amino or
carboxyl terminus of each of the five largest ORC sub-
units and purified all ten possible ORC complexes.
Electron microscopy of the purified ORC–MBP com-
plexes and two-dimential projections of the ORC–MBP
particles allowed the location of the MBP density to be
determined and hence the location of the termini of each
of the five largest ORC subunits within the ORC struc-
ture. Consistent with the studies on reconstitution of the
human ORC, the structure of yeast ORC showed that
the Orc2 and Orc3 subunits were adjacent to each other
and formed the base of the ORC structure. The Orc4 and
Orc5 subunits also formed a subdomain in the middle of
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ORC. The Orc1 subunit was located adjacent to the
Orc4 and Orc5 subunits and seemed to form a lobe on
the top of ORC. The location of Orc6, the only subunit
not tagged with MBP, was determined by comparing the
structures of ORC containing all six subunits with a
structure of the Orc1,2,3,4,5 complex lacking Orc6.
Orc6 localized adjacent to the Orc2,3 subdomain at the
base of ORC. This structural information is being used
to identify how ORC associates with DNA, how ATP
controls the function of ORC, and how ORC interacts
with DNA and other DNA replication proteins.
DYNAMICS OF ORIGIN RECOGNITION
IN HUMAN CELLS
Unlike in yeast cells, where ORC is a stable complex
throughout the cell division cycle and appears to be
bound to origins at all times, the dynamics of ORC
throughout the human cell division cycle is very differ-
ent. ORC is composed of six subunits and in contrast to
other eukaryotic initiators examined thus far, ORC in
mammalian cells is assembled and disassembled in a
cell-cycle-dependent manner.Assembly of human ORC
in vitro was found to be dependent on ATP binding to
the Orc4 and Orc5 subunits, because mutations in the
ATP-binding sites of Orc4 or Orc5 impaired complex
assembly. In contrast, Orc1 ATP-binding was not
required for ORC assembly. Immunofluorescence stain-
ing of human cells with anti-Orc3 antibodies demon-
strated cell-cycle-dependent association with a nuclear
structure. Immunoprecipitation experiments showed
that ORC disassembled as cells progressed through S
phase. ORC then reassembled during late mitosis and
early G1 phase. These data suggested that the assembly
and disassembly of ORC in human cells are uniquely
regulated and may contribute to restricting DNA repli-
cation to once in every cell division cycle.
The largest subunit of ORC, Orc1, was shown to be
degraded during the G1- to S-phase transition. To follow
up on this observation, the dynamics of Orc1 during the
cell division cycle was investigated. Time-lapse live-cell
images of human cells expressing fluorescently tagged-
Orc1 revealed a dynamic nuclear localization pattern
during G1 phase. Later during S phase, the MCM heli-
case proteins and proliferating cell nuclear antigen
(PCNA), a DNA replication fork protein, displayed
sequential waves of spatiotemporal patterns similar to
those of Orc1 in G1. In vivo labeling studies revealed
spatial overlap between the Orc1 distribution in G1 and
DNA replication patterning from cells pulse-labeled
with bromodeoxuridine or fluorescent dNTP during the
previous S phase.
These results suggest that the dynamic distribution
of Orc1 during G1 phase might pattern the nucleus for
subsequent events in S phase that lead to both spatial
and temporal control of DNA replication. In mammalian
cells, chromosomal domains occupy a specific nuclear
position and replicate at defined times during the S
phase of the cell division cycle. Thus, the spatiotempo-
ral pattern of DNA replication within a given cell type
is heritable and is linked to developmentally regulated
gene expression. The studies on Orc1 dynamics may
have uncovered a fundamental link between the organ-
ization of DNA replication and events that determine
when loci are activated during cell lineage specification.
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Ubiquitin (Ub)-mediated proteolysis is a process in
which covalent attachment of Ub to target proteins sig-
nals their destruction by the 26S proteasome. The con-
trolled destruction of proteins by this system is used to
fine-tune the levels of proteins within the cell, allows
cells to rapidly alter their protein composition in
response to particular signals, and provides rigorous
control and directionality to processes such as the cell
cycle. Our particular interest centers on how Ub-medi-
ated proteolysis regulates gene transcription. In recent
years, a body of evidence has accumulated suggesting
that the Ub–proteasome system (UPS) is directly
involved in the regulation of gene activity.We are inter-
ested in understanding how the UPS regulates tran-
scription and the consequences of this regulation for the
control of cell growth in normal and cancer cells.
Research in our laboratory is divided in two areas.
To study the basic processes that connect the transcrip-
tion and Ub systems, we perform biochemical and
genetic experiments using the baker’s yeast Saccha-
romyces cerevisiae as a model system. To understand
the biological significance of the intersections between
these systems, we study the human oncoprotein tran-
scription factor Myc.
REGULATION OF MYC
Myc is a basic helix-loop-helix leucine-zipper tran-
scription factor that features prominently in the control
of cell growth. Capable of acting as both a transcrip-
tional activator and repressor, Myc controls the expres-
sion of genes required for cell growth and division.
Consistent with the type of genes that it regulates, Myc
is also is a major human oncoprotein that features in a
variety of human cancers including leukemia, lym-
phoma, breast, colon, and lung cancer. It is estimated
that altered Myc expression or activity contributes to
about 70,000 cancer deaths in the United States each
year—about one third of all cancer fatalities.
Like many transcription factors, particularly those
involved in the control of cell growth, Myc is an unsta-
ble protein that is destroyed by Ub-mediated proteolysis.
THE UBIQUITIN–PROTEASOME SYSTEM AND CONTROL OF
TRANSCRIPTION IN NORMAL AND CANCER CELLS
W.P. Tansey A. Chakraborty R. Graf S. Salghetti
G. Collins D. Khalil D. Simpson
A. Daulny J. Kurland L. Wang
F. Geng A. Leung
Previous work in our laboratory has revealed that the
destruction of transcription factors such as Myc is fre-
quently connected to their ability to activate transcrip-
tion. Specifically, we have found that the same domain in
these proteins that allows them to activate transcription
is responsible for their destruction. We have also found
that, in some cases, transcription factors need to engage
the Ub system and become ubiquitylated in order to
function. This intimate connection between transcription
factor activity and turnover has two important ramifica-
tions. First, it predicts that components of the ubiquitin–
proteasome system will be directly and intimately
involved in the control of gene expression. Second, it
reveals that if we study the destruction of transcription
factors, we can learn not just about activator proteolysis,
but also about activator function. Thus, we believe that
by probing the mechanisms through which Myc is
destroyed by the UPS—the elements involved, the cel-
lular players that control Myc turnover, and the pathways
that govern Myc stability—we can also gain new insight
into how this enigmatic human oncoprotein functions.
Our current research is focused on exploiting the
connection between activity and turnover to learn more
about howMyc regulates gene expression programs rel-
evant to oncogenic transformation. Much of our work
is focused on the highly conserved elements within Myc
known as “Myc boxes” (Mb). The first two Myc
boxes—MbI and MbII—are within the transcriptional
activation domain of Myc and have been extensively
characterized for their contribution to Myc activity and
instability. More recently, however, we have turned our
attention to another highly conserved element within
Myc, “MbIII,” that we have found contributes to Myc
destruction and also has a critical role in Myc’s ability
to regulate apoptosis and oncogenic transformation in
vitro and in vivo. Although MbIII was first noted more
than 20 years ago, it has not been studied extensively.
Our finding that MbIII is an important part of the Myc
protein has provided us with an opportunity to probe
novel aspects of Myc function.
Focus on MbIII has centered on its contribution to
Myc-driven target gene regulation. We have found that
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MbIII is largely dispensable for the ability of Myc to
activate gene activity but is important for its ability to
repress Myc target genes. To understand the mechanism
through which MbIII contributes to repression, we have
used chromatin immunoprecipitation (ChIP) analysis to
probe transcriptionally relevant events that are modu-
lated by Myc in an MbIII-dependent manner. This
analysis has revealed an extensive role for histone
deacetylation in Myc-mediated gene repression. We
find that repression of Myc target genes such as Id2 and
Gadd153 is associated with a loss of histone H4 acety-
lation.We also find that repression of both genes can be
reversed by either deletion of MbIII or treatment of cells
with histone deacetylase (HDAC) inhibitors, suggesting
that active deacetylation of H4, mediated via MbIII, is
important for Myc-driven repression. To determine
which HDACs are responsible for this repression, we
screened a panel of short-hairpin RNA (shRNAs)
directed against each of the relevant HDACs. This
analysis revealed that HDACs 3 and 4 are involved in
repression of the Id2 andGadd153 genes, an interesting
result because both HDACs function in a common com-
plex.We have confirmed the relevance of the functional
data by showing that Myc interacts with HDAC3 and
recruits it to chromatin, all of which occurs in a MbIII-
dependent manner. These results reveal that one mech-
anism through which Myc represses transcription is via
HDAC recruitment; an exciting finding because this is
a previously unanticipated mode of Myc-mediated
repression, and because HDAC inhibitors are showing
promise in the clinic for the treatment of certain human
cancers. In the future, we will probe how Myc interacts
with HDACs, examine the contribution of this interac-
tion to oncogenesis, and ask whether Myc is a relevant
downstream target of therapeutic HDAC inhibition.
REGULATION OF TRANSCRIPTION BY THE UPS
Our original observation of the tight relationship
between transcriptional activation and Ub-mediated
destruction of transcriptional activators predicted that, at
some level, components of the Ub–proteasome system
would be involved in transcriptional regulation. During
the past several years, work from a number of groups,
including our own, has supported this prediction. For
example, we have found that Ub ligases can be recruited
to sites of transcription, where they perform essential
steps in gene activation, including driving postinitiation
changes in the entourage of RNA-polymerase-
interacting proteins. Other groups have found that Ub
ligases can promote coactivator exchange at promoters
in vivo, as well as targeting stalled RNA polymerases
for destruction to clear the path for successful gene tran-
scription following DNA-damage-mediated transcrip-
tional arrest. Moreover, ubiquitylation of histones has
been linked to transcriptional repression and shown to
participate in the regulation of covalent patterns of his-
tone modifications. Our ongoing studies in this area
continue to focus on the role of activator ubiquitylation,
but we are also studying ubiquitylation of RNA poly-
merase and histones and the relationship between the
Ub system and pre-mRNA processing.
We are particularly interested in understanding how
histone ubiquitylation influences the transcriptional sta-
tus of chromatin. In S. cerevisiae, the prototypical his-
tone ubiquitylation event involves H2B, which has a
single Ub group attached to a lysine residue 123 (K123)
within the protein. Monoubiquitylation of H2B at this
site is involved in a number of processes including acti-
vation of gene expression, gene silencing, and mitosis.
A few years ago, we showed that ubiquitylation of H2B
at K123 is also required for recruitment of proteasome
subunits to chromatin, which in turn promotes SAGA
(Spt-Ada-Gcn5-acetyltransferase) coactivator recruit-
ment and histone H3 methylation. Interestingly, the pro-
teasome binds only weakly to mono-Ub moieties,
suggesting that recruitment of proteasome subunits to
chromatin is indirectly modulated by histone monoubiq-
uitylation or that perhaps the ubiquitylation status of
H2B is more complex than previously thought.
To address the latter issue, we used a directed
approach to probe the extent of H2B ubiquitylation in
yeast cells. This analysis resulted in the surprising dis-
covery that H2B is extensively polyubiquitylated (Fig.
1). Polyubiquitylation of H2B occurs within the context
of chromatin and is not associated with H2B destruc-
tion. We have found that there are at least two distinct
modes of H2B polyubiquitylation: One that occurs at
K123 and depends on the Rad6/Bre1 ubiquitylation
machinery, and another that occurs on multiple lysine
residues and is catalyzed by an uncharacterized ubiqui-
tin ligase(s). Interestingly, we also find these ubiquity-
lation events are under the influence of different
combinations of Ub-specific proteases, suggesting that
they have distinct biological functions. These results
raise the possibility that the biological effects of ubiq-
uitylation of H2B are exerted via ubiquitin chains, rather
than a single Ub group. Our future research in this area
will aim at identifying the cellular machinery responsi-
ble for these noncanonical ubiquitylation events, delin-
eate the effects of the different Ub chains and linkages,
and determine how the poly-Ub chains we describe on
H2B contribute to proteasome subunit interaction with
chromatin.
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FIGURE 1 Histone H2B is polyubiquitylated. Yeast cells were engi-
neered to express either His-tagged wild-type or mutant (K48R or
K63R) nonremovable (G76A) ubiquitin, together with either Myc-
tagged (lane 1) or HA-epitope-tagged H2B (lanes 2–5). Cells were
lysed, and HA-tagged proteins present in the total lysate (“input”)
or His-purified (“Ni-NTA”) material were detected by western blot.
The position of free H2B is indicated, as is the position of the H2B-
Ub conjugates. Note that the monoubiquitylated form of H2B-HA
appears as a doublet in the input; we presume that this corre-
sponds to H2B-HA that is monoubiquitylated with either endoge-
nous Ub (lower band) or the slightly larger His-Ub.
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CANCER: GENETICS
Cancer Genetics focuses on understanding the genetic basis of cancer, cancer progression, and devel-
opment of resistance to chemotherapy.
Michael Wigler’s group uses comparative genome hybridization (CGH) analysis to study cancer and
human genetic disorders. Their method, a microarray-based technique called ROMA (representational
oligonucleotide microarray analysis) that arose from an earlier technique called RDA (representational dif-
ference analysis), reveals copy-number variations (CNVs), the deletions and duplications which underlie
cancer, many genetic disorders, and evolution. A variant called MOMA (methylation-specific oligonu-
cleotide microarray analysis), developed with Rob Lucito, is used to explore the role of DNA methylation
in cancer and genetics. The group focuses on breast cancer and leukemias with the aim of pinpointing
genes that cause cancer and discovering mutation patterns that predict treatment response and out-
come. With Jonathan Sebat, they have focused on autism, showing that spontaneous mutation has a
far greater role in that disorder than previously suspected. Together with Kenny Ye, they have developed
a new theory of autism’s genetic basis that explains otherwise bewildering patterns of inheritance. Their
theory may be relevant to other disabling genetic disorders.
Gregory Hannon has had a central role in the study of RNA interference (RNAi), a process by which
double-stranded RNA (dsRNA) molecules induce gene silencing. Hannon is credited with the discovery
of two enzymes, called Dicer and Slicer, critical in the RNAi machinery. (The work on Slicer was per-
formed in collaboration with Leemor Joshua-Tor.) Hannon’s lab has led the way in using RNAi to study
cancer biology and genetics. They have generated a library of short-hairpin RNAs that they and other
researchers are now applying broadly in gene-silencing studies. The short-hairpin molecules are partic-
ularly noteworthy, enabling researchers to get around a major problem in putting RNAi to work experi-
mentally. Hannon’s approach enables researchers to use RNAi to switch genes on and off in vivo and to
make inferences about gene function by observing model systems. His lab is using this method, among
other techniques, to identify new targets for cancer therapy.
Scott Lowe’s lab studies cancer gene networks and determines how genetic lesions affecting these
networks contribute to tumor development and resistance to cancer therapy. This year, Lowe and col-
leagues continued to study the process of cellular senescence, a potentially powerful mechanism for
suppressing tumors, and showed that senescent cells activate a form of immune surveillance that might
be harnessed therapeutically. In related work, Lowe has adapted RNA interference technology to produce
animal models in which genes can be switched on and off in a spatial, temporal, and reversible manner
and used this to study how correcting genetic defects that contribute to cancer can lead to tumor regres-
sion. Finally, Lowe continues to use an integrative approach to cancer gene discovery that combines
genomic information and mouse modeling to rapidly identify and characterize new cancer genes and
potential therapeutic targets.
In recent years, Robert Lucito, in collaboration with Michael Wigler, has had an important role in devel-
oping technologies, including RDA, ROMA, and CGH (comparative genome hybridization), that have
proven to be valuable to cancer researchers at Cold Spring Harbor and beyond. Lucito has conducted
studies using these techniques to detect copy-number changes in large sets of human ovarian and pan-
creatic cancer tissue samples. This year, the lab turned its attention to epigenetics, and specifically to the
study of methylation throughout the genome. When methyl groups in sufficient numbers attach to cyto-
sine bases in DNA, the packing of DNA into the chromosomes can be altered, reducing the levels at
which the methylated genes are expressed. Under circumstances that Lucito is exploring, this may be
critical in certain cells, a means by which normally protective tumor-suppressor genes are turned off,
rendering the cells tumorigenic.
Scott Powers’s work focuses on gene mutations that cause cancer and factors that influence
responses to specific anticancer drugs. Using DNA-copy-number analysis, the Powers group pinpoints
novel amplified oncogenes and then applies functional studies to address the validity of candidate genes
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and the mechanisms by which they are implicated in oncogenesis. Having successfully applied this
approach in liver and colon cancers, the lab recently turned its attention to lung cancer. This year, Pow-
ers and David Mu discovered three contiguous genes on human chromosome 14 that interact to reac-
tivate an early fetal gene expression pattern that results in cancer. They identified the mutation that triggers
this abnormal reactivation—which occurs in 20% of non-small-cell lung cancers—and showed that if
these genes are turned off, the cancer retreats.
Alea Mills is studying genetic pathways important in cancer and aging, identifying the genetic players
and determining how aberrations in their functions lead to human disease. This year, Mills’s “chromosome
engineering” efforts culminated in the identification of an important tumor suppressor gene that had
eluded investigators for three decades. Genomic analyses had clearly identified a human chromosome
called 1p36 that was frequently deleted in neural, epithelial, and hematopoietic malignancies, indicating
that the region harbored a tumor suppressor. The tumor-suppressing gene, ultimately identified as Chd5,
was shown by Mills to regulate an extensive network. The epigenetic role of Chd5 in development, can-
cer, and stem cell maintenance is currently being investigated. The Mills lab is also studying a protein
called p63, which causes developmental defects, protects from tumorigenesis, triggers cellular senes-
cence, and leads to accelerated aging in vivo.
Much of what is known about genome plasticity and genetic instability has been gleaned from com-
parative studies of sequence variations in model organisms, measured over evolutionary timescales.
Less is known about genetic variation over more rapid time intervals, within normal populations and
organisms. This has been the subject of CSHL Fellow Ira Hall’s research. Using a mouse model system,
he has investigated properties of DNA-copy-number fluctuation using comparative genome hybridization.
This work has indicated the questions that will drive Hall’s research in the coming years: How do new
copy-number variations arise? What are the prevalent mechanisms of duplication and deletion? Are dif-
ferent chromosomal regions or classes of DNA sequences more variable than others?
The identification of cancer stem cells with vital roles in tumor progression, maintenance, and recur-
rence has suggested that at least some cancers arise from malfunctioning developmental programs.
CSHL Fellow Patrick Paddison’s research, which focuses on how molecular pathways promote or con-
tain “stemness,” may therefore provide insight into cancer biology and point to new therapeutic strate-
gies. Using in vivo functional-genetic approaches, Paddison is identifying genes required for self-renewal
and lineage specification in embryonic and adult stem cells in humans and rodents. He seeks to deter-
mine whether these genes are involved in stem-cell-driven cancers.
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We continue to work across our two core areas of can-
cer genetics and small RNA biology, with each benefit-
ing from the insights of the other. The signature of our
approach remains comparative biology, working across
multiple organismal systems to extract the most funda-
mental aspects of the problems that we study. We apply
the tools of genetics, genomics, biochemistry, and
increasingly computational biology to try to identify the
inherent vulnerabilities of cancer cells and to understand
the biology of small RNAs.
This year, the lab continued its tradition of recruiting
and training young scientists.Wewere joined by four out-
standing postdocs—Andres Canela, Astrid Haase, Vihra
Sotirova, andVasilyVagin—whowill strengthen our can-
cer, genomics, and small RNA programs. Yaniv Erlich
and Colin Malone entered the laboratory from the Wat-
son School of Biological Sciences and have alreadymade
tremendous impacts. Michelle Rooks joined our genom-
ics efforts, Maria Mosquera joined to support our mouse
group, and HanaMizuno returned to the laboratory’s can-
cer program.We had the pleasure of hosting a number of
visiting scientists who bring their own perspective and
experience to our work. Rui Zhou, Ben Czech, and Nick
Rozhkov joined theDrosophila group, and Hannah Ben-
der, Carly Smith, Clare Rebbeck, and Karla Claudio-
Campos joined the Tasmanian Devil project. Antoine
Molaro is helping to push our understanding of piRNA
systems in mice. We benefited from the help of under-
graduate students, Edie Davis,YoungJooYang, andAnna
Jankowska. This year has also seen departures: Lin He
left to accept a faculty position at the University of Cal-
ifornia, Berkeley; Catherine Schlingheyde, a phenomenal
high school student, entered CaseWestern Reserve Uni-
versity; and Tom Gingeras, a visiting scientist, left us to
become a Professor at CSHL.
Summaries of our individual projects and programs
appear below.
RNA INTERFERENCE MECHANISMS AND APPLICATIONS
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J. Brennecke A. Girard C. Malone D. Siolas
A. Canela A. Haase K. Marran C. Smith
K. Chang L. He H. Mizuno V. Sotirova
S. Cheloufi X. He A. Molaro O. Tam
K. Claudio-Campos E. Hodges M. Mosquera V. Vagin
B. Czech I. Hotta E.P. Murchison Y. Yang
E. Davis I. Ibarra C. Rebbeck R. Zhou
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Developmental Regulation of piRNAs
in the Mouse Male Germ Line
A. Aravin
We have investigated the functions of Piwi proteins and
associated small RNAs (piRNAs) in the mouse germ
line. Originally, piRNAs were shown to be develop-
mentally regulated and expressed starting at the
pachytene stage of meiosis in the male germ line. To
gain a comprehensive picture of the role of the
Piwi/piRNA pathway in germ cells, we investigated the
expression of the three mouse Piwi members (Miwi,
Mili, and Miwi2) throughout spermatogenesis. We pro-
duced transgenic animals that express each Piwi family
member tagged with green fluorescent protein (GFP)
and myc/FLAG tags. Both Mili and Miwi2 are
expressed in male gonads during embryogenesis. The
onset of Mili expression (12.5 dpc) precedes that of
Miwi2 (14.5 dpc). Starting at E14.5, both proteins are
expressed in germ cells simultaneously; Mili is local-
ized exclusively in cytoplasm and Miwi2 is predomi-
nantly nuclear with few prominent cytoplasmic
granules. Miwi2 expression ceases soon after birth,
whereas Mili continues to be expressed until the hap-
loid round spermatid stage.
To gain insight into piRNA populations bound to each
protein, we immunoprecipitated protein–piRNA com-
plexes and cloned and deeply sequenced isolated RNAs.
Both proteins predominantly bound to small RNAs
derived from long terminal repeat (LTR)- and non-LTR-
containing retrotransposons. Although Mili has a pref-
erence for sense-strand piRNAs, Miwi2 prefers antisense
sequences. Furthermore, piRNAs bound to these two
proteins show features which suggest that they were
processed as a result of amplification loop with each
respective Piwi member being responsible for the for-
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mation of the 5′ ends of new piRNAs that preferentially
bind to other proteins. Molecular interactions between
the two proteins is also confirmed by delocalization of
Miwi2 from nucleus in Mili knockout animals.
The narrow window of Miwi2 expression during
embryogenesis corresponds to the time when methyla-
tion imprints of transposable elements are established
in male germ cells. Furthermore, methylation of L1 ele-
ments is greatly reduced in Miwi2 KO animals. To fur-
ther understand the interaction between Piwi/piRNA
and DNAmethylation pathways, we investigated piRNA
profiles in Dnmt3L KO animals that are unable to estab-
lish methylation of retrotransposon sequences. We
found that retrotransposon-derived piRNAs are in fact
more abundant in Dnmt3L KO animals as compared to
wild type. This finding indicates that derepression of
retrotransposons in Dnmt3L mutants leads to increased
production of piRNAs and places the Piwi/piRNA path-
way as an upstream determinant of DNA methylation.
Small RNA-directed DNA Methylation
in Mammals
A. Girard
The Piwi family of proteins and their Piwi-interacting
RNA (piRNA) partners have a central role in targeting
transposable elements for silencing in many animals. In
a first phase, transposon-derived piRNAs are specifically
generated, amplified, and then bound to a Piwi effector
protein. Through piRNA–target base-pair interactions,
transposon transcripts are recognized by the Piwi-piRNA
complex, which can then serve a scaffold for recruitment
of chromatin-modifying enzymes. In mammals, trans-
posons are silenced by both DNA methylation and
repressive histone modifications. DNA methylation on
several of those repetitive sequences is lost in Piwi
mutant mice. I am currently trying to understand the
requirement for Piwi proteins in DNA methylation (and
potentially histone modifications) on a genome-wide
scale, as well as the mechanism by which Piwi proteins
trigger chromatin changes on repetitive elements.
Roles for piRNAs in Transcriptional
Gene Silencing in Drosophila
K.F. Toth, A. Aravin
Mobile genetic elements populate the genomes of nearly
every living organism, and their potential negative effects
necessitate the development of strategies for transposon
control. This is especially critical in the germ line, where
mutations caused by transposon activity would accumu-
late with each passing generation. Silencing of genomic
repeats, including transposable elements, in Drosophila
melanogaster is mediated by a subclass of theArgonaute
proteins, termed Piwi proteins and associated piRNAs.
Piwi proteins are expressed exclusively in the germ line,
and genetic studies have implicated Piwi proteins in
germ-line integrity. Their associated piRNAs are 26–30
nucleotides long and are produced from discrete loci in
the genome. They act as guides for the identification of
targets of the Piwi proteins.
Some of the piRNA-based silencing is accomplished
by the target cleavage activity of Piwi proteins; however,
some data indicate a function of Piwi on the transcrip-
tional level. To address this possibility, we have asked
the following questions:
• Does the piRNA pathway have any role in transposon
regulation on the chromatin/transcriptional level?
• Is Piwi directly involved in transcriptional repression
of transposons by associating and altering chromatin?
To answer the first question, we have carried out
chromatin immunoprecipitation (ChIP) experiments
with different histone marks and chromatin-associated
factors from wild-type flies and strains deficient for
some of the piRNA pathway proteins. The obtained
DNA was analyzed by quantitative polymerase chain
reaction (Q-PCR) and by cloning and deep sequencing.
Preliminary results indicated that at least some of the
transposons show altered chromatin marks in the
mutants, indicating some role of the pathway on tran-
scriptional regulation.
To test whether Piwi is directly interacting with chro-
matin, we have performed ChIP experiments using
strains with tagged Piwi. In addition, fluorescent
microscopy was used to determine the subnuclear local-
ization of Piwi. Both the microscopic and biochemical
data indicate that Piwi is associated with chromatin and
that this association is dependent on the underlying
genomic sequence.
Endogeneous Small RNA Pathways
in Drosophila
J. Brennecke, C. Malone, B. Czech
Small RNA-directed silencing processes or RNA inter-
ference pathways participate vitally in chromatin regu-
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lation, repression of gene expression, viral defense, and
silencing of selfish genetic elements.At the core of each
pathway lies an Argonaute protein, which in its active
form is loaded with a single-stranded 21–30-nucleotide
small RNA, guiding the Argonaute protein complex to
RNA targets with complementary nucleotide signatures.
A variety of small RNA generating pathways act
upstream of distinct Argonautes, resulting in the spe-
cialization ofArgonaute effector complexes for the iden-
tity of their targets. We are interested in the in vivo
functions of Argonaute proteins in Drosophila, espe-
cially those acting to protect the genome against selfish
genetic elements such as transposons.
Besides our recent insights into the Piwi pathway,
which seems to have specifically evolved to fight trans-
posable elements, our recent work indicates that a clas-
sical RNA interference pathway involving small
interfering RNAs (siRNAs) loaded into Ago2 have an
important role in silencing transposons, likely in the
germ line and soma. The systematic analysis of Ago2-
bound small RNAs led to the discovery of multiple
classes of endogenous siRNAs, which seem to partici-
pate in viral defense, transposon silencing, and gene reg-
ulation. Our combined interest is in the systematic
deciphering of piRNA and siRNA-directed silencing
pathways in the Drosophila germ line, from biogenesis
to mode of action and in vivo function.
The Cell Biology of piRNAs in Drosophila
M. Dus
Animal and plant genomes contain large amounts of
transposons and other types of selfish DNA, comprising
up to 50% or more of their total content. These elements
are often considered “junk DNA,” but the accumulation
of repetitive elements at centromeres and telomeres sug-
gests beneficial or evolutionarily important roles of
transposons for chromosome biology. Nevertheless, the
deleterious consequences of their activity, especially in
germ-line cells, represent an ongoing challenge for the
host to keep uncontrolled replication of these parasitic
elements under control. With the expansion of selfish
genetic elements, genomes have evolved elaborate
defense mechanisms to suppress such proliferation.
InDrosophila, the female germ line is enveloped by a
monolayer of somatic cells called follicle cells. In both
germ-line and follicle cells, protection of the germ line
from parasitic genetic elements is mediated by Piwi pro-
teins and small 28-mer RNAs (piRNAs) derived from
transposons.A transposon-responsive amplification loop
involving the three Drosophila Piwi clade proteins,
Aubergine, Piwi, andAgo3, is required to mount a robust
defense. However, proteins other than Aubergine, Piwi,
and Ago3 are required to control transposon mobiliza-
tion, such as the RNA helicases, Armitage, and Spindle-
E, and the novel proteins Maelstrom, Zucchini, Squash,
and Krimper.The aim of our work is to dissect the role of
these proteins in transposon control, specifically to assign
them distinct positions in the pathway. With high-
throughput piRNA sequencing, localization studies, mass
spectrometry, and Q-PCRs, we have observed perturba-
tions in both small RNA profiles, transposon activation
and subcellular localization, for all proteins under inves-
tigation, indicating that each of them affects the pathway
at a different and discrete step. Our results indicate that
the defense mechanisms that control transposons in the
germ line are markedly different from those in the soma.
This suggests that in both compartments, evolutionary
forces have selected for defense mechanisms optimized to
control transposons active in specific cell types.
Probing the Biochemistry of piRNA
Pathways in Flies
A. Haase
I amworking to establish an in vitro system that allows us
to assay for specific events of piRNA biogenesis and to
then purify and characterize components involved in
these processing steps. Our in vitro system will consist
of recombinant Piwi proteins (produced in collaboration
with Leemor Joshua-Tor’s lab here at CSHL) or immuno-
precipitates, synthetic and in-vitro-transcribed piRNA
precursors, and different cell extracts as sources for the
processing activities. Using different experimental strate-
gies, we aim to purify and identify proteins involved in
piRNA biogenesis, especially components of the 3′-end
processing machinery, giving rise to piRNAs of distinct
size. In addition, we will investigate the impact of differ-
ent 5′ piRNA terminal nucleotides on their sorting into
distinct Piwi complexes. Finally, we want to analyze the
initiation phase of piRNA biogenesis with the aim of
identifying the initial determinants of piRNA processing.
Pseudogene-derived Small Interfering
RNAs in Mouse Oocytes
O. Tam, A. Aravin
Three small RNA classes in mammals regulate expres-
sion of genes or repeat elements: small interfering
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RNAs (siRNAs), microRNA (miRNAs), and Piwi-
interacting RNAs (piRNAs). In most mammalian tis-
sues, miRNAs are responsible for the bulk of small
RNA-mediated gene regulation through translational
inhibition. In addition to miRNAs, the male germ line
also possesses another highly abundant class of small
RNAs (piRNAs), which appears to be responsible for
the silencing of repeat elements (such as retrotrans-
posons) in the mouse genome through an as yet
unknown mechanism.
These observations, however, raised two conun-
drums: (1) Although the male germ line requires
piRNA-mediated silencing (as shown by male sterility
in mutants of the mammalian Piwi proteins), the
females are fertile and unaffected. Are piRNAs not
found or required in the female germ line? (2) siRNA-
mediated silencing via target cleavage remains active in
mammals (as demonstrated by gene knockdown by
exogenous siRNA), yet no endogenous siRNAs have
been reported. What then is the evolutionary require-
ment for maintaining cleavage activity in mammals
(which is conserved from platypus to humans)?
A recent deep-sequencing study into the small RNA
population of mammalian female germ line (oocytes)
has provided some answers to these conundrums. Using
Solexa/Illumina sequencing technology, we were able
to sequence and characterize the small RNA populations
in oocytes. We managed to obtain a profile of oocyte-
expressed miRNAs, as well as identifying a piRNA pop-
ulation that targets repeat elements (not previously
reported in the female germ line). The most interesting
observation, however, is the identification of a class of
small RNAs that resemble endogenous siRNAs. A
group of these “siRNAs” targets repeat elements in the
genome, potentially having a role in silencing them in
tandem with piRNAs (thus providing a possible expla-
nation for the fertility of female mice lacking mam-
malian Piwi proteins).
A second more interesting group appears to be gen-
erated through the interaction of a genic transcript and
an antisense transcript generated from a corresponding
pseudogene. We hypothesize that these two transcripts
form a double-stranded RNA, which upon Dicer pro-
cessing, leads to siRNAs targeting the corresponding
gene. Interestingly, these “siRNA”-generating genes are
up-regulated in the absence of Dicer, raising the possi-
bility that their regulation could be dependent on siRNA
production. The discovery of these endogenous siRNAs
will change the current model of small RNA-mediated
silencing in mammals and also provide the first evi-
dence of the evolutionary requirement of cleavage-
mediated RNA interference.
Specialization of Argonaute Proteins
in Mice
S. Cheloufi, O. Tam, T. Karginov
miRNAs and exogenously provided siRNAs interact with
four mammalianAgo proteins,Ago1 throughAgo4.Ago2
is the onlyArgonaute protein that has been demonstrated
to have a slicer activity responsible for cleaving target
mRNAs.We have shown thatArgonaute2 is essential dur-
ingmouse embryogenesis.Argonaute2-deficient mice are
lethal around mid-gestation with heart and neural tube
malformations. However, little is known about the differ-
ences between Argonautes during development. Individ-
ual knockouts ofAgo1,Ago3, andAgo4 and double- and
triple-knockout combinations are viable and fertile and
do not reveal any obvious developmental abnormalities.
To investigate the role of Ago2 during embryonic
development, we have generated Ago2-null embryonic
stem (ES) cells that fail to mount an siRNA-mediated
gene-silencing response.Ago2-null ES cells contribute to
the whole embryo at E10.5. Further time points of
chimeric studies will allow us to dissect the developmen-
tal potential of the Ago2-deficient ES cells. To identify
small RNA partners of theArgonautes during embryonic
development, we have constructed small RNA libraries
from mid-gestation embryos and extraembryonic tissues
and generated an miRNA expression profile of embry-
onic and extraembryonic tissues. We also generated
miRNA profiles inAgo2-null ES cells. Comparison with
a wild-type miRNA profile allowed us to identify several
miRNA clusters that were specifically reduced in the
absence of Ago2. One third of all miRNAs in extraem-
bryonic tissues is derived from one of these clusters,
although it shows low abundance in the embryo. To fur-
ther characterize the function of the slicing activity of
Ago2 during development. We have generated an Ago2
catalytically mutant mouse by mutating an essential
residue within the catalytic domain of ago2. Profiling of
the small RNA expression during embryogenesis together
with analyzing theAgo2 mutants will help us understand
howAgo2 functions during mouse embryogenesis.
microRNAs and Their Role in
Tumorigenesis
X. He, L. He
To date, most cancer research has focused on the alter-
nations of protein-coding genes. However, recent evi-
dence has suggested that alternations of noncoding
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RNA, particularly microRNAs (miRNAs), can also con-
tribute to tumor formation. For example, it has been
reported that a polycistronic miRNA cluster, mir-17-92,
cooperates with c-myc to accelerate tumor growth by
repressing apoptosis in a mouse model of B-cell lym-
phoma. These data provided some of the first evidence
that changes in noncoding RNAs could contribute to
human cancer. On the other hand, there is also evidence
that miRNAs can function as tumor suppressors since
some miRNAs, such asmir-15,mi-16, and let-7, exhibit
significant reductions in cancer.
We have identified mir-34 family miRNAs, mir-34a,
b, and c, as direct transcriptional targets of p53, a preva-
lent tumor suppressor gene. We have demonstrated that
ectopic expression of mir-34 in both primary and tumor
cell lines can induce growth arrest through repression of
cell cycle genes, including cdk4, cyclinE2, and met, and
we have shown in liver tumor models that tumor cells
overexpressing mir-34a have a disadvantage in tumor
initiation and maintenance. This result, consistence with
the fact that deletion ofmir-34a has been found in many
cancer types, indicates that mir-34a is a potential tumor
suppressor. In the coming year, we will further examine
the biological functions of miR-34 miRNAs in the p53
tumor suppressor network, focusing on identifying the
miR-34’s targets, validating the potential role of miR-34
as a tumor suppressor, and generating miR-34 knockout
mice to examine the consequence of its loss of function.
Assessing the Therapeutic Potential
of Small RNAs
F. Rollins
Recent advances in RNAi technologies have produced a
tremendous impact on cancer biology. New tumor sup-
pressors and oncogenes have been identified, and using
RNAi, we have tools to further understand the gene net-
works that underlie and drive processes in cells. One
drawback is the inability to use RNAi in vivo. I have
been working to further develop tools and methods for
using RNAi in vivo, both as a means for validation of
newly identified genes and to test potential therapeu-
tics. I have been developing a reporter for RNAi, and
once this project is completed, we will be able to test
different RNAi vehicles for efficacy and tissue distri-
bution. In this way, we can screen compounds and
develop models. The information generated by the
reporters will be used to understand which compounds
function best in certain tissues and to tailor experiments
to specific areas and genes of interest within animals.
Toward the $1000 Genome
Y. Erlich
The advent of single-molecule sequencing has trans-
formed the study of genomes, both in describing their
transcriptional output and in the cataloging individual
genetic variation. Presently, the power of these tech-
nologies is limited partly by short-sequence read lengths
and error rates higher than those seen with conventional
sequencing. To maximize both sequence output and
accuracy, we have probed the underlying sources of
error in the Illumina 1G platform. We find that the
major limitation of this method is the accumulation of
noise that gradually decreases the accuracy of base call-
ing. Noise can be separated into phasing, loss of signal
intensities, and a convergence of signals from base-spe-
cific fluorophores.We have developed a novel base-call-
ing algorithm that combines optimized phase modeling
and machine learning. Implementation of this program
increases the number of correct sequence reads by 30%
and significantly extends the useful read length
achieved on the platform.
Small RNA Pathways in Marsupials
and Monotremes
E.P. Murchison, H.S. Bender, C. Rebbeck, C. Smith,
K. Claudio-Campos
Our group is interested in understanding the molecular
basis of Tasmanian devil facial tumor disease (DFTD),
a transmissible cancer affecting Tasmanian devils. First
observed in 1996, DFTD has had a devastating toll on
theTasmanian devil, a marsupial carnivore native toTas-
mania. Karyotypic similarities between DFTD tumors
suggested that the disease is transmitted as an allograft.
Studies of microsatellite and mitochondrial variability
revealed that all DFTD tumors are indeed genetically
identical, indicative of a common origin. To ascertain
the tissue of origin and molecular pathogenesis of
DFTD, we have cloned and sequenced miRNA libraries
from DFTD and are sequencing full-length devil cDNA
libraries.
In addition, as part of the platypus genome consor-
tium, we have cloned, sequenced, and characterized
small RNAs in the platypus. The platypus and echidna
are the only extant egg-laying mammals, known as
monotremes. These animals have unique morphology
and development, displaying both mammalian and rep-
tilian features. Interestingly, this evolutionary intersec-
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tion is also apparent in the genome sequence, and we
found that the microRNAome of monotremes bears
resemblances to those of both mammals and chicken.
The platypus also has unusual sex chromosomes, with
five X and five Y chromosomes segregating through a
meiotic chain in the male germ line. We discovered a
large cluster of monotreme-specific miRNAs on one of
the X chromosomes that is extremely fast-evolving and
is expressed in testis. This cluster may have a role in
monotreme reproductive biology.
Genetic Strategies to Identify New
Targets for Cancer Therapy
K. Chang, K. Marran, J. Silva
By virtue of their accumulated genetic alterations,
tumor cells may acquire vulnerabilities that create
opportunities for therapeutic intervention. We have
devised a massively parallel strategy for screening
shRNA collections for stable loss-of-function pheno-
types. We have assayed from 6,000 to 20,000 shRNAs
simultaneously to identify genes important for the pro-
liferation and survival of five cultured mammary cell
lines. Lethal shRNAs common to these cell lines tar-
geted many known cell cycle regulatory networks. Cell-
line-specific sensitivities to suppression of protein
complexes and biological pathways also emerged, and
these could be validated by RNAi and pharmacologi-
cally. These studies establish a practical platform for
genome-scale screening of complex phenotypes in
mammalian cells and demonstrate that RNAi can be
used to expose genotype-specific sensitivities.
A Cytoskeletal Regeulator as a
Tumor Suppressor
J. Silva, K. Marran
Complete sequencing of the human genome has pro-
vided information on potentially all expressed genes and
has opened the door to the next scientific challenge: to
assign a specific function to every gene. RNAi has
recently emerged as a powerful genetic tool to conquer
this challenge by performing loss-of-function studies.
During the last several years, we have been developing
a highly efficient miRNA-based shRNA library that
facilitates genome-wide loss-of-function studies to
delineate molecular pathways.
Additionally, we have coupled this technology with
high-resolution genomic analysis (with the Wigler lab
here at CSHL) to identify novel tumor suppressor genes
recurrently deleted in human epithelial cancers. This
approach has led to the finding that suppression of
Cyfip1/Sra1, a component of the WAVE complex that
regulates cytoskeleton dynamics, disturbs normal
epithelial morphogenesis in vitro and cooperates with
oncogenic Ras to produce invasive carcinomas in vivo,
resulting from impaired cell adhesion and increased
motility. In addition, reduced expression of Cyfip1/Sra1
was found to be associated with poor prognosis in breast
and colon cancer patients. These results, have led me to
propose that Cyfip1/Sra1 is a putative tumor suppres-
sor in epithelial cancers.
Focal Genome Resequencing to
Identify Breast Cancer Susceptibility
Determinants
E. Hodges, J. Silva, M. Rooks [in collaboration with
D. McCombie, Cold Spring Harbor Laboratory]
Recently, we and other investigators have reported
enrichment techniques for genomic target capture and
directed resequencing of large subsets of the nonrepet-
itive genome. Our strategies combine hybrid selection,
either on microarrays or in solution, with massively par-
allel sequencing on the Illumina Genome Analyzer.
These methods are already proving to be highly com-
petitive in both efficiency and cost in contrast to other
target selection techniques including long-range and
multiplex PCR. Currently, we are developing optimized
platforms for in situ capture of protein-coding
sequences to enable extensive high-resolution surveys
of the mutational state of specified regions in multiple
affected individuals. Our goal is to reduce the amount of
starting material required while improving both target
specificity and base-pair coverage. This technology is
robust, reproducible, and portable to other laboratories.
We are currently performing focused resequencing
on candidate regions linked to familial breast cancer.
Mutations involving two high-penetrance breast cancer
susceptibility genes, BRCA1 and BRCA2, account for
nearly 30% of familial breast cancer. Although lower-
risk genes have been identified, mainly through a priori
candidate gene approaches, efforts to account for the
remaining 70% of familial breast cancer cases (referred
to as BRCAX families) have been fruitless, and the dis-
covery of additional predisposition genes continues to
be difficult. For this project, genome-wide linkage scans
performed across multiple BRCAX families identified
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three candidate regions representing about 140 genes.
To further characterize these regions, we have designed
capture arrays tiling all coding exons within these
regions and are using them to search for mutations that
represent high-penetrance risk factors.
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Apoptosis is a genetically controlled form of cell death
that is important for normal development and tissue
homeostasis. Senescence is a permanent form of cell
cycle arrest that can be triggered in response to cellular
stress. Both processes can efficiently eliminate incipient
cancer cells and are often disabled in malignant tumors.
Moreover, radiation and many chemotherapeutic agents
can induce either apoptosis or senescence in tumor cells,
and so the ability of tumor cells to mount an apoptotic
or senescence response may influence the outcome of
cancer therapy in patients. The goal of our research is to
understand how cancer genes control apoptosis and
senescence in normal cells, and how mutations that dis-
rupt these processes impact tumor development and
cancer therapy. Ultimately, we hope to exploit this infor-
mation to identify more effective and less toxic strate-
gies for treating cancer.
Control of Apoptosis by Oncogenes
and Tumor Suppressor Genes
U. Bialucha, A. Bric, R. Dickins, K. Diggins, C. Miething,
C. Scuoppo, J. Simon [in collaboration with former Cold
Spring Harbor Laboratory members C. Scott, J. Gil, and
H. Wendel; D. Beach, Institute of Cell and Molecular Science,
London; J. Teruya-Feldstein and R. Benezra, Memorial Sloan-
Kettering Cancer Center; E. Hernando, New York University;
and C. Cordon-Cardo, Columbia University]
Normal cells possess intrinsic tumor suppressor mech-
anisms that limit the consequences of aberrant prolifer-
ation. For example, deregulated expression of the
oncogene c-myc or disruption of the Rb pathway in nor-
mal cells can force aberrant S-phase entry and predis-
pose cells to apoptotic cell death. This increased
sensitivity to apoptosis acts through both p53-dependent
and -independent pathways and potently limits tumor
development.We have previously shown that oncogenes
can engage the ARF-p53 pathway to promote apoptosis
and that disruption of this pathway cooperates with
oncogenes to transform normal cells in vitro and pro-
DISSECTING TUMOR SUPPRESSOR GENE NETWORKS
CONTROLLING APOPTOSIS AND SENESCENCE
S. Lowe C. Bialucha R. Dickins B. Ma T. Pardee C. Semighini M. Yang
A. Bric K. Diggins M. McCurrach P. Premsrirut J. Simon L. Zender
D. Burgess Y. Hippo K. McJunkin A. Rappaport M. Spector Z. Zhao
A. Chicas V. Krizhanovsky C. Miething C. Scuoppo W. Xue J. Zuber
Y. Chien
mote tumorigenesis in vivo.We are currently interested
in identifying additional components of these programs
and understanding how they function in a “tumor sup-
pressor network.”
Cbx7 is a chromobox family protein and a compo-
nent of the polycomb repressive complex 1 (PRC1) that
extends the life span of cultured epithelial cells and can
act independently of Bmi-1 (another PRC1 component)
to repress the Ink4a/Arf tumor suppressor locus. To
determine whether CBX7might be oncogenic, we exam-
ined its expression pattern in a range of normal human
tissues and tumor samples. CBX7 was expressed at high
levels in germinal-center-derived follicular lymphomas,
where elevated expression correlated with high c-myc
expression and a more advanced tumor grade. By tar-
geting Cbx7 expression to the lymphoid compartment
in mice, we showed that Cbx7 can initiate T-cell lym-
phomagenesis and can cooperate with c-myc to produce
highly aggressive B-cell lymphomas, in part, by sup-
pressing apoptosis. These data identify CBX7 as the
first chromobox protein causally linked to cancer devel-
opment and may explain, at least in part, the low fre-
quency of INK4a/ARF mutations observed in human
follicular lymphoma (Scott et al. 2007).
Another area of interest in our group relates to the
impact of survival signaling on oncogenesis. We previ-
ously used the Eµ-myc lymphoma model to demonstrate
that the translation initiation factor eIF4E is a potent
oncogene in vivo and can promote resistance to certain
cancer therapies. Using the same model, we recently
showed that the oncogenic activity of eIF4E correlates
with its ability to become phosphorylated on Ser-209
and activate translation (Wendel et al. 2007). Further-
more, constitutively activated MNK1, the eIF4E Ser-
209 kinase, promoted tumorigenesis in a manner similar
to that of eIF4E, whereas a dominant-negative mnk
mutant inhibits the in vivo proliferation of tumor cells
driven by mutations that deregulate translation. Phos-
phorylated eIF4E promotes tumorigenesis primarily by
suppressing apoptosis, and, accordingly, the antiapop-
totic protein Mcl-1 was identified as one target of both
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phospho-eIF4E and MNK1 that contributed to tumor
formation. These results provide insight into how eIF4E
contributes to tumorigenesis and pinpoints an avenue
for protein translational control that may be suitable for
therapeutic intervention.
Control of Cellular Senescence
A. Chicas, Y. Chien, M.V. Krizhanovsky, M. McCurrach, W. Xue,
L. Zender [in collaboration with L. He, X. He, and G. Hannon,
Cold Spring Harbor Laboratory; E. Hernando, New York
University; and C. Cordon-Cardo, Columbia University]
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in cul-
tured human fibroblasts, and it is characterized by a
series of poorly understood markers. Senescent cells
remain metabolically active, but they are unable to pro-
liferate and display changes in gene expression that
could alter tissue physiology. As such, they are geneti-
cally “dead” and cannot contribute to tumor develop-
ment.Although “replicative” senescence is triggered by
telomere attrition and can be prevented by reactivating
telomerase, a similar endpoint can be produced acutely
in response to activated oncogenes, DNA damage,
oxidative stress, and suboptimal cell culture conditions.
These observations led us to propose that senescence
acts in parallel to apoptosis as a cellular response to
stress that suppresses tumorigenesis and mediate
responses to chemotherapy. On the basis of this anal-
ogy, much of our work on senescence is guided by our
past experience on apoptosis.
Our laboratory was the first to demonstrate that dereg-
ulated mitogenic oncogenes could drive cells into a senes-
cent state, thereby preventing oncogenic transformation,
and that senescence could contribute to the outcome of
chemotherapy in vivo. On the basis of the hypothesis that
senescence is an important tumor suppressive mechanism
in vivo, our laboratory continues to study the mechanisms
and biology of cellular senescence.
This year, we conducted a series of experiments to
show that p53-deficient liver carcinoma cells undergo
senescence following p53 reactivation in vivo (Xue et
al. 2007). Remarkably, although senescence is a cyto-
static program, the tumors underwent massive regres-
sion as a result of an attack by the immune system on
the senescent cells. Thus, despite the cytostatic nature
of the senescence program, senescent cells can turn over
in vivo. In addition, although it is established that
chronic inflammation triggered by senescent stromal
cells or other factors can promote tumorigenesis, our
work illustrates how innate immune cells—when tar-
geted against senescent tumor cells—can have antitu-
mor effects as well. We suggest that therapeutic
strategies that specifically harness these processes may
represent a promising therapeutic approach.We are also
exploring the interplay between senescent cells and the
tissue microenvironment in other pathologies, including
liver cirrhosis.
In collaboration with the Hannon laboratory here at
CSHL, we also identified a microRNA (miRNA) com-
ponent of the p53 tumor suppressor network that con-
trols senescence (He et al. 2007). Specifically, by
comparing miRNA expression profiles between wild-
type and p53-deficient cells, we identified a family of
miRNAs, mir-34a-c, whose expression reflected p53
status. Precursors of all three miR-34 family miRNAs
are direct transcriptional targets of p53, whose induc-
tion by DNA damage and oncogenic stress requires p53
both in vitro and in vivo. Ectopic expression of miR-34
induced cell cycle arrest in both primary and tumor-
derived cell lines, consistent with the observed ability
of miR-34 to down-regulate a program of genes pro-
moting cell cycle progression. The p53 network sup-
presses tumor formation through coordinated activation
of multiple transcriptional targets, and miR-34 may act
in concert with other effectors to inhibit inappropriate
cell proliferation.
Modulation of Gene Expression
Using RNA Interference
C. Bialucha, A. Bric, R. Dickins, K. Diggins, V. Krizhanovsky,
B. Ma, M. McCurrach, K. McJunkin, C. Miething, T. Pardee,
P. Premsrirut, A. Rappaport, C. Scuoppo, C. Semighini,
J. Simon, M. Spector, W. Xue, M. Yang, L. Zender, Z. Zhao,
J. Zuber [in collaboration with G. Hannon, Cold Spring
Harbor Laboratory; E. Hernando, New York University;
and C. Cordon-Cardo, Columbia University]
RNA interference (RNAi) is a powerful method for sup-
pressing gene expression in mammalian cells. Stable
knockdown of gene expression can be achieved by con-
tinuous expression of synthetic short hairpin RNAs
(shRNAs), typically from RNA polymerase III promot-
ers. However, primary microRNA transcripts (pri-miR-
NAs), which are endogenous triggers of RNAi, are
normally synthesized by RNA polymerase II (pol II).
With Gregory Hannon here at CSHL, we previously
showed that pol II promoters expressing rationally
designed pri-miRNA-based shRNAs (shRNAmir) produce
potent, stable, and regulatable gene knockdown in cul-
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tured cells and in animals, even when present at a single
copy in the genome. In practice, this shRNAmir vector
system is remarkably similar to cDNA overexpression
systems and should be a powerful tool for studying tumor
suppressor gene function in cells and animals.
We explored the potential of using reversible RNAi
to regulate endogenous gene expression in mice. As an
initial step, we generated transgenic mice containing an
inducible tet-responsive miR30-based p53 shRNA and
crossed them to a variety of tet-trans-activator trans-
genic strains. Upon providing or omitting doxycycline
(the tetracycline analog) in the drinking water, we could
reversibly reduce p53 expression in a tissue-specific
manner. We are now confident that this system has
wide-reaching potential as we showed that conditional
knockdown of p53 accelerated tumorigenesis and that
p53 reactivation led to tumor clearance (Dickins et al.
2007). This result not only demonstrates an important
role for p53 loss in lymphoma maintenance, but also
implies that similar systems can be used to validate drug
targets or particular pathways for therapeutic interven-
tion. In principle, similar systems can be used to spa-
tially and temporally control the expression of any
endogenous gene. We are currently pursuing second-
generation strategies to improve vectors and gene-tar-
geting approaches.
In addition to characterizing individual genes, we are
exploiting this in vivo system in a very powerful way to
identify new tumor suppressor genes. By expressing
pools of shRNAs in one animal, we can assess the role
of knockdown of hundreds of genes concurrently. We
are performing in vivo screens in both the Eµ-myc lym-
phoma and hepatocellular carcinoma mouse models.
Both screens are nearly complete and have led to the
validation of candidate tumor suppressor genes that are
currently being characterized.
Molecular Genetics of
Chemotherapeutic Drug Sensitivity
and Resistance
D. Burgess, Y. Hippo, B. Ma, M. McCurrach, K. McJunkin,
C. Miething, A. Rappaport, J. Simon, M. Spector, M. Yang,
Z. Zhao, J. Zuber [in collaboration with former Cold Spring
Harbor Laboratory member M. Hemann, Massachusetts
Institute of Technology; C. Cordon-Cardo, Memorial
Sloan-Kettering Cancer Center; S. Kogan, University of
California, San Francisco]
Our laboratory has a long-standing interest in under-
standing genetic determinants that influence the cellular
response to conventional chemotherapy with the long-
term goal of identifying mechanisms of drug resistance
and developing new drug targets. These efforts involve
a combination of experiments using RNAi to character-
ize drug sensitivity and resistance genes, genomic
approaches designed to identify genes that are linked to
poor treatment responses in patients, and animal mod-
eling studies to test new drugs and drug combinations
that might circumvent drug resistance.
Topoisomerase poisons are chemotherapeutic agents
that are used extensively for treating human malignan-
cies. These drugs can be highly effective, yet tumors are
frequently refractory to treatment or become resistant
upon tumor relapse. Using a rapid pool-based RNAi
screening approach and a well-characterized mouse
model of lymphoma, we explored the genetic basis for
heterogeneous responses to topoisomerase poisons in
vitro and in vivo. These experiments identified Top2A
expression levels as a major determinant of the response
to the topoisomerase 2 poison doxorubicin and showed
that suppression of Top2A produces resistance to dox-
orubicin in vitro and in vivo (Burgess et al., in press).
Analogously, using a targeted RNAi approach, we
demonstrated that suppression of Top1 produces resist-
ance to the topoisomerase 1 poison camptothecin, again
leading to drug resistance in vivo. Although the resist-
ance-promoting effects of topoisomerase suppression
were specific to their corresponding poisons, Top1
knockdown unexpectedly enhanced sensitivity to dox-
orubicin, leading to improved survival of tumor-bearing
mice. These results highlight the potential utility of com-
bining RNAi with mouse models to identify determinants
of therapeutic outcome in vivo. They further suggest
strategies for improving the effectiveness of topoiso-
merase poisons in the clinic by stratifying patients or
developing new sensitizing drug combinations.
In complementary efforts, we are continuing a multi-
institutional program to develop and use mouse models
of acute myelogenous leukemia to identify molecular
determinants of both conventional and targeted thera-
pies, with the goal of translating this information to
human patients. We are excited about the potential of
the program, as it provides all of the elements necessary
to validate the use of new mouse models as preclinical
test systems and translate this information into clinical
trials. We are also integrating experiments using mouse
models, genomics, and RNAi methods in an attempt to
increase the rate of discovery of genes that influence the
sensitivity and resistance of tumor cells to various ther-
apies in vivo. These efforts involve important collabo-
rations with several CSHL investigators and will be an
important part of future efforts.
69
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:52 PM  Page 69
V. Krizhanovsky
70
Lindemann R.K., Newbold A., Whitecross K.F., Cluse L.A., Frew
A.J., Ellis L., Williams S., Wiegmans A.P., Dear A.E., Scott
C.L., Pellegrini M., Wei A., Richon V.M., Marks P.A., Lowe
S.W., Smyth M.J., and Johnstone R.W. 2007. Analysis of the
apoptotic and therapeutic activities of histone deacetylase
inhibitors by using a mouse model of B cell lymphoma. Proc.
Natl. Acad. Sci. 104: 8071–8076.
Scott C.L., Gil J., Hernando E., Teruya-Feldstein J., Narita M., Mar-
tinez D., Visakorpi T., Mu D., Cordon-Cardo C., Peters G.,
Beach D., and Lowe S.W. 2007. Oncogenic properties of the
polycomb protein CBX7. Proc. Natl. Acad. Sci. 104: 5389–
5394.
Sotillo R., Hernando E., Diaz-Rodriquez E., Teruya-Feldstein J.,
Cordon-Cardo C., Lowe S.W., and Benezra R. 2007. Mad2
overexpression promotes aneuploidy and tumorigenesis in
mice. Cancer Cell 11: 9–23.
Wendel H.G., Silva R.L., Malina A., Mills J.R., Zhu H., Ueda T.,
Watanabe-Fukunaga R., Fukunaga R., Teruya-Feldstein J.,
Pelletier J., and Lowe SW. 2007. Dissecting eIF4E action in
tumorigenesis. Genes Dev. 21: 3232–3237.
Xue W., Zender L., Miething C., Dickins R.A., Hernando E.,
Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. 2007.
Senescence and tumour clearance is triggered by 53 restora-
tion in murine liver carcinomas. Nature 445: 656–660.
Zender L., Zuber J., and Lowe S.W. 2007. Snapshot: Genetic
mouse models of cancer. Cell 129: 838.
In Press
Burgess D.J., Doles J., Zender L., Xue W., Ma B., McCombie
W.R., Hannon G.J., Lowe S.W., and Hemann M.T. 2008.
Topoisomerase levels determine chemotherapy response in
vitro and in vivo. Proc. Natl. Acad. Sci. (in press).
Zender L. and Lowe S.W. 2008. Integrative oncogenomic ap-
proaches for accelerated cancer-gene discovery. Curr. Opin.
Oncol. 20: 72–76.
PUBLICATIONS
Bosco E.E., Wang Y., Xu H., Zilfou J., Knudsen K.E., Aronow B.J.,
Lowe S.W., and Knudsen E.S. 2007. The retinoblastoma
tumor suppressor modifies the therapeutic response of
breast cancer. J. Clin. Invest. 117: 218–228.
Dickins R.A., McJunkin K., Hernando E., Premsrirut P.K.,
Krizhanovsky V., Burgess D.J., Kim S.Y., Cordon-Cardo C.,
Zender L., Hannon G.J., and Lowe S.W. 2007. Tissue-specific
and reversible RNAi in transgenic mice. Nat. Genet. 39: 914–
921.
Feng Z., Hu W., de Stanchina E., Teresky A.K., Jin S., Lowe S.,
and Levine A.J. 2007. The regulation of AMPK beta1, TSC2,
and PTEN expression by p53: Stress, cell and tissue speci-
ficity, and the role of these gene products in modulating the
IGF-1-AKT-mTOR pathways. Cancer Res. 67: 3043–3053.
Flinterman M.B., Mymryk J.S., Klanrit P., Yousef A., Lowe S.W.,
Caldas C., Gäken J., Farzaneh F., and Tavassoli M. 2007.
p400 function is required for the adenovirus E1A mediated
suppression of EGFR and tumour cell killing. Oncogene 26:
6863–6874.
Ha L., Ichikawa T., Anver M., Dickins R., Lowe S., Sharpless N.E.,
Krimpenfort P., Depinho R.A., Bennett D.C., Sviderskaya
E.V., and Merlino G. 2007. ARF functions as a melanoma
tumor suppressor by inducing p53-independent senes-
cence. Proc. Natl. Acad. Sci. 104: 10968–10973.
He L., He X., Lowe S.W., and Hannon G.J. 2007. microRNAs join
the p53 network—Another piece in the tumour-suppression
puzzle. Nat. Rev. Cancer 7: 819–822.
He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W.,
Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S.,
Chen C., Lowe S.W., Cleary M.A., and Hannon G.J. 2007. A
microRNA component of the p53 tumour suppressor net-
work. Nature 447: 1130–1134.
Karni R., de Stanchina E., Lowe S.W., Sinha R., Mu D., and Krainar
A.R. 2007. The gene encoding the splicing factor SF2/ASF is
a proto-oncogene. Nat. Struct. Mol. Biol. 14: 185–193.
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:52 PM  Page 70
71
In addition to genetic mutation such as amplification and
deletion, epigenetic aberrations are frequent events that
can have far-reaching affects in the phenotype of a can-
cer cell. A common epigenetic modification is the
methylation of cytosine residues which are next to gua-
nine residues. It has been shown that methylation pres-
ent in the DNA of the transcriptional control region has
been involved in the silencing of gene expression of
tumor suppressors in cancer. We have adapted represen-
tational oligonucleotide microarray analysis (ROMA) to
methylation detection oligonucleotide microarray analy-
sis (MOMA). The present array queries all CpG islands
within the genome. To detect methylation, input DNA
(either tumor or normal) is cleaved with MspI and then
ligated to polymerase chain reaction (PCR) adaptors and
divided into two samples. One sample is digested with
the endonuclease McrBC, which recognizes and cleaves
methylated DNA with the promiscuous recognition
sequence A/GmC(N40-3000)A/GmC (Gast et al., Biol.
Chem. 378: 975–982 [1997]) depleting methylated se-
quences. The other sample, the reference, is mock-
digested. Both samples are amplified by PCR,
differentially labeled, and hybridized to the array.
This methodology was used on cell lines, and 11 of
11 methylation measurements were validated by bisul-
fite sequencing confirming its accuracy. Although the
standard method of methylation profiling of tumors is to
utilize matched normals, many tumor banks contains
tumor samples without matched normals. Using a set of
matched tumor normals (12 normals, 12 tumors) and a
set of matched and unmatched tumor normals (12 nor-
mals, 28 tumors), we developed statistical criteria for
identifying CpG islands most significantly altered
between tumor and normal even when unmatched. We
looked at all permutations comparing matched and
unmatched tumors to all normals and found that all
tumors generally varied similarly from the normals
whether matched or unmatched. In other words, all
tumors are similarly different from normals. We then
moved onto the analysis of a larger set of 40 breast
tumors, compared to 12 normal breast samples, and 11
ovarian tumors, compared to 7 normal ovarian samples.
Using the statistical criteria developed, we obtained a
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list of 916 significant alterations in breast cancer and
151 in ovarian cancer, many of which have previously
been documented to have altered methylation in cancer,
again demonstrating the ability of this methodology to
detect CpG methylation in cancer. For example, the
MTSS1 (metastasis suppressor 1) gene is known to be
preferentially methylated in several cancers including
breast cancer, and its lack of expression correlates well
with increased Her2 expression. Genes that we identi-
fied as being hypermethylated in the ovarian and breast
tumors include several HOX genes and protocadherins,
which are known to be methylated in many tumor types.
In addition to genes known to undergo methylation, we
have found new targets of methylation.We also detected
for the first time promoter methylation of a microRNA
gene, has-mir-9-3, occurring in more than half the
breast tumors. The expression of this microRNA has
been shown to be down-regulated transcriptionally in
breast and other cancers.
Studies suggest that the methylation profile can be
used to readily distinguish tumor samples from normal
samples. To confirm and extend these observations, we
performed hierarchical clustering on the 100 most sig-
nificantly altered CpG islands between breast tumors
and normals and ovarian tumors and normals. In all
sample sets, the normals segregated from tumors. We
also used a supervised machine-learning classifier to
identify the sensitivity and specificity of using methy-
lation to differentiate breast tumor samples from nor-
mals (the ovarian tumor data set was too small to
perform this analysis) and used a “leave-one-out”
cross-validation to calculate the sensitivity and speci-
ficity. Using only ten CpG islands, we achieved a clas-
sification accuracy of 94%. Sensitivity for tumor
detection was 92.5% (37/40) and specificity for tumor
detection was 100%, demonstrating the potential that
tissue can be identified as tumor or normal based on a
relatively small number of methylation alterations. In
addition, of the breast tumors, a subset has been shown
to segregate into six subclasses based on expression
analysis data; hierarchical clustering performed on the
methylation data recapitulated these subclasses,
demonstrating that the methylation data can be used to
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stratify tumor samples. We propose that the methyla-
tion data can be used to identify biomarkers that strat-
ify with clinical parameters, and we will be studying
this in the future.
We compared methylation status between promoter-
specific islands (TSS-CGIs) and nonpromoter islands
(non-TSS-CGIs), as well as non-island CpG dinu-
cleotides (non-CGIs), because this could be informative
with respect to tumor evolution. We found that the
methylation events that were frequently found were
methylation of specific TSS-CGIs and non-TSS-CGIs
and demethylation of non-CGIs. What was interesting
was that for the class of non-TSS-CGIs, although we
found some islands frequently methylated, the vast
majority were demethylated. However, this demethyla-
tion was random and rarely were the same islands
demethylated in multiple tumors. This greater prepon-
derance of demethylation in cancer without recurrence
suggests that the demethylation of non-TSS-CGIs is
more of a random event in the genome, compared to the
methylation of TSS-CGIs being specific. Perhaps this
is a result of the methylation of TSS-CGIs being posi-
tively selected during carcinogenesis in order to silence
tumor suppressor genes, whereas the demethylation is
not being selected for and the majority appears to be
random. More than likely, methyltransferases are uti-
lized for methylation, but it is unclear how demethyla-
tion occurs within an environment of methylation. It is
possible that it is as simple as the methylation process
on a whole being deregulated, resulting in some regions
being aberrantly methylated and others not being methy-
lated. Because we are looking at the tumor after its evo-
lution, we only see the cells most successful at survival.
The methylation of specific genes is selected for and the
majority of the other methylation events are not
observed because they are unselected. This will be the
subject of future studies.
Copy-number Analysis
of Cancer
R. Lucito, S. Chen, T. Auletta, J. Byrnes, N. Cutter
Mutation of the genome is central to the development
and progression of cancer. Mutations occur in the
genome of the precancerous cells and accumulate, alter-
ing gene function until the growth of these cells goes
unchecked. The genes responsible for cancer must be
identified if we are to understand the cellular pathways
that get subverted and allow the cell to become cancer-
ous. We have developed a genomic microarray tech-
nique, ROMA, to identify copy-number fluctuations.
PANCREATIC CANCER
According to the American Cancer Society, there will
be an estimated 37,170 cases of pancreatic cancer this
year. Of those, 33,370 patients will succumb to the dis-
ease. Although the number of cases is low, in compari-
son to several other cancers such as colon, lung, or
breast cancer, the survival rate for pancreatic cancer is
one of the lowest. Treatments can extend survival or
alleviate pain but seldom cure the patient. In fact, the
mean survival time is approximately 6 months. Because
the life span after diagnosis is very short, the number of
patients that receive tumor resections is very low. This
translates to few samples available for analysis. Because
of this, we are collaborating with many clinicians to put
together a useful tumor bank of pancreatic tissue for
analysis. Currently, we are collaborating with Dr. Ralph
Hruban of The Johns Hopkins University School of
Medicine, Dr. Daniel Von Hoff of the Arizona Cancer
Center, and Dr. VijayYajnic of the Massachusetts Gen-
eral Hospital, who will be providing pancreatic speci-
mens, clinical information, and expertise. To date, we
have analyzed 98 samples.We have confirmed many of
the known mutated regions and have identified less-
characterized regions.
One region on chromosome 19q12 that is amplified
is interesting because there has been confusion in the
literature as to which gene in the region is the oncogene
with respect to pancreatic cancer. A number of tumors
and cell lines have this region amplified, but two pri-
mary tumors are the most informative for defining the
epicenter or common region of mutation. Previously, we
have shown that a gene named p21-activated kinase
(PAK4) was overexpressed at the RNA level, overpro-
duced at the protein level, and overactivated as a kinase
in cells with genomic amplification. This protein was
also shown by other investigators to transform cells
when activated.
To elucidate the function of PAK4 in the tumor, we
have used short hairpin RNA (shRNA) constructs to
knock down the level of PAK4 in cells with the ampli-
con to determine the effect on tumorigenicity. After
knocking down the level of PAK4 in the cells, we col-
lected RNA and performed expression analysis to deter-
mine if there was a change in the cellular environment.
Tumors are very heterogeneous, including their expres-
sion repertoire. Therefore, we performed this analysis
for three separate cell lines with this region genomically
72
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:52 PM  Page 72
amplified and used the results from all three to filter out
noise and determine which were in common. Of the
genes found with expression affected by PAK4, one
interesting candidate is DUSP22 (JSP1), a phosphatase
that is involved in selective activation of the mitogen-
activated protein kinase (MAPK)/Jnk pathway, a path-
way described below important for cell survival.
The region with PAK4 amplification is found ampli-
fied in several cancers, including pancreas, breast, and
ovarian. Of these cancers, activity in breast cancer was
tested, and we have determined that its activity is
increased. Because PAK4 is found amplified in several
tumor types, we have generated a transgenic mouse with
PAK4 overexpressed in all tissues. The mice are 3
months old and, thus far, are phenotypically normal.We
plan to cross these mice to mice with other genes such
as activated K-ras, a gene known to activate PAK4 and
frequently activated in pancreatic cancer. Due to the
construction of the K-rasmice, the K-ras gene is turned
on only in specific tissue and thus we can test the role
of PAK4 in specific organs such as pancreas, breast, or
ovaries.
OVARIAN CANCER
We are also focusing on the analysis of ovarian cancer
using ROMA. Ovarian cancer has a relatively high inci-
dence and approximately 50% survival rate. In many
patients, the cancer is diagnosed late, often having
metastasized, the first symptoms being an accumulation
of fluid in the abdominal cavity. There have been few
genes discovered that are involved in the progression of
ovarian cancer. We will collaborate with Dr. Michael
Pearl of SUNY Stony Brook for access to tissue and
clinical information. We will also perform ROMA on a
tumor set of approximately 200 ovarian cancer samples
to identify gene-copy-number fluctuations to identify
candidate tumor suppressors and oncogenes.
At present, we have analyzed 121 tumors and have
compiled the data to identify regions commonly ampli-
fied or deleted. One such uncharacterized region we are
studying is a deletion on chromosome 5q14. This region
contains seven genes. Of the tumors analyzed, we had
copy number and expression and now have methylation
data. For all candidates, the three data types were inte-
grated. In addition, available published expression data
were also associated with the data (in this case, an ovar-
ian expression data set was available). It was found that
of the seven genes deleted, one gene was also methy-
lated and expression was repressed, including being
repressed in the available public expression data. This
gene is p21 RasGAP. The protein activates the intrinsic
GTPase acitivity of ras and once Ras is bound to GDP,
it is no longer active. Therefore, it essentially inhibits
Ras. Our hypothesis is that methylation represses tran-
scription of this inhibitor and thus leaves Ras in an
active state longer. We are presently knocking out Ras-
GAP in cells that express it at normal levels to deter-
mine the advantage to the tumor cell.
Mutational Analysis of Phosphatases
E. Lum, T. Auletta, [in collaboration with N. Tonks and
S. Muthuswamy, Cold Spring Harbor Laboratory]
The goal of this collaborative study is to integrate gene
discovery technology with experimental strategies
developed in Dr. Tonks’ lab for the characterization of
the protein tyrosine phosphatase (PTP) family of
enzymes, to investigate how tyrosine-phosphorylation-
dependent signaling pathways are disrupted in cancer.
Previously, we used genomic-copy-number data to
identify the phosphatases, LAR, PTPsigma, and VHY
gene-amplified in ovarian tumor specimens. LAR and
PTPsigma are receptor-like PTPs, display features of
cell-adhesion molecules, and have been implicated in
regulating the function of adhesion complexes that con-
trol cell–cell interactions and may be disrupted in can-
cer. VHY is a dual specificity phosphatase that the
Tonks’ lab has implicated in the activation of a signal-
ing pathway (the JNK pathway), which has a critical role
in the control of cell survival. MKP5 is another dual
specificity phosphatase that functions in the inactiva-
tion of the p38 and JNK MAPKs.
Oncogenes and tumor suppressor genes are fre-
quently altered in their expression between normal and
tumor specimens. Expression data from cell lines were
used to determine if any of the phosphatases were aber-
rantly expressed and to cross-check against the copy
number and methylation data. Of the phosphatase genes
found gene amplified, PTPsigma and LAR showed the
most significant expression changes, making them the
best candidates. In addition to our analysis of phos-
phatases that have undergone alterations with gene copy
number, we conducted transcriptional expression analy-
sis on the remaining phosphatases. Two sets of expres-
sion data were used to remove genes found in only one
set; 15 phosphatases showed overexpression and/or
underexpression in both sets. Of these, 3 overlapping
phosphatases were found to show significant change,
including DUSP6, PTPRK, and PTPRZ1; these will be
investigated further in the upcoming year.
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Interestingly, a binding partner for the receptor PTP
LAR, Liprin, is highly amplified and displays altered
gene expression. Liprin was shown originally to be
important for targeting LAR to focal adhesions and for
clustering the PTP at these sites, regulating cytoskeletal
function and interactions with extracellular matrix. This
observation not only highlights the potential signifi-
cance of LAR in ovarian cancer, but also, and more gen-
erally, introduces an interesting extension of the primary
project, i.e., an analysis of the proteins that interact with
the PTPs. The importance of genes that interact with
phosphatases is further highlighted by theMTSS1 gene
that was found methylated. The MTSS1 protein inter-
acts with RTPdelta, a receptor-like PTP, and cooperates
in cytoskeletal reorganization. We are currently collab-
orating with Dr. Tonks and Dr. Muthuswamy to deter-
mine the role ofMTSS1 in tumorigenesis.
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Chris Johns
James Byrnes
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The Mills lab (Fig. 1) designs and utilizes novel models
for elucidating the genetic and molecular basis of
human disease. Research areas include:
1. Determining the role of the chromatin remodeler
CHD5 in cancer and stem cell function.
2. Investigating of the role of the p53-related protein
p63 in development, cancer, and aging.
CHD5 IS A TUMOR SUPPRESSOR MAPPING TO 1P36
Deletions encompassing 1p36, a portion of the genome
residing on human chromosome 1, were first reported in
1977. Numerous studies of late-stage tumors have indi-
cated that 1p36 is frequently deleted in a variety of
human cancers, including those of the brain and blood,
as well as epithelial malignancies such as those of the
breast, colon, and prostate. Although this suggests that
an important cancer-preventing gene resides at 1p36,
this tumor suppressor gene had not been identified.
Within the past year, we identified Chd5 as a novel
tumor suppressor.We used chromosome engineering to
generate models with gain and loss of the region of the
genome corresponding to human 1p36 and studied these
models for predisposition to or protection from cancer.
Chromosome engineering combines the power of
gene targeting with Cre/loxp technology and allows the
generation of mouse strains that harbor precise
rearrangements such as deletions and duplications;
these models have loss and gain of specific regions of
the genome, respectively. This strategy allowed us to
identify a 4.3-Mb interval with potent tumor suppres-
sive activity. Whereas loss of this region caused a
marked increase in cellular proliferation that culmi-
nated in cancer in vivo, gain of the same interval trig-
gered excessive tumor suppression as observed by
augmented cellular senescence in cultured cells and
apoptosis in vivo. We used a combination of genetic
and molecular analyses to pinpoint the chromatin
remodeling protein Chromodomain, helicase, DNA-
binding domain protein 5 (Chd5) as the tumor sup-
pressor in the interval. In addition, we demonstrated
that Chd5 functions as a master regulator that facili-
tates p16/Rb- and p19/p53-modulated pathways.Analy-
MAMMALIAN FUNCTIONAL GENOMICS
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W. Keyes Y. Wu
ses of human gliomas revealed that Chd5 is frequently
deleted, suggesting that Chd5 loss contributes to this
particular neural malignancy. Mice heterozygous for
the region encompassing Chd5 are currently being
monitored for spontaneous tumors. In addition, we are
investigating the role of Chd5 in stem cells. This work
identifies a novel tumor suppressor, paving the way for
designing more effective anticancer therapies for a
wide variety of human cancers.
FUNCTION OF THE P53 HOMOLOG P63
p63 deficiency is tumor-protective.The discovery that
the p53 tumor suppressor is a member of a multigene
family that also includes p63 and p73 has brought the
p53 field into a new era. p63 is a transcription factor
structurally and functionally similar to p53; in contrast
to p53, however, p63 is rarely inactivated in human can-
cers. In fact, the 3q27 region to which p63 maps is fre-
quently amplified, or p63 is overexpressed in the
majority of epithelial tumors, suggesting that p63 has
oncogenic potential. We previously identified p63 and
generated a number of p63-deficient mouse models.
What was clear from the phenotype was that despite the
striking similarities between p63 and p53, they perform
very different functional roles in vivo: p63 is essential
for development of stratified epithelia, whereas p53 is
dispensable during embryogenesis but functions as a
potent tumor suppressor in the adult. More recently, we
found that in contrast to the high incidence of sponta-
neous tumors in p53+/– mice, p63+/– mice were not pre-
disposed to cancer. In fact, p63 heterozygosity
decreased the high tumor incidence of p53+/–mice, indi-
cating that haploid levels of p63 may even be tumor-
protective. Loss of the wild-type p63 allele did not occur
and p63 expression was maintained in the rare tumors
that did develop in the p63+/– cohort. p63+/– mice were
not even susceptible to chemical carcinogens. This indi-
cated that p63 does not perform a role equivalent to p53
in tumor suppression and that reduced p63 may provide
a novel tumor suppressive mechanism, suggesting that
modulation of p63-mediated pathways could offer an
effective strategy for anticancer therapy. We are cur-
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ent p63 proteins modulate the tumor-suppressive mech-
anism of cellular senescence.
p63 links cellular senescence and aging. Over the
course of the tumor study outlined above, we discovered
that p63+/– mice had a significant reduction in life span
and developed age-related pathology. Using a condi-
tional system to shut down p63 function specifically in
proliferating cells of stratified epithelia such as the skin,
we discovered an unanticipated link among p63, cellu-
lar senescence, and aging. Remarkably, p63 deficiency
activates a program of cellular senescence and leads to
accelerated aging. This finding suggests a mechanism
for the low tumor incidence of p63+/– mice: Cellular
senescence effectively removes aberrantly proliferating
cells from the proliferative pool, thus providing a tumor-
suppressive mechanism.A further understanding of how
p63-mediated pathways modulate stem cells and how
this affects aging and tumorigenesis is currently under
way. This work will provide a clearer understanding of
the mechanism of cellular senescence that will ulti-
mately impact our understanding of tumorigenesis and
stem cell homeostasis during aging.
PUBLICATIONS
Bagchi A., Papazoglu C., Wu Y., Capurso D., Brodt M., Francis
D., Bredel M., Vogel H., and Mills A.A. 2007. CHD5 is a
tumor suppressor at human 1p36. Cell 128: 459–475.
The Mills Laboratory: (Top row) Anindya Bagchi, Bill Keyes, Assaf Vestin, Cristian Papazoglu, Ying
Wu; (bottom row) Baoyi Li, Mathangi Ramesh, Ninche Alston, Alea Mills, Xuecui Guo. (Not shown:
Shilpi Paul.)
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A growing trend in cancer research is to focus less on
pure basic research and more on transforming labora-
tory discoveries into clinical applications. Translational
research, which includes the discovery and characteri-
zation of promising molecules or gene targets for can-
cer therapeutics, also involves establishing collabora-
tions with clinicians and industry so that we can move
basic laboratory discoveries forward into real applica-
tions. Highlighted below are our translational research
efforts in 2007.
A Functional Genetic Screen
Leads to a Potential New
Combination Therapy
N. Liu-Sullivan, J. Zhang, S. Powers [in collaboration
with G. Hannon, Cold Spring Harbor Laboratory, and
GlaxoSmithKline]
In late 2006, we joined a consortium of academic inves-
tigators who are funded by the pharmaceutical com-
pany GlaxoSmithKline (GSK) to propel the clinical
development of their candidate cancer drug portfolio.
There are two ways in which academic labs can help
move late-stage drug candidates forward into clinical
use. One is to discover a test that pinpoints which
patients will respond to the treatment. The other way is
to discover drugs that synergize with and significantly
increase the efficacy of the candidate drug.
Our project has focused on GSK’s polo-like kinase
inhibitor. The polo-like kinase gene (PLK1) is fre-
quently overexpressed in cancer and is associated with
higher proliferation and poor prognosis. Polo-like
kinase regulates several key events during mitotic pro-
gression, and its inhibition selectively kills cancer cells
for reasons that are not completely understood. To look
for genes that influence the response of cancer cells to
the polo-kinase inhibitor, we performed a functional
genetic screen targeting 1500 cancer-relevant genes
with a microRNA-based short hairpin RNA (shRNA)-
focused library. We found that silencing of the retinoic
acid receptor α gene (RARA) conferred resistance to
polo-kinase inhibition. Stimulation of this receptor by
its natural ligand and approved cancer drug retinoic
acid (ATRA) had the opposite effect of sensitizing can-
cer cells to polo-kinase inhibition. We are currently
working with GSK to determine whether these results
hold true in animal models and whether to move for-
ward into clinical trials with this combination therapy.
Gene Targets for New Cancer
Therapeutics in Liver Cancer
C. Cai, J. Zhang, Q. Liu, S. Powers [in collaboration with
S. Lowe, Cold Spring Harbor Laboratory]
The clinical success of Gleevec and Herceptin, which
target the mutated cancer genes BCR-ABL and HER2,
respectively, provided proof-of-principle that mutated
cancer genes are appropriate targets for cancer thera-
peutics. There is a shortage of such targets for liver can-
cer and our laboratory is currently receiving funding
from the National Institutes of Health (NIH) to find
cancer gene targets for this cancer type. As part of this
effort, in early 2007, we integrated the large RNA
expression and DNA copy-number liver cancer data
sets that we had accumulated to perform a genome-
wide determination of genes that are overexpressed as
a result of gene amplification.
We discovered that the most common amplicon in
liver cancer, the well-known 11q13 amplicon containing
CCND1 (the cyclin D1 oncogene discovered by David
Beach at CSHL in 1991), contains an additional candi-
date driver gene, FGF19. FGF19 encodes a secreted
growth factor and this type of protein can be easily inhib-
ited by monoclonal antibodies. We were therefore very
pleased when we found that FGF19 is indeed a func-
tional oncogene in liver cells. It is likely that FGF19was
overlooked by previous investigators because they were
studying tumor types in whichFGF19 is not turned on by
gene amplification. We are currently exploring the gen-
erality of FGF19 oncogene dependence in human liver
cancer cells, which will largely define how promising this
is as a gene target for a new liver cancer therapeutic.
We have also begun a systematic functional screen-
ing for the oncogenicity of amplified genes in liver can-
CANCER GENES
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Q. Liu M. Rajaram
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031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:52 PM  Page 77
78
cer. To do this, we have leveraged the NIH-funded
genome resource of sequence-verified human cDNA
expression vectors (the Mammalian Gene Collection).
From a select group of genes that are highly amplified
in human liver cancer samples, we have transferred 108
cDNAs into retroviral expression vectors. These vec-
tors were used to test effects on tumor formation in ani-
mals, and our results indicate that 17 of the 108 genes
are capable of driving cancer progression in liver cells.
Of these 17 new amplified oncogenes, 2 are capable of
being inhibited by antibodies.We are now focusing our
attention on determining whether these two genes are
promising targets for monoclonal antibody therapy.
Discovery of a Major New
Genetic Alteration in
Lung Cancer
D. Mu, Q. Liu, S. Powers [in collaboration with J. Kendall
in M. Wigler’s lab, Cold Spring Harbor Laboratory;
W. Gerard, Memorial Sloan-Kettering Cancer Center;
and A. Potti, Duke University]
This year, we discovered a novel genetic defect that
affects 20% of lung cancers. This gene-amplification
defect affects three genes that are located within a 150-
kb segment on chromosome 14 and results in increased
expression of the three transcription factors (TTF1,
NKX2-8, and PAX9). Both TTF1 and NKX2-8 have fun-
damental roles in fetal lung development, and PAX9 is
also a developmental transcription factor. We per-
formed functional studies to show that TTF1, NKX2-8,
and PAX9 cooperate to speed up the growth rate of lung
cells, implying that the 20% of lung tumors with this
novel mutation rely upon the synergistic interaction of
these developmental genes for rapid growth (see Fig.
1). We also showed that the affected lung tumors likely
remain addicted to each of the amplified genes using
RNA interference (RNAi). In collaboration with Dr.
William Gerald at Sloan-Kettering, we found that
amplification of this region is associated with late-stage
lung tumors and is possibly a risk factor for recurrence.
We hypothesize that certain lung cancers use gene
amplification of this region to reactivate a specific fetal
lung development process. We performed transcrip-
tome analysis to determine whether the global effects of
these amplified transcription factor genes could be used
to uncover clinically useful subtypes of human lung
cancer. In collaboration with Dr.Anil Potti at Duke Uni-
versity, we found that gene expression patterns corre-
sponding to different combinations of these
transcription factor oncogenes can predict both sensi-
tivity and resistance to cisplatin—the standard treat-
ment for advanced lung cancer—with much greater
accuracy than any predictor, including clinical param-
eters, previous genomic predictors, and P53 and K-RAS
status. This exciting result provides a potential new
diagnostic test to guide treatment in lung cancer.
FIGURE 1 Demonstration of oncogenic cooperation between the three genes within the
commonly amplified region of the 14q13 lung cancer amplicon. The recipient cell was a
nontumorigenic SV40-immortalized human lung epithelial cell. Derivatives expressing dif-
ferent combinations of the three genes were derived by retroviral transfection, and the
effect on growth was assayed by colony formation of cells plated at low density. Single
overexpressors of any of the three genes were without significant effect, but all pairwise
combinations showed significant growth-promoting effects.
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Genomic Identification of
New Therapeutic Targets and
Diagnostics in Melanoma
S. Powers [in collaboration with R. Lucito, Cold Spring Harbor
Laboratory; A. Houghton, N. Rosen, G. Schwartz, A. Halpern,
and J. Wolchok, Memorial Sloan-Kettering Cancer Center]
In late 2006, we established a collaboration with an
accomplished group of clinician-scientists studying
melanoma at Memorial Sloan-Kettering Cancer Center.
Our work in this collaboration is enabled by grants from
the LitaAnnenberg Hazen Foundation andmore recently
from the Starr Consortium. During the last year, we built
up a large data set of DNA copy-number alterations in
melanoma and have several amplified oncogene candi-
dates that we are evaluating for their suitability as ther-
apeutic targets. Our second approach has been to use
RNAi screening to look for genetic vulnerabilities in dif-
ferent classes of melanoma. This is a complementary
approach for target identification. Rather than aiming to
counteract the DNA alterations that drive melanoma for-
mation, we are conducting an unbiased search for
genetic vulnerabilities in cancer cells.
Most Focal Deletions in Colorectal
Cancer Are Secondary Consequences
of Cancer Progression
M. Rajaram, D. Mu, J. Zhang, Q. Liu, S. Powers
A basic premise of cancer research is that genetic alter-
ations that occur in many tumors—such as loss of TP53
or point mutational activation of K-RAS—provide an
important selective advantage to evolving tumor cells.
However, this year, we found that this is not necessarily
so, particularly for homozygous and other focal dele-
tions.
When we started our laboratory in 2004, we began a
comprehensive analysis of DNA copy-number alter-
ations in colon cancer genomes using high-resolution
ROMA (representational oligonucleotide microarray
analysis) arrays.As noted in prior annual reports, we ini-
tially believed that the numerous focal deletions which
we had discovered contained a treasure trove of tumor
suppressor candidates. We have now completed a sys-
tematic analysis of the biological significance of focal
deletions in colon cancer on a genome-wide scale. We
found that they occur independently of the two well-
established forms of genetic instabilities in colon can-
cers: chromosomal instability and the microsatellite
instability caused by mismatch repair defects. Instead,
the sites most frequently deleted closely match common
sites of chromosomal breaks caused by replicative stress.
We are now testing the hypothesis that the underlying
cause of these focal deletions is a distinct form of
genetic instability that results from replicative stress. A
prediction of this hypothesis is that the frequency of
recurrence does not need to reflect biological selection,
since its frequency is driven by the susceptibility of the
locus to replicative stress-induced breakage. In support
of this prediction, we found numerous distinctions
between recurrent focal deletions in colon cancer com-
pared to those affecting the well-established tumor sup-
pressor gene p16/INK4A in melanomas, and all of these
distinctions argue against a role for these focal deletions
in providing a selective advantage during colon cancer
progression. For example, deletions in colon cancer are
often within introns and have no effect on the expres-
sion of the underlying gene. Although we found rare
examples of focal deletions affecting bona fide tumor
suppressor genes (e.g., SMAD4), our analysis leads to
the sobering conclusion that most recurrent focal dele-
tions are inactive vestiges of cancer genome instability.
This doesn’t appear to be the case for all cancers; neither
liver cancer nor melanoma exhibit such deletions.
Development of a Web Site
for Mining CSHL ROMA Data Sets
J. Zhang, S. Powers [in collaboration with A. Leotta,
M. Wigler’s lab, Cold Spring Harbor Laboratory; W. Zhu,
Stony Brook University]
To help scientists at the CSHL Cancer Center take full
advantage of the substantial data sets of DNA copy-
number alterations in breast, colon, lung, melanoma,
liver, pancreatic, prostate, and other cancers that have
been generated here using ROMA during the past 3
years, we created an internal Web site—backed by a
dynamic database—that allows cancer biologists to
explore the amplification or deletion status of any gene
in a panel of more than 700 tumors. We also integrated
RNA expression data sets, and in the next year, we will
begin to incorporate the increasingly large amount of
cancer genome copy-number profiles that are being
generated by external groups. Our long-term goal for
this Web site is to integrate all genome-wide cancer
analyses (including mutational and methylation status)
to provide a simple, comprehensive platform to evalu-
ate a gene of interest for its potential involvement in
human cancer.
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MAMMALIAN GENETICS
We study variations in the human genome that arise
when a large segment of the genome is duplicated or
deleted. Such copy-number variations, or CNVs, can
arise somatically or in the germ line. The former are
often seen in cancer, distinguish cancers from the nor-
mal cells of the body, and provide clues for the origin
and behavior of the cancers. The latter distinguish indi-
viduals from each other and may be inherited, in which
case, they are known as copy-number polymorphism, or
CNPs, or they may arise spontaneously, in which case
they serve as engines of human diversity, and can cause
devastating genetic disorders, such as autism.
Our studies to date are largely based on a high-
throughput high-resolution microarray technology devel-
oped at CSHL called ROMA (representational
oligonucleotide microarray analysis), which itself was
based on an earlier technology developed at CSHL called
RDA (representational difference analysis) that was used
for discovering tumor suppressors, oncogenes, and
pathogens. ROMA is a form of a more general technol-
ogy called CGH, or comparative genome hybridization.
CGH is evolving, and part of our laboratory works on
technical improvements and extensions, such as the use
of a derivative technique called MOMA (methylation
detection oligonucleotide microarray analysis) to study
DNA methylation, and on more powerful statistical
methods for data interpretation. Part of the lab uses copy-
number data and DNA methylation status to study solid
cancers, especially breast cancer and B-cell chronic
leukemia (B-CLL). We seek to identify the genes most
frequently mutated in cancers and leukemias and, in gen-
eral, to determine whether genomic data can be used to
predict the outcome of the disease and its response to
therapy. Finally, part of the lab studies CNVs that may
underlie autism, congenital heart defects, and other pro-
found disorders of normal human development.
CANCER AND LEUKEMIA
In this past year, our studies on both breast cancer and
leukemia have moved from the discovery phase toward
COPY-NUMBER ANALYSIS AND HUMAN DISEASE
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clinical trials that will directly affect patient care. Our
work to date indicates the superiority of CGH to the tra-
ditional clinical standard of genome analysis: fluores-
cent in situ hybridization (FISH). In the breast cancer
area, we are participating in the evaluation of a clinical
trial initiated at the Radium Hospital in Oslo, Norway
that is designed to understand the role of bone marrow
micrometastasis in the clinical outcome of breast cancer.
The evaluation of copy-number data with clinical
parameters in this trial is still in progress. We have also
enrolled as collaborators with Memorial Sloan-Ketter-
ing Cancer Center (MSKCC) andYale University in the
retrospective molecular genomic analysis of cases from
previous clinical trials designed to discover better mark-
ers for successful treatment with chemotherapeutic
drugs.
We continue to focus on samples from two Scandi-
navian collaborations, with Anders Zetterberg at the
Karolinska Institute, Sweden, andAnne-Lisa Borresen-
Dale at the Radium Hospital, Norway, and with Larry
Norton at MSKCC, NewYork. These studies have elu-
cidated a set of loci, called epicenters, that are the recur-
rent sites for genome amplification and deletion in
breast cancer. The set of breast cancer epicenters over-
lap with epicenters from lung cancer (data from Scott
Powers and David Mu, CSHL) but are clearly a distinct
set. In fact, we can distinguish breast cancers from lung
cancers largely by the loci involved in amplification and
deletion, a method that may be useful in a clinical set-
ting. The epicenters are locations where many of the
genes that drive the progression of malignancy reside,
and hence, the elucidation of these loci may facilitate
drug design and the production of focused and less-
expensive tools for the evaluation of the clinical state of
cancers.
We have begun a series of studies on tumor hetero-
geneity. Clues to the progression of cancer, and its clin-
ical profile, are missed if we assume that each
individual’s cancer is a single clone with a single molec-
ular history.Work in progress indicates that at least half
of breast cancers are composed of multiple clones,
proves that sampling one region of the cancer for molec-
ular markers yields an incomplete picture, and provides
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clues about the origins of breast cancer: the stages
through which it passes and the speed with which it
evolves.
Our studies of B-cell leukemia, a collaboration with
Nick Chiorazzi of North Shore University Hospital,
Manhasset, New York, uses ROMA to identify essen-
tially all the known recurrent lesions that have been
observed in that disease, as well as several new epicen-
ters. We are in the process of designing B-CLL “tiling”
arrays that will allow us to examine the leukemic epi-
centers at greater resolution, so that we will be able to
narrow the gene candidates in each region and assess
their recurrence with greater accuracy. Such a B-CLL
chip may enable oncologists to rapidly assess the pro-
gression of the disease and guide decisions about ther-
apy. As with breast cancer, we now have evidence of
multiple clonogenic histories of leukemia in the same
patient.
We have made significant progress in our studies of
DNA methylation in cancer. Last year, we described
results achieved, in collaboration with Rob Lucito here
at CSHL, on a microarray platform (MOMA) designed
to detect methylation of CpG islands. Now, we have
identified genes that change methylation state during
the initiation and progress of breast tumors. In our first
efforts at determining the clinical significance of methy-
lation, we have analyzed approximately 80 tumors from
a clinical trial initiated at the Radium Hospital in Oslo,
Norway, that is designed to understand the role of bone
marrow micrometastasis in the clinical outcome of
breast cancer. The results of methylation microarray
analysis on this collection of patient samples along with
a separate collection of breast tumors and adjacent nor-
mal breast tissue show that the methylation patterns
clearly differ between normal tissue and tumor tissue.
More surprising, however, is the result that the tumor
DNAs naturally cluster into subgroups using methyla-
tion data alone. These subgroups match the clustering
determined by gene expression. These studies will help
us to understand the role of methylation in cancer etiol-
ogy and facilitate clinical subtyping.
GENETIC DISORDERS
Since our seminal discovery that CNV is common in the
human gene pool, we have studied the role of CNVs in
human disease and, in particular, the role of spontaneous
or de novo CNVs in autism. In a collaboration that con-
tinued with Jonathan Sebat here at cSHL, we tested the
hypothesis that de novo CNV is associated with autism
spectrum disorders (ASD). We performed CGH on the
DNA of patients and unaffected subjects to detect copy-
number variants not present in their respective parents.
Candidate genomic regions were validated by higher-res-
olution CGH, paternity testing, cytogenetics, FISH, and
microsatellite genotyping. Confirmed de novo CNVs
were significantly associated with autism. Such CNVs
were identified in about 10% of patients with sporadic
autism, in about 2% of patients with an affected first-
degree relative, and in only about 1% of controls. Most
de novo CNVs were smaller than microscopic resolution.
Affected genomic regions were highly heterogeneous and
included mutations of single genes.These findings estab-
lish de novo germ-line mutation as a more significant
risk factor for ASD than previously recognized and
clearly point to a new approach for the further study of
the genetic basis of this and other genetic disorders, such
as schizophrenia and congenital heart disease.
Consonant with the finding of spontaneous CNVs in
humans, studies in mice, a collaboration with Ira Hall
here at CSHL, have demonstrated that de novo CNVs
occur frequently in mice lineages. These studies indi-
cated that certain loci are vastly more unstable than oth-
ers and is consonant with the observation that many of
the de novo changes in humans are recurrent.
Additional analysis of autism incidence data, a col-
laboration with Kenny Ye at Albert Einstein School of
Medicine, has provided evidence for an important
genetic model for the disorder. Autism families are
divided into simplex (only one affected child) and mul-
tiplex (multiply affected children). In the latter case, we
found by inspecting the records from the AGRE con-
sortium that the risk to a male newborn in an estab-
lished multiplex family is nearly 50%, the frequency
expected of a dominant disorder. Our analysis of poly-
morphism data virtually rules out that this can be
explained as inheritance on the X-chromosome. We
find that overall autism incidence is consistent with a
model in which new mutations arise that have a strong
contribution to the disorder and are passed from a
resistant carrier parent to a child in dominant fashion.
One major source of resistance is in fact gender, and a
singularly important fact about autism is its lower inci-
dence in females.
We are now in the midst of preparing for a much
larger-scale study of spontaneous mutation in simplex
autism, dependent on a population of families being
organized by the Simons Foundation. Hopefully, this 3-
year study will lead to the identification of recurrent loci
that contribute to the majority of autism risk and might
thereby elucidate convergent pathways involved in the
etiology of the disorder, possibly leading to treatments
in some cases. One clear benefit of such a large study
will be in the design of clinical tests for genetic coun-
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seling, early detection, and perhaps matching patients
with the most effective therapies.
DATA GENERATION AND ANALYSIS
The major part of our group’s effort centers on the gen-
eration, analysis, and organization of data. This entails
developing protocols for conducting microarray exper-
iments; determining quality control, probe evaluation,
signal extraction, and segmentation (the method of
“observing” CNV); comparisons of sets of experiments,
including new statistical measures, data reduction, and
data summary; and construction of databases so that we
can communicate our results to other investigators.
Although we usually do not report our methods in this
forum, we are in the midst of preparing several manu-
scripts in which our new statistical, mathematical, and
computational ideas have a prominent role. Hopefully,
we will detail them in next year’s report.
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CANCER: SIGNAL TRANSDUCTION
Signal Transduction focuses on signaling pathways and cell architecture in normal and cancer cells.
Nicholas Tonks and colleagues study a family of enzymes called protein tyrosine phosphatases, or
PTPs, which have the beguilingly simple function of removing groups of phosphate molecules from other
proteins. PTPs are the “subtractive” half of a fundamental cell regulatory process called reversible phos-
phorylation. The opposite function—the adding of phosphate groups—is performed by enzymes called
kinases. The coordinated and competing actions of kinases and phosphatases control signaling output
in cells. By changing the phosphorylation state of proteins, PTPs initiate cascades that can profoundly
affect the health of entire organisms. Tonks’ group seeks to fully characterize the PTP enzyme superfamily,
understand how their activity modifies signaling pathways, and how those pathways are abrogated in seri-
ous illnesses, from cancer to Parkinson’s disease.
Linda Van Aelst’s lab is studying how aberrations in intracellular signaling involving enzymes called
small GTPases can result in disease. They are particularly interested in Ras and Rho GTPases, which have
roles in controlling cellular growth, differentiation, and morphogenesis. Alterations affecting Ras and Rho
function are involved in several diseases, including cancer and various neurodevelopmental disorders.
This year, Van Aelst’s team extended their study of mutations in a Rho-linked gene called oligophrenin-
1, determining that it is involved in the morphogenesis of dendritic spines, the main site of excitatory
nerve synapses. They are probing the implications for several illnesses. The lab also demonstrated that
a GTPase activator called DOCK7, previously shown to have a central role in axonal development and
morphology, is important in neuronal migration and may be involved in developmental pathology.
Yuri Lazebnik and his team are exploring the hypothesis that viruses and other common human
pathogens might be capable of causing cancer under certain conditions. They recently completed a
study demonstrating that massive chromosomal instability could be engendered by a transient event
causing destabilization of the genome without permanently affecting mechanisms such as mitosis or
proliferation. The agent, in this instance, was an otherwise harmless virus that caused chromosomal dis-
ruption by fusing cells whose cell cycle was deregulated by oncogenes. The resulting cells had unique
sets of chromosomes, or karyotypes, and some proved to be capable of producing aggressive epithe-
lial cancers in mice.
Senthil Muthuswamy regards the regulation of cell architecture as a driving mechanism in cancer. His
lab is studying cell systems, in culture and in vivo, to understand the relation between proliferation and
morphogenesis. In breast cancer, for instance, the morphogenic program seems to be disturbed. The lab
studies genes that regulate and maintain cell shape and has demonstrated that specific oncogenes, in
addition to inducing proliferation and inhibiting programmed cell death, “talk” via signaling pathways to
machineries involved in the regulation of cell morphology. The regulatory process goes awry, resulting in
cell structures manifesting dysfunctional morphological orientations, or “polarities,” an early step, perhaps,
in the genesis of cancerous lesions. Muthuswamy and colleagues are studying human epithelial cells
with the aim of understanding cancer-specific changes in polarity pathways and identifying potential ther-
apeutic strategies for epithelial and other cancer types.
Jacek Skowronski and colleagues study mechanisms involved in the induction of AIDS by human
and simian immunodeficiency viruses (HIV and SIV), focusing on the function of accessory proteins called
Nef, Vpr, and Vpx. These are important virulence factors, which modify the cellular milieu to disrupt adap-
tive and/or innate antiviral responses and provide an environment conducive for viral replication. This
year, Skowronski’s team explained how Vpr proteins in HIV and SIV overcome restrictions that host cells
impose on their reproduction, by associating with a protein complex that in turn perturbs the cell cycle
and DNA metabolism in infected cells. By providing a molecular framework for understanding virulence
factors such as Vpr, Skowronski hopes to augment efforts to rationally design drugs to control HIV-1
infection in humans.
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Despite their large variety of genetic abnormalities, cancer cells have been found to be extremely sen-
sitive to the reversal of certain mutations. The research of Raffaella Sordella is focused on the question
of why cells in certain cancers are responsive to the inhibition of one particular gene or gene product. Why,
for instance, do non-small-cell lung cancer cells that have a particular epidermal growth factor (EGF)
receptor mutation respond so dramatically to the drug Iressa? Answers are likely to bolster the search
for new targeted therapies and contribute to a better understanding of how cancer cells eventually
develop resistance to them. The Sordella lab is also interested in understanding the etiology of tumors
to which EGF receptor mutations give rise, which occur more frequently in women and people of Asian
descent.
Lloyd Trotman is examining genetic mechanisms involved in tumor suppression and tumor initiation
in mouse models. Trotman proceeds from his discovery several years ago that loss of a single copy of a
master tumor-suppressing gene called PTEN is sufficient to permit tumorigenesis in animal models of
prostate cancer. This disproved the common assumption that cancer could develop only if both copies
of a potent suppressor gene were lost. Paradoxically, Trotman and colleagues found that complete loss
of PTEN triggered senescence, a quiescent state that had the effect of delaying or blocking cancer in
affected cells. Currently, the lab is exploring the impact of varying PTEN expression levels, alone and in
conjunction with changes in other potent tumor suppressors including p53 in mouse models for prostate
cancer.
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Genomic instability (GIN), which is defined as an
abnormal and persistent change of a genome over time,
is a common feature of many solid cancers and is
thought to underlie malignant properties of these
tumors. In the majority of solid cancers, GIN is mani-
fested by chromosomal instability (CIN), a condition in
which the structure of chromosomes or their assortment
changes over time, making the affected cells aneuploid.
It is well documented that the maintenance of CIN
is enabled by deficiencies in proteins that police genome
integrity, such as the tumor suppressor p53, but the
cause(s) of CIN in sporadic cancers remains uncertain.
The primary suspects are DNA damage, or mutations
that deregulate telomere maintenance or mitosis, yet
such mutations have not been identified in the majority
of sporadic cancers.
We previously proposed a hypothesis that viruses can
contribute to carcinogenesis and tumor progression by
fusing cells. The consequences of this fusion could be
twofold: combining properties of cells and causing
chromosmal instability. During the previous year, we
demonstrated that fusing human cells which had rela-
tively stable genomes produced hybrids affected by mas-
sive chromosomal instability, as indicated by the
observation that each analyzed cell has a unique kary-
otype. Some of these hybrids, but not the parental cells,
produced aggressive, highly aneuploid, heterogeneous,
and transplantable cancers in mice.
Because many human viruses are fusogenic, we sug-
gested that viruses, including those that have not been
linked to carcinogenesis, contribute to cancer by causing
chromosomal instability through cell fusion.We also pro-
posed that detecting causes of cell fusion in solid cancers
might lead to viruses that directly or indirectly participate
in carcinogenesis. Last year, we began to develop exper-
imental systems to test several aspects of the hypothesis
that cell fusion caused by viruses contributes to cancer. In
the middle of the year, Dominik Duelli departed to set up
his own laboratory at Rosalind Franklin University, and
Amy Gottesman and I continued the study.
We previously found that fusion of normal human
cells causes cell cycle arrest, which was abrogated by
the adenoviral oncogene E1A or by ectopic expression
CELL-TO-CELL FUSION AS A LINK BETWEEN VIRUSES
AND CANCER
Y. Lazebnik D. Duelli
A. Gottesman
of mutated tumor suppressor p53. We postulated that
this arrest was caused by a mechanism that we named
the fusion checkpoint (FCP) and suggested that dereg-
ulation of the FCP by oncogenes could contribute to car-
cinogenesis. During 2007, we set up an experimental
system to study what the mechanism of this arrest is and
how it is regulated. A particular difficulty that we man-
aged to overcome was to develop an approach to ana-
lyze cell cycle distribution of individual nuclei in
heterokaryons and to distinguish heterokaryons from the
cells that became binuclear by failing to divide.
We also focused on investigating how cell fusion
causes chromosomal instability by considering two
hypotheses. One hypothesis is that CIN is a result of
tetraploidy, a natural consequence of cell fusion that
might overwhelm the mitotic machinery, thus decreasing
fidelity of chromosome segregation.Another hypothesis
is that cell fusion causes massive DNA breaks through a
process known as premature chromosome condensation,
or PCC.To distinguish between these hypotheses, we set
up a system in which cells can be either fused or made
tetraploid by inhibiting cytokinesis.
One caveat of our study that identified carcinogenic
hybrids was that we caused cell fusion by an infectious
retrovirus. Although we detected no carcinogenic effect
of the virus in a setting in which cell fusion was avoided,
the use of an infectious retrovirus left open the possi-
bility that the carcinogenic effect that we observed was
due to effects of retroviral infection, such as insertional
mutagenesis, that are unrelated to cell fusion. Therefore,
we began to develop an experimental system in which
cell fusion is caused by ectopically expressed viral fuso-
genic proteins. This system will also be useful in testing
whether cell fusion can affect tumor progression.
Overall, our work during this year has been primarily
focused on developing experimental systems that we
will use to determine how cell fusion causes cell cycle
arrest and how abrogation of this arrest by oncogenic
events leads to chromosomal instability. Irrespective of
whether any consequences of cell fusion contribute to
carcinogenesis, our research will develop an experi-
mental framework to test the role of chromosomal insta-
bility in cancer.
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Breast cancer is a leading cause of cancer death among
women. Current therapeutic strategies are mostly aimed
at controlling malignant breast cancers. Although these
strategies are helping patients by extending their life
span, they do not stop the cancer. We hope to develop
novel strategies that can control cancer better. Our
research has two broadly focused goals: (1) to develop
novel strategies to diagnose and treat cancer early (pre-
cancers) and (2) to identify strategies to enhance thera-
peutic response of drugs that are currently used in the
clinic.
NOVEL STRATEGIES TO TARGET PRECANCER
Increased rates of cell proliferation and disruption of
normal tissue architecture are the key changes observed
in premalignant lesions. Disruption of tissue architec-
ture is a key criterion used by pathologists to diagnose
and grade cancer, supporting a notion that pathways that
control tissue architecture have critical roles during can-
cer initiation and progression. Although pathways that
lead to an increase in cell number have been intensely
interrogated, very little effort is being directed toward
identifying pathways that mediate disruption of tissue
architecture. I believe that a detailed understanding of
the mechanism by which cell architecture is disrupted
during cancer will provide new insights into our under-
standing precancerous lesions that will not only iden-
tify a new class of drug targets, but also identify a new
class of biomarkers that can be used to predict progno-
sis of premalignant lesions.
All malignant breast cancers originate from epithelial
cells. In normal breast tissue, epithelial cells line the
ductal structures and are involved in secretion of milk.
These cells have a characteristic architecture referred to
as apical-basal polarity, where the apical surface faces
the lumen and the basal-lateral surface is in touch with
the surrounding microenvironment. The molecular
mechanisms by which the epithelial cells establish and
maintain polarity is an active area of investigation. There
are several proteins and protein complexes that function
as a highly interactive network during establishment and
EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy V. Aranda M. Nolan
K. Bergami A. Rosenberg
S. Chatterjee L. Zhan
A. Lucs
maintenance of epithelial cell polarity. One such com-
plex, the Par6/aPKC/Cdc42, regulates polarization
processes during epithelial morphogenesis, astrocyte
migration, and axon specification. We and other inves-
tigators have demonstrated that this complex is also
required for disruption of apical-basal polarity during
oncogene ErbB2-induced transformation and trans-
forming growth factor-β (TGF-β)-induced invasion of
mammary epithelial cells.
Our recent results show that expression of Par6 in
mammary epithelial cells induces epidermal growth
factor (EGF)-independent cell proliferation and devel-
opment of hyperplastic three-dimensional acini without
affecting apical-basal polarity. This was dependent on
the ability of Par6 to interact aPKC and Cdc42 but not
Lgl and Par3 and its ability to promote sustained acti-
vation of MEK/Erk signaling. Interestingly, Par6 is over-
expressed in estrogen-receptor-positive (ERtve) primary
human breast cancers and in ERtve precancerous breast
lesions. Either Par6β itself or the pathways it regulates
may be excellent candidates for predictive biomarkers or
drug targets for premalignant lesions.
Loss-of-function mutations in polarity genes, such
as Scribble, induce neoplastic overproliferation of
epithelial cells in Drosophila, suggesting that polarity
genes function as tumor suppressors by regulating cell
proliferation. The role polarity genes, including Scrib-
ble, have during tumorigenesis in mammals is poorly
understood. We have discovered that down-regulation
of Scribble promotes Myc-induced transformation of
mammary epithelial cells in culture and in mouse mod-
els of breast cancer by blocking Myc-induced cell death
with no detectable effect on proliferation. Surprisingly,
Scribble is required for Myc to activate the Rac-JNK (c-
Jun amino-terminal kinase) pathway and trigger apop-
tosis. Inhibition of Rac or JNK activity phenocopied
Scribble loss and blocked Myc-induced apoptosis, indi-
cating that the Scribble-Rac-JNK axis of signaling is a
novel regulator of Myc-induced transformation of mam-
mary epithelial cells. In addition, loss of Scribble blocks
luminal apoptosis during acinar morphogenesis of
breast epithelial cells in three-dimensional culture and
promotes development of dysplastic mammary ductal
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outgrowth in vivo. Our results demonstrate that Scribble
regulates cell death pathways during normal morpho-
genesis and Myc-induced transformation of mammary
epithelial cells. Thus, in mammals, Scribble functions
as a tumor suppressor by regulating cell death.
NOVEL TARGETS FOR ERBB2-POSITIVE
BREAST CANCERS
ErbB2 belongs to the EGF-receptor (EGF-R) family of
receptor tyrosine kinases. Amplification of erbB2
occurs in about 25% of breast cancers and is correlated
with a poor clinical outcome. Although ErbB2 is not
activated by direct binding of soluble ligands, it is acti-
vated by ligand-induced formation of heterodimers with
other EGF-R family members, namely, EGF-R/ErbB1,
ErbB3, and ErbB4. Overexpression of ErbB2 can also
result in ligand-independent receptor homodimerization
and activation. Overexpression of neu (the mouse
homolog of human erbB2) under the control of mouse
mammary tumor virus (MMTV) long terminal repeat
(LTR) results in mammary tumorigenesis, suggesting
that erbB2 can initiate tumorigenesis in vivo.
ErbB2 is a drug target for human breast cancer. A
humanized monoclonal antibody against the extracellu-
lar domain of ErbB2, Herceptin, is used to treat patients
expressing high levels of ErbB2 in combination with
chemotherapy. In patients who respond to the treatment,
Herceptin can delay mortality anywhere between 9
months to 3 years. However, almost 50% of the patients
with tumors that contain erbB2 amplification do not
respond to Herceptin and those who do respond develop
resistance to the drug, highlighting the need for better
options to treat patients with ErbB2-positive cancers. A
better understanding of the ErbB2 signaling pathway
can identify novel targets for combination therapy that
will significantly aid in our ability to treat patients with
ErbB2-amplified breast cancers.
Members of the ErbB2 signaling pathway can also
be coamplified with ErbB2 in breast cancer. For exam-
ple, Grb7, a Src homology domain (SH2) containing an
adaptor molecule that associates with ErbB2 and ampli-
fies signaling by ErbB2, is a component of the ErbB2
amplicon. In addition to the erbB2 amplicon, erbB2-
amplified tumors also possess several gains and losses
located elsewhere in the genome. Whether these
genomic alterations contain novel members of the
ErbB2 signaling pathway that are involved in initiation,
progression, and maintenance of erbB2-amplified breast
tumors is poorly understood.
We have discovered that Brk, a cytoplasmic tyrosine
kinase, is coamplified and coexpressed with ErbB2 in
human breast cancers. ErbB2 interacts with Brk and
increases its intrinsic kinase activity. Expression of Brk
enhances the ErbB2-induced activation of Ras/MAPK
(mitogen-activated protein kinase) signaling and cyclin
E/cdk2 activity to induce cell proliferation of mammary
three-dimensional acini in culture. To investigate
whether ErbB2 and Brk cooperate during mammary
tumorigenesis in a mouse model, we developed a novel
mammary fat pad transplantation system to generate
transgenic mammary tissue. This approach involves the
use of pluripotent mammary epithelial cells engineered
ex vivo that can be transplanted into epithelium-free
mammary fat pads.
Using this model, we show that expression of Brk
shortened the latency of ErbB2-induced tumors by pro-
moting cell proliferation with no effect on protection
from apoptosis. Furthermore, overexpression of Brk
confers resistance to the ability of Lapatinib, an ErbB2
kinase inhibitor, to inhibit ErbB2-induced proliferation.
Thus, we identified Brk as a novel drug target for
ErbB2-positive cancers. In addition, this study serves as
a proof-of-principle for conducting a large-scale inves-
tigation to identify novel targets for ErbB2-positive
breast cancers. Thus, we have made key advances both
in finding insights into the role polarity proteins have
during early stages of breast cancer and in finding a new
target for ErbB2-positive breast cancers.
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Our interest lies in understanding the molecular mech-
anisms that underlie the pathogenesis of AIDS and, in
particular, understanding the functional consequences
of interactions between viral proteins and the regulatory
machineries in the infected cells. The main focus of our
research is to understand the functions of Nef, Vpr, and
Vpx accessory virulence factors of human and simian
immunodeficiency viruses (HIV and SIV). We have
directed a major effort toward the identification of
mechanisms and downstream effectors that mediate the
effects of Nef and Vpr in the infected cells, and our
experiments have been concentrated in two main areas.
One major focus has been on the isolation and iden-
tification of cellular proteins that mediate the effects of
Nef on signal transduction and endocytic machineries.
This has led to the purification and microsequencing of
several cellular factors that associate with Nef in T lym-
phocytes. Importantly, one of Nef targets is a critical
molecular switch that regulates Rac GTPases down-
stream from chemokine- and antigen-initiated signaling
pathways. This interaction enables Nef to influence mul-
tiple aspects of T-cell function and thus provides an
important mechanism by which Nef impacts pathogen-
esis by primate lentiviruses.
The other major focus has been on identification of
downstream effectors of lentiviral Vpr and Vpx acces-
sory proteins. These experiments have led to the
description of several novel cellular proteins that tightly
associate with these factors in hematopoietic cells.
Among them are E3 ubiquitin ligase complexes that reg-
ulate cell cycle progression and the repair of damaged
DNA. The observation that Vpr tightly associates with
E3 ubiquitin ligase components is interesting because
HIV replication is known to be restricted by protein
ubiquitination. Remarkably, we found that both the Vpr
and Vpx proteins target a novel substrate adaptor for
Cullin 4 and function through their associated Cullin-4
E3 ubiquitin ligase complexes. Here, we describe in
more detail our studies of lentiviral Vpr.
FUNCTIONS OF VPR AND VPX LENTIVIRAL
ACCESSORY FACTORS
Vpr and Vpx are multifunctional accessory proteins of
simian and/or human immunodeficiency viruses (HIV-
CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Gierszewska M. Kwofie
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1, HIV-2, and SIV). One function of HIV-1 Vpr is to
mediate translocation of viral reverse transcription com-
plexes into the nucleus in nondividing cells, such as ter-
minally differentiated macrophages. The other is to
perturb the cell cycle progression of the infected cell.
Both functions are thought to be important for facilitat-
ing the HIV-1 life cycle in the infected host. Unlike HIV-
1, which possesses only the vpr gene, HIV-2 and
SIVmac specify both the vpr and a closely related vpx
gene. Interestingly, theVpr proteins encoded by SIV and
HIV-2 block cell cycle progression in the G2/M phase
similar to HIV-1 Vpr but do not have the ability to pro-
mote nuclear transport of the preintegration complexes
in nondividing cells. This latter function is thought to
be executed byVpx accessory factors encoded by these
HIV-2/SIV strains. Thus, two separable functions of the
HIV-1Vpr protein are encoded by distinct polypeptides
in HIV-2/SIV. We thought that comparative studies of
host-cell proteins that associate with Vpr/Vpx would
provide a interesting system in which to analyze the
molecular mechanisms mediating the cell cycle and
nuclear transport effects of these accessory proteins.
VPR AND VPX ASSOCIATE WITH CATALYTIC
AND REGULATORY COMPONENTS OF
CULLIN-4-BASED E3 UBIQUITIN LIGASE COMPLEXES
We used a combination of biochemical and proteomic
approaches to identify cellular proteins associated with
human and simian Vpr/Vpx proteins. Briefly, Vpr (or
Vpx) and its associated proteins were purified from cells
by two sequential immunoprecipitations and analyzed
by multidimensional protein identification technology
(MudPIT). MudPIT is a combination of chromato-
graphic and mass spectrometric procedures that allow
unbiased and sensitive identification of proteins in com-
plex mixtures. These experiments were carried out in
collaboration with Drs. Michael Washburn, Laurence
Florens, and Selene Swanson of Stowers Institute for
Medical Research (Kansas City, Kansas).
The MudPIT analysis identified three relatively
abundant polypeptides—DDB1, DDA1, and VprBP/
DCAF1—that were specifically and abundantly associ-
ated with both HIV-1 and SIVmacVpr proteins, as well
as with SIVmacVpx. DDB1 is an obligatory subunit of
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all known E3 ligase complexes assembled on a Cullin-
4 (Cul4) scaffold. VprBP/DCAF1, a known HIV-1Vpr-
binding protein recently shown to bind DDB1, is
thought to function as one of many substrate receptors
that recruit cellular proteins for ubiquitination by the E3
enzyme. DDA1 was also shown to bind DDB and has
been implicated for regulation of E3 ligase catalytic
activity. Thus, our findings tentatively linked Vpr to
Cul4 RING E3 (Cul4 E3) ubiquitin ligases. These
enzymes are known to regulate DNA repair and repli-
cation through ubiquitination of key components of
these processes.
Our subsequent biochemical studies revealed that
DDA1, DDB1, andVprBP/DCAF1 form a ternary com-
plex, which is then targeted by Vpr, and that this com-
plex links Vpr and Vpx proteins to the catalytic core of
the ubiquitin ligase organized on the Cul4 scaffold. The
notion that Vpr proteins target a Cul4-based E3 ubiqui-
tin ligase is interesting because previous evidence indi-
cated that replication of primate lentiviruses is restricted
to some extent by protein ubiquitination. These findings
raised the possibility that Vpr/Vpx promote lentivirus
replication by modulating protein ubiquitination in
infected cells.
VPRBP REGULATES CELL CYCLE
As aforementioned, Cul4 E3 ubiquitin ligases are
thought to control DNA replication and progression of
the cell cycle. We hypothesized that Vpr usurps
VprBP/DCAF1 and its associated Cul4 E3 to perturb
these processes. To address this possibility, we charac-
terized the normal function of VprBP using RNA inter-
ference and functional assays. Strikingly, cell cycle
analyses revealed that the majority of VprBP depleted
cells in the G1 and G2 phases. These findings indicated
that VprBP/DCAF1 is essential for progression of the
cell cycle.
Cell cycle arrests at the G1/S border and in G2 fre-
quently reflect activation of DNA damage checkpoints.
To assess whether VprBP/DCAF1 depletion activates
checkpoint responses, we next analyzed expression of
key checkpoint proteins and cell cycle regulators in
VprBP/DCAF1-depleted cells.We found that the steady
state of several proteins involved in the cellular response
to DNA damage, such as Ser-139-phosphorylated his-
tone H2A.X variant (γ-H2A.X), as well as the p53 and
p21 cyclin-dependent kinase inhibitor, which mediates
the p53-dependent DNA-damage checkpoint (35), were
all increased in VprBP-depleted cells. This indicated
that VprBP/DCAF1-depleted cells arrest at DNA-dam-
age checkpoints. Furthermore, these observations impli-
cate a role for VprBP/DCAF1 in DNA replication
and/or cellular response to damaged DNA.
HIV-1 VPR ARRESTS CELL CYCLE BY INTERACTING
WITH THE CUL4-DDB1[VPRBP] E3 COMPLEX
One conserved function of Vpr proteins is their ability
to arrest cells in the G2 phase of the cell cycle at the
DNA-damage checkpoint. Our finding that
VprBP/DCAF1 regulates the cell cycle and interacts
with checkpoint responses suggested that Vpr could
arrest the cell cycle through its interaction with
VprBP/DCAF1 and its associated Cul4 E3 ubiquitin lig-
ase. To address this possibility, a panel of HIV-1 Vpr
alleles were tested for their abilities to arrest cells in G2
and to bindVprBP and its associated Cul4 E3. Remark-
ably, we found perfect correlation between the ability of
Vpr to associate with theVprBP and its associated Cul4
and to arrest cells in the G2 phase of the cell cycle. This
evidence strongly supports the possibility that Vpr
manipulates the cell cycle by modulating the ubiquitin
proteasome system through its interaction with
VprBP/DCAF1-associated Cul4 ubiquitin ligase. Cur-
rent studies address how Vpr alters protein ubiquitina-
tion and how this impacts the lentivirus life cycle.
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According to theAmerican Cancer Society, non-small-
cell lung carcinoma (NSCLC) is the leading cause of
death from cancer in the United States. Most patients
with advanced NSCLC have a median survival of 4–5
months after diagnosis, and a 1-year survival of less
than 10%. The use of conventional chemotherapies for
NSCLC usually results in a very modest survival
increase, but at the cost of significant toxicity.
The development of “smart” drugs—targeting spe-
cific oncogenes that tumors depend on for survival—
has proven to be an effective therapeutic strategy in our
attempt to combat cancer and has therefore generated
much excitement in recent years. Such therapies are
associated with limited side effects and thus, wider ther-
apeutic windows of intervention. Successful examples
of targeted therapies include monoclonal antibodies
against cell surface proteins, i.e., Herceptin®
(trastuzamab) and Erbitux® (cetuximab); small-mole-
cule ATP antagonists targeting tyrosine kinase activity,
i.e., Gleevec® (imatinib), Iressa® (gefitinib), and
Tarceva® (erlotinib); and selective transcription factor
inhibitors, i.e., Tamoxifen.
Phase II and III clinical trials of small-molecule
inhibitors targeting epithelial growth factor receptor
(EGFR) tyrosine kinase activity, namely, gefitinib and
erlotinib, have indicated that a small subset of NSCLC
patients benefit substantially from EGFR inhibitor ther-
apy. Recently, we provided evidence showing that the
presence of specific EGFR somatic mutations corre-
lates highly with the positive dramatic response
observed in this subset of NSCLC patients. These
mutations affect four exons spanning the kinase domain
of the receptor. We demonstrated that the presence of
these mutations substantially alters the biochemical
properties of EGFR.
The studies conducted in our laboratory are aimed at
understanding how and why cancer cells become
dependent on mutant EGFR for their survival and how,
in instances of acquired resistance, these same cells
become refractory to EGFR-selective inhibition.
MOLECULAR TARGETED THERAPY OF LUNG CANCER: EGFR
MUTATIONS AND RESPONSE TO EGFR INHIBITORS
R. Sordella H. Archibald K. Melgar
C. Biot A. Ratner
S. Fenoglio A. Torres
T. Linsted
Functional Analysis of Mutant
EGFR Signaling Pathways
T. Linsted, C. Biot, A. Ratner, K. Melgar
One of the main goals of our studies is to understand why
inhibition of EGFR results in cancer cell death (oncogene
addiction). Several theories have been proposed to pro-
vide a molecular explanation to cancer cell dependency
on the activity of certain oncogenes. It has been hypoth-
esized that the presence of selective oncogenes (e.g.,
mutant EGFR) can lead to a rearrangement of preexisting
cellular signaling networks resulting in an increased vul-
nerability to apoptotic stimuli. More recently, our col-
league Dr. Jeff Settleman at the Massachusetts General
Hospital proposed an alternative theory termed “onco-
genic shock.” On the basis of this theory, oncogenes acti-
vate proapoptotic and antiapoptotic signaling pathways
characterized by different kinetic of inactivation. As a
consequence of oncogene inactivation, long-lived
proapoptotic pathways will not be effectively balanced by
prosurvival short-lived signaling pathways. This imbal-
ance in signaling supposedly results in cancer cell death.
We and other investigators have shown that mutant
EGFRs are characterized by an augmented kinase activ-
ity and an increased activation of AKT and STAT pro-
survival pathways. We are currently studying the
molecular mechanism underlying these qualitative sig-
naling differences. In addition, we are investigating
whether and how these same signaling pathways play a
part in determining cell addiction to mutant EGFR.
Identification of New Determinants of
Erlotinib and Gefitinib Sensitivity
S. Fenoglio
Retrospective studies have showed a high degree of cor-
relation between the presence of EGFR somatic muta-
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tions and responses to erlotinib and gefitinib treatment.
Yet not all patients harboring mutations within the
EGFR locus will respond to gefitinb and erlotinib treat-
ment, although other patients, whose tumors express the
wild-type EGFR allele only, have been reported to show
a partial response to EGFR-selective inhibition.
More recently, clinical and experimental data have
also indicated that the lengths of the response to gefi-
tinib and erlotinib treatment are highly variable, occa-
sionally lasting for more than 4 years; however, in most
cases, relapses are observed as early as 6 months. The
presence of secondary mutations within the EGFR locus
and amplification of the c-met gene have been specifi-
cally suggested to be important mechanisms of acquired
resistance.
We are interested in uncovering new determinants of
the cellular response to EGFR inhibition with the goal
of developing new therapeutic options for NSCLC treat-
ment.
To this aim, we developed an in vitro cell-based sys-
tem that leads to the identification of SOCS2 as a poten-
tial player in gefitinib and erlotinib primary and
acquired resistance. We are currently investigating the
molecular mechanism underlying the increased resist-
ance observed in cells overexpressing SOCS2.
Interestingly, we found that SOCS2 expression is
regulated in NSCLC by estrogen receptor activity and
that, in the context of NSCLC, estrogen antagonizes the
oncogenic potential of mutant EGFR by regulating the
expression of SOCS2. On the basis of these data, we are
investigating whether low levels of estrogen receptor
activity and SOCS2 are required for the establishment of
tumors driven by mutant EGFR. These findings could
provide new therapeutic options and could potentially
explain the observation that in postmenopausal women,
in which levels of estrogen are particularly low, lung
tumors containing mutant EGFR are more common.
Identification of New NSCLC
Therapeutic Targets
H. Archibald, A. Torres
On the basis of the successes of gefitinib and erlotinib,
our laboratory is also interested in uncovering new
oncogenes that, similar to EGFR, can be used as thera-
peutic targets for the treatment of NSCLC. To this aim,
we are utilizing functional genetic screens that will
allow us to uncover signaling pathways and genes to
which NSCLC cells rely on for their survival. The expe-
rience with gefitinib and erlotinib taught us that, in
some cases, molecular-targeted therapies will work in
only a small subset of patients. The low frequency of
genetically defined responsive patient subsets thus calls
for consideration of a broader sampling to achieve a rep-
resentation of genetic diversity. For example, to detect a
response similar to the one observed in the case of gefi-
tinib and erlotinib treatment in NSCLC patients (i.e.,
10%), we can estimate that a cell-based screen would
require a minimum of 50 cell lines.
On the basis of this consideration, we collected in the
past year more than 80 NSCLC-derived cell lines. By
using a compound-based screen, we were able to clas-
sify the cell lines of our in-house collection in several
clusters characterized by different sensitivities to a large
pool of compounds targeting signaling pathways known
to be deregulated in tumors. As a result, we identified a
subset of cell lines that display high sensitivity to
PDGFR-selective inhibitors. We are currently investi-
gating the molecular basis of their selective sensitivity
and, although the benefit of a PDGFR-based therapy in
the treatment of NSCLC has yet to be elucidated, in col-
laboration with Dr. Scott Powers’s group here at CSHL,
we are attempting to identify genetic markers that can be
used in the clinic for the upfront selection of tumors that
will respond to PDGFR-selective inhibition.
PUBLICATIONS
McDermott U., Sharma S.V., Dowell L., Greninger P., Montagut
C., Lamb J., Archibald H., Raudales R., Tam A., Lee D.,
Rothenberg S.M., Supko J.G., Sordella R., Ulkus L.E., Iafrate
A.J., Maheswaran S., Njauw C.N., Tsao H., Drew L., Hanke
J.H., Ma X.J., Erlander M.G., Gray N.S., Haber D.A., and
Settleman J. 2007. Identification of genotype-correlated sen-
sitivity to selective kinase inhibitors by using high-throughput
tumor cell line profiling. Proc. Natl. Acad. Sci. 104: 19936–
19941.
Mulloy R., Ferrand A., Kim Y., Sordella R., Bell D.W., Haber D.A.,
Anderson K.S., and Settleman J. 2007. Epidermal growth
factor receptor mutants from human lung cancers exhibit
enhanced catalytic activity and increased sensitivity to gefi-
tinib. Cancer Res. 67: 2325–2330.
93
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:52 PM  Page 93
The phosphorylation of tyrosyl residues in proteins is a
key component of the regulation of signaling pathways
that control many fundamental physiological processes,
including cell proliferation and differentiation. Protein
phosphorylation is a reversible, dynamic process in
which the net level of phosphate observed in a target sub-
strate reflects the coordinated activity of the kinases that
phosphorylate it and the protein phosphatases that cat-
alyze the dephosphorylation reaction.We study the fam-
ily of protein tyrosine phosphatases (PTPs), which, like
the kinases, comprise both transmembrane receptor-
linked forms, as well as nontransmembrane cytoplasmic
species and represent a major family of signaling
enzymes.
Overall, the objective of the lab is to develop tools for
analysis of PTP regulation and function and integrate
them with state-of-the-art cell and animal models to
define critical tyrosine-phosphorylation-dependent sig-
naling events in human disease. It is anticipated that
these studies will lead to identification of novel thera-
peutic targets and biomarkers at two levels. By elucidat-
ing the signaling function of PTPs in disease models, we
will reveal examples in which the PTPs themselves, or
regulators of PTP function, are targets. Furthermore, we
will use the PTPs as probes to define critical signaling
pathways in human disease fromwhich novel targets will
be identified.
There was significant turnover in our lab during the
last year. Deirdre Buckley went back home to Ireland to
take up the position of Senior Research Scientist at the
Biosciences Institute, University College Cork. Naira
Gorovits became a Scientific Analyst in the law firm of
Jacob, Medinger, and Finnegan LLP. Antonella Piccini
returned to Italy as a Research Associate at the NATO
Institute in Trieste. Shanta Hinton joined the faculty of
Hampton University, Virginia, as an Assistant Professor
in the Department of Biological Sciences.
Seung-Jun Kim came to the lab as aVisiting Scientist
from the Korea Research Institute of Bioscience &
Biotechnology at the University of Science & Technol-
ogy in Korea. Ulla Schwertassek joined us as a postdoc-
toral fellow, having completed her Ph.D. in the lab of Dr.
Tobias Dick at the German Cancer Research Center
PROTEIN TYROSINE PHOSPHATASES AND THE
CONTROL OF SIGNAL TRANSDUCTION
N.K. Tonks B. Boivin S.-J. Kim U. Schwertassek
F. Chaudhary L. Li D. Vasudevan
A. Haque G. Lin X.C. Zhang
(DKFZ) in Heidelberg. In addition, two graduate stu-
dents, Fauzia Chaudhary and Deepika Vasudevan, from
the Molecular and Cellular Biology Program at Stony
Brook, began their Ph.D. studies. Finally, Xiaoqun
Catherine Zhang joined the group as a ResearchAssoci-
ate.
FUNCTIONAL ANALYSIS OF THE “PTPOME”
We have now identified all of the PTP genes in the
human genome (there are ~100) and more recently have
extended our genomic sequence analysis to other organ-
isms. To date, various studies from many labs have
pointed to the functional importance of the PTPs in the
control of cell signaling. It is now apparent that the PTPs
have the capacity to function both positively and nega-
tively in the regulation of signal transduction. Further-
more, the PTPs have the potential to display exquisite
substrate, and functional, specificity in vivo. Neverthe-
less, the majority of the members of the PTP superfam-
ily have yet to be characterized. Hence, the PTPs remain
a largely untapped resource that can be exploited to
reveal new insights into the regulation of signal trans-
duction. Having defined the composition of the PTP
superfamily, the overall goal of this aspect of the work
in the lab is to develop the tools and reagents for a func-
tional analysis of the “PTPome,” i.e., to analyze the
function of members of the PTP superfamily, under nor-
mal and pathophysiological conditions, from the per-
spective of the family as a whole.
During the past year, we have completed construc-
tion of a library of short hairpin RNAs (shRNAs) that
targets each of the PTPs (five shRNAs for each PTP)
and therefore will allow us to interrogate systematically
the function of the members of this family of signaling
enzymes by RNA interference (RNAi) in various dis-
ease models. In addition, we have been assembling a
collection of antibodies to each of the PTPs, to facili-
tate analysis of protein suppression by RNAi, and a col-
lection of expression plasmids for each of the PTPs, to
facilitate follow-up studies on candidates identified in
RNAi screens.
Our first application of this library is being con-
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ducted in collaboration with Senthil Muthuswamy, who
is an expert in cell models of breast cancer, here at
CSHL. We have begun by using his three-dimensional
(3D) cell culture system, which recapitulates several
aspects of mammary gland architecture in vivo and has
been used to model the biological activities of cancer
genes, including the oncoprotein tyrosine kinase HER2
(ErbB2), which is overexpressed in about 25% of breast
tumors. In 3D culture, mammary epithelial cells
undergo a morphogenetic program that culminates in
the formation of multicellular structures that are remi-
niscent of acini in vivo. We are investigating the effects
of attenuating PTP expression on the ability of
MCF10A mammary epithelial cells to undergo differ-
entiation into acini and on the ability of HER2 to inter-
fere with that process.
Thus far, we have observed that suppression of a
receptor PTP, PTPRO, led to an increase in acini size,
which was associated with an extended period of prolif-
eration, without effect on apoptosis. In addition, we
observed that suppression of PTPRO enhanced the pro-
liferation and formation of multi-acinar structures
induced by HER2, suggesting a previously unknown
function for PTPRO in down-regulating signaling path-
ways triggered by HER2. In parallel, we tested the effects
of suppressing DEP-1, a receptor PTP that was first iden-
tified in this lab and has been suggested to have a tumor
suppressor function in colon. In contrast to PTPRO, sup-
pression of DEP-1 alone was sufficient to induce a multi-
acinar phenotype in MCF10A cells in 3D culture. These
experiments suggest that different PTPs exert distinct
effects in the control of acinar development, presumably
through differences in substrate specificity and through
regulation of distinct signaling pathways. Our studies to
date have now established the methodology for a sys-
tematic screen for the effects of PTP superfamily mem-
bers on mammary epithelial cell differentiation and we
are preparing to conduct such a screen.
In the interim, we have proceeded with a distinct
screen to define the function of PTPs in the regulation
of HER2-induced cell motility. In this case, we are using
MCF10A cells that express an inducible HER2 protein
and testing for the effects of PTP suppression on cell
migration in Transwell chambers, in the presence or
absence of a small-molecule dimerizer that activates the
kinase. In a proof-of-concept assay, we tested the effects
of suppressing PTP1B expression. Recent studies from
the Tremblay (McGill University, Montreal) and Neel
(Beth Israel Deaconess Medical Center, Harvard Med-
ical School) labs have shown that when mice expressing
activated alleles of HER2 were crossed with ptp1B-
knockout mice, tumor development was delayed and the
incidence of lung metastases was decreased. It has also
been shown that PTP1B is overexpressed in HER2-
transformed cells. Thus, PTP1B, which has a well-estab-
lished role in down-regulating insulin and leptin
signaling, appears also to have a positive role in regu-
lating signaling events associated with breast tumorige-
nesis. We noted that suppression of PTP1B attenuated
HER2-induced migration of MCF10A cells consistent
with such a positive signaling function. Interestingly,
suppression of the closely related enzyme TCPTP was
without effect. We are now examining the substrate
specificity of PTP1B in this context to define its mech-
anism of action. In addition, we have almost completed
our systematic analysis of the whole enzyme family in
this screen and have identified five PTPs for which sup-
pression enhanced HER2-dependent migration and one
PTP, suppression of which attenuated migration. In col-
laboration with Jim Hicks and Mike Wigler, here at
CSHL, we are also examining changes in expression, in
DNA methylation or mutations in these PTPs in breast
cancer compared to normal tissue. Currently, we are
defining optimal conditions for further analysis of the
substrate specificity and mechanism of action of the
PTPs identified in this screen. This approach shows
great potential to shed new light on the roles of PTPs in
the etiology of breast cancer.
REGULATION OF PTP FUNCTION BY
REVERSIBLE OXIDATION
The signature motif of the PTP family,
[I/V]HCxxGxxR[S/T], contains an invariant Cys residue,
which, due to the unique environment of the active site,
is characterized by an extremely low pKα. This promotes
the function of this Cys residue as a nucleophile in catal-
ysis, but it renders it highly susceptible to oxidation, with
concomitant abrogation of nucleophilic function and
inhibition of PTP activity. Work from several labs,
including this one, has now established that multiple
PTPs are transiently oxidized and inactivated in response
to a wide array of cellular stimuli, which represents a
novel tier of control of tyrosine-phosphorylation-
dependent signaling. Hence, the ability to detect
reversible oxidation of PTPs in vivo is critical to under-
standing the complex biological role of reactive oxygen
species (ROS) in the control of cellular signaling.
During the last year, we have completed development
of a new assay to measure reversible PTP oxidation in
cells. A manuscript describing this work is currently
under review. The assay utilizes the unique chemistry of
the invariant catalytic Cys residue in labeling the active
site of reversibly oxidized PTPs with biotinylated small
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molecules under mildly acidic conditions (Fig. 1). The
two biotinylated compounds used were a sulfydryl-reac-
tive iodoacetylpolyethylene oxide (IAP) probe and an
α-bromobenzylphosphonate (BBP) activity-based probe
(in collaboration with Zhong-Yin Zhang, Indiana Uni-
versity). Those PTPs that were oxidized in the original
sample can then be identified following purification by
streptavidin pull-down and visualization with strepta-
vidin-HRP (horseradish peroxidase). We have applied
this cysteinyl-labeling assay to the study of platelet-
derived growth factor (PDGF) receptor signaling in an
angiomyolipoma cell model. Interestingly, there were
close similarities in the pattern of reactive proteins that
were observed in both IAP- and BBP-labeling assays,
suggesting that this strategy leads to specific detection
of oxidized PTPs (Fig. 1). The composition of the PTP
superfamily has been defined, and thus the apparent
molecular weight of the reactive proteins can be used to
predict identity, which can subsequently be tested by
immunoblotting for candidate PTPs. We have detected
PDGF-induced reversible oxidation of members of both
classes of classical PTPs (receptor-like and nontrans-
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FIGURE 1 Comparison of IAP- and BBP-based probes for detection of reversibly oxidized PTPs in
PDGF-BB-transformed angiomyolipoma cells. Angiomyolipomas are benign tumors of the kidney that
express functional PDGF-R. This experiment was carried out in collaboration with Jack Arbiser (Emory
University) using cells that were derived in his lab from an angiomyolipoma, by immortilization following
sequential introduction of SV40 large T and telomerase (SV7tert). These cells express active PDGF-Rβ
but do not form tumors in nude mice. However, upon constitutive retroviral expression of PDGF-BB, the
cells became tumorigenic and produced high levels of ROS. In this experiment we compared PTP oxi-
dation in immortalized but untransformed SV7tert cells, PDGF-BB-transformed cells, and two tumor-
xenograft-derived PDGF-transformed cell populations (Tumor 1 and Tumor 2 cells). Cells were lysed
under anaerobic conditions in the presence of iodoacetic acid (IAA), an alkylating agent that modifies
covalently the thiolate anion of the active-site Cys in those PTPs that remained in a reduced state. In
contrast, any PTPs that were oxidized by the localized stimulus-induced production of ROS were pro-
tected from this irreversible alkylation. Lysates were then subjected to buffer exchange on a size-exclu-
sion chromatography column. In this key step, IAA was removed and the oxidized PTPs were reduced
back to the active state, in which they may react with biotinylated active-site-directed compounds.
Biotinylated proteins were purified on streptavidin–Sepharose beads, resolved by SDS-PAGE, and visu-
alized using streptavidin-HRP. (A) Structures of biotinylated IAP and BBP probes; (B) mechanisms of PTP
labeling by the IAP and BBP probes. (C) Serum-deprived (16 hours) angiomyolipoma cell lines (1,5:
SV7tert; 2,6: SV7tert-PDGF; 3,7: SV7tertPDGF-Tumor1; 4,8: SV7tertPDGF-Tumor2) were subjected to
the cysteinyl-labeling assay using either biotinylated IAP (1–4) or BBP probes (5–8).
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membrane PTPs) and of two different classes of dual
specificity phosphatases (DSPs) (VH1-like and PTEN-
like), which demonstrates the broader sensitivity of this
improved assay in comparison to preexisting techniques,
allowing us to detect representatives of all the major
subgroups of the PTP superfamily. Currently, in collab-
oration with various labs, we are applying this cysteinyl-
labeling enrichment strategy to study reversible PTP
oxidation in a variety of signaling pathways, which will
help delineate new signaling cascades and improve our
understanding of the complex biology of ROS signal-
ing in vivo.
During the past year, results from our collaboration
with T.C. Meng, Kay-Hooi Khoo, and their colleagues
at the Academia Sinica in Taiwan have been published.
We have used mass spectrometry to characterize the oxi-
dation status of each Cys residue in PTP1B that had
been isolated by immunoprecipitation from HepG2 and
A431 human cancer cells, which produce high levels of
ROS constitutively. We observed that up to 50% of
PTP1B was reversibly oxidized, and, due to the presence
of the high ROS levels produced constitutively in these
cells, we observed that up to 40% of PTP1B was irre-
versibly oxidized. In addition, our data show that the
oxidation of PTP1B is specific to the active site Cys,
with the other Cys residues in the protein remaining in
a reduced state. Our data also suggest that the high level
of intrinsic ROS may contribute to the transformed phe-
notype of HepG2 and A431 cells via constitutive inac-
tivation of cellular PTPs. Furthermore, it may be
possible now to apply this approach to determining the
stoichiometry of oxidation of specific PTPs in various
signaling contexts.
FUNCTIONAL ANALYSIS OF JSP1
Previously, we identified JSP1 (JNK stimulatory phos-
phatase 1) as a DSP that has the capacity to activate the
JNK mitogen-activated protein kinases (MAPKs)
specifically, exerting its effects upstream of the MAP2K
enzyme MKK-4 in the JNK signaling cascade. This
illustrates a new potential tier of control of the JNK sig-
naling pathway and a novel aspect of the role of protein
phosphatases in the control of MAPK signaling, raising
the possibility that JSP1 may offer a new perspective on
the study of various disorders associated with aberrant
JNK signaling. We have been characterizing mice that
contain a targeted deletion at exon 3 of the jsp1 gene,
resulting in the production of a truncated, inactive JSP1
protein of approximately 20 amino acids. These mice
reproduce at normal Mendelian ratios, display no obvi-
ous physical abnormalities, and have a life expectancy
similar to that of their wild-type controls. We are char-
acterizing two aspects of their phenotype, one of which
indicates that JSP1 may have a role in the neurodegen-
erative processes that lead to Parkinson’s disease,
whereas the other implicates JSP1 in the regulation of
innate and adaptive immunity.
Regulation of JNK signaling by JSP1 in a mouse
model of Parkinson’s disease. Parkinson’s disease (PD),
one of the most prevalent neurodegenerative diseases
affecting aging individuals, is characterized by disabling
motor defects arising from a progressive loss of
dopaminergic neurons in the substantia nigra pars com-
pacta (SNpc). Less than 10% of PD cases have been
linked to genetic factors and therefore the disease is
thought to be primarily sporadic in nature with unknown
etiology.Animal models of PD primarily involve the use
of neurotoxins, the most common being MPTP (1-
methyl-4-phenyl-1,2,4,6-tetrahydropyridine), adminis-
tration of which leads to dopaminergic neuronal cell
death and a Parkinsonian phenotype. Apoptosis is the
key cell death mechanism in both PD and in MPTP-
induced lesions, with the JNK signal transduction path-
way having a major role in this process. There is
significant interest in targeting the JNK pathway for PD
therapeutics; however, global inhibition of JNK activity
would be likely to have detrimental systemic affects, and
therefore it is important to identify key regulators of JNK
signaling in the context of neuronal cell death in PD.
To investigate the possibility that JSP1 may regulate
JNK signaling in the context of neuronal stress, we have
been examining the effects of MPTP on c-JUN phos-
phorylation in the SNpc of wild-type and jsp1–/– mice.
These studies are being performed with Serge Przed-
borski and his colleagues at Columbia University. Using
confocal fluorescence microscopy, we had observed sig-
nificant phosphorylation of c-JUN in the dopaminergic
neurons of wild-type mice at 6 hours post-MPTP treat-
ment, but this was dramatically lower in jsp1–/– mice.
This indicates that JSP1 may act positively to regulate
MPTP-mediated JNK signaling in dopaminergic neu-
rons. Our efforts during the last year have been focused
on quantitation of these effects using laser scanning
cytometry (iCys®) and we have been working in collab-
oration with Ed Luther at Compucyte to overcome a
variety of technical challenges. In particular, we had to
distinguish MPTP-induced JNK from the high basal
level of activity in brain tissue. Furthermore, we have
encountered a high-background antibody staining,
which is a consequence of the fixation conditions we
have to use. Nevertheless, we feel we have now opti-
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mized conditions, and our data indicate that in the
absence of jsp1, the activation of JNK signaling is
delayed. The next phase of this project will address the
substrates of the phosphatase that underlie these effects.
Modulation of innate and adaptive immunity by
JSP1. Our recent analysis of JSP1 knockout mice has
revealed that aged jsp1–/– animals (>1 year) develop
moderate splenomegaly, and this is associated with lym-
phoid hyperplasia and an expansion of memory T cells.
At an early age (1-month-old mice), jsp1–/– naïve CD4+
T cells display a reduced proliferative capacity com-
pared to wild type, as measured by thymidine incorpo-
ration and interleukin-2 (IL-2) production. However, at
4 months, jsp1–/– naïve CD4+ T cells display a moder-
ately increased proliferative capacity compared to wild
type. This apparent disparity can be explained by the
observation that wild-type CD4+ T cells undergo a dra-
matic decline in proliferative capacity as they age from
1 to 4 months. In contrast, although jsp1–/– CD4+ T cells
from young mice do not display as robust a response to
T-cell activation as their wild-type counterparts, they
display no significant age-dependent decline in prolif-
eration. These data, and the observation that aged
jsp1–/– mice possess an increased memory T-cell pool,
indicate that JSP1 may have important roles in aging of
the adaptive immune system. Our most recent data sug-
gest that ablation of JSP1 disrupts NFAT (nuclear fac-
tor of activated T cell) signaling, and our current efforts
are focused on defining the mechanism for these
effects.
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PTEN is a tumor suppressor that is among the most fre-
quently lost or mutated genes of human cancer. It is
unique in directly opposing the enzymatic activity of
phosphoinositol-3 kinase and the downstream proto-
oncogene Akt kinase, which promotes cell survival and
proliferation. This signaling pathway is deregulated in a
majority of, for example, breast, prostate, and brain
tumors. By modeling Pten loss in mice, we have dis-
covered how cells in the prostate can sense the complete
loss of Pten and respond to this insult by withdrawing
into cellular senescence, which is now recognized as an
early cell-intrinsic human antitumoral defense mecha-
nism. However, we have found that cells fail to respond
similarly to more subtle deregulation of Pten protein as
exemplified by its incomplete loss and that this leads to
cancer by a process that we term “senescence bypass.”
This finding combined with the senescence response
suggests that tumors should favor retention of some
PTEN. Indeed, many human cancers present with
incomplete PTEN loss, entirely consistent with these
findings and establishing PTEN as a haploinsufficient
tumor suppressor in such tissues.
Our studies of senescence bypass mechanisms have
so far revealed two molecular scenarios. In one, tissues
will spontaneously reduce Pten levels via the ubiquitin
pathway just enough to cross the threshold for abnormal
proliferation. In the second scenario, partial inactivation
of Pten and a select cooperating tumor suppressor (e.g.,
the nuclear body-forming protein Pml or the cell cycle
inhibitor p27) will suffice to produce senescence-free
cancers that form only in this specific combination.
Importantly, analysis of human tissues has confirmed the
relevance of these two scenarios in prostate and colon
cancer patients to name a few. Thus, our genetic analy-
sis of tumor progression in the mouse is allowing us to
develop and test novel conceptual and mechanistic
frameworks for cancer initiation and progression.
TUMOR SUPPRESSOR COOPERATION IN CANCER
Through our previous studies, we have learned that not
only quantitative regulation, but also qualitative regula-
EMERGING PRINCIPLES OF TUMOR SUPPRESSION
L. Trotman M. Chen
H. Cho
J. Williams
tion of Akt kinase controls Pten mutant tumorigenesis
and its progression via a senescence defeat or senes-
cence bypass pathway. The qualitatitve change in active
Akt kinase localization from the plasma membrane to
the nucleus is a direct consequence of loss of PML
nuclear bodies (NBs). We could show that in mice, Pml
achieves pAkt inactivation through its ability to recruit
both Akt and its phosphatase PP2a into these bodies
resulting in specifically nuclear Akt inactivation. These
findings demonstrated the importance of coordinated
Akt inactivation and revealed that this process is effi-
ciently achieved through the phosphatase Pp2a. Fur-
thermore, it highlighted how deregulating cellular Akt
partitioning via control of phosphatase activity could
bypass the senescence response.
Recently, a second direct phosphatase ofAkt, named
PHLPP, has been identified. PHLPP joins PTEN and
PP2a phosphatases with the potential of regulating
tumorigenesis. In contrast to the qualitative changes
mentioned above, PHLPP controls the amplitude ofAkt
activation, similar to PTEN. However, it is unclear (1)
whether PHLPP is a bona fide tumor suppressor and (2)
whether in the context of PTEN loss, loss of PHLPP
bypasses senescence (similar to PP2a targeting) or trig-
gers a senescence response in vivo (similar to complete
PTEN loss). We have gathered strong evidence sup-
porting a tumor-suppressive role for the PHLPP gene
in human cancers of various tissues. To validate its role
in vivo, we are crossing Phlpp null mice with Pten
mutant mice. This analysis will allow us to define tis-
sues where Phlpp is essential for tumor suppression and
answer the question of whether combined loss of these
two major Akt antagonists triggers senescence.
ROLE OF PTEN LEVELS IN CANCER INITIATION
AND TREATMENT
On the basis of our previously published work, the
actual Pten protein levels inside prostatic epithelia
decide over benign or malignant tumor formation (Trot-
man et al. PLoS Biol. 3: 385–396 [2003]), whereas com-
plete Pten loss was shown to prevent tumorigenesis
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through the p53-dependent senescence response until
p53 mutation paves the way for full-blown cancer.
Accordingly, prostates of mice harboring partial Pten
loss spontaneously degrade Pten to allow formation of
prostate cancer.Yet, importantly, these lesions do not go
on to completely lose Pten at the gene or protein level,
a compelling illustration of their ability to maximize
proliferation while avoiding the senescence response
caused by complete Pten loss. Our analysis of human
prostate cancer specimens also confirms frequent reten-
tion of clearly reduced PTEN levels. Therefore, by using
mouse models with partial Pten loss, we found that
spontaneous and subtle further reduction of Pten levels
triggers activation of the downstream oncogenic kinase
Akt, illustrating that a threshold must be crossed for ini-
tiation of cancer.
It is important to note that such spontaneous down-
regulation of Pten is never observed in the prostate of
wild-type animals, sometimes observed in the Pten+/–
prostate (30% of mice), and is always occurring in
Ptenhy/– animals (mice with one-fourth normal Pten lev-
els). These observations strongly suggest that lower Pten
levels increase the probability of its spontaneous reduc-
tion below the Akt-activating and tumor-promoting
threshold. Thus, they demonstrate the importance of sta-
ble Pten levels in a tissue even after Pten has received a
genetic hit. Because this finding should form the basis
of a therapeutic approach, we set out to test the thera-
peutic effect of Pten up-regulation in prostate. An
important open question behind this approach is
whether restoration of PTEN might not just antagonize
but also revert tumor growth, analogous to the concept
of oncogene addiction.
To address this issue experimentally, we have
designed reversibly inducible short-hairpin-based
microRNAs in collaboration with the labs of Drs. Lowe
and Hannon here at CSHL. As shown by Dr. Lowe’s
recent work, such hairpin designs can be used in vivo
for reversible knockdown, which permits investigation
of the therapeutic value of tumor suppressor restoration.
Through our approach, we will knock down Pten levels
in mouse prostate until tumors form analogous to the
models mentioned above. At this time, hairpin activity
will be blocked, Pten restored, and tumor volume mon-
itored for regression using magnetic resonance imaging
(MRI) methods. Of the 250,000 American men diag-
nosed with prostate cancer each year, approximately
half will present with partial PTEN loss in their lesions,
and thus, we expect our results to be of great importance
in establishing treatment modalities that interfere with
disease progression via PTEN stabilization.
MOLECULAR MECHANISMS OF PTEN
REGULATION IN CANCER
Despite its plasma membrane function, PTEN has been
consistently observed in cell nuclei, but the mechanism
and relevance of this localization have remained unclear.
We have recently resolved this paradox by demonstrat-
ing that contrary to polyubiquitination, nuclear PTEN
import depends on its monoubiquitination and that
mutation of the main PTEN ubiquitination site abolishes
import in vitro and in patients, giving rise to inheritable
Cowden’s disease because of low cytoplasmic PTEN
stability. But most notably, this mutant retains catalytic
activity, demonstrating that PTEN nuclear import is
essential for tumor suppression.
These findings exemplify an elemental insight into
cancer biology by demonstrating how the collaboration
of a genetic lesion (the inherited mutation) with a post-
translational cellular response (enhanced degradation)
cooperate in tumorigenesis. Through this analysis, we
have furthermore unraveled a link between two critical
means of PTEN regulation, namely, stability and nucle-
ocytoplasmic shuttling. We are currently investigating
the mediators of both processes in vitro by using RNA
interference approaches that can be expanded to in vivo
analysis.
PUBLICATIONS
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Research in my laboratory has focused on the role of
the Ras and Rho GTPase family members in signal
transduction. Ras and Rho family members have key
roles in cellular activities controlling cell growth con-
trol, differentiation, and morphogenesis. Alterations in
Ras and Rho functions have been shown to result in sev-
eral disease processes, including cancer and neurologi-
cal disorders. Our ultimate goal is to understand how
aberrations in Ras- and Rho-signaling components con-
tribute to the development of these disease processes.
Toward this end, my lab has continued to define the
functions of selected GTPases, their regulators, and
effectors in models of cancer and neurological disor-
ders. Below are highlights of the main projects that have
been carried out during the past year.
ROLE OF RAP1 SIGNALING IN
MORPHOGENETIC PROCESSES
The Rap1 protein, a member of the Ras family, was ini-
tially identified as an antagonist of oncogenic Ras pro-
teins; however, more recent studies indicate that the
function of Rap1 is largely Ras-independent. Increasing
evidence points to a critical role for Rap1 in the control
of epithelial morphogenesis, and recent studies suggest a
dysregulation of Rap1 signaling in malignant processes.
How Rap1 proteins exert their effects in vivo has
remained largely elusive. We previously described the
identification of the mammalian junctional proteinAF-6
as a Rap1-interacting protein. To demonstrate the physi-
ological relevance of this interaction, we decided to carry
out functional analyses of their orthologs (Rap1 and
Canoe) in the more genetically tractableDrosophila sys-
tem.We found that both Rap1 and Canoe are required for
epithelial migration events in the embryo and that Canoe
acts as a downstream effector of Rap1 in these processes.
More recently, we identified a Drosophila Rap1-spe-
cific exchange factor, dPDZ-GEF, which is responsible
for Rap1 activation in migrating embryonic epithelia.
Canoe (cno) acts downstream fromRap1 and dPDZ-GEF
in this event. We demonstrated that dPDZ-GEF/Rap1/
Canoe signalingmodulates cell shape and apicolateral cell
constriction in embryonic and wing disc epithelia. Inter-
RAS AND RHO GTPASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner N. Nadif Kasri
J. Janas R. Packer
K. John Y.-T. Yang
A. Kobayashi
estingly, our data indicate that dPDZ-GEF signaling is
linked to myosin II function. Both dPDZ-GEF and cno
show strong genetic interactions with the myosin II-
encoding gene, andmyosin II distribution is severely per-
turbed in epithelia of both mutants. These findings
provide first insight into themolecular machinery targeted
by Rap signaling to modulate cell shape in epithelial mor-
phogenesis at different developmental stages.
ROLE OF DOK PROTEINS IN MITOGENIC
AND ONCOGENIC SIGNALING
Dok-1 (also called p62dok) was initially identified as a
tyrosine-phosporylated 62-kD protein associated with
Ras-GAP in Ph+ chronic myeloid leukemia (CML)
blasts and in v-Abl-transformed B cells. This protein
was termed Dok (downstream of kinases), since it was
also found to be a common substrate of many receptor
and cytoplasmic tyrosine kinases. Subsequently, six
additional Dok family members have been identified.
Among them, Dok-1 and Dok-2 share the ability to bind
to a negative regulator of Ras, Ras-GAP. We described
previously that Dok-1 attenuates growth-factor-induced
cell proliferation and that Dok-1 inactivation in mice
causes a significant shortening of the latency of the fatal
myeloproliferative disease induced by p210bcr-abl. Strik-
ingly, in collaboration with Dr. Pandolfi’s group
(Memorial Sloan-Kettering Cancer Center), we also
found that mice lacking both Dok-1 and Dok-2 sponta-
neously develop a CML-like myeloproliferative disease,
likely resulting from increased cellular proliferation and
reduced apoptosis. Thus, Dok proteins function as neg-
ative regulators of mitogenic and oncogenic signaling.
To further delineate the function of Dok-1 in onco-
genic signaling, we examined the expression of Dok-1
protein in cells expressing various oncogene tyrosine
kinases. Interestingly, we observed that p210bcr-abl, v-Abl,
and oncogenic forms of Src induce down-regulation of
Dok-1 expression in a number of cells lines and that the
reduction in the levels of Dok-1 protein requires tyrosine
kinase activity of these oncogenes. Inactivation of tumor
suppressors is an event that is observed in numerous
tumors. Since the inactivation of the Dok-1 gene acceler-
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ates the progression of CML in mouse models, whereas
overexpression of Dok-1 dramatically inhibits the prolif-
eration of p210bcr-abl-expressing cells as well as Src-
induced transformation, our current findings suggest that
oncogene-induced down-regulation of Dok-1might be an
event that contributes to the progression of tumorigenesis.
ROLE OF RHO REGULATORS IN NEURONAL
DEVELOPMENT AND DISORDERS
Accumulating data indicate that the Rho family of
GTPases (including Rac, RhoA, and Cdc42) and their
regulatory molecules have critical roles in many aspects
of neuronal development and function. Their importance
in these processes is further emphasized by the findings
that mutations in Rho-linked genes are associated with
neurological disorders and defects in neuronal develop-
ment. The cellular and molecular mechanisms by which
aberrations in Rho signaling lead to such deficits remain
largely elusive. During the past year, we have focused on
the functional characterization of two upstream regula-
tors of the Rho GTPases in neuronal development and
function, namely, oligophrenin-1 and DOCK7.
Oligophrenin-1 (OPHN1), a gene located on chromo-
some Xq12, codes for a negative regulator of Rho
GTPases. Mutations in OPHN1 (which result in OPHN1
loss of function) have been reported in families with men-
tal retardation (MR) associated with epilepsy and/or cere-
bellar hypoplasia.Abnormal behavior, impaired language
skills, and motor development delays were noted for sev-
eral of these patients. Interestingly, similar deficits have
been observed in patients with autism. Until recently, the
function of OPHN1 in the brain remained unknown. We
demonstrated that OPHN1 is present in neurons of major
regions of the brain, including the hippocampus, cerebel-
lum, and cortex. Using antisense and RNA interference
(RNAi) approaches, we found that OPHN1 has a critical
role in spinemorphogenesis of CA1 pyramidal neurons in
hippocampal slices.We also demonstrated a biochemical
interaction between OPHN1 and Homer, a postsynaptic
adaptor molecule involved in spine morphogenesis and
synaptic transmission. Significantly, we more recently
obtained evidence that appropriate OPHN1 signaling is
required for developmental and activity-dependent mod-
ification of synaptic strength at CA3-CA1 synapses of the
hippocampus.Together, our data suggest a mechanism by
which mutations in OPHN1 can contribute to the cogni-
tive deficits observed in the OPHN1 patients.
The second protein, DOCK7, is a novel activator that
we identified for Rac GTPases and it belongs to the
DOCK180-related family. We found that DOCK7 is
highly expressed in major regions of the brain during
early stages of development and, importantly, that the
protein is asymmetrically distributed in unpolarized hip-
pocampal neurons and becomes selectively expressed in
the axon. We obtained evidence that DOCK7 has a crit-
ical role in the early steps of axon formation in cultured
hippocampal neurons. Knockdown of DOCK7 expres-
sion prevents axon formation, whereas overexpression
induces the formation of multiple axons. We further
demonstrated that DOCK7 and Rac activation lead to
phosphorylation and inactivation of the microtubule-
destabilizing protein stathmin/Op18 in the nascent axon
and that this event is important for axon development.
Our findings unveil a novel pathway linking the Rac acti-
vator DOCK7 to a microtubule regulatory protein and
highlight the contribution of microtubule dynamics to
axon development. More recently, we set out to monitor
neuronal polarization during the migration of newborn
developing neurons within an intact brain structure and
to establish DOCK7’s role in this process. In particular,
we implemented the in utero electroporation method that
enables highly efficient introduction of vectors coex-
pressing proteins or hairpin RNAs of interest with a flu-
orescent protein marker (e.g., enhanced green
fluorescent protein [EGFP] or t-dimerTomato) into ven-
tricular zone (VZ) cells in embryonic cerebral cortices.
Interestingly, our preliminary data suggest that DOCK7
knockdown leads to inhibition of normal cortical migra-
tion. We are currently further determining the role of
DOCK7 in the polarization and migration of cortical
neurons in brain slices and are also assessing its involve-
ment in the differentiation of living cerebellar granule
cells. Together, these studies will contribute to a better
understanding of the determinants/events involved in
neuronal polarization and differentiation and the role of
DOCK7 in these important processes.
PUBLICATIONS
Boettner B. and Van Aelst L. 2007. The Rap GTPase activator
dPDZ-GEF regulates cell shape in epithelial migration and
morphogenesis. Mol. Cell Biol. 22: 7966–7980.
Nadif Kasri N. and Van Aelst L. 2007. Spines, Rho GTPases and
mental retardation. In The new encyclopedia of neuro-
science—Synaptic organization and structure. Elsevier,
Oxford, U.K.
In Press
Nadif Kasri N. and Van Aelst L. 2008. Rho-linked genes and
neurological disorders. Pflugers Arch. 455: 787–797.
Nadif Kasri N., Govek E.E., and Van Aelst L. 2008. Characteriza-
tion of oligophrenin-1, a Rho-GAP lost in patients affected
with mental retardation: Lentiviral injection in organotypic
brain slice cultures. Methods Enzymol. 439: 255–266.
Sordella R. and Van Aelst L.V. 2008. Dialogue between
RhoA/Rock and members of the Par complexes in cell
polarity. Dev. Cell 14: 150–152.
102
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:52 PM  Page 102
NEUROSCIENCE
Using a combination of advanced theoretical and experimental approaches, neuroscientists at CSHL
seek to elucidate fundamental properties and mechanisms underlying key aspects of brain function, as
well as the working brain’s system properties, manifest in the design and logic of neural circuitry. Basic
science discoveries are being applied, at the same time, in studies of brain and neural system malfunc-
tion in illnesses such as schizophrenia, autism, Parkinson’s disease, and Alzheimer’s disease, which afflict
millions.
The focus of research in Grigori Enikolopov’s lab is on stem cells in the adult brain and the relation-
ship between the generation of new nerve cells, or neurogenesis, and mood disorders. They have gen-
erated several models to study how stem cells give rise to neural progenitor cells (NPCs) and, ultimately,
to neurons. They are using these models to determine the targets of antidepressant therapies, identify
signaling pathways that control neurogenesis, and search for neuronal and neuroendocrine circuits
involved in mood regulation. This year, the lab was part of a team that validated the first biomarker that
permits NPCs to be tracked, noninvasively, in the brains of living human subjects. This could help reveal
how neurogenesis is related to the course of diseases such as depression, bipolar disorder, Alzheimer’s,
Parkinson’s, and multiple sclerosis.
Jonathan Sebat’s laboratory is studying the role of genetic variation and, particularly, gene-copy-
number variation in autism and schizophrenia. This year, they published findings of a research collabo-
ration with Michael Wigler’s lab that indicated spontaneous mutations—gene mutations in children that
do not occur in either parent—are far more common in autism than previously thought. They are now try-
ing to identify which mutations occur in the largest fraction of cases and how each one causes pertur-
bations that lead to the autism phenotype. Is there a common biological process or pathway in which
some or all of the identified genes participate? Evidence suggests that the genes in question are rare high-
penetrance mutations and that they are connected within biological networks. Sebat and colleagues
have embarked on a study of schizophrenia that similarly seeks to discover the importance of sponta-
neous mutation in causality.
Roberto Malinow’s lab is investigating how neurons communicate and how that communication can
be modified, under normal and pathological conditions. In their extensive work on synapses in the rodent
brain, they have, for instance, monitored the movement of receptor molecules into synapses and have
demonstrated, in vivo, that this form of plasticity is associated with learning. Malinow’s team is determining
the molecular mechanisms by which NMDA- and AMPA-type receptors are delivered to and removed
from synapses. Their work suggests that an increase in synaptic AMPA receptors could be the molecu-
lar basis of memory storage, whereas an increase in NMDA receptors may control the ease with which
such modifications take place. The lab also applies its knowledge about synapses to the study of
Alzheimer’s disease, and specifically the question of how β-amyloid causes the loss of AMPA receptors
and the breakdown of synapses.
Hiro Furukawa’s lab is studying synaptic transmission at the molecular level. They focus on the NMDA
receptor, a very large molecule whose three-dimensional atomic structure the group has undertaken to
solve. They are especially interested in the structure of the so-called ligand-binding domain, the site at
which neurotransmitters dock with the receptor. There are at least four distinct NMDA receptor subtypes,
which are expressed differentially in different parts of the brain at different stages of life. Furukawa’s team
seeks to understand the pharmacological specificity of ligand binding in NR2A and NR2D subtypes, in
order to provide a blueprint for future drug design. The lab is also studying how risk factors for Alzheimer’s
disease, such as the APOE lipoprotein, associate with NMDA receptors.
Since biological mechanisms of memory are highly conserved through evolution, many features of
memory in higher organisms can be studied in simpler ones, such as fruit flies, that are easy to manipu-
late. Josh Dubnau and colleagues are using flies to study memory. They seek to identify genes and gene
pathways important for memory and likely to be conserved across phyla. Those shown to be conserved
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take on importance in research on human pathologies such as mental retardation and Alzheimer’s dis-
ease. They also seek to understand how the neural circuitry of the fly brain works. In an experiment in
what Dubnau calls artificial evolution, they hope to learn how higher-order networks of fly genes interact
in the formation of memory.
The Zador, Mainen, and Kepecs labs contribute to CSHL’s Center for the Neural Mechanisms of Cog-
nition (CNMC), which develops rodent models that combine behavioral training with electrophysiological
recording to understand the neurological basis of higher brain functions such as learning, memory, moti-
vation, and decision-making.
Anthony Zador’s lab investigates how the cortex processes sound, how that processing is modulated
by attention, and how it is changed by pathology. In the lab’s “core assay,” the response to sound stim-
uli of single neurons in the rodent auditory cortex is examined under varying behavioral conditions. Insights
obtained are relevant to the study of autism, an illness characterized by the disruption of auditory atten-
tion. In animal models of autism, Zador’s team is trying to link an inability to screen out background
sounds with changes in neural circuits that underlie this disruption. In other work, the lab has challenged
the standard model of sound representation in the auditory cortex, which predicts that neural represen-
tations of stimuli engage a large fraction of neurons. They have shown that a very small minority of avail-
able auditory neurons in a rat cortex react strongly when exposed to a specific sound.
Zach Mainen’s lab studies neural coding, or how information is represented in characteristic “spikes”
of neuronal electrical discharges. They view this problem in the broader context of neuroeconomics and
learning theory: How do animals select appropriate actions on the basis of experience, motivation, and
sensory information? Their work in rats has revealed how olfactory information is encoded and trans-
formed into adaptive decisions. Recently, the lab has shed light on the relation of neuronal serotonin
release and decision-making in animals and, separately, on an unexpected sensitivity in mammalian brain
circuitry deduced from their success in using light-emitting diodes to stimulate tiny subsets of neurons—
as few as 60 at a time—to prompt mice to perform a learned behavior.
Adam Kepecs studies neurobiological principles by which the brain makes decisions. He and his col-
leagues view decisions as elementary units of behavior, from which more complex behaviors are assem-
bled. Yet even simple decisions involve the integration of sensory and memory information with emotional
and motivational attributes, requiring the concerted action of millions of neurons across brain regions.
Therefore, they take an integrative approach, combining experiments involving controlled rodent behav-
ior with electrophysiology, molecular perturbations, and quantitative analysis. Their current work seeks to
elucidate the neurocomputational principles of decision-making, attempting to capture more elusive
attributes such as emotion, motivation, or confidence, and neuronal network mechanisms underlying
decisions, with particular focus on how specific cell types participate in the neural circuit dynamics of local
processing.
Holly Cline’s lab is determining the mechanisms by which activity in the brain controls neuronal growth,
the generation of synapses, and the development of organized sensory projections between different
brain regions. To understand the cellular events responsible for the stabilization of growing neuronal
branches, Cline and colleagues have delivered genes of interest into neurons and assessed the effects
on synaptic transmission, in nerves that connect the retina and a part of the brain called the tectum
involved in visual processing. In other experiments, they have obtained time-lapse imagery indicating
that neurons grow by a counterintuitive process: Many new branches are added to neurons, but the
majority are rapidly retracted. Cline has learned that visual experience is a key modifier in how these cir-
cuits are built.
Yi Zhong’s lab studies the neural basis of learning and memory. They work with fruit fly models to
study genes involved in human cognitive disorders, including neurofibromatosis and Noonan’s Syndrome.
Mutations of the neurofibromatosis 1 (NF1) gene cause learning defects and neurofibromas—nerve-
sheath tumors that split nerve fibers apart. The lab’s analyses of Drosophila NF1 mutants have revealed
how expression of the mutant gene affects a pathway crucial for learning. Further studies aim to reveal
mechanisms of pathology. This year, the lab discovered that the NF1 gene and the gene (called
corkscrew) causally implicated in Noonan’s share a biochemical pathway. Zhong and colleagues are also
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examining mechanisms of learning and memory at cellular and network levels in the Drosophila brain.
Their current focus is olfactory-related associative learning.
By comparing mechanisms of learning and memory in fruit flies, humans, and other organisms, Tim
Tully and colleagues have revealed ancient molecular pathways of memory conserved by evolution. They
have identified “candidate memory genes” in flies, which they are systematically disrupting, in vivo, to con-
firm behaviorally their affect on memory formation. The lab demonstrated this year that NMDA-receptor-
dependent long-term memory in flies occurs not only in the mushroom body, but also in a structure called
the ellipsoid body not previously implicated in memory formation. In these and other efforts, the lab seeks
a comprehensive genetic etiology of memory that will ultimately lead to more effective therapies for mem-
ory loss.
Josh Huang and colleagues study how the brain develops neural networks that use GABA, the brain’s
primary inhibitory neurotransmitter. Their work has implications in illness such as autism and schizo-
phrenia, which involve the altered development and function of GABAergic circuits. They have shown that
the maturation of GABAergic connections in the visual cortex is regulated by sensory experience during
a postnatal critical period. This year, they reported a surprising finding about GABA itself. It has long been
known that GABA binds to specific neuronal transmembrane receptors, precipitating a change in mem-
brane voltage. They now find that GABA also serves as a trophic factor, impacting signaling that deter-
mines whether a synapse is stable and whether axons will grow or retract.
Dmitri Chklovskii and colleagues are mapping the “wiring” of the rat brain using electron microscopy.
Images of extremely thin brain slices are “stacked” by a computer to assemble a three-dimensional brain
rendering. Even in a small volume, 1000 times thinner than a human hair, there are roughly 1000 axons
and 100 dendrites. The spatial organization, or “packing,” of axons and dendrites is random. Yet, the junc-
tion points at which axons and dendrites of different neurons exchange signals, called synapses, may
form based on a definite logic. The lab is expanding the area covered by their mapping project, which,
Chklovskii observes, is prelude to the larger aim of modeling the electrical activity of neuronal networks.
Alexi Koulakov and colleagues are trying to discover the mathematical rules by which the developing
brain assembles itself, with particular focus on the formation of sensory circuits such as those involved
in visual perception and olfaction. The visual system of the mouse is well-understood, in neuroanatomi-
cal terms. What is not known is how projections are generated that lead from the eye through the thal-
amus and into the visual cortex; how an individual’s experience influences the configuration of the
network; and what parameters for the process are set by genetic factors. Even less is known about the
assembly of the neural net within the mouse olfactory system, which, in maturity, enables the individual
to distinguish one smell from another with astonishing specificity and to remember such distinctions over
time.
Partha Mitra seeks to develop an integrative picture of the brain, incorporating theory, informatics,
and experimental work. His theoretical interests are primarily in formalizing the treatment of biological
function using ideas and methods from engineering. In informatics work, his lab is developing computa-
tional tools for analyzing neurobiological data, particularly electrophysiological data from experiments that
probe cognitive phenomena. Mitra has organized the Brain Architecture Project, a multi-institutional effort
to curate information from the literature about human neuroanatomical connectivity. In their experimen-
tal research, Mitra and colleagues, in collaboration with Josh Dubnau, study memory formation in the fruit
fly. The lab also studies the evolution of song culture in zebra finches.
CSHL Fellow Gilbert L. Henry studies cellular differentiation using the vertebrate taste bud as a model.
Taste buds comprise unspecialized “progenitor stem cells” at their base and periphery. These cells divide
and their daughters become specialized receptor cells that migrate toward the center and apex of the
taste bud. Different taste receptor cells respond to different tastes and each forms a number of synapses
on neurons that transmit information regarding the chemical nature of food to the brain. Henry is work-
ing to define both taste receptor and taste progenitor cells at molecular resolution.
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How does electrical activity in neuronal circuits give rise
to intelligent behavior? We believe that this question is
impossible to answer without a comprehensive descrip-
tion of the connectivity in neuronal networks. Such a
description may be a wiring diagram, which catalogs all
neurons and synaptic connections between them. In col-
laboration with several laboratories, we are reconstruct-
ing vertebrate and invertebrate wiring diagrams from
electrophysiological, light, and electron microscopical
data. To gain insight into brain function from the wiring
diagrams, we formulate engineering principles of brain
design and test them experimentally. By focusing ini-
tially on explaining the function of simpler organisms,
we are assembling a theoretical framework and accumu-
lating experience necessary to understand more complex
systems, such as the mammalian neocortex.
STATISTICAL CIRCUIT RECONSTRUCTIONS
FROM LIGHT MICROSCOPY AND
ELECTROPHYSIOLOGY
We have developed the necessary theoretical framework
to estimate, or reconstruct statistically, wiring diagrams
from the shapes of axonal and dendritic arbors visual-
ized with light microscopy. Such reconstructions are
based on the principle that physical proximity between
the axons of one neuron and the dendrites of another
predicts probabilistically synaptic connections between
the two. This principle is not new. However, only with
recent developments in cell labeling, imaging, and com-
puting infrastructure has the comprehensive geometric
description of neuronal connectivity become an attain-
able goal. As a demonstration, we have statistically
reconstructed the cortical column from three-dimen-
sional shapes of dozens of neurons labeled in vivo.
To determine how well geometric connectivity maps
correspond to functional connectivity, we compared
maps calculated from neuronal shapes with those
obtained electrophysiologically in collaboration with
Karel Svoboda’s laboratory here at CSHL. In many
cases, our maps accurately predicted connectivity on the
level of populations of neurons, i.e., projections between
cortical layers.
FROM NEURONAL CIRCUIT RECONSTRUCTIONS TO
PRINCIPLES OF BRAIN DESIGN
D. Chklovskii B. Chen Y. Mishchenko
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A geometric connectivity map is a particularly
appropriate description of cortical circuits in the face of
ongoing changes in connectivity. Previously, we pro-
posed that the growth and retraction of dendritic spines
could alter connectivity, and Svoboda’s laboratory has
observed such experience-dependent plasticity in adult
animals. As geometric connectivity maps rely on the
mostly stable layout of axons and dendrites, rather than
on the more volatile spines, they provide an invariant
description of cortical circuits.
Geometric maps have their limitations: They yield
the probability of connections but cannot predict for cer-
tain whether a given pair of neurons is connected. The
maps also do not capture the strong correlations we
found in synaptic connections in pairs and triplets of
neurons when we analyzed electrophysiological record-
ings by collaborators.
COMPLETE CIRCUIT RECONSTRUCTIONS
FROM ELECTRON MICROSCOPY
Electron microscopy is currently the only technique
capable of reconstructing wiring diagrams in their
entirety. By detecting synapses on electron micrographs
of serial sections and tracing axons and dendrites to
their somas, one can identify synaptically connected
neurons. The largest such reconstruction, the
Caenorhabditis elegans nervous system, was carried out
manually at the Medical Research Council (MRC),
Cambridge, England, and finalized by us.
Complete electron microscopic circuit reconstruc-
tion is a painstakingly slow process because of the sheer
amount of data involved.Axons and dendrites spanning
millimeters must be traced with a resolution of a few
nanometers. The reconstruction of the C. elegans nerv-
ous system, containing only 279 neurons, took the
equivalent of several decades of work to complete!
To reconstruct more complex circuits, we are using
techniques from image processing and machine learning
to develop automated tracing algorithms. So far, we
have reconstructed a neuropil volume of 1000 cubic
microns. We intend to scale up our automated algo-
rithms to fully reconstruct circuits of wide interest
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among neurobiologists, such as the fly brain, the verte-
brate retina, and the cortical column.
FROM WIRING DIAGRAMS TO BEHAVIOR
Armed with wiring diagrams, we are starting to under-
stand how electrical activity in neuronal circuits gener-
ates behavior. Our initial strategy is to focus on
relatively simple circuits and behaviors. Once those are
well understood, our experience will serve as a founda-
tion for reverse engineering more complex systems.
One such simple system is the neuronal control of
undulatory locomotion in C. elegans. Many species rely
on a central pattern generator for undulatory locomo-
tion. The C. elegans wiring diagram by itself does not
support required oscillations. This implies that undula-
tory locomotion likely relies on propriosensory feed-
back. To understand how locomotion arises, we combine
measurements of body muscle activity using a calcium
indicator and a simple model based on the known wiring
diagram.
This simple system demonstrates that even the com-
plete wiring diagram is not sufficient to understand how
a circuit works. Modeling circuit function requires
knowing certain dynamic parameters of neurons and
synapses, most of which are missing from the wiring
diagrams. The problem goes even deeper: Not only are
most of the parameters missing, but we do not even
know which of them are essential and which are not.
DESIGN PRINCIPLES BASED ON
OPTIMIZATION THEORY
For models of brain function to have predictive power,
an appropriate level of abstraction must be chosen and
the essential parameters must be identified and meas-
ured. When we look to disciplines where modeling is
well established, such as physics or engineering, we find
that model building must be based on fundamental prin-
ciples, or physical laws, such as the laws of conserva-
tion. Identifying similar fundamental principles in
biology would help constrain the choice of possible
models and focus our efforts.
As biological systems have evolved over hundreds of
millions of years, their design has been optimized under
various physical constraints. It is thus natural that a the-
oretical approach to biology must incorporate aspects
of constrained optimization. We quantitatively formu-
late principles of brain design and rely on optimization
theory to answer why questions.
A particularly successful example of optimization in
biology is the wiring economy principle proposed by
Ramón y Cajal more than 100 years ago. By quantita-
tively formulating and applying this principle, we were
able to make unexpected, experimentally testable pre-
dictions and explain many aspects of brain design, such
as the existence and structure of cortical maps, the spa-
tial arrangement of neurons, the existence of dendritic
spines, the dimensions of axons and dendrites, and the
segregation of the neocortex into the gray and white
matter. In addition to the many successes of our theo-
retical predictions, experiments have revealed several
discrepancies. These discrepancies led to the discovery
of another important principle of brain design: maxi-
mization of entropy (or information capacity). This prin-
ciple in turn explains several key properties of synapses
and the shapes of neurons.
Our research continues to focus on mapping the
brain’s structure and establishing its relationship with
function. We have reconstructed both statistical and
deterministic wiring diagrams and explained many
structural observations as outcomes of constrained opti-
mization. We plan to reconstruct wiring diagrams of
more complex circuits and understand their function by
combining anatomical, physiological, and theoretical
approaches.
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Our research is focused on understanding the mecha-
nisms by which experience controls the development of
the brain. We address this fundamental question by
examining the development of the visual system in
Xenopus tadpoles and the development of the spinal
cord in zebra fish. The visual system of Xenopus is well-
known for its experience-dependent plasticity. We have
established this preparation as an excellent experimen-
tal system in which to conduct in vivo time-lapse imag-
ing studies of neuronal development and synapto-
genesis, combined with both gene transfer and electro-
physiological studies of visual system function.
During the past 15 years, we have demonstrated a
role for afferent coactivity, postsynaptic N-methyl-D-
aspartate receptor (NMDAR) activity, and downstream
activation of calcium-dependent enzymes including cal-
cium/calmodulin-dependent protein kinase II (CaMKII)
in controlling retinotectal synaptic maturation, optic tec-
tal cell structural plasticity, and topographic map for-
mation (Wu et al., Science 274: 972 [1996]; Zou and
Cline, Neuron 16: 529 [1996]; Wu and Cline, Science
279: 222 [1998]; Zou and Cline, J. Neurosci. 19: 8909
[1999]; Ruthazer et al., Science 301: 66 [2003, 2006];
Haas et al., Proc. Natl. Acad. Sci. 103: [2006]).
More recently, we have demonstrated that visual
experience has multiple effects on visual system devel-
opment. A relatively brief period, 4 hours, of visual
experience enhances the growth rate of tectal cell den-
dritic arbors through a mechanism that requires gluta-
matergic transmission and the RhoA GTPases (Li et al.,
Nat. Neurosci. 3: 217 [2000]; Li et al., Neuron 33: 741
[2002]; Sin et al., Nature 419: 475 [2002]). This same
brief period of visual experience increases the excitabil-
ity of tectal neurons and their sensitivity to visual stim-
uli, through a mechanism that requires intracellular
polyamines, the modulation of α-amino-3-hydroxy-5-
methyl-3-isoazole receptor (AMPA-R) function and
compensatory changes in sodium channel activity
(Aizenman et al., Neuron 34: 623 [2002]; Aizenman et
al., Neuron 39: 831 [2003]).
The finding that we can use visual stimulation to
BRAIN DEVELOPMENT AND PLASTICITY
H. Cline J. Bestman J. Demas H. Li W. Shen
K. Bronson R. Ewald J. Li V. Thirumala
K. Burgos M. Hiramoto L. Schiapparelli R.-Y. Tzeng
S.-L. Chiu S.-Y. Lee P. Sharma K. Van Keuren-Jensen
J.S. da Silva J. Lee-Osbourne
modify the development and properties of the retino-
tectal system has spurred our interest in determining the
function of activity-induced genes on visual system
plasticity. For instance, our studies of Homer, Arc, and
CPG15 demonstrate that each has distinct roles in con-
trolling neuronal plasticity. Homer is a widely expressed
scaffold protein, which affects calcium signaling and
metabotropic glutamate receptor (mGluR) signaling. In
addition to finding a role in axon guidance (Foa et al.,
Nat. Neuronsci. 4: 499 [2001]; Foa et al., J. Comp. Neu-
rol. 487: 42 [2005]), our more recent work indicates that
experience-dependent changes in postsynaptic Homer
expression regulates mGluR-mediated plasticity of
retinotectal transmission (Van Keuren-Jensen and Cline,
J. Neurosci. 26: 7575 [2006]). This is particularly inter-
esting in light of recent work suggesting that mGluR-
mediated potentiation and depression of synaptic
transmission may have a role in developmental neuro-
logical disorders such as Fragile X.
CPG15, another activity-induced protein, is notewor-
thy because it a GPI-linked signaling molecule whose
expression results in a large increase in dendritic arbor
development, coupled with an increase in glutamatergic
retinotectal synaptic maturation and a coordinated elab-
oration of presynaptic retinal axon arbors (Nedivi et al.,
Science 281: 1863 [1998]; Cantallops et al., Nat. Neu-
rosci. 3: 1004 [2000]; Nedivi et al., J. Comp. Neurol. 435:
464 [2001]). We have recently shown that CPG15 medi-
ates these changes by promoting synapse formation,
which in turn enhances axonal arbor growth (Javaherian
and Cline, Neuron 45: 505 [2005]). These data suggest
that CPG15 is akin to an activity-induced targeted growth
factor. It now appears that many activity-induced genes
function in a homeostatic manner to maintain synaptic
strength within a functional operating range, despite
experience-dependent increases or decreases in synaptic
strength. This is the case for Arc (Rial Verde et al., Neu-
ron 52: 461 [2006]) and Homer, as well as ornithine
decarboxylase, which generates polyamines and thereby
regulates neuronal excitability and the strength of gluta-
matergic synaptic transmission.
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Enhanced Visual Activity In Vivo
Forms Nascent Synapses in the
Developing Retinotectal Projection
C.D. Aizenman
Patterned neural activity during development is critical
for proper wiring of sensory circuits. Previous work
demonstrated that exposing freely swimming Xenopus
tadpoles to 4 hours of enhanced visual stimulation
accelerates the dendritic growth rate of optic tectal neu-
rons in vivo (Sin et al., Nature 419: 475–480 [2002]).
Here, we test whether this same period of visual stim-
ulation increased synaptic maturation and formation of
new synapses in the retinotectal pathway.
We assessed synaptic properties of stage-48 tadpoles
that were exposed to a simulated-motion stimulus for
4–5 hours. On the basis of our findings that immature
retinotectal synapses have greater paired pulse facilita-
tion compared to more mature synapses, consistent
with a lower release probability (Pr), we used a paired
pulse protocol to elicit responses selectively from nas-
cent synapses with low Pr. Although AMPA:NMDA
ratios for single and paired stimuli were the same in
control tadpoles, visual stimulation caused a relative
decrease in the AMPA:NMDA ratio of the paired
response.We evoked retinotectal synaptic transmission
in the presence of Sr2+ to record asynchronous vesicle
release. We compared evoked mEPSCs (excitatory
synaptic currents) induced by single and paired stimuli
and found that visual stimulation selectively enhances
the amplitude and number of AMPAR-mediated mEP-
SCs evoked by paired stimuli relative to those evoked
by single stimuli.
Together, these results show that enhanced visual
stimulation affects both AMPAR- and NMDAR-medi-
ated responses in a population of synapses revealed by
paired-pulse stimulation. This suggests that in vivo visual
stimulation increases synapses that have a low Pr and
that have properties consistent with immature synapses.
Rapid Activity-dependent Delivery
of the Neurotrophic Protein CPG15
to the Axon Surface of Neurons
in Intact Xenopus Tadpoles
I. Cantallops
CPG15 (also known as Neuritin) is an activity-induced
GPI-anchored axonal protein that promotes dendritic
and axonal growth, and accelerates synaptic maturation
in vivo. Here, we show that CPG15 is distributed inside
axons and on the axon surface. CPG15 is trafficked to
and from the axonal surface by membrane depolariza-
tion. To assess CPG15 trafficking in vivo, we expressed
a ecliptic pHluorin (EP)-CPG15 fusion protein in optic
tectal explants and in retinal ganglion cells of intact
Xenopus tadpoles. Depolarization by KCl increased EP-
CPG15 fluorescence on axons. Intraocular kainic acid
(KA) injection rapidly increased cell surface EP-CPG15
in retinotectal axons, but coinjection of TTX and KA
did not. Consistent with this, we find that intracellular
CPG15 is localized to vesicles and endosomes in presy-
naptic terminals and colocalizes with synaptic vesicle
proteins. The results indicate that the delivery of the
neurotrophic protein CPG15 to the axon surface can be
regulated on a rapid timescale by activity-dependent
mechanisms in vivo.
Refining the Roles of GABAergic
Signaling during Neural
Circuit Formation
C.J. Akerman
Our understanding of the role of GABA signaling in cir-
cuit development is rapidly expanding.We review three
recent refinements in our understanding of the diverse
roles that GABA has at different stages of neural circuit
formation. Recent evidence has shown that
1. Depolarizing GABA has at least a permissive role in
promoting both excitatory and inhibitory synaptoge-
nesis in developing neurons (including newly gener-
ated neurons in the adult).
2. GABAergic circuits sculpt the temporal and spatial
aspects of synaptic integration. Consequently, early
developmental events affecting the establishment of
GABAergic circuits will control subsequent activity-
dependent refinements of information processing
and circuit function.
3. The molecular mechanisms by which GABAergic
signaling has a role in the regulation of the balance
between GABAergic and glutamatergic transmis-
sion in developing circuits. We concentrate on the
effects of the signaling by GABAA receptors, as
told from the point of view of the GABA-respon-
sive cells, and do not discuss mechanisms that gov-
ern GABA release or activity of GABAergic
neurons per se.
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Regulation of Dendritic Arbor
Development and Plasticity by
Glutamatergic Synaptic Input:
A Review of the Synaptotrophic
Hypothesis
K. Haas
The synaptotropic hypothesis, which states that synap-
tic inputs control the elaboration of dendritic (and
axonal) arbors was articulated by Vaughn in 1989.
Today, the role of synaptic inputs in controlling neuronal
structural development remains an area of intense
research activity. Several recent studies have applied
modern molecular genetic imaging and electrophysio-
logical methods to this question and now provide strong
evidence that maturation of excitatory synaptic inputs
is required for the development of neuronal structure in
the intact brain. Nevertheless, some studies fail to show
evidence that afferent inputs affect structural develop-
ment. We review data that both support and refute the
hypothesis with the expectation that understanding the
circumstances when the data do and do not support the
hypothesis will be most valuable.
NR2A and NR2B Have Distinct but
Overlapping Roles in Shaping the
Development of Dendritic Arbor
Morphology In Vivo
R.C. Ewald, K.R. Van Keuren-Jensen, C.D. Aizenman
NMDARs are important for neuronal development and
circuit formation. The NMDAR subunits NR2A and
NR2B are biophysically distinct and differentially
expressed during development, but their individual con-
tribution to structural plasticity is unknown. Here, we
test whether NR2A and NR2B subunits have specific
functions in the morphological development of tectal
neurons in living Xenopus tadpoles. Exogenous subunit
expression and endogenous subunit knockdown shifts
the synaptic NMDAR composition toward NR2A or
NR2B, as shown electrophysiologically. We analyzed
the dendritic arbor structure and found evidence for both
overlapping and distinct functions of NR2A and NR2B
in dendritic development. Control neurons obtain
regions of high local branch density in their dendritic
arbor, whereas exogenous expression of either NR2A or
NR2B decreases local branch clusters, indicating a
requirement for both subunits in dendritic arbor devel-
opment. Knockdown of endogenous NR2A, however,
reduces local branch clusters compared to knockdown
of NR2B, suggesting more complex NR2 signaling.
Analysis of the underlying branch dynamics shows
that exogenous NR2B-expressing neurons are more
dynamic than control or exogenous NR2A-expressing
neurons, demonstrating subunit-specific regulation of
branch dynamics. However, visual experience-depen-
dent increases in dendritic arbor growth rate seen in con-
trol neurons are blocked in both exogenous NR2A- and
NR2B-expressing neurons. Furthermore, AMPAR-
mediated synaptic transmission is decreased in neurons
with knocked-down or exogenous NMDAR composi-
tion, indicating overlapping roles for NR2A and NR2B
in regulating synaptic transmission. Thus, we show that
NR2A and NR2B have subunit-specific properties in
dendritic arbor development, but also overlapping func-
tions, indicating a requirement for both subunits in neu-
ronal development.
PUBLICATIONS
Aizenman C.D. and Cline H.T. 2007. Enhanced visual activity in
vivo forms nascent synapses in the developing retinotectal
projection. J. Neurophys. 97: 2949–2957.
Akerman C.J. and Cline H.T. 2007. Refining the roles of GABAer-
gic transmission during neural circuit formation. Trends Neu-
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The long-term goal of our research is to understand
memory. Dissection of complex behaviors such as mem-
ory and learning will require a multidisciplinary
approach that will include discovery and manipulation
of the relevant genetic, cellular, and anatomical pathways,
as well as computational modeling of how information
is processed in the brain.Work in genetic model systems
such as Drosophila can contribute to our understanding
in several ways. First, by enabling discovery of genes and
genetic pathways underlying behavior, such model sys-
tems provide entry points for dissection of cellular mech-
anisms that are often conserved. Second, systematic
manipulation of gene function in relevant anatomical loci
of the brain allows a conceptual integration of findings
from cellular and behavioral neuroscience.
Our gene discovery efforts already have identified a
role in memory for highly conserved pathway(s) involved
with subcellular control of translational regulation. Many
of these molecules have counterparts in vertebrates that
also appear to have important roles in brain function and,
in some cases, may be linked to human cognitive dys-
function. Our genetic investigations also provide insight to
investigate the neural circuitry relevant to memory
because gene expression patterns often suggest hypothe-
ses that can be tested by spatially restricted genetic manip-
ulations. Here, our recent findings demonstrate that
short-term and long-term memory are supported by
anatomically distinct memory traces. This appears to
reflect a fundamental (but poorly understood) feature of
memory formation.At the behavioral level, we are uncov-
ering conserved behavioral properties of learned fear that
may be relevant to fear disorders in humans.
Discovery of Genetic Pathways
Involved with Memory
J. Dubnau, C. Jurgensen, W. Li [in collaboration with T. Tully,
C. Zhang, and M. Zhang, Cold Spring Harbor Laboratory;
F. Li, Tsinghua University]
We have used two expression-profiling methods to iden-
tify transcriptional responses during memory consolida-
tion. First, we used Afymetrix arrays to compare
expression profiles after spaced training, which induces
GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Blum W. Li
M. Cressy H. Qin
C. Jurgensen
both short-term and protein-synthesis-dependent long-
term memory and massed training, which only induces
short-lived memory (Dubnau et al., Curr. Biol. 13: 286
[2003]). We thus identified a large number of candidate
memory genes differentially expressed at three different
retention intervals after spaced versus massed training.
Using real-time polymerase chain reaction (PCR) follow-
up assays, we confirmed differential expression for nearly
60 of these transcripts. As a second complementary
approach, we have recently used chromatin immunopre-
cipitation of posttranslationally modified histones, fol-
lowed by hybridization of the associated DNAwith tiling
arrays. This approach has led to the identification of an
overlapping set of transcripts with the expression profil-
ing. The points of overlap between these two approaches
and results of a forward mutagenesis screen (Dubnau et
al., Curr. Biol. 13: 286 [2003]) should identify genetic
pathways that are critical to memory formation.
Each candidate memory gene (CMG) identified by
the above microarray approaches serves as an entry
point for molecular genetic investigation of gene func-
tion in memory. These CMGs then become fodder for in
vivo genetic manipulations to forge mechanistic con-
nections between individual gene pathways and memory
formation. With that aim in mind, we are focusing on
subcellular control of neuronal translation, one of sev-
eral pathways suggested from the array experiments, as
well as from a forward mutagenesis screen (Dubnau et
al., Curr. Biol. 13: 286 [2003]). In humans, cellular
mechanisms of dendritic translation is of relevance to
the etiology of fragile-X mental retardation syndrome.
Our genetic studies inDrosophila already support a role
in memory for several components of this cellular
machinery. These include staufen and oskar, which are
known components of a cellular mRNA localization
machinery in oocytes, and pumilio, which is a transla-
tional repressor protein whose vertebrate orthologs are
highly conserved but largely unstudied.A large number
of the known components of the mRNA localization
machinery also were identified in our various screens,
as well as of the apparatus for regulating cytoplasmic
polyadenylation-regulated translational control. Impor-
tantly, many genetic reagents to manipulate these path-
ways are extant in Drosophila.
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Synaptic Targets of Pumilio
J. Dubnau, W. Li [in collaboration with G. Chen, A. Krainer,
T. Tully, Q.S. Zhang, M. Zhang, Cold Spring Harbor
Laboratory]
Drosophila Pumilio (Pum) protein is a translational reg-
ulator involved in embryonic patterning and germ-line
development. Recent findings demonstrate that Pum also
has an important role in the nervous system, both at the
neuromuscular junction (NMJ) and in long-term mem-
ory formation (Dubnau et al.,Curr. Biol. 13: 286 [2003]).
In neurons, Pum appears to have a role in homeostatic
control of excitability via down-regulation of para, a volt-
age-gated sodium channel, and maymore generally mod-
ulate local protein synthesis in neurons via translational
repression of eIF-4E. Aside from these, the biologically
relevant targets of Pum in the nervous system remain
largely unknown in any species. We hypothesized that
Pum might have a role in regulating the local translation
underlying synapse-specific modifications during mem-
ory formation. To identify relevant translational targets,
we used an informatics approach to predict Pum targets
among mRNAs whose products have synaptic localiza-
tion. We then used both in vitro binding and two in vivo
assays to functionally confirm the fidelity of this infor-
matics screening method.We find that Pum strongly and
specifically binds to RNA sequences in the 3′UTR
(untranslated region) of four of the predicted target genes,
demonstrating the validity of our method. We then
demonstrated that one of these predicted target
sequences, in the 3′UTR of discs large (dlg1), the
Drosophila PSD95 ortholog, can functionally substitute
for a canonical Nanos response element (NRE) in vivo
in a heterologous functional assay in the embryo (Fig. 1).
Finally, we show that the endogenous dlg1mRNA can be
regulated by Pumilio in a neuronal context, the adult
mushroom bodies (MB), which is an anatomical site of
memory storage (Fig. 2).Together, these findings identify
a PSD95 ortholog as a major neuronal target of Pumilio.
FIGURE 1 In vivo confirmation of predicted NRE elements. Car-
toon representations of the hb-transgene constructs and repre-
sentative examples from cuticle preparations of corresponding
transformant lines, showing normal/abnormal or rescued/partial
rescued abdominal segmentation. Transgenic lines containing
both hb NREs in either the normal context (wild type) or reinserted
into the deletion construct (hb1,2) are fully regulated by Pum and
yield embryos with the normal complement of eight abdominal
segments. Deletion of both of these NREs (hb∆) prevents Pum-
dependent translational repression leading to complete absence
of abdominal segmentation. Insertion of either one hb NRE (hb2)
or the predicted NRE from dlg1 (dlg1) are each sufficient to par-
tially restore abdominal development.
FIGURE 2 Dlg is repressed by overexpression of Pum in MB
Kenyon cells. MB expressing Gal4 line (OK107) was used to drive
expression of both UAS-mCD8::GFP and UAS-Pum transgenes.
Optical sections of the MB lobes. In wild type (top), Dlg expres-
sion is detected both in MB lobes and AL and in the MB pedun-
cle (not shown). In contrast, Dlg expression is dramatically
reduced in the MB lobes (bottom) and peduncle (not shown) of
Pum overexpressing MBs. AL glomeruli, also stained by Dlg anti-
body, serve as an internal control.
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Functional Anatomy
A. Blum, J. Dubnau
A conserved feature of memory is consolidation through
temporally distinct phases such as short-term, middle-
term, and long-term memory. Each of the phases can be
selectively disrupted by a variety of experimental manip-
ulations, suggesting that they are not only temporally dis-
tinct, but also mechanistically distinct. Another con-
served characteristic of memory is that the neuronal
structures involved with the initial storage are often insuf-
ficient or distinct from those involved with long-term
memory storage.This remarkable feature of memory has
been observed across a wide distribution of species and
has been found for both simple Pavlovian associations
and more cognitive tasks. But in no case are the underly-
ing cellular or circuit mechanisms understood.
In Drosophila, much work has been done to func-
tionally map circuitry required for early phases of mem-
ory. It is now well established that olfactory information
and the pathways that convey electric shock converge at
the MBs, a bilaterally symmetric neuronal structure con-
sisting of approximately 2500 neurons per hemisphere.
The intrinsic neurons of the mushroom body, the so-
called Kenyon cells, consist of three major subtypes
(α/β, α′/β′, and γ), each of which have distinct axonal
architectures. Together, these three groups of Kenyon
cells are believed to be the site of association of multi-
modal sensory stimuli. This notion is supported by a
wide variety of experiments from several labs that
demonstrate that a number of different learning mutants
can be rescued by transgenic expression restricted to one
class or another of Kenyon cell neurons. In particular,
rutabaga adenylyl-cyclase-dependent cAMP signaling
in γ lobe neurons is sufficient to support olfactory short-
term memory. In addition, we and other investigators
have shown that synaptic output from Kenyon cells is
required during retrieval (Dubnau et al., Curr. Biol. 13:
286 [2003]; Margulies et al., Curr. Biol. 15: 700
[2005]). Together, the data support a model in which ini-
tial odor-shock association requires cAMP-dependent
plasticity only in MB Kenyon cells and that retrieval
requires synaptic output from this structure in order to
drive behavioral responses to the odors.
We have conducted the first systematic investigation
of the requirements for cAMP signaling in each of the
three major Kenyon cell subtypes for each of the tem-
poral phases of memory. We have shown that the clas-
sic learning mutant rutabaga, a Ca2+-dependent adenylyl
cyclase, also has long-lasting memory defects (Fig. 3).
By expressing the rutabaga cDNA in each of the subsets
of Kenyon cell neurons, we have demonstrated that
short-term and long-term memory each are supported
by rutabaga signaling in distinct groups of neurons. The
most surprising finding is that short-term and long-term
memory can be separately rescued, suggesting that both
the initiation and maintenance of these traces is inde-
pendent.
Enhancer/Suppressor Screening
by Selective Breeding
M. Cressy, J. Dubnau [in collaboration with P. Mitra and
D. Valente, Cold Spring Harbor Laboratory]
Genetic investigation of memory has revealed that
underlying mechanisms are highly conserved across
phyla. The cAMP cascade, for example, has been impli-
cated in memory in both invertebrate and vertebrate ani-
mals, including humans. The informative power of
genetics derives in part not only from identification of
genes that influence phenotype, but also from analysis
of gene interaction. Saturation mutagenesis for embry-
FIGURE 3 rutabagamutants exhibit a severe defect in long-term
memory. Memory performance indices 24 hours after repetitive
spaced training are shown. Wild type (2U) and animals heterozy-
gous for each of two rutabaga alleles (2080/+ and RUT1/+) each
show robust and equivalent levels of long-term memory per-
formance. In contrast, animals homozygous for either allele (2080
or RUT1) or trans-heterozygous for the two alleles (RUT1/2080)
show severely deficient memory. All data are for females (F)
because rutabaga is X-linked. This phenotype has provided the
basis for mapping the neural circuits in which rutabaga signaling
is required for long-term memory (see text).
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onic patterning, for instance, identified most of the rel-
evant genes. Equally important, however, were second-
site suppressing and enhancing screens. This approach
allowed cell-signaling pathways and mechanistic
insights to be distilled from what otherwise would be
unconnected gene lists.
In the case of complex behavioral phenotypes such
as memory, forward mutagenesis has identified a num-
ber of relevant genes (Margulies et al., Curr. Biol. 15:
700 [ 2005]). Here too, the most informative instances
are where mechanistic interactions among genes are
understood. cAMP signaling is the most notable exam-
ple.Assembly of genes into functional networks, such as
the cAMP cascade, is the most challenging aspect of
genetics. Although suppressor/enhancer screens have
yielded some success, this approach is often not feasi-
ble for complex quantitative traits such as memory.
Moreover, modifier screens are only designed to detect
interactions between pairs of genes, but they generally
do not identify more complex gene networks. We are
using experimental evolution with identified memory
mutants (Dubnau et al., Curr. Biol. 13: 286 [2003]) as a
strategy to screen for networks of epistasis capable of
suppressing the role of cAMP signaling.
Selective breeding of extremes in behavioral pheno-
types has a long and fruitful history. In contrast with
screening for induced mutations, this strategy normally
relies on the presence of preexisting (natural) genetic het-
erogeneity in a starting population.This method was first
used to establish a genetic basis for several complex
behavioral traits in a variety of species, including learn-
ing ability in Drosophila. This approach provided a
means to estimate genetic variation in natural popula-
tions, to examine the process by which complex traits
evolve through selection, and to investigate pleiotropy.
Genetic analyses of the selected strains also demonstrated
that phenotypic extremes typically derived from interac-
tions among a constellation of alleles. Unlike forward
mutagenesis, this quantitative genetic strategy relies on
selection of combinations of alleles, thereby placing indi-
vidual gene function within a network of interactions.
This strategy also has the potential to reveal mechanisms
underlying evolution of phenotypic variation. In contrast
with forward mutagenesis, however, quantitative genetic
strategies on their own have not afforded an efficient
means to identify and manipulate individual genes. Even
with a variety of powerful quantitative-genetic mapping
methods (e.g., QTL mapping), molecular identification
of underlying loci has been challenging.
Each of the above genetic strategies thus offers com-
plementary strengths for discovery of mechanisms
underlying complex behavioral biology. Recent progress
in genome-wide sequencing and expression profiling
raises the possibility of combining the above methods.
There is as yet no case, however, where artificial selec-
tion of molecularly identified alleles has been used for
memory, no example where the evolution of a pheno-
type has been followed over successive generations at a
mechanistic level, and no study where selection has
been used to directly screen for suppression or enhance-
ment of a known signaling pathway. We are using this
strategy to identify networks of gene interactions. Our
approach relies on artificial selection over the course of
multiple generations to “evolve” combinations of
known and molecularly tagged gene variants that inter-
act to produce extreme levels of learning.
Extinction Learning: A Model for
Posttraumatic Stress Disorder
H. Qin, J. Dubnau
Repeated representation of the conditioned stimulus
(CS) without the reinforcement of the unconditioned
stimulus (US) results in the diminishment of condi-
tioned responding. This process is called extinction (of
Pavlovian conditioning). Extinction was first studied by
Pavlov in 1927 and has been reported in both appetitive
and aversive paradigms. Extinction is not simply erasing
the original CS-US association but appears to be a new
learning process that antagonizes the original memory.
This type of learning is important biologically, but it
also has received attention because of its potential rele-
vance to posttraumatic stress disorder (PTSD), in which
an individual continues to fear a particular set of stim-
uli or a context. This debilitating fear can be highly
resistant to extinction.
We are taking advantage of the abundant molecular
and genetic tools of Drosophila melanogaster to inves-
tigate mechanisms of extinction following Pavlovian
“fear” learning. We have established a robust assay of
extinction and have initiated a focused screen through
the extant mutants that affect olfactory memory. We are
also using spatially restricted expression of cDNA res-
cuing constructs to map the circuitry of extinction versus
fear learning.
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Our research is focused on stem cells in the adult organ-
ism and signaling molecules that control their fate. Our
main focus is on brain stem cells, which retain the abil-
ity to produce new neurons throughout adult life, a func-
tion that may be important for memory and for mood
regulation.We have generated several animal models to
track and isolate stem cells and new neurons, and we
use these models to study how disease and therapeutic
drugs affect stem cells of the brain. Furthermore, we
study stem cells of other tissues, looking for common-
alities among various types of stem cells on how they
decide on whether to stay quiescent, self-renew, or dif-
ferentiate. We also study the signals that mediate inter-
actions between stem cells and their microenvironment,
with particular attention to the regulatory role of a ver-
satile signaling molecule, nitric oxide (NO). Finally, we
are trying to translate the knowledge we generate with
animal models to human studies.
DEFINED STAGES OF THE NEUROGENIC CASCADE
IN THE ADULT HIPPOCAMPUS
New neurons are produced from stem cells through a
cascade of events that include symmetric and asym-
metric divisions, exit from the cell cycle, and continuous
changes of morphology, culminating with the young
neuron establishing connections with other cells and
STEM CELLS, SIGNAL TRANSDUCTION, AND BRAIN FUNCTION
G. Enikolopov J.M. Encinas N. Peunova
T. Michurina J. Tordo
J.-H. Park M. Vidal
becoming integrated into the preexisting neuronal cir-
cuitry. Production of new neurons is a dynamic process
that responds to a wide range of stimuli which can
enhance or suppress neurogenesis and may affect any
step of the differentiation cascade.
We aim to define each step of the cascade and to
determine the targets of important proneurogenic or anti-
neurogenic stimuli. Our main approach is to generate
transgenic reporter animal lines and to use them to dis-
sect the neurogenesis cascade into distinct stages and
then identify the steps that are specifically affected by a
particular stimulus. We have now combined a new tech-
nique of cell labeling that greatly increases the resolu-
tion of cell cycle analysis with phenotyping progenitor
cell populations. This enabled us to identify all of the
major proliferative steps in the life cycle of stem and pro-
genitor cells in the adult hippocampus. It allowed us to
present a new scheme of the neuronal differentiation cas-
cade in the hippocampus (in collaboration with Dr.Alex
Koulakov here at CSHL) (Fig. 1); this scheme will now
serve as a general platform upon which researchers will
be able to project the action of any agent that alters neu-
rogenesis. We used this scheme to identify the targets of
antidepressant drugs and treatments, exercise, radiation,
and chemotherapeutic agents and to address the mecha-
nisms that control the quiescence, self-renewal, differ-
entiation, and death of stem cells in the adult brain.
FIGURE 1. A schematic summary of the neuronal differentiation cascade in the hippocampus.
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NEUROGENIC TARGETS OF ANTIDEPRESSANT
THERAPIES
Emerging evidence indicates a close link between the
action of a diverse range of antidepressant therapies and
augmented generation of new neurons in the adult hip-
pocampus. Moreover, recent findings suggest that adult
hippocampal neurogenesis not only accompanies, but is
also required for the behavioral effects of antidepres-
sants (e.g., fluoxetine/Prozac). This discovery may clar-
ify several observations regarding the clinical course of
action of antidepressant drugs. For instance, it may
explain why an appreciable clinical effect of antide-
pressants usually takes at least 3–4 weeks: This period
may reflect the time required for neural stem cells to
proceed through the differentiation cascade and become
fully differentiated and integrated neurons.
We used the information on the stages of the neu-
ronal differentiation cascade (above) to determine the
cell populations targeted by various antidepressant ther-
apies in the adult and developing brain.We aim to deter-
mine whether different types of treatments that regulate
mood converge on the same step in the cascade or if
each has their own target populations, and to identify
signaling molecules that translate the treatment into an
increased number of new neurons. We have now deter-
mined the neurogenic targets of the SSRI (selective
serotonin reuptake inhibitor) antidepressant fluoxetine,
of electroconvulsive shock, of deep brain stimulation,
of physical exercise, and of cosmic radiation. We are
using the information we have developed to identify sig-
nals that control the quiescence and self-renewal of stem
cells, which direct the differentiation cascade in the
adult brain and which can be employed to repair the
damaged and aging brain.
IDENTIFYING NEURAL PROGENITOR CELLS
IN THE LIVE HUMAN BRAIN
To harness the full potential of stem cells in the brain, it
is necessary to be able to identify and track those cells
in the live brain. However, the present imaging tech-
nologies cannot be applied for identification of neural
stem cells in the human brain. In a collaborative effort
with Drs. Mirjana Maletic-Savatic, Petar Djuric, Helene
Benveniste, and Fritz Henn from Stony Brook Univer-
sity and Brookhaven National Laboratory, we used pro-
ton magnetic resonance spectroscopy (1H-MRS) to
develop a new approach for detecting stem and progen-
itor cells in the live brain.
We started by identifying and characterizing a new
biomarker enriched in neural stem and progenitor cells
and demonstrated its use as a reference for monitoring
neurogenesis in vitro. To detect low concentration of
stem/progenitor cells in vivo, a signal processing
method was developed that enabled the use of 1H-MRS
for the analysis of the biomarker in both rodent brain
and the hippocampus of live human subjects. We found
that the biomarker can be detected in the hippocampus
but not the cortex of adult animals and humans, that it
can be seen in stem cells transplanted into the cortex of
recipient animals, and that its relative concentration
increases when animals are subjected to electroconvul-
sive shock, which is a potent inducer of hippocampal
neurogenesis. Finally, we found that the biomarker is
higher in younger, as compared to older, tested patients,
consistent with studies, including those from our group,
that hippocampal neurogenesis strongly decreases with
age. Our findings open the possibility of investigating
the role of stem cells and neurogenesis in a wide variety
of human brain disorders, including psychiatric and
neurological disorders, and of evaluating the efficiency
of therapeutic interventions.
STEM CELLS IN NONNEURAL TISSUES
Tissue maintenance requires a constant supply of new
cells to replace those lost to stress and damage or
destroyed as part of a normal cell turnover program.
This replacement is made possible either by self-renewal
of differentiated cells or through the activity of tissue-
specific stem cells. Adult stem cells are usually mor-
phologically unspecialized, can survive for a long time
or undergo long-term self-renewal, and are located in
specialized niches that restrict their division and sup-
port their undifferentiated status.
We found that in our reporter mouse lines, originally
designed to mark neural stem cells, the nestin-driven
reporter expression also marks stem and progenitor cells
in a range of nonneuronal tissues. Expression of the
reporter can be seen in stem and progenitor cell popu-
lations of the hair follicle, liver, pancreas, skeletal mus-
cle, testis, and anterior pituitary. Furthermore, in several
other organs and tissues, the nestin-driven reporter is
expressed in locations expected for stem/progenitor
cells of those tissues (e.g., prostate, lungs, ovaries, thy-
roid, spinal cord, kidney, and mammary grand). These
findings suggest a close relation between the expression
of Nestin and the stem-like properties of cells in the
adult tissues. Furthermore, they provide a means to iso-
late stem and progenitor cells from those tissues, to use
genetic inducible fate mapping to identify and isolate
the progeny of such cells, and to examine the mecha-
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nisms that govern quiescence, division, differentiation,
death, plasticity, and self-renewal of stem cells in the
adult tissues.
NO, STEM CELLS, AND DEVELOPMENT
Nitric oxide (NO), a crucial regulator of vasodilation,
immunity, and neurotransmission, is also involved in
regulating the balance between proliferation and differ-
entiation in several developmental and differentiation
settings. NO can act both in autocrine and paracrine sig-
naling modes, activating soluble guanylate cyclase,
combining with reactive oxygen species, modifying pro-
teins, and inducing both short-term and long-term sig-
naling cascades.
We are interested in the mechanisms of NO signaling
and in its role in development and stem cell mainte-
nance. Among our recent advances are discoveries of a
new gene that mediates the action of NO, of the role that
NO has in regulating hematopoiesis, and of its role in
nervous system development.
We found a new NO- and stress-induced gene that
we named noxin, and we generated a knockout mouse
line where the noxin gene was inactivated. noxin expres-
sion is under tight control by the cell cycle but can be
strongly induced by a range of stress signals. noxin
expression arrests the cell cycle at G1 in a p53-inde-
pendent fashion. Importantly, loss or down-regulation
of noxin expression leads to increased cell death. Our
results suggest that noxin is a component of the cell
defense system: It is activated by various stress stimuli,
helps cells to withdraw from cycling, and opposes apop-
tosis.We are now analyzing noxinmutant mice to deter-
mine the function of noxin in organism development and
in response to stress.
We further found that the neuronal NO synthase iso-
form (nNOS) regulates hematopoiesis in vitro and in
vivo. nNOS is expressed in adult bone marrow and fetal
liver and is enriched in stromal cells, and its inactiva-
tion increases the number of hematopoietic progenitors
in the bone marrow and spleen. Our results describe a
new role for nNOS beyond its action in the brain and
muscle and suggest a model where nNOS, expressed in
stromal cells, produces NO which acts as a paracrine
regulator of hematopoietic stem cells.
Finally, we have found that during development, NO
coordinates two major morphogenetic processes, cell
division and cell movement. NO suppresses cell divi-
sion and facilitates cell movement, such that inhibition
of NO synthase during early development of Xenopus
increases proliferation in the neuroectoderm and sup-
presses convergent extension in the axial mesoderm and
neuroectoderm. NO controls cell division and cell
movement through two separate signaling pathways
(Fig. 2). Both rely on RhoA-ROCK signaling but can
be distinguished by the involvement of either guanylate
cyclase or the planar cell polarity regulator Dishevelled.
Through the cGMP-dependent pathway, NO suppresses
cell division by negatively regulating RhoA and con-
trolling the nuclear distribution of ROCK and
p21WAF1. Through the cGMP-independent pathway,
NO facilitates cell movement by regulating the intra-
cellular distribution and level of Dishevelled and the
activity of RhoA, thereby controlling the activity of
ROCK and regulating actin cytoskeleton remodeling
and cell polarization. Concurrent control by NO helps
ensure that the crucial processes of cell proliferation and
morphogenetic movements are coordinated during early
development. This study demonstrates the function of
NO in planar cell polarity and highlights its role as a
morphogenetic regulator.
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FIGURE 2. Schematic representation of the signaling pathways
mediating the action of XNOS1 during Xenopus development
(Peunova et al. 2007).
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Research in my group aims to understand the molecular
basis for biological activity and physical properties of
integral membrane receptors and ion channels involved
in neurotransmission.To achieve our goals, three-dimen-
sional structures are determined primarily by X-ray crys-
tallography, and the functional properties of target
proteins are assessed by structure-based site-directed
mutagenesis in combination with biophysical and bio-
chemical techniques including electrophysiology.
Specifically, we are focusing on three classes of inte-
gral membrane proteins, which demonstrate key roles in
mediating neuronal activities: N-methyl-D-aspartate
receptors (NMDARs), a ligand-gated cation channel that
opens upon binding to glutamate and glycine and medi-
ates excitatory synaptic transmission; low-density
lipoprotein (LDL) receptor-related protein (LRP), a
lipoprotein receptor that associates with NMDARs and
regulates the strength of synaptic transmission; and γ-
secretase, an intramembrane cleaving protease that
mediates regulated intramembrane proteolysis of amy-
loid precursor proteins and LRP. The functions of the
three classes of integral membrane proteins above are
interrelated. Dysfunction of these proteins is implicated
in various neurological disorders and diseases including
Alzheimer’s disease, Parkinson’s disease, seizure,
strokes, and schizophrenia. Our long-term goal is to
understand the molecular mechanism for functional
alteration of these proteins in disease states.
MECHANISM OF SUBTYPE SPECIFICITY
IN NMDA-RS
In 2007, we spent the majority of our effort in charac-
terizing the mechanism of ligand binding on NMDARs
by conducting X-ray crystallographic studies on the lig-
and-binding domain of the NR2D subunit (NR2D
S1S2). The NMDAR ion channels containing NR2D
have distinct properties characterized by exceptionally
longer deactivation kinetics and a higher affinity for
glutamate compared to those containing other NR2
subtypes (NR2A-C). Because each NMDAR subunit
has distinct physiological roles, a subunit specific com-
pound is preferred for the design of potential drugs. The
atomic information of the NR2D S1S2 may prove use-
ful for such purpose.
The bottleneck in X-ray crystallography is the for-
mation of high-quality crystals that diffract X-ray at a
level suitable for structural analysis. To acquire such
crystals, a sufficient (milligram order) amount of the
target proteins must be produced and purified to homo-
MOLECULAR ANALYSIS OF NEURONAL
RECEPTORS AND ION CHANNELS
H. Furukawa E. Karakas
N. Simorowski
FIGURE 1 Typical morphology of the NR2D S1S2 glutamate crystals with X-ray diffraction at 1.7 Å. Shown in the middle is the “clam
shell” structure of NR2D S1S2 in complex with glutamate (sphere). Glutamate is bound to the interdomain cleft between the upper and
lower domain of the “clam shell.”
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geneity. Studies on NR2D have lagged behind due to
difficulties in acquiring such protein samples.We have
conducted factorial screenings on the expression of
NR2D S1S2 and found conditions that allow us to
obtain 4 mg of the NR2D S1S2 proteins from 20 liters
of bacterial culture. The NR2D S1S2 proteins were
purified to homogeneity by the four-step purification
method involving Ni-NTA, anion- and cation-exchange
chromatography, and size-exclusion chromatography.
By using homogeneously purified proteins, we were
able to find conditions to produce crystals that dif-
fracted to 1.7-Å resolution. The X-ray diffraction data
were collected at the National Synchrotron Light
Source at Brookhaven National Laboratory. Using the
X-ray diffraction data, we recently obtained atomic
structures of the NR2D S1S2 ligand-binding core
bound to different ligands including glutamate,
NMDA, and aspartate. We are currently scrutinizing
atomic information of NR2D S1S2 to understand the
molecular mechanism underlying slow deactivation and
NR2D subunit specificity. Along the way, we are
designing functional experiments to assess structure-
based hypothesis by electrophysiological techniques.
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Amajor challenge in neuroscience is to understand how
behaviors emerge from the underlying neural networks
and their cellular constituents. In many areas of the ver-
tebrate brain, GABAergic interneurons are crucial in
establishing the functional balance, complexity, and
computational architecture of neural networks. GABA
interneurons regulate synaptic integration, probability,
and timing of action potential generation in glutamater-
gic principal neurons; they further generate and main-
tain network oscillations, which provide temporal
structures for orchestrating activities of neuronal popu-
lations. The rich variety and fine details of inhibition
are achieved by diverse types of interneurons, which
display distinct morphology, physiological properties,
and connectivity patterns. The physiological properties
of interneurons are optimized for generating a rich array
of firing patterns and synaptic dynamics to precisely
and efficiently control electrical signaling in neurons
and networks. Furthermore, different classes of
interneurons display characteristic axon arbors and
innervation patterns, which distribute their outputs to
discrete spatial locations, cell types, and subcellular
compartments in the network. Like glutamatergic con-
nections, GABAergic synapses are also modified by
usage, leading to reconfiguration of the inhibitory cir-
cuits by experience. Understanding the organization,
operation, and plasticity of GABAergic circuits is key to
discovering general principles that govern how infor-
mation is processed by neural circuits. My laboratory
combines genetic, imaging, and physiological
approaches to study GABAergic interneurons and cir-
cuitry in the cerebral and cerebellar cortex.
MOLECULAR MECHANISMS UNDERLYING
SUBCELLULAR ORGANIZATION OF
GABAERGIC SYNAPSES
Large principal neurons, such as neocortical pyramidal
neurons and cerebellar Purkinje neurons, consist of dis-
tinct anatomical and functional compartments; such dis-
tributed and compartmentalized processing greatly
increases the computational power of single neurons.
These physiological compartments arise from subcellu-
CONSTRUCTION AND FUNCTION OF THE GABA
INHIBITORY CIRCUITS
Z.J. Huang Y. Fu D. Kvitsiani R. Paik P. Wu
M. He M. Lazarus A. Paul X. Wu
S. Kuhlman J. Lu H. Taniguchi H. Yang
lar distribution of all major classes of ion channels,
receptors, and signaling mechanisms. Superimposed
upon these biophysical compartments is the subcellular
organization of synaptic connectivity, especially GABA
inhibitory synapses, which is essential for regulating
integration, spike timing, and back propagation in prin-
cipal neurons.
Until our discovery, the mechanisms underlying sub-
cellular synapse organization were almost entirely
unknown.We have demonstrated that subcellular target-
ing of GABAergic synapses is guided by genetically
determined mechanisms and does not involve experi-
ence-dependent neural activity (Chattopadhyaya et al.,
J. Neurosci. 24: 9598–9611 [2004]). Furthermore, we
discovered that the subcellular distribution of an L1 fam-
ily immunoglobulin protein (neurofascin186), recruited
by an ankyrin family membrane skeleton (ankyrinG480),
is a key mechanism that directs basket interneurons (Fig.
1) to innervate the axon initial segment of Purkinje neu-
rons (Ango et al., Cell 119: 257–272 [2004]). Because
ankyrinG also recruits voltage-gated sodium channels to
AIS (axon initial segment) to promote the initiation of
action potentials, “subcellular alignment” of ion chan-
nels and a specific class of inhibitory input may opti-
mize the regulation of spike generation and timing in
principal neurons. Importantly, the L1CAM (L1 cell
adhesion molecule) and ankyrin families consist of dif-
ferent members that localize to distinct subcellular com-
partments. We recently discovered that another member
of L1CAMs, CHL1 (close homolog of L1), contributes
to the innervation of Purkinje cell dendrites by stellate
interneurons (F.Ango et al., in press). Our findings sup-
port the general hypothesis that L1CAMs recruited to
subcellular domains by different ankyrins regulate sub-
cellular organization of GABAergic synapses.
ACTIVITY-DEPENDENT MATURATION
AND PLASTICITY OF INHIBITORY
SYNAPSES AND CIRCUITS
In addition to genetic programs, the construction of neu-
ral circuits requires activity-dependent regulation of neu-
rite growth and synapse formation. As key mediators of
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neural activity, neurotransmitters are particularly well
suited to sculpt connections by coupling synaptic trans-
mission with synaptic growth and refinement. Indeed,
glutamate signaling regulates nearly all aspects of exci-
tatory synapse development and plasticity. The develop-
ment of inhibitory synapses and circuits is also regulated
by neural activity, but the underlying mechanisms are
poorly understood. In particular, it is unknown whether
the inhibitory transmitter GABA itself plays a part. We
have demonstrated that the maturation of inhibitory
innervation targeted to the soma and proximal dendrites
of pyramidal neurons in visual cortex proceeds into ado-
lescence and is regulated by visual experience (Chat-
topadhyaya et al., J. Neurosci. 24: 9598–9611 [2004]).
We recently made a fundamental discovery that
GABA and its rate-limiting synthetic enzyme GAD67
act beyond their classic roles in inhibitory transmission
and mediate activity-dependent maturation and plastic-
ity of inhibitory synapses and innervation patterns (Chat-
topadhyaya et al. 2007). We hypothesize that, similar to
the role of glutamate in the development of excitatory
synapses, GABA signaling is an activity-dependent
mechanism to promote and coordinate presynaptic and
postsynaptic maturation during the development of
inhibitory synapses and axon arbors. Because GAD67
level is coupled to neuronal inputs, activity-dependent
GABA synthesis and signaling may provide a cell-wide
as well as synaptic mechanism to sculpt GABAergic
connectivity patterns. Our discovery provides major
insights into the fundamental mechanism of activity-
dependent maturation and plasticity of inhibitory cir-
cuitry and raises a series of questions regarding the
functional significance and underlying cellular and
molecular mechanisms.
Maturation of GABAergic circuits in the developing
visual cortex is regulated by sensory experience and, in
turn, influences the critical period of ocular dominance
(OD) plasticity.We discovered a role for polysialic acid
(PSA), presented by the neural cell adhesion molecule
(NCAM), in the maturation of GABA innervation and
OD plasticity. Our results suggest that developmental
and activity-dependent removal of PSA is a permissive
FIGURE 1 In vivo imaging of basket interneurons.
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mechanism that regulates the timing of the maturation
of GABA inhibition and onset of OD plasticity (di
Cristo et al. 2007).
GENETIC TOOLS TO VISUALIZE AND
MANIPULATE GABAERGIC NEURONS
AND CIRCUITS IN VIVO
The diversity and complexity of GABAergic cell types
are the basis for multifaceted functions of the GABA
system but have been largely impenetrable by conven-
tional anatomical and physiological techniques. Genetic
strategies hold the promise to “deconvolute” this com-
plexity because they tap into the intrinsic gene regula-
tory mechanism and logic that generate and maintain
the GABAergic system. We are building genetic tools
using Cre/loxP recombination-regulated gene expres-
sion to (1) visualize the morphology and connectivity
of GABA interneurons with synapse resolution, (2)
visualize the activity and activity history of interneu-
rons, and (3) manipulate the firing and synaptic trans-
mission of defined classes of cells at physiological time
scales.
Using recombineering technology, we are generating
more than 20 knockin “driver lines” expressing Cre or
inducible CreER to establish “genetic access” to all
major classes GABAergic neurons. In addition, we are
also constructing a new generation of Cre-activated
“reporter” mice to achieve high-level expression of flu-
orescent proteins (FPs) and “molecular switches”(MSs,
such as ligand- or light-induced ion channels) in vivo,
by incorporating a variety of amplification strategies. In
collaboration with Sacha Nelson at Brandeis University,
we are characterizing these drivers and reporter lines
and establishing a Web-based platform for disseminat-
ing the mice, reagents, and expression data (UO1-
MH078844-01; NIH Neuroscience Blueprint). These
driver mice will significantly accelerate progress in
studying all aspects of the GABAergic system.
Importantly, we recently incorporated virus-mediated
gene delivery into our scheme:We developed a method
that combines Cre-driver and Cre-activated adeno-asso-
ciated virus (AAV) vectors to achieve high-level and
cell-type-specific gene expression in the mouse brain.
This method allowed us to image, for the first time,
defined classes of inhibitory synapses in the live neo-
cortex in vivo. The engineering of AAV vectors is sim-
ple and economic, and viral transfection can be directed
to specific brain regions and developmental stages. We
have now generated “conditional AAVs” expressing
channnelrhodopsin, halorhodopsin, and allostatin to
manipulate the activity of inhibitory neurons in a num-
ber of our projects.We are further developing this strat-
egy to include viruses with larger capacity or
trans-synaptic properties. The genetic access to specific
cell types defined by Cre driver mice combined with
efficient and flexible delivery of an array of conditional
viruses to visualize and manipulate these cell types will
herald a new era for studying the organization and func-
tion of complex neural circuits.
GENE EXPRESSION PROFILE AND
PROGRAMS IN DIFFERENT CLASSES
OF GABAERGIC INTERNEURONS
The stunning heterogeneity and complexity of GABAer-
gic interneurons in their intrinsic and synaptic physiol-
ogy, morphology, and connectivity are likely conferred
by differential gene expression.A systematic character-
ization of gene expression profiles among GABAergic
cell types may provide the most comprehensive and
quantitative description of their molecular make-up and
yield fundamental insight into their classification, bio-
physical repertoire, and the genetic program directing
their development. We have generated an array of bac-
terial artificial chromosome (BAC) transgenic mice
expressing green fluorescent protein (GFP) in different
classes of GABAergic neurons. In collaboration with
my laboratory, Sacha Nelson at Brandeis University has
developed a method to manually purify GABA neurons
for microarray analysis (Sugino et al., Nat. Neurosci. 9:
99 [2006]). We are applying this method to the devel-
opment of the neural circuit in the cerebellar cortex.
The cerebellum is appealing because various trans-
genic mice label every major class of GABAergic neu-
rons and glia cells throughout development. These
studies may reveal novel biophysical properties, signal-
ing pathways, and transcription programs among
interneurons and also yield better tools (such as genes
that define novel cell types) for more refined genetic
manipulations. Such a non-hypothesis-driven approach
is essential to elucidate the genetic design of the
GABAergic system and its function and capacity for
plasticity.
GABAERGIC CIRCUITS IN NEURODEVELOPMENTAL
DISORDERS
We have recently received major funding from the
Simons Autism Research Initiative to study Rett Syn-
drome (RTT), the best characterized form of the autism
spectrum disorder, caused by mutations in the X-linked
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gene MeCP2. Our general hypothesis is that MeCP2
mutations perturb the postnatal maturation of the con-
nectivity, function, and plasticity in subsets of inhibitory
interneurons in distributed brain areas, leading to altered
development and maladaptive plasticity of neural cir-
cuits, and characteristic behavioral deficits.
In collaboration of Dr. Sacha Nelson at Brandeis Uni-
versity, we will combine genetic, genomic, imaging, and
physiological approaches to (1) identify the subset of
GABAergic neurons in specific brain regions that are
influenced by MeCP2 mutations at defined develop-
mental stages and during experience-induced plasticity,
(2) characterize the impact ofMeCP2mutations on gene
expression profiles in specific classes of neocortical
interneurons, and (3) determine the impact of MeCP2
mutations on the physiological properties and synaptic
innervation pattern of specific classes of neocortical
interneurons.
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Research in my newly established laboratory focuses on
the computational principles and neurobiological mech-
anisms of decision making.We view complex behaviors
as sequences of elementary decisions, which can be con-
veniently studied in isolation to expose their underlying
neural processes. Yet, even simple decisions involve the
integration of sensory and memory information with
emotional and motivational attributes requiring the con-
certed action of millions of neurons across brain regions.
Therefore, we take an integrative approach, combining
tightly controlled rodent behavior with electrophysiolog-
ical recordings to monitor neural activity, molecular tools
to perturb genetically identified neural circuit elements,
and quantitative analysis to guide and sharpen the neu-
robiological questions.
At present, we are pursuing two broad directions. First,
we seek to identify newneurocomputational principles that
go beyond the sensory and motor processes of decision
making by studying more elusive attributes such as emo-
tion, motivation, or confidence. Recently, we discovered
neural correlates of decision confidence in the orbitofrontal
cortex of rats, and we are currently investigating both the
neural mechanisms and algorithms by which this signal
supports adaptive behavior. Second,wewant to understand
how specific cell types participate in the neural circuit
dynamics of local processing, and how different brain
regions with specialized functions coordinate their activ-
ity. Toward this goal, we are adapting molecular and opti-
cal tools for use in behaving animals to identify and
manipulate defined neuronal subtypes and pathways.
Ultimately, we would like to gain mechanistic insights
into decision processes in the hope that these will be of
utility not only for a basic scientific understanding, but
also to lead to better treatments for brain dysfunctions of
decision making, such as pathological gambling, drug
abuse, and anxiety disorders.
Role of Orbitofrontal Cortex in Evaluating
Decision Confidence
A. Kepecs [in collaboration with Z.F. Mainen, Cold Spring
Harbor Laboratory]
If you are asked to evaluate your confidence in some-
thing you know—how sure are you that it is true—you
can readily answer. What is the neural basis for such
judgments? Is knowledge about beliefs an example of
the human brain’s capacity for self-awareness? Or is
there a simpler explanation that might suggest a more
basic yet fundamental role for uncertainty in neural
computation?
In collaboration with Naoshige Uchida (Harvard
University), Hatim Zariwala (CSHL), and ZachMainen
(CSHL), we addressed these questions by experimen-
tally manipulating the difficulty of perceptual decisions
and searched for a neural correlate of rats’ confidence
about getting a reward. We trained rats in a two-choice
odor-mixture categorization task that is well suited for
studying decision making in rodents. In this task, rats
report the dominant odor-mixture component by enter-
ing different choice ports. Their performance is nearly
perfect for pure odors and drops systematically with
mixture ratio (difficulty). We found a population of
neurons in orbitofrontal cortex (OFC) whose firing
tracked the difficulty of the decision and, surprisingly,
could even anticipate the outcomes of different trials of
the same difficulty. We were able to concisely explain
this pattern of data using a simple model of decision
confidence.We then devised a behavior, which showed
that rats could actually report their confidence when
probed with a subsequent decision. This demonstrated
that rats, like us, sometimes know how certain they are
in their answers. Taken together, our results support the
idea that decision confidence may be a widespread and
fundamental element of neural processing contributing
to adaptive behavior.
We seek to extend these initial observations by try-
ing to establish that confidence-related neural activity
in the OFC is causally related to confidence judgments.
This key issue will be approached several ways. First,
we will refine a variant of our categorization task where
the optimal amount of time to wait for a reward depends
quantitatively on the confidence in a decision. We will
then be in a position to ask whether confidence-related
neural activity in OFC can predict the timing of leaving
decisions on a trial-by-trial basis. Such result would
support the hypothesis that OFC contributes directly to
an uncertainty-guided behavior. Even if successful, it
remains possible that similar representations exist else-
where in the brain. Therefore, we will test whether OFC
NEURAL CIRCUIT DYNAMICS UNDERLYING DECISION MAKING
A. Kepecs D. Kvitsiani
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has a primary role in confidence-guided behaviors by
inactivating it. We hypothesize that shutting off OFC
leaves the odor-guided behavior intact while impairing
the use of confidence information to guide leaving
decisions. In collaboration with Erin Romberg (Ober-
lin) and Zach Mainen (CSHL), we are testing this
hypothesis. Our preliminary results show that lesions
of OFC significantly impair rats’ ability to report con-
fidence by waiting for delayed rewards without affect-
ing olfactory discrimination performance. Notably,
these findings are consistent with studies of human
patients with orbitofrontal lesions who are unable to
judge the degree of uncertainty, indicating that the
functions of OFC we are investigating in rats are con-
served across species.
These results suggest that a dynamic representation
of and access to an internal measure of decision confi-
dence is fundamental to adaptive behavior—even in
rats—and provide insights into the nature of the neural
processes underlying decision making. Our findings
establish neuronal correlates and behavioral assays that
lay a strong foundation for a broader examination of the
neural mechanisms underlying confidence estimation.
Gambling Rats: A New
Behavioral Task to Study
Confidence Judgments
A. Kepecs [in collaboration with L.-H. Tai and A. Zador,
Cold Spring Harbor Laboratory]
As humans, we assess and cope with uncertainty all the
time. Knowing how uncertain we are confers signifi-
cant benefits for a broad range of activities from the
sophisticated—managing a stock portfolio—to the
mundane—how much to bet in poker. Our previous
studies established that rats can report their confidence
by the length of time they are willing to wait for
delayed rewards. Here, we seek to establish another
behavioral task where rats will explicitly report their
confidence by entering different response ports.
Toward this goal, we are training rats in an auditory
tone categorization task (Fig. 1). Rats can initiate trials
by entering the center port that triggers the delivery of
an auditory tone. They are trained to respond to low
tones on the left and high tones on the right to receive
water rewards for correct choices. By varying the fre-
quency of tones, we can systematically change the dif-
ficulty of decisions: Tones near the category boundary
result in low accuracy, whereas tones far away from the
boundary produce high accuracy. In the “gambling”
version of this task, rats get an additional choice on
each response side between a near or “safe” port and a
far or “risky” port (Fig. 1). For correct responses, the
“safe” ports yield only a small amount of water reward
compared to “risky” ports. On the other hand, incorrect
responses to “risky” ports produce long time-out peri-
ods, during which new trials cannot be initiated. Thus,
the optimal strategy for the rat is to “bet risky” when
certain and receive a large water reward and “bet safe”
when uncertain to avoid the long time-out period for
incorrect choices. We plan to examine whether rats are
able to act on their degree of confidence and use this
optimal “gambling” strategy.
It has been argued that acting on the degree of con-
fidence requires sophisticated metacognitive capacity
requiring awareness and a neural architecture specific
to humans and other primates. Interestingly, there is a
rare human condition called blindsight in people with
injuries to early visual cortex, so that when patients are
asked to make a visual choice, they deny the awareness
of visual stimuli—and insist that they are guessing—
yet perform well above chance level. On the other hand,
because they do not seem to be aware of visual stimuli,
they cannot make appropriate confidence judgments.
Consequently, using a gambling paradigm, it has been
shown that people with blindsight wager money based
on their awareness, rather than performance, suggesting
FIGURE 1 Rat gambling task. A rat performing an auditory tone
categorization task. For low tones, the correct answer is left, and
for high tones, it is right. For each side, the rat has two options,
the near “safe” ports or the far “risky” ports. For correct
responses, the “safe” ports yield only a small amount of water
reward compared to “risky” ports, but an incorrect response to
“risky” ports results in a time-out punishment.
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that wagers can provide a way to quantitatively measure
awareness. Therefore, by establishing a behavioral par-
adigm to explicitly measure decision confidence on a
trial-by-trial basis, we will be in a position to ask mech-
anistic questions about the neural processes underlying
auditory awareness.
How Uncertainty Boosts Learning:
Dynamic Updating of
Decision Strategies
A. Kepecs [in collaboration with N. Uchida, Harvard;
Z. Mainen, Cold Spring Harbor Laboratory]
Making optimal decisions requires that decision strate-
gies be updated based on the successes and failures of
similar decisions made in the past. Specifically, rein-
forcement learning theory proposes that a quantitative
prediction error—the difference between expected and
observed outcomes—drives learning. Moreover,
according to statistical learning theory, the size of the
updates, i.e., the degree of learning, should depend on
the current estimates of uncertainty: Learn more when
uncertain and less when certain. However, there is only
limited direct evidence for these predictions, in part
because quantitative measurements of learning incre-
ments are difficult to assay experimentally.
If such learning processes are active, they may pro-
vide ongoing behavioral adjustments even in the absence
of explicit changes in behavioral contingencies that
would require overt learning. For example, during cate-
gorization tasks, the decision boundary can be learned
through reinforcement, but it may undergo continual
updating during performance thereafter. Therefore, we
used an olfactory categorization task to examine the
trial-by-trial updating of behavioral strategy.
Interestingly, we found that animals were dynami-
cally adjusting their decision strategy even after exten-
sive training. For difficult decisions (those near the
category boundary), the outcome is very informative
about location of the decision boundary, whereas the
outcome of pure odor trials (far from the decision
boundary) reveals little about the boundary. Accord-
ingly, the decision boundary should be adjusted more
following difficult trials with high uncertainty than for
trials with no uncertainty. Indeed, we found that rats
biased their decisions toward the more recently
rewarded direction as if their decision boundary was
shifted. Moreover, the magnitude of this bias was pro-
portional to the uncertainty of the previous decision, as
predicted. This bias, however, was only observed for
difficult decisions, suggesting that the category bound-
ary and not the side-bias was being updated. Thus, rats
not only have an estimate of their decision uncertainty,
but this estimate also appears to contribute to future
decisions. We are currently testing simple reinforce-
ment models to quantitatively account for these results.
Our observations of dynamic changes in decision
strategies even during well-learned behaviors suggest
that a theoretically optimal updating strategy based on
graded prediction error signals applies generally across
species and different learning paradigms.
Neural Circuit Dynamics of
Genetically Identified Neurons
in Behaving Mice
D. Kvitsiani, A. Kepecs [in collaboration with Z.J. Huang,
Cold Spring Harbor Laboratory]
In vitro studies of neural circuits provide a picture of
the brain with exquisite precision in neural connections
and dynamics between specific neural cell types. In
contrast, systems neuroscience studies revealed how the
activity of single neurons is correlated with perception
and behavior, albeit without knowing the identity of the
recorded neurons. Our goal is to bridge this gap by
developing a method to determine the molecular iden-
tity of the neurons recorded during behavior.
The availability of genetically targetable fluorescent
markers and activity reporters has revolutionized cellu-
lar neuroscience, and similarly, the recently character-
ized ChannelRhodopsin-2 (ChR2), a light-sensitive
cation channel, promises to do the same for systems
neuroscience. Using ChR2, genetically defined neuron
classes can be made light-activatable so that we can opti-
cally control the generation of spikes with millisecond
precision. We will use this optical control to identify
neurons using traditional extracellular electrodes that
can be used in behaving animals. Briefly, we will intro-
duce fiberoptic probes to deliver light along with our
electrodes. In this configuration, genetically specific
neuron populations expressing ChR2 can be unambigu-
ously separated on a recording electrode from the rest of
the neuronal population using light stimulation.
We will use this tool to understand how the diver-
sity of hippocampal inhibitory neuron cell types con-
tributes to neural circuit dynamics. Specifically, it is
known that the hippocampus exhibits different states of
activity and this network activity is organized as oscil-
lations spanning multiple timescales. The circuit
dynamics is known to change depending on a behav-
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ioral state of an animal. For instance, hippocampal
oscillations switch between distinct frequency bands
across different sleep states or when an animal enters
into active exploration mode. How are these distinct
modes of network dynamics generated and controlled?
What are the roles of different neural populations in
circuit dynamics? We hope to answer these questions
by adapting these optical-genetic tools for use in behav-
ing mice.
Toward this goal, we are collaborating with Josh
Huang’s lab here at CSHL to generate knockin mouse
lines labeling different populations of inhibitory
interneurons with Cre recombinase.Along with the Cre
lines, we are generating a reporter mouse line carrying
ChR2-coding sequences under a strong ubiquitous pro-
moter interspersed by a floxed transcriptional stop cas-
sette. These reporter mice will be bred to Cre mouse
lines to activate ChR2 in distinct interneuron classes.
As an alternative to this approach, we have managed
to use a viral strategy to conditionally express the very
same proteins in mouse brain. Specifically, we used
adeno-associated virurses (AAV) to deliver Cre acti-
vatable ChR2 protein into the hippocampus. This
approach achieved a high level of protein expression
that appears sufficient to be able to activate these neu-
rons with light. Our next step will be to develop cus-
tom-designed “drives” that can be used to implant
different fiber optic probes in combination with
tetrodes (four-wire electrodes). This will also require
miniaturizing our current “drives” so that they can be
implanted in freely behaving mice. Ultimately, we plan
to use this strategy to record and at the same time iden-
tify specific neural classes in behaving animals in other
brain areas and behaviors as well.
The development of these tools will also allow us to
test the roles of different neural classes by directly stim-
ulating them and observing the consequences on global
neural activity and behavior. This project is an example
of a new era in systems neuroscience, where molecu-
larly identified circuit elements can be monitored and
disrupted at high temporal precision.
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Our laboratory studies theoretical models for the devel-
opment of connectivity in the brain. We attempt to
understand how the effects of binding and activation of
chemical labels, such as Eph receptors and their ligands,
ephrins, can be combined with Hebbian plasticity. Gen-
eral methods advanced by us this year represent forma-
tion of more abstract neural network as a result of
interplay between genetic factors represented by molec-
ular labels and environmental information given by the
neuronal electric activity. Our theoretical methods allow
us to study the dynamics and configurations of biolog-
ically realistic neural networks.
Sperry versus Hebb: Topographic
Mapping in Isl2/EphA3
Mutant Mice
D. Tsigankov, A. Koulakov
In wild-type mice, axons of retinal ganglion cells
establish topographically precise projection to the
superior colliculus of the midbrain. This implies that
axons of neighboring retinal ganglion cells project to
the proximal locations in the target. The precision of
topographic projection is a result of combined effects
of molecular labels, such as Eph receptors and ephrins,
and correlated electric activity. In Isl2/EphA3 mutant
mice, the expression levels of molecular labels are
changed. As a result, the topographic projection is
rewired so that the neighborhood relationships be-
tween retinal cell axons are disrupted.
We argue that the effects of correlated activity pre-
senting themselves in the form of Hebbian learning
rules can facilitate the restoration of the topographic
connectivity even when the molecular labels carry con-
flicting instructions (Tsigankov and Koulakov 2008).
This occurs because the correlations in electric activ-
ity carry information about retinal cells’ spatial loca-
tion that is independent of molecular labels. We
therefore argue that experiments in Isl2/EphA3 knock-
in mice directly test the interaction between the effects
of molecular labels and correlated activity during the
development of neural connectivity (Fig. 1).
BIOPHYSICAL BASIS FOR NEURAL COMPUTATION
A. Koulakov D. Tsigankov
Optimal Axonal and Dendritic
Branching Strategies during
Development of Neural Circuitry
D. Tsigankov, A. Koulakov
In the developing brain, axons and dendrites are capable
of connecting to each other with high precision. Recent
advances in imaging allowed monitoring of the axon,
dendrite, and synapse dynamics in vivo. It was observed
that the majority of axon and dendrite branches formed
are retracted later during the development. In this study,
we computationally analyzed different axonal and den-
dritic branching strategies that minimize the number of
FIGURE 1 Topographic maps in Isl2/EphA3 knock-in mice as
obtained by the computational model. The complete map struc-
ture is coded by shades of gray according to the axonal origin in
retina as shown by the left column. In addition, the termination
zones for a small subset of axons indicated by the points are
shown for temporal (upper row), central (center row), and nasal
(lower row) labeling. In mutant animals, the axons are split into
two groups that terminate at different positions in the target. Thus,
modifications of the molecular labels lead to the rewiring of brain
connectivity. However, in the case of temporal injection in het-
erozygous knock-ins (center, top), two groups of axons blend into
the same terminations zone (dashed circle). We argue here that
this collapse of the two groups of axons occurs because of the
effects of correlated neural activity, which are capable of fixing the
map despite the counteracting molecular labels.
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transient branches required to establish connectivity with
particular precision.We applied these branching rules to
the development of retinotectal topographic connectivity
and found that axons and dendrites have different opti-
mal branching strategies.
The axonal optimal strategy is to form new branches
in the vicinity of existing synapses, whereas the optimal
rule for dendrites is to form new branches preferentially
in the vicinity of synapses with correlated presynaptic
and postsynaptic electric activity. We show that experi-
mentally observed different reactions to the NMDA (N-
methyl-D-aspartate) receptor block in the dynamics of
axonal and dendritic branching imply that that these two
branching strategies are implemented in the developing
brain.We suggest that the difference in branching strate-
gies of axons and dendrites could be detected by meas-
uring the spatial correlations between synapses and
branch points on the developing arbors. We thus predict
that these correlations should be reduced for dendrites
but not for axons under the conditions of the NMDA
receptor block.
Combinatorial ON/OFF Model
for Olfactory Coding
A. Koulakov [in collaboration with D. Rinberg and A. Gelperin,
Monell Chemical Senses Center, Philadelphia, Pennsylvania]
We study a model for olfactory coding based on spatial
representation of glomerular responses. In this model,
distinct odorants activate specific subsets of glomeruli,
dependent on the odorant’s concentration. The glomeru-
lar response specificities are understood statistically,
based on experimentally measured distributions of
detection thresholds. A simple version of the model, in
which glomerular responses are binary (the on/off
model), allows us to quantitatively account for the fol-
lowing results of human/rodent psychophysics: (1) Just-
noticeable differences in the perceived concentration of
a single odor (Weber ratios) are dC/C ~0.1; (2) the num-
ber of simultaneously perceived odors can be as high as
12; and (3) extensive lesions of the olfactory bulb do
not lead to significant changes in detection/discrimina-
tion thresholds. We conclude that a combinatorial code
based on a binary glomerular response is sufficient to
account for the discrimination capacity of the mam-
malian olfactory system (Koulakov et al. 2007).
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FIGURE 2 In silico structure of developing axons and dendrites.
In the model axons and dendrites evolve in time by creating and
eliminating new branches and retracting and elongating existing
ones. The synapses (circles) are created and eliminated between
the overlapping branch segments of axons and dendrites. Of the
900 simultaneously evolving axonal arbors, two are shown at
sequential time frames (A–D and E–H). Two shown dendrites are
the main recipients of the synaptic connections for two shown
axons when topography is established. The axonal branching is
biased toward their correct termination zone, providing the spa-
tial overlap with the arbors of the appropriate dendrites. The
synapses are then formed and maintained between appropriate
axons and dendrites, thus forming a topographic mapping.
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Our lab is studying the neural mechanisms of goal-
directed behavior. We work with a simple but flexible
psychophysical paradigm in which rats use odors to
guide spatial choices to obtain reward. We are particu-
larly interested in how olfactory information is encoded
and transformed into adaptive decisions.We discovered
several years ago that rats can respond accurately to sen-
sory information extremely quickly—in a single sniff—
and we are continuing to study the temporal limits and
mechanisms of rapid olfactory discrimination as well as
more complex computational problems such as concen-
tration- and background-invariant odor recognition and
odor-guided navigation.
To get at the underlying neural mechanisms, we are
using chronic multielectrode recording to monitor sin-
gle neuron activity and neural circuit interactions. We
recently found that the orbitofrontal cortex integrates
spatial and reward information to construct maps of
behavioral goals. Ongoing recordings focus on tempo-
ral coding in the olfactory cortex and the dynamics of
representations during learning. From a broader neu-
roeconomic perspective, we are also studying how the
brain deals with the costs of decisions (effort, delay,
uncertainty).
Finally, we are investigating how psychoactive drugs
alter behavior, beginning with ketamine, a drug thought
to mimic aspects of psychosis.We hypothesize that drug
states can be understood as specific perturbations of
neural circuit dynamics. An understanding of neu-
ropharmacology at the circuit level may lead to more
effective treatments for disorders such as Parkinson’s
disease and schizophrenia.
Should I Stay or Should I Go?
Neural Mechanisms of Patience
M. Murakami
Consider the situation in which you wait for a bus but it
is delayed. You have no idea when it arrives. There is
another option, taking a cab, which costs much more
THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen C. Feierstein M. Quirk M. Uchida
G. Felsen S. Ranade N. Xu
A. Kepecs M. Smear H.A. Zariwala
M. Murakami D. Sosluski
but is available immediately. How long do you wait for
the bus? When do you give up waiting for the bus and
decide to take a cab? In such circumstances, your brain
must compute the costs and benefits of the choices and
use that information for choosing an action—waiting or
giving up. In this study, we investigated a role of medial
prefrontal cortex (mPFC) and secondary motor cortex
(M2) in deciding to wait or not to wait.
We developed a task in which a rat is faced with a
waiting problem similar to the “bus-or-cab” dilemma.
There are two nose poke ports: One is for waiting and the
other is for delivering a water reward.A short delay (400
msec) after a rat pokes in the waiting port, a first tone is
played, and this signals the availability of a small reward
at the reward port. If the rat goes to the reward port after
the first tone, it receives a small amount of water reward.
If the rat waits longer in the waiting port, instead of going
to the reward port, then a second tone is played after a
random delay period of up to several seconds. If the rat
goes to the reward port after this second tone, it receives
a larger amount of water reward. In this task, after the
first tone is played, the rat is confronted with a choice
between going to the reward port to get small reward and
waiting for a second tone to get large reward.
Behavioral results showed that the time a rat is will-
ing to wait for a given set of reward amounts and delays
varies randomly from trial to trial. On some trials, the rat
will respond immediately after the first tone; on other
trials, it will withhold responding until after the second
tone; and on others, it will wait well past the first tone
but give up before the second.
We recorded neuronal activity from the mPFC and
M2 during this task.We found that the activity of a sub-
set of mPFC/M2 neurons can predict how long a rat will
withhold a response, i.e., the firing rate of these neu-
rons during a time window before the end of waiting
was significantly correlated with waiting time of the rat.
Individual neurons showed both positive and negative
correlations with waiting time. Predictive activity
occurred at different time points during the waiting
period and even before the waiting period. These results
support a possible role of mPFC/M2 in decision making
of waiting or not waiting.
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:53 PM  Page 131
132
Movement Selection and Initiation
in the Rat Superior Cilliculus
G. Felsen
We are interested in how the nervous system uses sen-
sory stimuli to select and initiate appropriate motor
actions. To this end, we have been studying how rats use
olfactory cues to guide choices about, and to initiate,
directional movements. We hypothesized that the supe-
rior colliculus (SC) could have an important role in
these processes, since it is known to produce orienting
movements, via descending projections to several motor
nuclei. In rats, it is not known how activity in the SC
underlies movement initiation and whether the SC is
also involved in selecting among potential movements.
To address these questions, we used tetrodes to
record from intermediate and deep-layer SC neurons in
well-trained rats performing a two-alternative choice
olfactory discrimination task. In each trial of the task,
the rat first entered a centrally located odor port, trig-
gering the delivery of an odor, and then moved to either
the left or right reward port to obtain a water reward.
The odor was either a pure compound or a mixture of
two compounds. One pure odor was rewarded follow-
ing a left choice and the other following a right choice,
and mixtures were rewarded according to their domi-
nant component.
We first analyzed activity during movement, as the
rat moved both toward the reward port and back to the
odor port. We expected to identify neurons that were
selective for the direction of movement, consistent with
previous results in primates. Although a population of
neurons was direction-selective, we found a large frac-
tion of neurons that preferred movement in one direction
when moving toward the water port but in the other
direction when returning to the odor port. These neurons
can be thought of as selective for a region of space within
the behavioral environment (e.g., the left side of the box).
Such spatial selectivity in the SC has not been reported
previously in rodents or primates, and together with
directionally, selective neurons could have an important
role in coordinating laterally orienting movements.
We next analyzed the activity during the premovement
epoch, defined as the 100 msec preceding the exit from
the odor port. The activity of many neurons during this
epoch depended on whether the upcomingmovement was
leftward or rightward and did not depend on the identity
of the odor being presented.Across the population, higher
firing rates preceded movement contralateral to the
recording site. In some cells, this direction selectivity dis-
appeared at the onset of movement, whereas in other
cells, it persisted during the movement.
These data suggest that prospective direction selec-
tivity in the SC is involved in the initiation of laterally
orienting movements. To determine whether the
observed selectivity causes, or is simply correlated with,
movement initiation, we used the GABAA agonist mus-
cimol to unilaterally inactivate the SC in rats perform-
ing the behavioral task. If SC output is necessary for
initiating contralateral movements, we would expect
inactivation to bias the rat toward ipsilateral movements.
Indeed, we found that muscimol, but not saline, deliv-
ered to the left SC biased the rat toward leftward
choices, and this bias was dosage-dependent. Thus, nor-
mal SC activity is necessary for initiating appropriate
directional movements.
Finally, we performed anatomical experiments to
determine whether the SC receives input directly from
an olfactory cortical region. Using a retrograde tracer,
we identified a projection from the lateral entorhinal
cortex, which is known to process olfactory informa-
tion. This pathway suggests the existence of a parsimo-
nious circuit for acting on olfactory-cued decisions.
Diversity and Precision of Neural
Activity in Serotonergic
Brainstem Nuclei
S. Ranade
Serotonin is a neurotransmitter implicated in a diverse
range of physiological functions and behaviors as well
psychiatric disorders including depression and anxiety.
Serotonin is released by neurons in a set of brainstem
nuclei called the raphe nuclei. The raphe system is by far
the most complex, divergent neuromodulatory system
in the brain. Our current understanding of serotonin
function has been gained mostly from pharmacology
and lesion studies. Neuronal recordings from animals
performing well-controlled behavioral tasks have
greatly increased our knowledge of dopamine and nor-
epinephrine function, but there have been few record-
ings from raphe neurons during behavioral tasks. We
hypothesize that such studies will yield novel insights
about raphe function, particularly at fast timescales.
In this project, we recorded from raphe nuclei in rats
performing a two-choice alternative odor discrimination
task (as described above). Rats were trained to associate
individual odors with water reward at one of two choice
ports. Correct responses were rewarded probabilistically
after a variable delay. This paradigm allowed us to study
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sensory, motor, and reward-related responses with high
temporal precision by aligning to nose poke events.
After training, rats were chronically implanted with
a six-tetrode recording drive. Tetrodes were targeted to
the raphe using a guide cannula. Recordings were
obtained from 54 neurons in seven rats over an average
of four to eight sessions per rat. Recording locations
were verified histologically following termination of
experiment. Raphe neurons showed diverse firing prop-
erties with respect to waveform characteristics, firing
rate, and sleep state modulation. By conventional crite-
ria, 10% of neurons were wide-spiking putative sero-
tonin neurons. Neuronal responses were analyzed with
respect to four epochs: odor sampling, movement,
reward anticipation, and reward consumption. Firing
rates of >70% neurons were modulated during at least
one behavioral epoch, with a large fraction tuned to mul-
tiple events. Many neurons responded to behavioral
events within 100 msec and some were even more pre-
cisely time-locked (order 20 msec), showing a very
strong (>40 sp/sec) phasic response, apparently to the
click produced by water valve opening.
A wide range of event-tuning characteristics were
observed in the recorded population. During odor sam-
pling, approximately one third of the units showed a
decrease in firing rate. A subset of neurons also showed
odor-induced activation, which, in rare cases, was stim-
ulus-selective. During the movement epoch, an equal
proportion of neurons showed enhancement and sup-
pression of firing. There were few instances of direc-
tion-selective tuning. A large proportion of neurons
(~40%) were inhibited during reward anticipation. A
small subset of neurons (10%) showed changes in firing
rate around the time of the expected reward. Putative
serotonin neurons showed no obvious association with
a specific response profile.
These recordings demonstrate that raphe neurons are
rapidly and precisely modulated by diverse behavioral
events. This is in accord with the known diversity of
serotonin function and the difficulty in accounting for it
with a simple unified theory. Functional diversity of
raphe responses likely reflects in part the diversity of
intrinsic properties and synaptic connectivity of neurons
within the nucleus. Classification of units into putative
serotonin and nonserotonin neurons did not yield any
obvious simplification of response diversity, highlighting
the need for methods relating firing patterns to precise
identification of neuronal cell types. Finally, the
observed functional diversity of raphe neurons is con-
sistent with the possibility that significant information
processing may occur within the raphe itself. Future
studies will focus on developing novel molecular genetic
approaches to selectively label and record activity of
populations of raphe neurons that are biochemically
homogeneous and/or share similar connectivity patterns.
Contextual Influences on
Olfactory Sensory Processing
N. Xu
Cognitive processes such as attention and expectation
are thought to exert top-down influences on sensory
information processing, leading to differential behavioral
responses as well as neural representations for identical
sensory stimuli under different stimulus or behavioral
contexts. How do such processes impact the neural rep-
resentation of odors in the primary olfactory cortex?
To examine this issue, we designed an odor discrim-
ination task (as described above) with varying occur-
rence probability of different odor mixture pairs in
different blocks of trials. The relative stimulus probabil-
ity was hypothesized to modulate the subjects’ expecta-
tion for the forthcoming stimulus while performing a
difficult odor discrimination. We found that this manip-
ulation indeed effectively modulated the subjects’behav-
ior. For difficult discrimination problems, performance
accuracy was significantly reduced when the probability
of occurrence of a given stimulus was lowered from 40%
to 10%. For easy discrimination problems, no significant
decrease was seen. These results provide behavioral evi-
dence that olfactory discrimination depends on stimulus
statistics, which would effectively modulate the subjects’
expectation for forthcoming stimuli.
We next performed chronic multielectrode recording
from the piriform cortex to test whether such modula-
tion of odor discrimination correlates with a modulation
of stimulus representation in the primary sensory cortex.
We found that neuronal responses were remarkably
modulated by the manipulation of stimulus statistics.
Analyses of these data are ongoing.
The “Where” Problem in Olfaction:
Behavioral Strategies and
Neural Mechanisms
M. Smear
Localizing the source of an odor often matters as much
as identifying it: Distinguishing a meal from a predator
is futile if you avoid the former or approach the latter.
Although our understanding of odor identification, the
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“what” problem of olfaction, has progressed consider-
ably, the “where” problem of olfaction has received rel-
atively little attention. We know that rats excel at
odor-guided navigation, but we do not know what
behavioral strategies and neural circuits they use.
A critical challenge to elucidating the neural mech-
anisms underlying odor tracking is reducing the behav-
ior to a form suitable to psychophysical techniques. To
this end, we have designed an “olfactorium” which is
essentially a two-armed maze in which the rat has to
navigate to the correct arm based on concentration cues.
Using a photoionization detector, we can obtain a sta-
tistical characterization of odor concentration patterns
with high spatial, temporal, and concentration resolu-
tion. In addition, we can precisely track the nose posi-
tion of a freely moving rat at video-rate time resolution
in real time. By combining odor concentration meas-
urements with tracked trajectories, we hope to recon-
struct the time-varying odor concentration pattern
experienced by a navigating rat, and thereby reverse
engineer its navigation strategies. In the future, we
intend to exploit rodent neuroscience’s growing arsenal
of tools for electrophysiology and transgenesis in the
context of olfacto-spatial psychophysics to understand
the neural circuitry of odor source localization.
The Neural Representation and
Impact of Decision Confidence
A. Kepecs, H. Zariwala, N. Uchida
If you are asked to evaluate your confidence in some-
thing you know—how sure are you that it is true—you
can readily answer. What is the neural basis for such
judgments? Is knowledge about beliefs an example of
the human brain’s capacity for self-awareness? Or is
there a simpler explanation that might suggest a more
basic yet fundamental role for uncertainty in neural
computation?
We addressed these questions by experimentally
manipulating the difficulty of perceptual decisions and
searched for a neural correlate of rats’ confidence about
getting a reward. We trained rats in a two-choice odor-
mixture categorization task that is well suited for study-
ing decision making in rodents. In this task, rats report
the dominant odor-mixture component by entering dif-
ferent choice ports. Their performance is nearly perfect
for pure odors and drops systematically with mixture
ratio (difficulty). Using this task, we could systemati-
cally manipulate the uncertainty of individual discrim-
inations by varying odor-mixture ratio.
We found a population of neurons in the orbitofrontal
cortex (OFC) whose firing tracked the difficulty of the
decision and, surprisingly, could even anticipate the out-
comes of different trials of the same difficulty.We were
able to concisely explain this pattern of data using a sim-
ple model of decision confidence. We then devised a
behavior, which showed that rats could actually report
their confidence when probed with a subsequent deci-
sion. This demonstrated that rats, like us, sometimes
know how certain they are in their answers. Taken
together, our results support the idea that decision con-
fidence may be a widespread and fundamental element
of neural processing contributing to adaptive behavior.
We began to extend these observations by testing
whether confidence-related neural activity in the OFC is
causally related to confidence judgments. Specifically,
we began to test whether the OFC has a primary role in
confidence-guided behaviors by inactivating it. We
hypothesize that shutting off the OFC leaves the odor-
guided behavior intact while impairing the use of con-
fidence information to guide leaving-decisions. In
collaboration with Erin Romberg here at CSHL (2007
URP), we are testing this hypothesis. Our preliminary
results suggest that lesions of OFC indeed significantly
impair the rats’ ability to report confidence by waiting
for delayed rewards without affecting olfactory dis-
crimination performance. Notably, these findings are
consistent with studies of human patients with
orbitofrontal lesions who are unable to judge degree of
uncertainty, indicating that the functions of the OFC we
are investigating in rats are conserved across species.
These results suggest that a dynamic representation
of and access to an internal measure of decision confi-
dence is fundamental to adaptive behavior—even in
rats—and provide insights into the nature of the neural
processes underlying decision making. Our findings
establish neuronal correlates and behavioral assays that
lay a foundation for a broader examination of the neu-
ral mechanisms underlying confidence estimation.
Neural Mechanisms of Ketamine
Psychoactivity in Behaving Rats
M. Quirk, D. Sosulski, C.E. Feierstein, N. Uchida
Ketamine is a psychoactive drug that has been described
clinically as mimicking acute psychosis and is consid-
ered one of the leading models for schizophrenia. More
recently, acute ketamine administration has also been
shown to be a promising therapeutic agent for treating
intractable depression. Understanding the mechanism
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of action of this drug has therefore generated consider-
able recent interest.
A prominent hypothesis for ketamine function is that
it acts to inhibit prefrontal cortical interneurons. This
idea links prominent glutamatergic and GABAergic the-
ories of schizophrenia, potentially explaining why this
NMDA (N-methyl-D-aspartate) receptor blocker results
in an increase in frontal glutamate release. Recently, H.
Homayoun and B. Moghaddam (University of Pitts-
burgh) provided support for this “disinhibition” hypoth-
esis by showing that ketamine selectively inhibits
putative interneurons in awake rats.
In our work, using multielectrode recordings in the
orbitofrontal cortex of behaving rats, we were able to
extend these results in several important ways. First, we
show that the effects of ketamine are specific to a lim-
ited subpopulation of GABAergic interneurons corre-
sponding to FS (“fast-spiking”) interneurons (basket
and chandelier cells). Second, we show using cross-cor-
relation analysis that, relative to other interneurons, the
ketamine-sensitive interneurons preferentially interact
with one another and receive greatly enhanced input
from local pyramidal neurons. Third, we show that in a
behavioral decision-making task, the firing of the keta-
mine-sensitive population is negatively correlated with
response time, a widely used index of motivational state
and reward expectancy.
From a translational perspective, these observations
provide insight into the mechanism by which ketamine
produces its psychoactive effects. From a basic science
perspective, they demonstrate the importance of linking
in vivo extracellular recordings to in vitro cell-type data
and illustrate the specificity of cell function within the
cortical microcircuit.
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Giullame Dugue
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My laboratory is directed toward understanding synap-
tic function, synaptic plasticity, and synaptic dysfunc-
tion. Through such an understanding, we hope to
elucidate how learning and memory are achieved and
how diseases corrupt them.
This year marks our 14th, and last, year at CSHL.
Since our arrival, much has changed in our field. When
we arrived, there was still little known about the mecha-
nisms underlying synaptic plasticity.We identified silent
synapses, which showed central synapses to be different
from peripheral synapses, and helped solve a conundrum
regarding long-term potentiation (LTP). We made con-
siderable headway in characterizing α-amino-3-hydroxy-
5-methyl-4-isoxazole proprionic acid (AMPA) receptor
trafficking and showed it to be an important underlying
mechanism in long-term potentiation (LTP). We have
further shown that this mechanism of plasticity under-
lies developmental plasticity as well as certain forms of
associative learning. PrimingAMPA receptor delivery to
synapses occurs during emotional arousal and enhances
learning. We have also seen that AMPA receptor traf-
ficking has a key role in the pathophysiology produced
by β-amyloid, an agent thought to be causative in
Alzheimer’s disease. Our more recent studies have iden-
tified a synapse that may be abnormally enhanced on
“disappointment” neurons and responsible for depres-
sion. It has been an exhilarating, although sometimes tur-
bulent, ride. I thank all those at CSHL who have made
this possible.
Dendritic and Axonal Secretion
of β-Amyloid Reduces Local
Spine Number and Plasticity
W. Wei, R. Malinow [in collaboration with S. Sisodia, University
of Chicago]
β-amyloid (Aβ), a peptide generated by neurons, is
widely believed to underlie the pathophysiology of
Alzheimer’s disease when overproduced. Recent stud-
ies indicate that this peptide can drive endocytosis of
TRANSMISSION AND PLASTICITY IN MAMMALIAN CENTRAL
SYNAPSES IN HEALTH AND DISEASE
R. Malinow J. Boehm H. Hu B. Li
N. Dawkins-Pisani H. Kessels H. Makino
H. Hagiwara M. Klein W. Wei
H. Hsieh C. Kopec
AMPA- and N-methyl-D-apartate (NMDA)-type gluta-
mate receptors and lead to loss of dendritic spines. We
now show that Aβ released from either presynaptic or
postsynaptic structures can have this effect. This
answers a long-standing question in the field regarding
the origin of Aβ responsible for synaptotoxic effects.
PSD-95 Is Required for Activity-driven
Synaptic Development
I. Ehrlich, R. Malinow
The activity-dependent regulation ofAMPA-type gluta-
mate receptors and the stabilization of synapses are crit-
ical to synaptic development and plasticity. One
candidate molecule implicated in maturation, synaptic
strengthening, and plasticity is PSD-95. Here, we find
that acute knockdown of PSD-95 in brain slice cultures
by RNA interference arrested activity-driven develop-
ment of synaptic structure and function, manifested by
reduced synaptic strength and altered spine morphol-
ogy. Surprisingly, PSD-95 was not necessary for the
induction and early phase of LTP expression. However,
following PSD-95 knockdown, chemically induced LTP
produced smaller changes in the size of stable spines,
and we observed a larger fraction of transient spines that
turned over more readily. Taken together, our data sup-
port a model in which PSD-95 is required for activity-
dependent synapse stabilization following initial phases
of synaptic potentiation.
Abnormally Enhanced Transmission
onto Lateral Habenula Neurons
Projecting to Ventral Tegmental
Area in Congenitally Depressed Rats
B. Li, R. Malinow [in collaboration with F. Henn, Brookhaven
National Laboratory]
Increased activity levels in the lateral habenula (LHb)
has been observed in humans during depression by
136
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fMRI (functional magnetic resonance imaging) stud-
ies. Neurons in the LHb have been prveviously shown
to become active and neurons in the ventral tegmental
area (VTA) reduce their activity during “disappoint-
ment” events in awake behaving monkeys. Here we
show that LBh neurons projecting to VTA show a five-
fold to tenfold increase in spontaneous miniature exci-
tatory synaptic current (EPSC) frequency in animals
bred to be sensitive to a depression model (learned
helplessness). These studies suggest that a defect at this
synapse is responsible for persistent disappointment
underlying depression.
Emotion Enhances Learning via
Norepinephrine Regulation of
AMPA Receptor Trafficking
H. Hu, E. Real, R. Malinow [in collaboration with J. LeDoux,
New York University; R. Huganir, The Johns Hopkins University]
Emotion enhances our ability to form vivid memories of
even trivial events. Norepinephrine (NE), a neuromodu-
lator released during emotional arousal, has a central role
in the emotional regulation of memory. However, the
underlying molecular mechanism remains elusive.
Toward this aim, we have examined the role of NE in
contextual memory formation and in the synaptic deliv-
ery of GluR1-containing AMPA-type glutamate recep-
tors during LTP, a candidate synaptic mechanism for
learning. We found that NE, as well as emotional stress,
induces phosphorylation of GluR1 at sites critical for its
synaptic delivery. Phosphorylation at these sites is nec-
essary and sufficient to lower the threshold for GluR1
synaptic incorporation during LTP. In behavioral exper-
iments, NE can lower the threshold for memory forma-
tion in wild-type mice, but not in mice carrying
mutations in the GluR1 phosphorylation sites. Our
results indicate that NE-driven phosphorylation of
GluR1 facilitates the synaptic delivery of GluR1-con-
tainingAMPA receptors, lowering the threshold for LTP,
thereby providing a molecular mechanism for how emo-
tion enhances learning and memory.
Spine Enlargement Precedes AMPA
Receptor Exocytosis during LTP
C. Kopec, B. Li, W. Wei, J. Boehm, R. Malinow
The changes in synaptic morphology and receptor con-
tent that underlie neural plasticity are poorly under-
stood. In this study, we used a pH-sensitive green fluo-
rescent protein (GFP) to tag recombinant glutamate
receptors and showed that chemically induced LTP
drives robust exocytosis of AMPA receptors onto den-
dritic spines. In contrast, the same stimulus produced a
small reduction of NMDA receptors from spines. LTP
produced similar modification of small and large
spines. Interestingly, during LTP induction, spines
increased in volume before surface incorporation of
AMPA receptors, indicating that distinct mechanisms
underlie changes in morphology and receptor content.
We are continuing these studies by establishing optical
methods to detect synapses that have undergone plas-
ticity.
Subcellular Distribution of AMPA
Receptors Depends on Stargazin,
Subunit Composition, and
Phosphorylation Events
H. Kessels, M. Klein, R. Malinow
Understanding the fate of synthesized AMPA receptors
is important in elucidating mechanisms of neuronal
function. For instance, studies have proposed that
increased synthesis ofAMPA receptors mediates synap-
tic plasticity. Here, we examine the effect of increased
synthesis ofAMPA receptor subunits GluR1 and GluR2
on their subcellular distribution. Virally driven expres-
sion of AMPA receptor subunits in rat organotypic hip-
pocampal slices results in increased levels in cell bodies
but little increase in dendritic regions and no change in
synaptic transmission. Stargazin (STG), an AMPA
receptor regulatory protein, promotes a large GluR1
redistribution into dendrites. Upon dendritic transport,
GluR1 can be protected from lysosomal degradation by
binding to STG or GluR1 phosphorylation. However,
increased dendritic GluR1 levels do not enhance surface
or synaptic levels of GluR1, indicating that simply
increasing the production of AMPA receptor subunit
GluR1 in dendrites cannot account for a change in
synaptic strength. STG also facilitates transport of
GluR2 into dendrites but does not protect GluR2 from
lysosomal targeting yielding no increase in total or sur-
face levels of dendritic GluR2. Interestingly, expression
of a phospho-mimetic mutated STG selectively
enhances surface and synaptic GluR2 but not GluR1
levels. Our data show that cellular localization ofAMPA
receptors is tightly controlled by subunit composition,
STG, and phosphorylation events.
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Our basic research philosophy is to combine theoreti-
cal, computational, and experimental approaches for
the study of complex biological systems, with a partic-
ular focus on neurobiological questions. Efforts in our
group fall into three main areas: Neuroinformatics,
Theoretical Engineering, and Quantitative Behavior
and Electrophysiology.
Our neuroinformatics research involves the applica-
tion of statistical and signal-processing tools to large
volumes of neurobiological data as well as the devel-
opment of informatics infrastructure for large-scale
data integration. Our study in the area of theoretical
engineering applies theories developed alongside
human-engineered systems to study the theoretical
principles underlying the design of biological systems.
The final area of our research is experimental and con-
sists of behavioral and electrophysiological studies in
multiple species including Drosophila, zebra finch,
macaque monkey, and human infants.
Continuing in theMitra laboratory in 2007 were Peter
Andrews (scientific informatics manager), Hemant
Bokil (postdoctoral fellow), Haibin Wang (postdoctoral
fellow), Dan Valente (postdoctoral fellow), and Jihene
Serkhane (postdoctoral fellow). Joining us in 2007 were
Jason Bohland (scientific informatics manager), John
Lin (scientific informatics developer), and Caizhi Wu
(postdoctoral fellow).
We have ongoing collaborations with multiple
research groups here at CSHL and other institutions,
which currently include electrophysiological studies in
macaques and humans with Nicholas D. Schiff and Keith
Purpura at theWeill Medical School of Cornell Univer-
sity, where Dr. Mitra is an adjunct associate professor; a
consortium of zebra finch researchers, including a long-
standing collaboration with Ofer Tchernichovski at City
College of NewYork (CCNY); study of memory forma-
tion inDrosophila, together with Josh Dubnau at CSHL;
and the Brain Architecture Project, begun in 2006 with
co-investigators at Harvard/Massachusetts General Hos-
pital, California Institute ofTechnology, and the Univer-
sity of Southern California.
Chronux: Open Source Software
for Neural Signal Processing
H. Bokil, P. Andrews
Nervous system activity can be measured at many spa-
tial and temporal scales, from electrophysiological
recordings of single neurons to monitoring large net-
works of neurons or brain areas with various imaging
technologies. For the last several years, our group has
been developing algorithmic and computational tools
for the statistical analysis of such neural time series data,
and we are encoding these tools into an open source
software package entitled Chronux (www.chronux.org).
This continuing project includes the development of a
high-quality numerical analysis library, data input-out-
put and management utilities, and a user interface that
gives experimental neuroscientists access to advanced
analysis tools.We expect that these tools will be critical
for advancing our understanding of systems-level neu-
roscience. We have made a number of additions and
changes to Chronux during the past year, and we are cur-
rently preparing a major release.
We have added the FTrack package to Chronux,
which is a video-based behavioral analysis system.
FTrack is able to track and record the trajectory of a sin-
gle animal being videotaped in an open arena. The soft-
ware is Matlab-based and comes with a GUI (graphical
user interface) to load movies, adjust parameters, and
track in an interactive environment. In response to user
feedback, we have modified the Matlab interface to
LOCFIT that is distributed with Chronux. A further
addition to Chronux is a data browser GUI which we
have been developing for visualization and analysis of
time-series data. The GUI is capable of simultaneous
display of multiple time series in a raster-like fashion,
which is useful for visualizing any type of multichannel
data such as EEG (electroencephalography) or MEG
(magnetoencephalography). The software is capable of
displaying raw voltage traces, as well as derived data
such as spectra and spectrograms.
INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra P. Andrews J. Serkhane
J. Bohland D. Valente
H. Bokil H. Wang
J. Lin C. Wu
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Song Learning in the Zebra Finch
H. Wang
Our principal goals are to provide the informatics infra-
structure for the integrative study of zebra finch vocal
development, to provide a theoretical framework that
brings together the different modalities of experimen-
tal data, and to develop signal-processing algorithms
for integrating the heterogeneous streams and for
hypothesis discovery and testing.
In the past year, progress has been made on the con-
struction of an information infrastructure to effectively
handle the multiterabyte data sets generated by the
project, including the continued construction of an
online storage resource, coupling of this resource to the
cluster at CSHL High-performance Computing Center
(HPCC) and development of interfaces to semantic
Web database technologies. We have also provided the
consortium of researchers with aWeb portal that is now
being actively used to manage digital resources within
the consortium, such as weekly meeting notes and elec-
tronic laboratory notebooks.
Our approach to signal processing is based on spec-
tral analysis, with appropriate adjustments made to the
algorithms to suit domain-specific needs. We studied
the characterization of birdsong using spectral correla-
tions. This measure complements the existing methods
in two ways: It does not require segmenting a song into
syllables, and it is not confined to a short time frame.
We used the high-performance computing cluster here
at CSHL to study the vocal development process of
zebra finch with this measure.
Toward an Integrative Model
of Memory in Drosophila
D. Valente
Memory is a process spanning many levels of organi-
zation from genetics to behavior. One of the major
challenges faced in neuroscience today lies in devel-
oping functional relationships between the genotype of
an organism and its behavioral phenotype, integrating
activity at each level. Applied to the problem of mem-
ory, such a relationship would span the scales and allow
unprecedented insight into how memories are formed
and stored. Whereas much Drosophila memory
research has primarily focused on developing detailed
descriptions of either the genetic networks or the neu-
ral networks involved in the process, only recently have
there been attempts to integrate knowledge at these lev-
els into a single, overarching description of memory.
Our project is focused on developing an integrative
model of memory, taking into account activity at each
level of organization.
In light of this, the past year has focused on the
development of two experimental setups, both of which
elucidate processes at the behavioral level and expand
the quantitative behavioral phenotype of wild-type
flies. The first setup is a flight simulator for tethered-
flight conditioning assays of Drosophila (seen in Fig.
1). Numerous studies have shown that flies can be con-
ditioned in this paradigm to avoid certain patterns pre-
sented to them in their visual environment. In
collaboration with Michael Dickinson’s lab at the Cal-
ifornia Institute of Technology, we have attempted to
replicate these well-documented visual learning stud-
ies. Although neither our lab nor the Dickinson lab has
been able to observe the learning reported in the liter-
ature, analysis of our results is beginning to show sub-
tle, yet important, differences between our setup and
the setup used in published studies. This seemingly
“failure” to replicate has turned out to be quite fortu-
itous, as it has led to further investigation of the impor-
tance of precisely timed feedback in this assay and has
initiated an investigation of the avoidance response of
flies to an intense heat stimulus. The avoidance
response has not been systematically studied in the lit-
erature, but it is required if one is to properly interpret
the results of any aversive conditioning assay in the
simulator. In all, this research is leading to a greater
understanding of learning and memory in this para-
digm.
Similarly to studies of flies in flight, measuring loco-
motor behavior of Drosophila in enclosed arenas is a
powerful way to obtain a quantitative behavioral phe-
notype. In collaboration with Ilan Golani of Tel Aviv
University, we have been studying the locomotor
FIGURE 1 The flight simulator in action.
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behavior of flies in the Open Field and have developed
quantitative measures to describe this behavior. The
majority of the measures previously used for this pur-
pose are relatively coarse: They either are based on
average velocities, thus ignoring fine-scale movements
of the fly, or simply count the number of times the fly
crosses a point on a linear track.
We have developed a video-tracking system to acquire
the trajectory of a fly over long timescales as it explores
a circular open-field arena and developed several met-
rics that take into consideration the dynamics of the entire
trajectory, as well as the interactions of the trajectory with
the geometry of the arena.These metrics are all based on
probability distributions of the fly’s behavior and can be
worked into nearly any behavioral setup. In addition, they
are relatively easy to calculate and can account for envi-
ronmental effects on the behavior. Such metrics comple-
ment those that are currently used to describe the
locomotor behavior of Drosophila, thus expanding the
behavioral phenotype for flies in this assay.
The Brain Architecture Project
J. Bohland, H. Bokil, J. Lin, C. Wu
Although the entire genomes of many species including
human have been sequenced, our understanding of the
architecture of the human nervous system, in terms of
the organization of its connections, remains crude. The
long-term objective of the Brain Architecture Project,
funded by the W.M. Keck Foundation, is to produce a
draft of the mesoscopic connectivity matrix for the
human brain as well as associated tools for visualization
and analysis. The project, which was in its first full year
in 2007, will initially focus on extracting the available
knowledge about human neuroanatomical connections
from the existing literature and making these data avail-
able to scientists and clinicians through a unified online
knowledge base. In 2007, a major focus was setting up
the infrastructure, designing appropriate data models,
and assembling a processing pipeline for machine-
assisted literature curation. The design of this workflow
mirrors those in place in the bioinformatics community,
which have largely been absent in neuroscience.
Any attempt to assemble a neuroanatomical connec-
tivity graph must, almost immediately, confront the
problem of how to partition the brain into a set of appro-
priate nodes or regions and how to label those regions.
Because multiple such schemes and naming conventions
appear in the extant literature, it is vital to have an under-
standing of how these systems relate to one another and
to develop a strategy for reconciling the different sys-
tems within a common framework in our project. Brain
Architecture Project researchers have developed an ana-
lytical spatial framework within which such different
parcellation schemes can be quantitatively compared and
have applied these methods in a comparison of different
digital atlases used in the neuroimaging community.The
results reveal a surprising lack of concordance between
atlases and point to the inadequacies of previous efforts
to address the neuroanatomical nomenclature problem.
These procedures instead provide probabilistic map-
pings between regions from different atlases, which will
facilitate and improve the accuracy of cross-study com-
parisons. These results and methods will be made avail-
able as an online tool in 2008.
The Brain Architecture Project also promises to
deliver tools for graph-theoretical analysis that can be
applied to the draft connectivity matrix. This year, proj-
ect members used graph-theoretical analyses to inves-
tigate a different network, that which represents the
greater neuroscience community, as constructed from a
database of scientific abstracts presented at the Society
for Neuroscience meetings from 2001 to 2006. Also
using tools from text mining, the structure of the neu-
roscience community was analyzed from these
abstracts, revealing community demographics, topic
clusters, the structure of funding sources, and the
dynamics of the field over time.
The first annual Brain Architecture Project meeting
was held May 20–22, 2007, at the Banbury Center. The
meeting was attended by many distinguished neurosci-
entists, anatomists, and clinicians, and discussion was
focused on the so-called nomenclature problem that
FIGURE 2 Comparison of human brain parcellation schemes.
(Lower left) The boundaries of two parcellations are drawn on
the same inflated cortical hemisphere. (Top right) The similarity
between eight different schemes as measured by an index cre-
ated in the lab, with above chance similarities in gray.
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exists in the delineation and naming of brain regions, as
well as the general need for experimental programs to
systematically map the mesoscopic connectivity pat-
terns in model species.
MISCELLANEOUS
This year saw the publication of a book by Drs. Mitra
and Bokil (Observed Brain Dynamics). This caps a
decade of work in the area of neural signal processing
and should provide a textbook suited to educating neu-
roscientists in advanced data analytical methods. Dr.
Mitra was codirector of two summer courses, the Neu-
roinformatics course at the Marine Biological Labora-
tories and the Integrative Analysis of High-throughput
Biological Data at CSHL. He also organized two Ban-
bury meetings, Design Principles in Biological Sys-
tems (the second of such annual meetings) and the first
annual meeting of the Brain Architecture Project.
Finally, Dr. Mitra was instrumental in putting
together a series of public science lectures entitled Sci-
ence Soirees at the Science, Industry, and Business
Branch of the NewYork Public Library. This series of
lectures, which featured speakers from CSHL as well
as elsewhere talking about scientific topics of general
interest to a broad audience, was well attended and
received coverage in the Village Voice.
PUBLICATIONS
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Large-scale differences in gene copy number called
copy number variants (CNVs) are a significant source of
human genetic variation. In contrast to DNA sequence
variants such as single-nucleotide polymorphisms
(SNPs) and microsatellite repeats, CNVs have not been
well-characterized. We seek to understand more about
the genomic locations, frequency, and stability of these
structural variants and their role in human disease.
Determining the Genetic Basis of Autism
J. Sebat, S. Yoon, M. Kusenda, P. Lin, D. Malhotra [in
collaboration with M. Wigler, K. Ye, B. Lakshmi, M. Ronemus,
and A. Krasnitz, Cold Spring Harbor Laboratory]
Our work on the genomic analysis of autism has made
distinct contributions to our understanding of the
genetic basis of cognitive disorders.We have shown that
microarray-based CNV analysis can detect copy-num-
ber mutations at a much higher resolution than cytoge-
netic methods, and we have used these methods to
identify a strong association of de novo copy-number
mutations with autism (Sebat et al. 2007). In the latter
study, we showed that spontaneous CNVs are frequent
in sporadic autism (10%), a rate much higher than in
healthy individuals, suggesting that the majority of
mutations that we detected contribute to the disorder. In
contrast, spontaneous mutations were not significantly
associated with disease in families with more than one
affected child, indicating that in terms of the genetic
mechanism involved, there is a distinction between the
familial and sporadic cases.
The mutations that we detected occurred at many loci
throughout the genome and few were detected more
than once. These results are consistent with the findings
of linkage studies and cytogenetics and support the
hypothesis that there are many genes in the genome that
potentially contribute to autism spectrum disorder
(ASD), with each gene contributing to only a small frac-
tion of cases. Our findings implicate specific genes in
autism, including genes involved in sterol metabolism,
hormonal signaling, and synaptic transmission; how-
ever, further studies are needed to determine the contri-
GENE-COPY-NUMBER VARIATION AND ITS ROLE
IN HUMAN DISEASE
J. Sebat M. Kusenda D. Malhotra
P. Lin S. McCarthy
V. Makarov S. Yoon
bution of each gene to the disorder in the broader pop-
ulation of patients. To this end, we have begun candi-
date gene studies, including sequencing and fine-scale
CNV analysis in a large sample of patients and controls.
Preliminary results suggest that more complete ascer-
tainment of variation within candidate regions may
reveal the greater extent of an individual gene’s contri-
bution toASD. For instance our recent work done in col-
laboration with Dan Geschwind (University of
California, Los Angeles) has found a convergence of
evidence from analysis of SNPs and CNVs implicating
the gene CNTNAP2 in ASD.
A Genomic Analysis of Schizophrenia
and Bipolar Disorder
J. Sebat, S. McCarthy, S. Yoon, P. Lin [in collaboration with S.
Gary, J. Watson, and T. Leotta, Cold Spring Harbor Laboratory]
A high spontaneous rate of structural mutation is a prop-
erty of the human genome and exists independently of
the phenotypes that emerge from it. Thus, our findings in
ASD may serve as a model for other disorders. We
hypothesize that rare highly penetrant mutations, includ-
ing a significant proportion that are CNVs, may also
have a role in the etiology of schizophrenia (Scz) and
bipolar disorder (BD). We have therefore recently initi-
ated genetic studies of Scz and BD, with a focus on fam-
ilies with sporadic and young-onset cases. In our study
of Scz, we have performed CNV analysis of 1200
patients and 1300 healthy controls.We have found strong
evidence for CNV risk factors at several loci in the
genome. Some of the mutations that we have identified
occur relatively frequently among patients (~0.5%) and
quite rarely in healthy individuals (<0.01%). In addition,
we examined the total abundance of rare CNVs among
patients and found that novel deletions and duplications
of genes were present in 15% of patients compared to
5% of controls (P = 0.0008). The abundance of rare vari-
ants was higher still (20%) among young-onset cases (P
= 0.0001). The association was independently replicated
in patients with childhood-onset schizophrenia (P =
0.017). In addition, we observed spontaneous mutations
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in about 4% of patients. Mutations in cases disrupted
genes disproportionately from signaling networks con-
trolling neurodevelopment, including neuregulin and
glutamate pathways. These results suggest that multiple,
individually rare mutations implicating genes in neu-
rodevelopmental pathways contribute to schizophrenia.
A Case Control Study of
Parkinson’s Disease
J. Sebat, D. Malhotra, S. Yoon
Parkinson’s disease (PD) is the most common neurode-
generative movement disorder characterized by age-
dependent increases in bradykinesia, muscular rigidity,
gait abnormalities, and a rest tremor. PD can arise from
multiple etiologies, including genetic mutations that for
the most part are uncommon. Evidence has been lack-
ing for the existence of common genetic variants with
large effect, but it does exist for multiple genes includ-
ing common alleles with small effect and rare highly
penetrant alleles. Such complex etiology is inherently
difficult to study using traditional genetic approaches.
Analysis of genome copy-number polymorphisms holds
great promise in identifying structural variants predis-
posing to PD pathology. We used an 85K probe repre-
sentational oligonucleotide microarray analysis (ROMA)
to screen 300 late-onset sporadic PD cases and an equal
number of matched controls from Caucasian and Chi-
nese cohorts. Findings include the detection of deletions
in both familial and sporadic cases involving two genes,
ZIC1 and ZIC4, which are related to cerebellar develop-
ment.Also detected were deletions of Parkin, a gene pre-
viously implicated in recessive early-onset PD. These
findings suggest that heterozygous deletions of Parkin
may also have a role in late-onset PD. More comprehen-
sive studies of candidate genes identified in this study
will help us to determine the contribution of these genes
to the disease.
Population-based Studies of
Copy-number variation
S. Yoon, M. Kusenda, D. Malhotra, V. Makarov [in collaboration
with K. Ye and C. Lee, Cold Spring Harbor Laboratory]
Much remains to be learned about the extent of “nor-
mal” structural variation in the human genome and its
implications for genetic studies of populations.We have
initiated a CNV-discovery effort that will focus on DNA
samples from the international HapMap project. The
key advantage of using HapMap samples for this study
is the availability of high-density SNP genotypes on the
same individuals. CNV data can be combined with SNP
data to determine, for example, whether a polymorphic
duplication or deletion is associated with a unique SNP
haplotype (indicating that the variant results from an
ancestral event that was inherited by descent) or with
many different haplotypes (suggesting recurrent struc-
tural mutation at that site). In addition, direct analysis
of copy-number variation is helpful for resolving aber-
rant patterns in the HapMap data that result from CNVs,
such as apparent non-Mendelian patterns of inheritance.
Here, we used a cluster-analysis-based method to detect
and genotype common CNVs (minor allele frequency
≥0.1) from microarray intensity data on a large popula-
tion (N = 2355). Single-oligonucleotide probes were
sufficient to detect novel CNVs, enabling us to map
common variants without bias in terms of size.A major-
ity of the more than 500 common CNVs identified in
this study were small and had not been previously
detected in humans or in the same data set using a stan-
dard algorithm for CNV discovery. These results led us
to estimate that approximately 2000 CNVs (>1 kb) are
common in this population.
Common duplications and deletions were gene-poor,
containing fewer exons on average than CNVs in gen-
eral. We determined the distribution of CNVs in East
Asian, Caucasian, and African American populations
and examined the association of CNVs with SNP-based
haplotypes. Interestingly, some CNVs were associated
with haplotypes showing evidence of recent positive
selection in humans. We hypothesize that some com-
mon CNVs identified here have phenotypic effects that
have been favored by natural selection.
PUBLICATIONS
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Strong association of de novo copy number mutations with
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Studies on Pavlovian learning in many animals have
revealed remarkably similar behavioral properties of
associative learning. Surprisingly, Pavlovian learning in
fruit flies also displays these behavioral properties, sug-
gesting a common underlying mechanism. Neural archi-
tecture of theDrosophila brain bears no resemblance to
that of mammalian brains, of course, which suggests
that the behavioral “homology of function” must result
from conserved cellular/molecular mechanisms. Con-
sistent with this view, several genes and genetic path-
ways have been identified to function in both vertebrate
and invertebrate associative learning, including N-
methyl-D-aspartate (NMDA) receptors, cAMP signal-
ing, cAMP response element binding (CREB)-
dependent gene transcription, and staufen- and fragile-
X mental retardation protein (FMRP)-mediated local
regulation of protein translation. This systematic, ration-
ale approach now is beginning to connect the biochem-
istry of memory formation with the molecular bases of
heritable forms of mental retardation. Translational
efforts (in collaboration with Helicon Therapeutics,
Inc.) also have generated two small-molecule drugs in
clinical trials and a drug development pipeline with six
novel programs.
MUTANTS AND MICROARRAYS
We continue work derived from earlier experiments on
regulated gene expression induced during memory for-
mation. We also continue to develop novel analytical
methods using “concordance” between fully replicated
experiments as the guiding metric.
We are also “connecting the dots” among various
memory mutants. Over the years, we have systematically
moved down the cAMP pathway, from G protein to
adenylyl cyclase, to cAMP phosphodiesterase, to cAMP-
dependent protein kinase (PKA), to CREB protein, to
staufen, pumilio, and dFMR. In collaboration with Drs.
M. Zhang and J. Dubnau here at CSHL, we also have
applied genomic informatics to identify discs large (dlg)
as a target of pumilio function (see Publications). Dr. S.
Xia in our lab has also taken a closer look at G-protein-
mediated signaling in olfactory behavior. By developing
NEUROGENETICS OF MEMORY IN DROSOPHILA
T. Tully K. Bell Y. Hua N. Sinha
F. Bolduc W. Lin H. Wang
Y. Chen M. Regulski S. Xia
H. Cox
four new assays for (1) spontaneous response to odor
intensity (quantity), (2) spontaneous response to odor
identity (quality), (3) conditioned response to odor inten-
sity, and (4) conditioned response to odor identity, Dr.
Xia has observed a genetic and anatomical dissection of
olfactory processing. Of note, Pavlovian discrimination
learning appears to alter odor preference behavior not by
changing the fly’s perception of odor identity, as
expected, but rather by changing the fly’s perception of
odor intensity. This observation suggests that cell-type-
specific wiring of mushroom body calyx by projection
neurons from the antennal lobe will determine the per-
ception of odor quality, whereas changes in synaptic
strength within calyx microdomains will alter the per-
ception of odor intensity.
CIRCUITS AND PHASES
We continue spatiotemporal experiments, which reveal
where in the adult brain long-term memory (LTM) for-
mation occurs. This year, we have shown that modula-
tions of the NMDA receptor subunit genes, NR1 and
NR2, restricted to adult mushroom bodies do not affect
one-day memory after spaced training. In a region out-
side of the mushroom bodies referred to as the ellipsoid
body, however, these samemodulations can either disrupt
or enhance LTM. These data suggest that NMDA-recep-
tor-dependent memory formation requires anatomical
FIGURE 1 dNR2 protein is expressed in the ellipsoid body of the
adult Drosophila brain. (a) Immunostaining for dNR2 showing
preferential (but not exclusive) expression of dNR2 protein in cell
bodies and neuropil of neurons comprising a subset of the ellip-
soid body, which itself is an anatomical compartment of the cen-
tral complex. (b) Feb170 enhancer-trap-driven expression of
green fluorescent protein (GFP). (c) Merged image of a and b,
revealing cells with a common expression.
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structures in the adult fly brain in addition to the mush-
room bodies. We speculate that persistent neural activity
from mushroom bodies is required to drive the memory
consolidation process in ellipsoid body in an NMDA-
receptor-dependent fashion (i.e., LTM requires gluta-
matergic transmission).
GENETIC MODELS OF DISEASE
We have succeeded to demonstrate an acute (biochem-
ical) requirement for FMR1 during LTM formation in
flies. Pharmacological study of fmr1 mutants also has
begun to establish the molecular mechanism by which
FMRP functions during behavioral (and presumably
synaptic) plasticity. Following on from this work, we
more recently have shown that LTM specifically is
blocked in dube3a15B mutants. This gene is the fly
homolog of ubiquitin ligase E3A (UBE3A), which has
been shown to underlie some cases of Angelmann syn-
drome in humans. Thus, we extend our fly models of
mental retardation.
We also have developed an oxidative stress-enhanced
model Parkinson’s disease in flies and currently are pur-
suing DNAmicroarray experiments to identify potential
genetic enhancers and suppressors of this disease state.
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How are different sensory stimuli represented distinctly
in neuronal spike trains? This classic problem in neu-
ronal coding is particularly challenging in the olfactory
system because of the vast chemical diversity of odors.
Our goal is to understand how odors are represented in
terms of spike trains and how learning modifies those
representations.
To represent the large number of odors, animals have
evolved a large family of olfactory receptors (ORs).
There are roughly 300 different ORs in humans, 1000 in
rodents, but only 61 inDrosophila, making the prospect
of understanding olfactory coding much more feasible
in this animal. In Drosophila, we can electrophysiolog-
ically characterize odor response properties of neurons
at several successive layers in the olfactory pathway,
starting in the sensory layer, up through areas of the fly
brain that are important for learning and memory. In
fact, only two synapses downstream from the sensory
layer is a brain area called the mushroom body (MB)
that is essential for learning and memory. Together with
the genetic techniques available to identify neurons and
to manipulate and optically record their activity, and the
learning and memory mutants isolated by behavioral
genetics, this constitutes an excellent experimental sys-
tem to study learning at multiple levels.
Our long-term goal is to understand how information
from two different sensory streams is bound together in
the brain when a fly learns that a particular odor is paired
with an aversive or appetitive taste.What changes in neu-
ral activity underlie this learning?What synapses change
strength? What ion channel properties change? How do
these changes alter cellular and population-level stimu-
lus representations so that the fly’s avoidance response
to the aversive taste is transferred to the odor?
Odor Representations in
Mushroom Body Neurons
G. Turner
Odors typically activate several different olfactory sen-
sory neurons, and it is thought that odor identity is
NEURAL CODING IN THE DROSOPHILA OLFACTORY SYSTEM
G. Turner R. Campbell
E. Demir
encoded combinatorially by an ensemble of coactive
sensory neurons. A highly combinatorial coding
scheme is also prominent at the second layer of the
pathway, where neurons also respond to many odors.
Although dense combinatorial coding provides the
first two layers of the network with a high capacity to
represent many different stimuli, there are drawbacks
to this format. When coding is dense and distributed,
an individual neuron participates in the representation
of several odors. Consequently, synaptic changes of
that neuron will alter the representation of many odors,
not just one, a problem referred to as synaptic inter-
ference.
To investigate how this problem is resolved, we
characterized odor responses in MB neurons, the next
layer of the pathway. In contrast to the first two layers
of the network, MB neurons are highly odor selective.
We found that representations of different odors were
less correlated in the MB neurons than in the sensory
neurons, indicating that synaptic interference would
indeed be diminished in the MB. However, there is a
trade-off between stimulus selectivity and the loss of
information: In the extreme case of an MB neuron that
responds to only a single odor, the problem of synap-
tic interference is solved; however, information about
all other odors has been lost to downstream layers of
the network. One way to preserve this information is
if individual MB neurons receive input from a variety
of PN (projection neuron) types from different
glomeruli. Combining input from different PN types
would enable the number of different MB tuning
curves to expand combinatorially. This diversity might
ensure that, even though individual MB neurons
respond to few odors, a given odor would likely evoke
a response somewhere in the population of 2500 MB
neurons.
We are testing these possibilities by (1) directly
measuring the convergence of different inputs onto MB
neurons, (2) assessing the diversity of MB odor tuning
curves, and (3) using behavioral methods to determine
whether this convergence endows the animal with odor
discrimination capabilities that cannot be attributed to
an individual sensory input channel.
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:53 PM  Page 147
Stimulus Selectivity and
Memory Formation
E. Demir
Using a mixture of genetics, behavior, and electrophys-
iology, we plan to directly test the hypothesis that the
high stimulus selectivity of MB neurons underlies the
specificity of olfactory memory. Our first goal is to
establish a behavioral measure for the accuracy of olfac-
tory memory formation and retrieval. Using a panel of
chemically similar odorants, we plan to test how effec-
tively flies can learn to discriminate these odors. This
psychometric measure of olfactory similarity is an
essential starting point for studying how olfactory rep-
resentations change during learning.
Using the genetic tools available in Drosophila, we
can manipulate sparseness levels and test the conse-
quences on accuracy of memory formation and retrieval.
Decreasing odor selectivity is predicted to make mem-
ory recall less accurate, whereas increasing selectivity
may increase the accuracy of learning, although there
may be a corresponding decrease in the capacity to learn
multiple associations.
We are also planning to determine how odor repre-
sentations change in the cells postsynaptic to the MB
neurons associative conditioning. MB output is required
for memory retrieval, strongly suggesting that the activ-
ity of these neurons will be modified by learning. We
aim to determine whether perceptual distance between
different odors is reflected in the spiking responses of
the MB output neurons.
PUBLICATIONS
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resentations by Drosophilamushroom body neurons. J. Neu-
rophysiol. 99: 734–746.
Ebru Demir
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My laboratory is interested in how neural circuits under-
lie normal processing and attention in the auditory cor-
tex, and how this processing is disrupted in cognitive
disorders such as autism. We use a combination of the-
oretical and experimental approaches to study how the
brain computes. Experimental approaches include elec-
trophysiological and imaging techniques at the molecu-
lar, synaptic, cellular, circuit, and behavioral levels.
Context Dependence and Response
Predictability in Rat Auditory Cortex
H. Asari
Sensory signal processing in the brain depends on stim-
ulus history and contexts. Classical linear encodingmod-
els with rather shorter timescales (typically, hundreds of
milliseconds), however, have failed to fully capture neu-
ral dynamics in the auditory cortex. Here, we used whole-
cell recordings in vivo to assess the relevant timescales
and how neural responses depend on the stimulus con-
text. We found that the changes in lower-order sound
properties (e.g., intensity) had larger and longer effects
than the changes in higher-order properties (e.g., ampli-
tude-modulation), and the context dependence sometimes
lasted as long as 4 seconds in some neurons. We also
showed that the predictive power for the best nonlinear
model, but not for the linear models even with static non-
linearities, asymptotically approached the predictable
response power on a timescale of seconds. These results
suggest that complex modulations on longer timescales
should be considered as well for fully understanding the
auditory cortical activities and functions.
Disruption of Auditory Cortical Circuits
by Autism Candidate Genes
T. Hromadka
Autism is a highly heritable disorder thought to arise
through disruption of neural circuits. Many candidate
genes have been implicated, but how these genes lead to
NEURAL CIRCUITRY OF UNDERLYING NORMAL AND
ABNORMAL PROCESSING IN THE CORTEX
A. Zador H. Asari S. Lima-Mainen L.-H. Tai
T. Hromadka G. Otazu Y. Yang
S. Jaramillo H. Oviedo
the autistic phenotype remains unclear. We hypothesize
that the circuit defect underlying autism involves an imbal-
ance between excitatory and inhibitory neural activity. To
test this hypothesis, we are using in vivo whole-cell patch-
clampmethods to compare the ratio of excitation and inhi-
bition elicited by auditory stimuli in single neurons in the
auditory cortex. Previous work from my laboratory has
shown that excitation and inhibition are exquisitely bal-
anced in the auditory cortex, and so this assay should be
a very sensitivemeasure of disruption in animal models in
which autism candidate genes have been disrupted.
Identifying Neurons with
Channelrhodopsin-2 during
In Vivo Recording
S. Lima, T. Hromadka
Neural circuits consist of a heterogeneous mixture of
neurons with different neuroanatomical projections and
patterns of molecular expression. Recordings of neural
activity in behaving animals reveal tremendous func-
tional heterogeneity as well: Nearby neurons often
respond very differently to the same stimulus or action.
However, little is known about how this structural cir-
cuit-level heterogeneity contributes to function, in part
because of the technical difficulty of identifying neu-
rons during in vivo recordings in behaving animals.
To overcome this difficulty, we have developed a
technique that allows us to “tag” subpopulations of neu-
rons for identification during in vivo electrophysiolog-
ical recordings. The tag is a light-gated ion channel—the
algal protein channelrhodopsin-2 (ChR2)—whose
expression can be genetically restricted to a subpopula-
tion of neurons. In the subpopulation of neurons
expressing ChR2, a brief flash of blue light triggers a
single action potential with millisecond precision.
We are using this approach to test the hypothesis that
neuroanatomical connectivity represents one important
structural correlate of the functional diversity in the rodent
cortex. To do this, we restrict ChR2 expression to subsets
of neurons in the rat auditory cortex (ACx). ACx pyram-
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we can directly compare the circuitry within the auditory
cortex to that of other sensory cortices, such as the better-
studied barrel cortex. Preliminary results indicate that
although the auditory cortex is organized according to
many of the same general principles, the detailed struc-
ture appears to be quite different.
Using Cortical Timing
Information to Guide Behavior
Y. Yang, G. Otazu, M. DeWeese
It is well established that animals can exploit the fine
temporal structure of some stimuli; for example, inter-
aural time differences of less than 1 msec are used for
spatial localization of sound. It is also clear that cortical
neurons can lock with millisecond precision to the fine
temporal structure of some stimuli. However, it has been
difficult to establish whether the fine temporal structure
of cortical responses can be used in a behavioral con-
text to guide decisions. Indeed, in the case of spatial
localization of sound, the relevant interaural time dif-
ference cues are processed below the level of the cortex
by means of specialized circuitry.
We have therefore adopted a direct approach to probe
the precision with which cortical timing information can
be used to guide behavior in the rat. To bypass subcor-
tical auditory pathways, we stimulate the primary audi-
tory cortex directly, using transient biphasic current
trains delivered via chronically implanted intracortical
microelectrodes. The behavioral paradigm we use is a
two-choice alternative task in which stimulus 1 consists
of the simultaneous stimulation of two intracortical sites
(A and B), and stimulus 2 consists of sequential stimu-
lation of the two sites separated by a brief interval dt
(A – dT – B). After the subjects are trained to perform
to criterion (1–2 weeks) with the initial long interstim-
ulus interval (dT >50 msec) for stimulus 2, we probe the
subjects’ psychophysical threshold by reducing dT, until
the subjects can no longer distinguish between the two
stimuli. Our initial experiments indicate that the cortex
can make use of information on a timescale as short as
10 msec, and possibly much less.
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idal neurons project to multiple brain regions, including
the amygdala, the posterior parietal cortex, and the con-
tralateral ACx, and presumably carry different informa-
tion about auditory stimuli to these centers.To targetACx
neurons specifically based on their projection pattern, we
inserted the ChR2-coding region into a herpes simplex
virus (HSV). The HSV travels in a retrograde fashion
through the axons of infected neurons. ChR2-tagged neu-
rons, i.e., neurons projecting to the infected area, can be
identified by their low-latency and reliable spiking
response to a brief light flash.Thus, for example, we have
used this approach to identify the subpopulation of layer-
5ACx neurons that project to the contralateral cortex.
This approach is general, in that any population to
which expression of ChR2 can be genetically restricted
can be tagged. Promising future applications include
tagging of different subpopulations of neurons based on
promoters (e.g., for subclasses of inhibitory interneu-
rons) and tagging of neurons in different cortical layers.
Separation of Sound Sources
by Awake Behaving Animals
T. Hromadka, G. Otazu, L.-H. Tai
Sounds in the natural world rarely occur in isolation, but
rather as part of a mixture. To survive, the auditory sys-
tem must be able to attend selectively to one sound
source and ignore others—and it does so more effec-
tively than any artificial system yet devised. To under-
stand how this is performed, we are using multielectrode
recording (tetrode) technology to monitor the activity
of many neurons simultaneously in awake, behaving
rodents performing an auditory discrimination task
(Hromadka and Zador 2007; Hromadka et al. 2008).
Mapping of Auditory Cortex Circuitry
Using Laser-scanning Photostimulation
H. Oviedo [in collaboration with I. Bureau and K. Svoboda,
Cold Spring Harbor Laboratory]
It is widely assumed that the organization of the sensory
cortex can be described by a “canonical” circuit.Accord-
ing to this view, sensory input from the thalamus arrives
at cortical layer 4, propagates to layer 2/3, and then
descends to layer 5 before exiting a brain region. How-
ever, until recently, it has been technically difficult to test
this hypothesis directly.We are applying a new approach,
laser-scanning photostimulation, to map the circuitry
within the rodent auditory cortex. Using this approach,
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We combine genetic and functional analyses in the study
of the neuronal and molecular bases of learning and
memory in Drosophila. We are involved in three proj-
ects to identify new molecular and neuronal events that
are essential in learning and memory. One project is
related to the normal and pathological function of the
gene corkscrew which is associated with Noonan syn-
drome. This syndrome shows a number of developmen-
tal defects as well as behavioral alterations. In particular,
we are studying the effect on behavior of point mutations
associated with the Noonan syndrome. In the second
project, we are studying the roles of the Aβ42 peptide
associated withAlzheimer’s disease in the modulation of
synaptic transmission and plasticity in Drosophila. The
third project is related to the integration of sensory infor-
mation in the mushroom body, a higher olfactory center
that is essential for olfactory associative learning. In this
project, we are examining the functional imaging of air-
flow response in the Drosophila mushroom body.
Role of the Drosophila Gene corkscrew in
Long-term Memory: New Insight into the
Pathogenesis of Noonan Syndrome
R. Pagani, I. Ho
Noonan syndrome is a dominant genetic disorder show-
ing developmental defects, high incidence of leukemia,
mental retardation, and behavioral disorders. Recently,
it has been identified that missense mutations in the
PTPN11 gene, which encodes the protein tyrosine phos-
phatase nonreceptor 11, SHP-2, are associated with
Noonan syndrome as well as several types of leukemia.
It is thought that gain-of-function mutations are associ-
ated with both Noonan syndrome and leukemia. The
SHP-2 protein is highly conserved in metazoans and has
an essential role in development through growth factor
and integrin signaling pathways. However, the genetic
and molecular mechanisms that mediate behavioral
alterations in Noonan syndrome have not been explored.
To examine the role of SHP-2 in behavior and the
underlying mechanisms, we began studying transgenic
Drosophila flies carrying point mutations associated with
NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
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Noonan syndrome, leukemia, or both disorders in the
Drosophila orthologous gene, csw. We have found that
gain-of-function mutations associated with Noonan syn-
drome, leukemia, or both disorders may mediate learn-
ing andmemory defects. Preliminary studies showed that
learning andmemory defects are not dependent on devel-
opmental alterations in the nervous system.Although the
csw function was involved in learning and long-term
memory, the mechanisms involved seem to be different.
For example, learning was affected by an increase in the
dosage of the csw gene, but not by missense mutations,
whereas long-termmemory seems to be more sensitive to
the mutation than the dosage of the gene.
In addition, a common behavioral property in inver-
tebrates and vertebras, including humans, is that multi-
ple sessions of learning spaced in time promote the
formation of a more enduring memory. SHP-2 seems to
be associated in long-term memory formation and reg-
ulating the time required to induce this memory during
spaced sessions of training.We are currently examining
the molecular and cellular bases of the role of csw in
memory formation in normal, mutant, and transgenic
flies. Further genetic, behavioral, and physiological
studies will improve our understanding of the role of
this gene in normal and pathological behavior.
Distinct Roles of Aβ42 Oligomers
and Fibrils in Modulation of Synaptic
Transmission and Plasticity Revealed
through Genetically Targeted
Expression in Drosophila
H.-C. Chiang, I. Hakker
Aggregation of amyloid-β-42 (Aβ42) peptides has been
suggested to be a primary cause of Alzheimer’s disease
(AD). To determine how endogenously secreted Aβ42
aggregates regulate synaptic functions under physiologi-
cal conditions, we examined the effects of expression of
Aβ42 targeted to the secretary pathway at the body-wall
neuromuscular junction of Drosophila larvae. Such
expression in the Drosophila adult brain leads to age-
dependent accumulation ofAβ42 deposits, memory loss,
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and neurodegeneration. Voltage-clamp recordings of
synaptic transmission and optic analysis of vesicle recy-
cling at presynaptic terminals consistently show that
expression of Aβ42 in neurons leads to a reduction of
neurotransmitter release. In contrast, expression ofAβ42
in postsynaptic muscle cells elicits an enhancement of
neurotransmitter release. Both effects are neutralized by
incubation with an antibody against Aβ peptides, sug-
gesting a role for secretedAβ42 peptides. Concomitantly,
application of exogenously preparedAβ42 oligomers and
fibrils elicited opposite effects, with oligomers reducing
but fibrils enhancing synaptic transmission.
Additional pharmacological studies and analysis of
long-term depression led us to the following conclusion:
Aβ42 peptides secreted from neurons act primarily as
oligomers that inhibit neurotransmitter release and exert
no effect on long-term depression. In contrast, fibrils are
major components secreted from muscle cells that
enhance synaptic transmission and long-term depression.
Thus, different types of cells may secret distinct forms of
Aβ42 aggregates, leading to fundamentally different
modulation of synaptic functions.
Functional Imaging of the Airflow
Response in the Drosophila
Mushroom Body
A. Mamiya, Y. Wang, C. Xu
TheDrosophilamushroom body (MB) is a higher-order
olfactory center that is essential for olfactory associa-
tive learning. It is thought to receive inputs from multi-
ple sensory modalities and associate them to form
memories. However, although olfactory input to the MB
is well-studied, less is known about inputs from other
sensory modalities. As an initial step in understanding
how the MB integrates various sensory information, we
are studying how the MB neurons respond to a simple
airflow stimulus.
We presented a very weak airflow to the antenna of
intact flies and monitored the activity of MB neurons in
vivo using two-photon calcium imaging. To monitor the
activities of different types of MB neurons, we used the
Gal4-UAS system to target the expression of the genet-
ically encoded calcium sensor GCaMP in specific neu-
rons. We found that a weak airflow can evoke strong
responses in MB neurons, suggesting that the airflow
stimulus comprises an important part of the input to the
MB. The input region of the MB responded only to air-
flow on, whereas some output regions responded to both
the airflow on and the airflow off, the airflow suggesting
possible functional processing of airflow information
within the MB.We also found that different types of MB
neurons respond with different dynamics to the same
airflow stimulus. Furthermore, we identified a func-
tional subdivision within a single type of MB neurons,
suggesting a functional organization of the MB at a
much finer scale than previously thought.
We are currently extending the study to investigate
how olfactory and airflow information interact in dif-
ferent types of MB neurons to better understand how
these neurons represent, integrate, and associate differ-
ent sensory information.
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PLANT GENETICS
The plant group at CSHL is carrying forward the pioneering spirit of Nobel Prize–winning work done at
the Laboratory by Barbara McClintock in the 1940s and 1950s. Uncovering the molecular processes
that govern how plants grow and develop is of fundamental biological interest and importance, with impli-
cations not only for agriculture, but also for human health. CSHL is part of global consortia of researchers
involved in the comprehensive sequencing of the Arabidopsis and maize genomes and leads the way in
studying RNA interference, a naturally occurring gene-silencing mechanism, in the context of plant mod-
els.
David Jackson’s lab studies genes and signals that regulate plant growth and architecture. This year,
they identified a gene that controls how plant cells communicate through small channels, called plas-
modesmata. Jackson’s lab also continues to identify maize genes with novel roles in development, includ-
ing, this year, those that control branching, stem cell proliferation, and leaf growth. One of these,
TILLERED1, encodes a transcription factor that controls the growth of branches and, thereby, the over-
all shape of the plant. This gene is particularly interesting because it responds to light and may provide
a way in which the plant responds to environmental conditions. Jackson and colleagues also have begun
to assemble a collection of fluorescent-protein-tagged maize lines that promises to enhance maize genet-
ics research through characterization of developmental gene pathways and identification of maize pro-
moters that can be used in crop improvement.
The growing tips of plants, called meristems, contain a population of stem cells that serve as a per-
sistent source of daughter cells from which new organs arise. They also produce signals important for
the determination and patterning of lateral organs. Marja Timmermans and colleagues study genes active
in the meristem. They have identified a protein complex that suppresses stem cell fate during organ
development. This complex includes the chromatin-remodeling factor HIRA, an epigenetic regulator that
controls stem cell identity, whose molecular mechanism the lab seeks to elucidate. They also study the
role of small regulatory RNAs as potential signals. In Arabidopsis and maize, they have shown that polar-
ity in leaves is specified through a novel patterning mechanism involving a cascade of opposing small
RNAs.
Plants and animals have evolved to make complex, multicellular organisms from single cells. But
plants grow in a way that is wholly distinct. The laboratory of Wolfgang Lukowitz studies genesis of the
plant “body-plan”—the molecular steps that regulate cell-fate decisions—and the impact of these deci-
sions on tissue specialization. Pathways important in the plant embryo operate throughout the plant’s life
cycle, including those that regulate the shoot meristem and maintain the stem cell population and the ratio
between differentiating and nondifferentiating cells. This raises the questions: What, then, is special about
the embryonic stage? What happens at the very beginning to establish polarity or the coordinates of the
body plan before other programs take over? These questions are at the focus of Lukowitz’s current
research.
Epigenetic mechanisms of gene regulation—chemical and conformational changes to DNA and the
chromatin that bundles it—have an important impact upon genome organization and inheritance and
have a role in the specification and maintenance of cell fate. Robert Martienssen’s lab investigates epi-
genetic mechanisms involved in gene regulation and stem cell fate in yeast and model plants including
Arabidopsis and maize. They have shed light on a phenomenon called position-effect variegation, asso-
ciated with plant color diversity and caused by inactivation of a gene positioned near densely packed
chromosomal material called heterochromatin. This year, Martienssen discovered that “slicing,” a central
mechanism of RNA interference, is implicated in position-effect variegation. His lab also published data
suggesting far more variation in wild populations of Arabidopsis than previously recognized, which they
attribute to epigenetic modifications of chromosomes, not changes in DNA sequence.
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In most plants, the early stages of embryogenesis fol-
low a predictable sequence of cell divisions and cell-
shape changes reflecting the coordinated fate decisions
that lay down the reference points of the body plan. Our
goal is to identify and understand the genetic network
regulating this process. We are working with the small
weed Arabidopsis, an inexpensive experimental model
with good comparability to economically more impor-
tant plants.
Paternal Control of
Embryonic Patterning
W. Lukowitz, M. Bayer, M. Galli
Plant development begins with an asymmetric division
of the zygote. This division entails a fundamental fate
decision that sets the stage for all subsequent pattern-
ing events: The small apical daughter cell will produce
the proembryo, whereas the large basal daughter cell
will mainly form the extraembryonic suspensor. The
mitogen-activated protein kinase kinase (MAPKK)
gene YDA promotes suspensor fate in the basal cells.
Loss of YDA activity essentially eliminates formation of
the extraembryonic suspensor, whereas hyperactive
variants of YDA suppress formation of the embryo often
to the extent that all daughters of the zygote appear to be
suspensor-like. On the basis of these findings, we have
proposed that the YDA MAPK cascade acts like a
molecular switch that promotes extraembryonic or sus-
pensor fate.
A mechanistic understanding of the YDA pathway
will require an inventory of its components. Using var-
ious approaches, five other genes with a likely function
in YDA-dependent signaling have been identified.Work
in the lab of S. Zhang (University of Columbia, Mis-
souri) has implicated MPK3 and MPK6 as redundant
MAPKs downstream from YDA in postembryonic
development. In collaboration, we have confirmed that
the same two MAPKs also function in the embryo. An
ongoing, systematic survey of Arabidopsis MAPKK
genes in our lab has, so far, implicated MKK9, MKK4,
CELL-FATE DECISIONS IN THE EARLY PLANT EMBRYO
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and MKK5: Expression of hyperactive variants in the
embryo has a similar, although often weaker, effect as
expression of hyperactive YDA variants. Thus, the YDA
MAPK cascade appears to consist of YDA, MKK9/4/5,
andMPK3/6. This MAPK cascade is required through-
out the life cycle, regulating, among other processes, the
size of the stem cell population in the shoot apical
meristem and the formation of guard cells in the leaf
epidermis.
In contrast, two components of theYDA pathway we
originally identified by virtue of their yda-like mutant
phenotypes in the embryo are not required after germi-
nation. TheGRD gene likely executes suspensor-specific
gene transcription in response to the YDA MAPK cas-
cade. GRD encodes a protein of the RWP-RK family, a
small group of predicted transcription factors that have
only been found in green algae and higher plants. The
only members of this family with an assigned function
both affect developmental fate decisions: minus domi-
nance (mid) from the unicellular alga Chlamydomonas
dominantly determines the mating type of gametes,
whereas nodule inception (nin) from the legume Lotus
japonicus promotes the colonization of roots with nitro-
gen-fixing symbiotic bacteria in response to Nod-factor
signaling. The GRD gene product contains two possible
MAPK phosphorylation sites, one of which has a high
score with different prediction algorithms and is con-
served in the rice homolog ofGRD.We have constructed
variants ofGRD in which one or both of these sites have
been mutated such that they cannot be phosphorylated
any more or such that they are mimicking the effects of
constitutive phosphorylation. These variants are being
tested in mutant plants.
Activation of the YDA MAPK cascade appears to
require the SSP gene. SSP encodes a member of the
receptor-like protein kinase family. In animals, these
proteins operate in association with cell surface recep-
tors, such as the interferon-1 receptor complex.We have
found that SSP protein is myristoylated as well as palmi-
toylated at its amino terminus and that these fatty acid
modifications effectively anchor the protein in the
plasma membrane. Both modifications are essential for
normal function: Mutation of the modified glycine or
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cysteine residue carrying the modifications cause mis-
localization of the SSP protein to the cytoplasm where
it remains inactive.Although SSP has been classified as
a protein kinase, key positions of the catalytic domain
are not conserved, and SSP variants that harbor transi-
tion-state mutations in the ATP-binding pocket fully
complement the phenotype of mutant embryos. This
would suggest that SSP is a “dead” kinase. On the other
hand, a small carboxy-terminal TRP domain of SSP that
likely mediates protein–protein interactions is
absolutely essential: Even deletions of a few amino
acids create completely inactive variants. Taken
together, our findings suggest that SSP functions as an
adapter protein at the plasma membrane.
What is the role of SSP in the YDA-dependent sig-
naling event? Unexpectedly, we found that SSP links
activation of the YDA MAPK cascade to fertilization.
Mutations in SSP show a very unusual parent-of-
origin effect: The phenotype of the zygote and embryo
is completely determined by the genotype of the pollen,
i.e., wild-type egg cells fertilized with mutant pollen all
develop as mutants, whereas mutant egg cells fertilized
with wild-type pollen all develop as wild type. This
paternal or male gametophytic effect appears to be
mediated by a tight control of SSP production in the
context of double fertilization. SSP transcripts are
expressed specifically in mature or germinating pollen
and, as judged from in situ hybridization, accumulate in
the two sperm cells. However, we have been unable to
detect the SSP protein in pollen, implying that transla-
tion of the mRNA is blocked. SSP protein can be visu-
alized after fertilization, where it outlines the zygote as
well as the micropylar endosperm, the other product of
the double fertilization event, This would suggest that
SSP transcripts are contributed to the zygote and
endosperm by the sperm cells. Consistent with this view,
in situ hybridization to sections of immature seed reveal
a weak but reproducible signal of SSP mRNA in the
zygote and the surrounding endosperm.
Why is the production of SSP controlled in such a
precise fashion? Forced expression studies demonstrate
that ectopic production of SSP is sufficient to trigger
YDA-dependent signaling in the cells of the leaf epider-
mis, implying that SSP can act as a signal. Taken
together, our work suggests a novel and truly uncon-
ventional mechanism for regulating MAPK signaling in
plant embryos and immediately raises a number of ques-
tions surrounding this event: How is SSP mechanisti-
cally connected to activation of the YDA MAPK
cascade?When after fertilization does the YDA pathway
become active and how long does it stay active? Our
current research focuses on addressing these issues.
A GATA Factor Positioning
the Proembryo Boundary
W. Lukowitz, T. Nawy
The embryonic root of Arabidopsis develops at the
boundary between the two cell types established with
the asymmetric division of the zygote: the suspensor
and proembryo. Root initiation is triggered by an induc-
tive signal from the lower-tier cells of the proembryo to
the uppermost suspensor cell and is dependent on the
plant hormone auxin.
Mutations in the GATA-type transcription factor
HAN eliminate all anatomical hallmarks associated with
root formation in the early embryo. However, about
20% of all han mutants eventually recover and, after a
lag period, form relatively normal seedlings. This unique
feature of han is in striking contrast to mutations in the
auxin signaling pathway, which typically result in root-
less seedlings and affect development throughout the
life cycle. Thus, HAN is not required for root formation
per se but specifically for initiating a root in the early
embryo.
An analysis of han mutants with a panel of molecu-
lar cell-fate markers revealed that the expression of root-
specific genes is not absent in the mutants but rather
shifted toward the center of the proembryo. For exam-
ple, a WOX5 reporter gene, normally expressed in the
uppermost suspensor cells and subsequently the center
of the incipient root, is found in a broad stripe across
the center of the proembryo. These observations sug-
gest that han mutations change the coordinates of the
fate map, shifting it toward the apex.
How can this global effect on the fate map be ration-
alized? The only known pathway with a global effect on
embryonic development is auxin signaling: Does HAN
influence auxin perception? Mutations in han suppress
the root-less embryo phenotype caused by loss of the
auxin response factor geneMP: In contrast tomp single
mutants, mp han double-mutant embryos do express
molecular markers for the incipient root and mp han
seedlings eventually form a normal root. Our initial con-
clusion from this finding was that HAN inhibits select
auxin responses, perhaps in direct antagonism to MP.
However, further tests did not recover any support for
this view. Instead, the genetic interaction between han
and mp is likely due to the peculiar way in which han
embryos form an incipient root: They do so at a time
different from wild type and from founder cells that
apparently are more tolerant to the loss ofMP.
Rather than acting on auxin perception or responses,
HAN may alternatively be involved in organizing auxin
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transport and distribution. Auxin flux in the early
embryo is dynamic and mediated by two groups of PIN
efflux transporters. After division of the zygote, PIN7
accumulates in the apical membranes of the basal
daughter and subsequently suspensor cells, pumping
auxin upward. Modest levels of auxin presumably accu-
mulate in the apical cell and are required for sustaining
its development to the proembryo. Once the proembryo
has about 32 cells, the direction of auxin transport is
reversed through an unknown mechanism, and apical-
to-basal auxin flux, one of the defining features of
plants, becomes established. This reversal of auxin flux
coincides with the accumulation of PIN1 and related
transporters in the basal membranes of the proembryo
cells and causes an accumulation of auxin in the upper-
most suspensor cell. It is the auxin maximum in the
uppermost suspensor cell that has a key role in trigger-
ing root initiation across the suspensor-proembryo
boundary.
HAN has a surprising and profound impact on auxin
flux in the early embryo, regulating the spatial expres-
sion of both PIN7 and PIN1. PIN7 expression, normally
confined to the suspensor, expands into the proembryo
of han mutants, resulting in the accumulation of PIN7
protein in the apical membrane of the lower tier cells
(Fig. 1). In a mirror image, PIN1 expression becomes
restricted to the cells of the upper tier. These findings
would suggest that the auxin maximum is shifted api-
cally in han mutants, a prediction that is confirmed by
the analysis a synthetic auxin-responsive reporter: A
new boundary between cells showing strong auxin
responses and cells showing no detectable response
forms in the center of han proembryos, resulting in root
initiation at this ectopic position. Taken together, HAN
appears to be required for positioning an instructive
boundary that normally forms between the suspensor
and the proembryo. It remains to be investigated
whether this boundary is specified through auxin, i.e.,
whether the phenotype of han embryos can be explained
by the effect of han mutations on auxin transport.
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FIGURE 1 Apical shift of PIN1 expression in han embryos. The
PIN1 auxin efflux carrier accumulates preferentially in the basal
membranes of wild-type proembryos (A), but expression is limited
to the upper tier cells in han mutants (B). Embryos at the 32-cell
stages are shown; their nuclei are stained with 4′-6-diamidino-2-
phenlyindole (DAPI) (gray), and the proembryo-suspensor bound-
ary is marked with an arrowhead.
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Transposon silencing, gene control, and stem cell func-
tion in plants, as well as heterochromatic silencing in
yeast, provide useful models for regulation in higher
organisms. In fission yeast, RNA interference (RNAi) of
centromeric transcripts regulates histone modification,
and we have found similar transcripts in Arabidopsis,
where small RNA, DNA methylation, and chromatin
remodeling regulate heterochromatin through trans-
posons and repeats. We have found that these mecha-
nisms function during chromosomal replication and have
a role in epigenetic inheritance. Stem cell function and
axis formation in Arabidopsis depends on asymmetric
leaves1 and on RNAi via spatially restricted microRNA
(miRNA) and trans-acting small interfering RNA
(siRNA).We continue to develop transposons and artifi-
cial miRNA as tools to probe genomic function.
During the past year, we were joined by graduate stu-
dents Jong-Jin Han,An-yun Chang, Eyal Gruntman, and
Undergraduate Research Program participant John Xue.
We said goodbye to visiting student Elphege Nora, who
returned to Paris, and sabbatical visitor Paulo Ferreira,
who returned to the University of Rio de Janeiro.
RNAi Guides Histone Modification
during the S Phase of Chromosomal
Replication
A. Kloc, M. Zaratiegui, E. Nora
Heterochromatin remains condensed throughout the cell
division cycle and silences genes nearby, but the mech-
anism by which heterochromatin is inherited has
remained obscure. Heterochromatic silencing and his-
tone H3 lysine-9 methylation (H3K9me2) depend, par-
adoxically, on heterochromatic transcription and RNAi.
We have shown that heterochromatin protein 1 in fis-
sion yeast (Swi6) is lost via phosphorylation of H3 ser-
ine-10 (H3S10) during mitosis, allowing hetero-
chromatic transcripts to transiently accumulate in S
phase. Rapid processing of these transcripts into siRNA
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promotes restoration of H3K9me2 and Swi6 after repli-
cation when cohesin is recruited. RNAi in fission yeast
is inhibited at high temperatures, providing a plausible
mechanism for epigenetic phenomena that depend on
replication and temperature, such as vernalization in
plants and position-effect variegation in animals. These
results explain how “silent” heterochromatin can be
transcribed and lead to a model for epigenetic inheri-
tance during replication (Fig. 1).
Heterochromatin, Histone Modification,
and RNAi in Fission Yeast
M. Zaratiegui, D. Irvine, S. Locke, A.-Y. Chang, M.W. Vaughn
[in collaboration with Yang Shi, Harvard Medical School;
Z. Cande, University of California, Berkeley]
We are applying a combination of forward and reverse
genetics, genomics, and biochemistry to further explore
the link between RNAi, histone modification, and het-
erochromatic silencing in the fission yeast Schizosac-
charomyces pombe. In one example, the histone
demethylase LSD1 represses and activates transcription
by demethylating histone H3K4me2 and H3K9me2,
respectively. Genetic ablation of the S. pombe homologs,
splsd1 and splsd2, resulted in slow growth and lethal-
ity, respectively, underscoring their physiological impor-
tance. Lsd1 and Lsd2 form a stable protein complex,
which exhibits demethylase activity toward methylated
H3K9 in vitro. Both proteins were associated with the
heterochromatin boundary regions and euchromatic
gene promoters. Loss of spLsd1 resulted in increased
H3K9me accompanied by reduced euchromatic gene
transcription and heterochromatin propagation.
Removal of the H3K9 methylase Clr4 partially sup-
pressed the slow-growth phenotype of lsd1 deletions.
Conversely, catalytically inactivating point mutations in
the lsd1 and lsd2 genes partially mimicked the growth
and heterochromatin propagation phenotypes. Taken
together, these findings suggest the importance of both
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enzymatic and nonenzymatic roles of Lsd1 in regulating
heterochromatin propagation and euchromatic tran-
scription.
Transposable Elements and
Epigenetic Control in Plants
R.K. Slotkin, M. Tanurdzic, E. Gruntman, R. Schwab, J. Xue, K.
DePre, M.W. Vaughn [in collaboration with W. Thompson, North
Carolina State University; R.W. Doerge, Purdue University]
Heterochromatin is composed of transposable elements
(TE) and related repeats. Like TEs, heterochromatin
silences genes located nearby and has a major role in
epigenetic regulation of the genome. siRNA correspon-
ding to heterochromatic sequences can be detected in
plants, animals, and fission yeast, indicating that these
sequences are transcribed. In plants, siRNA correspon-
ding to different classes of TEs depends on the DNA
methyltransferase MET1, the SWI/SNF ATPase,
DDM1, or both, but not on the histone deacetylase
SIL1. All three genes are required for silencing trans-
posons in the absence of RNAi, but they depend on
siRNA for resilencing in backcrosses. We are using
gene-trap insertions within silent TEs of various classes,
as well as developmental profiling of transcripts and
siRNA, to determine the origin of TE silencing mecha-
nisms in plants. In one example, plant cells grown in
culture exhibit genetic and genomic instability. Using a
tiling microarray, we have mapped the location and
abundance of histone and DNA modifications in a rap-
idly dividing, dedifferentiated cell suspension culture of
Arabidopsis. We have found dramatic changes in DNA
hypomethylation and activation of specific TEs in cul-
ture. High-throughput sequencing of siRNA revealed
that TEs activated in culture have reduced levels of a
specific size class of siRNA. These results implicate
RNAi and chromatin modification in the activation of
TEs in undifferentiated cells.
Epigenetic Natural Variation and
Polyploidy in Arabidopsis thaliana
M. Tanurdzic, M.W. Vaughn [in collaboration with L. Comai,
University of California, Davis; R.W. Doerge, Purdue University;
V. Colot, ENS, Paris, France]
Polyploidy in plants results in a variety of genetic and
epigenetic changes in gene expression from generation
to generation following the establishment of allopoly-
FIGURE 1 A model for cell cycle regulation of heterochromatic RNAi and histone mod-
ification. Cells in the G2 phase of the cell cycle have high levels of H3K9me2 and Swi6
associated with heterochromatic repeats and retain cohesin. Phosphorylation of H3S10
in mitosis results in loss of Swi6 (heterochromatin protein 1) and transcription of the
repeats in S phase. K9me2 levels fall during replication, but they are restored in S phase
by RNAi of the transcripts, which spreads K9 methylation from unreplicated to repli-
cated DNA, restoring levels of Swi6.
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ploids. The mechanisms that underlie these changes are
important in the short term (hybrid sterility) as well as
in the long term (hybrid vigor), as polyploids are stabi-
lized during evolution. We are using microarrays and
Solexa sequencing to profile chromatin modifications
and small RNA in synthetic allopolyploids from crosses
between tetraploid A. thaliana and tetraploid A.
arenosa. We profiled methylated DNA using tiling
microarrays of Arabidopsis Chromosome 4 in two
diploid ecotypes: Columbia and Landsberg. Repeated
sequences and TEs, especially long terminal repeat
retrotransposons, are densely methylated, but one third
of the genes also have sparse methylation in their tran-
scribed regions.AlthoughTEs are almost always methy-
lated, genic methylation is highly polymorphic, with
half of all methylated genes being methylated in only
one of the two ecotypes. A survey of loci in 96 Ara-
bidopsis accessions revealed a similar degree of methy-
lation polymorphism. Within-gene methylation is
heritable but is lost at a high frequency in segregating F2
families. Promoter methylation is rare, and gene expres-
sion is not generally affected by differences in DNA
methylation. siRNAs are preferentially associated with
methylated TEs, but not with methylated genes, indi-
cating that most genic methylation is not guided by
siRNA. This may account for the instability of gene
methylation if occasional failure of maintenance methy-
lation cannot be restored by other means.
Efficient Gene Silencing by
Artificial miRNAs in Arabidopsis
R. Schwab [in collaboration with D. Weigel, Tuebingen; W.R.
McCombie and G. Hannon, Cold Spring Harbor Laboratory]
RNAi is a powerful tool for gene discovery in plants, as
well as for genetic modification. The latest RNAi vec-
tors contain short hairpins that are modified precursors
of miRNAs, a class of endogenous small RNAs. These
produce a distinct small RNA sequence, which can be
modified and optimized, and is often called artificial
miRNA (amiRNA). A systematic approach is currently
being used to generate thousands of hairpins to silence
the majority of transcripts encoded by the model plant
A. thaliana. Numerous successful applications of amiR-
NAs in A. thaliana have been reported, but about 20%
of these amiRNAs did not trigger detectable gene silenc-
ing.We are investigating the nature of unsuccessful gene
silencing in A. thaliana by directly analyzing the effect
of local secondary structures in target transcripts and
also by an unbiased search for additional determinants.
Maize-targeted Mutagenesis:
A Knockout Resource in Maize
P. Ferreira, J.-J. Han, M.W. Vaughn [in collaboration with
W.R. McCombie, Cold Spring Harbor Laboratory]
The maize-targeted mutagenesis (MTM) population
comprises seed and tissue from 44,000 maize plants in
which Mutator transposons have been mobilized and
then stabilized genetically. Tissue was harvested in 18
two-dimensional “grids” of 48 x 48 plants each, and
genomic DNA was prepared from row and column
pools that permit cross-referencing of any individual
sample. Target sites flanking eachMutator insertion can
be amplified en masse from these pools by a variety of
polymerase chain reaction (PCR) methods. Sequencing
using massively parallel Illumina (Solexa) technology
followed by mapping back to the maize genome resulted
in identification of a high proportion of the flanking
sites, including control insertions previously recovered
by conventional means. By first comparing noninter-
secting row pools, and then row and column pools, it is
possible to distinguish preexisting (parental) insertions
from new germinal insertions at row-column intersec-
tions. We estimate that approximately 0.5 to 1 million
independent new insertions of Mutator elements in the
gene-rich portion of the genome can be identified with
only a few hundred sequencing reactions.
Gene Trapping and Chromatin
Charting in Arabidopsis
J. Simorowski, U. Ramu, R. Shen [in collaboration with
D. Spector and W.E. McCombie, Cold Spring Harbor
Laboratory; E. Lam, Rutgers University]
Our collection of Arabidopsis gene-trap and enhancer-
trap transposon lines has grown to more than 40,000
individual insertions, more than half of which have
been mapped to the genome by PCR and sequencing.
The resulting knockouts, along with phenotypic and
expression data, are made available to the public via
TRAPPER (http://genetrap.cshl.edu/), an interactive
database and ordering system. Reporter genes are
silenced by position-effect variegation when they are
located a few kilobases from the NOR (nucleolar
organizer) and depend on heterochromatic RNAi for
silencing. Similar insertions in centromeric satellite
repeats are also silenced.We have expanded this system
to include gene-trap transposons with lacR-GFP (green
fluorescent protein) chromosome charting beacons that
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enable chromosomal locations to be visualized in the
nucleus. These can be used to visually track individual
loci in living plants while simultaneously producing a
genome-wide “transcription potential map” via a com-
mon luciferase expression cassette. A direct correlation
among mobility constraint, subnuclear location, and
gene activity was observed in some cases. We provide
a resource for examining epigenetic control in living
cells within chromatin regions at the kilobasepair level
of resolution (http://charting. cshl.edu).
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Our major goal is to identify genes and signals that reg-
ulate plant growth and architecture. All organisms
develop by carefully controlling the flow of information
(“signals”) that passes between cells and tissues.We are
particularly interested in discovering these signals and
finding out how they work. In the last year, we have
identified a new gene that controls how plant cells com-
municate with each other through small channels, called
plasmodesmata. This gene is necessary for the cell-to-
cell movement of an important signal that is contained
in the KNOTTED1 homeodomain protein. KNOTTED1
is a transcription factor that is expressed in the plant
stem cells and is necessary to keep these cells in an
undifferentiated state. Plasmodesmata are tiny channels
that link plant cells to their neighbors, and they are crit-
ical for plant growth because they allow the flow of
nutrients and signals through growing tissues.
We also continue to identify maize genes with novel
roles in development. In the past year, genes that control
branching, stem cell proliferation, and leaf growth have
been identified. One of these, TILLERED1, encodes a
transcription factor that controls the growth of branches,
thereby controlling the overall shape or architecture of
the plant. This gene is particularly interesting because it
responds to light and may provide a way in which the
plant can control its growth in response to environmen-
tal conditions. Finally, we and colleagues have begun to
assemble a collection of “fluorescent-protein”-tagged
maize lines that will be an important resource for all
maize researchers. This is the first collection of its kind
and promises to enhance maize genetics research
through characterization of developmental gene path-
ways and identification of maize promoters that can be
used in crop improvement.
Regulation of Phyllotaxy
in Maize
R. Johnston, B.-H. Lee, T. Zadrozny
Leaves are positioned in ordered arrays along the stem,
forming patterns that are characteristic for different plant
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species. This arrangement on the shoot axis is termed
phyllotaxy. These patterns can be traced back to events
in the shoot apical meristem (SAM)—the reservoir of
stem cells at the shoot tip that is the site of leaf initia-
tion. The aim of this project is to investigate the mecha-
nisms that determine these patterns of leaf initiation.
The maize plant exhibits a very ordered pattern of
growth, making it an excellent model for the study of
phyllotaxy. Leaves of the main axis are initiated singly
in an alternate pattern, generating a distichous phyl-
lotaxy. aberrant phyllotaxy 1 (abph1) mutants, in con-
trast, have an altered phyllotaxy—leaves are initated in
pairs in a decussate pattern. Previous work by our lab
has shown that abph1 encodes a cytokinin-inducible
type-A response regulator (type-A RR) that is involved
in the negative regulation of cytokinin signaling, indi-
cating a role for cytokinin in phyllotactic patterning.
The plant hormone auxin is also implicated in leaf
initiation and phyllotaxy. Polar auxin transport is facil-
itated by the PIN1 protein. We found that PIN1 and
auxin levels are reduced in abph1 SAMs. To elucidate
interactions between auxin and ABPH1, we are using
transgenic lines expressing the PIN1 protein fused to a
yellow fluorescent protein and ABPH1 fused to a red
fluorescent protein. Confocal microscopy is being used
to investigate the localization of these two proteins in
the SAM. In addition, we are conducting experiments
in which abph1 embryos are cultured on auxin and the
effects on meristem size and phyllotaxy are determined.
To determine if the regulation of phyllotaxy by type-
A RRs is conserved in other species with different phyl-
lotactic patterns, type-A RR function is also being
investigated in the model dicot Arabidopsis thaliana.
We have obtained Arabidopsis lines that contain an
ethanol-inducible construct encoding an artificial
microRNA targeting ARR7 and ARR15 (from Jan
Lohmann, MPI, Tuebingen). These plants are being ana-
lyzed for alterations in phyllotaxy.
To further understand the regulation of maize phyl-
lotaxy, we are characterizing a second mutant, Abph2.
This mutation is dominant, and, unlike abph1, Abph2
phyllotaxy is initially normal and changes to decussate at
about leaf 5. This change is often preceded by the pro-
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duction of a fused leaf. Analysis of embryos indicates
that Abph2 SAMs are considerably wider than nonmu-
tant SAMs as early as 20 days after pollination.The iden-
tity of Abph2 remains unknown, and efforts are under
way to isolate this gene by positional cloning. The loca-
tion of Abph2 has been narrowed down to a region of
chromosome 7 between the predicted genes
AC195322.2_FG002 andAC201967.3_FG002. Because
there is a gap in the sequence information available for
this region of the maize genome, sequence similarity
(synteny) with the rice genome is being used to further
define the position of Abph2. Markers are being devel-
oped based on rice genes contained within this interval.
We are also conducting a mutagenesis screen to help
identify additional alleles of Abph2. Pollen from
homozygous Abph2 plants was treated with ethyl-
methanesulfate (EMS), a mutagenic compound, and
then used to pollinate nonmutant plants. Seeds obtained
from these crosses are currently being screened. Most
plants will have the dominant Abph2 phenotype. How-
ever, in cases where mutation has disrupted the Abph2
allele, the progeny should appear normal. It is hoped
that sequencing of genes from such “knockout” plants
will provide further clues as to the identity of Abph2. In
addition, this approach may generate abph2 loss-of-
function alleles that will provide information about the
normal role of abph2 in plant growth and development
and will help elucidate the mechanism by which it reg-
ulates maize stem cell function.
Investigating Cell-to-Cell Transport
Using Trichomes for
Genetic Screens
J. Wang, D. Bouyer, S. Choi
We performed genetic screens to identify regulators of
intercellular protein transport in plants. Plants use spe-
cific gates, plasmodesmata, to exchange nutrients and
macromolecules, such as proteins and RNA, between
cells. In fact, plasmodesmata are used to coordinate
developmental processes throughout the plant’s lifetime.
Although the existence of these channels has been
known for a long time, little is known about their molec-
ular composition and regulation. To characterize this
transport mechanism, we made use of certain proteins
that are mobile between cells. The mobility of these pro-
teins can be monitored by an epidermal phenotype, the
production of leaf hairs, called trichomes.
We performed a genetic screen to find factors that
regulate the cell-to-cell transport of the KNOTTED1
(KN1) homeodomain protein, the first plant transcrip-
tion factor found to move between plant cells. A fusion
of the homeodomain of KN1 with the GLABROUS1
(GL1) protein was able to complement trichome forma-
tion when expressed in the non-trichome-producing
subepidermal cells of a gl1mutant line. We showed that
this rescue was dependent on the ability of the KN1-GL1
fusion protein to move into the epidermal cells. Four
mutants have been identified in this screen, and we
mapped each to a small region of the Arabidopsis
genome. For two of the mutants, we amplified these
regions and sequenced them using Solexa high through-
put sequencing. In one of the regions, a single open read-
ing frame is disrupted by a point mutation that causes an
amino acid substitution.The encoded protein is predicted
to have a role in protein folding and is also thought to be
associated with membranes. Proteins need to undergo
partial unfolding prior to passage through the plasmod-
esmal pore, so this protein could be a core constituent of
these channels. Experiments to localize the protein are in
progress.Analysis of any genes isolated using our screen
should be informative as to the mechanism of intercel-
lular transport of KN1 and other mobile plant signals.
We also performed a screen using a negative regula-
tor of trichome development that leads to reduction of
trichomes when expressed from the subepidermis and
screened for mutants that revert to normal trichome pro-
duction, which would be expected if the negative regu-
lator is no longer transported to the epidermis. So far,
we isolated six mutants from this screen, which will be
analyzed in more detail in the future.
On the other side, we made use of a positive trichome
regulator, TRANSPARENT TESTA GLABRA 1 (TTG1).
TTG1 is able to complement the ttg1 mutant when
expressed from the subepidermis. Thus, the ability of
TTG1 to move between cells can be used to screen for
transport-deficient mutants, which should show a reduc-
tion in trichomes. We isolated 15 mutants from this
screen and they are now being characterized. TTG1 is
also interesting because it shows a functional conserva-
tion as well as diversification during evolution. The reg-
ulation of anthocyanin pigment production by TTG is
conserved throughout all plant species analyzed so far.
However, its involvement in trichome development is
not shared between different plants. Interestingly, the
feature of cell-to-cell mobility correlates with the
involvement of TTG1 in trichome initiation, a process
that requires cell-to-cell communication. The mobility
domain has been narrowed down to about 60 amino
acids that either confer or prevent the mobility of the
protein. This offers the possibility of analyzing an evo-
lutionary aspect of protein transport and its regulation.
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Thioredoxin-dependent Regulation
of Intercellular Trafficking
Y. Benitez, M. Cilia, A. San Roman, M. Gonzalez, S. Hearn
Plasmodesmata are cell-wall channels connecting plant
cells. Through them, metabolites, viral and endogenous
proteins, and mRNA are transported. This communica-
tion is environmentally and developmentally controlled,
but the molecular mechanism underlying this regulation
is not well understood. To address this question, A.
thaliana plants expressing the green fluorescent protein
(GFP) driven by a phloem-specific promoter were muta-
genized. In these plants, free GFP is able to diffuse,
being transported through PD out of the phloem. We
screened for mutants blocked in this transport. This
genetic approach led to the identification of five mutants
potentially involved in plasmodesmata regulation. These
mutants were affected in GFP unloading from the
phloem to the root meristem.Therefore, we named them
gat (pronounced “gate”) for “GFP arrested trafficking.”
In gat1, GFP was not transported from the phloem
in either the root or the shoot. Transmission electron
microscopy showed that plasmodesmata channels may
be branched and obstructed in the mutant, which might
be the cause of reduced intercellular communication.
gat1 plants do not develop meristems, and they die at
an early seedling stage. This gene encodes a thioredoxin
protein that is localized in plastids of shoot and root
meristems and developing tissues (Fig. 1). Thioredox-
ins have a role in the redox regulation of metabolic and
stress-related processes including sugar storage, photo-
synthesis, and defense. High levels of reactive oxygen
species (ROS) were found in gat1 root meristems, and
the mutant trafficking defects were phenocopied in
wild-type plants germinated in the presence of oxidants.
These data suggest that GAT1 is involved in the regula-
tion of symplastic transport by a ROS-dependent path-
way. Increased callose deposition and decreased starch
content in the root meristems of these mutants were also
observed. Callose involvement in the constriction of
plasmodesmata channels has been well documented,
and we speculate that gat1 plasmodesmata are also
obstructed by callose. Therefore, like GFP, sugars pro-
duced in the leaves during photosynthesis and translo-
cated in the phloem are not unloaded in the root
meristem. A direct supply of sucrose is necessary to
maintain the high growth rate characteristic of meris-
tems, and the excess is stored as reserve in the form of
starch granules. The arrested meristem growth and the
lack of starch granules in gat1 mutants are therefore a
consequence of the observed restricted trafficking phe-
notype. Agreeing with this hypothesis, gat1 plants are
partially complemented when sucrose is provided at ger-
mination, and plants can be maintained by this treat-
ment. Moreover, the ectopic expression of GAT1 in
mature leaves of wild-type plants led to an increase
accumulation of starch, delayed senescence, and a
delayed flowering. These plants also showed increased
symplastic transport capability as reported by the trans-
port of GFP from a primary target site in biolistic exper-
iments. These results indicate that GAT1 is both
necessary and sufficient to regulate symplastic com-
munication and carbohydrate metabolism, which are
both important in maintaining stem cell functions.
Hormone Signaling in Maize
S. DeBlasio, T. Zadrozny, A. Mohanty, Y. Yan [in collaboration
with A. Chan, The J. Craig Venter Institute; A. Sylvester,
University of Wyoming]
Similar to animal systems, hormones also have a key
role in the proper growth and development of plants.
The formation and patterning of lateral organs (i.e.,
roots, leaves, and flowers) in vital crop species such as
maize depend on the hormonally induced changes in
gene transcription that occur within meristematic stem
cells in response to cues from the environment. How
well these organs develop under normal and stressful
conditions often has major effects on important agro-
nomic processes including crop yield and nutrient con-
tent. One such class of plant hormones that acts to
mediate organ morophogenesis is the cytokinins.
In conjunction with another phytohormone, auxin,
cytokinins act to maintain the population of stem cells
FIGURE 1 Differential subcellular localization of a cytokinin
response regulator. Images show the localization of an ARR7-YFP
fusion in root cells (A), where it is predominantly cytoplasmic, and
in the leaf (B), where the fusion protein enters the nucleus.
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within the meristem as well as to promote their differen-
tiation by interactingwith histidine kinase (HKs) receptors
located on the plasma membrane. This initiates a phos-
phorelay cascade within the cell similar to the two-com-
ponent signaling transduction pathway first discovered in
bacteria. Binding of the hormone to the extracellular sur-
face of the HK induces conformational changes across the
membrane, which causes the cytosolic kinase domain to
transfer its phosphate group to a histidine phosphotrans-
fer (HP) protein. Once phosphorylated, the HP protein
shuttles from the cytoplasm to the nucleus and passes on
the phosphate to a specific group of transcription factors
known as B-type response regulators (RRs).Activation of
the B-type RRs leads to changes in gene expression of
proteins involved in various developmental pathways
including cell elongation, chloroplast differentiation, and
cell division. B-type RRs also induce transcription of A-
type RRs, which go on to negatively inhibit the cytokinin
phosphorelay cascade.
Although a lot has been learned from studying how
the cytokinin pathway works in the model plant system A.
thaliana, our lab is interested in understanding how the
hormone regulates organ formation in maize, a monocot
plant species that displays a pattern of organ development
different from that of Arabidopsis.With the recent advent
of more efficient transformation techniques and the near
completion of theMaize Genome Sequencing project, we
have focused on obtaining transgenic plants that natively
express fluorescently tagged versions of the maize HPs,
HKs, RRs, cytokinin oxidases, and putative cytokinin-
responsive proteins such as the cell cycle control protein
cyclin D to determine their (1) tissue specificity, (2) sub-
cellular localization, and (3) patterning during develop-
ment. Specifically, we are interested in knowing how and
if regulation of their localization during development dif-
fers from what has been seen for other flowering plants,
as well as to study their expression patterns in maize
organs not found in Arabidopsis, such as the male repro-
ductive structure, or tassel.
To date, our lab has successfully created stable maize
lines expressing at least one member of the cytokinin-
specific protein families mentioned above and are in the
process of characterizing their localization patterns in
multiple organs and cell types using confocal image
analysis.Interestingly, preliminary results suggest that
the subcellular localization of some these proteins may
differ between organ types. For example, in T1 trans-
genic maize seedlings expressing ARR7-YFP (an A-
type RR), the protein is located mainly in the cytoplasm
and around the nucleus of root cells (Fig. 1A). However,
in leaf epidermal cells, a greater concentration of
ARR7-YFP was observed within the nucleus (Fig. 1B).
We have also generated a series of marker lines that
highlight different subcellular compartments, including
tonoplasts, nuclei, peroxisomes, microtubles, plastids,
and various other structures that are made available to
the scientific community. We plan to use these lines to
analyze the changes that occur within the cell during
differentiation and development.
Inflorescence Meristem Size
Regulation in Maize
P. Bommert, P. Yin, J. Wang
The shoot apical meristem has a remarkable ability to
regulate its size during development, by balancing stem
cell proliferation with the incorporation of daughter cells
into primordia. We are particularly interested in study-
ing this process in maize, where a large number of meris-
tem proliferation or “fasciated” mutants are available.
We cloned the FASCIATED EAR2 (FEA2) gene and
found that it encodes a leucine-rich repeat (LRR) recep-
tor-like protein, orthologous to Arabidopsis CLAVATA2.
We also isolated the THICK TASSEL DWARF1 (TD1)
gene as a homolog of the LRR kinase CLV1. In Ara-
bidopsis, these proteins form a receptor complex that is
activated by the CLV3 ligand and repress the stem-cell-
promoting transcription factorWUSCHEL. Our genetic
analysis of fea2/td1 double mutants, however, suggests
that the simple CLV1-CLV2 coreceptor model is more
complex in maize, since double mutants are much more
severe than either single mutant alone. To address the
molecular nature of these effects, we are characterizing
the FEA2 receptor complex using immunoprecipitation
approaches. We are currently using a transgenic
35S::FEA2-GFP line in combination with anti-GFP
antisera to isolate the FEA2 receptor complex. Our first
results led to the identification of an uncharacterized
maize protein that has homology with an LRR receptor-
interacting protein from rice. This protein becomes
phosphorylated after receptor activation, suggesting it
may act downstream from the FEA2 receptor.
In addition to our biochemical approach, we are also
pursuing a genetic approach to isolate the compact plant2
(ct2) mutation. ct2mutants develop abnormally enlarged
inflorescence meristems, indicating that this gene also
affects meristem size regulation. Using approximately 900
ct2 F2 mutants, we narrowed down the chromosomal
location of the gene to an interval of 250 kb on chromo-
some 1 covered by two BAC (bacterial artificial chromo-
some) clones representing eight genes. Subsequent
sequencing of these genes in the ct2-Muszynski allele led
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to the identification of a transposon insertion in a lipoxy-
genase-encoding gene. Lipoxygenases are enzymes
involved in jasmonate biosynthesis. Jasmonates are phy-
tohormones and are known to regulate plant growth and
development. Cloning of the ct2 gene therefore provides
a possible direct link between jasmonate synthesis and/or
signaling and meristem size regulation. To further sub-
stantiate this, we are currently screening for additional ct2
alleles by a targeted EMS screen. Interestingly, our analy-
sis of ct2/td1 double mutants suggests that ct2 identifies
a pathway for regulation of meristem size that operates
independently of the CLAVATA pathway.
Tassel sheath and Tillered
Genes Regulate Diverse Aspects
of Plant Architecture
C. Whipple, S. Kotkin, K. Chen
Aerial plant development can be interpreted as a reitera-
tion of three basic units: the leaf, stem, and an axillary
meristem that will itself grow out and reiterate this pat-
tern. Together, these units constitute a phytomer that is
repeated throughout plant growth and development. It is
by modification of phytomer architecture that changes in
morphology occur. Distinct phytomer morphologies char-
acterize transitions in the plant life phase (e.g., vegetative
to reproductive), as well as species differences.Although
there is a lot known about the development of individual
phytomer components, little attention has been given to
how phytomer growth is modified either throughout the
life cycle of a single plant or through evolution.We have
been investigating two maize mutants that modify phy-
tomer development to affect plant morphology.
An interesting phytomer modification that occurs in
many plant species is the suppression of leaf development
after the transition to reproductive development. For
example, in most grass species, inflorescence leaves, also
called bracts, fail to grow, although a rudimentary bract
primordium does initiate. To understand the regulation of
bract suppression in grasses, we have begun an investi-
gation of maize mutants that fail to suppress bract devel-
opment, known as tassel sheath (tsh) (Fig. 2). We have
identified four different genes—tsh1, tsh2, tsh3, and
tsh4—that have this phenotype. With assistance from
Sean Kotkin (undergraduate) and Kay Chen (high school
student), we havemapped several of these genes.The tsh1
and tsh4 mutants have been cloned, and both are
expressed in the cells of the suppressed bract. Our pre-
liminary expression analysis indicates that Tsh4 regulates
Tsh1 and is thus upstream in a common pathway of bract
suppression. Currently, we are investigating Tsh1 in other
cereal grasses (rice and barley) where this gene appears
to have a conserved function. Ultimately, we hope to
understand the entire genetic pathway that regulates leaf
outgrowth, which could then be engineered to modify
plant architecture for agronomic purposes.
Another phytomermodification that varies in response
to environmental cues is the control of axillary meristem
outgrowth. In the grasses, axillary meristems initiate sev-
eral leaf primordia and then stop development, creating a
dormant bud. Subsequent growth of this bud depends on
a combination of internal and external cues. When these
buds are at the base of the plant, they can grow out to gen-
erate a new stalk, also called a tiller. Tiller growth is reg-
ulated by light signals, and so grasses produce fewer
tillers in a shaded environment, such as when they are
densely planted. We have cloned a maize mutant tillered
(till) that produces extra tillers and fails to suppress axil-
lary bud outgrowth. The Till gene is specifically
expressed in the young leaves initiated by axillary buds.
A collaboration with researchers at Cornell University
has shown that expression of Till is regulated by light
quality. An understanding of tiller growth has important
implications for increased biomass production that will
be necessary as we transition from fossil fuels to biofuels.
Characterization of the Function
of the RAMOSA3 Gene in Maize
N. Satoh-Nagasawa, T. Bourett, A. Mohanty, Y. Yang [in
collaboration with R. Feil and J. Lunn, Max-Planck Institute
of Molecular Plant Physiology, Golm; N. Nagasawa and
H. Sakai, Pioneer Hi-Bred, Delaware]
To elucidate the genetic and molecular mechanisms of
inflorescence branching, a major yield trait in crops, we
FIGURE 2 Development of the tasselsheath1 mutant of maize.
Wild-type maize inflorescences suppress the growth of leaves
(left). However, in the tasselsheath mutants (e.g., tsh1), this
growth suppression is lost, and leaves grow out to subtend the
inflorescence branches and the spikelet structures (arrows, right).
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are analyzing the ramosa3 (ra3) mutant of maize. By
observing single- and double-mutant phenotypes, we
found that RA3 functions upstream of another RA gene
(RA1) to establish the correct identity and determinacy
of axillary meristems in maize inflorescences. RA3was
cloned and found to encode a functional trehalose-6-
phosphate phosphatase (TPP). TPP is an enzyme that
catalyzes the metabolic conversion of trehalose-6-
phosphate (T6P) to trehalose.We also found that RA3 is
expressed at the base of axillary meristems in young
maize inflorescences.
From these studies, we developed two possible
hypotheses for the molecular mechanism of RA3 func-
tion. First, T6P or trehalose may act as a mobile sugar
signal during axillary meristem development in maize
inflorescences. Second, the RA3 protein itself may have
a regulatory function to control the expression of other
genes important for the determinacy of axillary meris-
tems.
To determine which of these hypotheses are correct,
we started several experiments. We investigated RA3
protein localization by fluorescent protein fusions and
immunolocalization. RA3 protein was localized in the
same domain as its mRNA, ruling out the possibility
that it acts as a mobile protein signal. Transient bom-
bardment assays of a RA3-YFP fusion protein showed
that it was localized in cytosol and nuclei. This local-
ization of RA3 protein has been confirmed by
immunolocalization, and its nuclear localization sup-
ports the hypothesis that it may have a regulatory func-
tion. We have also measured the concentration of
trehalose and T6P in young inflorescences of wild-type
and ra3 mutants and found no differences, suggesting
that the sugar signal hypothesis may not be correct. Sev-
eral additional experiments using transgenic plants are
also in progress.We tested the influence of reducing the
concentration of trehalose in axillary meristems by
expressing bacterial trehalase in the meristems. Treha-
lase is an enzyme that degrades trehalose. If trehalose
acts as a signal for morphogenesis of axillary meris-
tems, then plants expressing trehalase should phenocopy
ra3 mutants. We have also made catalytically inactive
RA3 alleles by point mutations in the enzyme active
site. The mutated RA3 protein should complement ra3
mutants if this protein has a role other than metabolism
of trehalose. We found weak complementation in a pre-
liminary experiment. These results lead us to think that
the RA3 protein may have a regulatory function in addi-
tion to or instead of its enzymatic function in vitro.
While we examine RA3 function in maize, we are
also interested the interaction of RA3 with other genes
in maize and in the function of RA3-like genes in other
plants.We have started to map ra3 suppressors in maize
and are isolating mutants in Arabidopsis in order to
define the function of these genes in a dicot species that
has very different inflorescence development. With
these experiments, we hope to characterize the mecha-
nism by which RA3 regulates inflorescence stem cell
fate and obtain a better functional insight of inflores-
cence development in maize.
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Development in higher plants is a continuous process as
organs emerge throughout the entire plant life cycle,
which for some plants extends over hundreds of years.
The growing tip of a plant, referred to as shoot apical
meristem (SAM), contains a population of stem cells that
divide to maintain the SAM and to generate daughter
cells from which lateral organs, such as leaves and flow-
ers, arise. The research in our lab aims to understand the
molecular mechanisms that distinguish indeterminate
stem cells from their differentiating derivatives. In addi-
tion, we are studying the role of stem-cell-derived sig-
nals in the patterning of lateral organs. Observations
from our lab indicate that microRNAs (miRNAs) are
among these meristem-derived signals. Moreover, stem
cells produce signals required for the establishment of
determinacy. This process involves an epigenetic silenc-
ing mechanism, indicating that the switch from stem cell
to differentiated cell is encoded not simply in DNA, but
also by proteins associated with DNA.
Adaxial/Abaxial Patterning of
Lateral Organs in Maize
F. Nogueira, D. Chitwood [in collaboration with M. Scanlon,
Cornell University, Ithaca, New York; K. Ohtsu and P. Schnable,
Iowa State University, Ames]
Outgrowth and patterning of lateral organs in plants
depend on the specification of adaxial-abaxial
(dorsoventral) polarity. We have shown that this asym-
metry is generated by a novel patterning mechanism
involving two distinct small RNAs. The 21-nucleotide
miRNA, miR166, delineates the abaxial/lower surface
of the leaf by restricting the expression domain of class
III homeodomain leucine zipper (HD-ZIPIII) transcrip-
tion factors that specify adaxial/upper fate. The abax-
ial-specific expression of miR166 is generated by a
second small RNA, the trans-acting short interfering
RNA tasiR-ARF, which accumulates on the adaxial side
of incipient and developing leaves. Our findings indi-
cate that organ polarity in leaves is ultimately specified
by regulating the spatial accumulation and relative effi-
PLANT DEVELOPMENTAL GENETICS
M. Timmermans D. Chitwood C. Hu
M. Declerck M. Lodha
C. Fernandez-Marco F. Nogueira
M. Guo A. Sarkar
cacy of tasiR-ARF and miR166. Despite our extensive
knowledge regarding the biogenesis and action of small
RNAs, little is known about the regulatory mechanisms
that exist to establish the correct pattern and levels of
small RNA activity.
Small RNAs are processed from long precursor tran-
scripts, and plant genomes typically contain numerous
precursor genes for the biogenesis of each particular
small RNA. For instance, the maize genome contains at
least ninemir166 loci, suggesting that the miR166 accu-
mulation pattern may result in part from the differential
regulation of individualmir166 family members. Detec-
tion of these miRNA precursors by in situ hybridization
has been unsuccessful. We therefore used laser capture
microdissection (LCM) in combination with reverse
transcriptase–polymerase chain reaction (RT-PCR) to
analyze the expression profiles of mir166 genes in spe-
cific domains of the SAM and young leaves. Although
some mir166 family members displayed overlapping
expression profiles, most mir166 genes exhibited
unique tissue and cell-type-specific expression patterns.
One of the tissue samples tested included cells from the
incipient leaf. Four mir166 family members are
expressed in that domain and are thus important candi-
dates for establishing adaxial-abaxial leaf polarity. Inter-
estingly, the mir166a precursor was found to be
expressed in the stem cells at the tip of the SAM. This
result was surprising, because these cells do not accu-
mulate mature miR166 and in fact express the hd-zipIII
targets at high levels. This suggests that miR166 accu-
mulation in plant stem cells is regulated in part at the
level of biogenesis or stability. In animals, miRNA
activity in stem cells is similarly regulated at the level of
biogenesis. How miRNA activity is controlled in stem
cells and whether such control is unique to stem cells
are questions for future research.
As mentioned above, adaxial-abaxial patterning in
maize also depends on the activity the tasiRNA, tasiR-
ARF, whose biogenesis from tas precursor transcripts is
initiated by an miR390 cleavage step. LCM separating
cells from the epidermal (L1) and subepidermal layers
(L2) of the SAM shows that tas transcripts accumulate
in both L1 and L2 layers. In contrast, the precursors of
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miR390 are detected only in the L1 layer of the SAM.
Using in situ hybridization, we have detected the accu-
mulation of mature miR390 in the adaxial domain of the
incipient leaf. More importantly, we found that miR390
accumulates in both the L1 and L2 layers of the incipi-
ent leaf. Our observations are consistent with a scenario
in which miR390 is produced exclusively in the L1 layer
but moves into the underlying cell layers. This presents
the possibility that miRNAs may move over a few cell
lengths from specific cell types, such as the epidermal
layer, to act as developmental signals during pattern for-
mation. We are currently also testing this possibility in
Arabidopsis.
Mobility of Small RNAs during
Adaxial-Abaxial Patterning
of the Arabidopsis Leaf
D. Chitwood, F. Nogueira [in collaboration with T. Montgomery,
M. Howell, and J. Carrington, Oregon State University, Corvallis]
The importance of the contribution of miRNAs to devel-
opment in multicellular organisms is well-established.
However, the exact mechanisms by which these mole-
cules contribute to development and possibly patterning
remain understudied. A recurring theme in pattern for-
mation is the interpretation of relative distance from a
point source through the activity of a mobile positional
signal. Our localization studies in maize suggest a non-
cell-autonomous component of the tasiR-ARF pathway,
via miR390 mobility that establishes adaxial-abaxial
polarity.
To more easily study the mechanisms by which such
noncell autonomy occurs, we are continuing our studies
in Arabidopsis. As in maize, precursors of miR390, as
detected by in situ hybridization, accumulate exclusively
in the L1 epidermal layer. This contrasts with the local-
ization of mature miR390, which is detected throughout
the leaf.At first glance, the localization of miR390 might
suggest that tasiR-ARFs are produced throughout the
leaf. However, miR390 requiresARGONAUTE7/ZIPPY
for activity. AGO7 reporter constructs indicate that
AGO7 is expressed in the adaxial/dorsal-most cells of
leaves, limiting the activity of miR390 and thus tasiR-
ARF biogenesis to these regions. Such a scenario is con-
sistent with our localization of tasiR-ARF activity using
transgenic sensor constructs, which show very strong
tasiR-ARF activity on the adaxial side of leaves. How-
ever, weaker tasiR-ARF activity was also detected on the
abaxial/ventral side of leaves outside the domain of
AGO7 expression and tasiR-ARF biogenesis. Consistent
with these tasiR-ARF sensor results, in situ hybridiza-
tion showed that tasiR-ARF accumulates in a graded pat-
tern that dissipates from the adaxial to the abaxial side of
leaves and may reflect mobility of tasiR-ARF from their
source of biogenesis to the abaxial side of leaves.
Our model of the contribution of the tasiR-ARF
pathway to leaf polarity through small RNA mobility
therefore involves the movement of two different small
RNAs: (1) miR390 moves from the epidermis into
subepidermal layers and (2) tasiR-ARFs move away
from the adaxial AGO7-restricted domain of miR390
activity, where they act most strongly, to the abaxial
side of leaves, where they act weakly (Fig. 1). That
movement of miR390 and tasiR-ARFs is essential for
their patterning activity in leaves sets a precedent for
the capacity of small RNAs to act as mobile positional
signals and possibly even as morphogens in develop-
ment.
Adaxial-Abaxial Patterning by
AS1 and AS2
F. Nogueira, M. Declerck, M. Guo
In Arabidopsis, we are using various genetic and bio-
chemical approaches to identify genes involved in the
spatiotemporal regulation of the polarizing small RNAs.
Several lines of evidence indicate that the DNA-bind-
ing proteins ASYMMETRIC LEAVES1 (AS1) and
FIGURE 1 Summary of localization patterns of different tasiR-
ARF biogenesis pathway members and a model of small RNA
mobility (dotted arrows) in leaves. miR390 accumulates noncell
autonomously throughout the leaf, outside of the L1 epidermis in
which its precursors localize. AGO7, which is required for miR390
activity and thus the biogenesis of tasiR-ARFs, is only present in
the adaxial-most cells of the leaf. The site of strongest tasiR-ARF
activity on the adaxial side of leaves corresponds to the source of
tasiR-ARF biogenesis; however, weaker tasiR-ARF activity that
reflects mobility is found on the abaxial side of leaves.
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ASYMMETRIC LEAVES2 (AS2) act together to regu-
late leaf morphology including adaxial-abaxial leaf
polarity. We recently determined that AS1-AS2 bind as
a complex to specific DNA sequence motifs in the pro-
moters of target genes to regulate their expression. To
begin to understand how AS1-AS2 contribute to organ
polarity, we used chromatin immunoprecipitation
(ChIP) to identify which members of the MIR166 pre-
cursor family and components of the tasiR-ARF bio-
genesis pathway are direct targets of AS1-AS2
regulation. We found that MIR166a, MIR166b,
MIR166c, and TAS3a are direct targets of AS1-AS2. To
verify the ChIP results, we are using GUS reporter con-
structs and RT-PCR analysis to determine the effect of
mutations in as2 on the expression of these targets. For
instance, we previously established that the full-length
promoter of MIR166a drives expression only in the
abaxial epidermal layer of young leaves. Using the
MIR166a::GUS reporter, we have shown thatMIR166a
is adaxially misexpressed in an as2mutant background.
Similarly, we have shown the transcript levels for
MIR166c are increased in as2. Currently, we are also
investigating the expression of a MIR166c::GUS
reporter in wild-type and as2 seedlings.
The abaxial determinants ARF3 and ARF4 are tar-
gets for tasiR-ARFs, and we have shown that transcript
levels for both genes are up-regulated in as2. Consider-
ing that TAS3a is a direct target ofAS1-AS2, these tran-
scription factors may control ARF3 and ARF4
expression through regulation of tasiR-ARF accumula-
tion. However, mutants defective in both the tasiR-ARF
and theAS1/AS2 pathways show an enhanced leaf phe-
notype, suggesting that both pathways converge to
repress ARF3 and ARF4 activity on the adaxial leaf sur-
face. To test the interaction between the AS1/AS2 and
tasiR-ARF pathways further, we generated as2 plants
containing a tasiR-ARF-insensitive allele of ARF3
(ARF3m), which contains silent mutations that preclude
the cleavage of the ARF3 mRNA by tasiR-ARFs. The
resulting mutants develop highly serrated abaxialized
leaves with abaxialized ectopic leaf-like outgrowths in
the margins. This is in contrast to the weak leaf polarity
defects observed in double mutants defective for AS2
and tasiRNA biogenesis. Expression of MIR166 pre-
cursors and its targets, and the expression of ARF4 and
components of the tasiR-ARF pathway are affected in
the as2 ARF3m plants. The enhanced polarity defects
resulting from expression of a tasiR-ARF-insensitive
allele of ARF3 in as2 as opposed to losing tasiR-ARF
activity in the as2 background may reflect feedback reg-
ulation in the tasiRNA pathway. This hypothesis is cur-
rently being tested.
Establishment of Determinacy
during Organ Development
M. Guo, M. Lohda, C. Hu
Indeterminacy within the SAM is specified in part by the
KNOX homeobox genes. Down-regulation of KNOX
expression is a key factor that distinguishes stem cells
and their immediate derivatives in the SAM from lateral
organ founder cells. Moreover, establishment of determi-
nacy in developing organs requires the continued silenc-
ing of the KNOX genes. We have previously shown that
this process involves the predicted DNA-binding proteins
AS1 and AS2, as well as the chromatin-remodeling fac-
tor HIRA. On the basis of expression and genetic analy-
ses, we proposed that these proteins are part of a novel
cellular memory system that keeps KNOX genes in an
“off ” state during organogenesis, thus preventing differ-
entiating cells from reverting into indeterminate stem
cells. We have gained important new insights into the
mechanism ofKNOX gene silencing by theAS1 complex
that confirm this hypothesis. ChIP experiments identified
two sites in the promoter of the KNOX targets BRE-
VIPEDICELLUS (BP) and KNAT2 that mediate AS1-
complex binding. Electrophoretic mobility-shift assays
were subsequently used to precisely define the cis
sequences required for binding of theAS1-AS2 complex
to BP. Consistent with earlier genetic data, we found that
AS1 requires AS2 for binding to the KNOX promoters
and that this repressor complex binds to the regulatory
motifs CWGTTD-KMKTTGAHW present at the two
ChIP sites in the promoters of theKNOX targets. The sig-
nificance of the two AS1-complex binding sites for sta-
ble BP silencing in leaves was demonstrated in vivo using
various BP promoter::GUS reporter constructs. Deletion
of either AS1-complex binding site resulted in misex-
pression of BP in wild-type leaves, indicating that both
binding sites act nonredundantly to repress BP during
organogenesis. This indicates that interaction between
AS1-AS2 complexes at the two sites is required for sta-
ble repression of BP in leaves. Promoter deletion analy-
sis further indicates that enhancer elements required for
BP expression in the leaf are located between the AS1-
AS2 complex binding sites. On the basis of these and ear-
lier results, we present a model for AS1-AS2–mediated
KNOX gene silencing that is conceptually similar to the
action of an insulator. We propose that interaction
betweenAS1-AS2 complexes creates a loop in theKNOX
promoter and, likely through recruitment of HIRA, leads
to the formation of a repressive chromatin state that main-
tains an enhancer region required forKNOX expression in
leaves silenced throughout organogenesis (Fig. 2).We are
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currently establishing chromatin conformation capture
assays (3C) to detect the loop in vivo.We are also testing
whether theAS1 complex is capable of forming a loop in
the BP promoter using in vitro assays.
We have previously reported that AS1-AS2 interact
with the chromatin-remodeling protein HIRA, which is
involved both in heterochromatic gene silencing and in
the epigenetic regulation of euchromatic genes. We are
therefore studying the role of HIRA in KNOX repres-
sion during leaf development using genetic and bio-
chemical approaches. As a first step, we are testing
whether KNOX gene silencing is associated with
changes in chromatin organization and/or DNA methy-
lation. Preliminary data indicate that acetylation and
methylation of specific histone residues on BP and
KNAT2 chromatin direct their activity in a tissue-spe-
cific manner.Additional observations also suggest a role
for the Polycomb group of silencing proteins in the reg-
ulation of these KNOX genes. These data will eventu-
ally clarify the molecular mechanism that represses
stem cell activity in differentiating lateral organs.
Regulation of Embryonic
Patterning by HIRA
C. Fernandez-Marco
HIRA is a key developmental regulator inmammals and in
plants. In mammals, loss of HIRA results in gastrulation
and patterning defects that lead to early embryonic lethal-
ity. In plants, loss-of-functionmutations inHIRA also lead
to embryo lethality. However, reduced expression ofHIRA
causes leaf defects that resemble the defects observed in
the as1 and as2mutants and leads tomisexpression of sev-
eral KNOX genes. To further dissect the role of HIRA in
stem cell homeostasis, we used the Arabidopsis TiLLing
service to screen for ethylmethanesulfate (EMS)-induced
mutations in the amino-terminal WD40-repeat domain
and the carboxy-terminal region of HIRA that interacts
withAS1.Thus far, we have obtained 12 independent hira
alleles, which exhibit a range of developmental pheno-
types, including defects in embryonic patterning, leaf
development, and flowering. Perhaps the most interesting
allele is hira-serpent, which contains a point mutation in
the evolutionary conserved fifthWD40 repeat.Themutant
phenotype is first apparent by the late globular stage of
embryogenesis.Mutants aremarked by abnormal patterns
of cell division, both in the proembryo and in the extraem-
bryonic suspensor. In particular, the protoderm cells of the
proembryo show aberrant planes of cell division. More-
over, the hypophysis, which normally divides to form a
lens-shaped cell that ultimately gives rise to the quiescent
center of the root stem cell niche, divides abnormally in
this hiramutant. To determine whether these morpholog-
ical abnormalities are correlated with alterations in cell
fate and patterning, we are examining the effects of this
hira mutation on the expression of molecular markers in
the developing embryo. Our preliminary results show that
specification of the protoderm and of cell fates in the api-
cal region is largely unaffected in this hiramutant. How-
ever, expression of the PIN7:GUS reporter, which
normally marks the basal cell lineages of the preglobular
embryo and the suspensor, was absent from the hypoph-
ysis and upper part of the suspensor in hira-serpent. Sus-
pensor formation involves processes of central importance
to embryogenesis such as establishment of apical-basal
embryo polarity, early cell differentiation, and pro-
grammed cell death. The phytohormone auxin has a key
role in these processes and in embryonic root formation.
Crosses to marker lines that are expressed in the suspen-
sor (IAA10:GFP andARF13:GFP), in the hypophysis and
lens-shaped cell (WOX5:GFP), or at auxin maxima
(DR5:GFP) are in progress to test whether auxin signaling
and/or cell-fate specification in the suspensor is perturbed.
These data will shed new light into the fundamental prin-
ciples of pattern formation in the plant embryo.
Global Expression Analysis of
Meristem Function and Leaf Initiation
A. Sarkar [in collaboration with M. Scanlon, Cornell University,
Ithaca, New York; P. Schnable, Iowa State University, Ames;
B. Buckner and D. Janick-Buckner, Truman State University,
Kirksville, Missouri]
Plant meristems comprise distinct histological and func-
tional domains. For instance, the stem cells are located
FIGURE 2Model for AS1-AS2–mediated KNOX gene silencing in
the leaf. The AS1-AS2 complex binds to regulatory motifs pres-
ent at two sites in the promoters of its KNOX targets immediately
upstream and surrounding an enhancer region required for
expression in developing leaves. Interaction between the AS1
complexes is required for stable KNOX gene silencing, suggest-
ing formation of a loop in the KNOX promoter that, likely through
recruitment of HIRA, leads to formation of a stable repressive
chromatin state that blocks enhancer activity throughout leaf
development. (Ovals) AS1-AS2; (rectangle) leaf enhancers.
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at the most apical tip in the so-called central zone,
whereas lateral organ founder cells are located on the
flanks of the SAM. Traditional genetic analyses have
demonstrated the importance of this meristematic
organization for normal plant development and have led
to the identification of some genes required for meris-
tem function and lateral organ development. To identify
novel and potentially redundant or essential genes that
function in discrete domains of the SAM or developing
leaf primordia, we are using a technique called laser
capture microdissection (LCM) that allows the isolation
of specific cells within a tissue or organ, in combina-
tion with microarray analyses to compare global gene
expression patterns between different cell populations.
Expression profiles between the following cell types
have been compared: (1) indeterminate stem cells in the
SAM and determinate cells of newly initiated leaf pri-
mordia; (2) the epidermal (L1) and subepidermal (L2)
layers of the SAM; and (3) SAMs and/or leaf primordia
from developmental mutants and wild-type plants.
We have used this approach to compare the gene
expression profiles in the SAM and first leaf primordia
from wild-type and leafbladeless1 (lbl1) mutants, which
are defective in the biogenesis of tasiRNAs and conse-
quently develop abaxialized leaves. We identified 352
genes whose expression levels are significantly altered in
lbl1. Genes that are differentially expressed between wild
type and lbl1 include (1) components of the tasiRNA
pathway, which suggests that potential feedback regula-
tion in the tasiRNA exists; (2) known determinants of
adaxial-abaxial polarity, which is consistent with the
abaxialization of lbl1 leaf primordia; (3) known devel-
opmental regulators; and (4) novel maize genes.
Classical surgical experiments along with our small
RNA expression studies revealed a critical contribution
for the L1 layer in adaxial-abaxial patterning. Interest-
ingly, 31 genes that are differentially expressed between
wild type and lbl1 are also differentially expressed
between the L1 and L2 meristem layers. These include
genes predicted to function in auxin or lipid signaling.A
role for such signaling pathways in organ polarity has
often been postulated, but insights into these develop-
mental mechanisms are lacking. lbl1 acts in the incipient
leaf to specify adaxial identity and to propagate leaf
founder-cell recruitment.We identified 17 genes that are
differentially expressed between wild-type and lbl1
SAMs and between the incipient leaf and the SAM
proper. Interestingly, we have identified three genes
whose expression was altered in all three comparisons,
making them very important candidates for further func-
tional analysis.
We are currently in the process of validating key dif-
ferentially expressed genes by real-time quantitative RT-
PCR, followed by in situ mRNA localization, and the
function of genes of particular interest will be determined
using functional genomics resources available in maize
and Arabidopsis. We are also taking a bioinformatics
approach to identify potential targets of tasiRNAs among
those genes that are up-regulated in lbl1 apices.This proj-
ect will provide a novel insight into gene networks con-
trolled by tasiRNAs and involved in leaf polarity.
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BIOINFORMATICS AND GENOMICS
The reference version of the human genome, along with those of other animal and plant genomes, pro-
vides an unprecedented starting point for understanding the correlation between the structure and func-
tion of genetic material. Data-intensive projects in genomics, proteomics, and related fields have created
an information explosion. Technologies such as DNA microarrays and high-throughput genotyping are
transforming experimentation, creating an information bottleneck that multidisciplinary teams at CSHL are
devising the technical and intellectual means to manage.
W. Richard McCombie and colleagues are using a new generation of sequencing instruments to deter-
mine variation in the genomes, transcriptomes, and epigenomes of animals and plants. As director of
CSHL’s Lita Annenberg Hazen Genome Sequencing Center, McCombie has led the effort to perform
high-throughput sequencing of several organisms, including the plant Arabidopsis, the fission yeast
Schizosaccharomyces pombe, and Homo sapiens. He and his team have successfully integrated next-
generation sequencers capable of generating 6 to 8 billion bases of sequence data weekly. The new
equipment is being devoted to the task of finding important points of sequence variation among individ-
uals. Very high capacity translates into the ability to look quickly at many genes and their mutations in large
numbers of people, work that is the predicate of associating mutations with the occurrence of illnesses
such as schizophrenia (a current focus of McCombie’s team) and cancer.
Lincoln Stein’s lab is developing databases, data analysis tools, and user interfaces to organize, man-
age, and visualize the vast body of information being generated by genome scientists. One vitally impor-
tant effort is the “Hap-Map” project, a database correlating single-nucleotide variations in the human
genome sequence with their occurrence in three distinct global populations. This year, Stein’s group,
which serves as the Data Coordination Center for the project, incorporated into the database informa-
tion about 40 susceptibility regions in 20 common human diseases, including diabetes, rheumatoid arthri-
tis, Crohn’s disease, coronary artery disease, and bipolar disorder. Another of the lab’s projects is
WormBase, a database of the genome and biology of the roundworm, Caenorhabditis elegans. The lab
also manages and curates the Reactome and Gramene databases. Reactome, a compendium of fun-
damental biological pathways in humans, integrates peer-reviewed literature with genomic information,
including a growing database of protein–protein interactions (now covering more than 2200 proteins).
Gramene is an online comparative mapping resource for rice and other monocots that now incorporates
the entire maize and Arabidopsis genomes, and partial popular and sorghum genomes. Stein’s group has
also created a Web site enabling members of the public to compare their own sequenced genomes to
the human reference genome.
Michael Zhang’s laboratory develops mathematical and computational methods that can be com-
bined with advanced experimental technologies to transform data into biological knowledge about tran-
scription and gene regulation, work that has manifold implications for the study of cancer and many other
diseases. Their tools, used by investigators throughout CSHL and beyond, are designed to identify func-
tional genetic elements within molecular sequences, as well as pathways that control and regulate gene
expression. Recently, Zhang’s group developed a series of computational tools that make use of statis-
tical pattern-recognition techniques to identify exons, promoters, and posttranslational regulation sig-
nals in large genomic DNA sequences. They are also studying alternative splicing of exons and collaborate
with other labs to characterize splicing enhancers and silencers. The lab’s interest in epigenetics has
resulted in development of an algorithm called the Human DNA Methylation Finder that predicts an impor-
tant class of epigenetic changes in human DNA. This is one of several efforts in the lab to correlate epi-
genetic markers with transcriptional activity.
Using multidisciplinary approaches combining computational analysis, modeling, and prediction with
experimental verification, Doreen Ware’s lab seeks a deeper understanding of genome organization in
plants. By looking comparatively across the genomes of plants in the same lineage—she focuses on
cereals such as rice and sorghum—Ware and colleagues seek answers to such questions as: How are
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genes conserved and lost over time? What are the fates of duplicated genes? Her team also studies
gene regulation in plants, specifically looking at regulatory elements and microRNA genes and their tar-
gets. In addition to understanding basic biological questions, the group also helps create bioinformatic
tools including public Web sites, open-source software, and analysis methods of value to the larger sci-
entific community.
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This work was performed in collaboration with Greg
Hannon at CSHL.
In January of 2007, the first of a new type of DNA
sequencer was installed. These instruments—the Solexa
1G—are considered disruptive technology because their
capabilities are so radically advanced relative to previous
instruments. Although these instruments have incredible
potential, it was clear that to use them effectively, they
required substantial technical and logistical development.
In addition, they would require the establishment of new
procedures for sample preparation and data analysis.
In brief, the instrument works in the following man-
ner. Sheared DNA is made blunt-ended and two differ-
ent adapters are ligated to it. The DNA is size-selected
(in the 150–300-bp range, typically) and slightly ampli-
fied. The DNA is then added to a flow cell, which is a
microscope slide sealed on the top with eight small
channels or lanes through it. The surface of the flow cell
is densely coated with a random distribution of two oli-
gos that are complementary to the two oligos added to
the ends of the fragments. The fragments bind to the oli-
gos on the surface and are amplified in situ. Following
amplification, sequencing is carried out.
A primer corresponding to one of the adapters is
added along with polymerase and the four nucleotides,
each of which is modified with a blocking group to pre-
vent further extension of the chain and a fluorescent dye
corresponding to which base it is (A, C, G, or T). The
reaction incorporates one base on each of the clusters
of molecules on the surface depending on which base
is next on the complementary strand of that molecule.
The surface of the flow cell is then imaged during laser
exposure and the image is stored. The blocking group
and dye are then cleaved, and the process is repeated
with another base addition. As sequencing progresses,
the images after each successive base addition are com-
pared and the base incorporated at each addition on a
given molecule is determined. This gives the sequence
of each fragment on the flow cell. The process typically
yields readlengths of 32–36 bases. This is very short,
but the power of the instrument comes in the number of
reads it generates.A single run of about 3 days generates
DEVELOPMENT OF NEXT-GENERATION SEQUENCING
TECHNOLOGY
W.R. McCombie V. Balija S. Muller M. Regulski
L. Cardone L. Nascimento L. Spiegel
M. Kramer D. Rebolini Z. Xuan
about 40 million reads. Thus, the total sequence pro-
duced is in excess of a billion bases per run.
The principal investigator’s (PI) lab was one of the
first to receive an Illumina instrument and also among
the first to receive multiple Illumina instruments.
Because our first instrument was installed in January
2007, we have been working to improve the results from
this instrument. This has been a difficult task and pre-
sented a wide variety of challenges. At this time, while
still striving to improve, we feel that we have built a sig-
nificant experience and knowledge base that has led to
a significant increase in our ability to operate these
instruments at high efficiency.
In addition to in-house training, the PI and a bioin-
formatics specialist have received 1 week of training at
Solexa, near Cambridge, U.K. The PI and collaborators
as well as several people in the PIs lab participated in a
course on next-generation sequencing (http://meet-
ings.cshl.edu/courses/c-seqtech08.shtml). We have
made significant progress in effectively using these new
instruments. Figure 1 shows output by the group since
the beginning of August.
BAR-CODED POOL SEQUENCED ON THE ILLUMINA
Sequencing throughput can be significantly increased
by sequencing multiple samples in the same lane of a
flow cell. The only prerequisite is the ability to distin-
guish among reads from different samples at the stage of
data analysis. To this end, we synthesized a set of library
adapters carrying identifying sequences, or bar codes.
Each sequence consists of a unique combination of four
nucleotides. This bar code is located on the 3′ end of
one of the standard Illumina adapters (P5), between the
region complementary to the sequencing primer and the
3′ terminal T.
The PAK4 region was amplified from six cell lines (5-
kb amplicons across the ~55-kb gene region). The result-
ing products for each cell line were then pooled and
sheared. Cell lines 1–5 were bar-coded with custom 4-bp
bar-code adapters and cell line 6 was ligated with the
standard Illumina adapter. All six cell lines were then
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pooled, loaded into six lanes of a flow cell, and sequenced
for 36 cycles. Following base calling, the reads were
sorted according to bar codes 1–5 or no bar code (stan-
dard adapter). The sequences with bar codes were
trimmed to remove the first 5 bp (bar code plusT), and all
the reads for each of the five bar-coded cell lines were
then aligned to the PAK4 reference sequence using Eland.
The results are shown in the table below. The results will
allow us to take better advantage of the throughput of the
instruments by allowing sample pooling within a lane.
Number of Percent of
reads aligned reads aligned
Total with 0–2 with 0–2
Bar code reads mismatches mismatches
PAK4 BC 1 1433892 537235 37
PAK4 BC 2 1049330 494947 47
PAK4 BC 3 1102938 464935 42
PAK4 BC 4 1226655 446634 36
PAK4 BC 5 922861 530735 57
DATA ANALYSIS
Following sequencing, the data are analyzed through a
data pipeline, which is a combination of the standard
Illumina pipeline and customized software we have
developed. The first part of the process is the standard
image extraction and base calling of the Illumina
pipeline.We then run this output into a customized pro-
gram to compare the sequences to the reference
sequence and call single-nucleotide polymorphisms
(SNPs). This program, written by Zhenyu Xuan, takes
into account both the sequence quality of the raw data
(as assigned by the Illumina base caller) and the fre-
quency of the variants present at a given residue. Both
of these thresholds are adjustable and will likely be
adjusted for different projects. Validation of a subset of
alleles using orthologous methods such as ABI3730
sequencing is thus essential for the determination of
proper thresholds for a given project. These steps and
the results from their use are described below.
SNP DETECTION BY RESEQUENCED SHORT READS
We have developed an algorithm to identify SNPs based
on Illumina-1G-sequenced short reads.We first mapped
all reads to the reference genome by ELAND. On the
basis of that alignment, we identified the frequently and
reliably sequenced alleles’ genotypes that differed from
the reference genome, which we call nonreference alle-
les (NRAs), as the potential SNP candidates. On the
basis of resequencing of the 55-kb human PAK4 gene
region without using whole-genome amplification
(WGA), we obtained 2.9 million reads that were
uniquely mapped in the PAK4 region (using 32
175
FIGURE 1 Comparison of total bases generated versus total high-quality bases for weekly
Illumina runs from October 2007 through mid-January 2008. Note output drops during
partial weeks around Thanksgiving and the Christmas and New Year’s Day holidays.
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nucleotides in mapping). These reads covered 95.30%
of the PAK4 region, which means that the average
sequencing depth reached more than 1700x. Using qual-
ity scores calculated by the Illumina genome analyzer
pipeline, we only chose the most reliably sequenced
bases (with quality score of 40) to calculate the fre-
quency of each NRA. We found that the distribution of
NRA frequency (called NRAF) at each position of the
genome followed a “W” shape (see Fig. 2), which had
peaks at 0, 0.5, and 1.0. Peak 0 corresponds to non-SNP
sites, whereas peak 1.0 corresponds to homozygous
SNPs and peak 0.5 corresponds to heterozygous SNPs.
The DNA sample we used is a HapMap sample,
NA11839, which has 21 known SNPs in the HapMap
project. Table 1 lists the NRAF frequencies of all 21
SNP sites. All known SNP sites are covered more than
100 times by high-quality reads. We found that both
known homozygous SNPs (rs1529712 and rs570278)
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FIGURE 2 Nonreference allele frequency distribution as a function of PAK4 rese-
quencing data. Only positions with at least 10x coverage of high-quality bases (qual-
ity score = 40) were calculated.
TABLE 1 Genotype and NRAF of known HapMap SNP sites in the PAK4 region
NA11839 Non-WGA WGA
dbSNP_id Location Genotype Ref. Genotype Sum_all Sum_NRA NRAF Genotype Sum_all Sum_NRA NRAF
rs1529712 44358807 TT C CT 453 452 0.9978 CT 133 132 0.9925
rs570278 44324653 GG C CG 2213 2207 0.9973 CG 1586 1581 0.9968
rs2085388 44320347 CT C CT 842 533 0.6330 CT 613 378 0.6166
rs692191 44314686 CT C CT 948 507 0.5348 CT 1233 587 0.4761
rs1549927 44319890 CT T TC 534 274 0.5131 TC 170 79 0.4647
rs17722300 44322375 AG G GA 1958 993 0.5072 GA 1389 655 0.4716
rs7257109 44354747 AG G GA 314 153 0.4873 GA 106 58 0.5472
rs12976130 44317640 CT C CT 1724 816 0.4733 CT 1950 902 0.4626
rs17795295 44323525 CT C CT 2100 993 0.4729 CT 2914 1358 0.4660
rs12611376 44318951 CT C CT 1304 603 0.4624 CT 510 245 0.4804
rs4803208 44316630 CG C CG 2496 1127 0.4515 CG 3606 1631 0.4523
rs513053 44332986 AG A AG 1131 495 0.4377 AG 633 282 0.4455
rs8107629 44324427 AG G GA 2409 1029 0.4271 GA 2504 1033 0.4125
rs12609418 44309292 CT C CT 717 262 0.3654 CT 547 142 0.2596
rs692475 44337574 CT T TC 586 207 0.3532 TC 118 46 0.3898
rs692257 44337190 CT T TC 721 248 0.3440 TC 187 62 0.3316
rs5828029 44319641 AT A AT 941 299 0.3177 AT 1299 390 0.3002
rs12611365 44319011 AG A AG 630 181 0.2873 AG 193 40 0.2073
rs692337 44329948 CG G GC 596 159 0.2668 GC 650 203 0.3123
rs529336 44345757 CT C C– 633 0 0.0000 CT 210 1 0.0048
rs691577 44348241 AG A A– 622 0 0.0000 AG 313 1 0.0032
HapMap-detected SNPs (21) are listed with their dbSNP id, genomic DNA location, and their reported genotype in sample NS11839. The
genotypes determined by Illumina sequencing reads are listed together with the total reads coverage (sum_all), occurrence of NRA (sum_NRA),
and NRAF (= sum_NRA/sum_all). Both results from sample prepared with or without whole-genome amplification are listed.
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have NRAFs very close to 1.0, and 17 of 19 known het-
erozygous SNPs have NRAFs from 0.2 to 0.7. The other
two heterozygous SNPs have NRAFs close to 0,
although both have been sequenced more than 600
times. This may point to possible false-positive SNPs in
the HapMap project, and we are doing capillary
sequencing to verify our results.
On the basis of the knowledge from known SNPs,
we used NRAF ≥ 0.2 for SNP calling and found 51
novel SNPs, including six homo-SNPs (NRAF > 0.9)
and 45 hetero-SNPs (0.2 < NRAF < 0.9). We are also
doing capillary sequencing to confirm them.
EFFECT OF WGA ON SNP DETECTION
We have also analyzed PAK4 resequenced data obtained
from whole-genome amplified DNA (Qiagen REPLI-g
Midi Kit). On the basis of our data, we did not find sig-
nificant differences between samples prepared with or
without WGA (see Table 1). In Figure 3, the NRAF
detected at each site by the two preparation strategies
are compared, and the correlation coefficient is 0.9758
for all sites covered at least 100 times and with NRAF
> 0.05.
The detection of sequence variants in Illumina data
presents a significant challenge given the error rates of
current base-calling algorithms. However, we have a
functioning pipeline in place, as well as the infrastruc-
ture for high-throughput resequencing with these next
generation sequencers.
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FIGURE 3 NRAF correlation for samples prepared with and with-
out whole-genome amplification.
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THE HUMAN HAPLOTYPE MAP
The International Human HapMap Project (www.
hapmap.org) is an international project to map out regions
of common genetic variability in the human genome by
genotyping three major world populations across a large
number of naturally variable sites. The resulting “haplo-
type map” will greatly reduce the cost of genetic associa-
tion studies to find cancer susceptibility genes and other
disorders with genetic components.
Our lab is a central participant in this project in our role
as the Data Coordinating Center (DCC). We manage the
central database for the project; allocate single-nucleotide
polymorphisms (SNPs) to the 11 genotyping centers;
coordinate data submission, quality checks, and quality
control; andmanage the public release of project data.The
HapMap Web site, which was developed in our lab,
describes the project in the four languages of the project
participants (English, French, Chinese, Japanese,Yoruba)
and provides access to the data both for bulk download
and for interactive querying and browsing.
During 2007, we enhanced the HapMap Web site to
provide tools to aid in designing and interpreting whole-
genome association studies. In particular, we now provide
a facility for merging the results frommultiple independ-
ent association studies to greatly increase their aggregate
power.We have also incorporated into theWeb site infor-
mation on a large number of common copy-number vari-
ations. In the past year, the HapMap Web site was used
for several landmark whole-genome association studies
that have identified novel genes implicated in type-1 and
-2 diabetes, hypertension, rheumatoid arthritis, tuberculo-
sis resistance, cardiovascular disease, inflammatory bowel
disease, and other medically significant traits.
We are now adding support for the storage and analy-
sis of individual genomes to the HapMap Web site, in
anticipation of a new crop of “personalized genomes” that
will appear in the next few years.
GRAMENE: A COMPARATIVE MAPPING
RESOURCE FOR GRAINS
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
GENOME-SCALE DATABASES OF PATHWAYS,
GENETIC VARIATION, AND EVOLUTION
L. Stein S. Avraham B. Faga T. Harris W. Spooner Z. Zha
S. Cain X. Feng A. Kanapin P. van Buren W. Zhao
N. de la Cruz G. Gopinathrao S. McKay G. Wu
Gramene allows researchers to compare the genetic and
physical maps of the major monocot crops, namely,
maize, barley, oats, sorghum, and wheat, to the emerg-
ing rice genomic sequence. This allows researchers to
identify candidate genes in the rice genome that corre-
spond to genetically mapped mutants and quantitative
traits in the nonrice crop they are studying. Hence, the
resource allows researchers studying traits in maize,
barley, and so forth the benefit of genomic sequencing
without waiting for the sequencing of these much larger
genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
mapped more than 1 million monocot expressed se-
quence tags (ESTs) to the rice genome, allowing gene
predictions to be further refined based on cross-species
comparisons.
A major milestone this year was the integration of
genome mapping information on 11 wild rice species to
the Gramene database. These species are adapted to a
wide range of conditions, including semidesert and
high-altitude sites. Our comparative maps provide a
detailed view of how these genomes evolved and diver-
sified from domestic life over a period of approxi-
mately 10 million years. By elucidating which regions
were selected for during the divergence and adaptation
of these species, we hope to provide information that
will allow plant breeders to create new robust varieties
of domestic rice.
We also used the information in the Gramene database
to identify previously unknown microRNAs (miRNAs)
in the rice, maize, and sorghum genomes. miRNAs are
thought to be responsible for regulating key events during
development and maturation. Our work provides the first
window into how these genes evolve and diversify in
plants.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
Our lab continues to be a major developer and main-
tainer of theWormBase database (www.wormbase.org),
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an online information resource for the small free-living
nematode, Caenorhabditis elegans. This organism is
favored as a simple model animal because of its small
genome size, experimental malleability, and well-under-
stood cellular anatomy. WormBase is a curated model
organism database developed as part of an international
collaboration that includes the California Institute of
Technology,Washington University at St. Louis, and the
Sanger Centre. Our lab is responsible for the Web site,
user interface, and software architecture for the project.
The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted genes,
alternative splicing patterns, oligonucleotide probes,
and evolutionarily conserved segments. It also contains
many other types of biological information, including
the C. elegans cell pedigree, the organism’s neu-
roanatomy, its genetic map, and the physical map from
which the genomic sequence was derived.
During 2007, we usedWormBase to sponsor a global
gene prediction algorithm competition called NGASP
(Nematode Gene-prediction ASsessment Project). This
competition involved 16 computational biology groups
to identify the combination of algorithms best able to
predict novel genes from nematode sequences.
REACTOME
Reactome (www.reactome.org) is a collaboration with the
European Bioinformatics Institute (EBI) and the Gene
Ontology Consortium to develop a Web-accessible re-
source for curated information about biological processes.
Reactome is organized like a review journal. Bench
biologists are invited to create modules that summarize
a particular aspect of their field. Currently, summations
include DNA replication, transcription, translation,
intermediary metabolism, the cell cycle, RNA splicing,
and hemostasis. Many more modules are under way.
Modules are similar to minireviews, except that each
paragraph of text is reduced to a series of logical asser-
tions that is entered into a database of processes and
macromolecules. The database is then used to drive a
Web site that can be browsed like a textbook or searched
with queries to discover pathways and connections.
During 2007, we brought the number of genes curated
in Reactome to 2500 proteins, covering about 15% of the
annotated portion of the human genome.We supplemented
this data set with functional interaction data frommicroar-
rays, protein interaction experiments, and other sources to
create an integrated network of functional interactions cov-
ering approximately 50% of the genome. This integrated
network is the largest one published to date, containing
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FIGURE 1 Reactome provides a tool for interpreting microarray expression studies. When a researcher
uploads a list of genes that are coordinately up- or down-regulated, the tool will identify and display
pathways that are overrepresented among those genes. Mousing over the affected pathways shows
detailed information on which genes were over- or underexpressed and how they relate to each other.
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more than 200,000 known and predicted gene interactions
(Fig. 1).We are now validating the network and are devel-
opingmethods to use it to interpret whole-genome associ-
ation and copy-number variation experiments, thereby
increasing the power of such studies.
GENERIC MODEL ORGANISM DATABASE PROJECT
In collaboration with the model organism system data-
bases FlyBase, SGD, and MGD, the Generic Model
Organism Database (GMOD) project is developing a set
of database schemas, applications, and interfaces suitable
for creating a model organism system database. These
tools significantly reduce the time and expense required
to create new databases to curate genomic information
coming out of various model organism system sequenc-
ing projects. 2007 saw the establishment of GMOD-based
model databases for chicken, cow, and Escherichia coli.
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COMPARATIVE GENOMICS: A MODEL FOR
UNDERSTANDING FUNCTION THROUGH
EVOLUTION AND GENOME ORGANIZATION
The cereal genomes are believed to have diverged from
one another within the past 50 million to 80 million
years (Ma). During this time, numerous genomic
rearrangements have occurred in cereal genomes, such
as segmental and tandem duplications, polyploidization,
and transposition. This is especially true for maize,
which has undergone tetraploidization and is known to
have many recent modifications to its genome structure
due to transposable elements. Previous studies have
shown that regions of conserved protein-coding gene
order between cereals represent functionally important
regions and potentially conserved phenotypes.
The comparative mapping and integration of
genomic sequence, genetic and physical maps, and phe-
notypes adds significant value to existing genome
sequencing and mapping studies, by allowing the trans-
fer of information across and within species. As part of
this work, our group contributes to the infrastructure of
Gramene (www.gramene.org). Gramene is a collabora-
tive that leverages sequence and functional information
from models and sequenced plant genomes for transla-
tional genomics in agriculture.
In the last year, our group, in collaboration with Dr.
Lincoln Stein’s group here at CSHL, completed several
milestones on the Gramene project, including data
updates, new acquisitions, analysis, and improvements
in visualization and performance. Most notable was the
addition of the Ensembl Compara pipeline to analysis
tools, which included the development of protein-based
gene trees and whole-genome nucleotide alignments.
The gene tree allows researchers to rapidly identify con-
served and nonconserved portions of plant genomes.
Protein-based gene trees allow us to rapidly identify
gene families that have remained the same, expanded,
or contracted in different genomes. Because orthologous
genes will in many cases have conserved function,
researchers can leverage the knowledge gained from
functional studies in one organism to infer or hypothe-
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size function in organisms for which no functional infor-
mation exists. These gene trees also allow researchers
to look for structural changes to these genes. Structural
polymorphisms can include single-amino-acid changes,
insertions, or deletions, or even gain or loss of an entire
exons. Observed differences may reflect artifacts of the
annotation process or diversification between species,
which could highlight potential new functions of these
genes. The whole-genome alignments complement the
protein-based comparisons identifying conserved non-
coding sequence.
In addition to understanding the evolution and role
of protein-coding genes, we are interested in under-
standing the evolution of noncoding genes and regula-
tory elements. Work in our group has focused on
analyzing a class of noncoding genes called microRNAs
(miRNAs). Specifically, we are interested in under-
standing if these noncoding genes have conserved gene
order or synteny between species, as has been found
among protein-coding genes. If the miRNA genes have
remained intact in conserved genome locations, this
would suggest that they also have maintained a similar
functional role during the evolution of cereals. For this
purpose, we have taken a two-prong approach, making
use of both experimental and computational resources to
characterize their genome location, gene structure, and
expression patterns. In the last year, we physically
mapped more than 30 miRNA genes in maize in col-
laboration with Georgia Davis at University of Missouri.
Subsequent syntenic analysis with rice revealed that
many of the miRNA genes are in regions of conserved
gene order. The fact that these miRNA genes have
remained intact, and in conserved genome locations,
throughout the divergence of rice and maize suggests
conservation of function. We took advantage of “next-
generation” sequencing approaches to characterize
miRNA (and small RNA?) transcripts in developing
seedling and inflorescence tissues of maize and
sorghum. These data sets were used to validate known
miRNAs, discover paralogous genes, and analyze dif-
ferential expression across species. Using 454 sequenc-
ing, we validated the expression of more than 55% of
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previously identified maize miRNAs and 74% of known
sorghum miRNAs; we also identified 31 maize and 14
sorghum paralogs, and five trans-acting small interfer-
ing RNAs. Approximately two thirds of these families
were predicted to have conserved protein-coding targets
across species. Differential expression analysis revealed
that most miRNA sequences have conserved expression
patterns at two key developmental stages, suggesting
conserved regulatory roles.
Previous work characterizing the miRNAs has
focused on the mature processed form of transcripts, but
these small 20–22-nucleotide RNAs originate from
much larger precursor transcripts. This past year, we
have experimentally characterized these longer precur-
sors using 5′–3′ race methods in maize and sorghum.
Preliminary results found that many of these precursor
structures are much larger than that predicted by the
stem-loop structure which is typically used to annotate
these noncoding genes. In addition, we found several
examples in which one precursor structure appears to
give rise to two mature miRNAs. We also found that
several of the plant miRNA genes contain introns simi-
lar to those of protein-coding genes. By characterizing
the primary transcript, we also established the start of
transcription, opening the way forward to identifying
proximal promoters and motifs responsible for regulat-
ing expression. By increasing our understanding of
these small RNA regulatory networks, we will increase
the potential of researchers and breeders to modify plant
developmental profiles and responses to stress in order
to positively meet the challenges of global environmen-
tal change and land allocation for agriculture in the
upcoming years.
SEQUENCE AND ANALYSIS OF THE MAIZE
B73 GENOME
From its domestication 8000 years ago in CentralAmer-
ica to its position today as the world’s leading harvested
grain, Zea mays has had an important role in human civ-
ilization, providing food, animal feed, and biofuel.
Maize also enjoys a long and distinguished history as a
model organism owing to its rich diversity and tractable
genetics. The complete sequence of the maize genome
would therefore propel advances in basic research as
well as agriculture and other industries.
The Maize Genome Sequencing Consortium was
launched with a 3-year grant from the National Science
Foundation to produce a complete sequence of the
maize (B73) genome. At 2.5 Gb, the maize genome
rivals mammalians in terms of size and is six times
larger than rice, owing to its high content of retrotrans-
posable elements. To meet the challenge of producing a
draft sequence, the consortium took a hierachial
approach, selecting a minimal tiling path of bacterial
artificial chromosome (BAC) clones from a 20x fin-
gerprint map and sequencing the BACs using a combi-
nation of shotgun and finishing of the unique regions of
the BACs.
In addition to our lab, those of Drs. McCombie, Stein,
and Martienssen here at CSHL are central participants
in the Maize Sequence Consortium. Now in its third
year, the project has produced complete sequences of
15,200 BAC clones comprising approximately 2 billion
nonredundant bases, all available via GenBank. Our lab’s
specific contributions include aiding the BAC selections
process, developing resources to assign unique regions of
the genome for finishing, and providing automated anno-
tations of the draft sequence. In the past year, we have
enhanced visualizations and performance at the project
Web site, produced annotations for the repetitive and
genic regions of the draft sequence, and provided pre-
liminary whole-genome comparisons with rice. The
analysis reveals that the maize genome has been largely
shaped by its history of tetraploidization, subsequent
rearrangement, and duplicate gene loss. Gene annota-
tions and comparative maps generated by this project are
available at the project Web site Genome Browser
(www.maizesequence.org) (Fig. 1).
ASSAYING MOLECULAR AND FUNCTIONAL
DIVERSITY IN MAIZE
Dissection of complex traits in higher eukaryotes still
remains one of the major challenges in biology. Cur-
rently, the dissection of complex traits involves either
the identification of large genomic regions or the testing
of genes one at a time. At the heart of both approaches
is a requirement for the construction of appropriate pop-
ulations within which segregating markers can be easily
scored. To address this issue in maize, we are partici-
pating with two projects: Maize Diversity and High
Scorable Markers for Trait dissections.
The Maize Diversity project’s main goals are to
understand molecular diversity of maize and teosinte,
develop resources for functional trait dissection, map
quantitative trait loci (QTL) across maize and teosinte,
and evaluate functional variation at candidate genes. In
2007, we updated the available data sets that we main-
tain as part of the public portal for the project data
Panzea (www.panzea.org) and improved visualization
tools. One such example of this was building a frame-
work for the display of diversity data using Google
Maps. This allows researches to view the genotype data
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in context to geographical distribution of the
germplasm. By integrating the geographical and geno-
type information, researchers can clearly see patterns of
loss or gain of diversity in candidate genes. In addition
to the development of computational tools for the proj-
ect, our group is interested in understanding the role
miRNA genes have had in the process of domestication
and improvement. To address this question, our group
identified candidate miRNA genes that have been incor-
porated into the genotyping platform provided by the
project. Preliminary results in 2007 suggested that a few
of these miRNA genes show a strong correlation with
several traits scored in these populations.
The second project builds upon resources developed
in the Maize Diversity and Maize sequencing project to
identify 1–2 million SNPs in maize (Zea mays ssp.
mays) by generating genome reduction libraries in the
diverse maize inbred lines. Importantly, these lines are
parents of the 5000 recombinant inbred lines (RILs) that
form the basis of the world’s largest ongoing complex
trait dissection project. In combination with this unpar-
alleled QTL mapping resource, these SNP alleles will
enable the resolution of numerous QTL down to the
gene level.
In the past year, our group and Dr. McCombie’s have
focused on developing robust analysis pipelines for han-
dling resequencing data sets for SNP discovery. On the
basis of preliminary analysis of the 454 and Solexa data
sets, we have decided to focus on the Solexa sequencing
platform, sacrificing longer read lengths for increased
genome coverage. In the next year, we anticipate hav-
ing 3x coverage per line, for more that 30x coverage
across ten lines to generate polymorphisms at approxi-
mately 400,000 locations in the maize genome. This
resource combined with the germplasm and genome
sequence described above will provide the most robust
resource for complex trait dissection in any higher
eukaryotic organism.
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FIGURE 1 Sample of a view of an annotated maize BAC available from www.maizesequence.org.
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In the last year, Dustin Schones finished his Ph.D. and
went on to a postdoctoral fellowship at the National
Institutes of Health/National Heart, Lung, and Blood
Institute.Visiting professor Fei Li returned to China, and
Dr. Xiaoyue Zhao joined the Biotech company Bionovo
in the Bay area. We had Josh Silverman as an URP stu-
dent from Duke University and H.Y.Weng as a summer
intern from Taiwan. Visiting Ph.D. student Xiaowo
Wang joined the lab in the fall fromTsinghua University
in China. The year 2007 has been very productive,
despite the severe budget cuts from the government.
Transcriptional Gene Regulation
NEW METHODS FOR IDENTIFYING AND
ACCESSING STATISTICAL SIGNIFICANCE
OF CIS-REGULATORY ELEMENT MOTIFS
In collaboration with Tsinghua University, a one-class
support vector machine (SVM)-based method OSCAR
has been developed (Jiang et al. 2007) that can outper-
form position weight matrix (PWM)-based methods.
For better accessing cis-element motif significance, we
developed a new method that allows users to compute
the p values for a motif or a module quickly using
empirical p values compiled from our CSHLmpd pro-
moters (Schones et al. 2007). We have also derived
mathematically rigorous p values for Markov motif
models, proved the problem is NP-hard (nondetermin-
istic polynomial-time hard), and implemented it in a fast
algorithm (Jiang et al. 2007) in collaboration with the
University of Waterloo and Tsinghua University.
NOVEL CORE-PROMOTER PREDICTION
ALGORITHMS
Two new state-of-the-art human core-promoter predic-
tion algorithms have been developed. One is CoreBoost
(Zhao et al. 2007) based on Random Forest and Tree
Boosting technology. The other is based on a newly pro-
posed multi-objective-simulated annealing-based opti-
mization method, Archive Multi-objective-simulated
Annealing (AMOSA) (Wang et al. 2007) in collabora-
tion with the Indian Statistical Institute and Tsinghua
University. Both have further improved the accuracy of
detecting TSSs (transcriptional start sites), including
those in non-CpG promoters.
MAPPING OF TISSUE-SPECIFIC PROMOTERS
AND CIS-REGULATORY ELEMENTS
Using chromatin immunoprecipitation (ChIP)-chip with
high-density genomic tiling arrays, we have mapped
active promoters in mouse embryonic stem cells and sev-
eral other adult organs in collaboration with Nimblegen
and the University of California at San Diego (Barrera et
al. 2008). Equipped with our suite of motif discovery
tools, we further extended our general study of tissue-spe-
cific transcription-factor-binding site (TFBS) motifs
(Smith et al. 2007) to more experimental systems in col-
laboration with various wet-bench scientists.We have also
investigated transcriptional regulation pathways in more
detail in hair follicles (Mignone et al. 2007, a collabora-
tion with the Enikolopov lab here at CSHL), in adipocytes
(Eguchi et al. 2008, a collaboration with Beth Israel Dea-
coness Medical Center), in blood cells (Yang et al. 2007,
a collaboration with the University of California, Los
Angeles), and in lung (Martinez et al. 2007, a collabora-
tion with Lovelace Respiratory Research Institute).
MOST CPG ISLANDS MAY BE PROTECTED
FROM DNA METHYLATION BY ZINC
FINGER PROTEINS
After developing algorithms for predicting CpG island
methylation (Fang et al., Bioinformatics 22: 2204–2209
[2006]), in collaboration with Tsinghua University, we
further studied DNA sequence characteristics in the
boundary regions of methylation-resistant CpG islands
and discovered that certain classes of zinc finger pro-
teins (e.g., CTCF, Sp1, MAZR, ETF, AP2, SPZ1,
KROX, and NF-κB) may have important roles in pro-
tecting such islands from methylation in human brains
and other tissues (Fan et al. 2007). This is consistent
with our recent genome-wide CTCFmapping data (Kim
et al. 2007).
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Posttranscriptional Gene Regulation
and Miscellanea
IDENTIFICATION OF SYNAPTIC TARGETS OF
DROSOPHILA PUMILIO
This is a multiyear project (Chen et al. 2008) mainly
supported by Dart Neuroscience Inc. and has just been
completed as a collaboration with the Dubnau, Krainer,
andTully labs here at CSHL.Drosophila Pumilio (Pum)
protein is a translational regulator involved in embry-
onic patterning and germ-line development. Recent
findings demonstrate that Pum also has an important
role in the nervous system, both at the neuromuscular
junction (NMJ) and in long-term memory formation. In
neurons, Pum appears to have a role in homeostatic con-
trol of excitability via down-regulation of para, a volt-
age-gated sodium channel, and may more generally
modulate local protein synthesis in neurons via transla-
tional repression of eIF-4E. Aside from these charac-
teristics, the biologically relevant targets of Pum in the
nervous system remain largely unknown.
We hypothesized that Pum might have a role in reg-
ulating the local translation underlying synapse-specific
modifications during memory formation. To identify
relevant translational targets, we used an informatics
approach to predict Pum targets among mRNAs whose
products have synaptic localization. We then used both
in vitro binding and two in vivo assays to functionally
confirm the fidelity of this informatics screening
method. We find that Pum strongly and specifically
binds to RNA sequences in the 3′UTR (untranslated
region) of four of the predicted target genes demon-
strating the validity of our method. We then demon-
strated that one of these predicted target sequences in
the 3′UTR of discs large (dlg1), the Drosophila PSD95
ortholog, can functionally substitute for a canonical
Nanos response element (NRE) in vivo in a heterolo-
gous functional assay. Finally, we show that the endoge-
nous dlg1mRNA can be regulated by Pum in a neuronal
context, the adult mushroom bodies (MB), which is an
anatomical site of memory storage.
ANALYSIS OF RNA SPLICING REGULATION
AND EVOLUTION
During the process of building a comprehensive splic-
ing database (http://rulai.cshl.edu/dbCASE) from de
novo mRNA/EST (expressed sequence tag) genome
alignments, we have discovered a new class of pre-
mRNA splice sites, dubbed “dual-specificity splice
sites,” which can function as either 5′ or 3′ splice sites in
vivo (Zhang et al. 2007). A careful statistical study of
alternative splicing (AS) in human and mouse indicates
that many of theAS products (e.g., inDBEST) are likely
to be nonfunctional; evolution favors frame-preserving
events and smaller-size exons (Zhang et al. 2007).
STUDIES ON MIRNAS, FEMALE GERM
LINE, AND AUTISM
In collaboration with Tsinghua University, we have
identified a comprehensive set of phylogenetically con-
served miRNA cis-regulatory elements across 12
Drosophila species (Wang et al. 2008). This is one of
the pioneer studies on genome-wide miRNA gene pro-
moter architectures.
Working with the Hannon lab here at CSHL, Z.Y.
Xuan studied miRNA regulation in a specific experi-
mental system: the p53 tumor suppressor gene network
in the mouse (He et al. 2007) and also investigated the
critical role of Dicer in the female germ line during
meiosis (Murchison et al. 2007). Working with Dr.
Wigler and other investigators here at CSHL, X.Y. Zhao
has proposed a unified genetic model for sporadic and
inherited autism (Zhao et al. 2007).
PUBLICATIONS
Das D. and Zhang M.Q. 2007. Predictive models of gene regula-
tion: Application of regression methods to microarray data.
Methods Mol. Biol. 377: 95.
Fan S., Fang F., Zhang X., and Zhang M.Q. 2007. Putative zinc
finger protein binding sites are over-represented in the
boundaries of methylation-resistant cpg islands in the human
genome. PLoS ONE 2: e1184.
He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W.,
Zender L., Magnus J., Ridzon D., Jackson A.L., Linsley P.S.,
Chen C., Lowe S.W., Cleary M.A., and Hannon G.J. 2007. A
microRNA component of the p53 tumour suppressor net-
work. Nature 447: 1130–1134.
Jiang B., Zhang M.Q., and Zhang X. 2007. OSCAR: One-class
SVM for accurate recognition of cis-elements. Bioinformatics
23: 2823–2828.
Jiang C., Xuan Z., Zhao F., and Zhang M.Q. 2007. TRED: A tran-
scriptional regulatory element database, new entries and
other development. Nucleic Acids Res. 35: D137–D140.
Kim T.H., Abdullaev Z., Smith A.D., Ching K.A., Loukinow D.,
Green R.D., Zhang M.Q., Lobanenkov V., and Ren B. 2007.
Analysis of the vertebrate insulator protein CTCF binding sites
in the human genome. Cell 128:1231–1245.
Martinez M.J., Smith A.D., Li B., Zhang M.Q., and Harrod K.S.
2007. Computational prediction of novel components of lung
transcriptional networks. Bioinformatics 23: 21–29.
Mignone J.L., Roig-Lopez J.L., Fedtsova N., Schones D.E., Man-
ganas L.N., Maletic-Savatic M., Keyes W.M., Mills A.A.,
Gleiberman A., Zhang M.Q., and Enikolopov G. 2007. Neu-
186
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:53 PM  Page 186
ral potential of a stem cell population in the hair follicle. Cell
Cycle 6: 2161–2170.
Murchison E.P., Stein P., Xuan Z., Pan H., Zhang M.Q., Schultz
R.M., and Hannon G.J. 2007. Critical roles for Dicer in the
female germline. Genes Dev. 21: 682–693.
Schones D.E., Smith A.D., and Zhang M.Q. 2007. Statistical sig-
nificance of cis-regulatory modules. BMC Bioinformatics 8:
19.
Smith A.D., Sumazin P., and Zhang M.Q. 2007. Tissue-specific
regulatory elements in mammalian promoters.Mol. Sys. Biol.
3: 73.
Wang X., Bandyopadhya S., Xuan Z., Zhao X., Zhang M.Q., and
Zhang X. 2007. Prediction of transcription start sites based
on feature selection using Amosa. Proc. Comp. Sys. Bioinf.
Conference. San Diego, Aug. 2007. World Scientific.
Yang Z., Jiang H., Zhao F., Shankar D.B., Sakamoto K.M., Zhang
M.Q., and Lin S. 2007. A highly conserved distal regulatory
element controls hematopoietic expression of GATA-2. BMC
Dev. Biol. 7: 97.
Zhang C., Zhao X., and Zhang M.Q. 2007. Functional in silico
analysis of gene regulatory polymorphism. In Bioinformatics
for geneticists: A bioinformatics primer for the analysis of
genetic data, 2nd ed. (ed. M.R. Barnes), pp. 281–310. Wiley-
VCH.
Zhang C., Hastings M.L., Krainer A.R., and Zhang M.Q. 2007.
Dual-specificity splice sites function alternatively as 5′ and 3′
splice sites. Proc. Natl. Acad. Sci. 104: 15028–15033.
Zhang C., Krainer A.R., and Zhang M.Q. 2007. Evolutionary
impact of limited splicing fidelity in mammalian genes. Trends
Genet. 23: 484–488.
Zhang C., Zhang X., Zhang M.Q., and Li Y. 2007. Neighbor num-
ber, valley seeking and clustering. Pattern Recog. Lett. 28:
173–180.
Zhang J., Jiang B., Li M., Tromp J., Zhang X., and Zhang M.Q.
2007. Computing exact p-values for DNA motifs (Part I).
Bioinformatics 23: 531–537.
Zhang M.Q. 2007. Computational analyses of eukaryotic pro-
moters. Review proceedings of Otto Warburg International
Summer School and Workshop on Networks and Regulation
(ed. P.F. Arndt and M. Vingron). BMC Bioinformatics (suppl.
6) 8: S2.
Zhang M.Q. 2007. Inferring gene regulatory networks. In Bioin-
formatics—From genomes to therapies (ed. T. Lengauer), pp.
807–828. Wiley-VCH.
Zhao X., Leotta A., Kustanovich V., Lajonchere C., Geschwind
D.H., Law K., Law P., Qiu S., Lord C., Sebat J., Ye K., and
Wigler M. 2007. A unified genetic theory for sporadic and
inherited autism. Proc. Natl. Acad. Sci. 104: 12831–12836.
Zhao X., Xuan Z., and Zhang M.Q. 2007. Boosting with stumps
for predicting transcription start sites. Genome Biol. 8: R17.
In Press
Barrera L.O., Li Z., Smith A.D., Arden K.C., Cavenee W.K., Zhang
M.Q., Green R.D., and Ren B. 2008. Genome-wide mapping
and analysis of active promoters in mouse embryonic stem
cells and adult organs. Genome Res.18: 46–59.
Chen G., Li W., Zhang Q.-S., Regulski M., Sinha N., Barditch J.,
Tully T., Krainer A.R., Zhang M.Q., and Dubnau J. 2008. Iden-
tification of synaptic targets of Drosophila Pumilio. PLoS
Comp. Biol. (in press).
Eguchi J., Yan Q.-W., Schones D.E., Kamal M., Hsu C.-H., Zhang
M.Q., Crawford G.E., and Rosen E.D. 2008. Identification of
interferon-regulatory factors (IRFs) as regulators of adipocyte
gene expression by mapping DNase hypersensitive sites dur-
ing adipogenesis. Cell Metab. 7: 86–94.
Wang X., Gu J., Zhang M.Q., and Li Y. 2008. Identification of phy-
logenetically conserved microRNA cis-regulatory elements
across 12 Drosophila species. Bioinformatics 24: 165–171.
Zhang C. and Zhang M.Q. 2007. Biomedical literature mining. In
Introduction to bioinformatics: A workbook approach (ed. V.
Mathura). Elsevier. (In press.)
187
031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:53 PM  Page 187
188
SWI/SNF-dependent Dismantling
of Pluripotency Networks in
Embryonic Stem Cells
P.J. Paddison, C. Cormier, T. James
Embryonic stem cells (ESCs) are cell lines derived from
the inner cell mass (ICM) of blastocyst-stage mammalian
embryos (Evans and Kaufman, Nature 292: 154 [1981];
Martin, Proc. Natl.Acad. Sci. 78: 7634 [1981];Thomson
et al., Science 282: 1145 [1998]). They can grow indefi-
nitely in culture and give rise to cells of all three embry-
onic germ layers as well as germ cells (Keller, Genes
Dev. 19: 1129 [2005]). For this reason, ESCs hold great
promise for regenerative medicine, where human ESC
derivatives might be used in cell replacement therapies.
COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of three years on projects
of their own choosing. Fellows are provided with a salary, research support, and technical assistance so
that they can accomplish their goals free of distraction. The interactions among research groups at the
Laboratory and the program of courses and meetings on diverse topics in biology contribute to a
research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1986), Scott Lowe (1995), and Marja
Timmermans (1998) are now members of the faculty at the Laboratory; Adrian is also the Director of the
Fellows program. After nine years at the Laboratory, Carol Greider (1988) left to join Johns Hopkins Uni-
versity School of Medicine, where she is now the Daniel Nathans Professor and Director of Molecular Biol-
ogy and Genetics. Eric Richards (1989) is now a Professor in the Department of Biology at Washington
University in St. Louis. After completing his fellowship, David Barford (1991) returned to the Laboratory
of Molecular Biophysics at Oxford University and is now a Professor of Molecular Biology at the Institute
of Cancer Research in London. Ueli Grossniklaus (1994) was a member of our faculty before leaving to
become a Professor at the Institute of Plant Biology, Universität Zürich, Switzerland. Térence Strick (2000)
left at the end of his fellowship to become a Group Leader at the Institut Jacques Monod, Centre National
de la Recherche Scientifique and Universités de Paris VI and VII.
The Laboratory’s three most recent CSHL Fellows are Gilbert (Lee) Henry, who joined the Laboratory
in 2000, and Patrick Paddison and Ira Hall, both of whom joined the Laboratory in 2004. Their reports are
listed below. Lee joined us from Doug Melton’s laboratory at Harvard University, where he earned his
Ph.D. for studies on Xenopus development. As a Fellow, Lee studied the molecular biology of taste recep-
tor cell differentiation. Ira was a graduate student at the Watson School of Biological Sciences, where he
worked in Shiv Grewal’s lab on the relationship between RNA interference and chromosome dynamics.
As a Fellow, he studied mammalian genomic instability and plasticity and characterized the contribution
of DNA copy-number polymorphisms to genetic variation in inbred mouse strains. Patrick was also a
graduate student at the Watson School of Biological Sciences, where he worked in Greg Hannon’s lab
on the development of RNA interference libraries. As a Fellow, Patrick has been using RNA interference
technology to establish the genetic requirements for embryonic stem cell self-renewal and differentiation.
Both Lee and Ira moved to Virginia this year: Lee left in July to work on a project headed by Thomas
Südhof at Howard Hughes Medical Institute’s (HHMI) Janelia Farm in Ashburn; Ira, who left in Novem-
ber, is now Assistant Professor in the Department of Biochemistry and Molecular Genetics at the Uni-
versity of Virginia in Charlottesville.
I. Hall
L. Henry
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031_194_ResSection.qxd:LAR_Template_2007  5/28/08  4:53 PM  Page 188
189
Nanog is an atypical homeobox domain transcription
factor that is one of several known key regulators that are
required to maintain pluripotency of ESCs (Chambers et
al., Cell 113: 643 [2003]; Mitsui et al., Cell 113: 631
[2003]). Current models posit that Nanog, along with fac-
tors such as Oct4 and Sox2, functions in cross-regulatory
networks that collectively repress differentiation-inducing
genes and activate those that are required for self-renewal.
To find regulators of self-renewal and lineage specifica-
tion, we used an RNA interference (RNAi) screening
approach to find modifiers of Nanog expression in ESCs.
Confirming the validity of the screening approach,
many previously known and recently identified players
in ESC self-renewal scored as Nanog activators, includ-
ing genes involved in major signaling pathways required
for pluripotency (i.e., LIF-Jak/Stat, Wnt-Cttnb1, and
Bmp-Smad4), as well as pluripotency transcription fac-
tors (e.g., Esrrb, Oct4, Sall4, Sox2, and Rif1). Among
genes scoring as Nanog repressors, we found the only
known direct, physiological repressor of Nanog, Tcf3,
as well as negative regulators of Jak/Stat, Cttnb1, and
Smad4 signaling and Raf1, which has known roles in
mESC differentiation. Chief among the novel screen hits
in this category were four core members of the Brg1-
associated SWI/SNF chromatin remodeling complex.
SWI/SNF regulates gene expression by locally affect-
ing chromatin structure to control access of transcription
factors and basal transcription machinery. Therefore,
SWI/SNF-dependent repression of ESC self-renewal
genes could result from direct regulation or from indirect
regulation, where SWI/SNF promotes expression of sec-
ondary factors, which, in turn, repress self-renewal gene
expression.To distinguish between these possibilities, we
compared the Smarcc1/Baf155-bound chromatin regions
of the mouse genome in ESCs with Smarcc1-dependent
changes in gene expression during ESC differentiation.
Genes displaying both Smarcc1 binding and altered gene
expression in its absence are candidates for direct regu-
lation by the SWI/SNF complex. From this analysis, we
find that the SWI/SNF complex has critical roles in ESC
lineage specification as a corepressor of self-renewal
genes, a coactivator of differentiation/lineage specific
genes, and a coordinator of developmental patterning.
PUBLICATIONS
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rent topics in microbiology and immunology), Springer-Ver-
lag, Heidelberg, Germany.
In Press
Paddison P.J. 2008. RNA interference in mammalian cell systems.
Curr. Top. Microbiol. Immunol. 320: 1–19.
Investigation of DNA Copy-number
Fluctuation using Genomic Microarrays
I. Hall, C. Egan
We are interested in pursuing a genome-wide examina-
tion of genetic instability and plasticity and in charac-
terizing the contribution of DNA copy-number
differences to natural variation. The arrangement and
copy number of chromosomal segments may vary
among species, strains, and individuals, and sponta-
neous DNA rearrangements are recognized to be causal
in the clonal evolution of cancers and in the etiology of
certain human diseases. Ancestral sequence relation-
ships within and between mammalian genomes indicate
a major architectural role for duplication and deletion
in shaping genomes over evolutionary time, but less is
known about how these processes contribute to genetic
variation across more rapid time scales within normal
populations and organisms. We aim to use the labora-
tory mouse as a model system to investigate the funda-
mental properties of DNA copy-number fluctuation in
mammals utilizing a form of comparative genome
hybridization termed representational oligonucleotide
microarray analysis (ROMA) (Lucito et al., Genome
Res. 10: 1726 [2000]).
Internal relationships within sequenced genomes show
that a significant portion (2–5%) of chromosomal DNA
in mammals is contained within segmental duplications
(defined as stretches of DNA within a single genome >1
kb in length and >90% identical to one another), and
duplicative events underlie the historical amplification
and diversification of many important gene families.
Sequence comparisons are essential to identify ancient
copy-number changes, but they are not well suited to
detect recent and ongoing genetic events because a com-
plete genome sequence (1) is usually derived from a sin-
gle individual, (2) relies upon assembly methods that are
confounded by large identical repeats, and (3) is still
impractical to attain for large genomes. Traditional
molecular techniques are inevi-tably limited (and
directed) to a small number of loci, and cytogenetic meth-
ods lack sufficient resolution to detect most changes.
ROMA allows for the simultaneous detection of DNA
copy-number variants (CNVs) and restriction-fragment-
length polymorphisms (RFLP) between any two related
DNA samples through comparative hybridization of sim-
plified genomic representations to high-density oligonu-
cleotide microarrays. This technique assays a large
portion of the genome in a relatively unbiased manner
and requires only that a complete genome sequence exist
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for the organism in question.A number of recent studies
have catalogued extensive copy-number differences
between humans, indicating that CNVs may account for
a substantial fraction of existing genetic variation.
The apparent evolutionary importance and contem-
porary prevalence of segmental copy-number variation
raise fundamental questions: How often do new CNVs
arise? Do CNVs arise through a random process? Does
copy number generally reflect the ancestry of a locus?
What are the prevalent mechanisms of duplication and
deletion? Are different chromosomal regions or classes
of DNA sequences more variable than others? Do dis-
tinct cells or cell types of an organism contain the same
genetic material?
The laboratory mouse is an ideal model system for
such investigations in that the human and mouse
genomes appear to have been shaped by similar muta-
tional forces, and the mouse offers the significant tech-
nical advantages of controlled crosses, experimental
manipulation, and a known breeding history.
GENETIC DIVERSITY IN INBRED MICE
During the past century, a large number of phenotypically
diverse inbred strains have been derived from a small
number of founder mice through brother-sister mating.
Because these founders were mixed descendants ofAsian
and European subspecies, each modern inbred line con-
tains a unique, recombinant mixture of chromosomal seg-
ments of distinct genetic origin.These genetic differences
are thought to underlie the many interesting physical and
behavioral traits for which modern strains vary.
To gain an understanding of the current genetic com-
position of the laboratory mouse and to evaluate the util-
ity of ROMA as a tool for mouse genetics, we have
profiled the genomes of a number of commonly used
inbred strains. Using a microarray containing approxi-
mately 83,000 probes, we have identified about 15,000
ROMA polymorphisms from 12 strains. More than one
third of these markers can be observed in a single strain
comparison, and further investigation with independent
methods indicates that about one fifth of them are CNVs
(the remainder are RFLPs and SNPs). These markers are
distributed throughout the genome in a punctate, highly
nonrandom fashion, and in collaboration with S. Sridhar
(Carnegie Mellon University), we have developed a seg-
mentation algorithm to identify ancestrally divergent hap-
lotypes and CNVs within our data (this model is based
upon previous work by L. Muthuswamy and M. Wigler
here at CSHL). We have compared ROMA polymor-
phisms to a curated set of 3.8 million single-nucleotide
polymorphisms (SNPs) and found that although the
majority of ROMA differences appear to be ancient in
origin and mirror the distribution of SNPs, significant
genomic changes have occurred since the establishment
of inbred lines in the early part of the 20th century.
GENOME STABILITY AND PLASTICITY
To assess the importance of segmental duplication and
deletion in generating de novo genetic variation, we are
examining genome stability through normal cycles of
somatic development and germ-line transmission in the
laboratory mouse.
A description of the genetic variation normally pres-
ent in somatic cells is important for a fewmajor reasons.
Each cancer is thought to begin with a single cell that
has diverged from its relatives, and the accumulation of
mutations is thought to be a cause of aging. DNA
rearrangement is also an established regulatory mecha-
nism; our own bodies generate a staggering diversity of
immunological molecules precisely through such “muta-
genic” processes, and more simple genetic systems (such
as various yeasts and bacteria) utilize reversible DNA
rearrangements to make heritable transcriptional deci-
sions. It is not known how common such mechanisms
are in mammals. In collaboration with CSHL’s J. Hicks
(theWigler lab) and K. Eggan (Harvard University), we
are pursuing a survey of somatic cell diversity in humans
and mice. We hope that these studies result in an esti-
mate of clonal variegation in mammals and help to iden-
tify unstable or hypervariable regions of the genome.
Mutation in the germ line is the basis for the intro-
duction of new alleles to a species and is relevant to our
understanding of evolution, population structure, and spo-
radic human disease. Previous estimates of the germ-line
mutation rate have relied upon the observation of spon-
taneous loss of function at a small number of genes and
do not adequately distinguish between classes of muta-
tions. Rates of segmental duplication and deletion have
been examined at just a few loci. Our analysis of genetic
diversity described above utilized multiple individuals
from each strain and thus represents a test of the pur-
portedly homozygous and uniform nature of the inbred
mouse genome. We found that inbred mice are indeed
very inbred but are rarely identical. We did not observe
residual heterozygosity of ancestral genetic variation, but
we often encountered one or more spontaneous CNVs
between closely related individuals of the same inbred
strain.This indicated that CNVsmight arise at a high rate
and that it might be possible to study this process directly.
During the past year, we completed a study of sponta-
neous DNA copy-number change across the entire mouse
genome. We collected pedigreed mice from many sepa-
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rate colonies of the C57BL/6 (B6) inbred strain, each
bred independently at different institutions around the
world. Using information obtained from breeders, we
constructed a genealogy spanning approximately 966
generations of inbreeding.We then used ROMA to iden-
tify 38 de novo CNVs among the B6 colonies.
To our surprise, almost half of the de novo CNVs
arose multiple times within distinct lineages: Eight of 38
CNVs arose once within B6 colonies but were also vari-
able among other classical inbred mouse strains, and ten
CNVs arose multiple times within closely related B6
colonies. Thus, significant changes in DNA copy num-
ber occur over relatively short timescales, and new seg-
mental variation is often the product of recurrent
mutation. The recurrent CNVs that we identified range
in size from 4 kb to 4 Mb, affect 43 known genes, and
fluctuate in copy number at rates of about 1 x 10–2 to 1 x
10–3/locus/generation—unprecedented rates for large
structural mutations.We used high-resolution tiling arrays
to map CNV breakpoints to approximately 500-bp reso-
lution and found that they recur through a spatially pre-
cise mechanism. Moreover, breakpoints are often found
within repetitive elements.
Given that we have significantly underestimated the
prevalence of recurrent CNVs and that many of those we
identified contain genes for which hypervariability might
be beneficial to a population (i.e., factors involved in
immunity, reproduction, and cognition), we believe that
recurrent structural mutation will prove to be a wide-
spread and phenotypically relevant process for creating
genetic variation in mammals.
PUBLICATIONS
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Structural and Functional Studies of the
Vertebrate Taste Bud
L. Henry, M. Siddiqui
We are interested in the molecular biology of taste
receptor cell differentiation. The mammalian taste bud
is a dynamic structure consisting of mitotically active
progenitor cells at its periphery and differentiated taste
receptor cells within its core. The basic goal of our
research is to understand how the daughters of the pro-
genitors select a particular fate. Because different
receptor cells are known to respond to different classes
of tastants, we hope that understanding this differenti-
ation process will help to illuminate details of both taste
bud structure and function. Toward this end, we have
undertaken an exhaustive effort to define at the level of
transcription the cellular diversity of the murine taste
bud. To do this, single-cell profiling is being used to
analyze the transcriptomes of taste receptor and pro-
genitor cells.
I have completed the design of a novel means of
amplifying mRNA from limiting amounts of starting
material. The method involves the use of a solid-phase
magnetic bead system wherein a 330-nm paramagnetic
bead is coupled to an mRNA capture oligonucleotide.
There are two novel aspects of the approach. First, the
beads are approximately ten times smaller in diameter
than beads used for similar purposes by other
researchers. This decrease in diameter sounds modest;
however, a tenfold decrease in diameter creates a ten-
fold increase in surface area and a 1000-fold increase in
bead concentration per unit volume. Both of these fea-
tures enhance the ability of the beads to bind to mRNA.
In addition, because nanometer sized beads settle
slowly, complicated agitation schemes are not required
during enzymatic manipulations, including PCR (poly-
merase chain reaction) which can be done directly on
the beads. The second novelty is the development of
hybrid DNA/RNA capture oligomers that specifically
prime cDNA synthesis while blocking extension in the
presence of other needed polymerases.
This advance greatly reduces a background problem
associated with cDNA amplification schemes where the
ends of the cDNA are adapted with common sequences
to allow PCR amplification. In addition, the approach is
universal in that it is possible to generate a single-
stranded RNA-based probe or a double-stranded DNA-
based probe.We have begun screening amplified probes
usingAffymetrix microarrays as a readout and are at the
initial stages of characterizing the transcriptomes of
individual taste receptor cells.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN’S REPORT
Another year has flown by at the Watson School of Biological Sciences (WSBS) and we are now in our
ninth year! After having served the School since its inception in 1999, I was appointed as the new Dean
in the summer of 2007. Dr. Lilian Clark, our previous Dean, moved to London to become Executive Direc-
tor of the Science Operations and Funding of Cancer Research U.K. Lilian had been with the School since
its inception, rising from Assistant Dean to Associate Dean and, in 2004, to Dean. Her contributions to
the School were many, from advising individual students on how to best approach their studies, to teach-
ing and fund-raising, to successfully establishing the WSBS graduate program as a model for other grad-
uate programs in the region. Lilian made sure that the School maintained its high standards, and matters
were dealt with professionally and with great expertise. The School is deeply indebted to Lilian and wishes
her all the best in her future endeavors.
Additional changes in the School’s administration include the return to his research by the previous
Director of Graduate Studies, Dr. William Tansey, and the departure of the School’s Administrative Assis-
tant, Eva Radeck.
As the new Dean, I plan to continue the School’s commitment to excellence and to ensure that our
students are prepared for the new era of quantitative biology. I have been associated with the Watson
School in curriculum development, teaching, mentoring, and advising and directed our Undergraduate
Research Program (URP) for 3 years. I plan to continue my active
role as a member of the School’s faculty as well as my research
program.
To allow me to effectively and efficiently lead both the School
and my research team, the School re-adopted its previous lead-
ership structure consisting of an academic Dean and an admin-
istrative Assistant Dean. In October 2007, the School appointed
Uwe Hilgert, Ph.D., as the School’s Assistant Dean. Dr. Hilgert
has been at CSHL’s Dolan DNA Learning Center (DNALC) since
2000, where he developed courses and taught students, teach-
ers, and college faculty to integrate bioinformatics investigations
with bench work. More recently, Uwe served the DNALC as
Assistant Director, managing its educational activities, including
its satellite center, DNALC West in Lake Success. He also had a key role in preparing the groundwork
for the DNALC’s upcoming expansion into New York City. Also new to the School is Kim Geer. Kim came
to us from a corporate environment and is the School’s new Administrative Assistant.
In fall 2007, Dawn Meehan was promoted to Director of Admissions and Student Affairs. Dawn has
been with the School since 2003 and continues to have a key role in the successful recruitment of out-
standing students worldwide. Her efforts to increase the visibility of our program dramatically increased
the number of students applying to the School. Dawn has also been instrumental in making sure that the
needs of our students are met, so that they may devote their time and energy fully to their academic and
research work.
Last but not least, Alyson Kass-Eisler, WSBS Postdoctoral Program Officer and Curriculum Coordi-
nator since 2003, continues to skillfully organize our postdoctoral programs and graduate student cur-
riculum. Her personal experiences as a Ph.D. student and postdoctoral fellow are extremely beneficial in
ensuring that our graduate students and postdocs are provided with all of the necessary support to lay
the foundation for the successful pursuit of their scientific careers. I am extremely grateful that Alyson con-
tinues to dedicate her expertise to the smooth and consistent flow of our programs.
Team Watson: (Left to right) Uwe Hilgert, Kim Geer, Leemor
Joshua-Tor, Dawn Meehan, Alyson Kass-Eisler
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Faculty Changes
In 2007, Adam Kepecs, Lloyd Trotman, and Doreen Ware joined the School as new faculty members. Dr.
Kepecs came to CSHL in 2002 to join the laboratory of Zachary Mainen as a postdoctoral fellow and was
appointed to Assistant Professor in February 2007. His research focuses on neuroscience, specifically the
neurobiology of decision making, neural circuits and neuroeconomics. Assistant Professor Lloyd Trotman
came to the Watson School in January 2007 from Memorial Sloan-Kettering Cancer Center where he con-
ducted postdoctoral research. His research will focus on molecular mechanisms of tumor suppression,
cancer treatment, and PTEN regulation. Our third new faculty member, Adjunct Assistant Professor Doreen
Ware, has been at CSHL since 2001 and is a computational biologist with the USDA Agricultural Research
Service. Her research focuses on comparative genomics in plants using bioinformatics and computational
biology to study genome evolution and diversity. We are very excited to have Adam, Lloyd, and Doreen work
with our students and look forward to their participation in other WSBS activities.
Faculty that left in 2007 include Dmitri (Mitya) Chklovskii, Tatsuya Hirano, Wolfgang Lukowitz, Michael
Myers, Karel Svoboda, and Tim Tully. As faculty members, all six served the School and its students in
various roles, including instructor, guest lecturer, rotation advisor, research mentor, examiner, and as
members of the Thesis and/or Admissions Committees. Drs. Chklovskii, Svoboda, and Tully will con-
tinue to serve the School as adjunct faculty. We wish them well in their new endeavors.
The Fourth WSBS Graduation
Graduation is a highlight of the year and April 22, 2007 saw the Watson School’s fourth graduation cer-
emony. The graduating class of 2007 was composed of Darren Burgess, Beth Chen, Catherine Cormier,
Claudia Feierstein, Tomás˘ Hromádka, Elizabeth Murchison, and Gowan Tervo, who were awarded the
Ph.D. degree, and Jonathan Kui, who was awarded a Master’s degree. The graduation was once again
a wonderful occasion where honorary degrees were bestowed on Drs. Sidney Brenner and Joseph Sam-
brook and on Mrs. Mary D. Lindsay. Dr. Brenner, who shared in the 2002 Nobel Prize in Physiology or
Medicine, delivered the commencement address.
As with each graduation, we extended a special welcome to the family members and friends of our
students. Among those, the parents of 2007 graduate Liz Murchison may have had the longest trip ever
for a family to join a WSBS graduation: six weeks from Tasmania to New York, traveling by boat and
train.
2007 WSBS Graduates
Student Thesis advisor Current position
Darren J. Burgess Scott Lowe With Dr. Alan Ashworth, Cancer Research U.K.,
London
Beth L. Chen Dmitri Chklovskii Currently exploring positions in San Francisco
Catherine Y. Cormier Yuri Lazebnik Scientific Liaison, Harvard Institute of Proteomics
Claudia E. Feierstein Zachary Mainen With Dr. Pierre-Marie Lledo, Institute Pasteur, Paris
Tomás˘Hromádka Anthony Zador With Dr. Anthony Zador, CSHL
Jonathan Kui Tim Tully Clinical Molecular Laboratory Technician, Weill
Medical College of Cornell University
Elizabeth Murchison Gregory Hannon With Dr. Gregory Hannon, CSHL
Dougal Gowan R. Tervo Karel Svoboda With Dr. Alla Karpova, Janelia Farm Research
Institute
Teaching Award
At this year’s graduation ceremony, Dr. Josh Dubnau was presented with the annual Winship Herr Fac-
ulty Teaching Award, named in honor of the School’s founding Dean. Josh, who was lead instructor of
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THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2001
Claudia E. Feierstein, February 16, 2007
Representation of goals, actions, and outcomes in rat
orbitofrontal cortex.
Thesis Examining Committee
Chair: Carlos D. Brody
Research Mentor: Zachary Mainen
Academic Mentor: Linda Van Aelst
Committee Member: Anthony Zador
Committee Member: Matthew Wilson, MIT
External Examiner: Geoffrey Schoenbaum,
University of Maryland School of
Medicine
Tomáš Hromádka, April 6, 2007
Representation of sounds in the auditory cortext of awake rats.
Thesis Examining Committee
Chair: Carlos D. Brody
Research Mentor: Anthony Zador
Academic Mentor: William Tansey
Committee Member: Dmitri Chklovskii
Committee Member: Zachary Mainen
External Examiner: Richard Harris, Rutgers University
Dougal Gowan R. Tervo, March 23, 2007
Development of molecular systems for the inactivation of
synaptic transmission.
Thesis Examining Committee
Chair: Roberto Malinow
Research Mentor: Karel Svoboda
Academic Mentor: Carlos D. Brody
Committee Member: Zachary Mainen
Committee Member: Nathaniel Heintz, The Rockefeller
University
External Examiner: Thomas Sudhof, University of Texas,
Southwest Medical Center
ENTERING CLASS OF 2002
Darren J. Burgess, March 28, 2007
RNAi genetic screens for chemotherapy response modifier
genes.
Thesis Examining Committee
Chair: Gregory Hannon
Research Mentor: Scott Lowe
Academic Mentor: Nicholas Tonks
Committee Member: Josh Dubnau
Committee Member: Senthil K. Muthuswamy
External Examiner: Carol Prives, Columbia University
Beth L. Chen, February 15, 2007
Neural network of C. elegans from anatomy to behavior.
Thesis Examining Committee
Chair: Alexei Koulakov
Research Mentor: Dmitri Chklovskii
Academic Mentor: Senthil K. Muthuswamy
Committee Member: Carlos D. Brody
Committee Member: Zachary Mainen
External Examiner: Cori Bargmann, The Rockefeller
University
Elizabeth Murchison, April 9, 2007
Genetic studies of mammalian Dicer.
Thesis Examining Committee
Chair: Senthil K. Muthuswamy
Research Mentor: Gregory Hannon
Academic Mentor: John R. Inglis
Committee Member: Alea A. Mills
Committee Member: Janet Partridge, St. Jude’s Children
Hospital
External Examiner: Richard Schultz, University of
Pennsylvania
2007 Graduation: (Left to right) Lilian Clark, Jonathan Kui, James D. Watson, Elizabeth Murchison, Bruce Stillman,
Beth L. Chen, Catherine Y. Cormier, Tomás˘ Hromádka, Claudia E. Feierstein, Darren J. Burgess, Dougal Gowan R. Tervo
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the Specialized Disciplines course in Genetics, was chosen by the students
for his enthusiasm, excellence, and creativity in teaching, and here is some
of what they had to say about the recipient:
Josh went above and beyond expectations more than any other instruc-
tor we had. He was well prepared for every lecture and made his lectures
interesting with great examples. He used humor and was a dynamic
speaker, easily maintaining the class’s attention and engaging the class in
discussion and debate. Most importantly, he was approachable and read-
ily available for extra help or just to discuss the material further. He clearly
cared tremendously for the class and our understanding and apprecia-
tion of genetics and put in extra effort to make it fun and interesting and
to make sure we understood the material.
Alumni Spotlights
Niraj Tolia, Ph.D., Entering Class 1999, received a B.Sc. from Imperial Col-
lege of Science, Technology, and Medicine, London, U.K. Following his
graduation from the Watson School in 2004, Dr. Tolia became a postdoc-
toral fellow in Leemor Joshua-Tor’s laboratory. In December 2007, Dr. Tolia
assumed a faculty position in the Department of Molecular Microbiology at
Washington University School of Medicine in St. Louis.
I remember my days as part of the first class entering the Watson School
of Biological Sciences. It was an exhilarating and unique experience to
be first in this exciting new model for graduate school and, by graduat-
ing within four years, to help prove the model a success. Eight years and
several graduating classes later, I can say without a doubt that the Wat-
Josh Dubnau
THESIS DISSERTATION DEFENSES (continued)
ENTERING CLASS OF 2003
Hiroki Asari, July 2, 2007
Auditory system characterization.
Thesis Examining Committee
Chair: Carlos D. Brody
Research Mentor: Anthony Zador
Academic Mentor: Z. Josh Huang
Committee Member: Alexei Koulakov
Committee Member: Eero P. Simoncelli, New York
University
External Examiner: Barak Pearlmutter, National
University of Ireland
Rebecca A. Bish, December 13, 2007
A novel role for the ubiquitin-binding zinc finger domain in DNA
repair.
Thesis Examining Committee
Chair: David L. Spector
Research Mentor: Michael P. Myers
Academic Mentor: Linda Van Aelst
Committee Member: Scott Lowe
Committee Member: Joshua LaBaer, Harvard University
External Examiner: Rui-Ming Xu, New York University
François Bolduc, October 2, 2007
Role of Drosophila Fragile X mental retardation protein and
the RNA interference pathway in Drosophila learning
and memory.
Thesis Examining Committee
Chair: Linda Van Aelst
Research Mentor: Tim Tully
Academic Mentor: Hollis Cline
Committee Member: Yi Zhong
Committee Member: Robert B. Darnell, The Rockefeller
University
External Examiner: Linda Restifo, University of Arizona
Wei Wei, December 12, 2007
The interplay between amyloid-β and neural activity.
Thesis Examining Committee
Chair: Z. Josh Huang
Research Mentor: Roberto Malinow
Academic Mentor: Jan A. Witkowski
Committee Member: Dimitri Chklovskii
Committee Member: Yuri Lazebnik
External Examiner: Sangram S. Sisodia, University of
Chicago
Niraj Tolia
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son School sets a new standard for higher education. This is a testament to the effort put forth by
the faculty, administrators, and students to create an environment where students come first. Now,
as an Assistant Professor of Molecular Microbiology at Washington University School of Medicine,
I expand on my thesis research and study the neglected disease of Malaria. My journey would not
have been what it is had it not been for the influence of the faculty at CSHL who were always will-
ing to listen and offer constructive advice.
Alumni Highlights
The scientific achievements of WSBS students continue to be outstanding. As a consequence, WSBS
graduates are thriving; they are successful in securing highly competitive awards and fellowships and
DOCTORAL THESIS RESEARCH
Academic Research
Student mentor mentor Thesis research
ENTERING CLASS OF 2001
Claudia E. Feierstein Linda Van Aelst Zachary Mainen Odor coding and neural correlates of behavioral
George A. and Marjorie H. Anderson Fellow choice in the olfactory cortex.
Thesis Defense: February 2007
Tomás˘ Hromádka William Tansey Anthony Zador Stimulus optimization in the auditory cortex.
Engelhorn Scholar
Thesis Defense: April 2007
Dougal Gowan R. Tervo Carlos D. Brody Karel Svoboda An inducible and reversible lesion of the
George A. and Marjorie H. Anderson Fellow corticothalmic projection.
HHMI Predoctoral Fellow
Thesis Defense: March 2007
ENTERING CLASS OF 2002
Allison L. Blum Hollis Cline Josh Dubnau Genetic, behavioral, and anatomical
Barbara McClintock Fellow characterization of Radish-dependent memory.
Darren J. Burgess Nicholas Tonks Scott Lowe Mammalian RNAi genetic screens: Discovery
Engelhorn Scholar and characterization of genes mediating the
Thesis Defense: March 2007 response to cancer therapy.
Beth L. Chen Senthil K. Muthuswamy Dmitri Chklovskii Neuronal network of C. elegans: From anatomy
Beckman Graduate Student to behavior.
Thesis Defense: February 2007
Shu-Ling Chiu Alea A. Mills Hollis Cline The role of insulin receptors in the development
Elisabeth Sloan Livingston Fellow of neuronal structure and function.
Elizabeth Murchison John R. Inglis Gregory Hannon The role of Dicer in mammalian development.
Engelhorn Scholar
Thesis Defense: April 2007
ENTERING CLASS OF 2003
Hiroki Asari Z. Josh Huang Anthony Zador Sparse overcomplete representation as a
Farish-Gerry Fellow principle for computation in the brain.
Thesis Defense: July 2007
Rebecca A. Bish Linda Van Aelst Michael Myers A proteomics approach to the study of ubiquitylation.
David H. Koch Fellow
Thesis Defense: December 2007
François Bolduc Hollis Cline Tim Tully Role of dFMR1 and the RNAi pathway in
William R. Miller Fellow Drosophila learning and memory.
Thesis Defense: October 2007
Monica Dus John R. Inglis Gregory Hannon Characterization of the biological roles of the
Engelhorn Scholar PIWI subfamily.
Angélique Girard Jan A. Witkowski Gregory Hannon The role of the Piwi family and Piwi-associated
Florence Gould Fellow small RNAs in mammalian spermatogenesis.
Christopher D. Harvey Adrian Krainer Karel Svoboda Visualization of MAPK activity in neurons.
David and Fanny Luke Fellow
Thesis Defense: February 2008
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DOCTORAL THESIS RESEARCH (continued)
Academic Research
Student mentor mentor Thesis research
Wei Wei Jan A. Witkowski Roberto Malinow Activity-dependent modulation of APP processing
Leslie C. Quick Jr. Fellow and Aβ production in rat hippocampal neurons.
Thesis Defense: December 2007
ENTERING CLASS OF 2004
Daniel H. Chitwood Alea A. Mills Marja Timmermans The contribution of small RNAs to positional
George A. and Marjorie H. Anderson Fellow signaling and the establishment of
adaxial-abaxial polarity in leaves.
Galen A. Collins Marja Timmermans William Tansey Role of ubiquitin ligases and activator destruction
Beckman Graduate Student in transcription.
Oliver L. Fregoso Nicholas Tonks Adrian R. Krainer Proteomic analysis to elucidate the splicing and
Seraph Foundation Fellow nonsplicing roles of SR proteins.
William Randolph Hearst Scholar
Keisha A. John Josh Dubnau Linda Van Aelst Identification of the molecular determinants
William Randolph Hearst Fellow and Scholar contributing to DOCK7’s role in neuronal polarity.
Shraddha S. Pai Anthony Zador Carlos D. Brody Determining the neuroanatomical loci and electrical
Charles A. Dana Fellow correlates of duration discrimination in the rat.
David R. Simpson Scott Lowe William Tansey Revealing insights into cancer biology with
Beckman Graduate Student tumor-derived mutations in c-Myc.
ENTERING CLASS OF 2005
Patrick M. Finigan Senthil K. Muthuswamy Bruce Stillman ORC1 degradation in the cell cycle.
Beckman Graduate Student
Amy Y. Leung David L. Spector William Tansey Role of H2B ubiquitylation in chromatin localization.
Beckman Graduate Student
Sarahjane M. Locke Josh Dubnau Robert Martienssen Histone H3 lysine 9 methylation and RNA
George A. and Marjorie H. Anderson Fellow processing in RNAi-mediated heterochromatin
formation in Schizosaccharomyces pombe.
Hiroshi Makino Hollis Cline Roberto Malinow Optical determination of the spatial distribution
Elisabeth Sloan Livingston Fellow of experience-dependent bidirectional
synaptic plasticity.
Katherine McJunkin Terri Grodzicker Scott Lowe Using negative-selection RNAi screens to identify
Robert and Teresa Lindsay Fellow novel treatment strategies for hepatocellular
carcinoma.
Frederick D. Rollins Jan A. Witkowski Gregory Hannon An RNAi screen for modifiers of cellular response
Cashin Fellow to the targeted therapeutic Erlotinib.
Oliver Tam David Jackson Gregory Hannon The role of RNAi machinery in oocyte maturation
Bristol-Myers Squibb Fellow and embryonic development of the mouse.
Jeremy E. Wilusz John R. Inglis David L. Spector Identification and functional characterization of
Beckman Graduate Student large nuclear retained noncoding RNAs
misregulated in breast cancer.
ENTERING CLASS OF 2006
Yaniv Erlich John R. Inglis Gregory Hannon microRNA target identification by systematic
Goldberg-Lindsay Fellow sensor expression.
Proposal Defense: February 2008
Eyal Gruntman Nicholas Tonks Robert Martienssen DNA methylation mutants in Arabidopsis thaliana
Elisabeth Sloan Livingston Fellow and their effect on whole-genome methylation
Proposal Defense: January 2008 patterns.
Colin Malone David J. Stewart Gregory Hannon Dissecting small RNA pathways in Drosophila.
Beckman Graduate Student
NSF Graduate Research Fellow
Proposal Defense: January 2008
Amy Rappaport William Tansey Scott Lowe Identification and characterization of tumor
Barbara McClintock Fellow suppressor genes in acute myeloid leukemia.
Proposal Defense: January 2008
Claudio Scuoppo Gregory Hannon Scott Lowe Identification of novel oncosuppressors through
Engelhorn Scholar an in vivo RNAi screen in the Eµ-Myc model.
Proposal Defense: February 2008
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are moving into faculty positions much faster than, on average, other new Ph.D.s. By December 2007,
25 students had completed our Ph.D. program. We are extremely proud of the fact that two of our 2004
WSBS graduates have assumed tenure-track faculty positions within 8 (Niraj Tolia) and 7 (Ira Hall) years
from matriculation—outstanding accomplishments and rare feats for most new Ph.D.s. Another 2004
WSBS graduate, Amy Caudy, holds an independent research position at the Lewis-Sigler Institute for Inte-
grative Genomics at Princeton University. Dr. Rebecca Ewald, 2006 WSBS graduate, assumed a posi-
tion in higher management with Roche Diagnostics in January 2008.
Although the short time span that has passed since most WSBS graduates received their degrees pro-
hibits any meaningful statistics, the striking successes of our graduates clearly show that the program is
living up to its promise and contributes extremely capable and productive individuals to science and aca-
demia worldwide.
Admissions 2007
The School received 243 applications for the 2007/2008 academic year and is deeply indebted to its
Admissions Committee, which reviewed, interviewed, and selected candidates for our doctoral program.
The Admissions Committee for the 2007 entering class comprised Gregory Hannon (Chair), Josh Dub-
nau, Leemor Joshua-Tor, Adrian R. Krainer, Robert Lucito, David L. Spector, Nicholas Tonks, Linda Van
Aelst, Anthony Zador, and William Tansey (ex officio)—a truly remarkable team!
Entering Class of 2007
On August 28, 2007, the Watson School opened its doors for the ninth time to welcome yet another new
class. This time, an unprecedented 14 students joined the School: Megan Bodnar, Ralph Burgess,
Joseph Calarco, Saya Ebbesen, Paloma Guzzardo, Kyle Honegger, Marek Kudla, Hassana Oyibo,
Michael Pautler, Maria Pineda, Yevgeniy (Eugene) Plavskin, Joshua Sanders, Zhenxun Wang, and Petr
Znamenskiy. Joseph, Paloma, and Marek previously participated in our summer undergraduate research
program, and Hassana and Joshua had worked several months in the labs of CSHL researchers Robert
Martienssen and Zachary Mainen, respectively.
Entering class of 2007 : (Back, left to right) Yevgeniy (Eugene) Plavskin, Zhenxun Wang, Kyle Honegger, Michael Pautler, Joseph (Joe)
Calarco, Petr Znamenskiy, Ralph Burgess, Marek Kudl a, Joshua Sanders. (Front, left to right) Paloma Guzzardo, Maria Pineda, Hassana
Oyibo, Megan Bodnar, Saya Ebbesen
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ENTERING CLASS OF 2007
Megan Bodnar, University of California,
Santa Barbara
Starr Centennial Scholar
Academic Mentor: Nicholas Tonks
Ralph Burgess, University College London
Starr Centennial Scholar
Academic Mentor: Gregory Hannon
Joseph Calarco, University of Toronto
David Koch Fellow
Academic Mentor: Senthil K. Muthuswamy
Saya Ebbesen, Oberlin College
Starr Centennial Scholar
Academic Mentor: David J. Stewart
Paloma Guzzardo, University of Puerto Rico
Leslie C. Quick Jr. Fellow
Academic Mentor: Adrian R. Krainer
Kyle Honegger, Northwestern University
Crick-Clay Fellow
Academic Mentor: John R. Inglis
Marek Kudła, Warsaw University
George A. and Marjorie H. Anderson Fellow
Academic Mentor: David Jackson
Hassana Oyibo, State College at
Farmingdale
Farish-Gerry Fellow
Academic Mentor: Hiro Furukawa
Michael Pautler, University of Guelph
William R. Miller Fellow
Academic Mentor: Robert Lucito
Maria Pineda, Barry University
Arnold and Mabel Beckman Graduate Student
Academic Mentor: Adrian R. Krainer
Yevgeniy (Eugene) Plavskin, Cornell
University
Alfred Hershey Fellow
Academic Mentor: Jan A. Witkowski
Joshua Sanders, Stony Brook University
Edward and Martha Gerry Fellow
Academic Mentor: Bruce Stillman
Zhenxun Wang, University of Wisconsin,
Madison
A*STAR Fellow
Academic Mentor: Alea A. Mills
Petr Znamenskiy, University of
Glasgow
David and Fanny Luke Fellow
Academic Mentor: Terri Grodzicker
Reflecting CSHL’s eclectic mix of nationalities, the entering class of 2007 is also quite international,
with students hailing from Canada, Columbia, Poland, Puerto Rico, Russia, Singapore, the United King-
dom, and the United States.
Academic Mentoring
The Watson School takes great pride in the level of mentoring that it offers its students. One of the very
special aspects in this regard is our two-tiered mentoring approach, whereby each student receives an
academic as well as a research mentor. Entering students select, by mutual agreement, a member of the
research or nonresearch faculty to serve as their academic mentor—a watchful guardian to look over and
encourage the student through the sometimes trying process of their doctoral education. This program
Entering class of 2007. Nothing builds team spirit better than a shared boat ride...
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continues to receive much support from the faculty who volunteer to be academic mentors, and it has
rightfully become a vital ingredient in our success.
The Fall Term Curriculum
Our faculty continues to do an outstanding job developing and delivering the curriculum. As ever, the Cur-
riculum Development and Integration Committee (CDIC) continues to carefully monitor and develop the cur-
riculum. With the changes to the School’s administration in the summer 2007, we also saw changes to the
CDICmembership: Adrian R. Krainer replacedWilliam Tansey as Chair, I replaced Lilian Clark, David L. Spec-
tor was replaced by David Jackson, and Z. Josh Huang and Nicholas Tonks were reappointed as members.
The fall 2007 Scientific Reasoning and Logic (SRL) core course, essentially unchanged from 2006, was
taught by Gregory Hannon (Lead Instructor), Leemor Joshua-Tor, David Jackson, Scott Lowe, Robert
Martienssen, and Glenn Turner, who replaced Anthony Zador.
The 2007 Scientific Exposition and Ethics (SEE) core course content remained essentially the same as it
was in 2006, but the structure of the instructor team changed: It was reduced from three faculty to two—
Jan A. Witkoswki as lead instructor and Alea A. Mills as instructor—and was supplemented by two post-
doctoral fellows, Danielle Irvin and William Keyes, as teaching assistants, a format our students have taken
to very well.
The content of the three Specialized Disciplines in Biology courses—Genetics and Cellular Structure
and Function, and Systems Neuroscience—has largely remained the same. Systems Neuroscience was
taught by its new lead instructor Anthony Zador, with guest lectures by CSHL faculty Drs. Brody, Cline,
Kepecs, Koulakov, and Malinow. Cellular Structure and Function will this time be offered as an intensive,
1-week course in the spring of 2008 to accommodate co-instructor Dr. Raffaella Sordella, who went on
maternity leave in fall 2007. Raffaella will teach this course with lead instructor Linda Van Aelst. Our
courses continue to attract outstanding external guest instructors:
Course Guest instructor Affiliation
SRL Thomas Clandinin Assistant Professor, Neurobiology, Stanford University
William C. Merrick Professor, Biochemistry, Case Western Reserve University
Charles J. Sherr HHMI Investigator and Herrick Foundation Chair, Genetics and
Tumor Cell Biology, St. Jude Children’s Research Hospital
Robert Tjian HHMI Investigator and Professor, Molecular and Cell Biology,
University of California, Berkeley
SEE Melissa S. Anderson Associate Professor and Director, Postsecondary Education
Research Institute, University of Minnesota
Katja Brose Editor, Neuron, Cambridge, Massachusetts
Maddy deLone The Innocence Project, New York
Nancy L. Jones Associate Professor, Center for Bioethics & Human Dignity,
Wake Forest University, North Carolina
Philip Reilly Chairman of the Board, Interleukin Genetics, Massachusetts
Michael Rogers Columnist, Practical Futurist, MSNBC, New York
SD-Genetics Charalambos Kyriacou Professor, Genetics, University of Leicester, U.K.
Trudy MacKay William Neal Reynolds Professor, Genetics, North Carolina State
University, Raleigh
Recruiting Efforts
Recruitment for the graduate program’s 2008 class and our URP 2008 was once again managed by
Ms. Dawn Meehan, the School’s Director for Admissions and Student Affairs. As in years past, Dawn trav-
eled the length and breadth of the country representing CSHL and the WSBS. The table starting on the
next page details recruitment fairs and conferences we have participated in, together with the names of
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2007 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Event Location Date WSBS representatives
Hunter College: Minority Access for Research CSHL January 17 Dr. Leemor Joshua-Tor, Professor and Dean
Careers Program Visit and Information Session Dawn Meehan, Director of Admissions and
Student Affairs
Dr. William Tansey, Professor
Dr. Anthony Zador, Professor
Wellesley College Women in Science Majors Fair Wellesley College February 14 Information sent for distribution
Ronald E. McNair Scholars Conference University of Maryland, College Park March 15–17 Dawn Meehan
Stony Brook University: Alliance for Graduate CSHL June 29 Dr. Josh Dubnau, Assistant Professor
Education and the Professoriate Visit and Dr. Leemor Joshua-Tor
Information Sessionr Dawn Meehan
The Protein Society 21st Annual Symposium Boston, Massachusetts July 22 Angélique Girard, Graduate Student
Graduate Program Fair
Wabash College: Information Session Wabash College August 30 Galen Collins, Graduate Student
XVII Undergraduate Research Symposium NSF/ Universidad Metropolitana, September 14–16 Dawn Meehan
UMET Model Institutions for Excellence Project San Juan, Puerto Rico
Hunter College: Minority Access for Research Hunter College September 19 Dr. Leemor Joshua-Tor
Careers Program Information Session Dawn Meehan
MIT Career Fair Massachusetts Institute of Technology September 20 Amy Rappaport, Graduate Student
MIT Information Session Massachusetts Institute of Technology September 21 Amy Rappaport
Big 10+ Graduate School Expo Purdue University September 24 Colin Malone, Graduate Student
Washington DC Area Universities: Graduate George Washington University September 24 Amy Leung, Graduate Student
School Fair
Pomona, Scripps, Harvey Mudd, Pitzer, and Pomona College September 24 Galen Collins
Claremont McKenna Colleges: Information
Session
Georgetown University: Information Session Georgetown University September 26 Amy Leung
The Johns Hopkins University: Information Session The Johns Hopkins University September 26 Jeremy Wilusz, Graduate Student
Notre Dame University: Information Session Notre Dame University September 26 Angélique Girard
Recruit in Canada Graduate School Fair Toronto, Canada September 30 Shraddha Pai, Graduate Student
Northwestern University: Information Session Northwestern University October 2 Dawn Meehan
Colgate University: Information Session Colgate University October 2 Dr. Robert Lucito, Assistant Professor
Cornell University: Information Session Cornell University October 2 Fred Rollins, Graduate Student
Amy Rappaport
The Chicago Graduate and Professional University of Illinois, Chicago October 2 Dawn Meehan
School Fair
Cornell University: Graduate and Professional Cornell University October 3 Frederick Rollins
School Day Amy Rappaport
University of California, Berkeley: Information University of California, Berkeley October 9 Colin Malone
Session
University of California, Berkeley: Graduate University of California, Berkeley October 10–11 Colin Malone
School Fair
Society for Advancement of Chicanos and Native Kansas City, Missouri October 11–14 Dr. Adrian R. Krainer, Professor
Americans in Science Dawn Meehan
University of Maryland, Baltimore County: University of Maryland, Baltimore County October 12 Keisha John, Graduate Student
Meyerhoff Scholarship Program Visit
Emory University: Information Session Emory University October 15 Dr. Uwe Hilgert, Assistant Dean
California Institute of Technology: Career Fair California Institute of Technology October 17 David Simpson, Graduate Student
Atlanta Universities Consortium: Graduate and Spellman College October 17 Dr. Uwe Hilgert
Professional School Information Day
University of California, Davis Graduate and University of California, Davis October 18 David Simpson
Professional School Day
Emory University Graduate School Fair Emory University October 18 Dr. Uwe Hilgert
Haverford College: Information Session Haverford College October 22 Patrick Finigan, Graduate Student
Swarthmore College: Information Session Swarthmore College October 23 Patrick Finigan
University of Pennsylvania: Information Session University of Pennsylvania October 23 Patrick Finigan
Tulane University: Graduate School Fair Tulane University October 24 Dr. Uwe Hilgert
Washington University, St. Louis: Information Washington University, St. Louis October 24 Dr. Leemor Joshua-Tor
Session
University of North Carolina, Chapel Hill: University of North Carolina, Chapel Hill October 25 Oliver Tam, Graduate Student
Information Session
University of California, Irvine Graduate and University of California, Irvine October 29 Angélique Girard
Professional School Day
Wesleyan University: Information Session Wesleyan University October 29 Dr. Uwe Hilgert
Sigma Xi Annual Conference and Research Orlando, Florida November 1–3 Dawn Meehan
Symposium
California Forum for Diversity in Graduate University of California, Davis November 3 Daniel Chitwood, Graduate Student
Education: Graduate School Fair
Yale University: Information Session Yale University November 5 Dr. Leemor Joshua-Tor
Dartmouth College: Information Session Dartmouth College November 6 Dr. Uwe Hilgert
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NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
Student CSHL research mentor Affiliation and program
An-Yun Chang Robert Martienssen Stony Brook, Molecular and Cellular Biology
Xin Feng Lincoln Stein Stony Brook, Biomedical Engineering
Jong Jin Han Robert Martienssen Stony Brook, Molecular and Cellular Biology
Nihan Kara Bruce Stillman Stony Brook, Molecular and Cellular Biology
Matthew Lazarus Z. Josh Huang Stony Brook, Neuroscience
Deepika Vasudevan Nicholas Tonks Stony Brook, Molecular and Cellular Biology
Assaf Vestin Alea A Mills Stony Brook, Molecular and Cellular Biology
Bin Xue Senthil K. Muthuswamy Stony Brook, Molecular and Cellular Biology
2007 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE (continued)
Event Location Date WSBS representatives
Princeton University: Information Session Princeton University November 8 Galen Collins
Annual Biomedical Research Conference for Austin, Texas November 8–11 Keisha John
Minority Students Dr. Adrian R. Krainer
Dawn Meehan
Princeton University: Graduate and Professional Princeton University November 9 Galen Collins
School Fair
Harvard University: Information Session Harvard University November 15 Dr. David Jackson, Professor
Vassar College: Genetics and Bioinformatics CSHL November 16 Dawn Meehan
Course Visit and Information Session Dr. Lincoln Stein, Professor
Dr. Doreen Ware, Adjunct Assistant Professor
National Autonomous University of Mexico: CSHL November 26 Dr. Leemor Joshua-Tor
Center for Genomic Sciences Undergraduate Dawn Meehan
Program Visit Dr. Bruce Stillman, CSHL President
Dr. Doreen Ware
Vanderbilt University: Information Session Vanderbilt University November 30 Dawn Meehan
Rice University: Information Session Rice University November 30 Information sent for presentation
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faculty, students, and administrators who represented WSBS on these occasions. To further raise aware-
ness of our programs, we also mailed more than 15,000 letters to colleges and universities in the United
States and abroad.
Interinstitutional Academic Interactions
It is important to bear in mind that many of the graduate students who pursue their thesis research at
CSHL are not in the WSBS graduate program. Indeed, the largest percentage of students are from Stony
Brook University (SBU) via a program established between CSHL and Stony Brook more than 30 years
ago. The WSBS provides an on-site “home” for these students, helps to ensure that they feel part of the
CSHL community, and assists them with the complexities of performing doctoral research away from their
parent institutions. This year, the students listed in the text box below joined us.
Graduate Student Seminar Series
A very important element of the graduate student experience at CSHL is the weekly Graduate Student
Seminar (GSS) series. These seminars are held from September through May and bring CSHL’s diverse,
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multi-institutional graduate student community together to hear seminars from their colleagues. In the
GSS, students present their research once a year, with two students presenting each week moderated
by a fellow graduate student as seminar chair. In attendance are also two faculty mentors who rotate
weekly.
The seminar series is open to the entire CSHL community and serves three important roles: (1) It gives
students an opportunity to hone their oral presentation skills; (2) it provides students an opportunity to
defend their research without the assistance of their research mentors such that they learn to stand on
their own two feet as they will have to throughout their careers; and (3) it provides students in the audi-
ence an opportunity to ask questions within their own peer group, thus learning the important roles of
audience participation for the advancement of research.
At the end of the evening, the attending faculty mentors provide presenting students a critique of their
presentation. In addition, audience members anonymously complete seminar evaluation forms, which are
given to the presenting students. In 2007, Josh Dubnau, Terri Grodzicker, Patrick Paddison, Arne Sten-
lund, Marja Timmermans, and Doreen Ware served as faculty mentors, bringing a breadth of knowledge
and experience to the seminar series.
Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also departures. The following graduate students and
postdoctoral fellows departed from the Laboratory during 2007:
Postdoctoral Fellows
Nobuki Aono Damien Garcia Hong Li Jorge Santos DaSilva
Alfonso Apicella Naria Gorovits Ping-I Lin Angshuman Sarkar
Jannic Boehm Michelle Hastings Albert Mellick Mayil Shanmugam
Jason Bohland Hongzhen He Yuriy Mishchenko Keishi Shintomi
Deirdre Buckley Lin He Amitabh Mohanty Philip Smith
Ingrid Bureau Shanta Hinton Tal Nawy Takuya Takahashi
Vincenzo DePaola Maarten Hoek Itay Onn Niraj Tolia
Ana Domingos Joseph Jun Hong Li Caroline van der Meijden
Dominik Duelli Prasanth Kumar Ping-I Lin Yalin Wang
Rebecca Ewald Kannanganattu Dhruv Pant Linda Wilbrecht
Tristan Fiedler Rotem Karni Antonella Piccini Min Yu
Andrea Gallavotti Alla Karpova Xinying Ren Chih-Chi Yuan
Rita Gandhi Charles Kopec Fabiola Rivas Xiaoyue Zhao
Supriya Gangadharan Byeong Ha Lee
Graduate Students
Darren Burgess Catherine Cormier Rebecca Kohnz Dougal (Gowan) Tervo
Cindy Chang Claudia Feierstein Shih-Chieh Lin Ruei-Ying Tzeng
Beth Chen Elvin Garcia Sabrina Nuñez Quan Wen
Wonchang Choi Adrienne Jones Stephanie Shaw Hong Zhao
Executive Committee
A large measure of the Watson School’s success can be traced to the sage advice, guidance, and gov-
ernance of the School’s Executive Committee. In 2007, as the new Dean, I replaced Lilian Clark as Com-
mittee Chair. David L. Spector, the new Director of Research, joined the Committee as ex officio member,
replacing Hollis Cline who left the Committee at the end of 2006. Assistant Dean Uwe Hilgert replaced
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William Tansey, previously Director of Graduate Studies, as ex officio member of the Committee. As hap-
pens each year, there was also turnover among the student representatives. WSBS representative David
Simpson was replaced by Eyal Gruntman. SBU representative Despina Siolas was replaced by Jane
Lee-Osborne. We are thankful for their honest and thoughtful advice. I wish to also thank faculty mem-
bers Terri Grodzicker, W. Richard McCombie, Alea A. Mills, Lincoln Stein, and Nicholas Tonks, all of whom
willingly and diligently give their advice and oversight and, in addition, who continue to serve on the Exec-
utive Committee.
External Advisory Committee
An outstanding External Advisory Committee (EAC) guides the School. This EAC consists of Dr. Keith
Yamamoto (Chair), Professor and Executive Vice Dean at the School of Medicine, University of Califor-
nia, San Francisco; Dr. Victor Corces, Professor, Department of Biology, Emory University, and Howard
Hughes Medical Institute (HHMI) Professor; Dr. Gail Mandel, Senior Scientist, Vollum Institute, Oregon
Health and Science University, and HMMI Investigator; Dr. Marguerite Mangin, Academic Programs Direc-
tor and Senior Research Associate, The Rockefeller University; Dr. Barbara Meyer, Professor of Genet-
ics and Development, University of California, Berkeley, and HHMI Investigator; and Dr. Frank Solomon,
Professor, Department of Biology and Center for Cancer Research, Massachusetts Institute of Technol-
ogy. The members of the Committee are noted for their leadership in graduate education in the biologi-
cal sciences and are recognized leaders in their fields of research. Although the EAC provided significant
input in 2007 to help guide the School through the restructuring of its leadership team, the Committee
did not meet in person. An on-campus EAC meeting is currently being organized for July 2008.
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher of
Molecular Biology of the Cell, who died of cancer in 1991) brings to CSHL an eminent researcher and
educator to give the Gavin Borden Lecture, which is dedicated to the graduate students at the labora-
tory. Dr. David Baker, Professor of Biochemistry at the University of Washington and HHMI Investigator,
was the 2007 Gavin Borden Fellow. His lecture “Prediction and Design of Macromolecular Structures and
Interactions“ was thoroughly enjoyed and evoked many questions from the audience. In addition, David
shared his experiences as a scientist during dinner as well as at a more structured roundtable discus-
sion with the students the following day.
Grants and Awards
Since 2002, WSBS has been the recipient of a Ruth L. Kirschstein National Research Service Award (also
known as Predoctoral Training Grant) from the National Institute of General Medical Sciences (NIGMS) at
the National Institutes of Health (NIH). Granted for 5 years, this award has funded up to five WSBS stu-
dents annually. In 2006, the School submitted a 323-page competitive renewal application for this grant,
requesting funding for six students. The evaluation process included a peer review and a site visit to the
School by a five-person team led by NIH Training Program Director Dr. Marion Zatz in fall 2006. Subse-
quently, our application received an outstanding Priority Score and, on June 18, 2007, we received the
fantastic news that the School had been granted an extension of its award for another 5 years.
Student Achievements
The WSBS students continue to impress us all with their accomplishments. They publish their research
findings in prestigious international journals and obtain fellowships to pursue their research interests. In
2007, Colin Malone received a Graduate Research Fellowship from the National Science Foundation.
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WSBS Family Events
Finally, I am pleased to announce that two WSBS students became parents and one was married: Beth
Chen (entering class of 2002) and her husband Pavel welcomed a son, Nicholas; Eyal (entering class of
2006) and his wife Naomi Gruntman welcomed son Jonathan; and Wei Wei (entering class of 2003) mar-
ried Peng Lui. Our congratulations and best wishes to all of them.
Leemor Joshua-Tor
Professor and Dean
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2007 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS
Aravin A.A., Sachidanandam R., Girard A., Fejes-Toth K., and Hannon G.J. 2007. Developmentally regulated piRNA clusters impli-
cate MILI in transposon control. Science 316: 744–747.
Bish R.A. and Myers M.P. 2007. Werner helicase-interacting protein 1 binds polyubiquitin via its zinc finger domain. J. Biol. Chem.
282: 23184–23193.
Brennecke J., Aravin A.A., Stark A., Dus M., Kellis M., Sachidanandam R., and Hannon G.J. 2007. Discrete small RNA-generat-
ing loci as master regulators of transposon activity in Drosophila. Cell 128: 1089–1103.
Brower-Toland B., Findley S.D., Jiang L., Liu L., Yin H., Dus M., Zhou P., Elgin S.C., and Lin H. 2007. Drosophila PIWI associates
with chromatin and interacts directly with HP1a. Genes Dev. 21: 2300–2311.
Carmell M.A., Girard A., van de Kant H.J.G., Bourc'his D., Bestor T.H., de Rooij D.G., and Hannon G.J. 2007. MIWI2 is essential
for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 12: 503–514.
Chitwood D.H. and Timmermans M.C.P. 2007. Target mimics modulate miRNAs. Nat. Genet. 39: 935–936.
Chitwood D.H., Guo M., Nogueira F.T.S., and Timmermans M.C.P. 2007. Establishing leaf polarity: The role of small RNAs and
positional signals in the shoot apex. Development 134: 813–823.
Dickins R.A., McJunkin K., Hernando E., Premsrirut P.K., Krizhanovsky V., Burgess D., Kim S.Y., Cordon-Cardo C., Zender L.,
Hannon G.J., and Lowe S.W. 2007. Tissue-specific and reversible RNA interference in transgenic mice. Nat. Genet. 39:
914–921.
Harvey C.D. and Svoboda K. 2007. Locally dynamic synaptic learning rules in pyramidal neuron dendrites. Nature 450:
1195–1200.
Houwing S., Kamminga L.M., Berezikov E., Cronembold D., Girard A., van den Elst H., Filippov D.V., Blaser H., Raz E., Moens
C.B., Plasterk R.H.A., Hannon G.J., Draper B.W., and Ketting R.F. 2007. A role for Piwi and piRNAs in germ cell maintenance
and transposon silencing in zebrafish. Cell 129: 69–82.
Hromádka T. and Zador A.M. 2007. Toward the mechanisms of auditory attention. Hear. Res. 229: 180–185.
Huber D., Petreanu L., Ghitani N., Ranade S., Hromádka T., Mainen Z., and Svoboda K. 2007. Sparse optical microstimulation
in barrel cortex drives learned behaviour in freely moving mice. Nature 451: 61–64.
Ibarra I., Erlich Y., Muthuswamy S.K., Sachidanandam R., and Hannon G.J. 2007. A role for microRNAs in maintenance of mouse
mammary epithelial progenitor cells. Genes Dev. 21: 3238–3243.
Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V.,Murchison E., Hannon G., and Abeliovich A. 2007. A microRNA feedback cir-
cuit in midbrain dopamine neurons. Science 317: 1220–1224.
Kopec C.D., Real E., Kessels H.W., and Malinow R. 2007. GluR1 links structural and functional plasticity at excitatory synapses.
J. Neurosci. 27: 13706–13718.
Kopec C.D., Kessels H.W.H.G., Bush D.E.A., Cain C.K., LeDoux J.E., and Malinow R. 2007. A robust automated method to ana-
lyze rodent motion during fear conditioning. Neuropharmacol. 52: 228–233.
Murchison E.P., Stein P., Xuan Z., Pan H., Zhang M.Q., Schultz R.M., and Hannon G.J. 2007. Critical roles for Dicer in the female
germline. Genes Dev. 21: 682–693.
Nogueira F.T.S., Madi S., Chitwood D.H., Juarez M.T., and Timmermans M.C.P. 2007. Two small regulatory RNAs establish
opposing fates of a developmental axis. Genes Dev. 21: 750–755.
Tervo D. and Karpova A.Y. 2007. Rapidly inducible, genetically targeted inactivation of neural and synaptic activity in vivo. Curr.
Opin. Neurobiol. 5: 581–586.
Vaughn M.W., Tanurdžic′ M., Lippman Z., Jiang H., Carrasquillo R., et al. 2007. Epigenetic natural variation in Arabidopsis thaliana.
PLoS Biol. 5: 1617–1629.
*Authors contributed equally to the work.
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SPRING CURRICULUM
Topics in Biology
ARRANGED BY Alyson Kass-Eisler and Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting Lectureship;
The Fairchild Martindale Visiting Lectureship; The Lucy and Mark Ptashne Visiting
Lectureship; The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference Center to
explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty. These
courses include morning or evening lectures as well as afternoon sessions during which students read
assigned papers. These intensive courses are modeled on the Cold Spring Harbor Laboratory Lecture
Courses held each summer at the Banbury Conference Center. In spring 2007, there were two such
courses: Fundamental Concepts in Statistics and Evolution.
Fundamental Concepts in Statistics
Attended by the entering classes of 2003 and 2004
INSTRUCTOR Martina Bremmer, Purdue University
GUEST LECTURERS Madhu Mazumdar, Weill Cornell Medical College
TEACHING FELLOWS Cherie Ochsenfeld, Purdue University
Gayla Olbricht, Purdue University
Statistics and mathematics have become an integral part of research in many areas of biology. New tech-
nology leads to large amounts of data produced in the fields of genomics, ecology and epidemiology. The
statistical methods required to analyze the data evolve
and adapt constantly with the changing demands.
However, the underlying principles of statistical analy-
sis remain the same.
This course focused on the fundamental statistical
concepts used in the analysis of biological data.
Emphasis was placed on statistical reasoning rather
than specific formulas and computations. However,
examples of statistical applications were discussed
and students were asked to apply the methods they
learned to real data sets using software. The major sta-
tistical concepts introduced in this course included
descriptive statistics, statistical inference, sampling
and sampling distributions, correlation, hypothesis
testing, experimental design, regression, and ANOVA.
The course integrated lectures by the instructor with
directed reading and interpretation of statistical analy-
ses in publications by the students. It was accompa-
nied by lab sections in which the students were
Statistics course participants: (Back row, left to right) François Bolduc,
Christopher Harvey, Daniel Chitwood, Cherie Ochsenfeld, Martina Bremer,
Gayla Olbricht, David Simpson, Galen Collins. (Front row, left to right) Mon-
ica Dus, Oliver Fregoso, Hiroki Asari, Keisha John, Wei Wei, Abhishek
Chakraborty, Rebecca Bish, Cindy Chang, Shraddha Pai, Angélique Girard
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instructed in conducting simple statistical analyses using software. In addition, invited speakers covered
special topics in the application of statistical methodology to the biological sciences. The course ran from
Sunday to Saturday, March 25–31, and was organized and largely taught by Martina Bremmer. This new
WSBS course was highly anticipated by the students who, overall, thought it was one of the most use-
ful and best organized courses they had taken.
Evolution
Attended by the entering classes of 2005 and 2006
INSTRUCTOR Nipam Patel, University of California, Berkeley
GUEST LECTURERS Casey Bergman, University of Manchester, U.K.
Rob DeSalle, American Museum of Natural History
John Flynn, American Museum of Natural History
TEACHING FELLOWS Philip Johnson, University of California, Berkeley
Brian Kraatz, University of California, Berkeley
Danielle Liubicich, University of California, Berkeley
The field of evolutionary biology touches upon all other areas of biological sciences, because every form
of life and every biological process represent an ongoing evolutionary “experiment.” Our aim in this course
was both to discuss our understanding of the mechanisms of evolution and to explore how evolutionary
data can be used to further our understanding of various biological problems.
The course began with a discussion of the diversity of organisms that currently exist and our meth-
ods for understanding the evolutionary relationships between these organisms. We then went on to study
how paleontological data are collected and used to understand the history of life on earth. We then exam-
ined how DNA sequence data can be used to understand the evolutionary history of organisms, genes,
and genomes. Within this molecular and genetic framework, our focus shifted to the mechanisms of
evolutionary change and how variation within populations leads to the evolution of new species. Finally,
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Evolution course participants: (Back row, left to right) Frederick Rollins, Amy Rappaport, Colin Malone, Adrienne Jones, Claire
Biot, Philip Johnson, Claudio Scuoppo, Eyal Gruntman, Hiroshi Makino, Jeremy Wilusz, Oliver Tam, Patrick Finigan, Yaniv
Erlich. (Front row, left to right) Brian Kraatz, Danielle Liubicich, Amy Leung, Katherine McJunkin, Sarahjane Locke, Nipam Patel
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we discussed how morphological changes are brought about through evolutionary changes in develop-
ment and gene regulation. The hope was that this course would provide the student with a general
overview of evolutionary biology and how to use evolutionary data to gain further insight into all manner
of biological problems. The course ran from Sunday, February 18, through Saturday, February 24. As in
previous years, the course was highly rated by all of the students.
Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Micklos
INSTRUCTORS Greg Chin (Lead, high school)
Amanda McBrien (Lead, middle school)
David Gundaker
Uwe Hilgert
Bruce Nash
Lauren Weidler
ADMINISTRATOR Carolyn Reid
As science plays an increasing part in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory’s Dolan DNA Learning Center,
where students teach laboratory courses to high school and middle school students. From these teach-
ing experiences, they learn how to communicate with nonbiologists and to inspire and educate creative
young minds. The teaching module entailed pairs of students teaching one morning or afternoon a week
for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the Watson School
students the didactic process—it was not until the fifth week that the graduate students taught on their
own. At the end of the 12 weeks, the students were very excited about their teaching experience.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in lab-
oratory rotations. These rotations provide students and faculty the opportunity to get to know one another
and to explore possibilities for doctoral thesis research. At the end of each rotation, students make short
presentations of their studies to the other students and their rotation advisors. These talks give students
an opportunity to share their laboratory experiences and to learn how to give a scientific presentation. With
this latter goal in mind, in addition to the research mentors, the instructors of the Scientific Exposition and
Ethics core course and members of the School’s Executive Committee attend the talks and give individual
feedback to students on their presentations. This year, 12 faculty members served as rotation mentors,
some mentoring more than one student.
ROTATION MENTORS Hollis Cline Ravi Sachidanandam
Josh Dubnau Raffaella Sordella
Gregory Hannon Lincoln Stein
Scott Lowe Glenn Turner
Robert Martienssen Linda Van Alest
Senthil K. Muthuswamy Anthony Zador
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FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation; The William Stamps Farish Lectureship
INSTRUCTORS Gregory Hannon (Lead)
David Jackson
Leemor Joshua-Tor
Scott Lowe
Robert Martienssen
Glenn Turner
GUEST LECTURERS Josh Dubnau Adrian R. Krainer
Eric Enemark Senthil K. Muthuswamy
Grigori Enikolopov Patrick Paddison
Hiro Furukawa Bruce Stillman
Adam Kepecs Anthony Zador
VISITING LECTURERS Thomas Clandinin, Stanford University
William Merrick, Case Western Reserve University
Charles Sherr, St. Jude Children’s Research Hospital
Robert Tjian, University of California, Berkeley
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the curriculum, students (1) acquired a broad base of knowledge about the bio-
logical sciences, (2) learned the scientific method, and (3) learned how to think critically. This course
consisted of six biweekly modules, each of which had a different theme. Each week, students read an
assigned set of research articles and, at the end of the module, provided written answers to a problem
set that guided them through several of the articles. Twice weekly, students attended lectures related to
the week’s topic that included concepts and fundamental information as well as experimental methods.
During each week, the students met among themselves to discuss the assigned papers not covered by
the problem set. Each week, students also spent one evening discussing the assigned articles with fac-
ulty. The last module, NIH Study Section, is unique in that the students assess proposed research that
has yet to be completed, rather than looking back on science that has already been done. The module
topics for this course were as follows:
Module 1 Gene Expression Module 4 Signaling in Development
Module 2 Cell Proliferation and Cancer Module 5 Neuroscience
Module 3 Macromolecular Structure and Function Module 6 NIH Study Section
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The Darrell Core Course on Scientific Exposition and Ethics
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation; The John P. and Rita M. Cleary Visiting
Lectureship; The Seraph Foundation Visiting Lectureship; The Susan T. and Charles
E. Harris Visiting Lectureship
INSTRUCTORS Jan A. Witkowski (Lead)
Alea A. Mills
TEACHING ASSISTANTS Danielle Irvine
William Keyes
GUEST LECTURER Walter Goldschmidts
VISITING LECTURERS Melissa Anderson, University of Minnesota
Katja Brose, Editor, Neuron
Maddy deLeone, The Innocence Project
Nancy Jones, Center for Bioethics & Human Dignity
Philip Reilly, Interleukin Genetics
Michael Rogers, The Practical Futurist, MSNBC
This core course offered instruction in the fundamental elements of scientific exposition—writing skills and
public speaking—and ethics. The ability to communicate effectively and to appreciate the intricacies of
ethical issues are essential skills for biologists. Both subjects were taught in a series of example-based
lectures and discussion groups. Writing skills included the fundamentals of modern scientific English
and the organization and preparation of papers, research abstracts, and grant applications. Oral pres-
entation skills were taught by instructors with different modes of presentation. Together with instructors,
students critiqued formal seminar presentations at the Laboratory. Instruction and discussions about
ethics included the ethical implications of biological discovery on society as well as the nature and bound-
aries of ethical behavior of scientists and their rights and responsibilities. A primary objective of the course
was that students consider exposition and ethics an integral part of scientific research.
Research Topics
ORGANIZERS Kimberley Geer
Alyson Kass-Eisler
This core course provided students with an in-depth introduction to the fields of research that the Lab-
oratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, at which
faculty members presented their current research topics and methods of investigation each Wednesday
evening over dinner. The students learned how to approach important problems in biology. These sem-
inars, together with the annual fall Laboratory In-House symposium, provided students with a basis for
selecting laboratories in which to do rotations. The weekly speakers were:
Hollis Cline Alexei Koulakov Partha Mitra Marja Timmermans
Josh Dubnau Adrian R. Krainer Senthil K. Muthuswamy Lloyd Trotman
Grigori Enikolopov Scott Lowe Scott Powers Glenn Turner
Hiro Furukawa Robert Lucito Jonathan Sebat Linda Van Aelst
Gregory Hannon Zachary Mainen Raffaella Sordella Doreen Ware
Z. Josh Huang Robert Martienssen David L. Spector Anthony Zador
David Jackson W. Richard McCombie Lincoln Stein Michael Q. Zhang
Leemor Joshua-Tor Alea A. Mills Arne Stenlund Yi Zhong
Adam Kepecs Vivek Mittal Bruce Stillman
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SPECIALIZED DISCIPLINES COURSES
This year, two of our Specialized Disciplines courses, Systems Neuroscience and Genetics, were held
in the fall. The third course, Cellular Structure and Function, will be taught in Spring 2008.
Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship; The Klingenstein Lectureship
INSTRUCTOR Anthony Zador (Lead)
GUEST INSTRUCTORS Carlos D. Brody
Hollis Cline
Adam Kepecs
Alexei Koulakov
Zachary Mainen
Roberto Malinow
This course introduced students to neuroscience, with a focus on learning and plasticity from its cellular
basis, through development, to systems and behavior. Both experimental and theoretical viewpoints were
explored. The course started with the basics of electrical signaling in neurons: ion channels, action poten-
tials, and synaptic transmission. The cellular basis of learning including Hebb’s postulates, LTP (long-term
synaptic potentiation) was discussed. The course explored the consequences of synaptic learning rules
by examining how experience shapes the wiring of the nervous system during development and investi-
gated how such building blocks translate into whole-organism behavior. The course then examined clas-
sical conditioning and asked how changes in synaptic transmission could underlie such behavior.
Associative learning computational models, of the learning process, were discussed as well.
From behaviors that focus on simple memories, the course turned to behaviors that require making
perceptual decisions. To do this, it covered some basic concepts of perceptual neuroscience, such as
neuronal “receptive fields,” and used these to discuss current results and models of perceptual decision-
making. Finally, the course turned to the learning of behaviors through reward and punishment, what is
known as reinforcement learning. The course concluded with a discussion of the role of dopamine in
reward and learning, the theory of reinforcement learning, and pathologies of reward-seeking behavior.
Genetics
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship; The Pfizer Lectureship; The George B.
Rathmann Lectureship; The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Josh Dubnau (Lead)
Lincoln Stein
VISITING LECTURERS Bambos Kyriacou, University of Leicester, U.K.
Trudy Mackay, North Carolina State University
In the past, “gene discovery” and association between gene and phenotype were accomplished in model
organisms. Our understanding of human disease then was advanced by identification of human
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orthologs associated with disease and by interventionist experiments using animal models of human
disease. The completion of the human genome sequence and the remarkable advances in molecular bio-
logical techniques have initiated a paradigm shift in genetics. Associations between gene variants and
disease now can be directly discovered in humans. Gene-to-phenotype functional associations can thus
be discovered in humans as well as in model organisms. Causal mechanistic relationships between
gene and phenotype can then be established using interventionist genetic experiments in animal mod-
els. This permits both a “vertical integration” to understand how molecular mechanisms influence func-
tional output across various levels of biological organization and a “horizontal integration” to understand
how genetic pathways have been conserved evolutionarily.
This course placed modern human genetics and genomics into the context of classical organismal
genetics. History, perspective, and technique were described around four levels of analysis: naturally
occurring variation, association studies, genome evolution, and genetic screens. How do gene mutations
help to define biological processes? How are more complex traits genetically dissected into simpler
(underlying) components? What concepts and techniques are used to organize genes into pathways and
networks? How are genes mapped, cloned, and engineered to identify functional domains of proteins?
What gene variation exists in natural populations? What are the functional consequences of gene vari-
ation? How is it detected? How are genomes organized and coordinately regulated? How can genomic
information be catalogued, organized, and mined? These questions and concepts were fleshed out
using examples from the literature.
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POSTDOCTORAL PROGRAM
Program Director Nicholas Tonks
Program Administrator Alyson Kass-Eisler
Cold Spring Harbor Laboratory (CSHL) is proud of its rich tradition in postdoctoral education and has a deep
commitment to the postdoctoral experience. CSHL has long been recognized as a place for nurturing young
scientists, with postdoctoral researchers being an integral part of the discovery process. The Laboratory cur-
rently employs approximately 140 postdoctoral fellows working in the laboratories of 40 principal investiga-
tors. Current fields of research expertise include genetics; molecular, cellular, and structural biology;
neuroscience; cancer; plant biology; and genomics and bioinformatics. The postdoctoral community at CSHL
is diverse and international, arriving at the Laboratory with many different backgrounds and with needs that
change during the course of the postdoctoral years.
To enhance the postdoctoral experience at CSHL, an office for postdoctoral education (the Postdoctoral Pro-
gram Office) was established within the WSBS to work closely with the postdoctoral fellows and the adminis-
tration to coordinate and organize educational and career development activities. The Office provides support
for current and arriving postdoctoral fellows as well as educational and career development programs. CSHL
has an active Postdoctoral Association, whose purpose is to represent the interests of the CSHL postdoctoral
community. In addition, the Postdoctoral Program Office also maintains a resource center containing career
information and job and fellowship opportunities; it organizes workshops and career development seminars, job
search forums, and grant-writing workshops and provides networking opportunities for postdoctoral fellows.
In 2007, there were significant changes to the WSBS administration. Dr. Lilian Clark, Dean since 2004, left
CSHL to direct the Science Operations and Funding of Cancer Research U.K., in London. In July 2007, Dr.
Leemor Joshua-Tor, a CSHL research faculty member since 1995, was appointed as Dean. Dr. Joshua-Tor
has participated in curriculum development, teaching, mentoring, and admissions since the School’s incep-
tion in 1999. In October 2007, Dr. Uwe Hilgert, who had been the Assistant Director of the Laboratory’s Dolan
DNA Learning Center, joined the WSBS as Assistant Dean. Drs. Joshua-Tor and Hilgert join Dr. Alyson Kass-
Eisler, the Postdoctoral ProgramOfficer, and Dr. Nicholas Tonks, the Scientific Director of the Postdoctoral Pro-
gram, who have been members of the administration since 2003.
Postdoctoral fellows are encouraged to participate in many of the Laboratory’s andWatson School’s activ-
ities, as they are an integral part of the community. The Dean hosts “Dean’s teas” with trainees who have
recently arrived at CSHL, with the goal of helping fellows make the most of their postdoctoral experience here
at CSHL. During these sessions, postdoctoral fellows are provided information on the services available
through the Postdoctoral Program Office and given copies of the excellent books by Kathy Barker, “At the
Bench: A Laboratory Navigator” and “At the Helm: A Laboratory Navigator,” published by Cold Spring Har-
bor Laboratory Press. In addition, Laboratory President, Dr. Bruce Stillman, holds a “Town Hall” meeting specif-
ically for postdoctoral fellows. This year’s Town Hall meeting took place on December 18, 2007. Among the
ideas that were discussed was the updating of the postdoctoral program Web site to enhance its usefulness
as a networking tool. Alyson Kass-Eisler will be working with a small committee of postdocs to put together
suggestions for the content and layout of this enhanced Web site.
In 2006, the Postdoctoral Program Office hosted a visit from Dr. Jing Li from the Merck Research Labora-
tories (MRL). CSHL has been a member of MRL’s Ambassador Recruitment Program since 2005. This pro-
gram provides the postdoctoral fellows and students at CSHL an inside connection to a scientist working at
MRL. As a result of this visit, three of the Laboratory’s trainees had their resumes submitted to the hiring man-
agers at MRL and a postdoctoral fellow from Dr. Bruce Stillman’s laboratory, Dr. Maarten Hoek, was hired as
a Research Scientist in the Apoptosis Research Group. On December 7, 2007, Dr. Li returned to the School
and 15 postdoctoral fellows discussed their career opportunities in one-on-one meetings with Dr. Li. We
expect that a number of candidates will be considered for employment at MRL again this year.
CSHL’s postdoctoral fellows have the opportunity to host an invited seminar speaker each year to partic-
ipate in the Thursday Seminar series. This speaker is chosen based on nominations from the postdoctoral fel-
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lows. The speaker for 2007 was Dr. Elizabeth Blackburn from the University of California, San Francisco. Dr.
Blackburn is a wonderful speaker, scientist, and role model and has won numerous awards for her work
including the 2006 Lasker Award. During her visit, Dr. Blackburn discussed new research developments in
telomerase biology and in the responses of cells and organisms to perturbations in telomere maintenance. She
also spent the day meeting with our postdoctoral fellows and faculty.
One of the nicest ways of exposing the Laboratory’s trainees to different career opportunities is by having
CSHL Alumni return to talk about their careers. This year, Dr. Alex Rai, a former graduate student with Dr.
David Helfman, came to discuss his training with the American Association of Clinical Chemistry and his cur-
rent position as an Assistant Attending at the Memorial Sloan-Kettering Cancer Center, Department of Clini-
cal Laboratories.
In 2007, the Laboratory also hosted a special seminar by Dr. Joan Steitz from Yale University and the
Howard Hughes Medical Institute entitled “Beyond Bias and Barriers: Fulfilling the Potential of Women in Sci-
ence.” This seminar was hosted by Dr. Michelle Hastings, a postdoctoral fellow in Adrian Krainer’s laboratory.
Dr. Joan Steitz is a member of the National Academy of Science and has been the recipient of many presti-
gious awards including the National Medal of Science and an honorary degree from our very own Watson
School of Biological Sciences
Since 2003, all postdoctoral fellows and graduate students at the Laboratory are being enrolled in the Sci-
ence Alliance of the New York Academy of Science (NYAS). The Science Alliance is a consortium of universi-
ties, teaching hospitals, and independent research facilities in the New York City metro area that have formed
a partnership with NYAS. The aim of the Alliance is to provide career and professional development monitor-
ing for postdoctoral fellows and graduate students in science and engineering, through a series of live events
and a dedicated Web portal. In addition, the Science Alliance gives graduate students and postdoctoral fel-
lows the opportunity to network with their peers across institutions and with key leaders in academia and
industry. Lori Conlan, Director of the Science Alliance, NYAS, visited the Laboratory to discuss “Navigating Your
Career Path“ and followed the seminar with a one-on-one curriculum vitae writing clinic for postdoctoral fel-
lows. Other Science Alliance programs this year included “From Idea to IPO: The Technology Venture Course,”
with Keynote Speaker David Anthony, Partner, 21 Ventures LLC; “Getting Started as a Successful Grant Writer
and Academician“ by Stephen W. Russell, D.V.M., Ph.D., Cofounder and Managing Member, Grant Writers’
Seminars and Workshops, LLC; “Professing Education“ with Keynote Speaker Sally Hoskins, City College of
New York; and “Writing for Scientific Publication” with David C. Morrison, Ph.D.; GrantsCentral.com; Emma
Hill, Journal of Cell Biology; Kalyani Narasimhan, Senior Editor at Nature; and John H.J. Petrini, Molecular
Biology Program at Sloan-Kettering Medical Institute.
Another program, entitled “What Can You Be with a Ph.D.?” has since 1996 connected postdoctoral
trainees with people who have discovered their own answer to that question. In 2007, the Science Alliance
along with Columbia and New York Universities expanded the program to a 2-day Career Convention, which
was attended and enjoyed by CSHL postdoctoral fellows.
In 2007, CSHL was extremely proud to be ranked in the Top 40 North American Institutes (#32), in The Sci-
entist’s annual survey of the “Best Places to Work: Postdoc.” Inclusion in this elite group of institutions required
positive feedback in the areas of Value of Postdoc Experience, Quality of Facilities and Infrastructure, Bene-
fits, Remuneration and Compensation, and Family and Personal Life. We hope to be included once again in
the 2008 survey, which is due out in March. In 2007, the WSBS also participated in the National Research
Council’s Assessment of Graduate Programs, which aims to provide a metric for comparing graduate pro-
grams in similar disciplines to each other. One component of this survey is the quality of the postdoctoral pro-
grams. We look forward to seeing the results of this survey, which will hopefully provide another measure of
the success of our program and for ways in which it can be improved.
Finally, the most telling measure of our postdoctoral program’s success is the ability of our postdoctoral fel-
lows to secure permanent positions at the end of their training. In 2007, the Laboratory’s departing postdoc-
toral fellows went on to positions at the Case Western Reserve University; Cell Press; The Chicago Medical
School; Florida Institute of Technology; INMED/INSERM, Marseilles, France; International Centre for Genetic
Engineering and Biotechnology, Trieste, Italy; Janelia Farm Research Campus; McKinsey & Co., Zurich Switzer-
land; Merck Research Laboratories; RIKEN, Japan; University of California, Berkeley; University of Illinois,
Urbana-Champaign; and Washington University, St. Louis, to name just a few.
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UNDERGRADUATE RESEARCH PROGRAM
Program Directors David Jackson
Lincoln Stein
Program Administrator Dawn Meehan
Every summer, approximately 25 undergraduates from around the world and across the country partic-
ipate in the CSHL summer Undergraduate Research Program (URP) to acquire a taste of original
research at the cutting edge of science. In 2007, 28 students participated in the URP, increasing the num-
ber of students who joined the program since its inception in 1959 to more than 700.
The fundamental objective of the program is to give students an opportunity to conduct first-rate
research. Participants learn about scientific reasoning, laboratory methods, theoretical principles, and sci-
entific communication. The specific objectives of the program are to (1) give college undergraduates a
taste of conducting original research at the cutting edge of science, (2) encourage awareness of the
physical and intellectual tools necessary for modern biological research, (3) foster an awareness of the
major questions currently under investigation in the biomedical and life sciences, and (4) promote inter-
actions with laboratory scientists through an immersion in the research environment.
During the 10-week program, URPs work with CSHL senior staff members on independent research
projects, specifically in the areas of cancer biology, neuroscience, plant biology, cellular and molecular
biology, genetics, macromolecular structure, and bioinformatics.
URPs work, live, eat, and play among CSHL scientists and have a very busy academic and social cal-
endar for the summer. They attend lectures in the Goldberg Faculty Lecture Series from CSHL and out-
side faculty members including, in 2007, talks by Dr. Stanley Maloy, San Diego State University, and Dr.
Peter Gergen, Stony Brook University. URPs also attend a seven-part Bioinformatics Workshop Series,
where they learn how to identify patterns in DNA and protein sequences and how to interpret them.
Lectures specifically designed for URPs were presented by CSHL faculty, including Dr. James Watson
(10 Rules for Science) and Dr. Jan Witkowski (Scientific Ethics). URPs were also invited to join Dr. and
Mrs. Watson for a pizza party and Dr. and Mrs. Stillman for dinner. BBQ and pool parties, volleyball
games, sailing lessons, designing the URP T-shirt, competing in the annual CSHL Plate Race and Scav-
enger Hunt, and the ever-famous URP versus PI volleyball match rounded out the engaging program.
As in the previous 47 years, URPs have yet to beat the CSHL PI team!
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2007 URPs wearing the T-shirt that won the URP T-Shirt Design Contest 2007: (Front row, left to right) Karla Claudio-Campos,
Lindsey Courtney, Rachel Sachs, Sarah Timm, Cindy Puente, John Xue. (Second row, left to right) John Angiolillo, Edith Davis,
Rebecca Krock, Christine Schenck, Christine Cho, Sarah Sansom, Erin Romberg, Kate Schmidt, Adrianna San Roman, Cher-
line Lee, Paul Wolski, Alison Spencer. (Third row, left to right) Matt Golub, Simon Quay, Ryon Graf, Vikram Agarwal, Andrew
Pao, Emily Combs, Alexander Korman, Josh Silverman
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Vikram Agarwal, University of Texas, Austin
Advisor: Dr. Lincoln Stein
Sponsor: National Science Foundation and Department
of Defense
Characterizing coverage and chromosomal rearrange-
ment in the Watson genome.
Jack Angiolillo, Amherst College
Advisor: Dr. Leemor Joshua-Tor
Sponsor: National Science Foundation and Department
of Defense
Attempting to crystallize and solve the structure for the
ORC 2-3 subcomplex.
Christine Cho, Brown University
Advisor: Dr. Josh Dubnau
Sponsor: National Science Foundation and Department
of Defense
microRNAs in memory: Characterization of miR276a
expression.
Karla Claudio-Campos, University of Puerto Rico,
Cayey
Advisor: Dr. Gregory Hannon
Sponsor: Howard Hughes Medical Institute
Devil facial tumor disease.
Emily Combs, Cornell University
Advisor: Dr. Doreen Ware
Sponsor: National Science Foundation and Department
of Defense
Validation of noncanonical introns in rice and a yeast one-
hybrid system in Arabidopsis thaliana.
Lindsey Courtney, Drury University
Advisor: Dr. Wolfgang Lukowitz
Sponsor: National Science Foundation and Department
of Defense
Exploring localization and complementation of the MAPK
pathway.
George Cutsail, University of Maryland, Baltimore
County
Advisor: Dr. Adrian R. Krainer
Sponsor: Libby Fellowship
The role of MNK2 isoforms in SF2/ASF-mediated trans-
formation.
Edith Davis, Wellesley College
Advisor: Dr. Gregory Hannon
Sponsor: Burroughs-Wellcome Fellowship
Identification of LATS-1 as a putative tumor suppressor
gene.
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Matt Golub, Stanford University
Advisor: Dr. Partha P. Mitra
Sponsor: National Science Foundation and Department
of Defense
The red-eye flight: Memory of a lifetime.
Ryon Graf, University of California, Irvine
Advisor: Dr. William Tansey
Sponsor: Emanuel Ax Fellowship
How to screen for genes that stabilize the proto-onco-
gene Myc.
Alexander Korman, University of Texas, Austin
Advisor: Dr. Yi Zhong
Sponsor: Garfield Fellowship
Pi3-kinase Akt1 pathway in Alzheimers flies.
Rebecca Krock, Washington University, St. Louis
Advisor: Dr. David L. Spector
Sponsor: H. Bentley Glass Fellowship
Gene localization with respect to transcriptional status.
Cherline Lee, Tuskegee University
Advisor: Dr. Bruce Stillman
Sponsor: William Townsend Porter Foundation
A screen for genes that suppress the pol30-8 silencing
defect.
Andrew Pao, The Johns Hopkins University
Advisor: Dr. W. Richard McCombie
Sponsor: Joan Redmond Read Fellowship
5′ ends of rice genome transcripts.
Cindy Puente, Hunter College
Advisor: Dr. Alea A. Mills
Sponsor: Hunter College Fellowship
Determining whether loss of heterozygozity of CHD5 is a
prerequisite for tumorigenesis.
Simon Quay, Whitman College
Advisor: Dr. Anthony Zador
Sponsor: National Science Foundation and Department
of Defense
The role of long-range callosal projections in the auditory
cortex.
Erin Romberg, Oberlin College
Advisor: Dr. Zachary Mainen
Sponsor: National Science Foundation and Department
of Defense
Uncertainty, decision-making, and orbitofrontal cortex.
At the beginning of the summer, each URP writes an abstract and presents a talk on his or her pro-
posed research. Concluding the program in August, all URPs prepare a final report and present their
results in 15-minute talks at the URP Symposium. The following 28 students, selected from over 800
applicants, took part in the 2007 program:
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Matthew Russell, University of California, San Diego
Advisor: Dr. Senthil K. Muthuswamy
Sponsor: Robert H.P. Olney Fellowship
Cell polarity and the initiation and progression of breast
carcinoma.
Rachel Sachs, Princeton University
Advisor: Dr. Alexei Koulakov
Sponsor: National Science Foundation and Department
of Defense
Application of the Watershed algorithm to spike sorting:
Error analysis and improvement.
Adrianna San Roman, Williams College
Advisor: Dr. David Jackson
Sponsor: National Science Foundation and Department
of Defense
Stop-and-go traffic: Regulating the gates of plasmodes-
mata.
Sarah Sansom, Ohio State University
Advisor: Dr. Marja Timmermans
Sponsor: Von Stade Fellowship
Understanding leaf polarity pathways.
Christine Schenck, Marist College
Advisor: Dr. Robert Lucito
Sponsor: William Shakespeare Fellowship
An investigation of histone modifications using ChIP-on-
chip.
Kathryn Schmidt, Yale University
Advisor: Dr. Linda Van Aelst
Sponsor: Steamboat Foundation
The role of the X-linked mental retardation protein
oligophrenin-1 in glutamate receptor signaling.
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Josh Silverman, Duke University
Advisor: Dr. Michael Q. Zhang
Sponsor: C. Bliss Memorial Fund
Novel miRNAs: Just a few clicks away.
Alison Spencer, University of Rochester
Advisor: Dr. Vivek Mittal
Sponsor: Former URP Fellowship
Identification and preliminary characterization of the vas-
cular endothelial growth factor receptor 2 expressing
cell in murine bone marrow.
Sarah Timm, Dickinson College
Advisor: Dr. Raffaella Sordella
Sponsor: David and Fanny Luke Fellowship
Non-small-cell lung cancer: Animal models and cancer
stem cells.
Paul Wolski, Cornell University
Advisor: Dr. Hiro Furukawa
Sponsor: Former URP Fellowship
Structural analysis of the NMDA receptor NR2D subunit
ligand-binding core.
John Xue, Cambridge University
Advisor: Dr. Robert Martienssen
Sponsor: Former URP Fellowship
The regulatory roles of ASYMMETRIC LEAVES1 and
putative RNA-dependent RNA polymerases in Ara-
bidopsis.
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PARTNERS FOR THE FUTURE
Program Director Yuri Lazebnik
Program Administrator Theresa Saia
The Partners for the Future Program, established by Dr. James Watson in 1990, provides an opportu-
nity for talented Long Island high school students to have hands-on experience in biomedical research
at Cold Spring Harbor Laboratory. This highly competitive program is open to Long Island high school
students in their junior year. Each high school science chairperson may nominate up to three students.
The top candidates are interviewed by CSHL scientists and up to ten top students are chosen to par-
ticipate in the program. Students selected to the program are paired with a scientist mentor and spend
a minimum of 10 hours per week, September through March of their senior year, conducting original
research. At the conclusion, the students present their projects to an enthusiastic audience of the stu-
dents’ scientific mentors and colleagues, CSHL administrators, parents, and teachers. Although the stu-
dents learn a great deal about modern biology and state-of-the-art research techniques, the main
advantage of the program is that they are exposed to day-to-day life in a lab. Interacting with scientists
and support staff, the students learn to define and pursue a research goal while solving problems that
may occur along the way.
We are proud to report that Catherine Schlingheyde, a Senior at Oyster Bay High School and a
2006/2007 Partners for the Future participant, won fourth place among 1705 entrants in the 2007
national competition of the Intel Science Talent Search. Catherine conducted the research for her proj-
ect on the workings of Argonaute, an important protein in the RNAi pathway, in the lab of Dr. Gregory
Hannon and received a $25,000 fellowship along with her prize. The 2007–2008 Partners for the
Future—chosen from among 23 nominations—are:
Partner High school CSHL mentor Laboratory
Kristen DePre Cold Spring Harbor High School Keith Slotkin Robert Martienssen
Madeleine Jensen Huntington High School Senthil K. Muthuswamy Senthil K. Muthuswamy
Bobby Klein Cold Spring Harbor High School Gidon Felsen Zachary Mainen
Katelyn Melgar North Shore High School Raffaella Sordella Raffaella Sordella
Daniel Minkin Portledge School Lakshmi Muthuswamy Michael Wigler
Damian Moskal Glen Cove High School Hsue-Cheng Chiang Yi Zhong
Sweta Sanghavi Floral Park Memorial High School Yoselin Benitez Alfonso David Jackson
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2007/2008 Partners for the Future participants: (Left to right) Madeleine Jensen, Sweta Sanghavi, Katelyn Melgar,
Kristen DePre, Bobby Klein, Damian Moskal, Daniel Minkin
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MEETINGS AND COURSES
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ACADEMIC AFFAIRS
The meetings and courses program at Cold Spring Harbor Laboratory communicates new discover-
ies, concepts, and methodologies to an international community of scientists. The program consists of
advanced laboratory and lecture courses, short courses at the Woodbury Genome Center, and large
meetings and biotechnology conferences that are held almost year round. More than 8000 scientists
ranging from graduate students and postdoctoral fellows to senior faculty come from around the world
to attend these events. A growing international program complements the main program of meetings
and courses.
In 2007, 27 laboratory and lecture courses covered a diverse array of topics in molecular biology,
neurobiology, structural studies, and bioinformatics. The primary aim of the courses is to teach stu-
dents the latest advances that can be immediately applied to their own research. Courses are always
being evaluated and updated to include the latest concepts and approaches. Increasingly, many cours-
es feature a strong computational component as biology grows ever more interdisciplinary, incorporat-
ing methodologies from computer science, physics, and mathematics. New Banbury cours-
es/workshops were started on Autism Spectrum Disorders and on Mechanisms of Alertness, Arousal,
and Attention. The course on Molecular Embryology of the Mouse celebrated 25 successful years with
a weekend reunion attended by many course alumni.
Instructors, course assistants, and course lecturers come from universities, medical schools,
research institutes, and companies around the world to teach at Cold Spring Harbor Laboratory. Their
excellence and dedication make the course program work so well. The full program of 2007 courses
and instructors are listed on the following pages. We would especially like to thank Drs. Greg Bashaw,
Mario De Bono, Abby Dernburg, Florian Engert, Tristan Fiedler, Janet Heasman, Mark Hubener, David
Kleinfeld, Lincoln Stein, Scott Waddell, and Christopher Wylie who all retired this year after many years
of service. We would also like to acknowledge the enormous teaching contributions of the late Dame
Anne McClaren, who taught and lectured in many of our courses, in particular the mouse course at
which she was a regular contributor almost every year since its inception in 1983.
Grants from a variety of sources support the courses. We were delighted to receive a significant
increase in our core course program grant from the Howard Hughes Medical Institute. The courses are
further supported by multiple awards from the National Institutes of Health (NIH) and the National
Science Foundation (NSF). The courses also depend on equipment and reagents that are loaned or
donated by a large number of companies. These are invaluable for making it possible to keep up with
the latest technologies.
The Laboratory held 24 meetings this year that brought together more than 7000 scientists from
around the world to discuss their latest research. New meetings on Computational Cell
Biology, Clinical Cardiovascular Genomics, and In Vivo Barriers to Gene Delivery, as well
as a workshop on Honey Bee Biology and Genomics, were held. A prime feature of the
meetings was that there were very few invited speakers. Meetings organizers selected
talks from abstracts that were submitted. This format ensured that the latest findings
were presented and that young scientists had the chance to describe their work.
The annual meetings on The Biology of Genomes and Retroviruses were oversub-
scribed, and many others attracted record attendances, including the meetings on
Systems Biology: Global Regulation of Gene Expression, Eukaryotic mRNA
Processing, and Neurobiology of Drosophila. Many of the meetings have become
essential for those in the field and are held on a biannual basis. Partial support for indi-
vidual meetings is provided by grants from NIH, NSF, foundations, and companies.
Core support for the meetings program is provided by the Laboratory’s Corporate
Patrons, Benefactors, Sponsors, Affiliates, and Contributors. Richard Treisman and Robert Tjian
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The Symposium—now in its 72nd year—continues to be the flagship conference of the meetings
program. This year’s meeting on Clocks and Rhythms addressed our current understanding of the
structure and function of biological clocks and rhythms and featured an opening workshop, 72 talks,
and 142 poster presentations. Opening night speakers included Joe Takahashi, Louis Ptác˘ek, Amita
Sehgal, and Ron Evans. Martin Raff presented the Reginald Harris lecture on “Intracellular timers in
oligodendrocyte precursor cells.” Charles Czeisler enlightened a mixed audience of scientists and lay
friends and neighbors with his Dorcas Cummings lecture on “Work hours, sleep and safety: Physician
heal thyself,” and Michael Menaker ended the meeting with a masterful and eloquent summary.
The joint Cold Spring Harbor Laboratory/Wellcome Trust conference series held at the genome cam-
pus south of Cambridge, England, included meetings on Interactome Networks, Integrative
Approaches to Brain Complexity, Functional Genomics and Systems Biology, and Pharmacogenomics.
These conferences follow the Cold Spring Harbor Laboratory model in that the majority of talks are
selected from the abstracts, and attracted 421 participants in total.
The success of the very large number of meetings and courses is also due to the skilled work of
many Laboratory staff and faculty who contribute their expertise, efforts, and good humor to the pro-
gram.
Terri Grodzicker
Assistant Director
Academic Affairs
David Stewart
Executive Director
Meetings and Courses Program
Bruce Stillman and Andrew Millar, Symposium speaker and
former URP participant
Dame Anne McLaren and Gillian Bates at the 25th
anniversary of the mouse course
Liz Murchison, Barbara Zane, and Andrew Mendelson
Terri Grozicker issuing the plate race rules
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The history of research into circadian rhythms can be traced back to the French astronomer Jean
Jacques Ortous de Mairan, who conducted experiments with plants grown in the dark in the early
1700s. His observations started a slow march joined by luminaries such as Carolus Linnaeus and
Charles Darwin interested in whether and how animals and plants measured time. The descriptive era
of circadian biology continued well into the latter half of the 20th century and was well summarized by
the last Symposium held on the topic in 1960, in which the opening address by Erwin Bunning con-
cluded that “thus far, however, such facts have not enabled us to draw far-reaching conclusions about
the nature of the [biological] clock.”
As with so many other disciplines in biology, the descriptive era has been revolutionized by the mol-
ecular era. Since the discovery and cloning of the first clock gene, period, more than 20 years ago,
tremendous progress has been made about the nature of the clock and how it functions in a wide vari-
ety of different plants and animals. Research previously limited to describing “the hands of the clock”
has been enormously successful in recent years in describing the inner anatomy and mechanism of the
clock in individual cells and in the whole organism.
Many in the chronobiology community are now, more than ever, attempting to place the molecular
and cellular details of the oscillatory machinery in the broader context of cellular physiology—for exam-
ple, the cell cycle—or organismal behaviors—for example, sleep and circadian behavior, and how these
may in turn be affected by the environment and/or disease. It is noteworthy that Christopher William
Hufeland wrote in his 1796 treatise The Art of Prolonging Life “The period of twenty-four hours formed
by the regular revolution of our Earth...is apparent in all diseases...it is, as it were, the unit of our natur-
al chronology.”
Our decision to focus the 72nd Symposium on circadian and related rhythms reflects the tremen-
dous advances molecular and cellular approaches have yielded thus far, a decision taken in part thanks
to an open letter from 18 prominent scientists in the field. The Symposium was arranged to cover a
range of themes associated with biological clocks and rhythms, ranging in scale from the molecular to
the whole organism, and addressed how aberrant function of the clock may have a causative role in
diverse human diseases and conditions. The Symposium provided a
unique synthesis of the exciting progress being made in the field of
chronobiology not only for the Symposia attendees, but also for a wider
global audience via interviews freely available on the World Wide Web and
through the Symposium proceedings.
In organizing this Symposium with considerable help from Terri
Grodzicker, we relied on the assistance of Steve Kay, Steve McKnight,
and Ueli Schibler, in particular, for suggestions for speakers. We also wish
to thank the first evening speakers, Joe Takahashi, Louis Ptác˘ek, Amita
Sehgal, and Ron Evans, for providing an overview of the areas to be cov-
ered. This year’s Reginald Harris Lecture was delivered by Martin Raff on
intracellular timers in oligodendrocyte precursor cells. We particularly wish
to thank Michael Menaker—one of three participants along with Patricia
DeCoursey and “Woody” Hastings, who attended both 1960 and 2007
72ND COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Clocks and Rhythms
May 30–June 4 316 participants
ARRANGED BY Bruce Stillman and David Stewart, Cold Spring Harbor Laboratory
U. Schibler, B. Stillman
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Symposia—for delivering a masterful and eloquent summary of the current state of the field, and to
Charles Czeisler who enlightened a mixed audience of scientists and lay friends and neighbors with his
Dorcas Cummings lecture on “Work hours, sleep, and safety: Physician heal thyself.”
This Symposium was attended by 316 scientists from more than 20 countries, and the program
included an opening introductory workshop, 72 oral presentations, and 142 poster presentations.
Essential funds to run this meeting were obtained from the National Institute of Neurological Disorders
and Stroke, a branch of the National Institutes of Health. In addition, financial help from the corporate
benefactors, sponsors, affiliates, and contributors of our meetings program is essential for these
Symposia to remain a success and we are most grateful for their continued support. Corporate Patrons
include Pfizer Inc. Corporate Benefactors include Amgen Inc.; GlaxoSmithKline; Merck Research
Laboratories; and Novartis Institutes for BioMedical Research. Corporate Sponsors include Abbott
Laboratories; Applied Biosystems; AstraZeneca; BioVentures, Inc.; Bristol-Myers Squibb Company;
Diagnostic Products Corporation; Forest Laboratories, Inc.; GE Healthcare Bio-Sciences; Genentech,
Inc.; Hoffman-La Roche Inc.; Johnson & Johnson Pharmaceutical Research & Development, LLC;
N. Kondo, P. DeCoursey
C. Czeisler, Dorcas Cummings Lecture
M. Rosbash, M. Raff
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Kyowa Hakko Kogyo Co., Ltd.; New England BioLabs, Inc.; OSI Pharmaceuticals, Inc.; Pall
Corporation; Sanofi-Aventis; and Schering-Plough Research Institute. Plant Corporate Associates
include ArborGen; Monsanto Company; and Pioneer Hi-Bred International, Inc. Corporate Affiliates
include Abcam Ltd.; Agilent Technologies; and USB Corporation. Corporate Contributors include Cell
Signaling Technology; Epicentre Biotechnologies; Hybrigenics, SA; Illumina; inGenious Targeting
Laboratory, Inc.; IRx Therapeutics, Inc.; and Millipore. Foundations include Albert B. Sabin Vaccine
Institute, Inc. and Hudson-Alpha Institute for Biotechnology.
C. Mahoney, A. Nikiforov
M. Macaluso, H. Wang
C. Jackson, S. Li
Symposium interviews
C. Green, M. Hastings, S. Golden
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Group Photo
Systems Approaches
Chairperson: U. Schibler, University of Geneva, Switzerland
Human Clocks and Rhythms
Chairperson: S. McKnight, University of Texas Southwestern
Medical Center, Dallas
Dorcas Cumming Lecture: Work Hours, Sleep, and
Safety: Physician Heal Thyself
C. Czeisler, Brigham and Women’s Hospital
Posttranscriptional and Posttranslational Mechanisms
Chairperson: M. Rosbash, HHMI/Brandeis University, Waltham,
Massachusetts
Seasons and Mood
Chairperson: P. DeCoursey, University of South Carolina,
Columbia
Models
Chairperson: M. Zatz, Journal of Biological Rhythms,
Bethesda, Maryland
Genetics of Rhythms
Chairperson: R. Silver, Columbia University, New York
Entrainment and Peripheral Clocks
Chairperson: J. Dunlap, Dartmouth Medical School, Hanover,
New Hampshire
Summary
M. Menaker, University of Virginia
PROGRAM
Symposium Workshop: Chronobiology Concepts and
Nomenclature
Part I: Molecular Basis of Rhythms Generation
S. Mackey, Texas A&M University
Part II: Neurophysiology of Pacemaker Function
S. Kuhlman, Cold Spring Harbor Laboratory
Part III: Sleep and Rhythms
J. Duffy, Harvard University
Introduction
S. Golden, Texas A&M University, College Station
Clockworks I/Lifespan
Chairperson: M. Young, HHMI/The Rockefeller University, New York
Neuroanatomy and Circuits
Chairperson: A. Sehgal, HHMI/University of Pennsylvania,
Philadelphia
Clockworks II and Proliferation
Chairperson: C. Green, University of Virginia, Charlottesville
Reginald B. Harris Lecture: Intracellular Timers in
Oligodendrocyte Precursor Cells
M. Raff, MRC Laboratory for Molecular Cell Biology and Cell
Biology Unit, University College London
Development and Aging
Chairperson: D. Bell-Pedersen, Texas A&M University, College
Station
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MEETINGS
Computational Cell Biology
March 6–9 162 participants
ARRANGED BY Thomas Pollard, Yale University
Les Loew, University of Connecticut Health Center
John Tyson, Virginia Polytechnic Institute & State University
The molecular pathways and networks that regulate many aspects of cell physiology are now known in
great detail, and they are so complex as to defy reliable understanding by informal, intuitive reasoning.
During the past 10 years, it has become clear that computer simulations based on realistic biophysical
models of regulatory networks can be useful in rationalizing diverse published observations and in guid-
ing new experimental studies. Success in this endeavor requires close collaboration among life scientists,
mathematical modelers, and computer scientists. In March 2001, Les Loew and his colleagues at the
University of Connecticut Health Center hosted the first multidiscipli-
nary workshop on Computational Cell Biology at the Cranwell Center
in Lenox, Massachusetts. The meeting was attended by an enthusias-
tic group of quantitative biochemists and cell biologists, modeling
experts, and software developers. The first meeting featured oral pre-
sentations and poster sessions that highlighted the interplay between
experiments and models and a unique afternoon session of software
demonstrations. By popular demand, the UConn group hosted two
more workshops, in 2003 and 2005. At the third meeting, a leadership
group was commissioned to find a more permanent “home” for the
meeting, with Cold Spring Harbor Lab identified as the first place to try.
When approached with this idea, David Stewart immediately gave his
full support and scheduled the first Computational Cell Biology Meeting
at Cold Spring Harbor in March 2007.
The 2007 meeting was organized by John Tyson, Les Loew, and Tom Pollard, assisted by a distin-
guished panel of session chairs. The format of the original workshops was maintained, including the
popular software demos, along with an emphasis on the most mature areas of the field (calcium sig-
naling, protein signaling networks, cytoskeleton and motility, development, bacterial physiology, cell
growth, division, and death). For oral presentations, the Lenox meetings had relied on invited talks by
established leaders in the field. For the CSH meeting, a decision was made to choose most oral pre-
sentations from abstracts submitted by registered participants. For such a young, evolving field of sci-
ence, this was a risky decision, but it proved to be a great success. Many young graduate students
and postdocs were given a chance to showcase their work before an interdisciplinary audience, and
they were successful in illustrating the power of a combined experimental-theoretical attack on out-
standing problems in cell biology. The quality of the poster session was also extremely high.
The meeting opened with a Keynote Address by Adam Arkin, who described his group’s novel
achievements in engineering the molecular regulatory networks of bacteria to desirable ends, such as
identifying, attacking, and killing tumor cells. These themes were taken up by young investigators (You,
Emonet, Weinberger, and Shou) who are building designer microorganisms.
Filling in at the last minute for a hospitalized Sydney Brenner, Tom Pollard gave the second Keynote
Address on cell motility and cell septation. The associated session included talks by Les Loew, who is
modeling Pollard’s ideas about actin dynamics; Julie Theriot, who is collaborating with Alex Mogilner
on cell shape and movement; and four young researchers (Civelekoglu, Needleman, Vavylonis, and
Sun), who are working on the mechanics of cell division. Protein signaling networks were covered by
T. Pollard, L. Loew, J. Tyson
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senior lecturers (Kholodenko and Sorkin) and junior scientists (Albert, Bakal, Bromberg, and
Kinkhabwala). Calcium signaling was covered by senior lecturers (Augustine, Ehrlich, and Smith) and
by a talented young African-American (Sherry-Ann Brown). Development was covered by senior lec-
turers (Reinitz and Shvartsman) and junior scientists (Umulis and Papatsenko). The cell cycle session
featured young investigators (Guang Yao on the G1-to-S transition in mammalian cells, and Joe
Pomerening, on the role of positive feedback in regulating mitosis in embryos and somatic cells) and
established investigators (Frank Uhlmann and Bela Novak on exit from mitosis in budding yeast). The
meeting ended on a somber note (cell death), featuring beautiful work on p53 signaling (Galit Lahav
and John Wagner) and caspase activation (John Albeck).
The uniformly high quality of the science reported at this meeting and the cooperative spirit of the
experimentalists, theoreticians, and computer scientists in attendance confirmed the decision of the
Cold Spring Harbor Meetings staff to welcome Computational Cell Biology into their regular meeting
schedule. The meeting will continue on its biennial schedule (March, 2009) for the indefinite future.
Quantitative measurements and realistic mathematical modeling are here to stay in molecular cell biol-
ogy, and this CSHL meeting promises to be a flagship venue for reporting the best developing work in
the field.
The meeting was well supported by a grant from the National Institutes of Health, through the
National Technology Center on Networks and Pathways at the University of Connecticut Health Center.
This support is sufficient for at least one more meeting on a similar scale.
S. Sreenath, C. Athale
PROGRAM
Keynote Address: Signaling, Uncertainty, and Design of
Natural and Artificial Cellular Systems
A. Arkin, University of California, Berkeley
Microbial Physiology
Chairpersons: A. Arkin, University of California, Berkeley; F.
Arnold, California Institute of Technology, Pasadena
Motility and Mitosis
Chairpersons: A. Mogilner, University of California, Davis; J.
Theriot, Stanford University School of Medicine, California
Development
Chairpersons: S. Shvartsman, Princeton University, New
Jersey; J. Reinitz, Stony Brook University, New York
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Keynote Address: The Comprehensive and the
Comprehensible
S. Brenner, Salk Institute of Biological Studies
Cell Signaling I
Chairperson: R. Iyengar, Mount Sinai School of Medicine,
New York
Cell Signaling II
Chairperson: B. Kholodenko, Thomas Jefferson University,
Philadelphia, Pennsylvania
Calcium Signaling
Chairpersons: G. Dupont, Université Libre de Bruxelles,
Belgium; B. Ehrlich, Yale University School of Medicine,
New Haven, Connecticut
Software Presentations
Chairpersons: R.D. Phair, Integrative Bioinformatics, Rockville,
Maryland; P. Mendes, Virginia Bioinformatics Institute,
Blacksburg
Cell Division Cycle
Chairperson: B. Novak, Budapest University of Technology &
Economics, Hungary
DNA Damage and Cell Death
Chairperson: Y. Lazebnik, Cold Spring Harbor Laboratory
A. Cowan, J. Wagner
C. Fall, I. Moraru
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Plant Genomes
March 15–18 137 participants
ARRANGED BY Steven Briggs, University of California, San Francisco
Gloria Coruzzi, New York University
Michael Snyder, Yale University
The theme of this meeting “From Sequence to Functional Networks” was meant to highlight how sys-
tems biology and network approaches have brought insights into genome function. The expertise of
the three coorganizers spanned the three major areas of the meeting: Plant Systems Biology (Coruzzi),
Genomics and Proteomics Technology (Snyder), and Translational Genomics (Briggs). A special orga-
nizational feature of the meeting was to include talks from nonplant model systems in order to stimu-
late cross-talk between plant and animal systems. This included inviting nonplant speakers as keynotes
and as lead speakers in most of the six sessions.
As systems and network approaches require advances in technology development and use, the
meeting also included a session on New Technologies (Computational and Experimental) and a work-
shop on Resources lead by Michael Snyder and Joe Ecker. The keynote talks spanned the three meet-
ing themes: Transcriptional networks (J. Chory); Use of proteomic technologies to biological discover-
ies (J. Yates); and Small RNA silencing networks (D. Balcombe). The talks by nonplant speakers
spanned these three broad themes as well: Developmental networks (S. Kim, Stanford; Aging in
humans); and TF-DNA and the Second genetic code (T. Hughes, Toronto); Proteomics and
metabolomics (M. Gerstein; Yale; Yeast protein networks), and Comparative genomics (K. Frazer;
Perlegen Sciences; SNPs and complex trait networks in mice).
A memorable highlight of the exchange between plant and animal systems included discussion of
Kim’s talk on aging in humans, in which Ian Sussex observed that as plants age vertically, they might be
more suitable for aging studies, where technical issues of comparing organs from individuals with differ-
ent genotypes would not be an issue. Advances in monitoring RNA and metabolites at the tissue and cel-
lular levels were highlighted in talks on gene networks in specific cell types (root, trichome, guard cells),
S. Briggs, J. Dangl, G. Coruzzi, D. Baulcombe
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and even spanned to ionomics where a new method ICP-MS was used to understand the tissue local-
ization of iron in plant seeds. Understanding gene network function was extended by comparative
genomic approaches in the important new area of natural variation. The New Technologies session includ-
ed bioinformatic and systems biology tools, including VirtualPlant, the Redundome, and Botany Array.
There was a high level of discussion and interaction at the meeting across species and systems, both dur-
ing the sessions and in informal interactions. The feedback on the meeting was that it was an excellent
mix of genomics and technology advancement and also an excellent opportunity for the plant genome
community to interact with the leaders of genomics and systems approaches in other model organisms.
This meeting was funded in part by the National Science Foundation.
PROGRAM
Keynote Speakers
J. Chory, Salk Institute for Biological Studies, La Jolla,
California
J.R. Yates, Scripps Research Institute, La Jolla, California
Networks I: Development
Chairperson: J. Chory, Salk Institute for Biological Studies, La
Jolla, California
Comparative Genomics
Chairperson: K. Frazer, Perlegen Sciences, Mountain View,
California
Networks II: Response to Environment
Chairperson: J. Dangl, University of North Carolina, Chapel Hill
Proteomics and Metabolomics
Chairperson: M.L. Guerinot, Dartmouth College, Hanover,
New Hampshire
New Technologies
Chairperson: K. Birnbaum, New York University, New York
Workshop: Resources
J. Ecker, Salk Institute for Biological Studies, La Jolla,
California
M. Snyder, Yale University, New Haven, Connecticut
Keynote Speaker
D. Baulcombe, Sainsbury Laboratory, John Innes Institute,
Norwich, U.K.
Translational Genomics
Chairperson: J. Leach, Colorado State University, Fort Collins
J. Willams
J. Yates III
M. Dunn, S. McDonald P. Rabinowicz, D. Jackson
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Imaging Neurons and Neural Activity: New Methods, New Results
March 22–25 198 participants
ARRANGED BY Atsushi Miyawaki, Riken Brain Science Institute
Joshua Sanes, Harvard University
Karel Svoboda, Janelia Farms, HHMI
This was the second time this conference was held; the first was in March, 2005. It focused
on imaging neuronal structure and function using a variety of advanced techniques, includ-
ing a wide range of light microscopy techniques, electron microscopy approaches, and
magnetic resonance imaging. The conference also explored emerging methodologies for
manipulating neuronal function with a particular emphasis on genetics and chemistry. This
unique forum was designed to stimulate future research studies in this important area and
to promote interactions among researchers in diverse basic scientific areas relevant to this
field.
Richard Axel delivered a fascinating Keynote Address on how he and his colleagues
have used genetically encoded probes of neuronal structure and function to learn about
olfactory processing in mice and Drosophila. Other talks were divided between those given
by invited speakers and those chosen from openly submitted abstracts.
Progress in the field was summarized in thoughtful concluding remarks by Karel
Svoboda. In all, this conference attracted 198 participants and 84 abstracts. Both oral and
poster presentations appear to include a substantial amount of unpublished work on the
frontier of neuronal imaging. Active interaction was achieved between neurobiologists and
chemists as well as between graduate students or postdocs and established scientists.
The general consensus of participants was that the meeting should be held again at Cold
Spring Harbor in 2009.
This meeting was funded in part with contributions from the Corporate Sponsors.
PROGRAM
Novel Photoactivation and Tagging Methods
Chairperson: R. Kramer, Columbia University, New York
Imaging of Neurons
Chairperson: H. Cline, Cold Spring Harbor Laboratory
Keynote Speaker
R. Axel, HHMI/Columbia University
Imaging of Neuronal Excitation and Signaling I
Chairperson: R. Friedrich, Friedrich-Miescher-Institute, Basel,
Switzerland
Imaging of Neuronal Excitation and Signaling II
Chairperson: R. Yuste, Columbia University, New York
Novel Methods to Dissect Neural Circuits
Chairperson: D. Chklovskii, Cold Spring Harbor Laboratory
LM (Superresolution)/EM
Chairperson: J. Sanes, Harvard University, Cambridge,
Massachusetts
K. Svoboda
J. Sanes
R. Yu, R. Axel
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Systems Biology: Global Regulation of Gene Expression
March 29–April 1 310 participants
ARRANGED BY Julia Bailey-Serres, University of California, Riverside
Nir Friedman, Hebrew University, Israel
Bing Ren, University of California, San Diego/Ludwig Institute for Cancer Research
Gene regulation coordinates complex metabolic and developmental programs of biological organisms.
The elucidation of distinct mechanisms of gene control is essential to the understanding of biological
processes from the single cell to organismal level. Recently, rapid progress has been made in applying
systems biology approaches to studies of gene regulation, and this
trend was clearly evident at this fifth meeting. The meeting was
marked by a record number of participants in its series and the high
quality of oral presentations and posters. The 3-day program cap-
tured recent advances in the knowledge of gene regulatory mecha-
nisms and in methods for collection and evaluation of the complex
data sets that capture the complexities of global gene regulation.
The opening session included a keynote presentation by a noted
interdisciplinary researcher, Uri Alon, who teases intricate networks
in cells down to simple terms with tools of theoretical physics and
experimental biology. The subsequent oral sessions were structured
to blend computational and experimental research that addresses
key issues in transcriptional and posttranscriptional regulation of
gene expression, including characterization of cis-regulatory ele-
ments in the genome, analysis of gene regulatory networks, quanti-
tative study of the dynamic transcriptional process in living cells, and systematic investigation of pro-
tein/RNA interactions.
This year’s meeting also featured a well-received session on the global regulation of gene expression
by microRNA (miRNA). Several talks exposed the importance of miRNA and other small noncoding RNAs
in regulation of gene expression at multiple levels, from modification of histone methylation status to
destabilization of transcripts to inhibition of mRNA translation. A session devoted to epigenetic regulation
of gene expression was another major new addition and the highlight of the meeting. Two short oral ses-
sions (four speakers) on Friday and Saturday after-
noons segued into a poster session. This year, a
best-poster prize was established for the first time
(thanks to the journal Genome Research) and was
awarded to Itai Yanai (Harvard), who presented a
study on comparative transcriptomics in C. ele-
gans and C. briggsae. Two preworkshop meet-
ings were held to benefit attendees who wished to
become more familiar with either computational or
experimental approaches in use to study global
gene expression networks.
This meeting was funded in part by the
National Science Foundation.
B. Ren, N. Friedman, J. Bailey-Serres
R. Kulkarni, L. Stubbs
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PROGRAM
Opening Session: Overture
Chairperson: N. Friedman, Hebrew University, Jerusalem,
Israel
Keynote Address: Simplicity in Biology
U. Alon, Weizmann Institute of Science, Rehovot, Israel
Genomic Regulatory Elements
Chairperson: D. Koller, Stanford University, California
Global Regulation by miRNA
Chairperson: S. Tenenbaum, State University of New York at
Albany
Transcriptional Regulatory Networks
Chairperson: M. Eisen, University of California, Berkeley
Evolution of Transcriptional Networks
Chairperson: M. Bulyk, Brigham and Women’s Hospital,
Harvard Medical School, Boston, Massachusetts
Dynamics—Gene Expression Analysis in Single Cells—
Change Over Different Timescales—Variation in
Expression in a Single Cell Type
Chairperson: J. Weissman, HHMI/University of California, San
Francisco
Posttranscriptional Processes
Chairperson: J. Bailey-Serres, University of California,
Riverside
Epigenetics and Transcription
Chairperson: B. Ren, Ludwig Institute for Cancer Research, La
Jolla, California
M. Eisen, M. Llinas
C. Herrmann, J. Reid, S. Aerts, A. Adler
C. Kuttler, F. Nielsen
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Synapses: From Molecules to Circuits and Behavior
April 18–22 148 participants
ARRANGED BY Hollis Cline, Cold Spring Harbor Laboratory
Richard L. Huganir, Johns Hopkins University School of Medicine/HHMI
Thomas Sudhof, University of Texas Southwestern Medical Center
The brain consists of a vast network of excitable cells (neurons) that conduct electrical impulses and com-
municate with each other via specialized junctions (synapses). Information is processed and stored in the
nervous system through patterns of electrical activity and via changes in the strength and structure of
synapses. All aspects of nervous system function, including perception, cognition, and action, depend on
proper information processing by synapses. As master regulators of neuronal
excitability and synaptic communication, ion channels and receptors lie at the
heart of neurobiology. In recent years, the molecular and cell biological analysis
of neuronal ion channels and receptors has revolutionized our understanding of
the basic mechanisms that control electrical signaling and synaptic function in the
nervous systems. The convergence of advances in biochemistry, molecular
genetics, microscopic imaging, and electrophysiology has made synaptic biolo-
gy one of the most exciting and rapidly growing in neuroscience. Increasingly, sci-
entists are moving to in vivo systems to investigate the synaptic basis of behav-
ior in living animals via the genetic engineering of channels, receptors, and other
synaptic proteins in mice and other model organisms.
The entire field is poised for further breakthroughs that will not only illuminate basic workings of the
brain, but also shed light on neurological and psychiatric diseases that stem from abnormal neuronal
excitability and synaptic dysfunction. Indeed, genetic association studies already point to genes for
synaptic structure and function as being involved in neuropsychiatric illnesses, in particular autism.
Future advances will be facilitated by cross-fertilization of ideas and technologies between scientists
studying channels, receptors, and synapses at all levels, in diverse organisms and using different
methodological approaches. To provide a forum that unites this exciting multidisciplinary area, the Cold
Spring Harbor Laboratory meeting on “Channels, Receptors, and Synapses” was renamed “Synapses:
From Molecules to Circuits and Behavior.”
The third “Synapses” meeting was very successful, bringing together participants from the United
States, Europe, and Asia in an atmosphere of social and scientific exchange. A wide range of topics
were discussed, including Modulation of channel and receptor function, Synapse formation,
Presynaptic function, Synaptic signaling mechanisms, Synaptic plasticity, Synaptic plasticity and devel-
R. Huganir, H. Cline
R. Zucker, S. SigristL. Jan, K. Shen
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opment, Synaptic plasticity and behavior, as well as Diseases of the synapse. Compared to earlier
meetings, the 2007 meeting emphasized the physiology and pathophysiology of synapses and the
behavioral and systems implications of their functions. More than 50 attendants were selected to give
oral presentations of their work and the majority of the rest presented posters. Outstanding plenary lec-
tures were given by Lily Jan and Catherine Dulac.
The overall response to the meeting was extremely positive, cementing the reputation of this Cold
Spring Harbor conference in the field. Attendees enjoyed the breadth of subjects covered and the
chance to interact with investigators in related but distinct fields. The unusual opportunity for junior
investigators (including postdocs and students) to present their own work was welcomed. However, at
the same time, it became clear that the field is in a state of change, a state that will be supported by
the changing nature of this meeting and will lead to more systems-oriented views. On the basis of its
continuing success, the “Channels, Receptors, and Synapses” conference will take place again in two
years (April 2009) with the same organizers.
This meeting was funded in part by the National Institute on Drug Abuse and the National Institute
of Mental Health, branches of the National Institutes of Health.
PROGRAM
Channel, Transporter, and Receptor Function
Chairpersons: D. Bergles, Johns Hopkins University School of
Medicine, Baltimore, Maryland; A. Triller, INSERM, Paris, France
Synaptic Function
Chairperson: C. McBain, NICHD, National Institutes of Health,
Baltimore, Maryland
Synapse Structure and Function
Chairpersons: C. Aoki, New York University, New York; M.
Ehlers, Duke University Medical Center, Durham, North
Carolina
Synapse Development
Chairpersons: A. Ghosh, University of California, San Diego;
Y. Jin, University of Calfiornia, San Diego
T. Sacktor, C. Powell
P. Shrestha, M. Nakajima S. Chatterjee, R. Chottekalapanda
Neuronal Plasticity
Chairpersons: R. Nicoll, University of California, San Francisco;
G. Turrigiano, Brandeis University, Waltham, Massachusetts
Keynote Speakers
C. Dulac, HHMI/Harvard University
L. Jan, HHMI/University of California, San Francisco
Synaptic Circuits
Chairpersons: W. Kristan, University of California, San Diego;
G. Turner, Cold Spring Harbor Laboratory
Synaptic Plasticity and Behavior
Chairpersons: R. Hen, Columbia University, New York;
M. Wilson, Massachusetts Institute of Technology,
Cambridge
Diseases of Synapses and Circuits
Chairpersons: M. Greenberg, Children’s Hospital, Boston,
Massachusetts; J. Shen, Brigham and Women’s Hospital,
Boston, Massachusetts
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The Ubiquitin Family
April 25–29 214 participants
ARRANGED BY Joan Conaway, Stowers Institute for Medical Research
Ray DeShaies, California Institute of Technology
J. Wade Harper, Harvard Medical School
This meeting represents the third Ubiquitin Family meeting following the successful inauguration of this
series in 2003. It focused on ubiquitin and a group of structurally related “ubiquitin-like” proteins and
their roles in regulation of various cellular processes. Major questions in the field include how specifici-
ty in ubiquitin and ubiquitin-like protein conjugation reactions is maintained and the molecular mecha-
nisms that are used to control the specificity of ubiquitin chain linkages. These questions are being ele-
gantly addressed using structural biology coupled with proteomics technology by an increasing num-
ber of investigators in the field. In addition, important advances continue to be made in understanding
how ubiquitin and its family members contribute to the operation of diverse cellular pathways, and how
these functions are perturbed in disease.
This year, the meeting attracted more than 212 scientists who engaged in lively discussions con-
cerning the role of ubiquitin in protein turnover, the structure and mechanism of a large multisubunit
protease called the proteasome that catalyzes the degradation of ubiquitinated proteins, and the
involvement of ubiquitin in signaling and membrane trafficking. A wide array of systems—including
yeast, C. elegans, and mammals—were used to probe the function of ubiquitin in diverse processes
ranging from control of mitosis to processing of unfolded proteins to development of neuronal connec-
tivity to control of mammalian circadian rhythms. In summary, this meeting has continued to be a uni-
fying forum that helps us understand the ever-growing roles of ubiquitin and ubiquitin-like proteins in
cellular physiology and disease.
This meeting was funded in part by the National Institutes of Health.
Y. Wan, W. Harper R. DeShaies, M. Solomon
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PROGRAM
UBL Conjugation, Removal, and Recognition I
Chairpersons: B. Schulman, St. Jude Children’s Research
Hospital, Memphis, Tennessee; D. Morgan, University of
California, San Francisco
UBL Conjugation, Removal, and Recognition II
Chairpersons: F. Melchior, University of Göttingen, Germany;
M. Peter, ETH Hönggerberg, Zürich, Switzerland
Nuclear Functions of UBL Proteins
Chairpersons: M. Dasso, NICHD, National Institutes of
Health, Bethesda, Maryland; A. D’Andrea, Dana-Farber
Cancer Institute, Harvard Medical School, Boston,
Massachusetts
Substrate Targeting and Degradation
Chairpersons: T. Baker, HHMI/Massachusetts Institute of
Technology, Cambridge; C. Hill, University of Utah,
Salt Lake City
Regulation of Intracellular Pathways
Chairpersons: K. Gould, HHMI/Vanderbilt University, Nashville,
Tennessee; P. Jackson, Genentech Inc., South San
Francisco, California
Quality Control
Chairpersons: K. Tanaka, Tokyo Metropolitan Institute of
Medical Science, Japan; J. Frydman, Stanford University,
California
UBLs in Signaling I
Chairpersons: P.P. DiFiore, FIRC Institute of Molecular
Oncology, Milano, Italy; I. Dikic, Goethe University Medical
School, Frankfurt, Germany
UBLs in Signaling II
Chairpersons: Z. Chen, HHMI/University of Texas
Southwestern Medical Center, Dallas; A. Bonni, Harvard
Medical School, Boston, Massachusetts
D. Germain-Desprez, M. Cohen Y. Yashiroda, T. Kinsako
B. Buschhorn, D. MorganD. Skowyra, S. Appikonda
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Telomeres and Telomerase
May 2–6 313 participants
ARRANGED BY Joachim Linger, Swiss Institute for Experimental Cancer Research
Vicki Lundblad, Salk Institute for Biological Studies
Dorothy Shippen, Texas A&M University
This conference consisted of eight sessions of talks and two poster sessions. As in 1999, 2001, 2003,
and 2005, the format was to invite two chairs per session, who were a mix of established scientists in
the field and younger scientists who had already made their mark by publishing as independent inves-
tigators. Many session chairs gave a scientific (12-min) presentation. The rest of the presentations (also
12-min) were chosen from submitted abstracts, allowing as many presentations as possible. These
presentations were primarily by graduate students and postdoctoral fellows. Attendance exceeded 300
participants, a high fraction of whom presented the 149 posters and 87 talks.
The talks and posters covered all aspects of telomere and telomerase biology, including telomerase
structure, enzymology, and regulation, telomere length regulation, protection and processing of chro-
mosome ends, the consequences of telomere dysfunction, telomere dynamics in cancer, and telom-
erase-independent telomere maintenance.
The scientific content was very high throughout the conference in both the talks and posters. A large
body of unpublished data was presented and extensively discussed in an open fashion. Formal and
informal discussions were lively and informative. The conference was judged to be highly successful
based on verbal and e-mail communications to the organizers. There is strong enthusiasm for anoth-
er meeting on the same topic in 2009.
This meeting was funded in part by the National Institute on Aging, a branch of the National
Institutes of Health.
E. Blackburn, C. Price, D. Shippen
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Telomerase Structure and Biochemistry
Chairpersons: T. Cech, HHMI/University of Colorado, Boulder;
C. Autexier, McGill University, Montreal, Canada
End Resection and Protection
Chairpersons: J. Karlseder, Salk Institute for Biological Studies,
La Jolla, California; E. Blackburn, University of California, San
Francisco
Telomeres and DNA Damage Sensing
Chairpersons: T. de Lange, The Rockefeller University, New
York; E. Gilson, Ecole Normale Supérieure, Lyon, France
Proteins Bound to Telomeric and Subtelomeric Chromatin
Chairpersons: F. Ishikawa, Kyoto University, Japan; D. Wuttke,
University of Colorado, Boulder
Telomere Length Regulation
Chairpersons: D. Shore, University of Geneva, Switzerland;
V. Zakian, Princeton University, New Jersey
Telomeres in Senescence, Proliferation, and Cancer
Chairpersons: J. Shay, University of Texas Southwestern
Medical Center, Dallas; S. Artandi, Stanford University
School of Medicine, California
Telomeres and Recombination
Chairpersons: R. Reddel, Children’s Medical Research
Institute, Westmead, Australia; M. McEachern, University of
Georgia, Athens
Consequences of Telomere Dysfunction
Chairpersons: J.P. Cooper, Cancer Research UK, London,
United Kingdom; C. Greider, Johns Hopkins University,
Baltimore, Maryland
Wine and cheese at Airslie
S. Heyn, K. Lisaingo S. Ahmed, C. Greider
T. Cech P. Lansdorp, C. Harley D. Shore, V. Zakian
245
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Workshop on Honey Bee Genomics and Biology
May 6–8 92 participants
ARRANGED BY Christine Elsik, Texas A&M University
Gene Robinson, University of Illinois, Urbana-Champaign
George Weinstock, Baylor College of Medicine
This meeting was well attended by researchers representing 13 countries. The workshop began with
keynote presentations by George Weinstock, William Gelbart, and Tom Seeley. They covered progress
in improving the honey bee genome sequence, insights from the
dozen Drosophila genome sequences, and an elegant behavioral dis-
section of colony decision-making in honey bee colonies, respective-
ly. Scientific sessions included Population genetics; Evolution and
comparative genomics; Neurobiology and behavior; Genomic tech-
nology and resources; and Caste, reproduction, aging, and immunity.
There were 29 papers presented during the sessions. A lively poster
session, containing 39 posters, was also held. A wrap-up session
included an exploration of “what now” and “what next” with plans to
hold subsequent meetings to build a strong honey bee genomics
community.
This meeting was funded in part by Roche, Inc. and 454 Life
Sciences, Inc.
G. Robinson, G. Weinstock
PROGRAM
Invited Speakers
G.M. Weinstock, Baylor College of Medicine
W.M. Gelbart, Harvard University
T. Seeley, Cornell University
Population Genetics
Chairpersons: R. Page, Arizona State University, Tempe; D.
Smith, University of Kansas, Lawrence
Evolution and Comparative Genomics
Chairpersons: S. Richards, Baylor College of Medicine,
Houston, Texas; H. Robertson, University of Illinois, Urbana-
Champaign
Neurobiology and Behavior
Chairpersons: C. Grozinger, North Carolina State University,
Raleigh; A. Mercer, University of Otago, Dunedin, New
Zealand
Genomic Technology and Resources
Chairpersons: R. Maleszka, Australian National University,
Canberra; D. Weaver, Bee Weaver Apiaries Inc., Narasota,
Texas
Caste, Reproduction, Aging, and Immunity
Chairpersons: M. Beye, Heinrich-Heine-Universität,
Düsseldorf, Germany; J. Evans, USDA-ARS, Beltsville,
Maryland
Concluding Remarks
G.E. Robinson, University of Illinois, Urbana-Champaign
J. Anzola, B. Scharlaken
J. Gadau, G. Bloch
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The Biology of Genomes
May 8–12 532 participants
ARRANGED BY Michael Ashburner, University of Cambridge
Kelly Frazer, Scripps Research Institute
Kerstin Lindblad-Toh, Broad Institute
Richard Wilson, Washington University
The annual Cold Spring Harbor Genome Sequencing and Biology meeting
marked the 18th annual gathering of genome scientists in this setting. The
past decade or more has seen remarkable progress in the mapping,
sequencing, and annotation of the genomes of many “model organisms”
and publication of finished and draft sequences of the human genome, in
addition to several model organisms and hundreds of bacteria. Just over
500 people from around the world attended the meeting, with more than
300 abstracts presented describing a broad array of topics relating to the
analysis of genomes from a number of different organisms.
The session topics included areas such as biological insights from
Genetics and genomics of nonhuman species, High-throughput genetics
and genomics, Cancer and functional genomics, Computational
genomics, Population genomic variation, Genetics of complex traits, and
Evolutionary genomics. There was considerable enthusiasm for the new
resequencing technologies that are becoming available and the science
that these technologies will enable. Dr. James Watson announced that his
genome had been sequenced completely and would be released in the
near future. The Friday afternoon keynote talks were delivered by Eddy
Rubin and Thomas Hudson.
The ELSI (Ethical, Legal, and Social Implications) panel chaired by
Francis Collins focused on ethical and social implications of research on natural selection in humans.
This meeting was funded in part by the National Human Genome Research Institute, a branch of
the National Institutes of Health; Roche, Inc.; and Solexa, Inc.
K. Frazer, H. Sussman
R. Durbin, E. Lander H. Peckham, F. De la Vega, M. Ashburner
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PROGRAM
Genetics and Genomics of Nonhuman Species
Chairpersons: D. Kingsley, HHMI/Stanford University,
California; G. Weinstock, Baylor College of Medicine,
Houston, Texas
High-throughput Genomics and Genetics
Chairpersons: E. Mardis, Washington University School of
Medicine, St. Louis, Missouri; M. Snyder, Yale University,
New Haven, Connecticut
Cancer and Functional Genomics
Chairpersons: A. Feinberg, Johns Hopkins University,
Baltimore, Maryland; M. Meyerson, Dana-Farber Cancer
Institute, Boston, Massachusetts
Computational Genomics
Chairpersons: R. Durbin, Sanger Institute, Hinxton, United
Kingdom; D. Haussler, University of California, Santa Cruz
ELSI Panel Discussion: Ethical and Social Implications
of Research on Natural Selection in Humans
Moderator: F. Collins, M.D., Ph.D., National Human
Genome Research Institute
W. Worley, J. Reecy, T. Hubbard J. McPherson, E. Mardis
H. Basta, M. McClure, J. Lyles C. Wade, C. Hitte
Panelists: P. Sabeti, M.D., Ph.D., Broad Institute,
Massachusetts Institute of Technology
S. Tishkoff, Ph.D., Department of Biology,
University of Maryland
M. Cho, Ph.D., Center for Biomedical
Ethics, Stanford University
Population Genomic Variation
Chairpersons: A. Clark, Cornell University, Ithaca, New York; P.
Sabeti, Broad Institute, Cambridge, Massachusetts
Genetics of Complex Traits
Chairpersons: G. Abecasis, University of Michigan, Ann Arbor;
P. Donnelly, University of Oxford, United Kingdom
Guest Speakers
E. Rubin, Joint Genome Institute, Lawrence Berkeley
National Laboratory
T. Hudson, Ontario Institute of Cancer Research
Evolutionary Genomics
Chairpersons: H. Robertson, University of Illinois, Urbana-
Champaign; J. Bennetzen, University of Georgia, Athens
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Phosphorylation, Signaling, and Disease
May 16–20 222 participants
ARRANGED BY Sara Courtneidge, The Burnham Institute
Ben Neel, Beth Israel Deaconess Medical Center
Nicholas Tonks, Cold Spring Harbor Laboratory
This seventh meeting brought together 222 scientists from the United States, Europe, the Far East, and
the South Pacific. Specifically focused on tyrosine phosphorylation in prior years, we expanded this
meeting to include the most current work on the structure, regulation, and function of all protein kinas-
es and protein phosphatases in biology. The meeting began with two opening Keynote Addresses by
Phil Cohen and Carol Greider.
The format of the meeting was designed around areas of biological interest, rather than according
to particular enzymes or enzyme families. A major thrust within the pharmaceutical industry is to exploit
signal transduction pathways as sources of targets for novel therapeutic strategies. Therefore, the pro-
gram for this meeting addressed the role of protein phosphorylation in the regulation of signal trans-
duction under normal and pathophysiological conditions.
The program included scientists from the United States, Europe, the Far East, and the South Pacific.
There were 51 speakers selected to present their data in sessions that dealt with Receptor-proximal
signaling; Physiology and disease; Cancer; Metabolic and stress signaling; Signaling pathways in sur-
vival and proliferation, and Model systems. The sessions were chaired by Deborah Morrison (National
Cancer Institute, Frederick, Maryland), Anjana Rao (Center for Blood Research, Harvard Medical
School, Boston), Gary Gilliland (HHMI/Brigham and Women’s Hospital, Boston), John Blenis (Harvard
Medical School, Boston), Roger Davis (HHMI/University of Massachusetts Medical School, Worcester),
Pier-Paolo Pandolfi (Memorial Sloan-Kettering Cancer Center, New York), and Alexandra Newton
(University of California, San Diego). A variety of systems were described with great progress reported
in genetic and biochemical approaches to the characterization of physiological functions for protein
phosphorylation.
The meeting was supported by grants from the National Cancer Institute, a branch of the National
Institutes of Health, and with contributions from the Corporate Sponsors.
N. Tonks, A. Newton P. Cohen, M. Arnone
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PROGRAM
Keynote Speakers
P. Cohen, University of Dundee
C. Greider, Johns Hopkins University School of Medicine
Receptor-proximal Signaling I
Chairperson: D. Morrison, National Cancer Institute, Frederick,
Maryland
Physiology and Disease
Chairperson: A. Rao, Center for Blood Research, Harvard
Medical School, Boston, Massachusetts
Cancer
Chairperson: G. Gilliland, HHMI/Brigham and Women’s
Hospital, Boston, Massachusetts
Metabolic and Stress Signaling
Chairperson: J. Blenis, Harvard Medical School, Boston,
Massachusetts
Signaling Pathways in Survival and Proliferation
Chairperson: R. Davis, HHMI/University of Massachusetts
Medical School, Worcester
Model Systems
Chairperson: P.-P. Pandolfi, Memorial Sloan-Kettering Cancer
Center, New York
Receptor-proximal Signaling II
Chairperson: A. Newton, University of California, San Diego
U. Guhe, J. Cho, S. Eminaga, J.-Z. Wu
B. Stronach, P. Marignani
K. Boyle, M. Hilger
J. Haley, S. Muthuswamy
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Retroviruses
May 22–27 489 participants
ARRANGED BY Thomas Hope, Northwestern University
Ned Landau, New York University
This conference was centered on recent advances in HIV/AIDS and other human and nonhuman retro-
viruses. Keynote Speakers Joe Sodroski and Bart Haynes presented engaging talks: Joe Sodroski
summarized the role of TRIM5α as an anti-HIV host factor. Dr. Sodroski identified TRIM5α as the major
factor that restricted HIV-1 replication in old world monkeys. Human TRIM5α does not restrict HIV-1,
but a point mutation that changes a single amino acid of the pro-
tein causes it to become a potent antiviral. This single amino acid
of TRIM5α has allowed HIV-1 to infect and spread in the human
population. At some point in human evolution, it is likely that indi-
viduals will be selected that have a mutation in TRIM5α that pro-
tects them and their offspring from becoming infected with HIV-1;
however, how long that will take is not known. Dr. Haynes is the
head of the NIH/Gates funded Center for HIV AIDS Vaccine
Initiative (CHAVI). He reviewed the origins of the consortium and its
current structure and operation as well as some of the findings that
it has made to date. These include a genome-wide scan for
human polymorphisms associated with resistance to AIDS. Two
loci were identified, one of which was a gene for a class I major his-
tocompatibility complex protein.
The more than 100 talks presented focused on all aspects of retrovirology. The host resistance fac-
tors TRIM5α and APOBEC3G were an area of notable research advances. The structure of the catalytic
domain of APOBEC3G was presented and several groups present-
ed their findings on its mechansim of inhibition. An unexpected role
for APOBEC3G in blocking reverse transcription was detected. A
fascinating study from Mike Emerman’s group investigated the role
of TRIM5α in preventing the infection of early humans about seven
million years ago with a nonhuman primate retrovirus. A nonfunc-
tional copy of the virus has been preserved in the chimpanzee
genome. A fragment of the virus was “brought back to life” by
putting it into a currently active retrovirus. The resulting virus was
susceptible to inhibition by human TRIM5α, suggesting that this
protein had protected early humans from becoming infected.
This was the first year of the annual Andy Kaplan prize that
commemorates Dr. Kaplan, a prominent AIDS researcher who
died last year. The prize was won by Sara Sawyer (Fred
Hutchinson) who showed that TRIM5α is one of the most highly selected genes in the human genome.
This gene is selected during evolution to have specific amino acid changes that allow TRIM5α to effec-
tively restrict the replication of retroviruses.
Another cellular gene, LEDG/F, was found to interact with the HIV integrase protein to direct inte-
gration of the viral DNA into transcriptionally active sites in the genome. Several talks probed the struc-
ture–function of the protein and knockout cells were generated and found not to support efficient inte-
gration of the virus.
Several talks focused on the Vpr accessory proteins of HIV-1. Vpr was shown to interact with a spe-
cific cellular E3 ubiquitin ligase that has a role in DNA replication and cell cycle control. Because of the
interaction, infected cells arrest in the G2 phase of the cell cycle.
T. Hope, D. Krementsov
K. Jones, N. Landau
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Other areas addressed included virus entry, assembly, reverse transcription, viral pathogenesis, and novel antivirals.
Frank Kirchhoff (Ulm, Germany) reported on the development of a novel peptide inhibitor of HIV-1 entry. Interestingly,
the peptide targets gp41 at its amino-terminal hydrophobic fusion peptide, a domain of the protein not previously
thought of as amenable to drug targeting.
Funding for this meeting was provided by the CSHL Corporate Sponsor program.
PROGRAM
Entry
Chairpersons: L. Albritton, University of Tennessee Health
Science Center, Memphis; J. Mak, Burnet Institute,
Melbourne, Australia
Assembly I
Chairpersons: M. Johnson, University of Missouri, Columbia;
K. Musier-Forsyth, Ohio State University, Columbus
Restriction Factors I (TRIM)
Chairpersons: C. Aiken, Vanderbilt University, Nashville,
Tennessee; W. Johnson, Harvard Medical School,
Southborough, Massachusetts
Keynote Speaker
B. Haynes, Duke University Medical Center
Assembly II
Chairpersons: J. Lingappa, University of Washington, Seattle;
M. Resh, Memorial Sloan-Kettering Cancer Center, New York
Integration
Chairpersons: S. Chow, University of California School of
Medicine, Los Angeles; A.M. Skalka, Fox Chase Cancer
Center, Philadelphia, Pennsylvania
Keynote Speaker
J. Sodroski, Dana-Farber Cancer Institute, Harvard Medical
School
RT/Antivirals
Chairpersons: M. Roth, UMDNJ–Robert Wood Johnson
Medical School, Piscataway, New Jersey; G. Tachedjian,
Burnet Institute, Melbourne, Australia
Pathogenesis
Chairpersons: J. Dudley, University of Texas, Austin; A.
Cimarelli, Ecole Normale Supérieure de Lyon, France
Restriction Factors II (APOBEC)
Chairpersons: X-F. Yu, Johns Hopkins University, Baltimore,
Maryland; V. Pathak, National Cancer Institute, Frederick,
Maryland
Accessory Proteins
Chairpersons: P. Cannon, Children’s Hospital Los Angeles,
California; C. de Noronha, Albany Medical College, New York
Transcription/Processing/Export/Translation/Packaging
Chairpersons: A. Rice, Baylor College of Medicine, Houston,
Texas; S. Carpenter, Washington State University, Pullman
S. Srivastava, S. Chakraborti
H. Taylor, L. Jones
R. Swanstrom, P. Jolicoeur
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Yeast Cell Biology
August 15–19 272 participants
ARRANGED BY Kerry Bloom, University of North Carolina, Chapel Hill
Peter Pryciak, University of Massachusetts Medical School
Lois Weisman, University of Michigan
This conference was the 12th biannual international meeting devoted to diverse aspects of cell biolo-
gy in yeast. This conference is unusual in that it encompasses a wide range of topics in cell biology but
is focused on a simple eukaryotic organism, the budding yeast Saccharomyces cere-
visiae, and includes other single-celled fungi such as Candida albicans, Pichia pastoris,
and Schizosaccharomyces pombe. This year, research advances were presented in ses-
sions organized around several major cell biological systems. New developments were
presented in the areas of the actin and microtubule cytoskeletons, membrane traffick-
ing, cell cycle and cell division, and signal transduction mechanisms. In addition, func-
tional genomics, proteomics, and bioinformatics were featured prominently, with remark-
able examples of using yeast to study genome-wide changes that accompany evolution.
It has become increasingly clear during the last several years that cell biological sys-
tems do not operate in isolation but are instead highly coordinated, and the mechanisms
of this coordination represent some of the most exciting research areas covered at the
meeting. These include the organization of membranous organelles by the cytoskeleton,
subcellular compartmentalization of cell cycle control proteins, regulation of cytoskeletal
organization by signal transduction pathways, and compartmentation within the nucle-
us. Complementing these integrative topics were new computational models for com-
plex molecular behavior, and new microscopic techniques for probing cell ultrastructure.
The result is that studies of yeast are approaching an unprecedented degree of sophis-
tication in the comprehensive, system-wide understanding of cellular function.
By virtue of a common interest in one organism, instead of one topic in cell biology,
the Yeast Cell Biology meeting continues to encourage extensive cross-fertilization of
ideas, insights, and methodologies, ultimately leading to an integrated view of eukaryot-
ic cell structure and function. Yeast remains an important testing ground for new tech-
K. Bloom
B. Andrews, K. Willis
L. Weisman
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nological developments and conceptual advances in biomedical sciences. Presentations at the 2007
meeting made clear that yeast will remain at the forefront of model systems and will advance our under-
standing of eukaryotic cell biology for many years. In summary, this was an exciting and memorable
meeting with attendees presenting some 225 scientific reports in 82 talks and 143 posters.
Funding for the meeting was provided by the CSHL Corporate Sponsor program.
PROGRAM
Chromosomes and Kinetochores
Chairperson: R. Rothstein, Columbia University Medical
Center, New York
Cell Cycle and Division
Chairperson: M. Segal, University of Cambridge, United
Kingdom
Trafficking
Chairperson: B. Wendland, Johns Hopkins University,
Baltimore, Maryland
Cytoskeleton
Chairperson: J. Vogel, McGill University, Montreal, Canada
Polarity and Morphogenesis
Chairperson: R. Miller, University of Rochester, New York
Physiology and Genomics
Chairperson: D. Botstein, Princeton University, New Jersey
Organelle Biology
Chairperson: D. Amberg, SUNY Upstate Medical University,
Syracuse
Signaling
Chairperson: J. Thorner, University of California, Berkeley
R. Strich, F. Luca
B. Vincent, R. Nash
E. Hong, J.M. Cherry, J. Park
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Eukaroytic mRNA Processing
August 22–26 339 participants
ARRANGED BY Douglas Black, HHMI/University of California, Los Angeles
Timothy Nilsen, Case Western Reserve University
Joan Steitz, Yale University School of Medicine
This sixth meeting was arranged to present and discuss recent developments in mRNA metabolism.
As in the past, regulated and alternative pre-mRNA splicing was a particular focus, as was the splicing
mechanism. Additional areas included mRNA quality control and decay, mRNA trafficking, and 3′-end
formation. Additional sessions covered computation analyses and genome-wide approaches and also
the coupling of RNA processing to transcription and export.
In splicing regulation, there has been significant progress in deciphering the detailed regulatory
mechanisms, as well as the biological roles of particular factors and splice variants. Individual groups
have identified specific points in the spliceosome assembly pathway affected by particular factors.
Another important trend that was touched on by a number of talks was new analytical methods by
microarray and high-density sequencing that allow assessment of global changes in splicing. Finally,
several talks examined the roles of splicing regulators in human disease and the development of splic-
ing targeted therapeutics.
In the splicing mechanisms, several talks illuminated new proofreading mechanisms that function at
the 5′ and 3′ splice sites. Other results indicated that different introns show differential dependence on
constitutive splicing factors. Several talks examined the conforma-
tional changes occurring during the catalytic cycle of the spliceo-
some and the role of the RNA components of the spliceosome in
catalysis. Important progress was also presented in structural stud-
ies of the different spliceosomal complexes. Several presentations
on 3′-end formation focused on links between polyadenylation and
transcription and quality control. Progress was described in charac-
terizing the structure of the cleavage and polyadenylation complex
and its individual components. Other talks examined the regulation
of these processes by specific factors.
Talks in the RNA trafficking session examined factors involved in
nuclear export of mRNAs. Other presentations described the local-
ization of mRNAs in the cytoplasm and their stabilization and trans-
lational regulation. Another focus was the modification of RNA-bind- J. Steitz, T. Nilsen, D. Black
C. Ortuno, J. Valdes, E. Garbarino-Pico
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ing proteins and their cross-regulation of each other. In terms of
surveillance and decay, significant progress was presented in
understanding the role of the exon junction complex and its
effects on translation and mRNA decay. Systems of inducing
decay in specific sets of mRNAs or other RNAs were dis-
cussed. The control of deadenylation and hyperadenylation
was another focus. Finally, several studies examined the cou-
pling of transcription to RNA decay pathways.
This meeting was funded in part by the National Cancer
Institute and the National Institute of Child Health and Human
Development branches of the National Institutes of Health, and
by the National Science Foundation. The Laboratory would in
addition like to thank the RNA Society for its support of this
meeting.
PROGRAM
RNA Transport and Localization
Chairperson: K. Weis, University of California, Berkeley
Regulation of Alternative RNA Processing Patterns I
Chairperson: K. Lynch, University of Texas Southwestern
Medical Center, Dallas
Global and Genome-wide Approaches to mRNA
Processing Analysis
Chairperson: C. Burge, Massachusetts Institute of Technology,
Cambridge
Splicing Mechanisms
Chairperson: C. Query, Albert Einstein College of Medicine,
Bronx, New York
RNA Decay and RNA Surveillance
Chairperson: J. Lykke-Andersen, University of Colorado,
Boulder
Special Lecture: Women In Science
J. Steitz, Yale University School of Medicine
Coupling of RNA Processing to Transcription
Chairperson: A. Kornblihtt, University of Buenos Aires,
Argentina
Regulation of Alternative RNA Processing Patterns II
Chairperson: J. Caceres, MRC Human Genetics Unit,
Edinburgh, United Kingdom
3′-end Maturation
Chairperson: C. Moore, Tufts University School of Medicine,
Boston, Massachusetts
H. Loza-Tavera, V. Portnoy
N.-C. Lau, R. Rounbehler
J. Potashkin, A. Krainer
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Mechanisms of Eukaryotic Transcription
August 29–September 2 388 participants
ARRANGED BY Barbara Graves, Huntsman Cancer Institute, University of Utah
Steven Hahn, Fred Hutchinson Cancer Research Center
Jerry Workman, Stowers Institute for Medical Research
Regulation of gene transcription has a central role in the growth and development
of eukaryotic organisms. Transcriptional responses occur as a consequence of
cell signaling, environmental stresses, and developmental cues. Thus, the field of
transcription encompasses a broad range of study from structural biology to
developmental biology. This meeting appropriately covered all aspects of eukary-
otic transcription and brought together a diverse group of scientists. This tenth
meeting on this topic consisted of eight plenary sessions and two poster sessions.
The meeting began with a new session entitled “Genomics” that covered the
wide range of mechanistic questions now being addressed at a genome-wide
level. Next, a session focused on the mechanisms surrounding “Initiation and acti-
vation.” A “Regulatory mechanism” session included nonconventional regulation of
gene expression through microRNAs, variant histones, and nonpolymerase II examples. A session
on “Elongation and termination” dramatically showed that regulation occurs beyond the transcrip-
tion initiation step. Large multiprotein complexes that function in activation and chromatin remodel-
ing were covered in two sessions. A “Signaling” session discussed the connections between DNA
binding transcription factors and signal transduction pathways. A final session presented research
using whole organisms to understand the use of a transcriptional mechanism for biological mecha-
nisms in development and disease. The role of the plethora of histone marks was sprinkled through-
out the sessions. The meeting was well-received by the participants and will occur again in 2009.
The meeting was funded in part by grants from the National Institutes of Health and the
National Science Foundation.
PROGRAM
Genomics
Chairperson: J. Lis, Cornell University, Ithaca, New York
Initiation–Activation
Chairperson: C. Wolberger, HHMI/Johns Hopkins University
School of Medicine, Baltimore, Maryland
Regulatory Mechanisms
Chairperson: H. Stunnenberg, NCMLS, Radboud University,
Nijmegen, The Netherlands
Elongation–Termination
Chairperson: J. Tyler, University of Colorado Health Science
Center, Aurora
Regulatory Complexes
Chairperson: M. Carey, University of California School of
Medicine, Los Angeles
Chromatin-histone Modification
Chairperson: R. Kingston, Massachusetts General Hospital,
Harvard Medical School, Boston
Signaling
Chairperson: M. Levine, University of California, Berkeley
Developmental Mechanisms
Chairperson: L. Tora, IGMBC, Illkirch, France K. Yamamoto, S. Block
J. Workman, K. Zaret
B. Graves
S. Hahn, J. Tyler
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CSHL/WELLCOME TRUST CONFERENCES
These conferences were held at the Hinxton Hall Conference Centre, located several miles south of
Cambridge in the United Kingdom, which forms part of the Wellcome Trust Genome Campus, together with
the Sanger Institute, and the European Bioinformatics Institute. The conferences are managed jointly by Cold
Spring Harbor Laboratory and the Wellcome Trust and follow the Cold Spring Harbor style in that the major-
ity of talks are chosen from openly submitted abstracts. The topics of the joint conference series emphasize
genomics and bioinformatics, or topics of particular interest to science in the United Kingdom or Europe.
Interactome Networks
August 29–September 3 92 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Anne-Claude Gavin, European Molecular Biology Laboratory
Marc Vidal, Dana-Farber Cancer Institute/Harvard Medical School
This third conference was held at the Wellcome Trust Genome Campus in Hinxton, United Kingdom
and attracted an audience of senior and junior investigators, postdoctoral, and (post) graduate
researchers in a range of disciplines who sought to share existing research and experience. The con-
ference addressed topics including ORFeome and other clone resources, Y2H and other binary assay
maps; pull-down mass spectrometry approaches; orthogonal binary assays; assembly/annotation:
integration with phenotypic, transcriptome and localization clustering data; domain-domain networks;
and interaction-defective genetics. Keynote Speakers were Wolfgang Baumeister and Ed Harlow.
PROGRAM
Cocomplex Mapping I
Chairperson: M. Vidal, Center for Cancer Systems Biology,
Dana-Farber Cancer Institute, Harvard Medical School,
Boston, Massachusetts
Keynote Address: Mapping Molecular Landscapes
Inside Cells by Cryoelectron Tomography
W. Baumeister, Max-Planck-Institute for Biochemistry
Binary Mapping
Chairperson: A.-C. Gavin, European Molecular Biology
Laboratory, Heidelberg, Germany
Cocomplex Mapping II
Chairperson: C. Sanderson, University of Liverpool, United
Kingdom
Combining Networks
Chairperson: T. Davis, University of Washington, Seattle
Network Components/Interactome Modeling I
Chairperson: F. Roth, Harvard Medical School, Boston,
Massachusetts
Interactome Modeling II
Chairperson: S. Wodak, Hospital for Sick Children, Toronto,
Canada
Interactome Modeling III
Chairperson: S. Wodak, Hospital for Sick Children, Toronto,
Canada
Keynote Speaker
E. Harlow, Harvard Medical School
Aerial view over the Francis Crick Auditorium and the Genome Campus.
Sanger Institute visible in background.
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Integrative Approaches to Brain Complexity
September 27–30 65 participants
ARRANGED BY Seth Grant, Wellcome Trust Sanger Institute
Nathaniel Heintz, HHMI/The Rockefeller University
Jeffrey Noebels, Baylor College of Medicine
This fourth conference addressed approaches ranging from sets of genes, from synapses to networked
brain functions. Emphasis was placed on large-scale approaches that generate accessible molecular
and biological databases. The conference was held at the Hinxton Hall Conference Centre, located
several miles south of Cambridge in the United Kingdom, which forms part of the Wellcome Trust
Genome Campus, together with the Sanger Centre, the European Bioinformatics Institute, and the
HGMP-MRC Resource Center.
PROGRAM
Welcome and Outline of Meeting
S. Grant, Wellcome Trust Sanger Institute
N. Heintz, HHMI/The Rockefeller University
J. Noebels, Baylor College of Medicine
Mapping Visual Pathways I
Chairperson: N. Logothetis, Max-Planck-Institute, Tübingen,
Germany
Mapping Visual Pathways II
Chairperson: T. Sejnowski, Salk Institute for Biological Studies,
La Jolla, California
Molecular Mechanisms of Disease
Chairperson: J. Noebels, Baylor College of Medicine, Houston,
Texas
Mapping Other Perceptual Pathways
Chairperson: G. Laurent, California Institute of Technology,
Pasadena
Network Imaging
Chairperson: J. Rossier, ESPCI-CNRS, Paris, France
Molecular Networks
Chairperson: S. Grant, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Developmental Disorders
Chairperson: N. Heintz, HHMI/The Rockefeller University, New
York
Network Synchrony and Ensembles
Chairperson: S. Grillner, Karolinska Institutet, Stockholm,
Sweden
Wellcome Trust Conference Center: Main conference center and Hinxton Hall
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Functional Genomics and Systems Biology
October 10–14 107 participants
ARRANGED BY Alvis Brazma, European Bioinformatics Institute
Thomas Freeman, University of Edinburgh
Katheleen Gardiner, Eleanor Roosevelt Institute
This first conference included oral presentations on mapping variations in humans and yeast; profiling
of epigenetic marks and alternative mechanisms of transcription initiation in the early vertebrate
embryo; and analysis of cell-based RNAi screens, to name a few. The conference followed a tradition-
al format similar to traditional Cold Spring Harbor meetings, in that the majority of oral presentations
were drawn from openly submitted abstracts.
PROGRAM
Session 1
Chairperson: A. Brazma, European Bioinformatics Institute,
Hinxton, United Kingdom
Session 2
Chairperson: N. Luscombe, European Bioinformatics Institute,
Hinxton, United Kingdom
Session 3
Chairperson: N. Luscombe, European Bioinformatics Institute,
Hinxton, United Kingdom
Session 4
Chairperson: K. Gardiner, University of Colorado, Denver
Session 5
Chairperson: K. Gardiner, University of Colorado, Denver
Session 6
Chairperson: S. Teichmann, MRC Laboratory of Molecular
Biology, Cambridge, United Kingdom
Session 7
Chairperson: S. Teichmann, MRC Laboratory of Molecular
Biology, Cambridge, United Kingdom
Session 8
Chairperson: L. Serrano, Centre for Genomic Regulation,
Barcelona, Spain
Session 9
Chairperson: L. Serrano, Centre for Genomic Regulation,
Barcelona, Spain
Session 10
Chairperson: T. Freeman, University of Edinburgh, United
Kingdom
Poster Sessions
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Pharmacogenomics
October 17–20 140 particpants
ARRANGED BY Alison Coffey, Wellcome Trust Sanger Institute
Michel Eichelbaum, Institute of Clinical Pharmacology
Steve Leeder, Children’s Mercy Hospital
Munir Pirmohamed, University of Liverpool
Dick Weinshilboum, Mayo Medical School
Roland Wolf, University of Dundee
This fifth conference focused on the opportunities presented by the growing contribution of emerging
genomic information and technologies to interdisciplinary approaches in the study of variable respons-
es of humans to drugs and toxic agents, and how research may benefit the individual. Topics covered
an in-depth focus on diverse areas including the biochemistry and physiology of drug action, uptake,
and metabolism, and how this affects genetics; the opportunities for discovery and design of new ther-
apeutic agents; personalizing medicine; understanding and managing adverse drug reactions; the
impact of academic and commercial initiatives; and ethical, legal, regulatory, and social consequences
of genetics applied to medicines.
Conference Centre and Hall
PROGRAM
Translation into Clinical Practice: Warfarin as a Paradigm
Chairpersons: R. Weinshilboum, Mayo Clinic College of
Medicine, Rochester, Minnesota; A. Coffey, Wellcome Trust
Sanger Institute, Hinxton, United Kingdom
Cancer Pharmacogenomics
Chairpersons: C.R. Wolf, University of Dundee, United
Kingdom; A. Futreal, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Human Genome Variation
Chairperson: M. Hurles, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Pharmacogenetics in Neuropsychiatric Disease
Chairpersons: M. Eichelbaum, Dr. Margarete Fischer-Bosch-
Institute of Clinical Pharmacology, Stuttgart, Germany; D.
Goldstein, Duke University, Durham, North Carolina
Epidemiological Approaches in Pharmacogenomics
Chairpersons: A. Morris, Ninewells Hospital & Medical School,
Dundee, United Kingdom; P. McKeigue, University College
Dublin, Ireland
Adverse Drug Reactions
Chairpersons: M. Pirmohamed, University of Liverpool, United
Kingdom; J.S. Leeder, Children’s Mercy Hospital, Kansas
City, Missouri
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Eukaryotic DNA Replication
September 5–9 331 participants
ARRANGED BY Stephen Bell, HHMI/Massachusetts Institute of Technology
Joachim Li, University of California, San Francisco
This was the ninth biannual meeting on eukaryotic DNA replication held at Cold Spring Harbor. Important
progress has been made in our understanding of eukaryotic DNA replication, and this meeting is crucial
in bringing together an international array of researchers investigating all aspects of eukaryotic DNA repli-
cation. The most recent advances in the field were presented together
with new approaches for analyzing DNA replication, making this meet-
ing the most important in the field. Investigators participated in the ten
scientific sessions and platform and poster presentations, marked by
spirited and enthusiastic exchanges of new results. In the scientific ses-
sions, many audience members participated in the question and
answer sessions, and the poster sessions were well-attended.
Sessions at the meeting included assembly of replication initiation
machines; replication timing and origin activation; genomic analysis of
DNA replication; damage responses and checkpoint controls; replica-
tion and the cell cycle; replication fork proteins; control of replication
during development; and origin selection. The meeting illustrated the
rapid advances in our understanding of the function of replication pro-
teins in initiation and elongation of DNA replication, the surveillance
mechanisms monitoring the accuracy of replication, a global genomic view of replication, and the coor-
dination between DNA replication and development.
Essential funding for the meeting was provided by the National Cancer Institute, a branch of the
National Institutes of Health, and the National Science Foundation.
S. Bell, J. Li
S. Chattopadhyay, D. Koepp
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From Structure to Function
Chairperson: L. Joshua-Tor, Cold Spring Harbor Laboratory
Origin Selection
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
Replisome Assembly
Chairperson: K. Labib, Cancer Research UK, Paterson
Institute for Cancer Research, Manchester
Cell Cycle Regulation and Connections
Chairperson: J. Blow, University of Dundee, United Kingdom
Special Session: NIH Review and Funding of Replication
Grants
Chairperson: C. Dearolf, NIGMS, National Institutes of Health,
Bethesda, Maryland
Damage and Replication Stress Responses
Chairperson: O. Aparicio, University of Southern California,
Los Angeles
Chromatin Interactions and Developmental Control
Chairperson: G. Almouzni, Institut Curie, Paris, France
Origin Identification and Replication Timing
Chairperson: A. Donaldson, University of Aberdeen, United
Kingdom
Fork Function During Replication and Repair
Chairperson: M. Foiani, IFOM-FIRC Institute for Molecular
Oncology, Milan, Italy
W. Feng, J. Sidorova, I. Lucas
A.-K. Bielinsky, B. Calvi, C. Nieduszynski
M. Wattambe-Oda, Y. Li
P. Wong
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Microbial Pathogenesis and Host Response
September 15–19 274 participants
ARRANGED BY Brendan Cormack, Johns Hopkins University School of Medicine
Theresa Koehler, University of Texas–Houston Medical School
James Slauch, University of Illinois, Urbana-Champaign
Despite advances in modern healthcare, infectious diseases continue to be major causes of human mor-
bidity and mortality. The evolution of microbial pathogens with humans has resulted in complex interac-
tions that impact the struggle between the infectious invader and the susceptible host.
Increased understanding of these interactions with the goal of developing new therapeutics
and preventive strategies requires collaborative and interdisciplinary scientific approaches.
This meeting brought together a diverse group of international scientists who approach the
study of bacterial and fungal pathogens from a broad range of perspectives. Investigators
from the disciplines of molecular microbiology, eukaryotic cell biology, immunology, and
genomics, and representing academia, industry, and the public health sector, shared recent
findings concerning microbial and host aspects of infectious diseases.
The meeting focused on bacterial and fungal pathogens and the host response and
defense to these invading microbes. Oral sessions were topic-based and included studies
of multiple and diverse organisms. Areas covered included effector delivery and function;
regulation of virulence; microbial communities; immune response to pathogens; genomes
and evolution of virulence; cell–cell communication; and microbial trafficking in cells and
tissues. Speakers for each session were a mixture of established leaders in the field and
young investigators. Several speakers, including some postdoctoral fellows and graduate
students, were chosen from submitted abstracts. Dr. John Mekalanos, Professor and
Chair of the Department of Microbiology and Molecular Genetics at Harvard Medical
School presented the Keynote Address. Dr. Mekalanos is an internationally recognized
leader in microbial pathogenesis. His talk, describing a newly discovered mechanism of
bacterial protein delivery to eukaryotic cells, was followed by lively discussion centering on
the similarities and differences between other protein delivery systems of pathogens.
J. Slauch
N. Salama, B. Cormack
J. Mekalanos, A. Lothigius
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The informal atmosphere combined with the broad perspectives of the meeting participants resulted in a free flow
of novel and refreshing ideas on pathogenesis, with the atmosphere of a small meeting. Active questioning and dis-
cussion followed all oral presentations, was evident throughout the posters sessions, and continued during a wine and
cheese reception and other social gatherings. We strongly encouraged submission of abstracts by junior researchers
in the field and many young investigators were in attendance. Some of these interactions have already produced fruit-
ful scientific collaborations.
This meeting was partially supported by funds from the National Institute of Allergy and Infectious Diseases and
Burroughs Wellcome.
PROGRAM
Effector Delivery and Function
Chairperson: J. Galán, Yale University, New Haven,
Connecticut
Regulation of Virulence
Chairperson: P. Sundstrom, Dartmouth Medical School,
Hanover, New Hampshire
Cell Surfaces
Chairperson: B. Murray, University of Texas Medical School,
Houston
Microbial Communities and Communication
Chairperson: V. Sperandio, University of Texas Southwestern
Medical School, Dallas
Genomes and Evolution of Virulence
Chairperson: J. Heitman, Duke University Medical Center,
Durham, North Carolina
Immune Response to Pathogens
Chairperson: N. Gow, University of Aberdeen, United
Kingdom
Keynote Speaker
J. Mekalanos, Harvard Medical School, Boston,
Massachusetts
Microbial Trafficking in Cells and Tissues
Chairperson: D. Russell, Cornell University, Ithaca, New York
F. Cerda. C. White-Ziegler
P. Bandyopadhyay, E. Lang A. Castillo, L. Forney
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Cell Death
September 26–30 325 participants
ARRANGED BY J. Marie Hardwick, Johns Hopkins University
Jürg Tschopp, University of Lausanne, Switzerland
Jungying Yuan, Harvard Medical School
This seventh Cold Spring Harbor meeting opened with two Keynote Addresses
delivered by Eileen White and Hermann Steller. Steller’s laboratory pioneered
the Drosophila model of cell death and delineated the pathways that frame the
field and this keynote address, in which he extended the knowledge gained
from this model organism to the mechanisms of human disease and potential
therapeutic targets. Eileen White, who originally demonstrated that inhibitors of
apoptosis directly contribute to tumorigenesis, addressed the intertwined
forces of apoptosis and autophagy in cancer. In addition to two poster ses-
sions, there were eight oral sessions entitled Biochemical mechanisms of cell
death, Mitochondria structure and function, Signaling pathways, Caspases and
other proteases, Alternative death pathways, Disease models and systems
biology, Multiple functions of cell death regulators in the nervous system, and
New strategies and directions. On the basis of the research presented, strate-
gies could be developed to treat a range of human disorders, from cancer to
neurodegenerative disease. In all, the meeting featured 229 presentations and
was attended by 325 participants representing more than 20 countries. J. Tschopp
PROGRAM
Keynote Speaker
J.M. Hardwick, Johns Hopkins University, Baltimore,
Maryland
Role of Apoptosis and Autophagy in Cancer
Chairperson: E. White, Rutgers University
Regulation of Caspases by Ubiquitin Pathway Proteins
Chairperson: Hermann Steller, The Rockefeller University
Biochemical Mechanisms of Cell Death
Chairperson: S. Kornbluth, Duke University Medical Center,
Durham, North Carolina
C. Distelhorst, Y. Lazebnik
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Mitochondrial Structure and Function
Chairpersons: R. Youle, NINDS, National Institutes of Health,
Bethesda, Maryland; J. Nunnari, University of California,
Davis
Cancer
Chairpersons: S. Lowe, Cold Spring Harbor Laboratory; K.
Vousden, Beatson Institute for Cancer Research, Glasgow,
United Kingdom
Signaling Pathways
Chairpersons: T. Mak, Ontario Cancer Institute, Toronto,
Canada; S. Nagata, Osaka University Medical School, Japan
Caspases and Other Protease Pathways
Chairpersons: D. Green, St. Jude Children’s Research
Hospital, Memphis, Tennessee; G. Evan, UCSF
Comprehensive Cancer Center, San Francisco, California
Alternative Death Pathways
Chairpersons: C. Thompson, University of Pennsylvania,
Philadelphia; B. Stockwell, Columbia University, New York
Disease Models and Systems Biology
Chairpersons: E. White, Rutgers University, Piscataway, New
Jersey; S. Cory, Walter & Eliza Hall Institute of Medical
Research, Melbourne, Australia
Multiple Functions of Cell Death Regulators in the
Nervous System
Chairperson: K. White, Harvard Medical School, Boston,
Massachusetts; E. Jonas, Yale University, New Haven,
Connecticut
New Strategies and Directions
Chairpersons: M.C. Simon, University of Pennsylvania,
Philadelphia; B. Hay, California Institute of Technology,
Pasadena
H. Steller, S. LarishJ. Bertout, A. Bagchi
T. Grodzicker, E. White
E. Shroff, C. Snyder
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Neurobiology of Drosophila
October 3–7 418 participants
ARRANGED BY Alex Kolodkin, HHMI/The Johns Hopkins Medical School
Amita Sehgal, HHMI/University of Pennsylvania
As in previous years, the goal of this meeting was to foster communication of ideas, techniques, and new
discoveries within the field of Drosophila neurobiology. The meeting was structured with platform and poster
presentations by a variety of researchers including graduate students, postdoctoral fellows, and junior and
senior faculty. The topics for the platform sessions were chosen to
reflect the areas of Drosophila neurobiology in which cutting-edge
advances are being made: neuronal and glial cell fate, neural circuits
and function, technology development, cell biology and pathology,
behavior, sensory systems, synaptic transmission, and process for-
mation. A small number of abstracts submitted in each of these areas
were selected by the respective session chairs for platform presenta-
tions, and the rest were presented as posters. The research reported
used a wide range of techniques, including genetic, molecular, cellu-
lar, biochemical, physiological, and behavioral approaches to basic
questions of nervous system development and function.
Among the highlights of the meeting were the creative ways in
which researchers are using Drosophila to understand the molecu-
lar and cellular underpinnings of many different physiological and pathological processes. Efforts to
humanize the fly are clearly proving to be successful in a number of areas such as the study of various
behaviors, neurodegenerative disorders, and even the blood-brain barrier. In addition, the meeting includ-
ed reports of important advances in the development of the nervous system, the perception of external
stimuli, in particular olfactory cues, by the fly, and the design of new technology. The Elkins plenary lec-
ture, which was presented by Richard Daniels from the Washington University School of Medicine,
described exciting new findings on the properties of a vesicular glutamate transporter and its role in
synaptic transmission. The environment of the meeting allowed many opportunities for informal discus-
sions among all participants. The high quality of the presentations, the development of novel techniques,
and the exciting new directions of Drosophila research demonstrate the vitality of this area. Discussions
at the meeting led to cross-fostering of ideas that was valuable to everyone in the field.
This conference is supported in part by funds provided by the National Institute of Neurological
Diseases and Stroke.
E. Kurant, A. Kolodkin
Y. Fang, A. Sehgal
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Neuronal and Glial Cell Fate
Chairperson: U. Gaul, The Rockefeller University, New York
Cell Biology and Pathology
Chairperson: L. Restifo, University of Arizona, Tucson
Elkins Memorial Lecture: The Function and Expression
of the Vesicular Glutamate Transporter
Chairperson: R. Daniels, Washington University School of
Medicine
Neural Circuits and Function/Technology
Chairpersons: J. Simpson, HHMI/Janelia Farm Research
Campus, Ashburn, Virginia; G. Miesenböck, Yale University,
New Haven, Connecticut
Sensory Systems/Technology
Chairpersons: K. Scott, University of California, Berkeley; G.
Miesenböck, Yale University, New Haven, Connecticut
Behavior
Chairperson: F.R. Jackson, Tufts University School of
Medicine, Boston, Massachusetts
Synaptic Transmission/Technology
Chairpersons: C.-F. Wu, University of Iowa, Iowa City; G.
Miesenböck, Yale University, New Haven, Connecticut
Process Formation and Guidance
Chairperson: K. Zinn, California Institute of Technology,
Pasadena
Watching closed circuit TV on Grace patio
J. DorstenL. Griffith, J. Sierralta
T. Voller, D. Pauls
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Clinical Cardiovascular Genomics
October 10–13 168 participants
ARRANGED BY David Ginsburg, HHMI/University of Michigan Medical School
Elizabeth Nabel, National Heart, Lung and Blood Institute
Eddy Rubin, Lawrence Berkeley National Laboratory
This first Cold Spring Harbor meeting was opened by Keynote Addresses delivered by Michael Brown,
Nobel laureate of Southwestern University Medical Center, and Eric Lander, of the Broad Institute of MIT
and Harvard. The two speakers epitomize the union of clinical genetics with genomics. Brown’s labora-
tory has pioneered investigations into the molecular basis of hypercholesterolemia, culminating in the
fundamental discoveries of the LDL receptor and of the molecular mechanisms that coordinate its
expression with cholesterol levels. Eric Lander has been one of the key driving forces behind the Human
Genome Project and has contributed a wide array of tools and ideas enabling the use of genomics in
studies of common human diseases. The opening session was followed by six oral sessions on Clinical
genomics to function, Genome-wide association studies, Rare mutations as cause of common CV dis-
eases, Analytical approaches, Large-scale clinical studies and resources and clinical models. In all, the
meeting featured 83 presentations and was attended by participants from more than 20 countries.
This meeting was funded in part by the Foundation for the National Institutes of Health and NHLBI
Programs for Genomic Applications.
D. Ginsburg, P. Gruber E. Rubin, L. Pennacchio
M. Brown, E. Nabel
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PROGRAM
Keynote Address
M.S. Brown, University of Texas Southwestern Medical
Center
Clinical Genomics to Function
Chairpersons: C. Seidman, Harvard Medical School, Boston,
Massachusetts; H. Dietz, Johns Hopkins University,
Baltimore, Maryland
Genome-wide Association Studies
Chairpersons: D. Altshuler, Harvard Medical School, Boston,
Massachusetts; D. Cox, Perlegen Sciences Inc., Mountain
View, California
Rare Mutations as Cause of Common CV Diseases
Chairpersons: R. Lifton, Yale University School of Medicine,
New Haven, Connecticut; L. Pennacchio, Lawrence Berkeley
National Laboratory, California
Analytical Approaches
Chairpersons: E. Boerwinkle, University of Texas, Houston; G.
Abecasis, University of Michigan, Ann Arbor
PGA Workshops
Large-scale Clinical Studies and Resources
Chairpersons: K. Stefansson, deCode Genetics, Reykjavic,
Iceland; C. O’Donnell, NHLBI Framingham Heart Study
Keynote Address
E. Lander, Broad Institute of MIT and Harvard
Clinical Models
Chairpersons: D. Ginsburg, HHMI/University of Michigan, Ann
Arbor; E. Topol, Scripps Research Institute, La Jolla,
California
D. Vaidya, L. Yanek, J. Herrera
D. Cox S. Eifert, M. Medina, I. Miljkovic Gacic
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Genome Informatics
November 1–5 206 participants
ARRANGED BY Michele Clamp, Broad Institute of MIT and Harvard
Tim Hubbard, Wellcome Trust Sanger Institute
Jason Swedlow, University of Dundee
This seventh CSHL/Wellcome Trust conference continues to highlight the latest developments in
genome research and, once again, was a vital and exciting meeting. This year, the conference was held
at Cold Spring Harbor Laboratory, which is located on the North Shore of Long Island 35 miles east of
Manhattan in New York State and is a research and educational institution with both a wide spectrum
of research programs and a broad educational mission. The conference followed a traditional format
similar to traditional Cold Spring Harbor meetings, in that the majority of oral presentations were drawn
from openly submitted abstracts.
The explosion of biological data requires a concomitant increase in the scale and sophistication of
information technology. This ranges from the storage of data and their associated data models, to the
design of effective algorithms to uncover nonobvious aspects of these data sets, to ontologies to con-
cisely describe biological information, and finally to software systems to support curation, visualization,
and exploration. The conference brought together some of the leading scientists in this growing field,
and researchers from other large-scale information-handling disciplines were also invited to attend.
Topics included Epigenomics; Comparative and evolutionary genomics; Ontologies and definitions;
Pathogenic microbe genomics; Regulation, pathways, and networks; Images, atlases, and reconstruc-
tion; and Assembly, annotation, and resources. For the first time, we had a session on Microbial
Pathogens, a field that most bioinformaticians are unfamiliar with and which generated much excitement
and discussion. The Keynote Speaker was Michael Ashburner, Department of Genetics, University of
Cambridge. In all, more than 30% of delegates came from outside North America, a highly unusual sta-
tistic for a U.S. meeting, and the meeting hosted 140 scientific presentations in talks and posters.
J. Reimand, J. Witkowski, H. Peterson
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Regulation, Pathways, and Networks
Chairpersons: M. Kellis, Broad Institute of Harvard and MIT,
Cambridge, Massachusetts; Z. Weng, Boston University,
Massachusetts
Pathogenic Microbe Genomics
Chairperson: J. Carlton, New York University, New York; J.
Parkhill, Wellcome Trust Sanger Institute, Hinxton, United
Kingdom
Assembly, Annotation, and Resources I
Chairpersons: E. Birney, European Bioinformatics Institute,
Hinxton, United Kingdom; J. Kent, University of California,
Santa Cruz
Epigenomics
Chairpersons: R. Martienssen, Cold Spring Harbor Laboratory;
T. Mikkelson, Broad Institute of MIT and Harvard,
Cambridge, Massachusetts
Keynote Address: Birds of a Feather
M. Ashburner, University of Cambridge
Assembly, Annotation, and Resources II
Chairpersons: E. Birney, European Bioinformatics Institute,
Hinxton, United Kingdom; J. Kent, University of California,
Santa Cruz
Images, Atlases, and Reconstruction
Chairpersons: R. Murphy, Carnegie Mellon University,
Pittsburgh, Pennsylvania; R. Waterston, University of
Washington, Seattle
Comparative and Evolutionary Genomics
Chairpersons: R. Hardison, Pennsylvania State University,
University Park; E. Margulies, NHGRI, National Institutes of
Health, Bethesda, Maryland
S. Prochnik, J. Stajich
E. Margulies, P. Good
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In Vivo Barriers to Gene Delivery
November 26–29 113 participants
ARRANGED BY Nori Kasahara, UCLA Geffen School of Medicine
Stephen Russell, Mayo Clinic College of Medicine
James M. Wilson, University of Pennsylvania
It is now 18 years since the first FDA-approved human gene transfer study, but this extremely promis-
ing field of endeavor is still nowhere close to realizing its full therapeutic potential. There have been a
few notable successes, such as the use of autologous nematopoiet-
ic stem cells transduced with the IL-2γ chain or adenosine deaminase
for the treatment of severe combined immunodeficiency. However,
the dream of genetically based therapies for the treatment of a multi-
tude of other more common human ailments has not yet been
achieved. Although clinical “home runs” have been few and far
between, the scientific understanding and technological underpinning
of gene therapy have been moving forward in leaps and bounds, and
there is currently a great deal of optimism that we are entering an era
in which we will see increasing numbers of clinically approved gene
therapy products. On the basis of this optimistic view of the field, it
was decided that now would be an excellent time to initiate a new
biannual series of Cold Spring Harbor meetings, focusing on the crit-
ical issue of in vivo barriers to gene delivery. The meeting was held the
week after Thanksgiving and attracted many eminent field leaders
and a strong showing of more junior scientists (more than 50% of
attendees were postdoctoral scientists or Ph.D. students).
The first session focused on noninvasive monitoring of gene deliv-
ery and expression, which is considered to be a critical consideration
in human gene therapy studies to give accurate insights into the rea-
sons why some patients respond and others do not. The second ses-
sion on mislocalization, sequestration, and targeting provided an
opportunity to consider new vector targeting strategies as well as a
number of interventions that can prevent vectors from becoming
sequestered in the liver or spleen after intravenous administration. A
third session focused on vector neutralization by complement pro-
teins, antiviral antibodies, and other blood factors that serve to
decrease the efficacy of vectors introduced by the intravenous route.
The use of cells as nonneutralizable “Trojan horses” that can transport
vectors to distant target sites was a recurring theme in this and other
sessions. The fourth session was on vector persistence at the target
site and dealt with the problem of rapid extinction of gene expression
that is frequently encountered in gene therapy studies. The fifth ses-
sion on extravasation and tissue penetration provided an opportunity
to explore strategies whereby gene transfer vehicles can be induced
to exit from the microcirculation and migrate within the interstitial fluid
space. The last session was devoted to the key issue of vector man-
ufacturing which, until now, has provided a significant bottleneck when moving from small-scale mouse
studies to large-scale human studies.
Overall, the meeting was considered a great success by those who attended. This was a highly
interactive group of scientists leading to stimulating discussions after each of the oral presentations and
J. Chulay, J. Wilson
S. Russell, D. Stewart
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very lively interactions at the poster sessions and, of course, in the bar after each of the evening sessions. Throughout
the meeting, it was clear that the field of gene therapy has reached a very exciting stage in its development and we
expect to see significant progress addressing the in vivo barriers to gene delivery by the time of the next meeting in
this series in 2009.
Funding for the meeting was provided by the CSHL Corporate Sponsor program.
PROGRAM
Monitoring Gene Delivery and Expression
Chairpersons: M. Barry, Mayo Clinic, Rochester, Minnesota; P.
Leopold, Weill Cornell Medical College, New York
Mislocalization, Sequestration, and Targeting
Chairpersons: L. Seymour, Cancer Research UK, University of
Birmingham; S. Russell, Mayo Clinic College of Medicine,
Rochester, Minnesota
Vector Neutralization
Chairpersons: J. Wilson, University of Pennsylvania,
Philadelphia; J. Bell, Ottawa Health Research Institute,
Canada
Persistence
Chairpersons: K. High, Children’s Hospital of Philadelphia,
Pennsylvania; N. Kasahara, UCLA Geffen School of
Medicine, Los Angeles, California
Extravasation and Tissue Penetration
Chairpersons: K. Bankiewicz, University of California, San
Francisco; J. Wolff, University of Wisconson, Madison
Special Lecture
R. Crystal, Weill Medical College of Cornell University
Manufacturing
Chairpersons: M. Federspiel, Mayo Clinic, Rochester,
Minnesota; K. Cornetta, Indiana University Cancer Center,
Indianapolis
S. Alves, D. Hui, S. Murphy, F. Mingozzi, E. Basner-Tschakarjan
T. Ota, T. Ong B. Schultz, A. Arnett K. Breous, A. Chekmasova
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Molecular and Immunological Approaches to Vaccine Design
November 29–December 2 52 participants
ARRANGED BY Peter Beverley, Jenner Institute for Vaccine Research, United Kingdom
Kathrin Jansen, Wyeth Pharmaceuticals
Susan Swain, Trudeau Institute
This fifth winter conference set out to examine whether the revolution in understanding molecular and
cell biology and new technologies that has taken place in recent years has begun to have a real impact
on how new vaccines are designed. Sessions ranged from an intensive scrutiny of the function of Th17
CD4 T cells, through those on the generation of protective immune memory and effector mechanisms
against infectious agents, to adjuvants, application of new technologies to difficult
diseases, and the problems of immunizing the young and the old. At the level of
the whole immunized animal, there remain gaps in understanding factors that
determine how different types of protective immunities are generated and main-
tained in response to different organisms and in different tissue sites. Even in
much-studied influenza virus models, the mechanisms underlying heterosubtypic
(cross-protective) cellular immunity remain obscure, although it is clear that cellu-
lar response can provide a clinically useful level of protection in the absence of
specific neutralizing antibody. Nevertheless, progress in understanding cellular
immune responses is impressive, and the development of assays for detecting
many cytokines simultaneously at the single-cell level is beginning to allow a much
more refined analysis of the heterogeneity of responses and has focused attention
on the importance of the quality as well as the magnitude of immune responses.
An important conclusion is that every pathogen induces immunological memory
with a unique functional profile. It is also clear that the recently appreciated
cytokine, IL-17, has a role in memory T-cell responses to both bacterial and viral
pathogens.
The meeting heard how new technologies are showing encouraging results in
difficult diseases. Prime boost immunization regimes using combinations of viral
vectors are generating impressive responses to malaria antigens, suggesting that
useful levels of protection may be achieved when different stages of the life cycle
are targeted simultaneously. Identification of relatively conserved molecules of
neisseria and staphylococci may lead to the development of new-generation vac-
cines for these organisms. In cancer, responses to tumor antigens can be
achieved by immunization with internally adjuvanted DNA plasmids, but clinical tri-
als of a therapeutic vaccine for HIV show how difficult it is to achieve success with
therapeutic vaccines. Although the HIV vaccine induced strong responses, many
of the responding cells had an exhausted phenotype and there was little effect on
viral load.
The very young and the old present particular difficulties for vaccinologists. In
the old, the immune system becomes increasing oligoclonal with a loss of diversi-
ty of the repertoire of naïve lymphocytes. Very large responses to a few pathogens,
particularly cytomegalovirus, are generated. Exactly how this impacts on respons-
es to other viruses in vivo remains to be determined. Nevertheless, in vitro assays
of cellular immunity appear to provide useful prognostic information on suscepti-
bility to influenza virus, again emphasizing its role in protection against a virus for
which neutralizing antibody is considered to be of paramount importance. In the
young, persistence of antibody responses is poor. The underlying cellular mecha-
P. Beverley, L. Dorrell
L. Schultz, K. Jansen
S. Swain, B. Rocha
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nism appears to be a failure of the bone marrow stroma to support survival of plasma cells responsi-
ble for long-term antibody production and the molecular defect a failure of young stromal cells to pro-
duce the TNF family member APRIL.
Although it is still difficult to understand the mechanisms of protection in many diseases, progress
in applying an understanding of pattern-recognition receptors to develop effective adjuvants is an
excellent example of the translation of fundamental understanding into practical applications.
Appreciation of the need for better understanding of fundamental immune mechanisms to improve the
rational design of vaccines is a goal of these conferences. The enthusiastic participation of attendees
in discussions, in and outside the formal conference sessions, suggests that this goal was achieved.
Funding for the meeting was provided by the CSHL Corporate Sponsor program.
PROGRAM
CD4 T-cell Subsets and Immunity
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
Generating Protective Immune Memory
Chairperson: S. Swain, Trudeau Institute, Saranac Lake, New
York
Effector Mechanisms Against Infectious Agents
Chairperson: S. Swain, Trudeau Institute, Saranac Lake, New
York
Adjuvants for Improved Vaccines
Chairperson: K. Jansen, Wyeth Vaccine Research, Pearl River,
New Jersey
Application of New Technologies to Difficult Diseases I
Chairperson: K. Jansen, Wyeth Vaccine Research, Pearl River,
New Jersey
Application of New Technologies to Difficult Diseases II
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
Vaccines in the Young and the Old
Chairperson: P. Beverley, Edward Jenner Institute for Vaccine
Research, Compton, United Kingdom
A. Shaw, P. Vink A. Kajaste-Rudnitski, D. Ye
A. Sher
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Rat Genomics and Models
December 6–9 131 participants
ARRANGED BY Timothy Aitman, Imperial College London
Norbert Hübner, Max-Delbrück-Center for Molecular Medicine
Anne Kwitek, University of Iowa
James Shull, University of Nebraska Medical Center
This successful fifth winter biotechnology conference has been held biannually
since 1999 at Cold Spring Harbor Laboratory, with a complementary meeting
outside of the United States (previously held in Europe, Japan, and Australia) in
the alternating years. Drs. Hübner and Kwitek joined previous organizers, Drs.
Shull and Aitman, in organizing this year’s conference. The conference series is
the first in the United States to focus exclusively on the strengths and uniqueness
of the rat as a model organism for biological research, with an emphasis on lever-
aging genetic and genomic approaches. The primary goals of this meeting are to
(1) promote interactions between biomedical researchers who utilize rat models
in the study of physiology, pathophysiology, toxicology, immunology, neuro-
science, and oncology, and (2) provide an interface between the research com-
munity and the various public and commercial resources that exist to support
biomedical research in which rat models are utilized. For the first time for this
meeting series, there was strong journal representation, with Editors attending
from Nature Genetics, Genome Research, and Physiological Genomics.
The meeting was organized into oral presentations by invited speak-
ers/session chairs as well as speakers selected following evaluation of submit-
ted abstracts, poster sessions, and workshops. There were also three outstand-
ing Keynote Addresses from world leading physiologists, geneticists, and
genome biologists: Allen Cowley, Jr., Richard Gibbs, and Ewan Birney. Two data-
base workshops were given to provide tutorial to genome databases (RGD and
Ensembl) and new Web tools (eQTL Explorer and MiMiR). Invited speakers by
session topic included Drs. Jirout, Maatz, Michalkiewcz, Moreno, and Silva
(Cardiovascular disease); Barkalifa, Behmoaras, Desarathy, Jagodic, Lazar,
Mordes, Pravenec, and Redei (Metabolism and inflammation); Gould,
Zschemisch, Adamovic, and Szpirer (Tumor biology); Johannason, Guryev, Lee,
Liska, Morrissey, Ockinger, and Wallis (Comparative disease genomics); Kwitek,
F. Liska, N. Hubner
A. Kwitek, E. Blankenhorn
T. Commers, J. Shull
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Aitman, and Petretto (Systems biology, pharmacology, and toxicology); Pruitt and Twigger (Genome
resources); Anegon, Liang, Mashimo, Stridh, and Teruel (Neuroscience); and Demers, Guertz, Kitada,
and van Boxtel (Manipulating the rat genome). This meeting featured 103 presentations (60 oral and 43
posters) and attracted participants from around the world. This meeting had an exceptional internation-
al representation, with more than half of the participants traveling from outside the United States.
This meeting was funded in part by the National Heart, Lung, and Blood Institute, a branch of the
National Institutes of Health.
PROGRAM
Cardiovascular Diseases
Chairpersons: A. Dominiczak, University of Glasgow, United
Kingdom; N. Hübner, Max-Delbrück-Center for Molecular
Medicine, Berlin, Germany
Keynote Address: Unraveling the Genomic Basis of
Complex Functions and Diseases
A.W. Cowley, Medical College of Wisconsin, Milwaukee
Metabolism and Inflammation
Chairpersons: H. Markholst, Hagedorn Research Institute,
Gentofte, Denmark; R. Holmdahl, Lund University, Sweden
Workshop I: Databases
Chairperson: S. Old, NHLBI, National Institutes of Health,
Bethesda, Maryland
Tumor Biology
Chairpersons: J. Shull, University of Nebraska Medical Center,
Omaha; T. Ushijima, National Cancer Center Research
Institute, Tokyo, Japan
Keynote Address: What’s Next for the Rat Genome?
R. Gibbs, Baylor College of Medicine
Comparative Disease Genomics
Chairpersons: P. Harris, Mayo Clinic, Rochester, Minnesota;
T. Scheetz, University of Iowa, Iowa City
Workshop II: Databases and Tools
Chairperson: S. Old, NHLBI, National Institutes of Health,
Bethesda, Maryland
Systems Biology, Pharmacology, and Toxicology
Chairpersons: H. Jacob, Medical College of Wisconsin,
Milwaukee; C.R. Wolf, University of Dundee, United
Kingdom
Keynote Address: The ENCODE Project—Understanding
Mammalian Genomes
E. Birney, European Bioinformatics Institute
Genome Resources, Informatics
Chairpersons: T. Serikawa, Kyoto University, Japan;
E. Cuppen, Hubrecht Institute, Utrecht, The
Netherlands
Neuroscience
Chairpersons: J. Flint, University of Oxford, United Kingdom;
T. Olsson, Karolinska Institutet, Stockholm, Sweden
Manipulating the Rat Genome
Chairpersons: Z. Izsvak, Max-Delbrück-Center for Molecular
Medicine, Berlin, Germany; J. Mullins, University of
Edinburgh, United Kingdom
M. Simakova, M. Jirout, M. Pravenec
J. Witkowski, R. Gibbs
M. Shimoyama, T. Serikawa
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities do
not adequately treat them. Our aim is to provide intensive study in the most recent developments and
techniques in these subjects and to prepare students to enter directly into research in a particular area.
To ensure up-to-date coverage of current research work, we bring together course faculty from many lab-
oratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 11–24
INSTRUCTORS K. Adelman, National Institutes of Health/NIEHS, Research Triangle Park, North Carolina
R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
ASSISTANTS A. Clark, NIEHS, Research Triangle Park, North Carolina
M. Choueiri, M.D. Anderson Cancer Center, Houston, Texas
S. Duellman, University of Wisconsin, Madison
B. Glaser, University of Wisconsin, Madison
Y.-C. Lee, M.D. Anderson Cancer Center/University of Texas, Houston
S. Nechaev, NIEHS, Research Triangle Park, North Carolina
M. Nie, University of California, Los Angeles
N. Thompson, University of Wisconsin, Madison
W. Turki-Judeh, University of California, Los Angeles
C. Winkler, University of California, Los Angeles
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This course was for scientists who were not familiar with techniques of protein isolation and characteri-
zation. It was a rigorous program that includes laboratory work all day and a lecture with discussion ses-
sion every evening. Each student became familiar with each of the major techniques in protein purification
by actually performing four separate isolations including (1) a regulatory protein from muscle tissue, (2) a
sequence-specific, DNA-binding protein, (3) a recombinant protein overexpressed in E. coli, and (4) a
membrane-bound receptor.
A variety of bulk fractionation, electrophoretic, and chromatographic techniques discussed included
precipitation by salts, pH, and ionic polymers; ion exchange, gel filtration, hydrophobic interaction, and
reverse-phase chromatography; lectin affinity, ligand affinity, oligonucleotide affinity, and immunoaffinity
chromatography; polyacrylamide gel electrophoresis and electroblotting; and high-performance liquid
chromatography. Procedures were presented for solubilizing proteins from inclusion bodies and refold-
ing them into active monomeric forms. Methods of protein characterization were utilized to include
immunological and biochemical assays, peptide mapping, amino acid analysis, protein sequencing, and
mass spectrometry. Emphasis was placed on strategies of protein purification and characterization.
Guest lecturers discussed protein structure, modification of proteins, methodologies for protein purifi-
cation and characterization, and applications of protein biochemistry to cell and molecular biology. In
addition to the instructors, speakers in the 2007 course included CSHL investigators Leemor Joshua-
Tor, Michael Myers, Bruce Stillman, and Nicholas Tonks.
PARTICIPANTS
Beebe, D., Ph.D., University of Wisconsin, Madison
Blewis, M., B.S., University of California, San Diego, La Jolla
Doctor, A., M.D., Washington University, St. Louis, Missouri
Franz, A., Ph.D., Harvard University, Cambridge, Massachu-
setts
Gupta, H., M.D., University of Alabama, Birmingham
Kao, H.-H., M.S., M.D. Anderson Cancer Center, Houston,
Texas
Kuznetsov, V., B.S., Cancer Research UK London Research
Institute, London, United Kingdom
Markelz, A., Ph.D., University at Buffalo, SUNY, Amherst,
New York
Mosessian, S., B.S,, University of California, Los Angeles
Pastor, W., A.B., Harvard University, Boston, Massachusetts
Schmidt, R., B.A./M.S., University of California, Los Angeles
Simon, G., B.S., The Scripps Research Institute, La Jolla,
California
Soh, H., Ph.D., University of California, Santa Barbara
Steinbrenner, J., Ph.D., University of Konstanz, Germany
Vershinin, M., Ph.D., University of California, Irvine
Wei, X., Ph.D., University of Pittsburgh, Pennsylvania
SEMINARS
Adelman, K., NIEHS/Research Triangle Park, North Carolina:
RNA polymerase is poised for development across the
genome.
Burgess, R., University of Wisconsin, Madison: Introduction to
protein purification, immunoaffinity chromatography.
Burgess, R. and Glaser, B., University of Wisconsin, Madison:
RNA polymerase-sigma factor interactions and use of
LRET-based assays for drug discovery and biochemistry.
Courey, A., University of California, Los Angeles: Sumoylation:
Links to epigenetic transcriptional control.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Protein crystal-
lography introduction and demonstration. DNA transloca-
tion in a relicative hexameric helicase.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Osteoblasts and prostate cancer metastasis.
Myers, M., Cold Spring Harbor Laboratory: Introduction to
mass spectroscopy for analyzing biological samples.
Nechaev, S., NIEHS, Research Triangle Park, North Carolina:
Analysis of promoter-proximal stalling.
Stillman, B., Cold Spring Harbor Laboratory: Role of ATP in
replication origin recognition.
Tonks, N., Cold Spring Harbor Laboratory: Signal transduction
from the protein tyrosine phosphatase perpective.
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Cell and Developmental Biology of Xenopus
April 14–24
INSTRUCTORS J. Heasman, Children’s Hospital Medical Center, Cincinnati, Ohio
C. Wylie, Children’s Hospital Research Foundation, Cincinnati, Ohio
ASSISTANTS A. Mir, Children’s Hospital Medical Center, Cincinnati, Ohio
M. Motta, Yale University School of Medicine, New Haven, Connecticut
Q. Tao, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
Xenopus is the leading vertebrate model for the study of gene function in development. The combina-
tion of lineage analysis, gene-knockout strategies, experimental manipulation of the embryo, and
genomic/bioinformatic techniques makes it ideal for studies on the molecular control of embryo pat-
terning, morphogenesis, and organogenesis. The course combined intensive laboratory training with
daily lectures from recognized experts in the field. Students learned both emerging technologies and
classical techniques to study gene function in Xenopus development. An important element was the
informal interaction between students and course faculty.
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Technologies covered included oocyte and embryo culture, lineage analysis, and experimental manip-
ulation of embryos; gain- and loss-of-function analysis using mRNAs and antisense oligos, whole-mount
in situ hybridization, immunocytochemistry, RT-PCR, and genomic/bioinformatic techniques; prepara-
tion of transgenic embryos; and use of Xenopus tropicalis for genetic analyses. This course was designed
for those new to the Xenopus field, as well as for those wanting a refresher course in the emerging tech-
nologies. This course was open to investigators from all countries. Additional lecturers in the 2007 course
included Daniel Buchholz, Ken Cho, Eddy de Robertis, Timothy Grammer, Raymond Keller, Mustafa
Khokha, Paul Krieg, and Janet Weber.
This course was supported with funds provided by the National Institute of Child Health and Human
Development, the National Science Foundation, and the Howard Hughes Medical Institute.
PARTICIPANTS
Abbas, A., Ph.D., Era’s Lucknow Medical College & Hospital,
Lucknow, India
Baird, L., B.Sc., University of Bath, United Kingdom
Bayramov, A., Ph.D., Institute of Bioorganic Chemistry,
Moscow, Russia
Charlesworth, A., Ph.D., University of Arkansas for Medical
Sciences, Little Rock
Drews, C., M.Sc., University Clinic Essen, Essen, Germany
Gao, Q., M.D., Evanston Northwestern Healthcare Research
Institute, Evanston, Illinois
Han, C.-L., Ph.D., Tri-Service General Hospital, Taipei, Taiwan
Harr, J., B.S., University of the Pacific, Stockton, California
Kong, S., Ph.D., Stowers Institute for Medical Research,
Kansas City, Missouri
Marchal, L., M.S., Institut de Biology of Development de Mar-
seille Luminy, Marseille, France
Mikryukov, A., M.S., Cancer Research Center of Laval Univer-
sity, Quebec City, Canada
Noble, A., Ph.D., University of Portsmouth, United Kingdom
Ochong, E., B.Sc., Liverpool School of Tropical Medicine, Liv-
erpool, United Kingdom
Ren, X., M.S., Free University of Brussels, Gosselies, Belgium
Singh, A., Ph.D., University of Miami, Florida
Virnik, K., Ph.D., NCI/NIH, Bethesda, Maryland
SEMINARS
Buchholz, D., University of Cincinnati, Ohio: Metamorphosis.
Cho, K., University of California, Irvine: Cell adhesion and tissue
assembly during Xenopus morphogenesis.
de Robertis, E., HHMI/University of California, Los Angeles:
Early zygotic cell and tissue specification.
Grammer, T., University of Berkeley, California: X. tropicalis and
genetic analysis of development 1.
Heasman, J., Children’s Hospital Medical Center, Cincinnati,
Ohio: Maternal control of Xenopus development.
Keller, R., University of Virginia, Charlottesville: Cell behavior
during early morphogenesis.
Khokha, M., Yale University, New Haven, Connecticut: X. tropi-
calis and genetic analysis of development 2.
Krieg, P., University of Arizona College of Medicine, Tucson:
Postgastrula organogenesis.
Weber, J., National Institutes of Health, Bethesda, Maryland:
Xenopus genomics and bioinformatics.
Wylie, C., Children’s Hospital Research Foundation, Cincinnati,
Ohio: Xenopus as a model system.
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Molecular Neurology and Neuropathology
June 6–12
INSTRUCTORS M. Cookson, National Institute on Aging/NIH, Bethesda, Maryland
J. Hardy, University College London, London, United Kingdom
H. Orr, University of Minnesota, Minneapolis
This intensive 1-week discussion course offered successful applicants a unique opportunity to learn the
latest concepts and methodologies associated with the study of human neurological disorders such as
Alzheimer’s, Parkinson’s, and epilepsy. Participants discussed in detail the strengths and weaknesses of
the accumulated experimental evidence underlying our current understanding of these diseases. Fun-
damental questions—such as how and why particular neurons die in certain disorders—were discussed
in the context of identifying the best experimental approaches to finding answers, whether through the
use of transgenic and/or lesion-induced mouse models, functional brain and/or cellular imaging, gain-/
loss-of-function molecular and viral approaches, cellular transplantation, or a combination of these
approaches. The course examined why many of these disorders share apparently common features of
protein aggregation, specific vulnerability of certain classes of neurons, and long incubation periods and
discussed to what extent these features reflect common pathological mechanisms.
The course further explored how the underlying mechanisms in these disparate disorders are tar-
geted for potential diagnostic and therapeutic gain. Extended seminars and discussion by a wide range
of leading investigators further illuminated developments in this rapidly moving field. Participation in the
course provided an essential conceptual and methodological framework for anyone intending to pursue
rigorous research.
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Speakers this year included Beverly Davidson (University of Iowa, Des Moines), Dennis Dickson (Mayo
Clinic, Jacksonville, Florida), Monica Driscoll (Rutgers, The State University of New Jersey), Karen Duff
(Columbia University, New York), Katrina Gwinn (NINDS, Bethesda, Maryland), Contantino Iadecola (Cor-
nell University, New York), James McNamara (Duke University Medical Center), Jerome Siegel (Veterans
Affair Greater L.A. Health Care System, California), Steven Warren (Emory University, Atlanta, Georgia),
Mathias Heikenwälder (Institute for Neuropathology, Zurich, Switzerland), Rosa Rademakers (Mayo Clinic
College of Medicine, Jacksonville, Florida), and Anthony Wynshaw-Borris (University of California, San
Diego).
PARTICIPANTS
Adams, S., Ph.D., Mayo Clinic Jacksonville, Jacksonville,
Florida
Aguirre, G., B.S., Cinvestav-IPN, Mexico City, Mexico
Ambegoakar, S., B.S., University of California, Los Angeles
Anvret, A., B.S., Karolinska Institute, Stockholm, Sweden
Chen, Y.-Y., B.S., Cold Spring Harbor Laboratory
De Paola, V., Ph.D., Cold Spring Harbor Laboratory
Gerris-Krol, H., B.S., Academical Medical Center, Amsterdam,
The Netherlands
Gill, D., B.S., University of Prince Edward Island, Charlotte-
town, Canada
Micsenyi, M., B.S., Albert Einstein College of Medicine, New
York
Morgenstern, N., B.S., Fundacion Instituto Leior, Buenos Aires,
Argentina
Mukerji, S., B.S., Case Western Reserve University, Cleveland,
Ohio
Pandey, U., Ph.D., University of Pennsylvania, Philadelphia
Reynolds, A., Ph.D., Princeton University, New Jersey
Scholz, S., Ph.D., National Institutes of Health, Bethesda,
Maryland
Shelton, S., Ph.D., University of Cincinnati, Ohio
Shi, P., B.S., University of Kentucky, Lexington
Van Biervliet, J., Ph.D., KU Leuven, VIB, Herestraat, Belgium
Wider, C., Ph.D., Mayo Clinic College of Medicine, Jack-
sonville, Florida
Wood, R., Ph.D., University of Southern California, Los Angeles
Wu, J., B.S., University of California, Irvine
Yao, J., B.S., University of Southern California, Los Angeles
Zetterstrom, P., B.S., Umea University, Umea, Sweden
SEMINARS
Cookson, M., National Institute on Aging, Bethesda, Maryland:
Parkinson’s disease.
Davidson, B., University of Iowa, Des Moines: Gene manipula-
tion therapy.
Dickson, D., Mayo Clinic Jacksonville, Florida: Neuropathologi-
cal aspects of neurodegeneration.
Driscoll, M., Rutgers University, Piscataway, New Jersey: Inver-
tebrate models.
Duff, K., Columbia University, New York: Models of Alzheimer’s
disease.
Gwinn, K., NINDS, Bethesda, Maryland: Clinical features of
neurological disorders.
Hardy, J., University College London, United Kingdom: Genet-
ics of neurodegenerative diseases.
Heikenwälder, M., Institute for Neuropathology, Zurich, Switzer-
land: The molecular biology of prion diseases.
Iadecola, C., Cornell University, Ithaca, New York: Stroke.
McNamara, J., Duke University, Durham, North Carolina: Neu-
rotrophins and epileptogenesis.
Orr, H., University of Minnesota, Minneapolis: Triplet repeat dis-
orders.
Rademakers, R., Mayo Clinic College of Medicine, Jack-
sonville, Florida: Tauopathies and other dementias.
Siegel, J., University of California, Los Angeles: Role of
hypocretin (Orexin) in narcolepsy, Parkinson’s, and normal
behavior.
Warren, S., Emory University, Atlanta, Georgia: Fragile X.
Wynshaw-Borris, A., University of California, San Diego: Disor-
ders of neuronal migration.
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Advanced Bacterial Genetics
June 6–26
INSTRUCTORS J. Kirby, University of Iowa, Iowa City
S. Lovett, Brandeis University, Waltham, Massachusetts
A. Segall, San Diego State University, San Diego, California
ASSISTANTS D. Ferullo, Brandeis University, Natick, Massachusetts
C. Gunderson, San Diego State University, San Diego, California
M.C. Roper, University of Connecticut, Storrs
H. Vlamakis, Harvard Medical School, Boston, Massachusetts
The course presented logic and methods used in the genetic dissection of complex biological processes
in eubacteria. Laboratory methods included classical mutagenesis using transposons, mutator strains,
and chemical and physical mutagens; the mapping of mutations using genetic and physical techniques;
modern approaches to the generation and analysis of targeted gene disruptions and fusions using PCR
and cloning methods; epitope insertion mutagenesis; and site-directed mutagenesis. Key components
of the course were the use of sophisticated genetic methods in the analysis of model eubacteria, and the
use of the wealth of new genomic sequence information to motivate these methods. Invited lecturers pre-
sented various genetic approaches to study eubacterial mechanisms of metabolism, development, and
pathogenesis.
Speakers in the course included John Battista (Louisana State University and A&M College), David
Botstein (Princeton University), Victor DiRita (University of Michigan Medical School), Susan Gottesman
(National Cancer Institute), Alan Grossman (Massachusetts Institute of Technology), Kelly Hughes (Uni-
versity of Utah), Stanley Maloy (San Diego State University), and Thomas Silhavy (Princeton University).
This course was supported with funds provided by the National Science Foundation.
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PARTICIPANTS
Aregger, R., M.S., University of Basel, Switzerland
Burger, L., M.S., University of Basel, Switzerland
Che, Y.-S., M.S., Osaka University, Japan
Dobrinski, K., B.S., University of South Florida, Tampa
Evans, T., B.A., University of Cambridge, United Kingdom
Galli, E., B.S., Newcastle University, United Kingdom
Grice, R., B.A., deCODE Biostructures, Bainbridge Island,
Washington
Hartman, T., B.S., Albert Einstein College of Medicine, Bronx,
New York
Iovine, N., Ph.D., New York University School of Medicine, New York
Iyengar, G., Ph.D., Columbia University, New York
Klebensberger, J., Diplom., University of Konstanz,
Germany
Lovmar, M., Ph.D., Goteborg University, Sweden
Marks, M., Ph.D., Grinnell College, Grinnell, Iowa
Reimann, S., Ph.D., Loyola University Chicago, Maywood,
Illinois
Shen, X., M.S., Harley McAdams and Mark Horowitz, Stanford,
California
Yuan, J., Ph.D., Harvard University, Cambridge, Massachusetts
SEMINARS
Battista, J., Louisana State University and A&M College, Baton
Rouge: Directed evolution of extreme radioresistance in E.
coli strain MG1655.
Bostein, D., Princeton University, New Jersey: How the
genome and the computer have changed biological
science.
DiRita, V., University of Michigan Medical School, Ann Arbor:
Genetic approaches to the study of two bacterial
pathogens: Vibrio cholerae and Campylobacter jejuni.
Gottesman, S., National Cancer Institute, Bethesda, Maryland:
Genetic dissection of small RNA roles in regulation.
Grossman, A., Massachusetts Institute of Technology, Cam-
bridge: Control of horizontal gene transfer and recognition
of self in Bacillus subtilis.
Hughes, K., University of Utah, Salt Lake City: Reducing the
irreducible complexity of the bacterial flagellum.
Kirby, J., University of Iowa, Iowa City: Multicellularity and sig-
nal transduction in bacteria.
Lovett, S., Brandeis University, Waltham, Massachusetts: New
mechanisms of replication fork repair: Template switch
repair and the interplay of DNA damage with the SigmaS
stress response.
Maloy, S., San Diego State University, California: Chromosome
perversions in Salmonella.
Segall, A., San Diego State University, California: DNA repair, a
novel target of antibiotics: A voyage from basic science to
practical application.
Silhavy, T., Princeton University, New Jersey: Outer-membrane
biogenesis in gram-negative bacteria.
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Ion Channel Physiology
June 6–26
INSTRUCTORS J. Diamond, National Institutes of Health, Bethesda, Maryland
M. Farrant, University College London, United Kingdom
M. Hausser, University College London, United Kingdom
COINSTRUCTOR K. Swartz, National Institutes of Health, Bethesda, Maryland
ASSISTANTS A. Alabi,, NINDS, Bethesda, Maryland
R. Ali, University College London, United Kingdom
L. Kelly, University College London, United Kingdom
S. Moore, Northwestern University, Evanston, Illinois
A. Scimemi, National Institutes of Health, Bethesda, Maryland
B. Stell, Universite Paris 5, Paris, France
The primary goal of this course was to investigate through lectures and laboratory work the properties
of ion channels that allow neurons to carry out their unique physiological functions in a variety of neural
systems. Areas of particular interest included channels that (1) are activated by neurotransmitters at cen-
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Bhakar, A., Ph.D., Massachusetts Institute of Technology,
Cambridge
Clemens, A., B.S., The University of Texas, Austin
Demir, E., Ph.D., Cold Spring Harbor Laboratory
Gertler, T., B.A., Northwestern University, Chicago, Illinois
Graham, D., B.S., Brown University, Providence, Rhode Island
Hiramoto, M., Ph.D., Cold Spring Harbor Laboratory
Hires, A., B.S., University of California, San Diego, La Jolla
Huang, W., B.A., University of California, San Francisco
Kozorovitskiy, Y., B.A., Princeton University, New Jersey
Martinez-Rubio, C., B.A., University of Puerto Rico, San Juan
Olveczky, B., Ph.D., Harvard University/MIT, Cambridge,
Massachusetts
Parekh, R., B.A., Pennsylvania State University, University
Park
tral and peripheral synapses, (2) are activated by voltage changes in axons and dendrites, (3) respond
to neuromodulators with changes in functional properties, and (4) are developmentally required and reg-
ulated. The research interests of guest lecturers reflected these areas of emphasis.
The laboratory component of the course introduced students to electrophysiological approaches for
the study of ion channels in their native environments. Hands-on exercises included patch-clamp record-
ing of ion channel activity in oocytes and in brain slice preparations. Different recording configurations
were used to examine macroscopic or single-channel activity. The advantages and disadvantages of dif-
ferent methods, preparation, and recording techniques were considered in relation to the specific scien-
tific questions being asked. Admissions priority was given to students and postdocs with a demonstrated
interest, specific plans, and a supportive environment to apply these techniques to a defined problem.
Guest speakers included Clay Armstrong (University of Pennsylvania), John Issac (Developmental
Synaptic/NINDS), Jeffry Isaacson (University of California, San Diego), Amy Lee (Emory University), Jef-
frey Magee (LSUHSC), Steven Siegelbaum (Columbia University), Ivan Soltesz (University of California,
Irvine), and Neson Spruston (Northwestern University).
This course was supported by the Howard Hughes Medical Institute.
PARTICIPANTS
SEMINARS
Armstrong, C., University of Pennsylvania, Philadelphia: The
gating of ion channels.
Hausser, M., University College London, United Kingdom:
Synaptic integration.
Isaac, J., Developmental Synaptic/NINDS, Bethesda, Mary-
land: Development of the layer-4 barrel cortex circuit.
Isaacson, J., University of California, San Diego, La Jolla:
Microcircuits.
Lee, A., Emory University, Atlanta, Georgia: Macromolecular
regulation of voltage-gated Ca+ channels.
Magee, J., Louisiana State University Health Sciences Center,
New Orleans: Dendrites.
Siegelbaum, S., Columbia University, New York: Hyperpolariza-
tion-activated cation channels and their function in neural
activity.
Soltesz, I., University of California, Irvine: Activity-dependent
plasticity of endocannabinoid signaling.
Spruston, N., Northwestern University, Evanston, Illinois: Den-
dritic integration and synaptic plasticity.
Swartz, K., NINDS/NIH, Bethesda, Maryland: K+ channel struc-
ture, permeation mechanisms, and gating. Mechanisms of
voltage sensing.
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Molecular Embryology of the Mouse
June 6–26
INSTRUCTORS D. Threadgill, University of North Carolina, Chapel Hill
P. Trainor, Stowers Institute for Medical Research, Kansas City, Missouri
COINSTRUCTORS V. Pachnis, National Institutes for Medical Research, London, United Kingdom
L. Pevny, University of North Carolina, Chapel Hill
ASSISTANTS S. Hutton, University of North Carolina, Chapel Hill
A. Iulianella,, Stowers Institute for Medical Research, Kansas City, Missouri
D. Natarajan, University of Cambridge, London, United Kingdom
J. Rivera-Perez, University of Massachusetts Medical School, Worcester
L. Sandell, Stowers Institute for Medical Research, Kansas City, Missouri
This intensive laboratory and lecture course was designed for biologists interested in applying their expert-
ise to the study of mouse development. Lectures provided the conceptual basis for contemporary
research in mouse embryogenesis and organogenesis, and laboratory practicals provided an extensive
hands-on introduction to mouse embryo analysis. Experimental techniques included in vitro culture and
manipulation of preimplantation and postimplantation embryos, embryo transfer, assisted reproduction
and cryopreservation, culture and genetic manipulation of embryonic stem cells, production of chimeras
by embryo aggregation and by ES cell injection, and transgenesis by pronuclear microinjection and
nuclear cloning. In addition, this year’s practicals featured increased emphasis on phenotypic analysis of
mutants, including techniques of histology, in situ hybridization, immunohistochemistry, skeletal prepa-
ration, vascular casting, organ culture, and tissue recombination.
This course was supported with funds provided by the National Cancer Institute.
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PARTICIPANTS
Afelik, S., Ph.D., University of Colorado Health Sciences Cen-
ter, Aurora
Aravin, A., Ph.D., Cold Spring Harbor Laboratory
Cai, L., B.S., University of North Carolina, Chapel Hill
Gaengel, K., Ph.D., Karolinska Institutet, Stockholm, Sweden
Garcia Gonzalo, F., Ph.D., The Salk Institute for Biological
Studies, La Jolla, California
Gebeshuber, C., M.S., Institute of Molecular Biology, Vienna,
Austria
Kostanova Pollakova, D., Ph.D., Institute of Molecular Biology,
Vienna, Austria
Liu, J., B.A., Wesleyan University, Middletown, Connecticut
Mommersteeg, M., M.S., University of Amsterdam, The
Netherlands
Ren, X., M.S., Free University of Brussels, Gosselies, Belgium
Ryan, N., B.S., Medical Research Council, London, United
Kingdom
Saze, H., Ph.D., National Institutes of Genetics, Japan
Shi, J., Ph.D., Novartis Institute of Biomedical Research, Cam-
bridge, Massachusetts
Wu, V., Ph.D., University of California, San Francisco
SEMINARS
Behringer, R., The University of Texas/M.D. Anderson Cancer
Center, Houston: Transgenics and insertional mutants.
Hadjantonakis, K., Memorial Sloan-Kettering Cancer Center,
New York: Mouse imaging.
Hochedlinger, K., Harvard Medical School and Harvard Stem
Cell Institute, Boston, Massachusetts: Nuclear reprogram-
ming.
Justice, M., Baylor College of Medicine, Houston, Texas: ENU
mutagenesis screens and chromosome engineering.
Lovell-Badge, R., MRC National Institute for Medical Research:
Sex determination.
Magnuson, T., University of North Carolina, Chapel Hill: Epige-
netics.
Majesky, M., Baylor College of Medicine, Houston, Texas: Vas-
culogenesis.
McLaren, A., University of Cambridge, United Kingdom: Germ
cells.
McMahon, A., Harvard University, Cambridge, Massachusetts:
Kidney organogenesis.
Mombaerts, P., The Rockefeller University, New York: Olfactory
system.
Nagy, A., Samuel Lunenfeld Research Institute, Toronto,
Canada: Gene targeting.
Ornitz, D., Washington University, St. Louis, Missouri: Skeletal
biology.
Pachnis, V., National Institutes for Medical Research, London,
United Kingdom: Enteric neural crest, gut, intestine devel-
opment.
Parada, L., University of Texas Southwestern Medical Center,
Dallas: Cancer tumor.
Pevny, L., University of North Carolina, Chapel Hill: Neural stem
cells neurogenesis.
Pfaff, S., The Salk Institute, La Jolla, California: Spinal cord
neurogenesis.
Rosenthal, N., European Molecular Biology Laboratory, Mon-
terortondo-Scala, Italy: Heart development.
Sherr, C., HHMI/St. Jude Children’s Research Hospital, Mem-
phis, Tennessee: Tumorigenesis, p53, Arf.
Solter, D., Max-Planck-Institut für Immunobiologie, Freiburg,
Germany: Preimplanation development.
Soriano, P., Fred Hutchinson Cancer Research Center, Seattle,
Washington: PDGF, Eph/Ephrin signaling.
Stewart, C., National Cancer Institute, Frederick, Maryland: ES
cells.
Tajbakhah, S., Pasteur Institute, Paris, France: Myogenesis and
muscle satellite stem cells.
Takahashi, J., HHMI/Northwestern University, Evanston, Illinois:
Behavioural genetic screens and development.
Tam, P., Children’s Medical Research Institute, Sydney, Aus-
tralia: Introduction to mouse development. Gastrulation and
formation of the body plan.
Threadgill, D., University of North Carolina, Chapel Hill: Quanti-
tative traits.
Trainor, P., Stowers Institute for Medical Research, Kansas City,
Missouri: Neural crest cells and crainofacial development.
Woychik, R., The Jackson Laboratory, Bar Harbor, Maine:
Mouse genetics.
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Integrated Data Analysis for High-throughput Biology
June 13–26
INSTRUCTORS H. Bussemaker, Columbia University, New York
V. Carey, Harvard University, Boston, Massachusetts
P. Mitra, Cold Spring Harbor Laboratory
M. Reimers, National Cancer Institute, Bethesda, Maryland
ASSISTANTS G. Halasz, Columbia University, New York
P. Gomez-Alcala, Columbia University, New York
D.W. Lucas, Columbia University, New York
J. Mar, Harvard University, Cambridge, Massachusetts
J. Zhang, Dana-Farber Cancer Institute, Walpole, Massachusetts
High-throughput biology, epitomized by the ubiquitous DNA microarray, is rapidly generating enormous
observation sets. Biologists seeking to make sense of this growing body of data need to have a firm
grasp of statistical methodology. This course was designed to build competence in quantitative meth-
ods for the analysis of high-throughput molecular biology data, from which meaningful inferences about
biological processes can be drawn. It also included the following:
• Review of multivariate statistics.
• R minitutorial.
• Expression and other microarrays: experimental design, scanning and image analysis, quality control,
normalization and probe-level analysis for spotted arrays or prefabricated chips, exploratory analysis,
tests of significance and multiple testing, using R and the Bioconductor.
• Discrimination and classification of samples.
• Identifying general regulation themes (e.g., Gene Ontology categories) in gene lists by statistical means.
• Promoter analysis in yeast using ChIP and expression data.
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• Identifying regulatory polymorphisms using SNP and expression data.
• Characterizing the effect of DNA amplifications and deletions on gene expression in cancer using
CGH and expression data on the same samples.
Speakers in this year’s course included Keith Baggerly (M.D. Anderson Cancer Center), Benilton Car-
valho (The Johns Hopkins University), Vivian Cheung (University of Pennsylvania), Aedin Culhane (Dana
Farber Cancer Institute/Harvard), Bruce Futcher (Stony Brook University), Jason Lieb (University of North
Carolina, Chapel Hill), Dana Pe’er (Columbia University), Anirvan Sengupta (Rutgers University), Michael
Snyder (Yale University), Richard Spielman (University of Pennsylvania), Danielle Thierry-Mieg (National
Institutes of Health), Jean Thierry-Mieg (National Institutes of Health), and John Zhang (Dana-Farber Can-
cer Institute).
The first week of the course concentrated on analysis of specific types of microarray data (expression,
Affymetrix, CGH, ChIP-chip, and SNP arrays) and proteomics. The second week explored biological
problems involving the integration of several types of high-throughput data. Data sets were drawn from
yeast, human polymorphisms, and cancer biology.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Chicas, A., Ph.D., Cold Spring Harbor Laboratory
Doherty, C., B.A., Michigan State University, E. Lansing
Ghavihelm, Y., M.S., CEA/Saclay, Gif sur Yvette, France
Margolis, R., Ph.D., NIDDK/NIH, Bethesda, Maryland
Meza-Zepeda, L., Ph.D., Rikshospitalet-Radiumhospitalet
Medical Center, Oslo, Norway
Miller, J., B.S., University of California, Los Angeles
Mohanty, S., Ph.D., ETH Zurich, Switzerland
Ni, X., B.S., The University of Chicago, Illinois
Nickles, D., Dipl., German Cancer Research Institute, Heidel-
berg, Germany
Palta, P., B.Sc., University of Tartu, Estonia
Speers, C., B.S., Baylor College of Medicine, Houston, Texas
Tantisira, K., M.D., Brigham and Women’s Hospital, Boston,
Massachusetts
Wang, W., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
Wichert, S., Dipl., Max-Planck-Institute for Experimental
Medicine, Goettingen, Germany
Yang, B.-Z., Ph.D., Yale University, West Haven, Connecticut
Zheng, Y., Ph.D., Stanford University, Stanford, California
Zhou, Y., Ph.D., Fox Chase Cancer Center, Philadelphia, Penn-
sylvania
SEMINARS
Baggerly, K., M.D. Anderson Cancer Centre, Houston, Texas:
Reverse-phase protein arrays.
Bussemaker, H., Columbia University, New York: Interfering
condition-specific activity of TFs. In vivo versus in vitro tar-
get specificity. The importance of posttranscriptional regula-
tion.
Cheung, V., University of Pennsylvania, Philadelphia: Genetics
of gene expression.
Culhane, A., Dana Farber Cancer Institute/Harvard, Cam-
bridge, Massachusetts: Exploratory analysis and ordination.
Futcher, B., Stony Brook University, New York: Analysis of cell
cycle data in yeast.
Lieb, J., University of North Carolina, Chapel Hill: Microarray
technology. ChIP arrays and histones.
Lucito, R., Cold Spring Harbor Laboratory: Methylation arrays.
Pe’er, D., Columbia University, New York: Module networks.
Reimers, M., Virginia Commonwealth University, Richmond:
Microarray preprocessing—QA and normalization. Epige-
nomic data analysis.
Reimers, M., Virginia Commonwealth University, Richmond,
and Carvalho, B., The Johns Hopkins University, Baltimore,
Maryland: Oligonucleotide arrays.
Sengupta, A., Rutgers University, Piscataway, New Jersey, and
Bussemaker, H., Columbia University, New York: Quantify-
ing the sequence specificity of TFs.
Snyder, M., Yale University, New Haven, Connecticut: ChIP-
chip and/or protein arrays.
Spielman, R., University of Pennsylvania, Philadelphia: Geneti-
cal genomics.
Thierry-Mieg, J. and Theirry-Mieg, D., National Institutes of
Health, Bethesda, Maryland: MAQC. Alternate splicing (and
tiling arrays?).
Threadgill, D., University of North Carolina, Chapel Hill: Geneti-
cal genomics via the collaborative cross.
Wigler, M., Cold Spring Harbor Laboratory: CGH in cancer.
Zhang, J., Dana-Farber Cancer Institute, Boston, Massachu-
setts: Methylation.
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Workshop on Autism Spectrum Disorders
June 14–21
INSTRUCTORS D. Geschwind, University of California, Los Angeles
P. Levitt, Vanderbilt University, Nashville, Tennessee
S. Spence, National Institute of Mental Health, Bethesda, Maryland
Autism spectrum disorders (ASDs) are developmental disorders with complex phenotypes defined by a
triad of symptoms that include disrupted social abilities, verbal and nonverbal communication skills, and
restricted interests with repetitive behaviors. Co-occurring neurological and medical conditions often
occur in these disorders. The underlying etiology remains a mystery, but ASDs are the most highly heri-
table of neuropsychiatric disorders. This workshop examined dimensions of ASD on various levels, includ-
ing sessions on characteristics of the clinical syndrome; neuropathology, imaging, and cognitive
neuroscience studies that implicate circuits and systems involved in ASD; the current state of findings
from human genetics; concepts regarding the developmental neurobiological basis of ASD; and the use
of experimental models and current etiological theories and hypotheses of ASD.
In addition to hearing about the most recent research in these areas, we explored and debated con-
troversial topics and challenges to basic assumptions in the field. An exceptional faculty with diverse
interests brought the most up-to-date results and theories to the students, making this workshop a valu-
able resource for young researchers starting out in this fast-moving and expansive field. Not only did it
help them build the foundation for their future research, but it also introduced them to many potential col-
laborators working to understand ASD from different disciplines.
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Speakers this year included B.J. Casey (Weill Medical College at Cornell University, New York), Richard
Davidson (University of Wisconsin, Madison), Eric Fombonne (McGill University, Toronto, Canada), Takao
Hensch (Harvard University, Cambridge, Massachusetts), Portia Iverson (Cure Autism Now, Los Ange-
les, California), Ami Klin (Yale University School of Medicine, New Haven, Connecticut), David Ledbetter
(Emory University School of Medicine, Atlanta, Georgia), Carlos Pardo-Villamizar (Johns Hopkins Uni-
versity School of Medicine, Baltimore, Maryland), Richard Paylor (Baylor College of Medicine, Houston,
Texas), Isaac Pessah (University of California, Davis), Isabelle Rapin (Albert Einstein School of Medicine,
Bronx, New York), and Jeffrey Rogers (Southwest Foundation for Biomedical Research, San Antonio,
Texas).
PARTICIPANTS
Addante, R., B.S., University of California, Davis
Aldinger, K., B.S., Univeristy of Chicago, Illinois
Alonso, A., Ph.D., New York State Institute for Basic Research,
Staten Island
Bhatara, A., B.S., McGill University, Montreal, Canada
Bill, B., B.S., University of Minnesota, Burnsville
Bowers, K., B.S., Johns Hopkins University, Washington D.C.
Carpenter, K., B.S., University of North Carolina, Chapel Hill
Chukoskie, L., Ph.D., Salk Institute, La Jolla, California
Cubells, J., Ph.D., Emory University, Atlanta, Georgia
Dinstein, I., B.S., New York University, New York
Duo, J., Ph.D., Kanazawa University, Kanazawa, Japan
Gjevik, E., Ph.D., Ulleval University Hospital, Oslo, Norway
Herzing, L., B.S., Northwestern University, Evanston, Illinois
Hoffman, E., Ph.D., Mount Sinai School of Medicine, New York
Kumar, R., Ph.D., University of Chicago, Chicago, Illinois
Lenroot, R., Ph.D., National Institutes of Health, Bethesda,
Maryland
Lieberman, D., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Maffie, J., B.S., New York University, New York
Pasca, S., B.S., I. Hatieganu University, Cluj-Napoca, Romania
Payne, C., B.S., Emory University, Atlanta, Georgia
Rehnstrom, K., B.S., National Public Health Institute, Helsinki,
Finland
Smith, S., B.S., California Institute of Technology, Pasadena
Walker, J., B.S., University of Texas Southwestern Medical
Center, Dallas
SEMINARS
Casey, B.J., Weill Medical College at Cornell University, New
York: Introduction to imaging. Imaging from a neural sys-
tems perspective.
Fombonne, E., McGill University, Montreal, Canada: Autism
epidemiology, part I and part II.
Geschwind, D., University of California, Los Angeles: Neu-
ropathology and introduction to neural systems.
Klin, A., Yale University, New Haven, Connecticut: Clinical pres-
entation, core features, measures. Autism spectrum disor-
ders broader phenotypes, phenotypic variability, and
outcomes.
Levitt, P., Vanderbilt University, Nashville, Tennessee: Introduc-
tion to developmental neurobiology.
Levitt, P., Vanderbilt University, Nashville, Tennessee: Neuro-
anatomical systems implicated in autism spectrum
disorders.
Rapin, I., Albert Einstein School of Medicine, Bronx, New York:
History of autism spectrum disorders.
Spence, S., National Institutes for Mental Health, Bethesda,
Maryland: Clinical assessments. Medical models/
comorbidities. Treatment overview. Endophenotypes—Lan-
guage delay, epilepsy, regression, OFC.
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Workshop on Mechanisms of Alertness, Arousal, and Attention
June 22–29
INSTRUCTORS B. Kieffer, Institut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch, France
D. Pfaff, The Rockefeller University, New York
Brain mechanisms for arousal, alertness, and attention underlie and are necessary for all cognitive func-
tions and all emotional expression. This course covered what is known about neuroanatomy, neuro-
physiology, and functional genomics and explored the medical consequences of their damage in human
patients, e.g., vegetative states, attention deficit hyperactivity disorder, autism, age-related dementias,
mood disorders, and sleep disorders. Public health problems related to vigilance, environmental toxins,
and fatigue states were of interest. Relevant techniques were discussed, with an emphasis on molecu-
lar genetics on neurochemistry and on human and animal behavior. Closely related topics such as cir-
cadian rhythms and sleep/wake physiology were included.
Speakers this year included Don Pfaff (The Rockefeller University), Mark Bellgrove (University of
Queensland, Australia), Robert Moyzis (University of California, Irvine), Turhan Canli (Stony Brook Uni-
versity), Gary Aston-Jones (University of South Carolina), Cliff Kentros (University of Oregon), Nicholas
Schiff (Cornell Medical School), Steven Laureys (University of Liege, Belgium), Tor Wager (Columbia Uni-
versity), Brigitte Kieffer (University of Strasbourg, France), Joseph Takahashi (HHMI/Northwestern Uni-
versity), Rae Silver (Columbia University), Ronald Szymusiak (University of California, Los Angeles), Allan
Pack (University of Pennsylvania Medical School), Justin Blau (New York University), and Steve Brown
(University of Zurich, Switzerland).
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PARTICIPANTS
Burgos-Ruiz, E., B.S., Georgetown University, Washington,
D.C.
Clerkin, S., B.S., City University of New York, Yonkers
Davis, J., B.S., University of British Columbia, Vancouver, BC,
Canada
Haley, D., Ph.D., University of Toronto, Canada
Itoi, K., Ph.D., Tohoku University, Sendai, Japan
Keating, G., Ph.D., Emory University School of Medicine,
Atlanta, Georgia
Larkin, E., B.S., Case Western Reserve University, Cleveland,
Ohio
McVay, J., B.S., University of North Carolina, Greensboro
Melloni, L., Ph.D., Brain Imaging Center, Frankfurt, Germany
Mooshagian, E., B.S., University of California, Los Angeles
Panos, J., B.S., Western Michigan University, Kalamazoo
Roos, A., B.S., University of Stellenbosch, Tygerberg, South
Africa
Vosko, A., B.S., University of California, Los Angeles
SEMINARS
Aston-Jones, G., University of South Carolina, Charleston:
Arousal and motivational systems involved in reward-
seeking.
Bellgrove, M., University of Queensland, Australia: Molecular
genetics of attention.
Blau, J., New York University, New York: Transcriptional and
posttranscriptional mechanisms running the circadian
clock.
Brown, S., University of Zurich, Switzerland: Clocks throughout
the body: Interesting mechanisms and powerful tools.
Canli, T., Stony Brook University, New York: Genes related to
affect.
Kentros, C., University of Oregon, Eugene: Attentional modula-
tion of hippocampal representation of information.
Kieffer, B., Institut de Genetique et de Biologie Moleculaire et
Cellulaire, Illkirch, France: Genetic influences on opiodergic
systems in the CNS and their importance for reward.
Laureys, S., University of Liege, Belgium: Imaging of CNS
responses in patients with impaired levels of consciouness.
Moyzis, R., University of California, Irvine: Genes influencing
attention deficit disorders.
Pack, A., University of Pennsylvania Medical School, Philadel-
phia: Genetic contributions to the control of sleep.
Pfaff, D., The Rockefeller University, New York: Introduction.
Mechanisms underlying generalized CNS arousal.
Schiff, N., Weill Medical College of Cornell University, New
York: Disorders of consciousness in neurological patients.
Silver, R., Columbia University, New York: Suprachiasmatic
nerve cells governing fluctuations in arousal, alertness, and
attention.
Szymusiak, R., University of California, Los Angeles: Preoptic/
hypothalamic nerve cells influencing temperature, sleeping,
and waking behavior.
Takashashi, J., Northwestern University, Evanston, Illinois: Tran-
scriptional controls over circadian rhythms.
Wager, T., Columbia University, New York: Neural bases of
placebo effects and pains.
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Advanced Techniques in Molecular Neuroscience
June 29–July 15
INSTRUCTORS J. Eberwine, University of Pennsylvania Medical School, Philadelphia
J. Kohler, Stanford University, California
C. Lai, Scripps Research Institute, La Jolla, California
R. Lansford, California Institute of Technology, Pasadena
ASSISTANTS T. Bell, University of Pennsylvania School of Medicine, Philadelphia
C. Challis, Scripps Research Institute, La Jolla, California
D. Huss, California Institute of Technology, Pasadena
T. Peritz, University of Pennsylvania Medical Center, Philadelphia
G. Poynter, California Institute of Technology, Pasadena
M. Samson, Harvard Medical School/HHMI, Boston, Massachusetts
T. Young-Pearse, Brigham and Women’s Hospital and Harvard Medical School, Boston,
Massachusetts
This newly revised laboratory and lecture course was designed to provide neuroscientists at all levels
with a conceptual and practical understanding of several of the most advanced techniques in molecular
neuroscience. The course curriculum was divided into three sections: an extensive and up-to-date set
of laboratory exercises, daily lectures covering the theoretical and practical aspects of the various meth-
ods used in the laboratory, and a series of evening research seminars. The informal and interactive
evening lectures were given by leading molecular neuroscientists and served to illustrate the ways in
which the various experimental approaches have been used to advance specific areas of neurobiology.
In this year’s course, the laboratory portion included topics such as an introduction to the design and
use of animal virus vectors in neurobiology; the use of small interfering RNAs (siRNAs) for regulating the
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expression of specific genes in neurons; practical exercises in gene delivery systems including mam-
malian cell transfection protocols and single-cell electroporation techniques for targeted gene transfer in
vivo; an introduction to overall strategies, use and design of BAC transgenic vectors; multiplex and whole-
genome expression analyses using the most recent DNA microarray technologies (including labeled probe
preparation, data analyses, mining, and interpretation); quantitative real-time RT-PCR analyses from small
numbers of cells (RNA purification, PCR optimization, interpretation of results); single-cell PCR and cDNA
library construction; and methods and application of RNA amplification (aRNA).
Each laboratory module was followed by comprehensive data analyses and interpretation, protocol
troubleshooting, and suggestions for ways to improve or modify the existing technique. Finally, course
participants were introduced to bioinformatics and a wide range of Internet resources that are available
to molecular neuroscientists.
Speakers in the course included: Robert Darnell (HHMI/The Rockefeller University), Beverly Davidson
(University of Iowa), Peter Hotez (George Washington University), Kenneth Kosik (Neuroscience Research
Institute), Jeff Lichtman (Harvard University), Pierre-Marie Lledo (Pasteur Institute), Donald Lo (Duke Cen-
ter for Drug Discovery), Ardem Patapoutian (The Scripps Research Institute), Peter Reinhart (Wyeth
Reseach), Karel Svoboda (Janelia Farm Research Campus/HHMI), and George Yancopoulos (Regen-
eron Pharmaceuticals, Inc.).
This course was supported with funds provided by the National Institute of Mental Health, the National
Institute of Neurological Disorders & Stroke, and the Howard Hughes Medical Institute.
PARTICIPANTS
Arregui, L., M.S., Cinvestav, Mexico
Felsen, G., Ph.D., Cold Spring Harbor Laboratory
Fioravante, D., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
Geddie, M., B.S., Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts
Ghosh, J., Ph.D., University of Washington, Seattle
Hsu, C., B.A., Boston University School of Medicine, Massa-
chusetts
Hundahl, C.A., Ph.D., University of Aarhus, Denmark
Jones, K., B.S., Univesity of California, San Diego, La Jolla
Koos, T., Ph.D., Rutgers University, Newark, New Jersey
Mayoral, S., B.S., Stanford University, California
Potter, G., Ph.D., University of California, San Francisco
Prescott, S., Ph.D., Salk Institute, La Jolla, California
Reyes-Colon, D., B.S., University of Puerto Rico, San Juan
Sequerra, E., M.Sc., Universidade Federal de Rio de Janeiro,
Brazil
Tang, L., B.S., Johns Hopkins University School of Medicine,
Baltimore, Maryland
Torbidoni, A., Lic., Facultad de Ciencias Biomedicas, Pilar,
Argentina
SEMINARS
Darnell, R., HHMI/The Rockefeller University, New York: RNA-
binding proteins and the regulation of neuronal synaptic
plasticity.
Davidson, B., University of Iowa College of Medicine, Iowa City:
RNA interference: Biological tool and therapeutic modality.
Eberwine, J., University of Pennsylvania Medical School,
Philadelphia: Molecular biology of dendrite functioning—A
few surprises... .
Hotez, P., George Washington University, Washington, D.C.:
The neglected tropical diseases: The ancient afflictions of
stigma and poverty.
Kosik, K., Neuroscience Research Institute, Santa Barbara,
California: Neuronal microRNAs.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Transgenic strategies for combinatorial expression of fluo-
rescent proteins in the nervous system.
Lledo, P.-M., Pasteur Institute, Paris, France: Wiring newborn
neurons with old circuits.
Patapoutian, A., The Scripps Research Institute, Del Mar, Cali-
fornia: The fifth sense: The chemistry and biology of tem-
perature and pain detection.
Reinhart, P., Wyeth Research, Princeton, New Jersey: Devel-
oping disease modifying therapeutics for the treatment of
Alzheimer’s disease.
Svoboda, K., Janelia Farm Research Campus/HHMI, Ashburn,
Virginia: Analysis of neuronal circuits.
Yancopoulos, G., Regeneron Pharmaceuticals, Inc., Tarrytown,
New York: FO generation mice fully derived from gene-tar-
geted embryonic stem cells.
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Advanced Techniques in Plant Sciences
June 29–July 19
INSTRUCTORS T. Brutnell, Boyce Thompson Institute, Ithaca, New York
V. Irish, Yale University, New Haven, Connecticut
E. Kellogg, University of St. Louis, Missouri
J. Normanly, University of Massachusetts, Amherst
ASSISTANTS L. Bai, Cornell University, Ithaca, New York
K. Geuten, Yale University, New Haven, Connecticut
M. Lewandowski, University of Massachusetts, Amherst
This course provided an intensive overview of topics in plant physiology, biochemistry, and development,
focusing on molecular genetic and analytical approaches to understanding plant biology. It emphasized
recent results from Arabidopsis, maize, and a variety of other plants and provided an introduction to cur-
rent methods used in plant molecular biology. It was designed for scientists with some experience in
molecular techniques or in plant biology who wish to work with plants using the latest technologies in
genetics, molecular biology and biochemistry. The course consisted of a vigorous lecture series, a hands-
on laboratory, and informal discussions.
Discussions of important topics in plant research were presented by the instructors and by invited
speakers. These seminars included plant morphology and anatomy; plant development (such as devel-
opment of flowers, leaves, male and female gametophytes, and roots); perception of light and photo-
morphogenesis; cell wall biosynthesis, function, and perception of hormones and application of research
results to addressing current agronomic problems. Lectures describing bioinformatics tools available to
the plant community and the resources provided by plant genome projects were also included. Speak-
ers provided overviews of their fields, followed by in-depth discussions of their own work.
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The laboratory sessions provided an introduction to important techniques currently used in plant
research. These included studies of plant development, mutant analysis, histochemical staining, tran-
sient gene expression, gene silencing, applications of fluorescent protein fusions, protein interaction and
detection, proteomics approaches, several different approaches to quantifying metabolites, transient
transformation, and techniques commonly used in genetic and physical mapping. The course also
included several short workshops on important themes in plant research.
Invited speakers included Kenneth Birnbaum (New York University), Andy Bhattacharjee (Agilent),
John Celenza (Boston University), Savithramma Dinesh-Kumar (Yale University), Richard Flavell (Ceres
Inc.), Kevin Folta (University of Florida), Erich Grotewold (The Ohio State University), Stacey Harmer (Uni-
versity of California, Davis), David Jackson (Cold Spring Harbor Laboratory), Georg Jander (Boyce
Thompson Institute, Cornell University), Nancy Kerk (Yale University), Cris Kuhlemeier (University of Bern),
Thomas Nuhse (University of Manchester, United Kingdom), Torbert Rocheford (University of Illinois),
Jocelyn Rose (Cornell University), Eric Schaller (Dartmouth University), Ian Sussex (Yale University), Peter
Tiffin (University of Minnesota), and Marja Timmermans (Cold Spring Harbor Laboratory).
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Alcantara, J., Ph.D., SemBioSys Genetic Inc., Alberta,
Canada
Bertea, C., Ph.D., University of Turin, Italy
Bokowiec, M., M.A., University of Virginia, Charlottesville
Burhans, D., Ph.D., Canisius College, Buffalo, New York
De Paoli, H., M.S., University of Sao Paulo, Ribeirao Preto,
Brazil
Feinberg, P., B.S., New York University, New York
Matus, T., Ph.D. candidate, Pontificia Universidad Catolica de
Chile, Santiago, Chile
Opanowicz, M., Ph.D., John Innes Centre, Norwich, United
Kingdom
Rosler, J., Dipl., Justus Liebig University Giessen, Germany
Ryden, A.-M., M.Sc., Groningen University, The Netherlands
Sheldon, S., Ph.D., Middlebury College, Connecticut
Tamaru, H., Ph.D., Gregor Mendel Institute of Molecular Plant
Biology, Vienna, Austria
Yoshida, Y., M.S., Kyoto University, Japan
Zepeda Jazo, A.I., M.S., University of Colima, Mexico
SEMINARS
Bhattacharjee, A., Agilent, Andover, Massachusetts: ChIP-chip
data analysis.
Birnbaum, K., New York University, New York: Root develop-
ment.
Callis, J., University of California, Davis: Protein turnover.
Celenza, J., Boston University, Massachusetts: Secondary
metabolites: Glucosinolates.
Dinesh-Kumar, S., Yale University, New Haven, Connecticut:
Plant pathogen interactions.
Flavell, R., Ceres, Inc., Thousand Oaks, California: Plant bio-
mass and energy.
Folta, K., University of Florida, Miami: Light regulation.
Grotewold, E., University of Ohio, Columbus: Regulatory net-
works.
Irish, V., Yale University, New Haven, Connecticut: Reproduc-
tive development.
Jackson, D., Cold Spring Harbor Laboratory: Shoot meristem
development.
Jander, G., Boyce Thompson Institute, Ithaca, New York:
Quantitative genetics.
Kellogg, E., University of Missouri, St. Louis: Phylogenetics.
Kuhlemeier, C., University of Bern, Switzerland: Phyllotaxis.
Normanly, J., University of Massachusetts, Amherst:
Metabolomics.
Nuhse, T., University of Manchester, United Kingdom: Pro-
teomics.
Rocheford, T., University of Illinois, Urbana: Secondary
metabolites, carotenoids.
Rose, J., Cornell University, Ithaca, New York: Cell walls and
biofuels.
Schaller, G.E., Dartmouth College, Hanover, New Hampshire:
Plant hormones.
Sussex, I., Yale University, New Haven, Connecticut: Introduc-
tion to plant structure.
Tiffin, P., University of Minnesota, Minneapolis: Evolution of
pathogen resistance.
Timmermans, M., Cold Spring Harbor Laboratory: microRNA
regulation.
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Neurobiology of Drosophila
June 29–July 19
INSTRUCTORS G. Bashaw, University of Pennsylvania, Philadelphia
S. Waddell, University of Massachusetts Medical School, Worcester
B. Zhang, University of Oklahoma, Norman
ASSISTANTS H. Bao, University of Oklahoma, Norman
T. Evans, University of Pennsylvania Medical School, Philadelphia
M. Krashes, University of Massachusetts Medical School, Worcester
L. Yang, University of Pennsylvania, Philadelphia
This laboratory/lecture course was intended for researchers at all levels from beginning graduate stu-
dents to established primary investigators who want to use Drosophila as an experimental system for
nervous system investigation. The three-week course was divided into the study of development, phys-
iology/function, and behavior. Daily seminars introduced students to a variety of research topics and
developed those topics by including recent experimental contributions and outstanding questions in the
field. Guest lecturers brought original preparations for viewing and discussion and direct laboratory exer-
cises and experiments in their area of interest. The course provided students with hands-on experience
using a variety of experimental preparations that were used in the investigation of current neurobiologi-
cal questions.
The lectures and laboratories focused on both the development of the nervous system and its role in
controlling larval and adult behaviors. In addition to an exposure to the molecular genetic approaches
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available in Drosophila, students learned a variety of techniques including embryo in situ hybridization,
labeling of identified neurons, electrophysiology (intracellular recording and patch clamping), optical imag-
ing of neuronal activity, and the analysis of larval and adult behavior. Collectively, the course provided a
comprehensive and practical introduction to modern experimental methods for studying the Drosophila
nervous system.
This year’s lecturers included Heather Broihier (Case Western Reserve University), Vivian Budnik (Uni-
versity of Massachusetts), Sarah Certel (Harvard Medical School), Josh Dubnau (Cold Spring Harbor Lab-
oratory), Aki Ejima (Brandeis University), David Featherstone (University of Illinois at Chicago), Fen-Biao
Gao (The Gladstone Institutes at UCSF), Leslie Griffith (Brandeis University), Gregory Jefferis (University of
Cambridge), Maurice Kernan (Stony Brook University), Haig Keshishian (Yale University), Edward Kravitz
(Harvard Medical School), Adelaine Leung (MRC-Laboratory of Molecular Biology), Mala Murthy (CalTech),
Amita Sehgal (HHMI/University of Pennsylvania), Ping Shen (University of Georgia), Stephan Sigrist (Uni-
versity of Wurzburg), Bryan Stewart (University of Toronto), Susan Tsunoda (Boston University), Glenn
Turner (Cold Spring Harbor Laboratory), Bruno van Swinderen (Neurosciences Institute), and Jie Xu (The
University of Georgia).
This course ws supported with funds provided by the National Institute of Mental Health, the National
Institute of Neurological Disorders & Stroke, and the Howard Hughes Medical Institute.
PARTICIPANTS
Altman, J., B.A., University of Washington, Seattle
Behnia, R., Ph.D., New York University, New York
Berry, J., B.S., Baylor College of Medicine, Houston, Texas
Brierley, D., B.Sc., King’s College London, United Kingdom
Chiang, A., M.S., National Centre for Biological Sciences,
Bangalore, India
Friedman, E., M.D., University of Pennsylvania/HHMI, Philadel-
phia
Holt, M., Ph.D., Max-Planck Institute for Biophysical Chemistry,
Goettingen, Germany
Im, S.H., M.S., Washington University School of Medicine, St.
Louis, Missouri
Imad, M., Ph.D., University of Arizona, Tucscon
Koch, M., Ph.D., VIB and Kuleuven, Leuven, Belgium
Loya, C., B.S., Harvard Medical School, Boston, Massachu-
setts
Seay, D., Ph.D., The Rockefeller University, New York
SEMINARS
Bashaw, G., University of Pennsylvania, Philadelphia: Axon
guidance. Genetics 101.
Brohier, H., Case Western Reserve, Cleveland, Ohio: Neuronal
identity.
Budnik, V., University of Masschusetts, Worcester: NMJ devel-
opment.
Featherstone, D., University of Illinois, Chicago: Development
and regulation of glutamatergic signaling.
Freeman, M., University of Massachusetts, Worcester: Glial
development and Fn. Bioinformatics 101.
Gao, F.B., University of California, San Francisco: Dendrite
morphogenesis.
Griffith, L. and Ejima, A., Brandeis University, Waltham, Massa-
chusetts: Courtship.
Jefferis, G., Cambridge University, Cambridge, United King-
dom: Olfactory system development. Mosaic genetic tech-
niques.
Kerman, M., Stony Brook University, New York: Mechanotrans-
ducers and mechanotransduction.
Keshishian, H., Yale University, New Haven, Connecticut: Neu-
ronal activity and synaptic plasticity.
Kravitz, E. and Certel, S., Harvard Medical School, Boston,
Massachusetts: Aggression.
Sehgal, A., University of Pennsylvania, Philadelphia: Circadian
rhythm and sleep.
Shen, P., University of Georgia, Athens: Feeding behavior.
Sigrist, S., European Neuroscience Institute, Gottingen, Ger-
many: Shedding light on assembly of synapse structure
and function.
Stewart, B., University of Toronto, Canada: Synaptic vesicle
exocytosis and beyond. Electrophysiology 101.
Tsunoda, S., Boston University, Massachusetts: Phototrans-
duction and the dynamic nature of signaling components in
the eye.
Turner, G., Cold Spring Harbor Laboratory, and Murthy, M.,
CalTech, Pasadena, California: Neural coding in the fly
brain: In vivo whole-cell patch-clamp recording methods.
Van Swinderen, B., Neuroscience Institute, San Diego, Califor-
nia: Visual learning/attention.
Waddell, S., University of Massachusetts Medical School,
Worcester: Introduction.
Waddell, S., University of Massachusetts Medical School,
Worcester, and Dubnau, J., Cold Spring Harbor Laboratory:
Olfactory learning and memory.
Zhang, B., University of Oklahoma, Norman: Synaptic vesicle
recycling.
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Structure, Function, and Development of the Visual System
July 6–19
INSTRUCTORS B. Chapman, University of California, Davis
W.M. Usrey, University of California, Davis
ASSISTANT C. Speer, University of California, Davis
This lecture/discussion course explored the functional organization and development of the visual sys-
tem as revealed by the use of a variety of anatomical, physiological, and behavioral methods. It was
designed for graduate students and more advanced researchers who wish to gain a basic understand-
ing of the biological basis for vision and to share in the excitement of the latest developments in this field.
Topics included phototransduction and neural processing in the retina; functional architecture of striate
cortex; cellular basis of cortical receptive field properties; the anatomy, physiology, and perceptual sig-
nificance of parallel pathways; functional parcellation of extrastriate cortex; the role of patterned neuronal
activity in the development of central visual pathways; and molecular mechanisms of development and
plasticity in the visual system.
Speakers in the course included Katja Brose (Cell Press), E.J. Chichilnisky (Salk Institute for Biologi-
cal Studies), Dennis Dacey (University of Washington), James DiCarlo (Massachusetts Institute of Tech-
nology), Marla Feller (University of California, San Diego), David Fitzpatrick (Duke University), Bill Guido
(Virginia Commonwealth University), Michael Hawken (New York University), Judith Hirsch (University of
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Southern California), Nancy Kanwisher (Massachusetts Institute of Technology), Rich Krauzlis (Salk Insti-
tute for Biological Studies), Tirin Moore (Stanford University), Tony Movshon (New York University), Jay
Neitz (Medical College of Wisconsin), Tatiana Pasternak (University of Rochester), Clay Reid (Harvard
Medical School), Ed Ruthazer (McGill University), Mike Shalden (University of Washington), Murray Sher-
man (University of Chicago), Lee Stone (NASA Ames Research Center), and David Williams (University
of Rochester).
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Caplovitz, G., B.S., Dartmouth College, Enfield, New Hamp-
shire
Federer, F., B.S., University of Utah, Salt Lake City
Goris, R., B.S., University of Leuven, Belgium
Henriksson, L., B.S., Helsinki University of Technology, Espoo,
Finland
Hussar, C., B.S., University of Rochester, New York
Jiang, F., B.S., University of Texas, Dallas
Karlen, S., B.S., University of California, Davis
Kurki, I., B.S., University of Helsinki, Finland
Law, J., B.S., University of Edinburgh, United Kingdom
MacKenzie, K., B.S., Brandeis University, Waltham, Massachu-
setts
Mauck, M., B.S., Medical College of Wisconsin, Milwaukee
Morhardt, D., B.S., Virginia Commonwealth University, Richmond
Muhammad, R., B.S., Massachusetts Institute of Technology,
Cambridge
Olkkonen, M., B.S., Justus-Leibig University, Giessen, Ger-
many
Rochefort, N., Ph.D., Institute of Neuroscience, Munich, Ger-
many
Schmidt, A., B.S., Max-Planck Institute for Brain Research,
Frankfurt, Germany
Shushruth, S., B.S., University of Utah, Salt Lake City
Soto-Sanchez, C., Ph.D., University of Southern California, Los
Angeles
Swearington, J., B.S., Medical University of South Carolina,
Charleston
Wang, C., Ph.D., Washington University, St. Louis, Missouri
Wang, X., B.S., University of Southern California, Los Angeles
Wei, H., B.S., University of Louisville, Kentucky
Weng, C., B.S., State University of New York, College of
Optometry
SEMINARS
Brose, K., Cell Press, Cambridge, Massachusetts: Behind the
scenes of the review process at neuron.
Chapman, B., University of California, Davis: How the visual
system got its stripes.
Chichlilnisky, E.J., The Salk Institute, La Jolla, California:
Ensemble coding of visual information in primate retina.
Dacey, D., University of Washington, Seattle: Parallel visual
pathways and retinal microcircuits.
DiCarlo, J., Massachusetts Institute of Technology, Cambridge:
Neuronal representation of the visual world: What is the
ventral visual stream doing?
Feller, M., University of California, San Diego: The mechanisms
and function of retinal waves.
Fitzpatrick, D., Duke University, Durham, North Carolina: The
functional architecture of cortical circuits.
Guido, W., Virginia Commonwealth University, Richmond:
Development of the retinogeniculate pathway: Structure,
function, and underlying mechanisms.
Hawken, M., New York University, New York: Structure and
function in macaque monkey V1.
Hirsch, J., University of Southern California, Los Angeles:
Comparing thalamus with cortex: Conserved and unique
features of neural circuits that build visual receptive fields.
Kanwisher, N., Massachusetts Institute of Technology, Cam-
bridge: fMRI investigations of the functional organization of
the ventral visual pathway.
Krauzlis, R., The Salk Institute, San Diego, California: Coordina-
tion of voluntary eye movements.
Moore, T., Stanford University, California: Neural control of
visual spatial attention.
Movshon, A., New York University, New York: Visual response
properties of MT neurons.
Neitz, J., Medical College of Wisconsin, Milwaukee: Photopig-
ments and photoreceptors: Their evolution and their role in
vision.
Oberdorfer, M., National Institutes of Health, Bethesda, Mary-
land: NEI/NIH support for vision research.
Pasternak, T., University of Rochester, New York: Responses
to behaviorally relevant visual motion in primate cortex.
Reid, C., Harvard Medical School, Boston, Massachusetts:
Imaging neurons in the brain.
Ruthazer, E., McGill University, Montreal, Canada: Visual sys-
tem development in fish and frogs.
Shadlen, M., University of Washington, Seattle: A vision of
decision-making.
Sherman, M., University of Chicago, Illinois: Role of thalamus in
the flow of information to cortex.
Steinmetz, M., Center for Scientific Review/NIH, Bethesda,
Maryland: Peer review at NIH.
Stone, L., NASA Ames Research Center, Moffett Field, Califor-
nia: Visual processing for perception and oculomotor
action.
Usrey, M., University of California, Davis: Visual processing in
the retinogeniculocortical pathway.
Williams, D., University of Rochester, New York: The limits of
human vision.
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Eukaryotic Gene Expression
July 18–August 7
INSTRUCTORS M. Bulger, University of Rochester School of Medicine, Rochester, New York
T. Oelgeschläger, Marie Curie Research Institute, Oxted, United Kingdom
A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
ASSISTANTS V. Caputo, Marie Curie Research Institute, Oxted, United Kingdom
G. Fromm, University of Rochester, Rochester, New York
P.F. Wang, University of Nebraska Medical Center, Omaha
This course was designed for students, postdocs, and principal investigators who have recently ventured
into the exciting area of gene regulation. The course focused on state-of-the-art strategies and tech-
niques employed in the field. Emphasis was placed both on in vitro and in vivo protein–DNA interactions
and on novel methodologies to study gene regulation. Students made nuclear extracts, performed in vitro
transcription reactions, and measured RNA levels using primer extension. Characterizations of the DNA-
binding properties of site-specific transcription factors were carried out using electrophoretic mobility shift
and DNase I footprinting assays. In addition, students learned techniques for the assembly and analysis
of chromatin in vitro, including transcription assays, chromatin footprinting, and chromatin remodeling
assays.
During the past few years, the gene regulation field has developed in vivo approaches to study gene
regulation. Students were exposed to the chromatin immunoprecipitation technique. They used RNAi
for specific knockdown experiments in mammalian cells. In addition, determining cellular gene expres-
sion profiles has been accelerated tremendously by DNA microarray technology. Students received
hands-on training in performing and interpreting results from DNA microarrays.
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Experience with basic recombinant DNA techniques was a prerequisite for admission to this course.
Lectures by the instructors covered the current status of the gene expression field, theoretical aspects
of the methodology, and broader issues regarding strategies for investigating the regulation of gene
expression in eukaryotes. Guest lecturers discussed contemporary problems in eukaryotic gene regula-
tion and technical approaches to their solution.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Camargo, M., Ph.D., University of Sao Paulo, Brazil
Hsu, C.-P., Ph.D., Academia Sinica, Taipei, Taiwan
Johnson, M., Ph.D., Teagasc, Fermoy, Republic of Ireland
Karouzakis, E., M.S., University of Hospital Zurich, Switzerland
Kimura, M., Ph.D., Gifu University School of Medicine, Japan
Kurata, H., Ph.D., Washington University School of Medicine,
St. Louis, Missouri
Mannikarottu, A., Ph.D., Albany College of Pharmacy, New
York
Monrad, A., M.S., University of Copenhagen, Denmark
Prucca, C., M.Sc., Mercedes & Martin Ferreyra Medical
Research, Cordoba, Argentina
Puliafito, A., Ph.D., University of California, Santa Barbara
Shilov, B., Ph.D., Siberian State Medical University, Tomsk,
Russia
Sonderby, I., M.S., Copenhagen University, Denmark
Stoytcheva, Z., Ph.D., University of Hawaii, Honolulu
Teixeira, C., Ph.D., New York University, New York
White, A., M.S., Rutgers University, Piscataway, New Jersey
Yip, S.P., Ph.D., The Hong Kong Polytechnic University, China
SEMINARS
Becker, P., Ludwig Maxmilians Universität, München, Germany:
Dosage compensation in Drosophia: Beginning and end of
generalization.
Berger, S., The Wistar Institute, Philadelphia, Pennsylvania:
Histone modifications and gene expression.
Bickmore, W., Western General Hospital, Edinburgh, United
Kingdom: Linking nuclear organization and gene expres-
sion.
Bulger, M., University of Rochester, New York: Patterns of his-
tone modification and gene expression erythroid cells.
Buratowski, S., Harvard Medical School, Boston, Massachu-
setts: The RNA polymerase II CTD mediates multiple mech-
anisms for suppressing cryptic transcription.
Conaway, J., Stowers Institute for Medical Research, Kansas
City, Missouri: The basal transcription machinery: Biochem-
istry of a multicomponent system.
Fraser, P., The Babraham Institute, Cambridge, United King-
dom: Higher-order chromatin/chromosome conformations,
transcription, and nuclear organization of the genome.
Hahn, S., Fred Hutchinson Cancer Research Center, Seattle,
Washington: Transcription initiation and activation.
Levine, M., University of California, Berkeley: Gradient thresh-
olds in the Drosophila embryo and heart cell migration in
the ciona tadpole.
Oelgeschläger, T., Marie Curie Research Institute, Surrey,
United Kingdom: Role of the core promoter in the regulation
of RNA polymerase II transcription.
Roeder, R., The Rockefeller University, New York: Transcription
by RNA polymerase II.
Schultz, P., Institut de Genetique et de Biologie Moleculaire et
Cellulaire, Strasbourg, France: Structural studies of tran-
scription complexes by electron microscopy and tomogra-
phy.
Shiekhattar, R., The Wistar Institute, Philadelphia, Pennsylva-
nia: The RNAi machinery.
Shilatifard, A., Stowers Institute for Medical Research, Kansas
City, Missouri: Transcription elongation control, histone
methylation, and human leukemia.
Tora, L., Institut de Genetique et de Biologie Moleculaire et Cel-
lulaire, Strasbourg, France: TFTC/STAGA HAT COMPLEX
links stress response, histone, H2B deubiquitination-depen-
dent chromatin remodeling, and transcription activation.
Tsukiyama, T., Fred Hutchinson Cancer Research Center, Seat-
tle, Washington: Chromatin remodeling determines tran-
scriptional orientation.
Workman, J., Stowers Institute for Medical Research, Kansas
City, Missouri: Protein complexes that modify chromatin for
transcription.
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Biology of Memory
July 22–August 4
INSTRUCTORS K. Martin, University of California, Los Angeles
J. Raymond, Stanford University, California
This lecture course provided an introduction to cellular, molecular, and systems approaches to learning
and memory. It was suited for graduate students and postdoctoral fellows in molecular biology, neuro-
biology, and psychology, as well as research workers who are interested in an introduction to this field.
The course covered topics ranging from behavioral considerations of learning and memory to gene reg-
ulation in the nervous system. The lectures provided an intensive coverage of modern behavioral stud-
ies of learning and memory, the cell and molecular biology of neuronal plasticity, cellular and molecular
mechanisms of simple forms of learning and memory, and systems approaches to learning in vertebrates
and humans. Lectures were complemented by exercises in which students worked in small groups with
lecturers to discuss topical issues in learning and memory, to evaluate recent studies, and to identify and
formulate new research questions and approaches. The course was thus designed not only to introduce
students to the field of learning and memory, but also to provide an intellectual framework upon which
future studies can be built.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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PARTICIPANTS
Borlikova, G., B.S., Okinawa Institute of Science & Technology,
Uruma, Japan
Chen, D., B.S., Mount Sinai School of Medicine, New York
Ch’ng, T.H., Ph.D., University of California, Los Angeles
De Pasquale, R., B.S., Scuola Normale Superiore, Pisa, Italy
Dieguez, Jr., D., Ph.D., Boston University, Massachusetts
Hornsberger, M., B.S., McGill University, Montreal, Canada
Jeffrey, R., B.S., University of California, Los Angeles
Jorgensen, A., B.S., Lundbeck University, Valby, Denmark
Kennedy, P., B.S., Mount Sinai School of Medicine, New
York
King, S., B.S., University of Virginia, Richmond
Kinzer-Ursem, T., B.S., California Institute of Technology,
Pasadena
Lazaro-Munoz, G., B.S., New York University, New York
Miles, L., B.S., Emory University, Atlanta, Georgia
Moreira, F., Ph.D., Johannes Gutenberg University, Mainz, Ger-
many
Nguyen-Vu, T.D.B., B.S., Stanford Medical School, California
Shin, S.-L., Ph.D., Stanford University, California
Shobe, J., Ph.D., University of California, Irvine
Shrager, Y., B.S., University of California, San Diego
Taylor, A., Ph.D., California Institute of Technology, Pasadena
Ye, X., B.S., University of California, Irvine
SEMINARS
Bargmann, C., The Rockefeller University, New York: C. ele-
gans.
Bargmann, C., The Rockefeller University, New York, and Tully,
T., Cold Spring Harbor Laboratory: Model genetic systems
for studying memory.
Brody, C., Princeton University, New Jersey: Computational
approaches to learning and memory.
Byrne, J., University of Texas–Houston Medical School, Hous-
ton: Aplysia as a model system for studying memory.
Dan, Y., University of California, Berkeley: Spike-timing-depen-
dent plasticity.
Eichenbaum, H., Boston University, Massachusetts: Hip-
pocampal-mediated memories.
Holland, P., Johns Hopkins University, Baltimore, Maryland:
Learning theory.
Kennedy, M., California Institute of Technology, Pasadena: Bio-
chemistry of synaptic plasticity.
LeDoux, J., New York University, New York: Amygdala-medi-
ated memories.
Madison, D., Stanford University School of Medicine, California:
Synaptic plasticity, LTP, and LTD.
Martin, K., University of California, Los Angeles: Cell biology of
learning-related plasticity.
Raymond, J., Stanford University, California: Cerebellar-medi-
ated memories.
Silva, A., University of California, Los Angeles: Molecular cogni-
tion: Animal models of cognitive disorders.
Squire, L., University of California, San Diego: Historical
overview of memory research. Studies of memory in
humans.
Sur, M., Massachusetts Institute of Technology, Cambridge:
Map plasticity in the cortex.
Tully, T., Cold Spring Harbor Laboratory: Drosophila.
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Imaging Structure and Function in the Nervous System
July 24–August 13
INSTRUCTORS F. Engert, Harvard University, Cambridge, Massachusetts
M. Hubener, Max-Planck Institute of Neurobiology, Martinsried, Germany
D. Kleinfeld, University of California, San Diego, La Jolla
J. Waters, Northwestern University, Chicago, Illinois
ASSISTANTS F. Albineau, Harvard University, Cambridge, Massachusetts
A. Kampff, Harvard University, East Aurora, New York
T. Mrsic-Flogel, University College London, United Kingdom
V. Nagerl, Max-Planck Institute of Neurobiology, Munich, Germany
M. Rhiannon, University of Oxford, United Kingdom
A. Trevelyan, University of Newcastle, United Kingdom
P. Tsai, University of California, San Diego, La Jolla
J. Tyler, Arizona State University, Tempe
R. Vislay, Harvard University, Cambridge, Massachusetts
Advances in light microscopy and digital image processing, and the development of a variety of power-
ful fluorescent probes, present expanding opportunities for investigating the nervous system from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies.
The primary emphasis of the course was on vital light microscopy. Students learned the principles of
light microscopy, as well as use of different types of electronic cameras, laser-scanning systems, func-
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tional fluorophores, delivery techniques, and digital image-processing software. In addition to transmit-
ted light microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell
function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated (“caged”) compounds,
and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological methods
were covered. Particular weight was given to multi-photon laser-scanning microscopy and to newly avail-
able biological fluorophores, especially green fluorescent protein (GFP) and its variants. We used a spec-
trum of neural and cell biological systems, including living animals, brain slices, and cultured cells.
Participants had a strong background in the neurosciences or in cell biology.
Lecturers in the course included Hollis Cline (Cold Spring Harbor Laboratory ), Karl Deisseroth (Stan-
ford University), David DiGregorio (Universite Paris 5), Oliver Griesbeck (Max-Planck Institute of Neurobi-
ology), Kalanit Grill-Spector (Stanford University), Fred Lanni (Carnegie-Mellon University), Jeff Lichtman
(Harvard University), Jerome Mertz (Boston University), Tom Mrsic-Flogel (University College London),
Venkatesh Murthy (Harvard University), Valentin Nagerl (Max-Planck Institute of Neurobiology), Claudia
Racca (Newcastle University), Botond Roska (FMI), Petra Schwille (Tu Dresden, Germany), Karel Svo-
boda (Janelia Farm Research Campus/HHMI), Karen Willig (Max-Planck Institute for Biological Chemistry),
and Xiaowei Zhuang (Harvard University).
This course was supported with funds provided by the National Institute of Mental Health, the National
Institute of Neurological Disorders & Stroke, and the Howard Hughes Medical Institute.
PARTICIPANTS
Brennan, K,, Jr., M.D., University of California, Los Angeles
Chen, B.-S., Ph.D., NINDS/NIH, Bethesda, Maryland
Dhawale, A., B.Sc., National Centre for Biological Sciences,
Bangalore, India
Ewers, H., M.S., ETH Zurich, Switzerland
Helling, I., Dipl., Max-Planck Institute for Neurobiology, Munich,
Germany
Histed, M., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
Kim, J.H., Ph.D., Oregon Health & Science University,
Portland
Li, B., Ph.D., Cold Spring Harbor Laboratory
Pelletier, J., Ph.D., Universite de Montreal, Canada
Santhakumar, V., Ph.D., University of California, Los Angeles
Scimemi, A., Ph.D., National Institutes of Health, Bethesda,
Maryland
Wu, L.-J., Ph.D., University of Toronto, Canada
SEMINARS
Cline, H., Cold Spring Harbor Laboratory: Tadpoles rock.
Deisseroth, K., Stanford University, California: Light-triggered
activation/silencing.
DiGregorio, D., Universite Paris 5, Paris, France: Flash photoly-
sis.
Engert, F., Harvard University, Cambridge, Massachusetts:
Home-brew 2-photon overview.
Engert, F. and Kampff, A., Harvard University, Cambridge, Mas-
sachusetts: Shot noise, ImageJ, CCD cameras, PMTs.
Griesbeck, O., Max-Planck Institute of Neurobiology, Martins-
ried, Germany: Geneticially encoded sensors.
Grill-Spector, K., Stanford University, California: fMRI.
Hubener, M., Max-Planck Institute of Neurobiology, Martinsried,
Germany: Intrinsic imaging.
Kleinfeld, D., University of California, San Diego, La Jolla: De-
noising 1. De-noising 2. Blood flow. Voltage-sensitive dyes.
Lanni, F., Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Basic microscopy. Basic microscopy diffraction theory.
Light sources. DIC, Dot tube, Apotome, Demo.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Confocal microscopy.
Mertz, J., Boston University, Boston, Massachusetts: Nonlinear
techniques.
Mrsic-Flogel, T., University College London, United Kingdom:
Ca bulk loading in vivo.
Murthy, V., Harvard University, Cambridge, Massachusetts:
Synaptofluorins.
Naegerl, V., Max-Planck Institute of Neurobiology, Munich, Ger-
many: Bring in da noise: 2p nuggets and applications.
Racca, C., Newcastle University, Newcastle upon Tyne, United
Kingdom: Electron microscopy.
Roska, B., FMI, Basil, Switzerland: Viruses.
Schwille, P., Tu Dresden, Saxony, Germany: FCS
Svoboda, K., Janelia Farm Research Campus/HHMI, Ashburn,
Virginia: Basics of 2p imaging. Advanced 2p FRET< FLIM,
2p uncaging. 2p and Serial EM.
Tsai, P., University California, San Diego, La Jolla: Basic optical
design. Basic design scanning: Fluorescence.
Waters, J., Northwestern University, Evanston, Illinois: Organic
Ca indicators. In vivo Ca imaging.
Willig, K., Max-Planck Institute of Neurobiology, Goettingen,
Germany: Breaking the resolution limit.
Zhuang, X., Harvard University, Cambridge, Massachusetts:
STORM.
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Yeast Genetics and Genomics
July 24–August 13
INSTRUCTORS B. Errede, University of North Carolina, Chapel Hill
F. Luca, University of Pennsylvania, Philadelphia
M. Whiteway, National Research Council of Canada, Montreal
ASSISTANTS V. Kuravi, University of Pennsylvania, Philadelphia
H. Lavoie, McGill University, Montreal, Quebec, Canada
M. Mangos, National Research Council of Canada, Montreal, Quebec
This course was a modern state-of-the-art laboratory course designed to teach the students the full
repertoire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces cere-
visiae. Combinations of classical genetic approaches were emphasized, including the isolation and char-
acterization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular genetic
techniques included various types of yeast transformations, gene replacement with plasmids and PCR,
construction and analysis of gene fusions, and generation of mutations in cloned genes.
Students used classical and molecular approaches to gain experience in identifying and interpreting
various kinds of genetic interactions including suppression and synthetic lethality. They were immersed
in yeast genomics and performed and interpreted experiments with DNA arrays. The participants gained
first-hand experience in modern cytological approaches such as epitope tagging and imaging yeast cells
using indirect immunofluorescence, GFP-protein fusions, and a variety of fluorescent indicators for vari-
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ous subcellular organelles. Lectures on fundamental aspects of yeast genetics were presented along
with seminars given by outside speakers on topics of current interest.
This year’s speakers included David Amberg (SUNY Upstate Medical University), Angelika Amon
(Massachusetts Institute of Technology), Judith Berman (University of Minnesota), Charlie Boone (Uni-
versity of Toronto), James Broach (Princeton University), Dan Burke (University of Virginia), Dean Dawson
(Tufts University), Kara Dolinski (Princeton University), Daniel Finley (Harvard Medical School), Daniel Lew
(Duke University), Andrew Murray (Harvard University), Liza Pon (Columbia University), Jeffrey Strathern
(National Cancer Institute), and Lorraine Symington (Columbia University College of Physicians and Sur-
geons).
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Basu, A., B.S., The Rockefeller University, New York
Behar, M., Lic., The University of North Carolina, Chapel Hill
De Smet, C., M.S., Utrecht University, The Netherlands
Durand, D., Ph.D., Carnegie-Mellon University, Pittsburgh,
Pennsylvania
Im, Y.J., Ph.D., NIDDK/NIH, Bethesda, Maryland
Iofik, A., M.S., University of Tartu, Estonia
Ketel, C., Ph.D., University of Minnesota, Minneapolis
Kinkhabwala, A., Ph.D., Max-Planck Institute for Molecular
Physiology, Dortmund, Germany
Rest, J., Ph.D., University of Chicago, Illinois
Reyes, A.C., Ph.D., Göteborg University, Sweden
Reynolds, N., M.S., The Ohio State University, Columbus
Rocha, W., Ph.D., University of Montreal, Canada
Rydén, A.-M., M.Sc., University of Groningen, The Netherlands
Sankovich, S., B.S., CSIRO, Parkville, Australia
Sanyal, S., M.S., Cornell/Rockefeller/Sloan-Kettering, New
York
Sigurgislason, H., M.S., University of Iceland, Reykjavik
SEMINARS
Amberg, D., SUNY Upstate Medical University, Syracuse, New
York: Actin up in the Amberg lab.
Amon, A., Massachusetts Institute of Technology, Cambridge:
Causes and consequences of aneuploidy.
Berman, J., University of Minnesota, Minneapolis: Genomics
and genome instability in Candida albicans.
Boone, C., University of Toronto, Canada: Large-scale map-
ping of genetic and chemical-genetic interactions in yeast.
Broach, J., Princeton University, New Jersey: Nutrient sensing
and information processing in yeast.
Burke, D., University of Virginia, Charlottesville: Spindle check-
points.
Dawson, D., Oklahoma Medical Research Foundation, Okla-
homa City: Meiotic centromere coupling: Holding chromo-
somes together to help them fall apart.
Finley, D., Harvard Medical School, Boston, Massachusetts:
The ubiquitin-proteasome system.
Lew, D., Duke University, Durham, North Carolina: Cell polarity
and cell cycle control.
Murray, A., Harvard University, Cambridge, Massachusetts:
How yeast cells find a mate.
Pon, L., Columbia University, New York: Mitochondrial motility
and inheritance in budding yeast: Lessons from the
nucleus.
Strathern, J., National Cancer Institute, Frederick, Maryland:
The fidelity of transcription.
Symington, L., Columbia University College of Physicians and
Surgeons, New York: Mechanisms of homologous recom-
bination.
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Cellular Biology of Addiction
August 7–13
INSTRUCTORS C. Evans, University of California, Los Angeles
M. Von Zastrow, University of California, San Francisco
ASSISTANTS C. Bryant, University of Chicago, Illinois
M. Puthenveedu, University of California, San Francisco
Drug addiction is the most costly neuropsychiatric disorder faced by our nation. Acute and repeated
exposure to drugs produces neuroadaption and long-term memory of the experience, but the cellular and
molecular processes involved are only partially understood. The primary objective of the workshop was
to provide an intense dialogue of the fundamentals, state-of-the-art advances and major gaps in the cell,
and molecular biology of drug addiction.Targeted to new or experienced investigators, the workshop
combined formal presentations and informal discussions to convey the merits and excitement of cellu-
lar and molecular approaches to drug addiction research.
With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop
comprehensive models of neuroadaptative processes fundamental to addiction, withdrawal, craving, and
relapse to drug use and to brain function, in general. A range of disciplines and topics were represented,
including noninvasive brain imaging to identify drug targets and adaptive processes; neuroadaptative
processes at the molecular and cellular level, neural networks and their modulation, the relevance of
genotype to susceptibility and drug response; tolerance and adaptation at the cellular level; and
approaches to exploiting the daunting volume generated by neuroinformatics.
This workshop provided an integrated view of current and novel research on neuroadaptive responses
to addiction, fostered discussion on collaboration and integration, and provided critical information
needed to construct a model of addiction as a disease and novel molecular targets for biological treat-
ments. Beyond the plane of scientific endeavor, the information is vital for formulating public policy and
for enlightening the public on the neurobiological consequences of drug use and addiction. The pro-
posed workshop was designed to generate interest in this level of analysis, open conduits for collabo-
rations, and present novel routes to investigating the neurobiology of addictive drugs.
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Speakers in the course included Huda Akil (University of Michigan), George Augustine (Duke Univer-
sity Medical Center), Wade Berrentini (University of Pennsylvania), Lakshmi Devi (Mount Sinai School of
Medicine), Robert Edwards (University of California, San Francisco), David Goldman (NIAAA/LNG), Marin
Iguchi (University of California, Los Angeles), Peter Kalivas (Medical University of South Carolina), Brigitte
Kieffer (Institute de Genetique et de Biologie Moleculaire et Cellulaire, France), George Koob (Scripps
Research Institute), Mary Jean Kreek (The Rockefeller University), Angus Nairn (Yale University School of
Medicine), Eric Nestler (University of Texas Southwestern, Dallas), Marina Picciotto (Yale University), John
Pintar (University of Medicine & Dentristry of New Jersey), Michael Rosenfeld (University of California,
San Diego), Wolfgang Sadee (The Ohio State University), John Williams (Vollum Institute), Robert Williams
(University of Tennessee), Renping Zhou (Rutgers University College of Pharmacy), and Jon-Kar Zubeita
(University of Michigan).
This course was supported with funds provided by the National Institute of Drug Abuse.
PARTICIPANTS
Avena, N., Ph.D., The Rockefeller University, New York
Bland, S., Ph.D., University of Colorado,
Chen, X., Ph.D., Virginia Commonwealth University
Corlett, P., Ph.D., Cambridge University, United Kingdom
Culbertson, C., B.S., University of California, Los Angeles
Duke, A., B.S., Harvard Medical School,
Frantz, K., Ph.D., Georgia State University
Garcia-Fuster, J., Ph.D., University of Michigan
Gaval, M., B.S., Emory University
Hostetler, C., B.S., University of California, Davis
Nair, S., Ph.D., National Institute on Drug Abuse/NIH,
Bethesda, Maryland
Riley, B., Ph.D., Virginia Commonwealth University
Rothwell, P., B.S., University of Minnesota
Sable, H., Ph.D., University of Illinois, Urbana-Champaign
Tanabe, J., M.D., University of Colorado Health Sciences Center
Tidgewell, K., B.S., University of Iowa
Wallace, M., Ph.D., University of California, San Francisco
Wallach, M., Ph.D., Oregon Health & Science University
Wargelius, H., B.S., Uppsala University, Sweden
Williams, T., B.S., Weill Medical College of Cornell University
Yang, B.-Z., Ph.D., Yale University, New Haven, Connecticut
Yaragudri, V., Ph.D., Nathan Kline Institute for Psychiatric
Research
Yu, J., B.S., University of California, San Francisco
Zhu, J., Ph.D., University of South Carolina
SEMINARS
Akil, H., University of Michigan, Ann Arbor: Vulnerability to drug
abuse: Genetics and neuroplasticity.
Augustine, G., Duke University, Durham, North Carolina:
Synapsins: Roles in synaptic vesicle trafficking and behav-
ioral responses to psychotropic drugs.
Berrentini, W., University of Pennsylvania, Philadelphia: Whole-
genome association studies of nicotine dependence.
Devi, L., Mount Sinai School of Medicine, New York: Het-
erodimerization of mu and delta opioid receptors: A role in
modulating analgesia and addiction.
Edwards, R., University of California, San Francisco: The regu-
lation of monoamine transporters.
Evans, C. and Von Zastrow, M., University of California, San
Francisco: Introduction and course overview.
Goldman, D., NIH/NIAAA, Rockville, Maryland: Functional
genetic variation addiction vulnerability via stress resiliency.
Iguchi, M., University of California, Los Angeles: Drug abuse
and public policy: Making science matter.
Kalivas, P., Medical University of South Carolina, Mount Pleas-
ant: Can we forget to be addicted?
Kieffer, B., Institute de Genetique et de Biologie Moleculaire et
Cellulaire, Illkirch, France: Genetic approaches to study opi-
oid receptor function.
Koob, G., Scripps Research Institute, La Jolla, California: Neu-
rocircuitry of addiction: From reward to antireward.
Kreek, M.-J., The Rockefeller University, New York: Endor-
phins, gene polymorphisms, stress responsivity, and spe-
cific addictions: Selected topics.
Nairn, A., Yale University, New Haven, Connecticut: Dopamine-
regulated signal transduction mechanisms and the actions
of psychostimulants.
Nestler, E., University of Texas Southwestern, Dallas: Molecular
mechanisms of drug addiction.
Picciotto, M., Yale University, New Haven, Connecticut: Molec-
ular mechanisms underlying nicotine addiction.
Pintar, J., University of Medicine & Dentistry of New Jersey, Pis-
cataway: Genetic studies of opiod system function.
Pollock, J., National Institute on Drug Abuse/NIH/DHHS,
Bethesda, Maryland: Everything you wanted to know about
funding at NIH but you didn’t know who or what to ask.
Sadee, W., Ohio State University, Columbus: Searching for
polymorphisms that affect gene expression and mRNA pro-
cessing.
Williams, J., Vollum Institute/Oregon Health Sciences Univer-
sity, Portland: Opioids actions on single neurons and
synaptic connections.
Williams, R., University of Tennessee, Memphis: Gene expres-
sion networks in the mouse brain and their linkage to
addiction biology.
Zhou, R.P., Rutgers University, Piscataway, New Jersey: Devel-
opment of the midbrain dopaminergic pathways.
Zubeita, J.-K., University of Michigan, Ann Arbor: Neurochemi-
cal measures of stress and reward response circuitry in the
human brain.
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C. elegans
August 11–26
INSTRUCTORS S. Ahmed, University of North Carolina, Chapel Hill
M. de Bono, MRC/Cambridge, United Kingdom
A. Desai, Ludwig Institute for Cancer Research, La Jolla, California
ASSISTANTS A. Couto, MRC-Laboratory of Molecular Biology, Cambridge, United Kingdom
A. Dammermann, University of California, San Diego
L. Shtessel, University of North Carolina, Chapel Hill
This course was designed to familiarize investigators with C. elegans as an experimental system, with an
emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to teach
students how to successfully exploit the information generated by the C. elegans genome project. The
course was suited for those who have a current training in molecular biology and some knowledge of
genetics but no experience with C. elegans, as well as students with some prior worm experience who
wished to expand their repertoire of expertise.
The following topics were covered both in the laboratory and by lectures from experts in the field:
worm pushing, C. elegans databases and worm bioinformatics, anatomy and development, forward
genetics, chemical and transposon mutagenesis, generation of transgenic animals, expression pattern
analysis, reverse genetics, construction and screening of deletion libraries, and RNA inactivation. The
course was designed to impart sufficient training to students in the most important attributes of the C.
elegans system to enable students to embark on their own research projects after returning to their home
institutions.
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Speakers in the course included Andrew Dillin (The Salk Institute for Biological Studies), Monica Driscoll
(Rutgers, The State University of New Jersey), Marie-Anne Felix (Institut Jacques Monod, CNRS), Andrew
Fraser (The Wellcome Trust Sanger Institute), Barth Grant (Rutgers, The State University of New Jersey),
Jonathan Hodgkin (University of Oxford), Geraldine Seydoux (The Johns Hopkins University School of
Medicine), Kang Shen (Stanford University), and John White (University of Wisconsin).
This course was supported with funds provided by the National Institute of Child Health and Human
Development.
PARTICIPANTS
Arous, B.J., M.S., Ecole Normale Superieure, Paris, France
Butcher, R., Ph.D., Harvard Medical School, Boston, Massa-
chusetts
Gillan, V., Ph.D., University of Glasgow, United Kingdom
Guo, Z., B.S., Harvard University, Cambridge, Massachusetts
Hatin, I., Ph.D., Universite Paris Sud, Orsay, France
Hinas, A., M.S., Swedish University of Agricultural Sciences,
Uppsala, Sweden
Jagadeeswaran, R., Ph.D., University of Chicago Medical Cen-
ter, Illinois
Kikis, E., B.A., Northwestern University, Evanston, Illinois
Kirstein, J., M.S., Free University Berlin, Germany
Knoefler, D., M.S., University of Michigan, Ann Arbor
Li, X.-P., Ph.D., Rutgers, The State University of New Jersey,
New Brunswick
Neveu, P., M.S., Ecole Normale Superieure, Paris, France
Rhode, C., M.S., Massachusetts Institute of Technology, Cam-
bridge
Salinas, G., Ph.D., Universidad de la Republica, Uruguay
Salomon, M., B.S., University of Florida, Gainesville
Simonsen, K., M.S., University of Southern Denmark, Odense
M, Denmark
SEMINARS
Ahmed, S., University of North Carolina, Chapel Hill: DNA
repair.
de Bono, M., MRC-Laboratory of Molecular Biology, Cam-
bridge, United Kingdom: Behavior.
Desai, A., University of California, La Jolla: Cell biology of the
early embryo.
Dillin, A., The Salk Institute for Biological Studies, La Jolla, Cali-
fornia: Aging.
Driscoll, M., Rutgers, The State University of New Jersey, Pis-
cataway: Neurodegeneration.
Felix, M.-A., Institut Jacques Monod, CNRS, Paris, France:
Evolution and vulva formation.
Fraser, A., The Wellcome Trust Sanger Institute, Hinxton,
United Kingdom: RNAi.
Grant, B.,, Rutgers, The State University of New Jersey, Piscat-
away: Endocytosis.
Hodgkin, J., University of Oxford, United Kingdom: Pathogene-
sis and immunity.
Seydoux, G., Johns Hopkins University School of Medicine,
Baltimore, Maryland: Germ cell fate.
Shen, K., Stanford University, California: Synapse formation.
White, J., University of Wisconsin, Madison: Microscopy.
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X-Ray Methods in Structural Biology
October 15–30
INSTRUCTORS W. Furey, V.A. Medical Center/University of Pittsburgh, Pennsylvania
G. Gilliland, Centorcor R&D, Inc., Radnor, Pennsylvania
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT J. Luo, Centocor R&D, Inc., Radnor, Pennsylvania
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensified laboratory/computational course focused on the major techniques used to deter-
mine the three-dimensional structures of macromolecules. It was designed for scientists with a working
knowledge of protein structure and function but who are new to macromolecular crystallography.
Topics covered included basic diffraction theory, crystallization (proteins, nucleic acids, and com-
plexes), crystal characterization, X-ray sources and optics, synchrotrons, crystal freezing, data collection,
data reduction, multiple isomorphous replacement, multiwavelength anomalous diffraction, molecular
replacement, solvent flattening, noncrystallographic symmetry averaging, electron density interpretation,
molecular graphics, structure refinement, structure validation, coordinate deposition and structure pres-
entation. Participants learned through extensive hands-on experiments. Each student crystallized sev-
eral proteins and determined at least one structure by several methods, in parallel with lectures on the
theory and informal discussions behind the techniques.
Speakers in the course included Paul Adams, Zbigniew Dauter, Paul Emsley, Wayne Hendrickson,
Xinhua Ji, Leemor Joshua-Tor, Morten Kjeldgaard, Gerard Kleywegt, Anastassis Perrakis, Randy Read,
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David Richardson, Jane Richardson, Robert Sweet, Thomas Terwilliger, Dale Tronrud, David Waugh, and
John Westbrook.
This course was supported with funds provided by the National Cancer Institute and the Howard
Hughes Medical Institute.
PARTICIPANTS
Bick, M., B.S., The Rockefeller University, New York
Chan, S., Ph.D., NIEHS, Research Triangle Park, North Car-
olina
Forsgren, N., M.S., Umea University, Sweden
Kalathur, R., Ph.D., National Cancer Institute, Frederick, Mary-
land
Koharudin, L., Ph.D., University of Pittsburgh School of Medi-
cine, Pittsburgh, Pennsylvania
Langelier, M.-F., Ph.D., Thomas Jefferson University, Philadel-
phia, Pennsylvania
Lee, J., B.A., Mayo Graduate School, Rochester, Minnesota
Magliery, T., Ph.D., The Ohio State University, Columbus
Magnusdottir, A., B.S., Karolinska Institutet, Stockholm, Swe-
den
Mehboob, S., Ph.D., University of Illinois, Chicago
Mohanty, S., Ph.D., Auburn University, Alabama
Noinaj, N., B.A., University of Kentucky College of Medicine,
Lexington
Qi, Y., B.S., Harvard University, Cambridge, Massachusetts
Ren, X., Ph.D., National Institutes of Health, Bethesda, Mary-
land
Schaaf, G., Ph.D., University of North Carolina, Chapel Hill
Stuwe, T., B.S., EMBL Heidelberg, Germany
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, Berkeley, California:
Introduction to PHENIX (& CNS). Structure refinement.
Dauter, Z., Argonne National Laboratory, Illinois: Anomalous
data collection.
Emsley, P., University of York, United Kingdom: Model-building
tools in coot.
Furey, W., V.A. Medical Center/University of Pittsburgh, Penn-
sylvania: Patterson group therapy. Isomorphous replace-
ment and anomalous scattering. Noncrystallographic
symmetry averaging. MAD phasing, a classical approach.
Solving flattening/pPhase combination. Solving structures
with BnP.
Gilliland, G., Centocor, Inc., Radnor, Pennsylvania: Course
overview: The structure determination of biological macro-
molecules. Crystallization strategies.
Hendrickson, W., Columbia University, New York: MAD phas-
ing: Theory and practice.
Ji, X., National Institute of Standards & Technology, Rockville,
Maryland: Structural basis for dsRNA processing RNase III:
How Dicer dices. Structure presentation. DNA translocation
in a replicative hexameric helicase.
Kjeldgaard, M., Aarhus University, Denmark: Electron density
fitting from A to O.
Kleywegt, G., University of Uppsala, Sweden: Just because it’s
in Nature doesn’t mean it’s true... (macromolecular struc-
ture validation).
McPherson, A., University of California, Irvine: Crystallization of
macromolecules I. Crystallization of macromolecules II.
Symmetry, periodicity, unit cells, space groups, Miller
planes, and lattices. Waves, vectors, and complex num-
bers. Fundamental diffraction relationships and Bragg’s law.
Diffraction patterns, reciprocal space, and Ewald’s sphere.
Fourier transforms and the electron density equation. Pat-
terson techniques. Mechanisms of crystal growth. Heavy
atoms and anomalous scatterers. Crystallization review.
Perrakis, A., Netherlands Cancer Institute, Amsterdam, The
Netherlands: Automated model building and refinement
with ARP/W/ARP.
Pflugrath, J., Rigaku Americas Corporation, The Woodlands,
Texas: Data collection: Design and setup I. Data collection:
Design and setup II. Cryocrystallography. Scaling and
merging synchrotron data. Away from the edge: Sulfur SAD
with chromium radiation.
Read, R., University of Cambridge, United Kingdom: Molecular
replacement: From Pattersons to likelihood with a SAD
commentary. Likelihood and experimental phasing.
Richardson, D. and Richardson, J., Duke University Medical
Center, Durham, North Carolina: Detection and repair of
model errors using MolProbity.
Sweet, R., Brookhaven National Laboratory, Upton, New York:
Fundamental of crystallography. X-ray sources and optics.
Terwilliger, T., Los Alamos National Laboratory, Los Alamos,
New Mexico: Automated structure solution and model-
building.
Tronrud, D., University of Oregon, Eugene: Macromolecular
refinement I. Macromolecular refinement II. Difference elec-
tron density maps. The structure of the FMO protein at 1.3
Å resolution.
Waugh, D., National Cancer Institute, Frederick, Maryland: Pro-
tein engineering for X-ray crystallographers.
Westbrook, J., Rutgers, The State University of New Jersey,
Pisacataway: Automating PDB deposition.
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Programming for Biologists
October 17–30
INSTRUCTORS S. Lewis, University of California, Berkeley
S. Prochnik, DOE–Joint Genome Institute/University of California, Berkeley
L. Stein, Cold Spring Harbor Laboratory
J. Tisdall, DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS J. Aerts, Bioinformatics Group, Scotland, United Kingdom
J. Babayev, Pioneer Hi-Bred, Johnston, Iowa
J. Leipzig, DuPont Experimental Station, Wilmington, Delaware
T. Marques, University of Washington, Seattle
S. Robb, University of Utah, Salt Lake City
G. Thorisson, University of Leicester, United Kingdom
‘
Today the computer is an indispensable part of a research biologist’s toolkit. The success of the human
and other organism genome projects has created terabytes of data on everything from genetic linkage
mapping, to nucleotide sequences, to protein structures, stashed away in databases around the globe.
Large-scale technologies such as DNA microarrays and high-throughput genotyping have transformed
the nature of laboratory experimentation. Furthermore, even when biologists are not generating large
data sets of their own, they will want to collect and analyze data from myriad sources in the pursuit of
novel candidates or even entire research avenues.
A few years ago, it might have been sufficient to use Excel spreadsheets for managing laboratory
data and canned Web interfaces for searching, but as the volume of data grows and the subtlety of
280-336_Courses.qxd:LAR_Template_2007  5/27/08  1:03 PM  Page 320
321
analysis increases, these techniques, even supplemented by some simple programming skills, have
become inadequate. Modern biologists must be adept at juggling disparate data sets in order to pursue
their research. Designed for students and researchers with some prior programming experience, this 2-
week Advanced Bioinformatics program gave biologists the expanded bioinformatics skills necessary to
construct computational systems that can exploit this increasingly complex information landscape, with
an emphasis on fitting the wide range of existing analysis tools into extensible bioinformatics systems.
The course combined formal lectures with hands-on sessions in which students worked to solve a
series of problem sets covering common scenarios in the acquisition, validation, integration, analysis,
and visualization of biological data. For their final projects, students posed problems using their own data
and worked with one another and the faculty to solve them. The prerequisites for the course were a basic
knowledge of UNIX, procedural Perl programming, HTML document creation, and the database query
language SQL. Lectures and problem sets covering this background material were available online, and
students studied this material before starting the course.
Note that the primary focus of this course was to provide students with practical programming expe-
rience, rather than to present a detailed description of the algorithms used in computational biology. For
the latter, we recommended the Computational and Comparative Genomics course.
Speakers in the 2007 course included Tyler Alioto, Emina Begovic, Scott Cain, George Hartzell, Matt
Hibbs, Gabor Marth, Jason Stajich, Paul Thomas, and Mark l.
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Beutler, A., Ph.D., Mt. Sinai School of Medicine, New York
Bharti, A., Ph.D., Rutgers, The State University of New Jersey,
Piscataway
Burbano, H., M.Sc., Max-Planck Institute for Evolutionary
Anthropology, Leipzig, Germany
Carre, W., Ph.D., Roslin Institute, Roslin, United Kingdom
Clay, I., M.Sc., Cambridge University, Cambridge, United King-
dom
Ding, Y., Ph.D., The Jackson Laboratory, Bar Harbor, Maine
Fu, F., M.S., Iowa State University, Ames
Hall, I., Ph.D., Cold Spring Harbor Laboratory
Hancock, A., B.S., University of Chicago, Illinois
Haritunians, T., Ph.D., Cedars-Sinai Medical Center, Los Ange-
les, California
Kalatskaya, I., Ph.D., Universite de Montreal, Canada
Lashbrook, N., B.A., Stony Brook University, New York
Lindberg, J., M.S., Royal Institute of Technology, Stockholm,
Sweden
Llaca, V., Ph.D., DuPont, Wilmington, Delaware
Maricic, T., M.Sc., Max-Planck Institute for Evolutionary Anthro-
pology, Leipzig, Germany
Merkel, A., M.Sc., University of Canterbury, Christchurch, New
Zealand
Mihindukulasuriya, K., Ph.D., Washington University, St. Louis,
Missouri
Nowick, K., Ph.D., Lawrence Livermore National Laboratory,
Livermore, California
Pelizzola, M., Ph.D., Yale University, New Haven, Connecticut
Roda, O., B.S., Institute for Systems Biology, Seattle, Washing-
ton
Tecle, I., Ph.D., Cornell University, Ithaca, New York
Tsukuda, T., Ph.D., University of New Mexico, Albuquerque
Yuhki, N., Ph.D., National Cancer Institute, Frederick, Maryland
SEMINARS
Alioto, T., University Pompeu Fabra, Barcelona, Spain: Gene
prediction.
Begovic, E., University of California, Berkeley: Multiple
sequence alignment + molecular evolution 1. Molecular
evolution.
Cain, S., Cold Spring Harbor Laboratory: Gbrowse.
Hartzell, G., University of California, Berkeley: Database design.
Perl DBI (Rose: DB). Perl and HTML. Perl and CGI. Good
programming elective.
Hibbs, M., Princeton University, New Jersey: Microarrays.
Lewis, S., University of California Berkeley: Perl III.
Marth, G., Boston College, Chestnut Hill, Massachusetts:
Sequence variation.
Prochnik, S., DOE–Joint Genome Institute/University of Califor-
nia, Berkeley: Perl VI. Perl review VII (writing OOP modules).
Perl pipelines.
Stajich, J., University of California, Berkeley: BioPerl I. BioPerl
II.
Stein, L., Cold Spring Harbor Laboratory: Perl I. Perl II. Perl V.
Thomas, P., SRI International, Menlo Park, California: Protein
functional assignment.
Tisdall, J., DuPont Experimental Station, Wilmington, Delaware:
Scientific computing elective.
Yandell, M., University of Utah, Salt Lake City: Blast.
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Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 18–31
INSTRUCTORS V. Allan, University of Manchester, United Kingdom
K. Hu, Indiana University, Bloomington
S. Huang, Northwestern University School of Medicine, Chicago, Illinois
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
J. Waters, Harvard Medical School, Boston, Massachusetts
ASSISTANTS C. Wang, Northwestern University Medical School, Chicago, Illinois
M. Wozniak, University of Manchester, United Kingdom
This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochemistry,
and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well as protein and RNA
dynamics in living cells. It emphasized the use of the latest equipment and techniques in fluorescence
microscopy, including confocal laser-scanning microscopy, deconvolution methods, digital image pro-
cessing, and time-lapse imaging of living specimens. The course was designed to present students with
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state-of-the-art technology and scientific expertise in the use of light microscopy to address basic ques-
tions in cellular and molecular biology. It was also designed for the molecular biologist who is in need of
microscopic approaches and for the cell biologist who is not familiar with the practical application of the
advanced techniques presented in the course.
Among the methods presented were the preparation of tagged nucleic acid probes, fixation methods,
detection of multiple DNA sequences in single nuclei or chromosome spreads, cellular localization of RNA,
localization of nucleic acids and proteins in the same cells, use of a variety of reporter molecules and
nonantibody fluorescent tags, indirect antibody labeling, detection of multiple proteins in a single cell, and
the use of GFP variants to study protein expression, localization, and dynamics. In each method, several
experimental protocols were presented allowing the students to assess the relative merits of each and to
relate them to their own research. Students were encouraged to bring their own nucleic acid, protein, or
antibody probes to the course, which were used in addition to those provided by the instructors. The lab-
oratory exercises were supplemented with lectures given by invited distinguished scientists, who present
up-to-the-minute reports on current methods and research using the techniques being presented.
Speakers in the course included Richard Day, Joseph Gall, Rudolf Oldenbourg, Thomas Ried, Green-
field Sluder, and David Spector.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Bonilla, D., B.Sc., Texas A&M Health Science Center, College
Station
Chen, M., Ph.D., The Salk Institute, La Jolla, California
Evans, A., B.S., University of Texas, Austin, Port Aransas
Fulcher, J., B.S., University of California, Los Angeles
Galifianakis, N., Ph.D., New York University School of Medi-
cine, New York
Gumy, L., Ph.D., University of Cambridge, United Kingdom
Henriksson, S., M.S., Uppsala University, Sweden
Hollien, J., Ph.D., University of California, San Francisco
Kumanova, M., M.D., University of Pennsylvania, Philadelphia
Nedbal, J., M.Sc., King’s College London, United Kingdom
Proenca, C., B.A., Weill Cornell Medical College, New York
Scahill, C., B.A., Cambridge University, United Kingdom
Soong, B.-W., Ph.D., National Yang-Ming University Faculty of
Medicine, Taipei, Taiwan
Weech, M., Ph.D., University of North Carolina, Chapel Hill
Williams, J., B.S., Cold Spring Harbor Laboratory
Ye, X., M.S., University of California, Irvine
SEMINARS
Allan, V., University of Manchester, United Kingdom: Immuno-
cytochemistry.
Day, R., University of Virginia, Charlottesville: Seeing colors:
Applications and limitations of the fluorescent proteins.
Gall, J., Carnegie Institution, Baltimore, Maryland: The develop-
ment of in situ hybridization.
Greenfield, S., University of Massachusetts Medical School,
Worcester: You can observe a lot just by watching: The
charm of live cell analysis.
Hu, K., Indiana University, Bloomington and Murray, J., Univer-
sity of Pennsylvania School of Medicine, Philadelphia: Basic
introduction to light and fluorescence microscopy.
Huang, S., Northwestern University School of Medicine,
Chicago, Illinois: Introduction to FISH.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Other microscopy methods for live cell imag-
ing. Confocal microscopy and other thick-specimen tech-
niques.
Oldenbourg, R., Marine Biological Laboratory, Woods Hole,
Massachusetts: Live cell imaging with polarization
microscopy.
Ried, T., National Cancer Institute/NIH, Bethesda, Maryland:
Mechanisms and consequences of chromosomal aberra-
tions in cancer cells.
Spector, D., Cold Spring Harbor Laboratory: Localization of
gene expression by FISH and in living cells.
Waters, J., Harvard Medical School, Boston, Massachusetts:
Digital detectors and digital imaging fundamentals.
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Revolutionary Sequencing Technologies and Applications
November 6–17
INSTRUCTORS G. Hannon, Cold Spring Harbor Laboratory
E. Mardis, Washington University School of Medicine, St. Louis, Missouri
G. Marth, Boston College, Chestnut Hill, Massachusetts
W. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Baylor College of Medicine, Houston, Texas
M. Zody, Broad Institute, Cambridge, Massachusetts
ASSISTANTS A. Briggs, Max-Planck Institute for Evolutionary Anthropology, Leipzig, Germany
J. Glasscock, Washington University School of Medicine, St. Louis, Missouri
M. Hickenbotham, Washington University School of Medicine, St. Louis, Missouri
V. Magrini, Washington University School of Medicine, St. Louis, Missouri
A. Quinlan, Boston College, Allston, Massachusetts
D. Stewart, Boston College, Chestnut Hill, Massachusetts
During the last decade, large-scale DNA sequencing has markedly impacted the practice of modern
biology and is beginning to affect the practice of medicine. With the recent introduction of several revo-
lutionary sequencing technologies, costs and timelines have been reduced by orders of magnitude, facil-
itating investigators to conceptualize and perform sequencing-based projects that heretofore were
prohibitive. Furthermore, the application of these technologies to answer questions previously not exper-
imentally approachable is broadening their impact and application.
This intensive 12-day course explored applications of next-generation sequencing technologies, with
a focus on commercially available methods. Students were instructed in the detailed operation of sev-
eral revolutionary sequencing platforms, including sample preparation procedures, general data handling
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through pipelines, and in-depth data analysis. A diverse range of biological questions were explored,
including DNA resequencing of human genomic regions (using cancer samples as a test case), de novo
DNA sequencing of bacterial genomes, and the use of these technologies in studying small RNAs, among
others. Guest lecturers highlighted their own applications of these revolutionary technologies. We encour-
aged applicants from a diversity of scientific backgrounds including molecular evolution, development,
neuroscience, cancer, plant biology and microbiology.
This course was sponsored equally by Applied Biosystems, Illumina, and 454 Life Sciences.
PARTICIPANTS
Caudy, A., Ph.D., Princeton University, New Jersey
Duan, S., Ph.D., University of Massachusetts Medical School,
Worcester
Farrell, A., B.A., GeneDx, Gaithersburgh, Maryland
Figueiredo, L., M.Sc., Federal University of Minas Gerais, Belo
Horizonte, Brazil
Hall, I., Ph.D., Cold Spring Harbor Laboratory
Hlavata, I., M.Sc., National Institute of Public Health, Czech
Republic
Hoberman, R., B.A., McGill University, Montreal, Quebec City,
Canada
Liljedahl, U., Ph.D., Uppsala University, Sweden
Lofts, L., M.Sc., USAMRIID, Frederick, Maryland
Peris, M., Ph.D., Applied Biosystems, Foster City, California
Pradervand, S., Ph.D., University of Lausanne, Switzerland
Sisneros, N., B.S., University of Arizona, Tucson
Stromberg, M., Ph.D., Boston College, Chestnut Hill, Massa-
chusetts
Yeo, G., Ph.D., Salk Institute, La Jolla, California
SEMINARS
Briggs, A., Max-Planck Institute for Evolutionary Anthropology,
Leipzig, Germany: Massively parallel sequencing of ancient
DNA.
Gingeras, T., Affymetrix, Santa Clara, California: Genome-wide
transcription maps reveal an interleaved organization of
functional elements and likely regulatory strategies.
Hannon, G., Cold Spring Harbor Laboratory: miRNAs and biology.
Hercus, C., Synamatix, Kuala Lumpur, Malaysia: Synamatix-
based search and analysis approaches using massively
parallel sequence data.
Mikkelsen, T., Broad Institute, Cambridge, Massachusetts:
Genome-wide maps of chromatin state in pluripotent and
lineage-committed cells.
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Phage Display of Proteins and Peptides
November 6–17
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, La Jolla
ASSISTANTS C. Gronwall, Royal Institute of Technology, Stockholm, Sweden
S. Kacir, University of Pennsylvania, Philadelphia
K. Noren, New England BioLabs, Ipswich, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of phage
and selection of desired antibodies from the library. Students learned the theoretical and practical aspects
of constructing combinatorial libraries from immune and nonimmune sources, as well as the construc-
tion of synthetic antibody libraries. Antibodies were selected from the library by panning. Production,
purification, and characterization of antibody fragments expressed in E. coli were also covered. Peptide
phage display was used to identify a monoclonal antibody’s epitope.
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The lecture series, presented by a number of invited speakers, emphasized PCR of immunoglobulin
genes, the biology of filamentous phage and the utility of surface expression libraries, expression of anti-
bodies in E. coli and mammalian cells, antibody structure and function, catalytic antibodies, directed pro-
tein evolution, retroviral and cell display libraries, the immunobiology of the antibody response, and recent
results on the use of antibodies in therapy. The theory and practical implications for selection from phage
displayed libraries of random peptides, cDNA products, and semisynthetic proteins were also explored.
Seminar speakers in the course included Carlos Barbas, Germaine Fuh, Caroline Gronwall, Robert
Charles Ladner, Christopher Noren, Sachdev Sidhu, Don Siegel, Gregg Silverman, Robyn Stanfield, and
K. Dane Wittrup.
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Brenner-Morton, S., M.S., HHMI/Columbia University, New
York
Chen, Y., Ph.D., Sanofi Aventis, Bridgewater, New Jersey
Cottier, V., Ph.D., ESBATech AG, Zurich-Schlieren, Switzerland
Cullen, P., Ph.D., Monash University, Victoria, Australia
Gilchuk, P., M.S., Institute of Molecular Biology and Genetics,
Kyiv, Ukraine
Hopkins, J., B.Sc., University of Queensland, St. Lucia,
Queensland, Australia
Karhu, N., M.Sc., Next Biomedical Technologies, Helsinki, Fin-
land
Leong, S., Ph.D., University of Wisconsin, Madison
Molano, I., B.S., Medical University of South Carolina,
Charleston
Piterina, A., M.S., University of Limerick, Republic of Ireland
Soerensen, M., M.S., University of Aarhus, Denmark
Tassev, D., B.S., Memorial Sloan-Kettering Cancer Center,
New York
Velanac, V., Dipl., Max-Planck Institute for Experimental Medi-
cine, Goettingen, Germany
Walper, S., B.S., The University of Southern Mississippi, Hat-
tiesburg
Weiss, Y., M.S., Tel Aviv University, TIsrael
SEMINARS
Barbas, C., The Scripps Research Institute, La Jolla, California:
Software and hardware for genomes: Polydactyl zinc finger
proteins and the control of endogenous genes.
Fuh, G., Genetech, Inc., San Francisco, California: Use of
phage display in development of therapeutic antibodies.
Ladner, R.C., Dyax Corporation, Cambridge, Massachusetts:
Phage display of peptides and Kunitz domains.
Noren, C., New England BioLabs, Beverly, Massachusetts:
Phage peptide libraries: The Ph.D. for peptides.
Sidhu, S., Genetech, Inc., San Francisco, California: Antibody
phage display and chemical diversity in antigen recognition.
Siegel, D., University of Pennsylvania Medical Center, Philadel-
phia: Cell surface selection of combinatorial antibody
libraries.
Silverman, G., University of California, San Diego, La Jolla:
Repertoire cloning of SLE autoantibodies.
Stanfield, R., The Scripps Research Institute, La Jolla, Califor-
nia: Stuctural molecular biology of antibodies.
Wittrup, K.D., Massachusetts Institute of Technology, Cam-
bridge: Yeast display libraries.
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Proteomics
November 6–19
INSTRUCTORS P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Institute of Proteomics, Cambridge, Massachusetts
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
ASSISTANTS R. Bish, Cold Spring Harbor Laboratory
A. Farley, Vanderbilt University, Nashville, Tennessee
E. Hainsworth, Harvard Medical School, Cambridge, Massachusetts
J. Jennings, Vanderbilt University, Nashville, Tennessee
E. Simon, University of Michigan, Ann Arbor
S. Srivastava, Harvard University, Cambridge, Massachusetts
S. Volk, University of Michigan, Blissfield
This intensive laboratory and lecture course focused on two major themes in proteomics: protein profil-
ing and functional proteomics. In the profiling section of the course, students learned about cutting-edge
protein separation methods, including hands-on experience with 2D gel electrophoresis, multidimen-
sional liquid chromatography, and affinity purification of protein complexes. The course covered both
MALDI and ESI high-sensitivity mass spectrometry, including peptide mass mapping and tandem mass
spectrometry, quantification, and phosphoproteomics.
Students learned to use several informatics tools available for analyzing the data. In the functional
proteomics section of the course, students learned about recombinational cloning, high-throughput pro-
tein isolation, and protein microarrays. They used robots to execute high-throughput methods including
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expression, purification, and characterization of proteins. They also printed and analyzed their own self-
assembling protein microarrays, which were used for protein–protein interaction studies. The overall aim
of the course was to provide students with the fundamental knowledge and hands-on experience nec-
essary to be able to perform and analyze proteomics experiments and to learn to identify new opportu-
nities in applying proteomics approaches to their own research.
Speakers in the course included Ron Beavis, Claudio Calonder, Brian Chait, Pierre Chaurand, Karl
Clauser, Paul Huang, Darryl Pappin, Michael Synder, David Tabb, Paul Tempst, and Ileana Cristea.
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Agwu, E., M.M.L.S., Kampala International University,
Bushenyi, Uganda
Altug, H., B.S., Boston University, Massachusetts
Barnes, A., Ph.D., University of North Carolina, Chapel Hill
Dam, S., M.Sc., University of Aarhus, Denmark
Dinglasan, R.D., Ph.D., Johns Hopkins Bloomberg School of
Public Health, Baltimore, Maryland
Fernandez, E., Ph.D., Wellcome Trust Sanger Institute, Cam-
bridge, United Kingdom
Hand, R., B.S., University of North Carolina, Chapel Hill
Kim, J., Ph.D., Washington University School of Medicine, St.
Louis, Missouri
McKenney, P., B.S., New York University, New York
Novak, S., Ph.D., Agriculture Research Division, Edmonton,
Canada
Nerelius, C., M.S, Swedish University of Agricultural Sciences,
Uppsala
Oakley, F., B.S., University of Iowa, Iowa City
Ruggiero, A., Ph.D., Vanderbilt University, Nashville, Tennessee
Singh, M., M.Sc., International Centre for Genetic Engineering
and Biotechnology, New Delhi, India
SEMINARS
Beavis, R., University of British Columbia, Vancouver, B.C.,
Canada: Proteomics bioinformatics.
Chait, B., The Rockefeller University, New York: Proteomic
analysis of protein complexes.
Chaurand, P., Vanderbilt University School of Medicine,
Nashville, Tennessee: Tissue imaging and profiling by mass
spectrometry.
Clauser, K., Broad Institute/Massachusetts Institute of Technol-
ogy: De novo interpretation of tandem mass spectra.
Colonder, C., Zeptosens Bioanalytical Solutions, Switzerland:
Reverse protein arrays.
Cristea, I., The Rockefeller University, New York: Analysis of
protein–protein interactions via immunoaffinity purifications.
Huang, P., Massachusetts Institute of Technology,
Charlestown: Phosphoproteomics.
Pappin, D., Applied Biosystems, Framingham, Massachusetts:
Quantative proteomics.
Synder, M., Yale University, New Haven, Connecticut: Applica-
tion of protein arrays.
Tabb, D., Vanderbilt University, Nashville, Tennessee: Mass
spectrometry data analysis.
Tempts, P., Memorial Sloan-Kettering Cancer Center, New
York: Serum biomarker.
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Computational and Comparative Genomics
November 7–13
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT D. Triant, Louisana State University, Baton Rouge
This course presented a comprehensive overview of the theory and practice of computational methods
for gene identification and characterization from DNA sequence data. The course focused on approaches
for extracting the maximum amount of information from protein and DNA sequence similarity through
sequence database searches, statistical analysis, and multiple sequence alignment, whole-genome analy-
sis, and comparative genomics. Additional topics included identifying signals in unaligned sequences
and integration of genetic and sequence information in biological databases. The course combined lec-
tures with hands-on exercises; students were encouraged to pose challenging sequence analysis prob-
lems using their own data.
The course made extensive use of local WWW pages to present problem sets and the computing tools
to solve them. Students used Windows and Mac workstations attached to a UNIX server; participants
were comfortable using the Unix operating system and a Unix text editor. It was designed for biologists
seeking advanced training in biological sequence analysis, computational biology core resource directors
and staff, and scientists in other disciplines, such as computer science, who wish to survey current
research problems in biological sequence analysis.
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The primary focus of this course was the theory and practice of algorithms used in computational
biology, with the goal of using current methods more effectively and developing new algorithms. Stu-
dents more interested in the practical aspects of advanced software development were encouraged to
apply to the course on Programming for Biology.
Speakers in the course included Stephen Altschul, Peter D’Eustachio, Eric Green, Ross Hardison,
Eric Sayers, Cynthia Spudich, and James Taylor.
This course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Abraham, D., Ph.D., University of Virginia, Charlottesville
Budroni, S., M.S., Perugia University, Perugia, Italy
Bush, E., Ph.D., Harvey Mudd College, Claremont, California
Cheng, M.L., B.S., Celera, Rockville, Maryland
Kahsay, R., Ph.D., Dupont CR&D, Wilmington, Delaware
Lessick, R., Ph.D., Johns Hopkins University, Baltimore, Mary-
land
Levenstien, M., Ph.D., Memorial Sloan-Kettering Cancer Cen-
ter, New York
Noli, A., M.S., Stowers Institute for Medical Research, Kansas
City, Missouri
Patel, D., M.Sc., University of Nottingham, Loughborough,
United Kingdom
Plata, G., B.S., International Center for Tropical Agriculture,
Cali, Columbia
Ryder, E., Ph.D., Worcester Polytechnic Institute, Pennsylvania
Sales, G., M.Sc., Universita degli Studi di Torino, Torino, Italy
Samollow, P., Ph.D., Texas A&M University, College Station
Sethuraman, A., Ph.D., Stanford Human Genome Center, Palo
Alto, California
SEMINARS
Altschul, S., National Library of Medicine, Bethesda, Maryland:
Statistics of sequence similarity scores. Iterated protein
database searches with PSI-BLAST.
D’Eustachio, P., New York University School of Medicine, New
York: Representing biological processes: Reactome and
other pathway databases.
Green, E., Genome Technology Branch, Bethesda, Maryland:
Inter- and intraspecies sequence comparisons: Deducing
genome function in health and disease.
Hardison, R., Pennsylvania State University, University Park,
and Taylor, J., New York University, New York: Comparative
genomics I: Tools for comparative genomics. Genome
computation and gene regulation.
Pearson, W., University of Virginia, Charlottesville: Alignment
algorithms: Large-scale alignment. Protein evolution and
sequence similarity searching. Algorithms for biological
sequence comparison. Hidden Markov models and protein
profiles. Identifying consensus sites.
Sayers, E., National Library of Medicine, Bethesda, Maryland:
NCBI resources for bioinformatics and computational biol-
ogy. NCBI genome resources.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Approaches to multiple sequence alignment.
Spudich, G., EMBL–European Bioinformatics Institute, Hinxton,
United Kingdom: The ENSEMBL database of genomes I.
ENSEMBL/Biomart II.
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The Genome Access Course
April 24–25, August 28–29, November 28–29
TRAINERS G. Howell, The Jackson Laboratory
B. King, The Jackson Laboratory
L. Reinholdt, The Jackson Laboratory
R. Sachidanandam, Cold Spring Harbor Laboratory
The Genome Access Course is an intensive 2-day introduction to bioinformatics that was held multiple
times in 2003 and trained almost 110 participants in total. The core of the course was designed to
cover the manipulation and analysis of sequence information. The course was broken into modules
designed to give a broad overview of a given topic, with ample time for examples chosen by the instruc-
tors. Each module included three parts: discussion of theory and methods, coverage of software and
Web resources, and use of selected tools with examples (including those supplied by the students).
The modular design allowed the instructors to tailor the presentation to the interests of the students.
Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple
Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis.
Applications to the course were open to all on a first-come first-served basis, subject to basic eligi-
bility requirements. The course was held at the Laboratory’s newly opened Genome Research Center
at Woodbury located seven miles south of the main Laboratory campus. Each student was provided
with a PC laptop with wireless modem for the duration of the course. Students were encouraged to sup-
ply problem sets and sequences of interest to the trainers for possible incorporation as examples in the
modules. Materials were made available on the Web and students continued to ask questions of the
trainers as they applied what they had learned in their individual endeavors.
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April 24–25
Afonina, I., Nanogen Inc., Bothell, Washington
Al-Assah, R., Abu Dhabi University, United Arab Emirates
Burdick, K., Zucker Hillside Hospital-NSLIJHS, Glen Oaks,
New York
De Oliveira, A., Federal University of Pelotas, Brazil
DeRosse, P., Zucker Hillside Hospital, Glen Oaks, New York
DeWille, J., Ohio State University, Columbus
Deys, K., USDA-ARS, Geneva, New York
Gillmor, S., University of Pennsylvania, Philadelphia
Goldberg, A., Oakland University, Rochester, Michigan
Gomos-Klein, J., City University of New York, Hunter College,
New York
Gutierrez-Nava, M. de la Luz, DuPont, Wilmington, Delaware
He, M., Cold Spring Harbor Laboratory
Inlow, J., Indiana State University, Terra Haute
Iovine, N., New York University School of Medicine, New York
Lahiji, A., City University of New York, Hunter College, New
York
Lencz, T., The Zucker Hillside Hospital, Glen Oaks, New York
Lin, P.I., Cold Spring Harbor Laboratory
Liu, G., University of Iowa, Iowa City
Mills, A., Cold Spring Harbor Laboratory
Min, M., Correlagen Diagnostics, Inc., Waltham, Massachu-
setts
Newton, S., University of Iowa, Iowa City
Paul, A., Cold Spring Harbor Laboratory
Rakoff-Nahoum, S., Yale University School of Medicine, New
Haven, Connecticut
Rivera, R., University of Pennsylvania, Philadelphia
Rogoz, A., City University of New York, Hunter College, New
York
Rojas, J., Regeneron Pharmaceuticals, Tarrytown, New York
Shumay, E., Brookhaven National Laboratory, Upton, New York
Stein, P., University of Pennsylvania, Philadelphia
Sun, A.-Q., Mount Sinai School Medicine, New York
Tom, H.-I, The Johns Hopkins University, Baltimore, Maryland
Vermeulen, N., Nanogen Corporation, Bothell, Washington
Wang, W., Memorial Sloan-Kettering Cancer Center, New York
Zieve, G., Stony Brook University, New York
August 28–29
Baker, B., Yale University, New Haven, Connecticut
Buchholtz, E., Wellesley College, Massachusetts
Carr, E., Raritan Valley Community College, Somerville, New
Jersey
Cepko, C., Harvard Medical School, Boston, Massachusetts
Chen, T.-H,, Boston University, Cambridge, Massachusetts
Johnson, S., Cardinal Health, Milford Center, Ohio
Lefterova, M., University of Pennsylvania, Philadelphia
Li, J., Wayne State University, Detroit, Michigan
Miller, R., The Johns Hopkins University, Baltimore, Maryland
Pelc, T., Midwest Research Institute, Rockville, Maryland
Perumbeti, A., Cincinnati Children’s Hospital Medical Center,
Ohio
Ramachandran, B., Amgen Inc., South San Francisco, Califor-
nia
Rule, A., Mayo Clinic, Rochester, Minnesota
Stepien, C., Wellesley College, Massachusetts
Weiss, S., Brigham and Women’s Hospital, Boston, Massachu-
setts
Yang, G., Mount Sinai School of Medicine, New York
Yi, R., The Rockefeller University, New York
November 28–29
Alcantara, S., University of Texas Southwestern Medical Cen-
ter, Dallas
Andrews, Z., Yale University, New Haven, Connecticut
Broder-Fingert, S., Massachusetts General Hospital, Boston
Cidado, J., Novartis (NIBRI), Cambridge, Massachusetts
Enzmann, B., University of California, Los Angeles
Felice, K., University of Connecticut Health Center, Farmington
Golovan, S., University of Guelph, Canada
Jesionowski, A., University at Buffalo, New York
Kapheim, K., University of California, Los Angeles
Kebede, H., Texas Tech University, Lubbock
Koh, I.S., HanYang University, College of Medicine, Seoul,
South Korea
Kopplin, L., Case Western Reserve University, Cleveland,
Ohio
Li, Z., Columbia University, New York
Lin, F., Novartis Institutes of BioMedical Resarch, Cambridge,
Massachusetts
Litonjua, A., Brigham and Women’s Hospital, Boston, Massa-
chusetts
Marti-Subirana, A., Phoenix College, Arizona
McGrath, J.M., USDA-ARS, East Lansing, Michigan
Moschenross, D., University of Connecticut, Farmington
Muehlschlegel, J., Brigham and Women’s Hospital, Boston,
Massachusetts
Pal, D., Columbia University, New York
Reid Lombardo, K., Mayo Clinic, Rochester, Minnesota
Samten, B., University of Texas Health Center, Tyler
Sotolongo, B., University of Miami School of Medicine, Florida
Srivastava, D., Boston Biomedical Research Institute, Water-
town, Massachusetts
Strauss, S., Oregon State University, Corvallis
Triche, E., Yale University School of Medicine, New Haven,
Connecticut
Zheng, J., Carolinas HealthCare System, Charlotte, North Car-
olina
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Cold Spring Harbor Laboratory acknowledges the generosity of the following companies who loaned equipment and reagents
to the various courses:
Agilent Technologies
Ambion Inc.
A.M.P.I.
Applied Precision Inc.
Applied Scientific
Instrumentation, Inc.
Astro-Med Inc.
Axon Instruments
Becton Dickinson Labware
Berthold Technologies USA,
LLC
Bioptechs Inc.
Bio-Rad Laboratories
Burleigh Instruments, Inc.
Cambrex Bio Science Rockland
Inc.
Carl Zeiss, Inc.
Charles River Laboratories Inc.
Chroma Technology
Corporation
Dagan Corporation
David Kopf Instruments
Delaware Diamond Knives
Denville Scientific Inc.
Diagnostic Instruments
Drummond Scientific Company
Epicentre Technologies
Eppendorf North America
Fotodyne Inc.
GE Healthcare
Genetix USA Inc.
Hamamatsu Photonic Systems
Hampton Research
Harvard Apparatus, Inc.
Instrutech Corp.
Intelligent Imaging Innovations
Inc.
Invitrogen Corporation
Jackson Immunoresearch
Laboratories
James A. Hill
Kinetic Systems Inc.
Leica Microsystems Inc.
Luigs & Neumann
Lumera
Millipore Corporation
Modulation Optics, Inc.
Molecular Devices Corporation
Molecular Probes Inc.
Nalge Nunc International
Narishige International USA, Inc.
Nasco
New England BioLabs, Inc.
Nikon Inc.
Olympus America Inc.
Pel Freez Biologicals
Perkin Elmer Life and Analytical
Sciences
Pierce Chemical Co.
Promega Corp.
QIAGEN Inc.
Q-Imaging Inc
Richard Allan Scientific
Rigaku/MSC
Roche Applied Science
Sage-N Research
Scigene
Sigma-Aldrich
Siskiyou Corporation
Spectra-Physics Lasers Inc.
Stratagene
Sutter Instruments
Tecan US, Inc.
The Jackson Laboratory
ThermoFinnigan
Thermo Labsystems
The Vibratome Company
T.I.L.L. Photonics GmbH
Torrey Pines Scientific
Universal Imaging Corporation
VDS Vosskuhler GmbH
Vector Laboratories
Warner Instruments
Waters Corp
Zeitz-Instrumente Vertriebs
GmbH
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Title Host
January
Dr. Mary Beth Hatten, The Rockefeller University New direction in CNS migration Linda Van Aelst
Dr. Ian Macara, University of Virginia Parsing the polarity code: Polarization in epithelia Linda Van Aelst
and neurons
Dr. Christopher Lima, Memorial Sloan-Kettering Posttranscriptional protein modification by the Bill Tansey
Cancer Center ubiquitin-like modifier SUMO
February
Dr. Joan Massagué, Memorial Sloan-Kettering Identifying metastasis genes and functions Vivek Mittal
Cancer Center
Dr. Todd Golub, Broad Institute of Harvard and Signatures for cancer discovery Scott Powers
Massachusetts Institute of Technology
Dr. Arturo Alvarez-Buylla, University of California, Mosaic organization of adult neural stem cell niche Grisha Enikolopov
San Francisco
Dr. Christoph Klein, Clinical Center of the Univer- From minimal systemic cancer to metastasis: Yuri Lazebnik
sity of Regensburg, Germany Lessons from the direct analysis of single
disseminated cancer cells
March
Dr. Brenton Graveley, University of Connecticut Alternative splicing of Dscam: The making of Adrian Krainer
Health Center 38,000 isoforms
Dr. Max Wicha, University of Michigan Self-renewal pathways in normal and malignant Senthil Muthuswamy
human mammary stem cells
Dr. Michael Greenberg, Children’s Hospital of Signaling networks that regulate synapse Linda Van Aelst
Boston, Harvard Medical School development and cognitive function
Dr. Susumu Tonegawa, Massachusetts Institute Molecular, cellular, and circuit mechanisms for Josh Huang
of Technology hippocampal memory
Dr. Michael Dickinson, California Institute of How flies fly Partha Mitra
Technology
April
Dr. Liz Blackburn, University of California, Responses of cells and organisms to perturbing Fabiola Rivas
San Francisco telomerase (Hannon Lab)
September
Dr. Charles Sherr, St. Jude Children’s Research ARF tumor suppressor Scott Lowe
Hospital
Dr. Richard Myers, Stanford University Global genomic analysis of transcription and Adrian Krainer
inherited traits in humans
October
Dr. Oliver Hobert, Columbia University Medical Regulatory logic of neuronal diversity in C. elegans Josh Huang
Center
Dr. James Carrington, Oregon State University Specialized small RNA pathways in Arabidopsis Marja Timmermans
Dr. Carol Greider, Johns Hopkins School of Telomerase and the consequences of telomere Scott Powers
Medicine dysfunction
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings. These weekly seminars keep the CSHL staff current on the latest scientific developments and
broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar speak-
ers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in an infor-
mal setting.
SEMINARS
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November
Dr. Douglas Wallace, University of California, A mitochondrial paradigm for metabolic and Terri Grodzicker
Irvine School of Medicine degenerative diseases, aging, and cancer
Dr. Matthew Scott, Stanford University School Communicating with hedgehogs Josh Dubnau
of Medicine
December
Dr. Antoine Van Oijen, Harvard Medical School Under the hood of the peplisome: A single- Leemor Joshua-Tor
molecule view of DNA replication
Title
January
Anindya Bagchi (Mills Lab) Of mice and men: Road to the human 1p36 tumor suppressor
Ira Hall The dynamic behavior of DNA copy-number variation in inbred mice
Marissa Nolan (Muthuswamy Lab) Polarity proteins multitask: Par6 induces proliferation in breast epithelial cells
February
Tom Gingeras Genome-wide transcription maps reveal interleaved organization, new classes of
RNAs, and possible function for pervasive transcription
Miguel Zaratiegui (Martienssen Lab) Transcriptional landscape of a centromere
March
Rita Gandhi (Hirano Lab) Separating sisters (chromatids): When and where?
Tony Zador Auditory cortex: From synapses to behavior
DingCheng Gao (Mittal Lab) Targeting endothelial progenitor cells in tumor metastasis
Partha Mitra The origin of EEG and LFP signals and a correction to the Hodgkin–Huxley
equations for action potential propagation
Fabio Nogueira (Timmermans Lab) Big roles for small RNAs in organ polarity
April
Senthil Muthuswamy Cell polarity: Defining a new regulatory mechanism for cancer progression
October
Gonzalo Otazu (Zador Lab) Task-dependent suppression of sound responses in auditory cortex
Alexei Koulakov Activity and chemoaffinity in the development of neural maps
Chaolin Zhang (Zhang Lab) Genome evolution and signals involved in fidelity and regulation of pre-mRNA splicing
November
Patrick Paddison The mammalian Swi/Snf complex is required for lineage commitment and
specification in embryonic stem cells
Lin He (Hannon Lab) microRNAs in the oncogenic and tumor suppressor network
Bruce Stillman Control of the chromosome cycle in human cells by the origin recognition complex
December
David Mu (Powers Lab) Novel lung oncogenes and clinical implications
Scott Lowe Dissecting tumor suppressor gene networks in vivo
Zhenyu Xuan (Zhang Lab) Bioinformatics study in next generation sequencing
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor Laboratory’s In-House Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. The seminars also afford a nec-
essary opportunity for the graduate students and postgraduate staff to develop their skills in organizing,
presenting, and defending their research.
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BANBURY CENTER
EXECUTIVE DIRECTOR’S REPORT
The year 2007 marked my 20th year as director of the Banbury Center. The Center continues to be a
thrilling place to work, providing opportunities to help develop and promote new and important fields of
research. The year proved to be one of the busiest ever in the 30 years since the first meeting was held
in 1977. There were 25 scientific meetings, and the Center was used for nine courses. As usual, local
organizations, including the Lloyd Harbor Conservation Board and the Cold Spring Harbor School
District, made use of the calm of the Center for discussion meetings. Altogether, 36 events were held
at Banbury in 2007, and these were attended by 672 participants whose demographics remain very
similar from year to year. The proportion of participants from the United States was 77%, drawn from
no fewer than 40 states, a record number. As usual, New York, California, Massachusetts, and Maryland
provided most of these participants (46%). Foreign participants came from 23 countries, and atten-
dance by scientists from companies was higher than in previous years, comprising 10% of the total.
There were two most interesting and important meetings dealing with social and policy issues relat-
ing to the uses of scientific knowledge. Protecting Public Trust in Immunization, funded by the Albert B.
Sabin Vaccine Institute, has the potential to be one of the most important meetings to be held at
Banbury. Vaccination against infectious agents is, unquestionably, the greatest contribution that science
has made to improving our health, most especially that of children. Diseases such as polio are virtually
forgotten in most countries; smallpox, the great scourge, has been eliminated; and a vaccine against
human papillomaviruses is likely to reduce greatly the incidence of cervical cancer. But the absence of
infections such as measles, mumps, and rubella has led to a perception that these, too, have disap-
peared, and the vaccination rates of the MMR (measles, mumps, rubella) vaccine have fallen. This has
been accelerated by fears that the MMR vaccine, and/or the mercury once used as a preservative,
Banbury Lane
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causes autism. Every study has shown that these fears are unfounded, but the perception remains and,
as a consequence of the falling use of the MMR vaccine, these diseases are reappearing and killing chil-
dren. Participants in this meeting discussed what can be done in general to persuade the public of the
need for vaccination and to reestablish the public’s trust in vaccines. A very distinguished group of par-
ticipants included representatives of parent advocate organizations, the World Health Organization, the
Department of Health and Human Services, Congress, and academic institutions. We were particularly
pleased that Louis W. Sullivan, Secretary of Health and Human Services in the administration of George
H.W. Bush, attended.
The second science and society discussion meeting also dealt with the vexed issue of how scientif-
ic knowledge is used and misused, particularly in the political decision-making process. To what extent
should political influences determine what research is done and how scientific data are used?
Contemporary examples include the U.S. government’s attitudes toward human embryonic stem cell
research and global warming. What is needed is a rational approach to decision-making, based on the
best evidence available. Retreat from Reason reviewed these issues and explored how rationality might
be reintroduced into public discourse. The participants were particularly eclectic, drawn from the worlds
of science, politics, and the media. They included, for example, Michael Crichton (Jurassic Park), Chris
Mooney (Seed Magazine), Lord Taverne (Sense about Science), and Lee Silver (Princeton University). It
was a fascinating occasion.
The Alfred P. Sloan Foundation is noted for the support it gives to fledgling areas of research. The
Foundation provides funds at a critical period when such fields may not yet have developed a commu-
nity and have not produced a body of work sufficient to establish themselves for federal funding. Four
years ago, in 2003, the Sloan Foundation supported two workshops at Banbury to discuss molecular
“bar codes.” These are based on the sequence of a mitochondrial gene, COXI, which is identical among
individuals of a species but differs sufficiently among species so that it can be used to identify (bar-code)
species. The Foundation’s initiative has been tremendously successful. There is now a Consortium for
the Barcode of Life, with 150-member organizations worldwide, coordinating and standardizing bar-
code efforts. It is expected that a half-million species will be bar-coded during the next 5 years. The
Sloan Foundation funded a follow-up discussion workshop at Banbury in 2007. Participants discussed
both the effectiveness and limitations of bar coding, and it was agreed that bar coding is fulfilling its
promise. Indeed, it is progressing so well that a major goal of the meeting was to explore how bar cod-
ing can be exploited beyond its present use in taxonomy. There were also important discussions of how
to analyze and integrate the large amount of data being produced; effective visualization tools are
essential for presenting these data in an interpretable fashion to researchers.
There were two particularly interesting meetings in neuroscience. The Swartz Foundation has sup-
ported meetings at Banbury since 1999, and the topics are always fascinating. New Frontiers in Studies
of Nonconscious Processing was no exception. “Nonconscious processing” seems like a paradox—
How can our brains process information without us being aware of it? And if it happens, how can we
be aware that we are not aware of it happening?! A little reflection shows that a great deal of our brain
activity must be devoted to nonconscious processes. What makes the topic intriguing is its implications
for the classic and ever-lasting issue of free will. Experiments have indicated that we reach a decision
about how to act before we become aware of the decision. So, our conscious mind, which we gener-
ally believe to be “in control” of such decisions, is not; the decision is made and then our conscious
mind acts as though it reached the decision. The broad range of the topic was evident in the disciplines
represented: social psychologists, cognitive psychologists, neural physiologists, and philosophers.
The second neuroscience meeting that was even broader in its coverage was Interdisciplinary
Memory Symposium in Neurosciences and the Humanities. The primary focus of the meeting was on
memory, the thesis being that, just as neuroscientists explore the physical workings of the brain with the
tools of electrophysiology and molecular biology, so writers and artists explore and record the mental
experiences of human beings. One thinks immediately of Proust’s À la recherche du temps perdu. The
participants explored the extent to which the insights of those in the humanities might guide neurosci-
entists in developing and evaluating their models of human memory. We moved from the genetics and
340
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molecular biology of memory in fruit flies, through higher-level processes in more complex brains, to the
role memory plays in art, literature, theater, film, and music. It proved to be a fascinating and very suc-
cessful discussion workshop.
Sydney Gary, who came to Banbury as the first-ever Assistant Director, has been promoted to the
position of Director, Research Operations, and is now based on the main Laboratory campus. Sydney
took responsibility for the neuroscience programs at Banbury and, most importantly, interacted with
David Stewart in developing new forms of the neuroscience lecture courses at Banbury. She did a great
job and we are very sorry to lose her.
Banbury Center could not operate at the level that we did in 2007 without the outstanding efforts of
many people, most especially Bea Toliver, Ellie Sidorenko, and Sydney Gary at the Conference Room,
Basia Polakowski at Robertson House, and Mike Peluso and the grounds crew who look after the
Banbury estate. It is only through their hard work and that of the Laboratory’s Food Services and
Housekeeping that Banbury can continue to fulfill its mission of being the world’s best venue for seri-
ous discussions of biomedical research.
Jan Witkowski
Executive Director
Back of Banbury Center; meeting coffee break
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MEETINGS
Epithelial Mesenchymal Transition
February 25–27
FUNDED BY OSI Pharmaceuticals, Inc.
ARRANGED BY J.D. Haley, OSI Pharmaceuticals, Inc.
A.J. Dannenberg, New York Presbyterian Hospital, Cornell
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A key step in the development of cancer is the epithelial-mesenchymal transition. This reprogramming
results in dedifferentiation and ultimately redifferentiation of tumor cells, so that the cells gain the ability
to migrate and invade other tissues, i.e., metastasize. These invading mesenchymal-like tumor cells can
then redifferentiate, leading to the reacquisition of proliferative self-renewal capacity and tumor growth
at metastatic sites. These processes have a major role in the progression of cancer. Participants at this
meeting reviewed the clinical and pathobiological significance of the epithelial-mesenchymal transition:
the molecular signaling pathways that promote and maintain a mesenchymal-like tumor state and the
animal, cell, and pathway models that might be used to further investigate the epithelial-mesenchymal
transition.
Introductory Remarks and Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Epstein, OSI Pharmaceuticals, Inc., Farmingdale, New York
SESSION 1: Molecular Aspects of EMT
Chairperson: R.A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
J.D. Haley, OSI Pharmaceuticals, Inc., Farmingdale, New
York: EMT: A basis for the design of rational drug combina-
tions.
R.A. Weinberg, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Regulators of the EMT.
A. Cano, Instituto de Investigaciones Biomedicas, Madrid, Spain:
J.S. Condeelis, D. Spector
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Regulation of EMT by snail and lysyl oxidase-like proteins.
A. Csiszar, Institute of Molecular Pathology, Vienna, Austria:
ILEI: A cytokine essential in EMT, tumor formation, and
metastasis in epithelial cells.
R. Kalluri, Harvard Medical School, Boston, Massachusetts:
Targeting EMT in organ fibrosis.
SESSION 2: Cell Function and EMT
Chairperson: S. Muthuswamy, Cold Spring Harbor Laboratory
D. Radisky, Mayo Clinic Cancer Center, Jacksonville, Florida:
Matrix metalloproteinase-induced EMT in breast and lung.
S. Muthuswamy, Cold Spring Harbor Laboratory: Polarity pro-
teins regulate initiation and progression of carcinoma.
J.S. Condeelis, Albert Einstein College of Medicine, Bronx,
New York: mRNA targeting is disrupted in metastatic carci-
noma cells leading to EMT.
SESSION 3: Pathology and In Vivo Modeling
Chairperson: T. Brabletz, University of Erlangen-Numberg, Germany
T. Brabletz, University of Erlangen-Numberg, Germany:
Malignant progression in colorectal cancer: EMT, beta-
catenin, and cancer stem cells?
V. Brunton, Beatson Institute for Cancer Research, Glasgow,
United Kingdom: Role of Src and FAK tyrosine kinases in
tumor progression.
A. El-Naggar, The University of Texas M.D. Anderson Cancer
Center, Houston, Texas: p-Src and E-cadherin have a major
role in the epithelial-mesenchymal transition of head and
neck squamous carcinoma.
S.M. Dubinett, University of California, Los Angeles:
Inflammation: Dependent regulation of EMT in lung cancer.
Specific Issues and Priorities
Moderator: D. Epstein, OSI Pharmaceuticals, Inc.. Farmingdale, New York
A. Cano
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When Is Amyloid Functional and When Is Amyloidogenesis
Pathological?
March 11–14
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J.W. Kelly, Scripps Research Institute
K. Hsiao Ashe, University of Minnesota Medical School, Minneapolis
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Amyloid has a key role in a number of degenerative disorders, but much is still unknown about the nor-
mal functions of amyloid, how the process of amyloidogenesis leads to neurodegeneration, and when
amyloid is protective. Participants reviewed what is and what is not known about functional amyloid for-
mation in a variety of tissues and contrasted this with disease-associated amyloid. Pathological amy-
loidogenesis (and why this process leads to tissue toxicity) was discussed in the context of amyloid,
prion, and related diseases and type II diabetes.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Principles of Protein Misfolding
Chairpersons: C. Weissmann, Scripps Florida, Jupiter; D.
Walsh, University College Dublin, Republic of Ireland
H.A. Lashuel, Swiss Federal Institute of Technology, Lausanne,
Switzerland: Understanding the biochemical and structural
basis of amyloid toxicity in Alzheimer’s and Parkinson’s disease.
M. Vendruscolo, University of Cambridge, United Kingdom:
Prediction of protein aggregation propensities.
W.E. Balch, The Scripps Research Institute, La Jolla, California:
Molecular and structural contributions of membrane traffick-
ing to misfolding disease.
M. Bucciantini, University of Florence, Italy: Cell membranes as
primary targets of protein aggregate cytotoxicity.
R.I. Morimoto, Northwestern University, Evanston, Illinois: Toxic
protein states and the collapse of protein homeostasis.
E.R. Kandel, HHMI/Columbia University, New York: On the per-
sistence of memory storage.
K. Si, Stowers Institute for Medical Research, Kansas City,
Missouri: Does Drosophila Orb2 behave like a prion?
SESSION 2: Transmissible Prions and Amyloid Proteins
Chairpersons: R.I. Morimoto, Northwestern University,
Evanston, Illinois; G.T. Westermark, Linkoping University,
Sweden
J. Collinge, University College London, United Kingdom: Prion
strains, transmission barriers, and neurotoxicity.
C. Weissmann, Scripps Florida, Jupiter: How do cells distin-
guish between prior strains?
S.B. Prusiner, University of California, San Francisco: Synthetic
prions formed from amyloid.
B. Caughey, NIH/NIAID Rocky Mountain Laboratories, Hamilton,
Missouri: Prion protein oligomerization and TSE disease.
R. Tycko, National Institute of Diabetes and Digestive and
Kidney Diseases, NIH, Bethesda, Maryland: Molecular struc-
ture of amyloid and yeast prion fibrils.
M. Jucker, University of Tubingen, Germany: Induction of Aβ-
amyloid in transgenic mice.
J. Collinge, B. Caughey
S. Prusiner, J. Witkowski
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SESSION 3: Functional Prions and Amyloids
Chairpersons: S.B. Prusiner, University of California, San Francisco; W.E. Balch, The Scripps
Research Institute, La Jolla, California
R.B. Wickner, National Institutes of Health, Bethesda,
Maryland: Yeast prions (PSI+) and (URE3) are disease agents
in yeast.
M. Chapman, University of Michigan, Ann Arbor: Protein mis-
folding done right: The biogenesis of curli fibers by E. coli.
D.M. Fowler, The Skaggs Institute of Chemical Biology, La
Jolla, California: Functional amyloid in mammals; the biogen-
esis of pigmentation.
M. Gebbink, University Medical Centre Utrecht, The
Netherlands: Misfolded proteins, hemostasis, and immuno-
genicity: “The crossbeta pathway.”
A.B. Bowman, Vanderbilt University Medical Center, Nashville,
Tennessee: Duplication of Atxn1 suppresses SCA1 neu-
ropathology by decreasing incorporation of polyglutamine-
expanded ataxin-1 into native complexes promoting inclu-
sion formation.
SESSION 4: Pathological Amyloids and Misfolding Group 1
Chairpersons: S. Finkbeiner, University of California, San Francisco; B. Caughey, NIH/NIAID Rocky
Mountain Laboratories, Hamilton, Montana
G. Hotamisligil, Harvard School of Public Health, Boston,
Massachusetts: Unfolding story of diabetes, ER stress, and
insulin action.
A. Dillin, Salk Institute, La Jolla, California: The genetics of
age-regulated proteotoxicity: From worm to mouse.
M. Staufenbiel, Novartis Institutes for Biomedical Research
Basel, Switzerland: Amyloid-associated pathological alter-
ations in the brain of APP transgenic mice.
D. Walsh, University College Dublin, Republic of Ireland: Cell-
derived Aβ oligomers and their role in Alzheimer’s disease.
S. Lesne, University of Minnesota, Minneapolis: Identification
and characterization of Aβ*56, a pathological Aβ assembly,
causing early memory dysfunction.
SESSION 5: Pathological Amyloids and Misfolding Group 2
Chairpersons: J. Collinge, University College London, United Kingdom; M. Staufenbiel, Novartis
Institutes for Biomedical Research Basel
P.H. Axelsen, University of Pennsylvania School of Medicine,
Philadelphia: Pro-oxidant activity of amyloid-β proteins.
R. Vassar, Northwestern University, Chicago, Illinois: Multiple
personalities of Aβ: Positive and negative memory functions,
intraneuronal toxicity, and BACE1 elevation in AD.
S. Finkbeiner, University of California, San Francisco:
Identifying species of polyglutamine proteins in situ that best
predict neurodegeneration.
G.T. Westermark, Linkoping University, Sweden: Formation of
intracellular IAPP-amyloid kills the β cells.
Summary
J.W. Kelly, Scripps Research Institute, La Jolla, California
K. Hsiao Ashe, University of Minnesota Medical School,
Minneapolis
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International Workshop on Conifer Genomics
March 18–21
FUNDED BY Arborgen, Canadian Forest Service; European Union Evoltree; Genome British Columbia;
Genome Canada; Oregon State University; Port Blakeley Tree Farms; Starker Forests;
University of California, Davis; University of Georgia; University of Maine; USDA Forest Service
ARRANGED BY D.B. Neale, University of California, Davis
J. Dean, University of Georgia
G.T. Howe, Oregon State University
M.S. Greenwood, University of Maine
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The goals of this workshop were to advance conifer genomics research and the application of genom-
ic tools to increase forest productivity, enhance forest health, and obtain a better understanding of all
aspects of forest biology, including adaptation to environmental stresses and climate change. To this
end, participants summarized the status of conifer genomics worldwide, examined the strategies pur-
sued in other genome projects, and explored the potential of comparative genomics to advance our
understanding of diverse coniferous species. There were also extensive discussions on the steps to be
taken: determining priorities, coordinating research, and improving communications among genomic
scientists, resource managers, ecologists, forest health specialists, research administrators, and other
forest biologists.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcome and Meeting Objectives: D.B. Neale, University of California, Davis
D. Rogers
SESSION 1: Why Conifer Genomics?
Chairperson: G.T. Howe, Oregon State University, Corvallis
M.S. Greenwood, University of Maine, Orono: History of conifer
genomics.
G.T. Howe, Oregon State University, Corvallis: Importance of
conifers: Who benefits from conifer genomics research?
R. Mangold, USDA Forest Service, Arlington, Virginia:
Genomics for forest health.
D.L. Rogers, Genetic Resources Conservation Program,
University of California, Davis and Center for Natural Lands
Management, Fallbrook, California: Ecological genomics and
conservation biology.
R.C. Purnell, Weyerhaeuser Company, Hot Springs, Arkansas:
Genomics for forest industry.
SESSION 2: Organization and Funding of Conifer Genomics
Research
Chairperson: B. Goldfarb, North Carolina State University,
Raleigh
G.S. Foster, USDA Forest Service, Washington, D.C.:
Genomics and the USDA Forest Service.
A. Klein, The National Science Foundation, Arlington, Virginia
and Center for Natural Lands Management, Fallbrook,
California: Genomics research from competitive grants pro-
grams at NSF, DOE, and USDA.
A. Kremer, INRA UMR BIOGECO, Cestas, France: International
coordination and funding for genomics research.
N. Wheeler, Molecular Tree Breeding Services, LLC, Centralia,
Washington: Genomics education and outreach.
M.J. Morgan, Genome Canada, Ottawa, Canada: Genome
Canada’s research portfolio in forestry research.
BREAKOUT SESSION 1: Why Conifer Genomics?
Organization and Funding of Conifer Genomics Research
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SESSION 3: Status of Non-Conifer Genomics
Chairperson: D.B. Neale, University of California, Davis
C.H. Langley, University of California, Davis: Population
genomics: Racing technologies and scrambling analysis.
J. McPherson, Baylor College of Medicine, Houston Texas:
Sequencing and genomics of large and complex genomes.
R. McCombie, Cold Spring Harbor Laboratory: Maize
genomics.
O. Savolainen, University of Oulu, Finland: Genomics of natural
populations of Arabidopsis.
S.P. DiFazio, West Virginia University, Morgantown: Populus
genomics.
SESSION 4: Status of Conifer Genomics
Chairperson: M.S. Greenwood, University of Maine, Orono
J. Mackay, University Laval, Canada: Conifer genomics in
Canada.
M. Cervera, INIA-CIFOR, Madrid, Spain: Conifer genomics in
Europe.
S. Cato, SCION Research, Rotorua, New Zealand: Conifer
genomics in Australia and New Zealand.
D.B. Neale, University of California, Davis: Conifer genomics in
the United States.
SESSION 5: Key Components of a Conifer Genomics Program
Chairperson: J. Dean, University of Georgia, Athens
J. Dean, University of Georgia, Athens: Introduction and gene
discovery.
J. Bohlmann, University of British Columbia, Vancouver,
Canada: Gene expression profiling, proteomics, and
metabolomics.
D. Nelson, Southern Institute of Forest Genetics, Saucies,
Mississippi: Mapping and genome structure.
M. Hinchee, ArborGen LLC, Summerville, South Carolina:
Transgenic conifers in the private and public sectors.
K. Ritland, University of British Columbia, Vancouver, Canada:
Power of comparative genomics.
S. Gonzalez-Martinez, CIFOR-INIA, Madrid, Spain: SNPs and
association genetics.
J. Lee, University of California, Davis: Conifer bioinformatics.
M. Morgante, Universita’ di Udine, Italy: Prospects for a conifer
genome sequence.
BREAKOUT SESSION 2: Key Components of a Conifer Genomics Program
SESSION 6: Future of Conifer Genomics
Chairperson: J. Dean, University of Georgia, Athens
J. Dean, University of Georgia, Athens: Action items for conifer
genomics.
BREAKOUT SESSION 3: Future of Conifer Genomics
Breakout session summaries
Large group discussion
MEETING SYNTHESIS
D.B. Neale, University of California, Davis
G. Howe
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R.C. Kessler, Harvard Medical School, Boston, Massachusetts:
A brief overview of the epidemiology of depression.
R.R. Krishnan, Duke University Medical Center, Durham, North
Carolina: Medical basis of depression.
D.S. Charney, Mount Sinai School of Medicine, New York:
Neurobiology of Depression: From Molecules to Mood
April 1–4
FUNDED BY Eli Lilly & Company, Memory Pharmaceuticals, Sepracor Inc., AstraZeneca
Pharmaceuticals, Roche Pharmaceuticals, Wyeth Pharmaceuticals
ARRANGED BY R.S. Duman, Yale University School of Medicine
G. Enikolopov, Cold Spring Harbor Laboratory
R. Hen, Columbia University, New York
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Depression is a devastating illness that effects 15–20% of the population, resulting in enormous personal
suffering and economic loss to society. Despite intensive research, the neurobiological mechanisms under-
lying the etiology and treatment of major depressive disorders have not been identified. The focus of this
meeting was to undertake a comprehensive and integrated assessment of the current state of knowledge
of depression research, including analysis of the genetic, molecular, and cellular determinants of mood and
depression in animal models and in humans. The neurobiology of stress, which can precipitate or exac-
erbate depression, was discussed, as well as the behavioral consequences of stress exposure.
Welcome: S. Gary, Banbury Center, Cold Spring Harbor Laboratory,
SESSION 1: Overview/Introduction
Chairperson: H. Akil, University of Michigan, Ann Arbor
Introduction: R.S. Duman, Yale University School of Medicine, New Haven, Connecticut
G. Enikolopov, Cold Spring Harbor Laboratory
R. Hen, Columbia University, New York
Novel targets for antidepressant therapeutic development:
Evidence from proof of concept clinical studies.
M. Fava, Massachusetts General Hospital, Boston: How effec-
tive are antidepressant drugs?
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SESSION 2: Pathophysiology
Chairperson: R.R. Krishnan, Duke University Medical Center, Durham, North Carolina
W.C. Drevets, NIH/NIMH DIRP, Bethesda, Maryland:
Neuroimaging studies of depression.
S.H. Lisanby, Columbia University, New York: Targeting the
neurocircuitry of depression with focal brain stimulation.
H.K. Manji, National Institute of Mental Health, Bethesda,
Maryland: Cellular plasticity cascades: Genes to behavior
pathways in the pathophysiology and treatment of severe
mood disorders.
G. Sanacora, Yale University School of Medicine, New Haven,
Connecticut: Potential contributions of the amino acid neuro-
transmitter systems to the pathophysiology and treatment of
major depressive disorder.
D.R. Rubinow, University of North Carolina, Chapel Hill:
Affective dysregulation: Lessons from reproductive neuro-
science.
SESSION 3: Stress and Growth
Chairperson: H.K. Manji, National Institute of Mental Health, Bethesda, Maryland
B.S. McEwen, The Rockefeller University, New York: Stress-
induced structural remodeling in brains of animals models.
R. Hen, Columbia University, New York: Neurogenesis and
depression.
G. Enikolopov, Cold Spring Harbor Laboratory: Neurogenic
targets of antidepressant therapies.
R.S. Duman, Yale University School of Medicine, New Haven,
Connecticut: Neurotrophic factors in the pathophysiology
and treatment of depression.
H. Akil, University of Michigan, Ann Arbor: Searching for novel
molecules for mood disorders.
SESSION 4: Genetics and Epigenetics
Chairperson: R. Hen, Columbia University, New York
J. Gingrich, Columbia University, New York: Development con-
tributions to affective disorders.
K.-P. Lesch, University of Wurzburg, Germany: Life
stress–serotonin interaction in depression: Evidence from
knockout mice and functional imaging.
K. Ressler, Emory University, Atlanta, Georgia: CRH and BDNF
systems in depression: Recent genetic and molecular
results.
H. Reul, University of Bristol, United Kingdom: Epigenetic
mechanisms in stress-induced transcriptional activation and
behavioral adaptation.
A. Kumar, University of Texas Southwestern Medical Center,
Dallas: Genome-wide epigenetic and genetic changes
underlying striatal plasticity associated with mood disorders.
SESSION 5: Cognition/Motivation
Chairperson: R.S. Duman, Yale University School of Medicine, New Haven Connecticut
A. Markou, University of California, San Diego:
Psychostimulant drug withdrawal as an inducing condition in
models of depression.
W. Carlezon, Harvard Medical School, Belmont,
Massachusetts: Importance of CREB-mediated dynorphin
regulation in the study and treatment of mood disorders.
J.R. Taylor, Yale University School of Medicine, New Haven,
Connecticut: Murine models of depression: Linking mole-
cules to cognitive-motivational function.
SESSION 6: Conclusions/Future Directions
Co-Chairpersons: D.S. Charney, Mount Sinai School of
Medicine, New York; H. Akil, University of Michigan, Ann
Arbor
A. Markou
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New Frontiers in Studies of Nonconscious Processing
April 8–11
FUNDED BY The Swartz Foundation
ARRANGED BY T.D. Wilson, University of Virginia, Charlottesville
A. Dijksterhuis, University of Amsterdam, The Netherlands
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There has been a renaissance of research on nonconscious processing, but much of this research is
occurring in separate disciplines at different levels of analysis, from behavioral research to studies of neu-
ral processes. The goal of this meeting was to bring together people from different disciplines who are
interested in nonconscious mental processing and its relationship to consciousness, broadly defined.
Even more than is usual for a Banbury Center meeting, a very wide spectrum of disciplines was repre-
sented: social psychology, cognitive psychology, neural physiology, and philosophers. The expectation
was that these participants would learn from each other, discovering that they had previously unsus-
pected interests in common, and that this would lead to new research directions and collaborations.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: P. Winkielman, University of California, San Diego
Introductory Remarks: T.D. Wilson, University of Virginia, Charlottesville
A. Dijksterhuis, University of Amsterdam, The Netherlands
D. Gilbert
T.D. Wilson, University of Virginia, Charlottesville: The necessity
of nonconscious processing.
D.M. Wegner, Harvard University, Cambridge, Massachusetts:
Unconscious wellsprings of conscious will.
A. Dijksterhuis, University of Amsterdam, The Netherlands: On
unconscious thought.
J.W. Schooler, University of British Columbia, Canada:
Challenges of distinguishing between unconscious process-
es and processes that are experienced but in the absence of
meta-awareness.
D. Gilbert, Harvard University, Cambridge, Massachusetts:
Conscious misprediction of unconscious processes.
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SESSION 2
Chairperson: D. Gilbert, Harvard University, Cambridge, Massachusetts
J. Swartz, The Swartz Foundation, East Setauket, New York:
The Conscious “pop”: A nonconscious processing frame-
work for problem solving.
T. Sejnowski, The Salk Institute for Biological Studies, San
Diego, California: Searching for hidden treasure uncon-
sciously.
X.-J. Wang, Yale University School of Medicine, New Haven,
Connecticut: Concept of a decision threshold in sensory-
motor processes.
A.G. Greenwald, University of Washington, Seattle: Using
knockout strategies to reveal conscious function.
M.N. Shadlen, HHMI/University of Washington, Seattle:
Decisions, time, probability, and indeterminacy: Big ideas
from small experiments.
SESSION 3
Chairperson: J.W. Schooler, University of British Columbia, Canada
R. Hassin, Hebrew University, Jerusalem, Israel: The noncon-
scious executive.
H. Aarts, Utrecht University, The Netherlands: Implicit motiva-
tion and regulation of goals and their pursuit.
S. Dehaene, CEA/SAC/DSV/DRM/Neurospin, Yvette, France:
Human brain mechanisms of subliminal processing and con-
scious access.
T.L. Chartrand, Duke University, Durham, North Carolina:
Nonconscious mimicry.
SESSION 4
Chairperson: C.N. Macrae, University of Aberdeen, United Kingdom
M. Ferguson, Cornell University, Ithaca, New York: On implicit
evaluation.
P.S. Churchland, University of California, San Diego, La Jolla:
Nonconscious imitation and valenced representations.
A. Bell, University of California, Berkeley: Emergence into con-
sciousness viewed from the levels framework.
D.L. Schacter, Harvard University, Cambridge, Massachusetts:
Priming, implicit memory, and the brain: A neuroimaging per-
spective.
SESSION 5
Chairperson: D.M. Wegner, Harvard University, Cambridge, Massachusetts
C.N. Macrae, University of Aberdeen, United Kingdom: When
consciousness slips: Priming the absent mind.
K. Berridge, University of Michigan, Ann Arbor: Hidden brain–
emotion components in desire and dread.
P. Winkielman, University of California, San Diego: Emotion
and awareness.
H. Cohen, T. Sejnowski
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Molecular Approaches to Pain: Translational
Potential and Challenges
April 15–18
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M.E. Csete, Emory University School of Medicine, Atlanta, Georgia
J. Prager, University of California, Los Angeles, School of Medicine
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Pain remains a daunting clinical problem, and advances in understanding the molecular underpinnings
of pain have not translated easily into new therapies. Much of this can be attributed to communication
difficulties among the basic scientists uncovering the mechanisms of pain, the researchers developing
new pain treatments, and the clinicians seeking to treat pain. Because advances in managing pain have
come from diverse clinical and basic science communities, this meeting was held to foster communi-
cation among molecular biologists, neurobiologists, pharmacologists, anesthesiologists, neurologists,
and neurosurgeons. Our current understanding of pain initiation and maintenance was reviewed, as well
as the molecular biology of distinct pain syndromes, mechanisms of pain relief, and genetic predispo-
sition to pain and responses to therapy.
Introductory Remarks: S. Gary, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Systems/Big Picture
Chairperson: M.E. Csete, Emory University School of Medicine, Atlanta, Georgia
J. Prager, University of California, Los Angeles, School of
Medicine: Introduction and overview.
K.E. McCarson, University of Kansas Medical Center, Kansas
City: Molecular mechanisms of CNS plasticity during persist-
ent pain.
C. Sommer, Julius-Maximilians Universitat, Wuerzburg,
Germany: Role of cytokines in chronic pain.
T. Samad, Harvard Medical School and Massachusetts
General Hospital, Charlestown: Modulators of inflammatory
pain hypersensitivity.
P.P. Mitra, Cold Spring Harbor Laboratory: Signal processing
methods for LFP and EEG time series for rapid monitoring of
brain state.
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SESSION 2: Pathology
Chairperson: J. Prager, University of California, Los Angeles, School of Medicine
M. Garcia, University of Missouri, Columbia: Neurofilament-
dependent neuronal growth and death.
A.L. Oaklander, Harvard Medical School and Massachusetts
General Hospital, Boston: Major effects of minor distal nerve
injuries.
A.S.C. Rice, Imperial College, London, United Kingdom:
Modeling HIV-related neuropathies.
J.D. Glass, Emory University School of Medicine, Atlanta,
Georgia: Mechanisms of axonal degeneration.
SESSION 3: Channels, Receptors, and Genes
Chairperson: M.E. Csete, Emory University School of Medicine, Atlanta, Georgia
J. Mao, Massachusetts General Hospital, Charlestown:
Neuronal glucocorticoid receptor and neuropathic pain.
Q. Ma, Dana-Farber Cancer Institute, Boston, Massachusetts:
Runx1 coordinates nocioceptor phenotypes necessary for
thermal and neuropathic pain.
SESSION 4: Pharmacology/Therapies/Novel Targets
Chairperson: J. Prager, University of California, Los Angeles, School of Medicine
J. Prager, University of California, Los Angeles, School of
Medicine: Neuromodulation: A multitude of targets for modu-
lating the nervous system.
L. Mendell, Stony Brook University: Stopping pain in its tracks.
J. Kurreck, Free University Berlin, Germany: RNA interference
for target validation: Investigations of the functional role of
TGRPV1 in neuropathic pain.
D. Fink, University of Michigan School of Medicine, Ann Arbor:
HSV-mediated gene transfer for the treatment of chronic
pain.
M.E. Csete, Emory University School of Medicine, Atlanta,
Georgia: Can stem cells treat pain?
R.J. Lewis, The University of Queensland, Indooroopilly,
Australia: Analgesic conotoxins: Xen2174 and related stories.
SESSION 5: Clinical/Translation
Chairperson: J. Prager, University of California, Los Angeles, School of Medicine
R.J. Schwartzman, Drexel University College of Medicine,
Philadelphia, Pennsylvania: Pathophysiology of CRPS.
R. Gallagher, University of Pennsylvania School of Medicine,
Philadelphia: Clinical challenges for translational research.
M. Csete, J. Prager
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Interactome Mapping Project for Human and Model Organisms
April 22–25
FUNDED BY Open Biosystems and individual participants
ARRANGED BY M. Vidal, Dana-Farber Cancer Institute, Boston, Massachusetts
For more than half a century, it has been conjectured that interact-
ing macromolecules form complex systems of functionally inter-
acting components and that the molecular mechanisms underlying
most biological processes correspond to particular steady states
adopted by such cellular networks. However, until recently, sys-
tems-level theoretical conjectures remained largely unappreciated,
mainly because of the lack of supporting experimental data. In
recent years, new large-scale high-throughput techniques are gen-
erating these data at an unprecedented rate. The participants at
this meeting reviewed issues in interactome research with the goal
of writing a white paper describing the goals and needs of an inter-
actome mapping project for human and model organisms.
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Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
M. Vidal, B. Chait
Interactome meeting coffee break
SESSION 1: Biological Networks Properties I
Chairperson: M. Vidal, Dana-Farber Cancer Institute, Boston, Massachusetts
M. Gerstein, Yale University, New Haven, Connecticut:
Understanding protein function on a genome-scale using
networks.
T. Ideker, University of California, San Diego: Protein interaction
networks.
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SESSION 2: Cocomplex Membership Maps
Chairperson: M. Vidal, Dana-Farber Cancer Institute, Boston, Massachusetts
M. Walhout, University of Massachusetts Medical School,
Amherst: Large-scale transcription factor–DNA interaction
mapping using gene-centered protein–DNA interactome
mapping.
J. Greenblatt, University of Toronto, Canada: Protein purifica-
tion and genetic interactions to define protein complexes
and functional pathways.
N. Krogan, University of California, San Francisco: Unbiased
biology: Functional insights from quantitative physical and
genetic interaction data sets.
T. Pawson, Mt. Sinai Hospital, Toronto, Canada: Domain-
based interactions.
SESSION 3: Binary Maps
Chairperson: R.L. Finley, Wayne State University, Detroit, Michigan
S. Lalonde, Carnegie Institution of Washington, Stanford,
California: Toward a comprehensive Arabidopsis protein
interactome map: Systems biology of the membrane pro-
teins and signalosomes.
C. Sanderson, University of Liverpool, United Kingdom: High-
resolution human protein interaction networks.
R.L. Finley, Wayne State University, Detroit, Michigan:
Completing the Drosophila protein interaction map.
E. Wanker, Max Delbrück Center for Molecular Medicine,
Berlin, Germany: Automated yeast two-hybrid interaction
mapping.
G. Wright, Cell Surface Signaling Laboratory, Cambridge,
United Kingdom: Filling the blind spot: High-throughput iden-
tification of extracellular low-affinity interactions.
SESSION 4: Biological Networks Properties II
Chairperson: M. Vidal, Dana-Farber Cancer Institute, Boston, Massachusetts
P. Bork, EMBL, Heidelberg, Germany: Temporal aspects of
protein networks.
A.-L. Barabasi, University of Notre Dame, Indiana: Human dis-
easome: Using protein interaction to explore human dis-
eases.
G.F. Temple, National Human Genome Research Institute,
Bethesda, Maryland: Human protein expression clones for
the research community.
A. Califano, Columbia University, New York: An integrated
human B-cell interactome for the dissection of lymphoid
malignancies.
F. Roth, Harvard University, Boston, Massachusetts:
Combining protein interactions with contextual genomic evi-
dence to predict mammalian gene function.
SESSION 5
Chairperson: M. Vidal, Dana-Farber Cancer Institute, Boston, Massachusetts
B.T. Chait, The Rockefeller University, New York: Rapid
immunoisolation of protein complexes.
L. Stein, Cold Spring Harbor Laboratory: The Reactome
Database of Biological Pathways.
T. Ito, University of Tokyo, Kashiwa, Japan: Y2H and MS
approaches for annotating protein interactions and modifica-
tions.
K.C. Gunsalus, New York University, New York: Probing
molecular networks in C. elegans.
SESSION 6: Lessons from the Human Genome Project
Chairperson: M. Vidal, Dana-Farber Cancer Institute, Boston, Massachusetts
M. Vidal, Dana-Farber Cancer Institute, Boston,
Massachusetts: Time for an Interactome Mapping Project!
G.M. Weinstock, Baylor College of Medicine, Houston Texas:
Thoughts on the elation of Interactome and Genome proj-
ects.
SESSION 7: Summary and Future Developments
Chairperson: B.J. Wold, California Institute of Technology, Pasadena
337_390_LAR_Banbur.qxd:LAR_Template_2007  5/28/08  1:27 PM  Page 355
Fragile-X Syndrome and Mechanisms of Synaptic Translation
April 29–May 2
FUNDED BY NIH/National Institute of Mental Health (through a grant to the University of Illinois)
ARRANGED BY S. Warren, Emory University, School of Medicine, Atlanta, Georgia
E. Berry-Kravis, Rush University Medical Center, Chicago, Illinois
K. Clapp, FRAXA Research Foundation, Newburyport, Massachusetts
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Fragile-X syndrome is an inherited autistic spectrum disorder resulting from the functional absence of
the RNA-binding protein FMRP. FMRP normally suppresses the translation of target transcripts, and its
absence results in overabundance of some of the encoded proteins. FMRP is found within and at the
base of dendritic spines that are involved in synaptic plasticity, and it is believed that FMRP may have
a critical role in this process. This meeting focused on the regulation of local protein synthesis at the
synapse and its consequences for neurobehavioral phenotypes. Modulation of local protein translation
may be one approach for rational drug design for Fragile-X syndrome. Leaders in research on process-
es involved in synaptic protein synthesis and those involved with FMRP biology participated, to better
understand FMRP function at the synapse and the neural behavioral results of its absence.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introducing Fragile-X Patients: K. Clapp, FRAXA Research Foundation, Newburyport, Massachusetts
P. Vanderklish, K. Huber, E. Klann
SESSION 1: FXS Phenotypes in Models and Man I
Chairperson: E. Berry-Kravis, Rush University Medical Center, Chicago, Illinois
W.T. Greenough, University of Illinois, Urbana: FMRP-interact-
ing molecules and brain phenotype.
I. Bureau, Cold Spring Harbor Laboratory: Multiple develop-
mental circuit defects in the barrel cortex of Fragile-X mice.
S. Chattarji, National Centre for Biological Sciences,
Bangalore, India: Fragile-X mental retardation protein and
spine plasticity in the amygdala.
F. Bolduc, Cold Spring Harbor Laboratory, New York: Fragile-X
mental retardation protein is selectively required for long-term
associative memory.
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SESSION 2: FXS Phenotypes in Models and Man II
Chairperson: W.T. Greenough, University of Illinois, Urbana
S. McBride, Albert Einstein College of Medicine, Bronx, New
York: Age-dependent cognitive impairment in a Drosophila
Fragile-X model and its pharmacological rescue.
B.A. Oostra, Erasmus Universiteit Rotterdam, The Nether-
lands: Behavioral experiments in FRAX mouse and man.
E. Berry-Kravis, Rush University Medical Center, Chicago,
Illinois: Modifying behavior, biophysical measures, and cogni-
tion with lithium in FXS.
SESSION 3: Neuronal Transport
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston, Texas
G.T. Bassell, Emory University, Atlanta, Georgia: The stimulat-
ing travels and functions of FMRP.
E.W. Khandjian, Laval University, Quebec, Canada: Trafficking
FMRP-RNP granules in dendrites.
W. Sossin, McGill University, Montreal, Canada: Defining the
multiple types of RNA particles/granules that are present in
hippocampal neuron’s axons.
I. Jeanne Weiler, University of Illinois, Urbana-Champaign: The
cargo hypothesis of Fragile X: Applications to testing and
analysis.
R.S. Zukin, Albert Einstein College of Medicine, Bronx, New
York: AMPA receptor mRNA trafficking in dendrites and dys-
regulation in Fragile X.
SESSION 4: Functional Studies
Chairperson: B.A. Oostra, Erasmus Universiteit Rotterdam, The Netherlands
T.A. Jongens, University of Pennsylvania School of Medicine,
Philadelphia: Role of the siRNA pathway in the regulation of
dFMRP expression.
D.L. Nelson, Baylor College of Medicine, Houston, Texas:
FXRs and FMR1 function.
R.B. Darnell, The Rockefeller University, New York: Cross-link-
ing-IP studies on Nova.
P.W. Vanderklish, Scripps Research Institute, La Jolla,
California: High-throughput proteomics: Comparison of
synaptic fractions from wild-type and Fmr1 KO mice—new
differences and maybe some new targets.
SESSION 5: Mechanisms of Translation
Chairperson: G.J. Bassell, Emory University, Atlanta, Georgia
S.T. Warren, Emory University School of Medicine, Atlanta,
Georgia: FMRP dephosphorylation reveals an immediate-
early dendritic signaling pathway.
R.D. Blitzer, Mount Sinai School of Medicine, New York:
Stimulation-dependent regulation of dendritic translational
capacity by mTOR.
M. Costa-Mattioli, McGill University, Montreal, Canada:
Translational control of long-term synaptic plasticity and
memory storage.
H. Tiedge, State University of New York, Brooklyn: Dendritic
BC1 RNA in translational control mechanisms.
E.M. Schuman, California Institute of Technology, Pasadena:
Regulation of local protein synthesis by synaptic transmis-
sion.
J.D. Richter, University of Massachusetts Medical School,
Worcester: Translational control by CPEB.
SESSION 6: Studies of Synaptic Mechanisms and Activity
Chairperson: S.T. Warren, Emory University School of Medicine, Atlanta, Georgia
K.M. Huber, University of Texas Southwestern Medical Center,
Dallas: Conservation of LTD mechanisms utilized by Gq-cou-
pled receptors: Implications for Fragile X.
K. Broadie, Vanderbilt University and Medical School,
Nashville, Tennessee: mGluR-dependent and -independent
translation regulation by dFMRP in synaptic mechanisms.
C. Portera-Cailliau, University of California, Los Angeles:
Imaging the origin of dendritic spine abnormalities in Fragile-
X syndrome.
G. Dolen, Massachusetts Institute of Technology, Cambridge:
Correction of Fragile-X syndrome in mice by reduced expres-
sion of mGluR5.
R.K.S. Wong, State University of New York, Downstate Health
Science Center, Brooklyn: Divergent mGluR signaling and
physiological responses.
E. Klann, New York University, New York: Plasticity and behav-
ioral phenotypes in mutant mice with altered translational
control.
R.E. Paylor, Baylor College of Medicine, Houston, Texas:
Modifying behavioral phenotypes of Fragile-X mouse
models.
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Retreat from Reason
May 5–6
FUNDED BY Private support
ARRANGED BY J. Morris, International Policy Network, London
G. Ohrstrom, Ohrstrom Foundation Inc., New York
M. Ridley, Newcastle, United Kingdom
J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
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Modern technologies—especially biotechnology—are providing important benefits to society and will
continue to do so. However, public perception of these technologies in both Europe and the United
States, and the legal and regulatory environment in which they are developed, is increasingly hostile. As
a result, access to those technologies in Europe and the United States is becoming increasingly restrict-
ed, and investments in research and development of new technologies are being curtailed or redirect-
ed to less hostile environments. The purpose of this seminar is to bring together researchers and com-
municators with a deep interest in the development and dissemination of new technologies. The hope
is that through this discussion, a greater understanding of the causes of hostility to modern technolo-
gies will emerge, and paths forward for improving public perception and legal/regulatory environments
will be identified.
Introduction to Banbury Center: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Chairperson: G. Ohrstrom, Ohrstrom Foundation, Inc., New York
Keynote Address: L.M. Silver, Princeton University, New Jersey
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Panel 1: Attacks on Technology: What Have We Learned?
Chairperson: J. Morris, International Policy Network, London, United Kingdom
Panelists: B. Ames, Children’s Hospital Oakland Research Institute, California
P. Reiter, Institut Pasteur, Paris, France
D. Taverne, House of Lords, London, United Kingdom
Panel 2: Media Representation of Technology Issues
Chairperson: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Panelists: R. Bailey, Reason Magazine, Charlottesville, Virginia
V. Postrel, Dynamist, Dallas, Texas
C. Mooney, Seed Magazine, Washington, D.C.
Chairperson: G. Ohrstrom, Ohrstrom Foundation Inc., New York
Keynote Address: V. Postrel, Dynamist, Dallas
Panel 3: Psychology of Acceptance of and Opposition to Technology
Chairperson: M. Ridley, Newcastle, United Kingdom
Panelists: M. Crichton, Santa Monica, California
T. Kealey, The University of Buckingham, United Kingdom
S. Dudley, Office of Management & Budget, Washington, D.C.
M. Ridley, T. Kealey, V. Postrel
M. Crichton, L. Silver
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Design Principles in Biological Systems
May 6–8
FUNDED BY The National Science Foundation
ARRANGED BY P.P. Mitra, Cold Spring Harbor Laboratory
M.W. Kirschner, Harvard Medical School, Boston, Massachusetts
R.M. Murray, California Institute of Technology, Pasadena
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This workshop brought together scientists with strong theoretical or mathematical backgrounds and an
active interest in applying engineering principles to the study of biological systems. Discussions and pre-
sentations at the workshop focused on the premise that evolutionary solutions or designs, although not
themselves engineered, may nevertheless be studied in their existing forms in the framework of theo-
ries developed for human-engineered systems. The workshop provided an opportunity for biological
researchers to learn about engineering theories that may be relevant to their work and to promote col-
laborations by bringing interesting biological problems to the attention of engineering theorists and com-
puter scientists.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction to Meeting: P.P. Mitra, Cold Spring Harbor Laboratory
SESSION 1: Engineering and Biology
Chairperson: R.M. Murray, California Institute of Technology, Pasadena
R.J. Full, University of California Berkeley: Challenges of an
integrative systems biology.
D. Koditschek, University of Pennsylvania, Philadelphia:
Evolution of a framework for development of gaits.
M. Khammash, University of California, Santa Barbara:
Stochastic gene expression: New analysis tools and case
studies.
R. Milo, Harvard Medical School, Boston, Massachusetts:
Energy optimization and the design of photosynthesis.
D. Kleinfeld, University of California, San Diego: Topology,
dynamics, and neuronal control of cortical blood flow.
C. Myers, Cornell University, Ithaca, New York: Polymorphic
programming in biology and engineering.
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SESSION 2: Evolution
Chairperson: P.P. Mitra, Cold Spring Harbor Laboratory
M.W. Kirschner, Harvard Medical School, Boston,
Massachusetts: Physiological and evolutionary adaptation in
hemoglobin.
M. Levine, University of California, Berkeley: Gene networks in
animal development and evolution.
C. Queitsch, Harvard University, Cambridge, Massachusetts:
Chaperone Hsp90 as a molecular mechanism of genetic and
environmental canalization.
S.C. Stearns, Yale University, New Haven, Connecticut:
Evolutionary principles of phenotypic design.
P. Niyogi, University of Chicago, Illinois: Computational nature
of language learning and evolution.
SESSION 3: Evolution in Engineering
Chairperson: M.W. Kirschner, Harvard Medical School, Boston, Massachusetts
J. Doyle, California Institute of Technology, Pasadena: Robust
and evolvable architectures.
R.M. Murray, California Institute of Technology, Pasadena:
Systems engineering and architecture.
SESSION 4: Engineering and Biology (with an Emphasis on Evolution)
Chairperson: J. Carlson, Clay Mathematics Institute, Cambridge, Massachusetts
M.A. Savageau, University of California, Davis: Quantitative
evolutionary design of an oxidative stress response system in
human erythrocytes.
A. Sengupta, Rutgers, The State University of New Jersey,
Piscataway: Geometry of parameter space in regulatory net-
works: Investigating measures of robustness.
H. Karten, University of California, San Diego, La Jolla:
Multiple “systems” in the visual “system”: An attempt to
break the bottleneck.
B. Mishra, New York University, New York: Evolutionary mod-
els and systems biology.
C. Myers, University of Utah, Salt Lake City: Engineering
genetic circuits.
C.C. Hilgetag, Jacobs University Bremen, Germany: Spatial
organization of neural connectivity.
SESSION 5: Synthetic Biology (with Thoughts on Evolution)
Chairperson: M.E. Csete, Emory University School of Medicine, Atlanta, Georgia
C.D. Smolke, California Institute of Technology, Pasadena:
Engineering RNA devices as communication and control
systems.
D. Endy, Massachusetts Institute of Technology, Cambridge:
Very small-scale integrated biological systems.
P.A. Silver, Harvard Medical School, Cambridge: Designing
biological memory and logic.
M. Levine, D. Endy
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The Brain Architecture Project
May 20–22
FUNDED BY The W.M. Keck Foundation
ARRANGED BY P.P. Mitra, Cold Spring Harbor Laboratory
L. Swanson, University of Southern California, Los Angeles
H. Breiter, Massachusetts General Hospital, Charlestown
J. Doyle, California Institute of Technology, Pasadena
C. Allen, Cold Spring Harbor Laboratory
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This Project is a new collaborative effort in human neuroanatomical research supported by the W.M.
Keck Foundation. The initial goal of the project is to produce a draft of the “connectivity matrix” of the
human brain, along with analytical and visualization tools. The main focus was collation and integration
of human neuroanatomical information in the existing literature into a comprehensive database. This
was the first in what will be a series of annual meetings intended to promote the development of use-
ful resources for the neuroscience research and clinical communities, as well as to receive valuable
feedback and input from collaborators and invited external advisors. Progress to date was reviewed,
and there were sessions focused on the reconciliation of classical neuroanatomical and MRI mor-
phometry-based systems of nomenclature.
Opening Session: Introducing the Brain Architecture Project
Introduction of Project and Goals: P.P. Mitra, Cold Spring
Harbor Laboratory
Overview of Progress and Meeting Agenda; Introductions to
Project Members and Meeting Participants: C.B. Allen, Cold
Spring Harbor Laboratory
Additional Remarks: H. Breiter, Massachusetts General Hospital,
Charlestown
L.W. Swanson, University of Southern
California, Los Angeles
Introductory Remarks: S. Gary, Banbury Center, Cold Spring
Harbor Laboratory
N. Schiff, C. Allen, D. Herrera
SESSION 1: Related Projects
Chairperson: G. Burns, University of Southern California, Los Angeles
D.M. Bowden, University of Washington, Seattle:
Terminological needs of a portal to neuroscience on the
Web.
L.W. Swanson and M. Bota, University of Southern California,
Los Angeles: Classical nomenclature and the Brain
Architecture Management System (BAMS).
C.B. Allen, Cold Spring Harbor Laboratory: Overview of the
CoCoMac database.
C.C. Hilgetag, Jacobs University Bremen, Germany:
Perspectives on CoCoMac from an end-user.
S. Habeer, University of Rochester, New York: Three-dimen-
sional models of projection pathways in the macaque brain.
D. Kennedy, N. Makris, and H. Breiter, Massachusetts General
Hospital, Charlestown: MRI-based neuroanatomic parcella-
tion and labeling systems: Implications for broad, communi-
ty-based utility.
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SESSION 2: Proposed Scenarios for Nomenclature
Reconciliation
Chairperson: C.B. Allen, Cold Spring Harbor Laboratory
Direct comparison of MRI parcellation systems (BAP mem-
bers)
Reconciliation Scenarios (BAP members)
Moderated Discussion
SESSION 3: Networks
Chairperson: C.B. Allen, Cold Spring Harbor Laboratory
P.P. Mitra, Cold Spring Harbor Laboratory: Structure and
dynamics of networks: An informal review of models and
analysis tools.
SESSION 4: Coordinating with Atlasing Projects
Chairperson: H. Barbas, Boston University, Massachusetts
E.G. Jones, University of California, Davis: Brain atlases and
terminology.
D.C. Van Essen, Washington University School of Medicine,
St. Louis, Missouri: Cortical partitioning and connectivity
analyzed using surface-based atlases and approaches.
A.W. Toga, Laboratory of Neuro Imaging, Los Angeles,
California: Multisubject, multisite brain atlasing projects: Past
and future experiences.
SESSION 5: Advisor Input: Open discussion with advisors
on overall project goals and plan.
SESSION 6: White Paper Input: Open discussion to voice
the needs of neuroanatomy and connectivity research.
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The Laboratory Diagnosis of Lyme Disease
September 9–12
FUNDED BY Centers for Disease Control and Prevention and NIH—National Institute of Allergy
and Infectious Diseases
ARRANGED BY P.J. Baker, NIAID, National Institutes of Health, Bethesda, Maryland
R.J. Dattwyler, New York Medical College, Valhalla
B.J.B. Johnson, CDC, DVBID, Fort Collins, Colorado
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Lyme disease continues to be a difficult infection to diagnose and treat,
even 25 years after the discovery that it was caused by a spirochete
transmitted by tick bites. Banbury Center has been the venue for Lyme
disease discussion meetings almost annually since 1991, and it is fas-
cinating to see how the topics for meetings have cycled through basic
research, diagnosis, and treatment. This year, the meeting returned to
the problems and possible solutions of diagnosis. This is clearly a mat-
ter of the greatest importance in infectious diseases. The correct diag-
nosis must be made as early as possible so that the correct treatment
can be administered as soon as possible.
Introductory and Welcoming Remarks
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
P.J. Baker, NIAID, National Institutes of Health, Bethesda, Maryland
Goals for the Conference
M. Gomes-Solecki, R. Dattwyler
B.J.B. Johnson, CDC, DVBID, Fort Collins, Colorado
R.J. Dattwyler, New York Medical College, Valhalla
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SESSION 1: Serodiagnosis of Lyme Disease in Clinical Practice I
Chairperson: A.C. Steere, Massachusetts General Hospital, Boston
B.J.B. Johnson, CDC, DVBID, Fort Collins, Colorado: Initial
efforts to standardize the serodiagnosis of Lyme disease:
Rationale, history, and retrospective studies.
M. Aguero-Rosenfeld, Westchester County Medical Center,
Valhalla, New York: Lyme serology: Two-tier revisited.
M.J. Binnicker, Mayo Clinic, Rochester, Minnesota: Evaluation
of automated western blot processing, scanning, and inter-
pretive systems in the serologic diagnosis of Lyme disease.
A.C. Steere, Massachusetts General Hospital, Boston:
Prospective study of serologic tests for Lyme disease.
J.A. Branda, Massachusetts General Hospital, Boston: A new
approach to antibody testing in the diagnosis of Lyme disease.
SESSION 2: Serodiagnosis of Lyme Disease in Clinical Practice 2
Chairperson: S. O’Connell, Southampton General Hospital, United Kingdom
B. Wilske, University of Munich, Germany: Diversity of B.
burgdorferi sensu lato in Europe and implications for diagno-
sis of Lyme borreliosis.
S. O’Connell, Southampton General Hospital, United
Kingdom: Lyme diagnostics and clinical advice provision in
the U.K.: Experience of a reference laboratory.
H. Hofmann, University of Munich, Germany: Serological follow
up in patients with early and late Lyme borreliosis:
Densitometric evaluation of a new Line Blot compared to
quantitative ELISA.
P.J. Krause, Connecticut Children’s Medical Center, Hartford:
Absence of serologic cross-reactivity between B. burgdorferi
and B. microti.
A.R. Marques, LCI, NIAID, National Institutes of Health,
Bethesda, Maryland: Evaluation of CSF in the diagnosis of
neuroborreliosis.
C.P. Quinn, CDC, Atlanta, Georgia: Development and valida-
tion of quantitative serological assays.
SESSION 3: VosE and C6 Peptide
Chairperson: M.T. Philipp, Tulane University Health Sciences Center, Covington, Louisiana
M.T. Philipp, Tulane University Health Sciences Center,
Covington, Louisiana: Comparative antigenicity of VlsE, C6,
and other VlsE invariant regions and domains.
G.P. Wormser, New York Medical College, Valhalla: C6 vs.
two-tier testing: A multicenter study.
S.J. Wong, New York State Department of Health, Albany:
Comparison of Athena Multi-Lyte B. burgdorferi VlsE1 lgG+
pepC10 IgM test system to two-tier Lyme serology.
M.J. Gomes-Solecki, New York Medical College, Valhalla:
Multiantigenic peptide assay for the serodiagnosis of Lyme
disease.
P. Lahdenne, University of Helsinki, Finland: Improved serodi-
agnosis of Lyme disease with recombinant protein variants
from different borrelial genospecies.
SESSION 4: Future Directions
Chairperson: A.G. Barbour, University of California, Irvine
R.B. Porwancher, Infectious Disease Consultants, P.C.,
Mercerville, New Jersey: Improving Lyme disease diagnosis
through bioinformatics.
I. Schwartz, New York Medical College, Valhalla: Host-gene
expression as a diagnostic test for B. burgdorferi infection.
P.L. Felgner, University of California, Irvine: Whole proteome
microarrays for serodiagnostic antigen discovery.
A.G. Barbour, University of California, Irvine: Discovery and
rediscovery of B. burgdorferi antigens: A genome-wide array
approach.
J. Carroll, University of Pittsburgh, Pennsylvania: Paralogous
gene family 54 and proteomic approaches to serodiagnosis.
SESSION 5: Future Directions II
Chairperson: S.E. Schutzer, UMDNJ–New Jersey Medical School, Newark
A.R. Marques, LCI, NIAID, National Institutes of Health,
Bethesda, Maryland: B-cell-attracting chemokine CXCL 13 in
patients with post-Lyme disease syndrome.
M. Eshoo, Ibis Biosciences, Carlsbad, California: Identifying
unknown pathogens by mass spectrometry.
S.E. Schutzer, UMDNJ–New Jersey Medical School, Newark:
Proteomics of Lyme disease.
Special Presentation: Populist syndromes: Toxic mold and chronic Lyme disease
M. Edesess, International Development Enterprises, Lakewood, Colorado
SESSION 6: Regulation of Diagnostic Testing
Chairperson: B.J.B. Johnson, CDC, Fort Collins, Colorado
S. Hojvat, FDA/CDRH/OIVD, Rockville, Maryland: FDA
regulation of Lyme disease serological tests for the
detection of B. burgdorferi antibodies.
SESSION 7: Recommendations of the Conferees
Roundtable: Session chairs and conveners
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Champalimaud Foundation: Neuroscience
September 13–14
FUNDED BY The Champalimaud Foundation
ARRANGED BY A. Damasio, University of Southern California, Los Angeles
J.D. Watson, Cold Spring Harbor Laboratory
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The Champalimaud Foundation has decided to establish an international institute of research and clin-
ical practice, focused on cancer and neurological illnesses. Initial plans are under way, including the for-
mation of partnerships with a number of outstanding international universities, teaching hospitals, and
research institutions. As part of these initial plans, the Foundation held two discussion workshops at
Banbury, the first on neuroscience and the second on cancer (see next page). The following critical
questions were put to the invited experts: What kind of science should be pursued? What should the
balance be between clinical work and basic research? What new technologies or concepts can best be
developed and applied?
Introduction: A. Damasio, University of Southern California,
Los Angeles
J.D. Watson, Cold Spring Harbor Laboratory
Chairperson of Meeting: A. Damasio, University of Southern
California, Los Angeles
SESSION 1: Current Plans from Champalimaud Foundation I
Neuroscientists (led by Z. Mainen) and reaction from the Group
of Advisors
SESSION 2: Current Plans from Champalimaud Foundation II
SESSION 3: Building a Successful Neuroscience Program:
Useful Paths and Pitfalls
SESSION 4: Final Discussion and Recommendations
J. Watson, L. Beleza, A. Damasio
Z. Mainen
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Champalimaud Foundation: Cancer Research
September 15–16
FUNDED BY The Champalimaud Foundation
ARRANGED BY C. Caldas, Cancer Research UK, Cambridge
J.D. Watson, Cold Spring Harbor Laboratory
Introduction—The Champalimaud Foundation Cancer
Program
J.D. Watson, Cold Spring Harbor Laboratory
C. Caldas, Cancer Research UK, Cambridge
Chairperson of Meeting: C. Caldas, Cancer Research UK,
Cambridge
SESSION 1: Cancer Genomes and Epigenomes in the Era of
Very Cheap Sequencing
Discussion Leaders:
B.J. Ponder, Cancer Research UK, Cambridge: Germ-line
genomics.
M. Loda, Dana-Farber Cancer Institute, Boston,
Massachusetts: Somatic genomics.
SESSION 2: Cancer Microenvironment: Angiogenesis and
More
Discussion Leaders:
J. Folkman, Children’s Hospital, Boston, Massachusetts:
Angiogenesis.
D. Hanahan, University of California, San Francisco: Tumor
stroma.
SESSION 3: Cancer Imaging: Seeing It All Noninvasively
Discussion Leader:
R. Blasberg, Memorial Sloan-Kettering Cancer Center, New
York: State of the art in molecular imaging.
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SESSION 4: Cancer Models: Building Mice with “Humanized”
Cancer
Discussion Leaders:
S. Lowe, Cold Spring Harbor Laboratory: RNAi in mice.
D.A. Tuveson, Cancer Research UK, Cambridge: Engineering
mice with “human-like” tumors.
SESSION 5: Experimental Cancer Therapeutics: The Way
Ahead
Discussion Leaders:
C.J. Marshall, Institute of Cancer Research, London, United
Kingdom: A systems approach to targeting kinase pathways.
S. Aparicio, BC Cancer Research Centre, Vancouver, Canada:
Image-based high-throughput “synthetic-lethal” screens.
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SESSION 6: Cancer Stem Cells: Does It Matter?
Discussion Leaders:
C. Eaves, BC Cancer Research Centre, Vancouver: Breast
stem cells and the molecular phenotypes of breast cancer.
P.G. Pelicci, European Institute of Oncology, Milan, Italy: PML
and leukemia stem cells.
SESSION 7: Final Discussion: The Ideal Cancer Research
Institute—Balancing Fundamental and Applied Research
Discussion Leaders:
B.J. Ponder, Cancer Research UK, Cambridge
P. Marks, Memorial Sloan-Kettering Cancer Center, New York
J. Folkman, J. Botelho, D. Hanahan, J. Watson
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Drug Discovery, Biomarkers, and Clinical Trials for ALS
September 23–26
FUNDED BY Greater New York Chapter of the ALS Association
ARRANGED BY E.P. Pioro, The Cleveland Clinic, Ohio
M.D. Cudkowicz, Harvard Medical School, MGH, Boston, Massachusetts
L. Bruijn, The ALS Association, Palm Harbor, Florida
N. Kayadjanian, The ALS Association, San Diego, California
As we understand more about the underlying mechanisms involved in cell death in ALS, several new
targets for therapeutic development have been identified. Some of the key challenges associated with
the development of therapies for ALS include the degree of cell death at the time of diagnosis and the
length of clinical trials required to determine whether the drug is effective in slowing disease progres-
sion. This workshop evaluated some of the exciting new areas and opportunities for drug discovery and
development, and explored the development of biomarkers and clinical trial design.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Drug Discovery Efforts in ALS
Chairperson: J.D. Rothstein, The Johns Hopkins University School of Medicine, Baltimore, Maryland
L. Bruijn, The ALS Association, Palm Harbor, Florida:
Introduction.
R. Pacifici, MRSSI/CHDI, Inc., Los Angeles, California: Drug
discovery and development in other orphan diseases
such as Huntington’s disease: Opportunities and
challenges.
P.T. Lansbury, Link Medicine, Corporation, Cambridge,
Massachusetts: Therapeutic strategies for slowing ALS
progression.
J.M. McCall, PharMac LLC, Kalamazoo, Michigan: Drug dis-
covery and development: Challenges and opportunities.
J.D. Rothstein, The Johns Hopkins University School of
Medicine, Baltimore, Maryland: Modulation of astroglial function
in ALS: Small-molecule discovery, relevant biomarkers and PET.
SESSION 2: High-throughput Screening
Chairperson: R. Pacifici, MRSSI Inc., Los Angeles, California
D.F. Fischer, BioFocus DPI, Leiden, The Netherlands: High-
throughput target and drug discovery in human stem-cell-
derived motor neurons.
J. Staunton, CombinatoRx, Inc., Boston, Massachusetts:
Platform for testing combination therapies in high-throughput
cell-based assays.
SESSION 3: Delivery Systems
Chairperson: M.D. Cudkowicz, Harvard Medical School,
MGH, Boston, Massachusetts
D. Drummond, Hermes Biosciences, Inc., South San
Francisco, California: Immunotargeted lipid nanocarriers for
small-molecule and nucleic acid therapeutics.
Z. Xu, University of Massachusetts Medical School, Worcester:
RNAi therapy for ALS.
T.M. Miller, Washington University School of Medicine, St.
Louis, Missouri: Antisense and ALS.
General Discussion
M.D. Cudkowicz, Harvard Medical School, MGH, Boston,
Massachusetts
P. Kauffman, J.M. McCall
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SESSION 4: Clinical Trials in ALS
Chairperson: P. Kaufmann, The SMA Clinic, Columbia University Medical School, New York
M.D. Cudkowicz, Harvard Medical School, Massachusetts
General Hospital, Boston: Overview.
W.W. Bryan, Biologics Consulting Group, Inc., Rockville,
Maryland: Is ALS one disease or many different diseases?
B. Ravina, Strong Health Medical Center, Rochester, New
York: Clinical trial designs in Parkinson’s disease.
S. Wieland, CytRx Corporation, Los Angeles, California:
Clinical trial design in ALS for product approval.
B. Levin, Columbia University, New York: Sequential statistical
designs for selecting from competing therapies.
D.A. Schoenfeld, Harvard School of Public Health, Boston,
Massachusetts: Design considerations for trials of ALS
therapies.
SESSION 5: Biomarkers I
Chairperson: N. Kayadjanian, The ALS Association, San Diego, California
E.P. Pioro, The Cleveland Clinic, Ohio: Overview.
M. Benatar, Emory University, Atlanta, Georgia: Strategies for
presymptomatic biomarker identification in familial ALS.
M. Strong, UH-LHSC, London, Ontario, Canada: FTD-TDP43
and other clues as biomarkers/pathology.
J.S. Paulsen, University of Iowa, Iowa City: Lessons from other
diseases: Huntington’s disease.
M. Lowe, The Cleveland Clinic Foundation, Ohio: Imaging
techniques.
J.M. Shefner, State University of New York, Upstate Medical
University, Syracuse: Physiological outcome measures in
ALS clinical trials.
General Discussion:
E.P. Pioro, The Cleveland Clinic, Ohio
SESSION 6: Biomarkers II
Chairperson: E.P. Pioro, The Cleveland Clinic, Ohio
R.H. Brown, Massachusetts General Hospital, Charlestown:
Overview.
R. Bowser, University of Pittsburgh School of Medicine,
Pennsylvania: Use of biomarkers to identify therapeutic tar-
gets and monitor disease progression.
SESSION 7: Animal Models
Chairperson: L. Bruijn, The ALS Association, Palm Harbor, Florida
D.S. Howland, High Q Foundation, New York: Standardization
of preclinical testing in mouse models of ALS and HD: A
pipeline for targets and compounds.
Panel Discussion: Challenges for Preclinical and Clinical
Development of Therapies for ALS
Chairperson: M.D. Cudkowicz, Harvard Medical School, MGH,
Boston, Massachusetts
Panelists: J. McCall, PharMac LLC, Kalamazoo, Michigan: Drug
development.
B. Ravina, University of Rochester, New York: Clinical
trials.
R.H. Brown, Massachusetts General Hospital,
Charlestown: All aspects.
W.W. Bryan, Biologics Consulting Group Inc., Rockville,
Maryland: Regulatory issue.
D.S. Howland, High Q Foundation, New York: Animal
models.
Wrap Up and Closing Remarks
L. Bruijn, The ALS Association, Palm Harbor, Florida
D.F. Fischer
B. McCreedy, Metabolon, Inc., Research Triangle Park, North
Carolina: Metabolomic approach to biomarkers for ALS.
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Science: Get It Across!
September 28–October 3
FUNDED BY Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine
ARRANGED BY H. Fröhlich, Boehringer Ingelheim Fonds, Heidesheim, Germany
C. Walther, Boehringer Ingelheim Fonds, Heidesheim, Germany
The Boehringer Ingelheim Foundation returned to the Banbury Center for their biannual fellows meeting
in North America. In addition to providing training for their fellows, the Foundation very generously sup-
ported a special lecture by a visiting young scientist, given in Grace Auditorium and open to all CSHL
scientists. The first recipient of this honor was Jennifer A. Zallen, Head of the Morphogenesis and
Polarity Laboratory at Memorial Sloan-Kettering Institute, who spoke on "Shaping the embryo: Cellular
dynamics in development."
Opening Remarks: H. Fröhlich, Boehringer Ingelheim Fonds, Heidesheim, Germany
Introduction: C. Walther, Boehringer Ingelheim Fonds, Heidesheim, Germany
Sammis Hall in the fall
Speakers
W. Wells, Global Alliance for TB Drug Development, New York:
Basic lecture on writing techniques and how to structure
papers.
H. Ploegh, Whitehead Institute, Cambridge, Massachusetts:
What makes success in science?
B. Tansey, Cold Spring Harbor Laboratory: Representation of
scientific information: Graphic and rhetoric.
B. Tansey, Cold Spring Harbor Laboratory: Group A starts the
graphic assignment and Group B delivers 10-minute-presen-
tation.
B. Tansey, Cold Spring Harbor Laboratory: Review of the
videotaped presentations (Group B).
B. Tansey, Cold Spring Harbor Laboratory: Group B starts the
assignment and Group A delivers 10-minute-presentation.
B. Tansey, Cold Spring Harbor Laboratory: Review of the
videotaped presentations (Group A).
J.A. Zallen, Memorial Sloan-Kettering Cancer Center, New
York: Shaping the embryo. Cellular dynamics in develop-
ment.
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Genetics of Crop Domestication
October 14–17
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M.D. Purugganan, New York University
E.S. Buckler, Cornell University, Ithaca, New York
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The development of domesticated species was a pivotal event in the rise of human civilizations and has
served as a metaphor for the evolution of new taxa. In recent years, geneticists and plant scientists have
made significant advances in identifying genes associated with domestication, as well as using molecular
data to explore the evolutionary process of domestication. Archaeologists have also made strides in
unraveling the record of crop and farm animal use in many sites across the world and have begun to
explore the cultural, ecological, and evolutionary patterns associated with domestication. As for many
Banbury meetings, the organizers ensured an interesting meeting by having participants from varied back-
grounds—genomic scientists, molecular biologists, plant breeders, evolutionary geneticists, and archae-
ologist—in this case, to explore the origins and evolution of domesticated plant and animal species.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Plant and Animal Domestication and the Archaeological Record
Chairperson: J.F. Wendel, Iowa State University, Ames
D.Q. Fuller, University College London, United Kingdom:
Progress and challenges in the Archaeobotany of Asian rice:
Spikelet bases, immature harvests, and inferring domestica-
tion process.
B.D. Smith, Smithsonian Institution, Washington, D.C.:
Combing genetics and archaeology in documenting the early
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history of four crop plants in the Americas: Bottle gourd,
squash, maize, and sunflower.
M.A. Zeder, Smithsonian Institution, Washington, D.C.:
Defining domestication: How advances in genetics and
archaeology are reshaping our understanding of domestica-
tion and its origins.
G. Wilcox, National Centre for Scientific Research, Saint-Paul-
le-Jeune, France: Origins of cultivation and domestication of
cereals and pulses: Evidence from Near Eastern archaeologi-
cal sites.
P.L. Morrell, Monsanto Company, Chesterfield, Missouri:
Genetic evidence for a second domestication of barley
(Hordeum vulgare) east of the Fertile Crescent.
P. Gepts, University of California, Davis: A Phaseoulus per-
spective on crop domestication.
D.G. Bradley, Trinity College Dublin: Genetic hoof prints;
genetic insight into bovine domestications.
G. Larson, Uppsala University Biomedical Center, Sweden:
Breaking down genomic barriers: How domestication affects
an organism’s ability to hybridize with multiple wild species.
R.K. Wayne, University of California, Los Angeles: Dog origins,
domestication, and evolution.
J.F. Wendel, Iowa State University, Ames: Jeans, genes, and
parallel domestication of cultivated cottons.
P. Tiffin, University of Minnesota, St. Paul: Population genetics of
the progenitor: Geographic structure and diversity in teosinte.
SESSION 3: Selection in Domesticated Genomes
Chairperson: P. Tiffin, University of Minnesota, St. Paul
C.D. Bustamante, Cornell University, Ithaca, New York: Statistical
methods for inferring demographic history of domesticated
plant and animal species from SNP genotype data: Preliminary
data, potential pitfalls, and possible solutions.
Y. Kim, Arizona State University, Tempe: The pattern of selec-
tive sweeps in derived populations.
A.L. Caicedo, University of Massachusetts, Amherst: Genome-
wide patterns of nucleotide polymorphism in domesticated rice.
M.D. Purugganan, New York University, New York: Nature of
selection in the rice genome.
S.I. Wright, York University, Toronto, Canada: Demographic
history and selection during maize domestication.
T. Brown, University of Manchester, United Kingdom: Using
computer simulations to test models of crop origins.
SESSION 4: Genetic Architecture and Molecular Genetics of Domestication
Chairperson: A.L. Caicedo, University of Massachusetts, Amherst
T. Sang, Michigan State University, East Lansing: Genetics and
phylogenetics of rice domestication.
S. McCouch, Cornell University, Ithaca, New York: Emerging
story of rice domestication.
J.M. Burke, University of Georgia Plant Biology, Athens:
Genetics and the domestication of sunflower.
W. Powell, National Institute of Agriculture Botany, Cambridge,
United Kingdom: Evolution and domestication of barley and
wheat: New insights from population-based resequencing of
candidate genes.
E.S. Buckler, Cornell University, Ithaca: Genetic architecture of
maize trait variation.
L. Andersson, Uppsala University, Sweden: Molecular character-
ization of trait loci gives new insight in chicken domestication.
K.M. Olsen, Washington University in St. Louis, Missouri:
Molecular evolution of an adaptive cyanogenesis polymor-
phism in white clover.
N. Weeden, Montana State University, Bozeman: Genetic
basis of morphological and physiological changes associated
with the domestication of pea, P. salivum L.
Meeting Wrap Up and Discussion of Future Research
P. GeptsSESSION 2: Origins of Agricultural Species: Molecular Data
Chairperson: D.Q. Fuller, University College London, United
Kingdom
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Protecting Public Trust in Immunization
October 17–19
FUNDED BY Albert B. Sabin Vaccine Institute, with support from the Robert Wood Johnson
Foundation and Autism Speaks
ARRANGED BY L.Z. Cooper, Sabin Vaccine Institute, New York
H. Larson, Harvard Center for Population & Development, Cambridge, Massachusetts
S.L. Katz, Duke University Medical Center, Durham, North Carolina
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Vaccine preventable diseases (with few exceptions) are at an all time low in the United States. This suc-
cess reflects the biologic effectiveness of specific vaccines, sound public policy, implementation in deliv-
ering vaccines to target audiences, and a history of high levels of public trust in vaccine safety and effi-
cacy. This trust is an expression of a special social contract that is key to the success of immunization
programs. However, we cannot be complacent in assuming trust in public health recommendations,
and, indeed, a significant number of parents have serious concerns about safety. Antivaccine activists
are gaining momentum. Given these recent trends, it is critical to take a closer look at public trust in
vaccines. This discussion meeting reviewed the status of public trust in immunization, clarified its
strengths and weaknesses, identified strategies to increase trust, and made recommendations to stake-
holders in the “vaccine endeavor.”
Keynote Speaker: H.R. Shepherd, Sabin Vaccine Institute, New Canaan, Connecticut
Introduction of Speaker: Robert Wright, Autism Speaks, New York
SESSION 1: A Frame of Reference
Chairperson: S.L. Katz, Duke University Medical Center, Durham, North Carolina
L.Z. Cooper, Sabin Vaccine Institute, New York: Why Sabin
convened this colloquium?
D.G. Salmon, National Vaccine Program, DHHS, Washington,
D.C.: Government roles in protecting public trust in immunization.
D. Pineda, Immunizations for Public Health, Galveston, Texas:
Words matter: Risk communication and public trust.
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L. Gordon, I. Sullivan
Group General Discussion and charge to Breakout Group A: What should be key features immu-
nization programs to sustain public trust of individuals to be served?
Group’s Report
SESSION 2: Painful Examples: Evolution of Distrust and Lessons to be Learned
Chairperson: L.Z. Cooper, Sabin Vaccine Institute, New York
SESSION 3: Global Issues: Biologic and Sociocultural/Political Complexities Challenge Public Trust
A. Polio and Beyond, Tetanus and Hepatitis Vaccines
Chairpersons: A. Bentsi-Enchill, World Health Organization,
Geneva, Switzerland
H. Larson, Harvard Center for Population & Development,
Cambridge, Massachusetts
N. Khuri-Bulos, Jordan University Hospital, Amman
K. Hartigan-Go, The Zuellig Foundation, Makati City,
Philippines
B. Other Challenges, Including Balancing National vs.
International Interests
Chairperson: S.L. Katz, Duke University Medical Center,
Durham, North Carolina
J.D. Grabenstein, Merck Vaccines & Infectious Diseases, West
Point, Pennsylvania: HPV, a new primary audience, different
challenges.
D.R. Johnson, Sanofi Pasteur, Swiftwater, Pennsylvania: Ups,
downs, and ups with totavirus vaccine.
L. Sullivan, Morehouse School of Medicine, Atlanta, Georgia: A
broader perspective on public trust and immunization.
Brief Comments from the “Communicators”
Chairperson: C.D. DeAngelis, Journal of the American
Medical Association, Chicago, Illinois
Panel: C. Cole, Sesame Workshop, New York
L. McNeill, Food and Drug Administration, Rockville,
Maryland
B. Mulach, NIAID, National Institutes of Health, Bethesda,
Maryland
G. Nowak, Centers for Disease Control and Prevention,
Atlanta, Georgia
D. Pineda, Immunizations for Public Health, Galveston,
Texas
Discussion: Autism—The MMR Questions Evolution of
Chimerical Concerns
Panel: N. Halsey, The Johns Hopkins University School of
Hygiene & Public Health, Baltimore, Maryland
G. Nowak, Centers for Disease Control and Prevention,
Atlanta, Georgia
S. Bernard, SafeMinds, Tyrone, Georgia
A. Shih, Autism Speaks, New York
M. McCormick, Harvard School of Public Health, Boston,
Massachusetts: A special perspective: The IOM-ISRC expe-
rience—Trust, a steep hill.
Breakout Group B
What are the lessons to be learned from these recent challenging examples? Reflect on both the
processes of communication and the specific content of the information.
Breakout Group B Reports and Open Discussion
Breakout Group C
Since immunization science provides content essential for
communication and building public trust, what are solutions
for enhancing immunization safety science?
Group’s Report and Group Discussion: Selecting most
important solutions
Open Comments: What have we missed? What will you take
away? What will you do toward protecting public trust?
Panel: L.Z. Cooper, Sabin Vaccine Institute, New York
S.L. Katz, Duke University Medical Center, Durham, North
Carolina
H. Larson, Harvard Center for Population & Development,
Cambridge, Massachusetts: Wrap up by the organizers,
including next steps and final group discussion.
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Microbial Forensics: Enduring Research Pathways
October 21–24
FUNDED BY U.S. Department of Homeland Security and individual participants
ARRANGED BY S. Schutzer, UMDNJ–New Jersey Medical School, Newark
B. Budowle, Federal Bureau of Investigation Laboratory, Quantico, Virginia
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A major thrust of microbial forensics is the continuing quest for technologies and strategies that can
improve the characterization of samples. At present, these fall into two major categories: nucleic-acid-
based assays and chemical assays. The former enable association (or elimination) of a pathogen with
specific sources using genetic information, and the latter provides information on the processes used to
grow, stabilize, and/or disseminate the agent. In both areas, technologies are needed for rapid, high-sen-
sitivity, and highly specific analysis of pathogens in limited and complex samples. Participants sought to
identify the requirements of such technologies, to better guide the community in research and develop-
ment and administrators in selecting what to support.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 2: Proteomics
Chairperson: B.L. Marrone, Los Alamos National
Laboratory, New Mexico
J.N. Adkins, Pacific Northwest National Laboratory, Richland,
Washington: Mass spectrometry identification of forensic
material.
K.L. Wahl, Pacific Northwest National Laboratory, Richland,
Washington: Mass spectrometry tool for identifying nonpro-
tein non-DNA signatures.
SESSION 3: DNA Typing Technologies
Chairperson: J.J. Dunn, Brookhaven National Laboratory,
Upton, New York
W.R. McCombie, Cold Spring Harbor Laboratory: Comparison
of high-throughput sequencing capabilities.
M. Srinivasan, 454 Life Science, Bradford, Connecticut: 454
sequencing.
M.R. Furtado, Applied Biosystems, Foster City, California:
Solid and multiplex SNP technologies.
SESSION 1: Overview
Chairperson: S. Schutzer, UMDNJ–New Jersey Medical School, Newark
B. Budowle, Federal Bureau of Investigation, Quantico, Virginia:
Microbial forensics and enduring technologies.
P.T. Pesenti, U.S. Department of Homeland Security,
Washington, D.C.: DHS program for long-term needs to sup-
port field and goals.
J.P. Burans, U.S. Department of Homeland Security, Frederick,
Maryland: National labs and NBFAC efforts in enduring tech-
nology.
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SESSION 4: Threat Assessment and Legal Issues
Chairperson: P.J. Jackson, Los Alamos National Laboratory, New Mexico
J. Smith, Federal Bureau of Investigation, Washington, D.C.:
Credible threat assessments: Bases and practices.
R.P. Harmon, Alameda County District Attorney’s Office,
Oakland, California: Legal issues for technologies, routine,
new, and one-of-a-kind, Daubert.
SESSION 5: Improving Template Quality for Downstream Assays
Chairperson: R.P. Harmon, Alameda County District Attorney’s Office, Oakland, California
M. Eshoo, Ibis Bioscience, Carlsbad, California: Whole-
genome amplification.
T.E. Evans, New England BioLabs, Inc., Ipswich,
Massachusetts: DNA repair.
S. Schutzer, UMDNJ–New Jersey Medical School, Newark:
Integration of proteomics and genomics.
S.P. Velsko, Lawrence Livermore National Laboratory,
California: Analytical technologies for nonbio signatures.
SESSION 6: Interpretation
Chairperson: S.A. Morse, Centers for Disease Control and Prevention, Atlanta, Georgia
B. Budowle, Federal Bureau of Investigation, Quantico,
Virginia: Needs for interpretation of results.
M.A. Feinberg and J. Bannan, Federal Bureau of Investigation,
Quantico, Virginia: Technology and attribution needs for the FBI.
SESSION 7: Bioinformatics
Chairperson: J.P. Burans, U.S. Department of Homeland Security, Frederick, Maryland
O. White, Institute for Genome Sciences, University of
Maryland School of Medicine, Baltimore: Bioinformatics tools
for genomics for identifying regions, genes, function.
T. Slezak, Lawrence Livermore National Laboratory, California:
Bioinformatics tools and the BKC for attribution.
SESSION 8: Distinguishing Natural Outbreaks from Intentional Use
Chairperson: J. Smith, Federal Bureau of Investigation, Quantico, Virginia
P.S. Keim, Northern Arizona University, Flagstaff: Attribution
using microbial databases.
S.A. Morse, Centers for Disease Control & Prevention, Atlanta,
Georgia: Tracing disease outbreaks.
C.L. Cooke, National Counterproliferation Center, Washington,
D.C.: Scenarios on interpretation of DNA evidence.
W.W. Laegreid, University of Illinois, Urbana: Response and
interpretation: Finding the tainted mad cow.
D.L. Rock, University of Illinois at Urbana-Champaign:
Interpreting FMDV outbreak data.
SESSION 9: Utility of Microbial Population Genetics and Legal Aspects
Chairperson: P.T. Pesenti, U.S. Department of Homeland Security, Washington, D.C.
D.E. Dykhuizen, Stony Brook University, New York: Tipping in
phylogenetic analysis.
J. Yadav, University of Cincinnati College of Medicine, Ohio:
Genomic approach for microbial pathogen detection and
issues of interpretation.
R.P. Harmon, Alameda County District Attorney’s Office,
Oakland, California: HIV as a microbial forensic model.
T. Cebula, U.S. Food and Drug Administration, Laruel,
Maryland: Summary of SWG mock trial: Impression of a day
in court.
A. Martinez-Fonts, Department of Homeland Security,
Washington, D.C.: Discussion on strategy for identifying
promising technologies to support.
SESSION 10: Identification and Installation of Promising Technologies
Chairperson: A. Martinez-Fonts, Department of Homeland Security, Washington, D.C.
Wrap Up
Chairpersons: B. Budowle, Federal Bureau of Investigation, Quantico, Virginia; S. Schutzer, UMDNJ–
New Jersey Medical School, Newark
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Using Bar-code Data in Studies of Molecular and
Evolutionary Dynamics
October 28–31
FUNDED BY Alfred P. Sloan Foundation
ARRANGED BY D.E. Schindel, Smithsonian Institution, Washington, D.C.
M. Blaxter, University of Edinburgh, United Kingdom
P. Gilna, University of California, San Diego
R.G. Harrison, Cornell University, Ithaca, New York
D.M. Rand, Brown University, Providence, Rhode Island
M. Veuille, Museum d’Histoire Naturelle, Paris, France
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The Barcode of Life Initiative is generating an enormous volume of nucleotide sequence data from an
homologous region of the animal mitochondrial genome. These data are being collected to build an
information infrastructure for taxonomic research and for the rapid identification of species for diverse
applied purposes such as border control of agricultural pests. This body of standardized gene
sequence data may present allied fields of research with new and unanticipated opportunities as well.
This workshop, the third in the series held at the Banbury Center, brought together population biolo-
gists, geneticists, bioinformaticians, and evolutionary biologists for the purpose of exploring the poten-
tial “off label” uses of DNA bar-code data.
Historical Background: J.H. Ausubel, The Rockefeller University, New York
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
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SESSION 1: Overview of Bar-code Data
Chairperson: P. Gilna, University of California, San Diego
D.E. Schindel, Smithsonian Institution, Washington, D.C.:
Linking bar-coded data to multiple users.
R. Hanner, University of Guelph, Ontario, Canada: Bar-code
data standard and trace analysis.
S. Ratnasingham, University of Guelph, Ontario, Canada: The
Barcode Life Data Systems: An informatics platform for the
biodiversity informatics community.
M. Hajibabaei, University of Guelph, Ontario, Canada:
Minimalist bar-code sequences.
SESSION 2: Species Boundaries, Speciation Processes, and Models
Chairperson: R.G. Harrison, Cornell University, Ithaca, New York
R.G. Harrison, Cornell University, Ithaca, New York: Multilocus
approaches to defining species boundaries.
M. Blaxter, University of Edinburgh, United Kingdom: Defining
and constructing MOTUs.
M. Stoeckle, The Rockefeller University, New York: Iterative
taxonomy-DNA bar-coding cycle provides insights into
species limits in birds.
J. Hey, Rutgers University, Piscataway, New Jersey: Population
assignment likelihoods in a phylogenetic and demographic
model.
A. Meyer, University of Konstanz, Germany: Sharing of mito-
chondrial DNA haplotypes in cichlid fishes.
SESSION 3: Phylogeography, Community Evolutions, and the Use of Bar Codes for Multispecies
Studies
Chairperson: M. Veuille, Museum d’Histoire Naturelle, Paris, France
M. Veuille, Museum d’Histoire Naturelle, Paris, France: Can we
extend intraspecific population genetics to community popu-
lation genetics?
E. Bermingham, Smithsonian Tropical Research Institute,
Balboa, Republic of Panama: Phylogeography of Caribbean
birds.
G. Stone, University of Edinburgh, United Kingdom: Beyond
the bar code: Setting our sites on reconstructing community
evolution.
L. Knowles, University of Michigan, Ann Arbor: Statistical phy-
logeography.
SESSION 4: Selection on and Variation in Mitochondrial DNA Sequences
Chairperson: D.M. Rand, Brown University, Providence, Rhode Island
D.M. Rand, Brown University, Providence, Rhode Island: Bar
codes and selection of mtDNA.
T. Barraclough, Imperial College London, Ascot, United
Kingdom: Patterns of divergent selection from combined
bar-code and phenotypic data.
R. Nielsen, University of Copenhagen, Denmark: Statistical
approaches for DNA bar coding.
G. Wallis, University of Otago, Dunedin, New Zealand: Beyond
the bar: Roles for a million COI sequences in studies of
molecular adaptation.
SESSION 5: Visualization of Large Sequence Data Sets
Chairperson: D.E. Schindel, Smithsonian Institution,
Washington, D.C.
M. Hajibabaei, University of Guelph, Ontario, Canada:
Visualizing bar-code data.
SESSION 6: Final Discussion of Conclusions,
Recommendation, and Action Items
Chairperson: D.E. Schindel, Smithsonian Institution,
Washington, D.C.
E. Bermingham, M. Stoeckle
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Interdisciplinary Memory Symposium in Neurosciences
and the Humanities
October 31–November 2
FUNDED BY The Selz Foundation, Inc.; The Satenik and Adom Ourian Educational Foundation;
Haig R. Nalbantian; Marsh & McLennan Companies—MMC Matching Gifts to Education
Program; The Daniel and Joanna S. Rose Fund, Inc.; Mr. and Mrs. Howard Phipps, Jr.
ARRANGED BY S. Nalbantian, Long Island University, Brooklyn, New York
P. Matthews, GlaxoSmithKline, Oxford University, United Kingdom
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The subject of human memory offers intriguing and exciting possibilities for interdisciplinary exchanges
between the humanities and neuroscience. Just as the neuroscientist explores the physical workings of the
brain with the tools of electrophysiology and molecular biology, so writers and artists explore and record
the mental experiences of human beings. This interdisciplinary symposium discussed the ways in which
the insights of those in the humanities can inform the models of human memory based on neuroscience.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction to the Symposium: S. Nalbantian, Long Island University, Brooklyn, New York; Paul Matthews,
GlaxoSmithKline, Oxford University, United Kingdom
Keynote Address: Representations of Memory in Twentieth Century Art: Painting Modernism’s Memories
L. Dalrymple Henderson, University of Texas, Austin
SESSION 1
J. Dubnau, Cold Spring Harbor Laboratory: The genetic basis
of memory: Memories of a fly?
J.-P. Changeux, Institut Pasteur and Collège de France, Paris,
France: Brain plasticity and the epigenetic variability of mem-
ory: Consequences in artistic contemplation and creation.
J.L. McClelland, Stanford University, California: Connectionist
modeling of parallel processing and complementary memory
systems.
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SESSION 2
B. Favorini, University of Pittsburgh, Pennsylvania: The theatre
of memory: The scene is memory!
S. Nalbantian, Long Island University, Brooklyn, New York:
Literature as a laboratory for memory research: Literary case
studies as evidentiary material.
J. Burt Foster, George Mason University, Fairfax, Virginia:
Memory in the literary memoir: Nabokov, Yeats, Mary
McCarthy.
SESSION 3: Interdisciplinary Panel for the Creation of a “Third Discourse” for Memory Research;
Discussion
Chairpersons: S. Nalbantian, Long Island University, Brooklyn, New York; P. Matthews, Oxford
University, United Kingdom
Topics for Discussion:
1. Identification of the most likely areas where humanists can
illuminate the memory process in an exploratory or confir-
matory fashion.
2. Pertinence of neuroscientific models to humanistic data.
3. Consideration of the way literature and the arts can be
used as data with emphasis on artistic and linguistic fac-
tors. Possibilities for neuroimaging testing studies of
human subjects.
4. Cross-disciplinary vocabulary.
5. Inroads to creativity.
6. Publication of a volume stemming from this symposium.
SESSION 4
F. Vidal, Max-Planck Institute for the History of Science, Berlin,
Germany: The Cerebral subject: Memory, self and the brain
in film.
Respondent: J.D. Talasek, National Academy of Sciences,
Washington, D.C.
P. Matthews, GlaxoSmithKline, Oxford University, United
Kingdom: Neuroimaging, memory, and brain disorders.
R. Stickgold, Harvard Medical School, Boston,
Massachusetts: Dream analysis memory: Reactivation and
reconsolidation.
Respondent: V. Doyère, CNRS, Université Paris Sud, Orsay,
France
SESSION 5
D. Hertz, Indiana University, Bloomington: Poetry and music:
What makes us remember?
M. Tramo, M.D., Harvard Medical School, Boston,
Massachusetts: The neurobiology of memory for music.
P. Michon, Collège International de Philosophie, Paris, France:
Epistemological models in social and neuroscientific memory
studies: A philosophical inquiry.
Respondent: R. Phipps, Center for Process Studies,
Claremont Graduate University, California: Whitehead’s phi-
losophy and memory.
J. Pierre-Changeux
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From Statistics to Genes: Figuring Out the Molecular Basis
of Complex Traits
November 4–7
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY A. Chakravarti, The Johns Hopkins University School of Medicine, Baltimore, Maryland
L. Kruglyak, Princeton University, New Jersey
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Studies of the genetic basis of complex traits are being transformed by a convergence of two related
developments: genome-wide association studies that are providing a growing list of susceptibility loci
for common diseases, and, studies of model organisms that are providing increasingly detailed descrip-
tions at the molecular level. Both of these developments are being driven by new technologies, access
to genomic sequence, and functional information. This meeting brought together leaders in three
areas—human genetics, model systems, and technology—to chart the future course of understanding
complex disease.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Overview: A. Chakravarti, The Johns Hopkins University School of Medicine, Baltimore, Maryland; L. Kruglyak,
Princeton University, New Jersey
SESSION 1: Complex Traits in Model Systems I
Chairperson: L. Kruglyak, Princeton University, New Jersey
SESSION 2: Complex Traits in Model Systems II
Chairperson: H.G. Parker, CGB/NHGRI/NIH, Bethesda, Maryland
G.C. Gibson, North Carolina State University, Raleigh:
Drosophila as a model for complex traits and diseases.
P. Wittkopp, University of Michigan, Ann Arbor: Genomic
sources of regulatory variation.
L. Steinmetz, EMBL Heidelberg, Germany: Fine mapping and
functional characterization of complex traits in yeast.
G. Yvert, CNRS, Lyon, France: Cell-to-cell stochastic variation
in gene expression as a complex trait in yeast.
J. McCusker, Duke University Medical Center, Durham, North
Carolina: Complex traits in a simple eukaryote.
M. Nordborg, University of Southern California, Los Angeles:
Whole-genome association in Arabidopsis.
M. Rockman, Princeton University, New Jersey: Complex trait
genetics in C. elegans.
D. Stern, Princeton University, New Jersey: Morphological evolu-
tion through multiple cis-regulatory mutations at a single gene.
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G. Churchill, G. Yvert, M. Nordborg, A. Chakravarti
SESSION 3: Complex Trait Model Systems III
Chairperson: P. Wittkopp, University of Michigan, Ann Arbor
M. Shapiro, University of Utah, Salt Lake City: Genetic basis of
parallel evolution in stickleback fish.
H.G. Parker, CGB/NHGRI/NIH, Bethesda, Maryland: The long
and short of canine fixed trait mapping.
B.A. Hamilton, University of California, San Diego; School of
Medicine, La Jolla, California: Architectures of modifier gene
networks: Thoughts from two examples.
G.A. Churchill, The Jackson Laboratory, Bar Harbor, Maine
SESSION 4: Human Complex Trait Dissection and Evolution
Chairperson: L. Pennacchio, Lawrence Berkeley National Laboratory, California
D.B. Goldstein, Duke University, Durham, North Carolina:
Genome-wide association studies in host response to HIV.
A.C. Kong, DeCode Genetics, Reykjavik, Iceland: Recent gene
discoveries and new challenges.
M. McCarthy, The Churchill Hospital, Oxford, United Kingdom:
Thinking big: Genes involved in type-2 diabetes, adiposity,
and height.
S. Deutsch, University of Geneva Medical School, Switzerland:
Phenotype mapping in cell lines.
S. Tishkoff, University of Maryland, College Park: Genetic and
phenotypic variation in Africa.
G. Wray, Duke University, Durham, North Carolina: Genome-
wide imprints of selection and the evolution of complex traits
in humans.
SESSION 5: New Technologies
Chairperson: A. Chakravarti, The Johns Hopkins University School of Medicine, Baltimore, Maryland
S. Kruglyak, Illumina, Inc., San Diego, California: Tools for
whole-genome association studies.
J. Sebat, Cold Spring Harbor Laboratory: Analysis of genome
copy-number variation in psychiatric disease.
L. Pennacchio, Lawrence Berkeley National Laboratory,
California: Deep resequencing in the Dallas Heart Study.
T.S. Mikkelsen, Broad Institute, Cambridge, Massachusetts:
Mammalian epigenomics.
SESSION 6: Final Discussion and Future Directions
Discussion
A. Chakravarti, The Johns Hopkins University School of
Medicine, Baltimore, Maryland, and L. Kruglyak, Princeton
University, New Jersey.
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Second Environment Ontology Workshop
November 14–16
FUNDED BY U.S. National Science Foundation’s Research Coordination Network
grant (DBI 0234147) to the Gramene Database
ARRANGED BY P. Jaiswal, Cornell University, Ithaca, New York
N. Morrison, University of Manchester, United Kingdom
D. Field, Oxford University, United Kingdom
S. Lewis, Lawrence Berkeley National Laboratory, California
B. Smith, University at Buffalo, New York
M. Ashburner, University of Cambridge, United Kingdom
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An ontology is a controlled, structured vocabulary developed to represent entities in a given domain and
the relations between them. The use of a standardized, consistent nomenclature means that informa-
tion can be searched by computers, enabling them to share and integrate information without human
intervention. There is, for example, a Gene Ontology that has been developed so that different genome
databases can “talk” to each other. Participants in this workshop are attempting do derive an ontology
to describe the environments in which organisms live. Such an ontology would facilitate the retrieval of
any biological record anchored to the environment ontology, whether in sequence or genome databas-
es, tissue banks, or museum collections. Developing (and implementing) such ontologies is a far from
trivial endeavor and participants learned how Gene Ontology developed as well as planning future
steps.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
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SESSION 1
Chairperson: P. Jaiswal, Cornell University, Ithaca, New York
P. Jaiswal, Cornell University, Ithaca, New York: Welcome
and introductory remarks.
B. Smith, University at Buffalo, New York: EnvO introduc-
tion.
M. Ashburner, University of Cambridge, United Kingdom:
Progress on EnvO+GAZ ontology development.
N. Morrison, University of Manchester, United Kingdom:
Ontology maintenance and Web site + database logistics.
C. Mungall, Lawrence Berkeley National Laboratory, California:
Phenote annotation tool.
Case Studies with EnvO annotations:
P. Dawyndt/Bart van Brabant
L. Schriml/Aaron Gussman
D. Field
N. Sarkar
SESSION 2
Chairperson: N. Morrison, University of Manchester, United Kingdom
New Case Studies for Potential EnvO Annotations
J. White
S. Greene
L. Hirschman
V. Markowitz
S. Ratnasingham
M. Ashburner, University of Cambridge, United Kingdom:
Hands-on work on ontology.
SESSION 3
Chairperson: B. Smith, University of Buffalo, New York
S. Lewis, University of California, Berkeley: Summary from
Day-1.
SESSION 4
Chairperson: S. Lewis, University of California, Berkeley
M. Ashburner, University of Cambridge, United Kingdom:
Hands-on work on ontology.
B. Smith, University of Buffalo, New York: Discussion of fund-
ing possibilities.
N. Morrison, University of Manchester, United Kingdom:
Identify potential projects, databases, and collaborators.
S. Lewis, University of California, Berkeley: Summarizing the
meeting, action items, and wrap up.
L. Hirschman
M. Ashburner, University of Cambridge, United Kingdom:
Hands-on work on ontology.
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Podosomes and Invadopodia: Signatures of the Wandering Cell?
November 26–29
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY G. Jones, King’s College, University of London, United Kingdom
J.S. Condeelis, Albert Einstein College of Medicine, Bronx, New York
A. Huttenlocher, University of Wisconsin, Madison
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Examples of cell migration include leukocytes involved in immune surveillance and innate immunity, and
other cell types during morphogenetic movements of embryonic development, in wound healing, and in
the invasion and dispersal of metastatic tumor cells. To a large extent, these cell movements depend on
the degradation of extracellular matrix components by focal secretion of matrix metalloproteinases.
Localized degradation of the matrix is found at adhesive (podosomes) and protrusive (invadopodia) loca-
tions in a variety of cell types including leukocytes and invasive carcinoma cells. Research on the role of
these transient membrane-associated organelles in cell motility suggests that they are involved in direct-
ed cell migration and chemotaxis in vitro and in vivo. Participants reviewed recent findings and develop-
ments and discussed the importance of these structures in cell migration, inflammation, morphogenesis,
and metastasis. There was vigorous discussion of the relationship between podosomes and invadopodia.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Principles of Cell Motility
Chairperson: G. Jones, King’s College London, United Kingdom
General Discussion on Terminology: Do podosomes =
invadopodia = invadosomes?
Discussion Leaders:
G. Jones, King’s College, University of London, United
Kingdom
J.S. Condeelis, Albert Einstein College of Medicine, Bronx,
New York
A. Huttenlocher, University of Wisconsin, Madison: Principles of
cell motility: Neutrophil chemotaxis in vivo.
P. Friedl, University of Würzburg, Germany: Invadopods in
three-dimensional invasion?
J.S. Condeelis, Albert Einstein College of Medicine, Bronx, New
York: Invadopod regulation and function in breast tumor
metastasis.
F. Gertler, Massachusetts Institute of Technology, Cambridge:
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An invasion-specific Mena isoform promotes cancer cell
invasion and potentiates EGF responses.
S. Muthuswamy, Cold Spring Harbor Laboratory: Changes in
cell polarity pathways regulate cell invasion.
P. DeCamilli, Yale University, New Haven, Connecticut: Role of
dynamin in cell physiology.
SESSION 2: Podosome Regulation
Chairperson: A. Huttenlocher, University of Wisconsin, Madison
G. Jones, King’s College London, United Kingdom:
Podosomes in myeloid leukocytes.
S. Linder, University of Munich, Germany: Regulation of
podosome dynamics in human macrophages.
R. Buccione, Consorzio Mario Negri Sud, Italy: Regulation of
invadopodia biogenesis.
D. Cox, Albert Einstein College of Medicine, New York: WASP
phosphorylation and podosome regulation.
R. Baron, Yale University, New Haven, Connecticut: Src regula-
tion of podosomes using the osteoclast as a model system.
I.M. Anton, Centro Nacional de Biotecnología/CSIC, Spain:
Contribution of WIP to podosome formation in dendritic cells
and mature osteoclasts.
S. Tsuboi, Burnham Institute for Medical Research, La Jolla,
California: Role of the WASP-WIP complex in podosome for-
mation in macrophages.
SESSION 3: Actin-based Motility
Chairperson: J.S. Condeelis, Albert Einstein College of Medicine, Bronx, New York
L.M. Machesky, Cancer Research UK, United Kingdom: Role
of Arp2/3 complex and IRSp53-MIM proteins in actin mem-
brane interactions.
J. Taunton, University of California, San Francisco: Actin-
dependent feedback to N-WASP: A signal amplification
mechanism for invadopodia expansion.
J.A. Cooper, Washington University, St. Louis, Missouri: Role
of cortactin and HS1 in actin assembly in osteoclasts and
lymphocytes.
J.E. Bear, University of North Carolina, Chapel Hill: Role of
coronins in cancer cell invasion and motility.
J. Theriot, Stanford University, California: Large-scale coordi-
nation of actin polymerization, contraction, and adhesion in
motile keratocytes.
SESSION 4: Cell Signaling in Invasive Motility
Chairperson: F. Gertler, Massachusetts Institute of Technology, Cambridge
S.A. Courtneidge, Burnham Institute for Medical Research, La
Jolla, California: Role of the adaptor protein Tks5 in cancer
cell invasion and embryonic development.
A.S. Mak, Queen’s University, Kingston, Canada: Calpain-4 in
podosome formation.
M.A. Chellaiah, University of Maryland, Baltimore: Podosomes
and invadopodia: Role in extracellular matrix degradation
and migration in osteoclasts and prostate cancer cells.
E. Genot, Université Bordeaux, Pessac, France: Endothelial
podosomes: A new tool for remodeling the vascular bed.
H. Gil-Henn, Yale University School of Medicine, New Haven,
Connecticut: Pyk2 in podosome organization and bone
remodeling.
S.C. Mueller, Georgetown University Medical Center,
Washington, D.C.: Invadopodia: Src and the cell-protease
interface.
S.A. Weed, West Virginia University, Morgantown:
Phosphoregulation of cortactin function.
SESSION 5: Invadopodia and Cancer Invasion
Chairperson: J.S. Condeelis, Albert Einstein College of Medicine, Bronx, New York
C. Streuli, University of Manchester, United Kingdom: Integrins
in breast development and cancer.
E. Sahai, Cancer Research UK, London, United Kingdom:
Mechanisms of cell invasion in three-dimensional environments
and in living tumors.
A. Weaver, Vanderbilt University Medical Center, Nashville,
Tennessee: Microenvironmental regulation of invadopodia.
J.F. Marshall, University of London, United Kingdom: Targeting
integrin α-v β-6 for the imaging and therapy of carcinoma.
N. Carragher, AstraZeneca, Loughborough, United Kingdom:
Modeling distinct modes of tumor cell invasion for drug discovery.
General Discussion and Terminology: Do podosomes =
invadopodia in composition and function?
Discussion Leaders:
A. Huttenlocher, University of Wisconsin, Madison
G. Jones, King’s College London, United Kingdom
J.S. Condeelis, Albert Einstein College of Medicine, Bronx,
New York S. Mueller, R. Buccione
S. Courtneidge, G. Jones
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Cell Transplantation as a Therapy for Parkinson’s Disease
December 9–12
FUNDED BY Private support
ARRANGED BY A. Bjorklund, University of Lund, Sweden
H. Cline, Cold Spring Harbor Laboratory
O. Lindvall, Lund University Hospital, Sweden
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Previous clinical trials have shown that transplants of fetal dopamine neurons can survive and function
in the brains of patients with Parkinson’s disease. Therapeutically valuable and long-lasting clinical
improvement has been observed in subgroups of patients, but troublesome graft-induced dyskinesias
have been noted in a significant number of cases. Further development of a dopamine cell replacement
therapy for Parkinson’s disease will critically depend on the development of alternative sources of cells
for grafting. Participants critically examined the issues that need to be resolved in order to bring the cell
replacement approach into a clinically successful and competitive therapy for patients with Parkinson’s
disease.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Clinical Trials: A Critical Assessment of the Results Obtained in Patients with Fetal DA
Neuron Transplants
Chairperson: D. Eidelberg, Feinstein Institute for Medical Research, Manhasset, New York
T.B. Freeman, University of South Florida, Tampa: The Tampa–
Mount Sinai trial.
C.R. Freed, University of Colorado School of Medicine,
Denver: The Denver–Columbia trial.
I. Mendez, Dalhousie University, New York: The Halifax program.
O. Lindvall, Lund University Hospital, Sweden: The Lund–
London–Marburg program.
T.B. Freeman, University of South Florida, Tampa:
Neurosurgical aspects.
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P. Piccini V. Tabar, S. Goldman
SESSION 2: What Is Required to Make a Cell Transplantation Therapy Clinically Competitive?
Chairperson: R.A. Barker, University of Cambridge, United Kingdom
G. Nikkhah, Abt. Stereotaktische Neurochirugie, Freiburg,
Germany: Pattern and extent of recovery in grafted patients.
S. Dunnett, Cardiff University, South Wales, United Kingdom:
Behavioral criteria in rodent models.
D.E. Redmond, Yale University School of Medicine, New
Haven, Connecticut: Behavioral criteria in primate models.
A. Bjorklund, University of Lund, Sweden: Necessary proper-
ties of grafted cells.
SESSION 3: Generation of Dopamine Neurons from ES Cells
Chairperson: S. Dunnett, Cardiff University, South Wales, United Kingdom
B. Reubinoff, Hadassah University Medical Organization,
Jerusalem, Israel: Human embryonic stem cells for
Parkinson’s disease.
J. Ericson, Karolinska Institute, Stockholm, Sweden: Intrinsic
determinants in stem cell engineering.
K.-S. Kim, McLean Hospital, Harvard Medical School,
Belmont, Massachusetts: Potential cell sources and animal
models for Parkinson’s disease.
E. Arenas, Karolinska Institute, Stockholm, Sweden: Reduced
proliferation and enhanced dopaminergic differentiation by
Wnt5a.
SESSION 4: In Vivo Performance of Stem-cell-derived Dopamine Neurons: Survival, Function,
Tumorigenesis
Chairperson: A. Bjorklund, University of Lund, Sweden
L. Studer, Memorial Sloan-Kettering Cancer Center, New York:
Directed differentiation and purification of human ES-cell-
derived dopamine neurons.
S.-C. Zhang, University of Wisconsin, Madison: Survival and
function of DA neurons derived from hES cells.
S.A. Goldman, University of Rochester Medical Center, New
York: DA neurons derived from human ES cells in coculture.
J. Takahashi, Kyoto University, Japan: In vivo functional studies
in primates.
SESSION 5: Critical Issues for the Development of a Stem Cell Therapy for Parkinson’s Disease
Chairperson: O. Lindvall, Lund University Hospital, Sweden
Theme 1: Transplant-induced Dyskinesia
Speaker: K. Steece-Collier, University of Cincinnati, Ohio
Discussant: D. Kirik, University of Lund, Sweden
Open Discussion
Theme 2: Strategies to Avoid Tumor Formation
Speaker: V. Tabar, Memorial Sloan-Kettering Institute for
Cancer, New York
Discussant: J. Takahashi, Kyoto University, Japan
Open Discussion
Theme 3: Patient Selection and Efficacy
Speaker: R.A. Barker, University of Cambridge, United
Kingdom
Discussants: D. Eidelberg, Feinstein Institute for Medical
Research, Manhasset, New York; P. Piccini, Imperial
College London, United Kingdom
Open Discussion
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DOLAN DNA LEARNING CENTER
EXECUTIVE DIRECTOR’S REPORT
Preparing students and families to thrive in the gene age
TECHNOLOGY
ADMINISTRATION INSTRUCTION BIOMEDIA DEVELOPMENT
Mary Lamont Elna Carrasco Steven Blue Cornel Ghiban
Valerie Meszaros Jennifer Cutillo John Connolly Bruce Nash
David Micklos Natalia Hanson Eun-Sook Jeong Jermel Watkins
Karen Orzel Brian Lang Susan Lauter
Carolyn Reid Erin McKechnie Chun-hua Yang
Amanda McBrien
Lauren Weidler
For practical, philosophical, and political reasons, plant research has lagged behind medically oriented
research. Practically, the plant cell presents its own tremendous barrier to research. Although animal cells
are surrounded by a single permeable membrane, plant cells also include a tough cell wall. This “wooden
box” makes plant cells difficult to genetically engineer. Transformation—the process of inserting a new
DNA sequence into a living cell and the constraining point in the genetic engineering of a species—was
first accomplished in bacteria in the 1970s and in animal cells in the 1980s. However, plant cells could
not be reliably transformed until the 1990s.
Philosophically, humans are naturally self-absorbed with improving the quality and length of their own
lives. After World War II, this desire was translated into political will by Vannevar Bush. As director for the
Office of Scientific Research and Development (OSRD), he had marshaled the academic research effort
in support of the war. In his 1945 report, Science, The Endless Frontier, Bush eloquently argued that the
federal government should maintain the strong sponsorship of academic research it had established dur-
ing the war, but to bend it toward fostering improved public health. This led to the rapid expansion of the
National Institutes of Health (NIH) and its rise as the preeminent medical research organization in the
world. In the 1960s, Mary Lasker joined with Senators J. Lister Hill and John E. Fogarty to raise public
and political awareness of cancer, which stimulated the ascension of the National Cancer Institute as the
largest of all the national institutes.
Plant research had received early federal support through the system of land grant universities estab-
lished by Congress in 1862. Now sponsored by the Department of Agriculture, this decentralized research
program produced the “green revolution” that dramatically increased crop yields through a combination
of improved plant cultivars, petrochemical fertilizers, and mechanization. However, despite the lobbying
of congressmen from agricultural states, in the post-war era, the Department of Agriculture’s research
budget fell far behind NIH’s. At $2.3 billion, the Department of Agriculture’s 2007 research budget was
less than 10% of the NIH’s $28.4 billion budget.
In the last 10 years, basic plant research has received a new champion—the National Science Foun-
dation (NSF). Given NIH’s public health mandate, NSF has been excluded from funding most human or
medically oriented research. Thus, NSF sat on the sidelines during the sequencing of the human genome
and important model organisms. However, with the advent of the National Plant Genome Initiative (NPGI)
in 1988, NSF rose to fill a vacuum in plant genome sequencing that was not being filled by the Depart-
ment of Agriculture. NSF became the lead agency in the focused effort to determine the DNA sequences
of the grains and other crop plants that feed most of the world’s population—with the hope that insights
into plant genomes would fuel a second green revolution, allowing us to feed the ten billion people
expected to occupy the planet by 2050. During the last decade, NPGI provided $780 million in research
funding, culminating in a $29.5 million NSF project to sequence the maize (corn) genome.
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iPlant Consortium
With the maize genome sequence imminent, NSF announced in 2007 a $50 million grant competition to
establish a cyberinfrastructure to integrate genome data with insights across many disciplines of plant
research. The DNALC was fortunate to have been included in the iPlant Consortium, headed by the Uni-
versity of Arizona, which won this 5-year award. Through a series of symposia and workshops, the iPlant
Consortium will engage the research community to identify a number of “grand challenges” whose res-
olution will include input from scientists working at all levels of plant function and organization: molecu-
lar biology, genetics, genomics, biochemistry, cell biology, physiology, plant breeding, systematics,
ecology, and evolutionary biology. Each Grand Challenge Team will then work with computer scientists
at the University of Arizona and Cold Spring Harbor Laboratory to develop a “discovery environment” that
will provide bioinformatics and database tools to integrate findings across disciplines. As a member of
the Education, Outreach, and Training (EOT) Component, the DNALC will work with the project team to
embed outreach materials within the iPlant portal, thus tightly linking plant research and education.
The DNALC will receive $2.1 million to develop an educational gateway at the iPlant portal and work
with the Grand Challenge Teams to develop educational interfaces to the Discovery Environments. Our
objective is to get tools and data sets into the hands of high school and college faculty who are “gate-
keepers” at the cusp of research and science education. We will extract elements from the Discovery
Environments and package them with example data in intuitive, visually appealing interfaces. The objec-
tive is to engage novices and allow them to quickly learn the rudiments of integrative analysis and then
generalize these skills to gain insight into biological concepts. Whenever possible, each tool will be pack-
aged in an attractive “skin” and take on the properties of a stand-alone, desktop object.
During years 2–5 of the grant, we will conduct a nationwide program of 1.5-day workshops to train
1000 science teachers on how to use the iPlant tools for student projects that support integrative and
computational thinking. The workshops will target faculty in the “2+2+2” continuum of advanced high
school, two-year college, and four-year college. These biologists will need a basic understanding of how
to use the Discovery Environments and educational interfaces to apply to their own research and to use
with classes they teach.
Continuing Plant Research Collaborations
Plant biologists are now in transition from an era when their experiments were limited by the time required
to collect new data to a new age when there is literally too much new data to effectively analyze. Faced
with exponentially accumulating data from genome sequencing projects, plant scientists rely heavily on
computers to search for genes and other functional components of chromosomes. The iPlant award
marked the culmination of the DNALC’s continuing effort to train teachers on how to access this sort of
genome data and to analyze it with the same tools used by research biologists.
In 2007 we thus continued several collaborations with researchers to provide high school and college
faculty access to the new world of plant genomics. We worked with CSHL researchers Lincoln Stein and
Doreen Ware on their NSF-funded Gramene project, which provides informatics tools for analyzing and
comparing grain genomes. Our companion Internet site, Dynamic Gene (www.dynamicgene.org), pro-
vides background information on gene analysis and bioinformatics tools that enable students to analyze
genes from the newly sequenced rice genome. Because many of these genes have only been predicted
using computer algorithms, students may well be the first “scientists” to examine many of these genes
in detail.
Animated tutorials in the Meaning, Structure, and Evidence sections of the site explain how DNA
sequence encodes information, how computers identify patterns that predict gene structures, and how
experimental evidence complements computer predictions to correctly identify genes. The Annotation
section provides detailed instructions on how to analyze a predicted gene with Apollo, research software
developed to analyze the Drosophila genome. The Projects section allows students to download frag-
ments of the rice genome, annotate predicted genes, and upload their results to compare with classmates
or share with researchers. During the year, Faculty Fellows Bob Wheeler (Pine Creek High School, Col-
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orado Springs, Colorado) and Debra Burhans (Canisius College, Buffalo, New York) contributed many
improvements to the site, including narrated tutorials and animations on experimental evidence used to
confirm computer predictions.
We continued our collaboration with CSHL researchers Dick McCombie and Marja Timmermans, and
Mike Scanlon at Cornell University to encourage underrepresented minorities to teach and study plant
genomics. In past summers, six Faculty Fellows have spent 2 weeks working in plant genome labs at
CSHL or Cornell and 1 week working with us at the DNALC. In 2007, we collaborated with Faculty Fel-
lows Gokhan Hacisalihoglu and Diomede Buzingo to conduct teacher training at their home institutions—
Florida Agricultural & Mechanical University (Tallahassee) and Langston University (Oklahoma). These
3-day workshops presented a lab and Internet-based curriculum on modern plant research to mixed
groups of high school and college faculty. Fellows Olga Kopp, Mary Smith, Muhammad Mian, and Javier
Gonzalez also hosted 1.5-day follow-up workshops at their institutions: Utah Valley State College (Orem,
Utah), North Carolina Agricultural & Technical State University (Greensboro, North Carolina), Rust College
(Holly Springs, Mississippi), and Texas Agricultural & Mechanical University (Weslaco, Texas). Building on
previous workshops conducted at each site, the follow-ups introduced teachers to mobile “footlockers”
that include PCR (polymerase chain reaction) and electrophoresis equipment needed to conduct exper-
iments that test for GM foods and to analyze transposon polymorphisms in maize and Arabidopsis. Work-
shop participants can borrow the equipment footlockers from host institutions for use in their classes,
removing a major barrier to the implementation of modern experiments in plant molecular genetics.
Record Year for New Grants
The educational grant programs to which the DNALC applies are suffering from the same low funding
rates as research programs. Evidence of the dire straights at the NSF: There are no longer any distinct
programs to provide in-service training for science teachers. These programs had, since the 1950s, pro-
vided summer institutes that kept science teachers up to date and were a major source of funding for
our own training activities. Despite this extremely difficult funding situation, we obtained three new
teacher-training grants. Along with the iPlant award, these grants brought to $3.67 million the total of new
federal and foundation grants received—our largest 1-year total since opening in 1988.
NSF Course, Curriculum, and Laboratory Improvement Program: Phase II Project ($444,134
over 2 years). Today’s biology students will face the future challenge of unraveling the biological mean-
ing of the millions of genome sequences that are rapidly accumulating in DNA databases. RNA interfer-
ence (RNAi) provides a powerful tool to move directly from DNA sequence to the analysis of gene function
in living organisms. During Phase I of this project, we developed an experiment- and bioinformatics-
based curriculum, Silencing Genomes, that explores RNAi in the model eukaryotic organism, Caenorhab-
ditis elegans. The curriculum begins with observation of mutant phenotypes and basic worm “husbandry”
and then progresses to simple methods to induce RNAi and use RNAi to rescue (compensate) a mutant
phenotype. A more advanced experiment uses “single-worm PCR“ to examine the mechanism of RNAi,
comparing the DNA of worms with identical phenotypes induced by either RNAi or a gene mutation. The
curriculum culminates with open-ended methods that support student projects. Students can perform
RNAi “from scratch” using bioinformatics to identify a target gene and develop their own RNAi reagents.
Students also have free access to the DNALC’s collection of RNAi feeding strains, which can be used to
screen for genes involved in a particular biological pathway.
An online lab notebook Silencing Genomes (www.silencinggenomes.org) combines lab methods with
user-friendly features adapted from the DNALC’s popular text DNA Science, including flow charts, reagent
recipes, and extensive instructor information. Supporting resources include photos and video of
Caenorhabditis elegans mutants, as well as a simple checkout system to obtain any of 80 C. elegans
mutants and Escherichia coli feeding strains. The site also provides a launch pad for bioinformatics exer-
cises that accompany each experiment. This is, to our knowledge, the first integrated set of RNAi exper-
iments specifically designed for the teaching laboratory, and the completion of the Phase I project
coincided with the awarding of a 2006 Nobel Prize for the discovery of RNAi.
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The Phase II project will introduce the Silencing Genomes curriculum to 208 college teachers at week-
long workshops conducted at eight sites nationwide. At least half of the workshops will be conducted at
historically Black or Hispanic institutions, which will triple participation by underrepresented minorities. In
a unique capacity-building effort, workshop participants will collaborate to develop targeting vectors to
silence approximately 100 C. elegans genes, which will be freely available to students and teachers. Dur-
ing a 1.5-day follow-up workshop, participants will test their feeding vectors and develop online multi-
media portfolios, including videos, a notes-enabledWiki report, and a simple bulletin board. Thus, each
vector will include its own evolving record of how it has been developed and used by a community of
committed “experts.”
NIH Science Education Partnership Award: Phase II Project ($377,644 over 2 years).With Phase
I funding, we developed Inside Cancer (www.insidecancer.org), a multimedia Internet resource for under-
standing the molecular genetic basis of cancer. On a biological level, the site takes students inside the
cell to explore the molecular and genetic roots of cancer. On a sociological level, it provides the insider’s
perspective of the world of cancer research. One objective is to help students understand how modern
concepts from molecular and cellular genetics are being integrated into ideas about cancer diagnosis,
prevention, and treatment. Another objective is to allow students to learn modern biology in the same way
as basic cancer researchers—by meeting scientists, seeing how experiments are done, and visualizing
the unseen world of genes and molecules.
The Phase II project will focus on disseminating the Inside Cancer site to precollege teachers and
evaluating its educational effects. During the term of the grant, 800 secondary biology and health teach-
ers will receive intensive training at 1-day workshops held at 20 sites nationwide. The workshops will be
Participants in the Amgen Leadership Sympo-
sium documented their RNAi research projects
on the Silencing Genomes site’s newly devel-
oped wiki, with online multimedia portfolios for
the RNAi feeding vectors and bacterial strains
they developed.
391_414_LAR_DNALC.qxd:LAR_Template_2007  5/21/08  3:14 PM  Page 396
397
conducted in conjunction with teacher professional meetings and science outreach programs at univer-
sities and historically Black and Hispanic institutions. Forty workshop participants will receive fellowships
to conduct second-round training to reach an additional 640 teachers. Participants’ teaching behaviors
will be monitored over time, and a controlled study will compare attitudinal and learning effects among
280 high school students. We will also develop an online Teacher Center with links to teaching stan-
dards, tools to build custom multimedia presentations, and an exchange for collaboratively generated les-
son plans.
Howard Hughes Medical Institute (HHMI) Initiative for Biomedical Research Institutions
($746,243 over 5 years). This professional development program is a collaboration with the New York
City Department of Education (DOE) to develop a strong base of teachers who can competently intro-
duce six “targeted” experiments in genetics and biotechnology at identified points in required science
courses. The program focuses on the 8th and 9th grade levels, where all students receive their first, and
often last, exposure to genetics and biotechnology. During the course of the grant, 820 teachers will
receive 4 days of training, which will certify them to implement the target labs. Embedded within the
school year, the certificate training will allow educators to readily implement their new knowledge and abil-
ities. Two weeks of leadership training conducted during the summer will then allow 160 teachers to
extend their expertise, develop student research capabilities, and formulate biology electives. An equip-
ment footlocker and reagent kit administered by the DNALC will also support each targeted lab.
The project will be unique in the extent to which student and purpose-built computer tools and mul-
timedia items will support teacher learning. A mini-Internet site, or Lab Center, will accompany each tar-
geted laboratory and will include (1) a video introduction to the experiment, (2) interactive and PDF
versions of the experiment, (3) follow-up activities, (4) science stories that relate the experiment to local
research, (5) scientist interviews, (6) animations, and (7) selected links. Registered teachers will be able
to customize the Lab Center to include class name, selected links, bulletin board for class announce-
ments, and lab results. An editor will allow teachers to select from more than 3000 multimedia items and
include them in windows within the Lab Center. Each customized Lab Center will be stored on the
DNALC server and accessed by students using a unique address associated with the teacher’s profile.
We will increase the local appropriateness of instruction by linking each lab to NY “science stories,” a
series of minidocumentaries about the past or current work of notable researchers from CSHL, The
Rockefeller University, Columbia University, American Museum of Natural History, Cornell University, and
other New York institutions.
Harlem DNA Lab
The HHMI was a substantial step toward the fruition of our dream of a DNALC facility to serve the students
and teachers of New York City. Since its founding in 1988, the DNALC has provided hands-on experiments
for a third of amillion students from the NewYorkMetropolitan area during half-day field trips, in-school instruc-
tion, and week-long DNA camps. The natural clientele for this enrichment has been students who attend
schools within a 40-minute commute of Cold Spring Harbor. In 2002, we partneredwith the North Shore–Long
Island Jewish Health System to open a satellite facility, DNALCWest, in Lake Success. However, because of
rules that restrict New York City school buses from traveling outside the city, the DNALC’s local programs
have primarily benefited the relatively affluent school systems of Nassau and Suffolk Counties.
In July 2006, we received a $50,000 planning grant from the Goldman Sachs Foundation to develop
support for a satellite center to extend the DNALC’s expertise in genetics instruction to the students and
teachers of New York City. As part of the HHMI proposal, New York City Schools Chancellor Joel Klein
provided us exclusive use of a 1200-square-foot classroom in the John S. Roberts Educational Complex
(MS45) in East Harlem in which to provide teacher training. By year’s end, this space had been renovated
identically to our facility in Cold Spring Harbor, including our signature student lab desks, and opened on
schedule in early spring 2008.
Because the HHMI teacher-training program will occupy only about 20% of the lab’s capacity, the
facility will support a broader program of science enrichment to New York City students. Harlem DNA Lab
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will serve approximately 4000 6th to 12th grade students per year, offering them access to accelerated
lab experiences that heretofore have been primarily offered to students from Long Island. The Jerome L.
Greene Foundation provided $100,000 for equipment for experiments ranging from basic genetics and
cell microscopy to modern DNA manipulation and forensic biology. State-of-the art gene chip readers and
DNA sequencers will help us begin to fulfill our vision of enabling every New York City student to see
their own DNA before they graduate from high school.
During the academic year, each John S. Roberts student will participate in three to four genetics lab-
oratories at the facility, and students from schools throughout New York City will visit the facility for half-
day “lab field trips.” During the summer, week-long camps will provide intensive enrichment for top
students citywide. (The DNALC has applied for funding from the New York State Excelsior Scholars Pro-
gram to support 4 weeks of instruction for middle school students in summer 2008.) A cadre of student
interns will provide lab support and conduct independent research projects that will allow them to com-
pete in state and national science competitions—and seamlessly transition to research projects at local
universities and research institutions.
All activities are sequenced, so that a student can grow academically and be tracked through multi-
ple experiences over a period of years. The experiments embody key concepts and process skills of the
New York City Scope and Sequence for Science, the New York State Science Core Curriculum, and the
Renovations to the former graphics lab in J.S. Roberts Junior High School were near completion in early December.
The Harlem DNA Lab logo is used on brochures, letterhead, and the Harlem DNA Lab Internet site
(www.dnalc.org/harlemdnalab/).
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National Science Education Standards. The lab program is also in synch with New York City’s strong
existing base of biological and clinical research and the emerging biotechnology industry that will be sup-
ported at the new East River Science Park.
Harlem DNA Lab will make cost-effective use of instructional technology and methods developed
with more than $26 million in federal and foundation grants. The venture will also draw on our experience
in establishing teaching centers worldwide. Like DNALCWest, the Harlem DNA Lab will be a satellite—
directly administered by the DNALC and staffed by DNALC personnel. In this way, we can control the
quality of instruction and offer New York City students an experience that is identical to that received by
their Long Island peers.
Harlem DNA Lab can provide a reproducible model for how science institutions can interact with large
school systems to help transform science education for urban students. We also hope that it will estab-
lish our presence in Manhattan and provide a springboard for the establishment of a stand-alone facility
equal in size to the Dolan DNALC (10,000 square feet).
Supporting Real Forensic Biology
In the mid-1980s, British researcher Sir Alec Jeffreys coined the term “DNA fingerprinting” and was the
first to use DNA variations (polymorphisms) in human paternity, immigration, and murder cases. Jeffreys
discovered a class of repeat polymorphisms, termed VNTRs (variable number of tandem repeats), in
which a DNA sequence is repeated end-on-end. Like boxcars in a train, different numbers of DNA repeats
create alleles that differ in length. The alleles inherited from mother and father can be separated by elec-
trophoresis, and the specific combination is “scored” as a genotype.
In the late 1980s, the DNALC worked in parallel to researchers as they developed a PCR-based assay
for human VNTRs called D1S80. Although D1S80 became the first amplified polymorphism used in foren-
sic biology—and was part of the evidence in the O.J. Simpson murder case—the DNALC abandoned
this experiment because the different alleles proved to be impossible to distinguish using simple gel elec-
trophoresis. In the meantime, human forensic analysis moved on to STRs (short tandem repeats), which
are detected on a DNA sequencer.
With the current rage over forensic biology, caused primarily by the television show Crime Scene
Investigation (CSI), we decided to revive D1S80 analysis for student field trips. This required entirely
revamping the way in which we analyze student DNA. First, we developed a fast PCR protocol that uses
a two-temperature profile to cut cycling time in half—to just 30 minutes. Second, we shifted elec-
trophoresis to an Agilent microfluidics chip that separates D1S80 alleles in 2 minutes per sample. Ampli-
fied DNA fragments pass through microfluidic channels and each digital output displays the concentration
and size of each allele. A set of 12 samples is entirely analyzed in 30 minutes, including generating a PDF
genotype report for each student. The electropherogram result is identical to a single channel of the
CODIS panel used in criminal investigations.
As a result, students can have a complete experience in forensic DNA analysis—from introduction, to
buccal DNA isolation, to PCR amplification, to electrophoretic analysis, to analysis of electropherograms
and population genetics—in a single 3.5-hour lab session. D1S80 forensic analysis will be routinely avail-
able in 2008 for classes visiting the Dolan DNALC and Harlem DNA Lab. We believe that we will be first
group worldwide to make this sort of automated DNA analysis available to large numbers of precollege
students.
This state-of-the-art technology was made possible through two important donations. Leo Brizuela,
Director of Biology at Agilent Technologies and a former CSHL employee, arranged the donation of a Bio-
analyzer valued at $16,280. Tom White, Chief Scientific Officer of Celera, arranged the donation of a
super-fast Veriti thermal cycler, valued at $7,995, from Applied Biosystems. Dr. White was an early sup-
porter of our work to popularize PCR, helping us to obtain an educational license and donating several
of our first PCR machines in the early 1990s.
During the year, we also continued to support a second forensic DNA experiment by providing free
sequencing of student DNA samples submitted by biology classes worldwide. This project analyzes the
DNA found in the cell’s energy-producing organelle, the mitochondrion (mt). With thousands of copies
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of the mt chromosome per cell, as opposed to two copies of nuclear chromosomes, mt DNA is abun-
dant in tissue samples. Thus, mt DNA is the DNA of last resort in forensic cases where tissue remains
are very old or degraded. Forensic analysis usually focuses on the noncoding “control” region of the mt
chromosome that rapidly accumulates mutations and, thus, is highly variable between people. This is the
same DNA analyzed by National Geographic’s Genographic Project and described in the popular book
The Seven Daughters of Eve. Notably, mt DNA was used to identify the remains of the Romanov royal
family and to determine the relationship of Neandertal fossils to modern humans.
Using DNALC protocols or ready-to-use kits available from several science suppliers, students use
PCR to amplify a 440-nucleotide sequence of their mt control region and send their amplified samples
to the DNALC via overnight mail. The student samples are prepared for sequencing by college interns
Alina Duvall (Hofstra University) and Jennifer Aiello (Long Island University at C.W. Post). The samples are
then sent to the CSHL sequencing center in Woodbury, where they are processed on an Applied Biosys-
tems 3730xi Genetic Analyzer. The finished sequences are uploaded to a student DNA database at the
DNALC’s BioServers Internet site (www.bioservers.org). The Sequence Server site provides tools to per-
form comparative analysis of mt DNA sequences from world populations, as well as ancient samples,
including Neandertal and Otzi “the ice man.”
In 2007, we sequenced 6303 student DNA samples submitted by high schools and colleges from 34
states and British Columbia. On average, results were posted on the Sequence Server site within 16
days of receipt. The free Sequencing Service is made possible by the donation of sequencing reagents
by Applied Biosystems.
Visitation and Student Instruction
Annual visitation reached 41,897 in 2007. This included 19,973 students who conducted experiments
at the DNALC or DNALCWest and 10,629 who received in-school instruction by DNALC staff members.
More than half of all visitors (20,909) were middle school students who conducted experiments under the
CSI-DNALC: Using the new Bioanalyzers, gel images and electropherogram results are available to each student.
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banner of Genetics as a Model for Whole Learning (GMWL). Cablevision’s Long Island Discovery multi-
media show drew 6750 visitors, primarily fourth graders studying Long Island history.
A record 971 students participated in week-long summer camps conducted at the DNALC, DNALC
West, Central Islip High School, Sarah Lawrence College (Bronxville), and Aspen High School (Colorado).
This great result was facilitated by a new system for online registration and payment via PayPal. More than
60% of parents took advantage of this streamlined way of enrolling their children, saving valuable staff
time.
The roundworm C. elegans made its first appearance in summer camps this
year. In Fun with DNA, 5th to 6th grade students used stereomicroscopes to com-
pare wild-type and mutant worms, illustrating that gene mutations cause visible
changes in traits. In Genetic Horizons, 8th to 9th graders used RNAi to induce
phenotypes and bioinformatics to learn more about the genes they were disrupt-
ing. These were likely the first middle school students in the world to use RNAi!
We also initiated a collaboration with Project Grad Long Island, a nonprofit
organization that works within economically disadvantaged communities to
increase high school graduation rates. Project Grad provided scholarships and
daily bussing for 26 middle school students from the Westbury school district to
attend a week-long camp at DNALC West. This custom experience—combin-
ing hands-on labs from our popular Fun with DNA and World of Enzymes
camps—was designed to build a strong foundation in basic genetics and molec-
ular biology for future high school work.
The annual Great Moments in DNA Science honors seminar series drew 437
students for insights into modern biological research. Dr. Elizabeth Murchison
explained how scientists are attempting to understand the genes involved in a
mysterious transmissible cancer in Tasmanian devils, with the hope of saving
this unique animal from extinction. Dr. Bill Keyes discussed an intriguing theory
about how cellular mechanisms aimed to protect our bodies from cancer may also contribute to aging.
In the final lecture, Dr. James Watson presented anecdotes from his latest book about how to succeed
in science. Saturday DNA! continued to be popular with both students and adults, drawing 350 partici-
pants for hands-on sessions ranging from “Jellyfish Genes” to “CSI: Learning Center.”
In its second year, our partnership with Cold Spring Harbor High School (CSHHS) provided a chal-
lenging experience for ten students. The year-long “capstone” course was coinstructed by DNALC staff
and CSHHS biology teacher Scott Renart, with students coming on alternate days to the DNALC for
their final two class periods. The course emphasized critical thinking and included experiments and inde-
pendent projects across a range of biological systems. A bacterial unit focused on recombinant DNA
technology and gene manipulation; a plant unit analyzed transgenes in genetically modified food and
newly sequenced genes in rice; human-based experiments used molecular tools to examine human ori-
gins and genetic variation; and work with C. elegans introduced the cutting-edge RNAi technique.
During the winter, graduate students from the Watson School of Biological Sciences completed 12
half-day teaching sessions during their annual rotation at the DNALC. During the first phase of training,
each pair of students observed a DNALC instructor at work and organized a lesson plan that integrated
their own perspectives. In the second phase, each pair worked closely with a DNALC instructor to
coteach several labs, developing their communication skills and preparing them for independence. Dur-
ing the final phase, each pair was responsible for presenting an entire lab, under the close observation
of a DNALC staff member. After completing this cycle for middle and high school classes, students chose
three additional lessons to independently demonstrate instructional and classroom management skills.
Faculty Training
In 2007, more than 500 educators participated in a variety of professional development activities con-
ducted at sites around the United States and Europe. With sponsorship primarily from the NSF, we col-
laborated with 13 host institutions to conduct 1.5–5-day workshops on plant genomics, bioinformatics,
Fifth grade students observe C. elegans.
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and RNAi. Demand for these workshops remained strong, with 384 applicants competing for 226 spaces.
Five of these workshops were conducted at historically Black (HBCU) or Hispanic (HACU) institutions,
where 36% of participants were Black or Hispanic. Overall, 27% of participants at offsite workshops
were underrepresented minorities, mirroring their proportion among American residents (2005 Census
Figures). An additional 250 educators attended workshops at professional meetings in the United States
and Europe, which covered topics including neurobiology, bioinformatics, the molecular genetics of taste
and smell, detecting GM foods by PCR, DNALC online tools for education, and forensic analysis of the
Romanov family remains.
Twenty-five high school teachers, representing 14 states and Singapore, attended the annual Amgen
Leadership Symposium in Human and Genomic Biology. Initiated in the mid-1990s with NSF support,
the Leadership Symposium is the DNALC’s capstone course, aimed at providing super-order training for
progressive biology teachers who emphasize hands-on instruction in genetics or biotechnology. During
their 3-week residence, participants lived and breathed science on the CSHL campus, where they walked
in the footsteps of Nobel laureates.
The curriculum began with 2 weeks of the DNALC’s latest experiments on RNAi, human DNA poly-
morphisms, and bioinformatics. Participants explored RNAi in the roundworm C. elegans, first observ-
ing mutant phenotypes and learning basic worm care, progressing to simple methods of inducing RNAi,
and then to the construction of their own reagents to “knock down” a gene of their choice. Participants
examined their own DNA for several polymorphisms. Point mutations in mitochondrial DNA and an Alu
insertion on chromosome 16 provided an entry point into the study of human populations and early
migrations of our species. A mutation in a taste receptor correlated with the ability to taste the bitter
chemical phenylthiocarbamide (PTC), showing the relationship between genotype and phenotype. Par-
ticipants used a variety of online tools and DNA sequence analysis software to find gene elements in
DNA sequences, to find genes in databases, and to compare computer predictions with biological evi-
dence. The Symposium concluded with a week of independent or group projects that included optimiz-
ing RNAi methods for classroom instruction, screening a variety of supermarket foods for DNA evidence
of genetic modification, annotating newly discovered genes from the rice genome, and creating video
introductions to RNAi experiments. The experience was further enhanced by seminars by CSHL plant
biologist Robert Martienssen, CSHL structural biologist Leemor Joshua-Tor, and Nobel laureate James
Watson.
Leadership participants strike a pose with James Watson and Learning Center staff on the DNALC terrace.
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The DNALC continued to provide teacher training under its long-term collaboration with the Singa-
pore Ministry of Education. Initiated in 2000 with a visit by Minister Rear Admiral Teo Chee Hean, the
collaboration was guided by a memorandum of understanding through which licensed DNA learning
centers were established at the Singapore Science Center and National Institute of Education. Two jun-
ior college teachers and an instructor from the Singapore Science Center participated in the Leadership
Symposium, and five elementary teachers came in November for a 2-week attachment. The attachment
included hands-on lab work, lab preparation, and instructional pedagogy. The Singaporean teachers
observed and cotaught labs alongside DNALC instructors and visited several local elementary schools.
Each teacher developed a plan for translating their experience into hands-on instruction for Singaporean
students.
Internet Visitation and Development
Visits to DNALC Internet sites rose to 7.14 million in 2007. The brightest spots were
the Image Archive on the American Eugenics Movement, which more than doubled
to 731,913 visits, and Inside Cancer, which increased 63%, to 196,138 visits. We
began tracking the amount of data downloaded from our sites in February and were
impressed to see that our content-based sites averaged more than 47 gigabytes (GB)
per month. According to answers.com, one GB of data is roughly equivalent to 1000
novels at 100,000 words each, 18 hours of MP3 music, or 12 hours of Flash video.
DNA Interactive, our richest multimedia site, came out on top of this statistic, serving
a total 1200 GB in the year.
We launched two new Internet sites in 2007. Silencing Genomes offers labora-
tory and bioinformatics exercises to introduce students to RNAi and its effects on C.
elegans anatomy and behavior. Dynamic Gene introduces modern concepts of gene
analysis and provides “doable” student projects using research tools to analyze new
genome data. RedOrbit.com, a science community site, recognized Silencing
Genomes (June 13) as well as Inside Cancer (August 27) as “Red Hot Sites of the Day.”
Internet site (content- Average Average
based sites and laboratory/ visit monthly Visits % Change
bioinformatics sites) (min) bandwidth in 2007 from 2006
Gene Almanac 8:33 66.45 GB 1,923,185 –16.37
DNA from the Beginning 8:32 29.68 GB 1,451,572 –1.99
Your Genes, Your Health 7:40 46.97 GB 962,151 –13.72
DNA Interactive & myDNAi 8:24 100.43 GB 1,459,865 15.26
Image Archive on the American 16:28 11.83 GB 731,913 120.86
Eugenics Movement
Inside Cancer 7:09 30.08 GB 196,138 62.98
BioServers 16:10 2.29 GB 251,597 10.13
Genetic Origins 7:04 1.59 GB 132,748 –12.06
Greenomes 3:27 0.40 GB 9,443 10.60
Dynamic Gene 6:20 0.60 GB 7,986 n.a.
Silencing Genomes 8:11 0.44 GB 12,168 n.a.
DNALC Kits/Carolina Collaboration 15:26 1.60 GB 4,396 n.a.
All sites 7,143,172 2.00
Educators, students, and scientists
present their idea of a gene on
Dynamic Gene’s home page.
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We were disappointed, however, by the decreased visitation to our home page, Gene Almanac, and
to Your Genes, Your Health and DNA from the Beginning. The decrease at Gene Almanac most likely
reflects the fact that increasing numbers of visitors now reach our family of Internet sites directly by Inter-
net searches, without going by way of the home page. We believe that the decreases at Your Genes, Your
Health and DNA from the Beginning relate to the fact that content created in Adobe’s multimedia author-
ing tool Flash is less “visible” to search engines than html-based sites. As the volume of Web content
increases exponentially and people increasingly rely on Internet searches, we will need to solve this prob-
lem of search engine visibility.
We have already undertaken several simple strategies: registering site maps on Google; creating html
directories of the sites on our servers; and cross-featuring newer sites on other more established sites
or within the Resources section of Gene Almanac. We are also working on more involved solutions to the
visibility problem. Beginning in July, our sites benefited from “piggybacking” on a Google AdWords grant.
AdWords is Google’s advertising program that displays “sponsored” links on the right side or top of a
search results page. Through the grant, we receive these advertisements free of charge. For each DNALC
Web site, a set of keywords is stored in the AdWords account. Each time one of the keywords is typed
into Google’s search box, a short ad for the site is displayed and logged as an “impression.” If the searcher
clicks on our ad, it counts as a “click-through” and a cost per click of up to $1.00 is applied. DNA from
the Beginning is our most successful site on AdWords, with 2,608,437 impressions and 43,356 click-
throughs. Not surprisingly, 79.28% of these click-throughs resulted from a search of “DNA.” All DNALC
sites received 5,901,454 impressions and 62,740 click-throughs, which would have cost $37,106 for a
commercial enterprise to purchase from Google. A quick analysis of search engine referrals in the first
half of 2007 (prior to initiating the AdWords program) versus the second half showed an 2% increase.
In addition, the increasing use of sophisticated search engines to find specific information runs counter
to narrative structure of our older content sites. Thus, we are decomposing all our Internet sites into con-
tent “atoms” that can be searched for and viewed independently. Using the content management sys-
tem (CMS) created for Genes to Cognition Online, each item is equipped with meta-tags that make it
more visible to search engines and more useful to end users. Each animation and video item is saved as
an individual atom of content with a CMS entry including keywords, media type, and educational uses
and context. We are also linking the atomized content to a specialized search tool/viewer that will soon
be a major feature of a redesigned Gene Almanac portal. We look forward to the day when our CMS,
meta-tag, and search tool/viewer will deliver exactly what any visitor is looking for.
Genes to Cognition Online
A cornerstone of DNALC’s strategy to maintain its leadership in online science education has been to stay
in touch with thought leaders in research and education. Thus, late in 2006, we hosted New Horizons in
Internet Site Development, a 2.5-day conference that brought together experts in cognitive and neural
science, learning theory, and technology to determine how research can support science teaching using
advanced Internet technologies. In 2007, we responded to insights from the conference with a number
of content and design initiatives to improve Genes to Cognition (G2C) Online, an Internet site on the
molecular basis of human thinking and disorders of thinking that we are developing under grants from
the Dana Foundation and the William and Flora Hewlett Foundation.
Insights were collated to produce a working paper of performance indicators, intended to guide proj-
ect development. One of the main recommendations was the need to create a smooth interface for inter-
acting with content. We responded by creating a networked map that builds on open-source code recently
developed by The Media Lab at the Massachusetts Institute of Technology. The map displays site con-
tent as a network of dimensional content “atoms.” These atoms cluster around major nodes such as
schizophrenia, autism, or neuroimaging and are direct translations of expert concept maps we elicited
from science experts in 2006. The atom map provides an enticing interactive entrée to G2C Online con-
tent, allowing users to visualize relationships between content items. Rolling over an atom provides a pre-
view of the content item—such as “The schizophrenic brain,” below—which can be accessed by a single
click. Users can also make use of traditional online mapping tools such as zoom and pan.
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We also addressed search and navigation functions. A familiar problem with Internet sites built in Flash
is that users encounter difficulty switching between recently visited items. Thus, we developed a history
function that keeps track of content that makes for easy forward/backward navigation.
Interactivity with content was a major theme in our Advisory Panel meeting, which we convened in
October. We followed up on the Panel’s recommendation to make the atom map the primary tool for
accessing content. Now, when users visit G2C Online, their first interaction with material will be with the
map, which provides a visual impact. Further interaction with the atoms should encourage users to make
associations between different areas of research.
Following the meeting, we agreed to build two major interactive animations, which will be the center-
piece of the G2C Online project—an interactive brain map and a three-dimensional action potential ani-
mation. We are currently in negotiations with an animation studio, AXS-3D, to develop the content. The
14 advisors and staff members who attended the annual meeting were pleased with the free-flowing and
frank discussions and willingness to take changes on board.
Project development was additionally guided by a series of evaluations conducted with the Center for
Children and Technology. We used two different types of assessments, which enabled us to troubleshoot
potentially problematic content and design issues. One-on-one qualitative evaluations with students from
Philadelphia and New York City high schools allowed us to assess how students independently explore
G2C Online. We learned that Internet site users generally cannot view animations and listen to narration
simultaneously. In response, we restructured relevant items to make animation and narration features
sequential as opposed to parallel. The second arm of the evaluation program consisted of a usability
study conducted with 92 high school students from Long Island and Philadelphia. We identified problems
with functionality and slow-loading media items that were addressed in a subsequent revision of the site.
G2C Online content continues to evolve. During the year, we edited more than 200 video items and
made many available on our demo site. We collaborated with the Dana Foundation to repackage and host
68 articles from www.dana.org. In addition, we stepped up production of educational tools and created
a number of innovative media, including:
∞ Fly School, an interactive game that allows students to structure experiments to test memory in normal
and mutated fruit flies. This module was developed in collaboration with CSHL researcher Tim Tully.
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Another step in the evolution of the Genes to Cognition Internet site; users will navigate the site using the net-
work map. Project staff expect to launch the site in 2008.
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∞ Model Center, a bioinformatics tool that allows students to compare protein sequences in different
model organisms.
∞ Chromosome Map Viewer is also a bioinformatics tool that allows students to examine the chromo-
some locations and biological functions of genes associated with cognitive disorders.
Staff and Interns
In October, DNALC Assistant Director Uwe Hilgert left to become Assistant Dean of the Watson School
of Biological Sciences. Reared on a riverboat in Germany, Uwe received a Ph.D. from the Max-Planck
Institute for Plant Breeding in Cologne and conducted postdoctoral research at the University of Arizona.
Uwe started at the DNALC in 2000 as a high school instructor and then quickly became leader of bioin-
formatics teacher training under an HHMI grant. As Assistant Director, beginning in 2005, Uwe assumed
responsibility for all of the DNALC’s professional development activities, in addition to overseeing the
instructional staff and the operations of DNALCWest. Uwe’s stamina, dedication, and attention to detail
will be sorely missed.
After Uwe’s departure, the assistant directorship was split into two positions. Amanda McBrien
became Assistant Director for Instruction, and Bruce Nash became Assistant Director for Science.
Amanda joined the DNALC 1998, and under her direction, the middle school program has grown by
65% and become a major source of annual operating income. She brings to her new position intimate
knowledge of local school systems and experience as an expert trainer. Amanda is responsible for the
smooth running of student programs, including field trips, in-school instruction, summer camps, and
Watson School teaching rotations. Bruce Nash earned his Ph.D. in molecular genetics at the University
of Toronto and conducted postdoctoral research on cell division in C. elegans at the University of Ore-
gon. He was specifically recruited to bring C. elegans and RNAi technology to the DNALC. Bruce is
responsible for technical support of the lab and DNA sequencing programs, development of new labs,
and external teacher training.
At mid year, we lost three innovative and inspirational instructors. Greg Chin returned to his native
San Jose to spend time with his family. After receiving a Ph.D. in Developmental Biology from Stanford
University and conducting postdoctoral research at the DNAX Research Institute, Greg was recruited in
2005 (along with Bruce Nash) to jump-start our RNAi effort. David Gundaker moved to Dover, Massa-
chusetts, with his family to accept a full-time teaching position at the Charles River School. He came to
the DNALC in 2005 with master’s degree in education and real-world teaching skills developed in mid-
dle schools in Colorado and Long Island. Laura Johns took a position with the technical support staff of
the biotech company, Invitrogen. With a bachelor’s degree in genetics and graduate studies in marine
chemistry, Laura brought the technical skills needed to administer our DNA sequencing service.
We were pleased to bolster the DNALC’s instructional staff by welcoming two high school instructors,
Jermel Watkins and Brian Lang, and one middle school instructor, Jennifer Cutillo. We were especially
happy to welcome back Jermel, who began his science career as a DNALC intern from 1994 to 2000.
During the summers, he also worked alongside his father and DNALC collaborator Jerry Watkins, teach-
ing DNA Science to minority students from his home school, Central Islip. Jermel went on to earn his
Ph.D. in molecular and cellular pharmacology at Stony Brook University. After receiving his bachelor’s
degree from South Hampton College in marine microbiology, Brian worked as a lab technician at Pall Cor-
poration. He went on to receive a master’s degree in secondary education and New York State certifi-
cation. After receiving her bachelor’s degree in biology and secondary education from Providence College,
Jennifer taught life science and biology for 2 years in Boston.
The BioMedia Group received a boost when Stephen Blue started late in the year as a part-time mul-
timedia designer. Stephen is a graduate of Parsons School of Design, where he is an adjunct computer
instructor.
In the spring, the administrative staff lost two strong clerical workers. Nancy Daidola left to pursue per-
sonal goals, and Stacy Leotta took on a position in the CSHL Office of Sponsored Programs. Prior to join-
ing the DNALC in 1999, Nancy built her skills in administration at Grumman Aerospace and as real estate
agent with Coldwell Banker Sammis. Nancy performed a myriad of administrative tasks that kept the
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DNALC running smoothly. Stacy joined the DNALC in 2005, using her database skills to aid in the com-
puterization of the front office. Valerie Meszaros arrived in the spring to fill the open administrative position
left by Stacy. Valerie, a Long Island native, was formerly an editor and writer for Healing Tao Press.
Our internship program continues to offer Long Island high school and college students the oppor-
tunity to gain practical laboratory experience. Joining the intern program in 2007 were Charmaine Browne
(Westbury High School), Victoria Grace (Oyster Bay High School), Emily Lopes (Commack High School),
and Stephanie Parascandolo (Half Hollow Hills High School). Tara Dolan (University of Miami) and Danielle
Sganga (Vanderbilt University), who were graduates of the first CSH Partnership Program, joined with cur-
rent Cold Spring Harbor High School student Rachel Gellerman to work on RNAi and C. elegans under
the guidance of Bruce. New members of the intern team joined returning high school students Seth
Schortz (Half Hollow Hills High School) and Matthew Levy, Hal Mutlu, Arielle Scardino, Nick Wilken, and
Janice Yong (all of Kings Park High School). Several interns returned from college to assist with summer
workshops: Benjamin Blond (Amherst College), Joseph Hakoopian (Cornell University), Alexandra Sloane
(Loyola College), and Margarita Varer (SUNY Binghamton).
High School intern Rachel Stephan (Kings Park), was a semifinalist in the 2007 Intel Science Talent
Search for her project on eliminating polychlorinated biphenyls from the environment. Rachel won first
place in the environmental science category of the International Science and Engineering Fair and pre-
sented her project in New Mexico.
In August, we bid farewell to the following interns as they left for their freshman year at college: Matt
Giambrone (Walt Whitman High School) to Cornell University; Carissa Maurin (Lynbrook High School) to
Monmouth University; Ronnie Morasse (Plainedge High School) to Stevens Institute of Technology, and
Brittany Woods (Cold Spring Harbor High School) to Boston College.
Expert Advisors and Corporate Support
We are lucky to have high-level support from two advisory bodies: the DNALC Committee and the Cor-
porate Advisory Board (CAB). The Education Committee formulates policy and assists with strategic
planning, whereas the CAB provides a liaison to the Long Island business community. The CAB conducts
an annual golf tournament and a fund campaign that are the major sources of unrestricted funds to sup-
port the DNALC.
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New staff at the DNALC in 2007 (left to right): Jennifer Cutillo, Jermel Watkins, Brian Lang, Stephen Blue, and
Valerie Meszaros
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2007 Workshops, Meetings, and Collaborations
January 2–5 Site visit by Debra Burhans, Canisius College, Buffalo, New York
January 4 Site visit by Magda Hayden, Bob Isakkson, Elena Perrez, and Peter Quick, Bank of America,
Melville, New York
January 14 Site visit to Gates Foundation, Washington, D.C.
January 16 Site visit by Stephanie Tzall and Charlie Pamaro, Brooklyn Technical High School, New York
January 18 Site visit by Mike Hyde and Rick Woychik, Jackson Laboratory, Bar Harbor, Maine
January 20 Saturday DNA!, “Designer Experiment” and “Macro Concepts of Microarrays,”
January 25 Site visit by Robert Hoppenstedt, Bethpage Federal Credit Union, Bethpage, New York
January 25 Site visit to Center for Children and Technology, New York, New York
February 1 Cold Spring Harbor High School Partnership Program, Independent Project Presentations,
DNALC
February 5–8 Cancer Biomedical Informatics Grid (caBIG) Meeting, Washington, D.C.
February 8 Site visit by Christopher Hahn and Teresa Kemp-Zielenski, United Way Long Island
February 10 Saturday DNA!, “The Mystery of Anastasia Romanov” and “Mitosis, Meiosis, and Chromo-
somes, Oh Mei!,” DNALC
February 13 Site visit by Exploratorium Center for Learning and Teaching, San Francisco, California
February 15 Site visit by Lewis Ranieri, Computer Associates and Hyperion, and Peter Quick, Bank of
America, Melville, New York
February 23–24 NSF Plant Molecular Genetics and Genomics Follow-up Workshop, with Minority Fellow Mary
Smith, Greensboro, North Carolina
February 28 Site visit by Syd Mandelbaum and WLIW Channel 21, Garden City, New York
March 1 Site visit by Walter J. Dillingham, Jr., Bank of America, New York, New York
March 5, 12, 19 Reading Your DNA, Cold Spring Harbor Central School District Adult Education Workshop,
DNALC
March 7 G2C Online interview with Daniel Weinberger, National Institute of Mental Health, Bethesda,
Maryland
March 16–17 NSF Plant Molecular Genetics and Genomics Follow-up Workshop, with Minority Fellow
Muhammad Milan, Holly Springs, Mississippi
March 19–20 G2C Online interview with Seth Grant, Wellcome Trust Sanger Institute, Hinxton, United
Kingdom
March 22 G2C Online interview with James Watson, CSHL
March 22 Site visit by Charterhouse School, Surrey, United Kingdom
March 23–24 NSF Dynamic Gene Workshop, Austin Community College, Texas
March 24 Saturday DNA!, “When Dinosaurs Roamed the Earth” and “CSI: Learning Center,” DNALC
March 24 DNA Extraction Student Workshop, American Museum of Natural History, New York, New York
March 25–26 NSF Plant Molecular Genetics and Genomics Follow-up Workshop, with Minority Fellow Javier
Gonzalez, Weslaco, Texas
March 26–April 1 National Science Teachers Association Annual Meeting, St. Louis, Missouri
March 27 Hewlett Open Education Meeting, Houston, Texas
March 27–28 NSF Dynamic Gene Workshop, St. Louis Science Center, Missouri
March 28 G2C Research Programme Meeting, London, United Kingdom
April 2 Site visit by Peter Jann, Life Science Zurich Learning Center, Zurich, Switzerland
April 3 Lymphatic Research Foundation meeting, Huntington, New York
April 6–7 NSF Plant Molecular Genetics and Genomics Follow-up Workshop, with Minority Fellow Olga
Kopp, Orem, Utah
April 12 Search Engine Strategies Meeting, New York, New York
April 13 New York City Department of Education meeting, New York
April 13–14 NSF Dynamic Gene Workshop, Colorado Springs, Colorado
April 17 Great Moments in DNA Science Honors Seminar: “The Devils’ Own Hell: Tasmanian Devil
Transmissible Cancer,” Elizabeth Murchison, CSHL
April 17 New York City Department of Education meeting, New York
April 19 G2C Online interview with William Kristan, University of California, San Diego
April 21 Saturday DNA!, “How Does Your Garden Grow?” and “Eureka! Art of Scientific Discovery,”
DNALC
April 21 DNA Extraction Student Workshop, American Museum of Natural History, New York, New York
April 23 Great Moments in DNA Science Honors Seminar: “Cancer and Aging: Getting the Balance
Right,” Bill Keyes, CSHL
April 25 Site visit from The Times of Northport, New York
April 25 Meeting with Tom Taratko, New York City Department of Education, New York
April 26, May 3, 10 Reading Your DNA, Adult Education Workshop, American Museum of Natural History, New York
April 30 Great Moments in DNA Science Honors Seminar: “Rules for Science,” James Watson
May 1 Site visit by William Mak and Suet Ying Lee, Hong Kong Biotechnology Education Resources
Centre Limited, China
May 7 NewYork State Department of Education Task Forcemeeting, New York Hall of Science, New York
May 9 Site visit by Doug Postl, Agilent Technologies, Wilmington, Delaware
May 11 New York City Department of Education meeting, New York
May 15 Site visit by Marion Conway, Roslyn Savings Foundation, and Tom Calabrese, Daniel Gale
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Sothebys Real Estate
May 17 The Human Genome Project: Library Training presentation “What DNA Says About Our Human
Family,” Baruch College, New York, New York
May 21 Cold Spring Harbor Laboratory Association meeting, DNALC
May 19 Saturday DNA!, “Fruit Fly Island” and “Tracking Ancient Treks,” DNALC
May 24 Site visit by John Passarelli and Tom Gibbons, Notre Dame Club Development, New York, New York
May 31 Site visit by Robert Root, Brumsic Brandon, Oneil Eastmond, and Constance Clark, Westbury
Public Schools; Robert Troiano, and Kim Arias, Project Grad; and Christopher Hahn and Terri
Kemp Zielenski, United Way of Long Island
June 1–2 NSF Dynamic Gene Workshop, Canisius College, Buffalo, New York
June 2 As the Worm Turns Student Workshop, American Museum of Natural History, New York, New York
June 4–8 NSF Plant Molecular Genetics and Genomics Workshop, Oklahoma City, Oklahoma
June 5 Site visit by Bob Frehse and Ligia Cravo, Hearst Foundation, New York, New York
June 6 Site visit to Northport High School, New York, for G2C Online
June 6 Cold Spring Harbor High School Partnership Program graduation ceremony, CSHL
June 6, 13, 20 Reading Your DNA, Adult Education Workshop, American Museum of Natural History, New York, New
York
June 7 Site visit by Kidgie Williams, Hospitality Committee for United Nations Delegations, Inc., and
United Nations’ family members, New York, New York
June 8 Site visit by Anne Marie Agnelli, Computer Associates International, Inc., Islandia, New York
June 9 Saturday DNA!, “Jellyfish Genes,” DNALC
June 13–14 National Science Foundation iPlant Site Review, University of Arizona, Tucson
June 16 The Iceman Cometh Student Workshop, American Museum of Natural History, New York, New York
June 20 Site visit by Bob Keller, Keyspan Foundation, Hicksville, New York
June 21 G2C Online interview with Portia Iversen, Los Angeles, California
June 25–29 NSF Plant Molecular Genetics and Genomics Workshop, with Minority Fellow Gokhan Hacisali-
hoglu, Tallahassee, Florida
June 25–29 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC West
Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
June 28 Site visit by Rod Miller, University of the Sciences in Philadelphia (USP), Russell DiGate, Philadel-
phia College of Pharmacy, and John Porter, Faculty Council, USP, Pennsylvania
July 2–8 DNA Science Workshop, Central Islip, New York
DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC West
July 9 Site visit by Anna Pascucci, University of Naples, and Liceo Scientifico Statale “G. Salvermini,”
Sorrento, Italy
July 9–13 DNA Science Workshop, DNALC West
Genetic Horizons Workshop, DNALC
World of Enzymes Workshop, DNALC
July 9–27 Amgen Leadership Symposium, DNALC
July 12 Site visit by Oscar Orrantia Vernaza, Pilar Morla de Orrantia, and Pilar Orrantia Quentin,
Junta de Beneficencia in Guayaquil, Ecuador
July 12–13 National Science Foundation CCLI Grant Review, Arlington, Virginia
July 13 G2C Online interview with Thomas Nuhse, University of Manchester, United Kingdom
July 16 G2C Online interview with Jonathan Sebat, CSHL
July 16–20 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC West
Human Genomics Workshop, DNALC
July 20 Site visit by Bill and Ursula Niarakis, Hoffman Center, Long Island, New York
July 23–27 Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC
July 30–August 3 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC West
Fun with DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
July 31 Site visit by Bob Keller, Keyspan Foundation, Hicksville, New York
August 2 Site visit by Leslie Beller, Christine Knight, Edward Murphy, and Douglas Taylor, University of Vir-
ginia
August 6–10 DNA Science Workshop, DNALC
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC
World of Enzymes Workshop, DNALC West
August 9 Site visit by Fran Brennan, Veeco Instruments, Woodbury, New York
August 14 Site visit by Joe Novak, G2C Online Advisory Panel, and Joan Novak
August 14 Site visit by Jeff Carstens, Sovereign Bank, Long Island, New York
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August 20–24 New York City Department of Education DNA Science and PCR and Bioinformatics Work-
shops, Brooklyn Technical High School, Brooklyn, New York
August 20–24 DNA Science Workshop, Sarah Lawrence College, Bronxville, New York
August 21 Site visit by Karen Agostisi and Tricia Russell, Office of Congressman Steve Israel
August 23–24 Hackathon Meeting, Chicago, Illinois
August 28 Bioinformatics Seminar, International Chromosome Conference, Amsterdam, The Netherlands
August 31 PTC Bioinformatics, International Chromosome Conference, Vienna Open Lab, Vienna, Austria
August 31 Site visit by Bob Keller, Keyspan Foundation, Hicksville, New York
September 24 Site visit by Dmitri Dumas, Diefendorf Capital Planning Associates, Locust Valley, New York
October 11 Site visit by Roy Crawford, The University of Waikato, New Zealand, and Renee Crawford
October 13 President’s Council Meeting at DNALC, Sydney Brenner, Salk Institute; Phil Sharp, McGovern
Institute for Brain Research at Massachusetts Institute of Technology; Gregory Hannon and
Marja Timmermans, CSHL
October 15 G2C Online Advisory Panel Meeting, DNALC
October 20 Saturday DNA!, “Breaking Up is Hard to Do” and “The Ins and Outs of Cancer,” DNALC
October 22–24 Howard Hughes Medical Institute Precollege Program Director’s meeting, Washington, D.C.
October 31 Enhancing Collaborative Leadership for Improved Performance in Science Education,
(ECLIPSE), Albany, New York
Oct. 31–Nov. 2 Novartis Exploratory Oncology Development Group Educational meeting, DNALC
November 5 Site visit by Ed Lee, Apollo Developer, Berkeley Bioinformatics and Ontologies Project,
Lawrence Berkeley National Labs, California
November 7 Site visit by Yoshi Ishikawa, Masahiro Nei, and Lee Shuett, Nikon Instruments
November 12 Site visit by Bob Keller, Keyspan Foundation, Hicksville, New York
November 16–18 Howard Hughes Medical Institute Genomics Education Meeting, Chevy Chase, Maryland
November 17 Saturday DNA!, “Yeasty Beasties” and “Beyond DNA,” DNALC
November 27–28 NSF Dynamic Gene Workshop, National Science Foundation, Decatur, Georgia
November 28 National Association of Biology Teachers, “Sense in Molecules,” Atlanta, Georgia
November 29 National Association of Biology Teachers meeting, “Detecting GM Food by PCR,” “Dynamite
WWW Teaching Resources,” Atlanta, Georgia
December 5 Presentation to New York State Genetics Task Force, New York University Medical Center
December 7 NSF Dynamic Gene Workshop, Caltech, Pasadena, California
December 7 Singapore Primary Teachers Attachment, DNALC
December 15 Saturday DNA!, “Iceman” and “The Buzz on Bees,” DNALC
December 21 G2C Online interview with Jon Lieberman, Psychologist, Hampton Bays, New York
Sites of Major Faculty Workshops 1985–2007
Key: Middle School High School College
ALABAMA University of Alabama, Tuscaloosa 1987–1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA California State University, Fullerton 2000
California Institute of Technology, Pasadena 2007
Canada College, Redwood City 1997
City College of San Francisco 2006
Contra Costa County Office of Education, Pleasant Hill 2002
Foothill College, Los Altos Hills 1997
Harbor–UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute, Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001
San Francisco State University 1991
San Jose State University 2005
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994, 2007
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA Armwood Senior High School, Tampa 1991
Florida Agricultural & Mechanical University, Tallahassee 2007
North Miami Beach Senior High School 1991
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University of Miami School of Medicine 2000
University of Western Florida, Pensacola 1991
GEORGIA Fernbank Science Center, Atlanta 1989, 2007
Morehouse College, Atlanta 1991, 1996–1997
HAWAII Kamehameha Secondary School, Honolulu 1990
IDAHO University of Idaho, Moscow 1994
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990–1992
National Center for Biotechnology Information, Bethesda 2002
St. John’s College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Beverly High School 1986
Biogen, Cambridge 2002
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MINNESOTA University of Minnesota, St. Paul 2005
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990–1991
Rust College, Holly Springs 2006–2007
MISSOURI Stowers Institute for Medical Research, Kansas City 2002
Washington University, St. Louis 1989, 1997
NEVADA University of Nevada, Reno 1992
NEW HAMPSHIRE New Hampshire Community Technical College, Portsmouth 1999
St. Paul’s School, Concord 1986, 1987
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
NEW YORK Albany High School 1987
American Museum of Natural History 2007
Bronx High School of Science 1987
Canisius College, Buffalo 2007
Columbia University 1993
Cold Spring Harbor High School 1985, 1987
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988–1995,
2001–2004,
2006–2007
DNA Learning Center 1990, 1992,
1995, 2000
DNA Learning Center 1990–1992
DNA Learning Center West 2005
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine 1997
New York City Department of Education 2007
New York Institute of Technology 2006
New York Institute of Technology 2006
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
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The Rockefeller University 2003
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987–1990
Stuyvesant High School, New York 1998–1999
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Lake Saranac 2001
Union College, Schenectady 2004
U.S. Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Center for Health Research, Triangle Park 2003
North Carolina Agricultural & Technical State University, Greensboro 2006–2007
North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA Oklahoma City Community College 2000
Oklahoma City Community College 2006–2007
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Clemson University, Clemson 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS Austin Community College-Rio Grande Campus 2000
Austin Community College-Eastview Campus 2007
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Texas A&M, AG Research and Extension Center, Weslaco 2007
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
Utah Valley State College, Orem 2007
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
Virginia Polytechnic Institute and State University, Blacksburg 2005
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001
University of Washington, Seattle 1993, 1998
WASHINGTON, D.C Howard University 1992, 1996
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999
Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
AUSTRIA Vienna Open Lab 2007
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001–2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University, Uppsala 2000
THE NETHERLANDS International Chromosome Conference, Amsterdam 2007
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2007 PUBLICATIONS
SERIALS
Genes & Development, Vol. 21, 1–3406 (www.genesdev.org)
Genome Research, Vol. 16, 1–1952 (www.genome.org)
Learning & Memory, Vol. 14, 1–868 (www.learnmem.org)
Protein Science, Vol. 16, 1–2784 (www.proteinscience.org)
RNA, Vol. 13, 1–2388 (www.rnajournal.org)
Cold Spring Harbor Symposia on Quantitative Biology, Vol. 71:
Regulatory RNAs, Bruce Stillman and David Stewart (eds.)
(Available in print and online)
Cold Spring Harbor Protocols (www.cshprotocols.org)
LABORATORY MANUALS
Genetic Variation: A Laboratory Manual, Michael P. Weiner,
Stacey B. Gabriel, and J. Claiborne Stephens
Single-Molecule Techniques: A Laboratory Manual,
Paul R. Selvin and Taekjip Ha
HANDBOOKS
C. elegans Atlas, David H. Hall and Zeynep F. Altun
Safety Sense: A Laboratory Guide, Second Edition
MONOGRAPHS
Adult Neurogenesis, Fred H. Gage, Gerd Kempermann,
and Hongjun Song
Invertebrate Neurobiology, Geoffrey North and Ralph J.
Greenspan
Molecular Biology of Aging, Leonard P. Guarente,
Linda Partridge, and Douglas C. Wallace
The TGF-β Family, edited by Rik Derynck and Kohei Miyazono
TEXTBOOKS
An Introduction to Nervous Systems, Ralph J. Greenspan
Evolution, Nicholas H. Barton, Derek E.G. Briggs, Jonathan A.
Eisen, David B. Goldstein, and Nipam H. Patel
Molecular Biology of the Gene, Sixth Edition, James D. Watson,
Tania A. Baker, Stephen P. Bell, Alexander Gann, Michael
Levine, and Richard Losick
SCIENCE AND SOCIETY
Career Opportunities in Biotechnology, Toby Freedman
Max Perutz and the Secret of Life, Georgina Ferry
Phage and the Origins of Molecular Biology, The Centennial Edi-
tion, John Cairns, Gunther S. Stent, and James D. Watson
OTHER
CSHL Annual Report 2006: Yearbook Edition
CSHL Annual Report 2006
Banbury Center Annual Report 2006
Watson School of Biological Sciences Annual Report 2006
WEB SITES
http://www.genesandsignals.org: Web site to accompany
Epigenetics with figures made available on our resource
Web site
http://www.cshl-symposium.org; Symposia, Vol. 71 added to
online Symposia Web site
A selection of recently published books The journal publishing program
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COLD SPRING HARBOR LABORATORY PRESS
EXECUTIVE DIRECTOR’S REPORT
Cold Spring Harbor Laboratory’s first-class biomedical research is complemented by an unmatched program
of professional and public education in gene science. The vehicle for much of this service is the work of Cold
Spring Harbor Laboratory Press. Its evolution into a highly respected, independent, professional publisher has
produced six research journals, two of them among the most highly ranked in science; the world’s most
widely used laboratory manuals, including the most highly cited book in biology; a prestigious monograph
series; the most historically important conference proceedings in molecular biology; and best-selling primers
on professional skills development for scientists. These activities enhance the work of other divisions, such
as the Dolan DNA Learning Center, and produce revenue that supports the work of the Laboratory as a
whole and identifies its name with quality, reliability, and excellence.
In 2007, despite challenging market conditions, CSHL Press generated a substantial operating excess,
with a preliminary 2007 margin of just under $500,000 on revenues of $10.371 million. The Press’ total
financial contribution to the Laboratory was more than $1.1 million.
Journals
Revenues from journal publishing continued to be a major contributor to this success, increasing by 4.5%
from 2006. For the established titles, there was growth in both subscription base and advertising revenue.
Our newest journal, Cold Spring Harbor Protocols, exceeded subscription revenue projections in its first full
year and requests for institutional trial subscriptions continue to increase steadily, auguring well for this online-
only publication’s future. Although growth continues in most established markets such as the United States
and Western Europe through targeted sales efforts to individual institutions, opportunities for expansion are
also being sought in the world’s emerging scientific communities, through new multijournal package sub-
scription sales to institutional consortia in India, Korea, and countries in South America. The Press has been
active in China for several years, and in 2007, a 3-year contract extension was signed with the National Sci-
ence and Technology Library to continue Press journal access at more than 400 institutions in this country.
417
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Throughout our program, the use of print copies is declining as individual scientists make more extensive
use of Web-based editions and as institutional libraries focus on developing electronic collections. In 2007
alone, online use of articles in CSHL Press journals grew by 30%. In response, the online archives of Genes
& Development and Genome Research were extended to include all issues ever published for each journal,
and the decision was made to reduce the frequency of print issues of Learning & Memory to twice yearly in
2008, in anticipation of the journal’s becoming an online-only publication in 2009. Print issues remain an
important vehicle for advertisers, but opportunities for online advertising have increased, for example, with
the distribution of tables of content by e-mail, and companies with products to offer our readers are devel-
oping an appetite for their use.
The utility of the editorial content of our journals continues to be enhanced by the continuous develop-
ment of tools and features that result from our 10-year-long online-publishing partnership with Stanford
University’s HighWire Press. A new contract with HighWire was negotiated to enhance our online journal
platform while reducing costs. New versions of our online journals will launch in Fall 2008 with innovative
“Web 2.0” features, greater flexibility for content display, and customized functions that will assist both read-
ers and authors.
Although its technology base is now vital to a journal’s success, the quality of its content remains the most
important differentiator. By all availablemetrics,Genes & Development andGenomeResearch are consistently
ranked among the most distinguished journals in the fields of genetics and developmental and cell biology.
Learning &Memory, with its more specialized emphasis on cellular andmolec-
ular approaches, is receivingmore submissions than ever. And the journals we
publish for scientific societies, Protein Science and RNA, also have encourag-
ing usage trends.
Research published in our journals was featured widely in the popu-
lar press. Television, newspaper, and magazine coverage in 2007 included
features on CNN, MSNBC, BBC, ABC News, and FOX News networks,
Time, Newsweek, US News & World Report, Forbes, Wired, Scientific
American, National Geographic, New Scientist, San Francisco Chronicle,
Washington Post, USA Today, International Herald Tribune, Boston Globe,
and The Daily Telegraph, as well as innumerable online news sources.
Books
Fourteen newbookswere published this year. As the list below indicates, they included timely and highly regarded
manuals, handbooks,monographs, and history/biographies. Themost keenly anticipatedwas the first book that
the Press has independently developed for undergraduate teaching, Evolution, by Nicholas Barton, Derek
Briggs, Jonathan Eisen, David Goldstein, and NipamPatel. An innovative synthesis of evolutionary andmolec-
ular biology, Evolutionwaswelcomed by reviewers and teachers as “superb,” “outstanding,” and “compelling.”
The book has a companionWeb site (www.evolution-textbook.org) that contains extensive chapter notes, fig-
ures and tables from the book, and two online-only chapters, and is already in use at Harvard, Stanford, Uni-
versity of Pennsylvania, Oxford, and numerous other major universities in the U.S. and Europe.
Thirteen contracts were signed for new books that included advanced textbooks, manuals, monographs,
and a number of titles promoting the public’s engagement with science. Five agreements were signed with
foreign publishers for translations of titles into Chinese, Japanese, and Korean, and two contracts were signed
for foreign reprint rights.
Marketing and Sales
Just as the distribution and purchase of scientific information has changed dramatically throughout the past
decade, our strategies, techniques, and in-house skills have followed suit. This year, the reorganization of our
book and journal marketing and sales departments continued and the boundaries between their activities
418
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melted still more. The work of these departments maintains the visibility of the Press, the Laboratory, and their
educational products and services in an increasingly dense information world. A monthly electronic newslet-
ter, now reaching 45,000 subscribers, announces new titles, notable journal articles, and Press news, and
promotes other divisions of the Laboratory, including the Dolan DNALC, the Meetings and Courses pro-
gram, and developments at the Library and Archives.
Investment in new staff and skills permitted significant enhancement of the CSHL Press Web site in 2007,
with improved searching, Web indexing, a new layout, and new features such as RSS feeds. Beneath the sur-
face, further technical improvements included tools for tracking usage and strengthening sales efforts, as well
as dynamic intrapage updating for more efficient site maintenance. Podcasts and slide showswere developed
for specific titles, including one that highlighted the life of Max Perutz, narrated by the author ofMax Perutz and
the Secret of Life, Georgina Ferry. And the Executive Editor ofCSHProtocols, David Crotty, began a blog called
Benchmarks that has a growing audience. Online features such as these offer readers, potential book buyers,
and prospective authors the opportunity to learn more about the background and content of our publications.
These additional efforts are associated with an increase in direct sales: The proportion of books sold through
our Web site and our major online bookselling partner Amazon.com rose to a record high in 2007.
The Press published its first online information in 1997. Ten years later, what is most surprising is not
that science publishing has changed, but that, fundamentally, so much has remained the same for so
long. For much of the past decade, the Press, like most of its peers in academic publishing, has found
ways to place on the Web information that was developed for print publication. At last, that way of think-
ing is giving ground to an online-first approach. A major goal for the Press is the invention of a means of
publishing books online that places book content firmly in the information universe of individual scientists,
with a viable business model. A strategy for achieving that goal has been developed and will be imple-
mented in 2008, with the assistance of a strengthened editorial staff.
Meanwhile, journal publishing continues to struggle toward business models that combine financial viabil-
ity with maximum possible access to content. Journals such as ours provide a vital community service that
requires a full-time staff, including scientifically trained professionals. These journals lack the circulation to
become supported through advertising alone and cannot rely solely on publication fees provided by elite sci-
entists with support from wealthy foundations. Our response has been to offer authors in all journals that we
publish the option to have their papers made freely accessible immediately on publication, in return for a fee.
However, for the past 5 years, all papers published inGenes &Development andGenomeResearch have been
made freely available only 6 months after publication and deposited in the PubMedCentral database of the
419
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National Library of Medicine. In this respect, the Press is attempting to render its journals compliant with the
public access requirements of organizations such as The Wellcome Trust, the Howard Hughes Medical Insti-
tute, and most recently the National Institutes of Health, while remaining financially viable and continuing to be
valuable contributors to the Laboratory’s economy.
Staff
In 2007, we welcomed new colleagues Delia King, Kathy LaForgia, Christina Lo, Robert Majovski, Stephanie
Novara, Keri Paterakis, Ted Roeder, Patricia Serpe, and Lauren Schmidt. We said farewell, thanks, and
good luck to Cher Mattes and Roberta Salant.
A complete list of staff members of the Press as of December 2007 is printed elsewhere in this volume.
The Laboratory is privileged to have the contributions of such capable and hardworking professionals, with
whom it is my pleasure to work. I wish to extend special thanks to the individuals who have the added
responsibility of providing leadership in the diverse departments and projects of the Press: Jan Argentine,
David Crotty, Alex Gann, Terri Grodzicker, Bill Keen, Wayne Manos, Marcie Siconolfi, Hillary Sussman, Linda
Sussman, and Denise Weiss.
John R. Inglis
Executive Director
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2007
(with comparative financial information as of December 31, 2006)
2007 2006
Assets:
Cash and cash equivalents $ 25,576,470 23,563,414
Accounts receivable 2,669,325 2,995,007
Grants receivable 9,037,130 7,859,380
Contributions receivable, net 67,093,000 43,226,518
Publications inventory 4,033,100 3,720,386
Prepaid expenses and other assets 4,049,972 2,015,019
Investments 333,635,052 308,108,275
Investment in employee residences 5,446,047 5,557,353
Restricted use assets 3,991,338 3,598,745
Deposits with bond trustee 29,483,468 46,014,949
Land, buildings and equipment, net 159,204,452 130,942,408
Total assets $ 644,219,354 579,417,878
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 19,998,678 12,450,777
Deferred revenue 4,003,091 3,585,913
Bonds payable 97,200,000 97,200,000
Total liabilities 121,201,769 113,236,690
Commitment and contingencies
Net assets:
Unrestricted 219,853,852 213,562,751
Temporarily restricted 119,623,060 82,791,081
Permanently restricted 183,540,673 169,827,356
Total net assets 523,017,585 466,181,188
Total liabilities and net assets $ 644,219,354 579,417,878
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2007
(with summarized financial information for the year ended December 31, 2006)
Temporarily Permanently 2007 2006
Unrestricted Restricted Restricted Total Total
Revenue and other support:
Public support—contributions and
non-Federal grant awards $ 18,471,699 46,374,702 6,786,787 71,633,188 59,431,937
Federal grant awards 30,887,232 – – 30,887,232 33,128,165
Indirect cost allowances 19,634,082 – – 19,634,082 20,258,404
Investment return utilized 18,299,207 – – 18,299,207 10,741,551
Program fees 4,103,754 – – 4,103,754 4,192,163
Publications sales 10,404,661 – – 10,404,661 9,319,286
Dining services 3,640,595 – – 3,640,595 3,780,431
Rooms and apartments 2,804,675 – – 2,804,675 3,043,489
Royalty and licensing fees 1,092,311 – – 1,092,311 693,345
Miscellaneous 910,490 – – 910,490 931,666
Net assets released from restrictions 9,542,723 (9,542,723) – – –
Total revenue and other support 119,791,429 36,831,979 6,786,787 163,410,195 145,520,437
Expenses:
Research 65,315,923 – – 65,315,923 62,822,726
Educational programs 12,017,459 – – 12,017,459 13,565,968
Publications 10,241,091 – – 10,241,091 9,351,363
Banbury Center conferences 1,342,587 – – 1,342,587 1,124,415
Dolan DNA Learning Center programs 1,413,157 – – 1,413,157 1,325,479
Watson School of Biological 3,206,295 – – 3,206,295 2,973,896
Sciences programs
General and administrative 13,111,199 – – 13,111,199 13,619,460
Dining services 5,109,292 – – 5,109,292 4,981,661
Total expenses 111,757,003 – – 111,757,003 109,764,968
Excess of revenue and other support
over expenses 8,034,426 36,831,979 6,786,787 51,653,192 35,755,469
Other changes in net assets:
Investment return in excess of
amount utilized 1,333,223 – 6,926,530 8,259,753 20,946,485
Change in fair value of interest
rate swap (3,076,548) – – (3,076,548) (3,370,108)
Increase in net assets 6,291,101 36,831,979 13,713,317 56,836,397 53,331,846
Net assets at beginning of year 213,562,751 82,791,081 169,827,356 466,181,188 412,849,342
Net assets at end of year $ 219,853,852 119,623,060 183,540,673 523,017,585 466,181,188
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CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2007
(with comparative financial information for the year ended December 31, 2006)
2007 2006
Cash flows from operating activities:
Increase in net assets $ 56,836,397 53,331,846
Adjustments to reconcile increase in net assets
to net cash provided by operating activities:
Change in fair value of interest rate swap 3,076,548 3,370,108
Depreciation and amortization 6,397,045 6,032,302
Net appreciation in fair value of investments (17,332,229) (24,403,523)
Contributions restricted for long-term investment (9,760,257) (30,918,132)
Changes in assets and liabilities:
Decrease in accounts receivable 325,682 2,740,444
(Increase) decrease in grants receivable (1,177,750) 492,837
Increase in contributions receivable (26,406,799) (31,856)
Increase in publications inventory (201,657) (851,626)
(Increase) decrease in prepaid expenses and other assets (329,586) 535,210
Increase in restricted use assets (392,593) (372,207)
Decrease in accounts payable and accrued expenses (560,202) (1,042,172)
Increase (decrease) in deferred revenue 417,178 (651,641)
Net cash provided by operating activities 10,891,777 8,231,590
Cash flows from investing activities:
Capital expenditures (34,659,089) (21,123,188)
Proceeds from sales and maturities of investments 84,438,846 97,347,685
Purchases of investments (92,610,279) (124,641,857)
Net change in investment in employee residences 88,191 434,677
Net cash used in investing activities (42,742,331) (47,982,683)
Cash flows from financing activities:
Permanently restricted contributions 6,786,787 14,917,606
Contributions restricted for investment in land, buildings
and equipment 2,973,470 16,000,526
Decrease in contributions receivable 2,540,317 4,383,403
Decreasse (increase) in deposits with bond trustee 16,531,481 (46,014,949)
Debt issue costs paid – (2,240,577)
Increase (decrease) in accounts payable relating to capital expenditures 5,069,642 (276,659)
Repayment of notes payable (38,087) (35,551)
Redemption of 1993 Suffolk IDA Bond – (3,000,000)
Issuance of bonds payable – 55,000,000
Net cash provided by financing activities 33,863,610 38,733,799
Net increase (decrease) in cash and cash equivalents 2,013,056 (1,017,294)
Cash and cash equivalents at beginning of year 23,563,414 24,580,708
Cash and cash equivalents at end of year $ 25,576,470 23,563,414
Supplemental disclosures:
Interest paid $ 3,812,914 2,614,630
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GRANTS January 1–December 31, 2007
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2007 Funding
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Support Dr. Lowe 03/01/07 02/29/08 $425,826 *
Dr. McCombie 04/15/07 04/14/08 473,927 *
Program Project Support Drs. Hannon/Krainer/Lazebnik/Lowe/
S. Muthuswamy/Myers/D. Spector/
Stenlund/Stillman/Tansey 01/01/07 12/31/11 4,358,993 *
Dr. Stillman–CSHL Cancer Center Core 08/15/05 07/31/10 4,086,019
Drs. Lowe/Hannon/S. Muthuswamy 04/01/04 03/31/09 945,214
Dr. Huang 09/08/06 08/31/11 716,542
Pioneer Award Support Dr. Cline 09/30/05 07/31/10 827,584
Merit Award Support Dr. Malinow 05/01/92 04/30/10 656,267
Dr. Tonks 08/01/91 03/31/09 665,593
Contract Support
SAIC-NCI Dr. Hannon 01/01/07 06/30/08 250,000 *
Research Support Dr. Chklovskii 07/08/01 06/30/09 289,291
Dr. Cline 12/01/04 11/30/09 580,461
Dr. Dubnau 09/15/04 06/30/09 346,786
Dr. Enikolopov 07/01/07 06/30/09 226,463 *
Dr. Hannon 09/01/05 08/31/09 330,161
Dr. Huang 07/15/05 04/30/09 371,658
Dr. Joshua-Tor 07/01/07 06/30/12 402,438 *
Dr. Joshua-Tor 07/01/05 06/30/09 282,059
Dr. Joshua-Tor 02/01/06 01/31/10 293,750
Dr. Krainer 09/21/07 08/31/11 620,984 *
Dr. Lowe 07/01/99 07/31/09 405,752
Dr. Malinow 04/01/95 02/29/08 575,356
Dr. Martienssen 08/01/07 07/31/11 428,531 *
Dr. Mills 12/26/07 11/30/12 314,922 *
Dr. Mitra 03/04/05 02/28/09 477,978
Dr. Mittal 04/01/04 02/28/09 296,523
Dr. S. Muthuswamy 03/01/06 02/29/08 83,246
Drs. Powers/Lowe 12/02/06 11/30/11 374,754
Dr. Sebat 04/01/07 03/31/10 732,400 *
Dr. Sebat 09/30/05 07/31/10 405,328
Dr. Skowronski 04/01/98 04/30/08 664,320
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the Federal Government and through grants, cap-
ital gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2007.
*New grants awarded in 2007
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Grantor Program/Principal Investigator Duration of Grant 2007 Funding
Dr. D. Spector 04/01/07 03/31/11 662,242 *
Dr. D. Spector 09/01/04 08/31/08 310,885
Dr. Stein 05/04/07 03/31/11 1,275,000 *
Dr. Stein 09/25/06 06/30/09 407,213
Dr. Stein 04/01/07 02/28/11 1,003,650 *
Dr. Stenlund 07/01/07 06/30/08 419,375 *
Dr. Stillman 07/01/91 05/31/08 559,923
Dr. Svoboda 12/04/98 11/30/08 290,223
Dr. Svoboda 06/01/03 03/31/08 281,255
Dr. Svoboda 03/01/04 02/28/09 325,452
Dr. Tansey 05/01/07 04/30/11 377,250 *
Dr. Tonks 07/01/05 06/30/09 369,649
Dr. Tonks 07/21/06 05/31/10 289,122
Dr. Tully 03/01/03 02/29/08 361,613
Dr. Van Aelst 05/01/03 04/30/08 321,835
Dr. Zador 01/23/03 12/31/07 401,791
Dr. Zhang 08/13/07 07/31/11 318,804 *
Dr. Zhong 07/01/03 06/30/08 329,067
Research Subcontracts
NIH/Booz Allen Hamilton caBIG Dr. Stein 03/07/07 03/06/08 14,968
Consortium Agreement
NIH/Brookhaven National Laboratory Dr. Stillman 09/01/06 08/31/11 36,624
Consortium Agreement
NIH/Caltech Consortium Agreement Dr. Stein 09/01/03 08/31/08 545,266
NIH/Caltech Consortium Agreement Dr. Svoboda 04/04/03 02/29/08 144,637
NIH/Columbia University Consortium Dr. Lowe 08/18/06 07/31/11 415,385
Agreement
NIH/Columbia University Consortium Drs. Wigler/Sebat 09/01/06 05/31/10 286,067
Agreement
NIH/Georgia Institute of Technology Dr. D. Spector 09/30/06 09/29/11 140,000
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Van Aelst 07/10/03 06/30/08 338,319
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Mittal 04/01/04 03/31/09 137,498
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Hannon 05/04/07 03/31/11 114,738 *
Consortium Agreement
NIH/Oxford University Consortium Dr. Stein 03/01/06 02/28/11 157,509
Agreement
NIH/Rutgers University Consortium Dr. Mitra 12/08/04 11/30/08 107,916
Agreement
NIH/University of California–Berkeley Dr. Stein 09/01/07 08/31/10 67,800 *
Consortium Agreement
Fellowship Support Dr. Chicas 04/01/06 03/31/09 52,048
Dr. Demas 02/16/07 02/15/10 49,646 *
Dr. Slotkin 09/15/06 09/14/09 45,976
Dr. Yang 03/01/06 02/28/09 52,048
Career Development Support Dr. Silva 04/01/07 03/31/08 112,383 *
Graduate Training Support Dr. Joshua-Tor/Watson School of 07/01/02 06/30/12 205,229
Biological Sciences
Course Support X-Ray Methods in Structural Biology 07/01/07 06/30/12 69,935 *
Immunocytochemistry, In Situ 07/01/98 08/31/10 81,983
Hybridization, and Live Cell Imaging
*New grants awarded in 2007
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Grantor Program/Principal Investigator Duration of Grant 2007 Funding
Programming for Biology 07/07/00 08/31/09 55,168
C. elegans 08/01/98 08/31/11 76,335
Integrated Data Analysis for High- 05/01/07 04/30/08 70,860 *
throughput Biology
Neurobiology of Drosophilia 07/01/01 06/30/12 66,552
Advanced Techniques in Molecular 07/01/01 06/30/12 75,438
Neuroscience
Imaging Structure and Function in 07/01/01 06/30/12 82,399
the Nervous System
Cell and Developmental Biology of 04/01/93 03/31/09 21,243
Xenopus
Protein Purification and Characterization 01/01/83 03/31/11 86,000
Molecular Embryology of the Mouse 01/01/83 03/31/11 98,000
Eukaryotic Gene Expression 01/01/83 03/31/11 97,836
Proteomics 07/01/03 06/30/11 74,192
Yeast Genetics and Genomics 07/01/07 05/31/10 47,500 *
Meeting Support Microbial Pathogenesis and Host 05/15/03 04/30/08 13,787
Response
Eukaryotic mRNA Processing 08/01/03 07/31/08 6,000
The Ubiquitin Family 04/11/07 03/31/12 5,000 *
The Biology of Genomes 04/08/05 03/31/08 31,388
Phosphorylation, Signaling, and Disease 05/01/07 04/30/08 4,000 *
Rat Genomics and Models 09/30/05 08/31/08 15,000
Receptors, Channels, Synapses 04/01/06 03/31/11 29,475
72nd Symposium: Clocks and Rhythms 04/01/07 03/31/08 10,000 *
Telomeres and Telomerase 05/01/07 04/30/08 20,000 *
Neurobiology of Drosophilia 07/01/07 06/30/08 10,000 *
Mechanisms of Eukaryotic Transcription 07/01/07 06/30/08 3,000 *
Genome Informatics 08/02/07 07/31/08 22,000 *
Cell Death 09/14/07 08/31/12 5,000 *
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Hannon 09/01/06 08/31/09 400,000
Dr. Jackson 07/01/05 06/30/10 1,002,269
Dr. McCombie 09/01/06 08/31/08 1,130,076
Drs. Stein/Ware 10/01/07 09/30/11 1,589,300 *
Dr. Stein 12/15/03 11/30/08 1,580,029
Research Support Dr. Jackson 04/01/07 03/31/10 140,000 *
Dr. Lukowitz 04/01/05 03/31/08 129,260
Dr. Timmermans 09/01/06 08/31/09 130,000
Dr. Timmermans 09/01/06 08/31/09 164,319
Dr. Van Aelst 08/15/05 07/31/08 135,266
Dr. Ware 09/01/03 08/31/08 276,273
Dr. Zador 10/01/07 09/30/09 10,751 *
Dr. Zhang 09/15/03 08/31/08 91,000
Research Subcontracts
NSF/Cornell University Consortium Dr. Timmermans 09/01/06 08/31/08 103,520 *
Agreement
NSF/Cornell University Consortium Dr. Ware 11/01/06 10/31/08 150,000 *
Agreement
NSF/National Center for Genome Dr. Stein 09/01/05 08/31/08 57,816
Research Consortium Agreement
NSF/New York University Consortium Drs. McCombie/Martienssen 10/01/04 09/30/09 257,992
Agreement
NSF/North Carolina State University Dr. Martienssen 10/01/04 09/30/09 185,892
Consortium Agreement
*New grants awarded in 2007
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NSF/University of Arizona Consortium Dr. Stein 10/01/06 09/30/08 152,775
Agreement
NSF/University of California–Berkeley Dr. Jackson 08/01/06 07/31/11 209,119
Consortium Agreement
NSF/University of California–Davis Dr. Martienssen 09/01/06 08/31/10 258,944
Consortium Agreement
NSF/University of Florida Consortium Dr. Martienssen 08/01/07 07/31/09 97,991 *
Agreement
NSF/University of Wisconsin Consortium Drs. Stein/Ware 01/01/04 12/31/08 214,457
Agreement
NSF/Washington University Consortium Drs. McCombie/Martienssen/Stein/Ware 11/15/05 10/31/08 1,432,423
Agreement
Fellowship Support C. Malone 06/01/07 05/31/08 40,500 *
Undergraduate Training Support Dr. Clark/Watson School of Biological 04/15/05 03/31/08 117,473
Sciences
Meeting Support Plant Genomes 03/01/07 02/29/08 14,880 *
Eukaryotic mRNA Processing 08/15/07 07/31/08 3,000 *
Neurobiology of Drosophilia 07/01/07 06/30/08 12,713 *
Eukaryotic DNA Replication 08/15/07 07/31/08 3,000 *
Mechanisms of Eukaryotic Transcription 08/15/07 07/31/08 3,000 *
Course Support Molecular Techniques in Plant Science 07/01/07 06/30/08 85,680 *
Advanced Bacterial Genetics 07/15/04 06/30/09 77,450
Cell and Developmental Biology of 05/01/07 04/30/10 20,000 *
Xenopus
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/05 08/31/08 120,224
Dr. McCombie 09/15/04 09/14/09 382,425
Dr. Stein 09/22/03 09/14/08 244,953
Dr. Timmermans 09/15/06 09/14/09 133,359
Fellowship Support Dr. Whipple 09/15/06 09/14/08 63,181
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 02/01/06 01/31/09 169,500
Dr. Hannon 02/15/06 02/14/09 169,500
Dr. Lazebnik 12/01/06 11/30/09 210,000
Drs. Lucito/Tonks 08/01/07 07/31/08 251,750 *
Dr. Mu 07/01/07 06/30/10 167,500 *
Dr. Wigler 04/01/04 08/31/08 1,378,250
Dr. Zhong 12/15/04 12/14/08 334,511
Fellowship Support X. He 07/16/07 02/15/08 17,500
D. Khalil 12/01/06 11/30/09 33,300
E. Murchison 02/16/05 07/15/07 12,500
A. Rosenberg 02/28/05 02/28/08 30,000
D. Simpson 09/01/06 08/31/09 32,400
*New grants awarded in 2007
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Research Subcontracts
U.S. Army/New York University School Dr. Lucito 09/27/04 09/26/09 124,266
of Medicine Consortium Agreement
UNITED STATES DEPARTMENT OF ENERGY
Research Subcontracts
DOE/Texas A&M Consortium Agreement Dr. Ware 09/15/06 09/14/08 39,528 *
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
Breast Cancer Help Inc. Dr. Sordella 02/01/07 01/31/08 7,337 *
Elaine Hayes Special Effects Salon Dr. S. Muthuswamy 07/01/07 06/30/08 20,000 *
F.M. Kirby Foundation, Inc. Dr. Turner 10/01/07 09/30/08 75,000 *
OSIA NYS General Lodge Foundation Inc. Dr. Sordella 02/01/07 01/31/08 2,000 *
W.I. Youth Enrichment Serv. Inc. Dr. Sordella 02/01/07 01/31/08 5,337 *
Program Project Support
The Leukemia & Lymphoma Society Dr. Lowe 10/01/03 09/30/08 1,250,000
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lukowitz/Martienssen/ 07/01/07 06/30/12 1,600,000 *
Timmermans/Ware
Theodore R. and Vada S. Stanley Drs. Watson/McCombie/Sebat 07/01/07 06/30/12 5,000,000 *
Research Support
American Cancer Society Dr. Wigler 01/01/07 12/31/07 10,000 *
American Cancer Society Dr. Wigler 01/01/06 12/31/10 60,000
American Cancer Society Dr. Mills 07/01/06 06/30/10 240,000
Anonymous Gift Dr. Malinow 09/01/06 08/31/08 130,000
Anonymous Gift Dr. Sebat 09/01/07 08/31/09 248,689 *
Anonymous Gift Dr. Zador 09/01/07 08/31/09 500,000 *
Ashner Family Evergreen Foundation Dr. Mitra 04/01/07 03/31/08 9,000 *
Autism Speaks, Inc. Dr. Zador 07/01/07 06/30/10 150,000 *
Mr. and Mrs. Donald E. Axinn Drs. Lowe/Hannon 2007 250,000 *
Brain Tumor Society Dr. Hannon 11/01/06 10/31/08 100,000
Breast Cancer Help Inc. Dr. S. Muthuswamy 07/01/07 06/30/08 7,337 *
Breast Cancer Research Foundation Dr. Wigler 10/01/07 09/30/08 250,000 *
Clear Channel Worldwide (Walk 97.5 FM) Dr. S. Muthuswamy 04/01/07 03/31/08 4,000 *
Breast Cancer Research Walk
Coleman Fung Foundation Inc. Dr. Zador 02/01/07 01/31/10 50,000 *
Mr. and Mrs. James Cook Dr. Lazebnik 04/01/07 03/31/08 2,500 *
Mrs. Shelby Cullom Davis Dr. Hannon 01/15/07 01/14/08 1,600,000 *
Eisai Co., Ltd. Dr. Malinow 10/01/07 09/30/08 10,000 *
The Eppley Foundation for Research, Inc. Dr. Enikolopov 07/01/07 06/30/08 35,000 *
Find A Cure Today (F.A.C.T.) Dr. S. Muthuswamy 12/01/07 11/30/08 30,000 *
FSMA Dr. Hastings 01/15/06 08/31/07 70,444
Genentech, Inc. Dr. Hannon 04/24/07 04/23/08 500,000 *
The Ryan Gibson Foundation Dr. M. Spector 08/01/07 07/31/08 50,000 *
The Joni Gladowsky Breast Cancer Dr. S. Muthuswamy 12/01/07 11/30/08 32,678 *
Foundation
GlaxoSmithKline Dr. Powers 09/20/06 09/19/08 484,476
GlaxoSmithKline Dr. S. Muthuswamy 10/01/06 09/30/08 168,024
Glen Cove C.A.R.E.S., Inc. Dr. S. Muthuswamy 04/01/07 03/31/08 2,000 *
Robert I. Goldman Foundation Dr. Mittal 12/31/07 12/30/08 30,000 *
Dr. Leo A. Guthart Drs. Lowe/Hannon 2007 250,000 *
Irving A. Hansen Memorial Foundation Dr. Tansey 08/01/07 07/31/08 20,000 *
The Thomas Hartman Foundation Dr. Tonks 07/01/07 06/30/09 172,518 *
Ira Hazan Dr. Enikolopov 12/01/07 11/30/08 200,000 *
*New grants awarded in 2007
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The Lita Annenberg Hazen Foundation Dr. Powers 11/01/07 10/31/08 250,000 *
Hearts for Cancer Dr. S. Muthuswamy 12/01/07 11/30/08 5,830 *
Hope for Depression Research Dr. Enikolopov 01/01/07 12/31/07 110,000 *
Foundation, Inc.
Human Frontier Science Program Dr. Dubnau 10/01/06 09/30/09 109,980
Organization
Islip Breast Cancer Coalition Inc. Dr. S. Muthuswamy 09/01/07 08/31/08 25,000 *
Joan's Legacy: The Joan Scarangello Dr. Sordella 12/01/07 11/30/09 50,000 *
Foundation to Conquer Lung Cancer
V. Kann Rasmussen Foundation Dr. Trotman 09/01/07 08/31/12 50,000 *
The Karches Foundation Dr. Wigler 07/01/05 06/30/10 466,147
W.M. Keck Foundation Dr. Mitra 07/01/06 06/30/09 500,000
The Charles H. Leach, II Foundation Dr. Enikolopov 03/01/07 02/29/08 2,000 *
Lehman Brothers Foundation Dr. Trotman 11/01/07 10/31/08 25,000 *
L.I.A.B.C. Dr. Wigler 2007 27,018 *
Margaret and Richard Lipmanson Dr. Furukawa 07/01/07 06/30/08 50,000 *
Foundation
Little Louie Foundation Dr. Van Aelst 05/01/07 04/30/08 10,000 *
Long Beach Breast Cancer Coalition Dr. S. Muthuswamy 03/01/07 02/29/08 3,000 *
Long Island 2-Day Walk to Fight Breast Dr. S. Muthuswamy 08/01/07 07/31/08 29,000 *
Cancer, Inc.
Manhasset Women's Coalition Against Dr. Powers 01/01/07 12/31/08 85,000 *
Breast Cancer
Manhasset Women's Coalition Against Dr. S. Muthuswamy 01/01/07 12/31/07 15,000 *
Breast Cancer
Manyu Ogale Fund Dr. Stillman 10/01/07 09/30/08 505,000 *
The G. Harold and Leila Y. Mathers Dr. Huang 07/01/07 06/30/10 194,093 *
Charitable Foundation
The Elizabeth McFarland Breast Dr. Wigler 12/01/07 11/30/08 67,158 *
Cancer Fund
The Don Monti Memorial Research Dr. Lowe 06/01/06 12/31/07 400,000 *
Foundation
The Don Monti Memorial Research Dr. Lowe 09/01/07 08/31/08 150,000 *
Foundation
Louis Morin Charitable Trust Dr. D. Spector 12/01/07 11/30/08 35,000 *
Louis Morin Charitable Trust Dr. Zador 12/01/07 11/30/08 35,000 *
Muscular Dystrophy Association Dr. Krainer 07/01/07 06/30/10 254,000 *
NARSAD Dr. Enikolopov 09/15/06 09/14/08 50,000
NYSTAR Dr. Paddison 03/01/07 02/28/09 115,957 *
Philip Morris USA Dr. Mittal 07/01/07 06/30/08 423,750 *
Philips Research North America Dr. Lucito 04/01/07 03/31/09 274,288 *
Philips Research North America Dr. Wigler 04/01/07 03/31/09 322,534 *
Diane Emdin Sachs Memorial Fund Dr. Mu 12/01/07 11/30/08 31,114 *
The Simons Foundation Dr. Mills 01/01/07 12/31/09 462,968 *
The Simons Foundation Dr. Huang 10/01/07 09/30/10 423,853 *
Debra P. Sondock Dr. Lazebnik 04/01/07 03/31/08 10,000 *
Starr Cancer Consortium Dr. Hannon 11/01/07 10/31/09 480,000 *
Starr Cancer Consortium Dr. Krainer 11/01/07 10/31/09 300,000 *
Starr Cancer Consortium Dr. Powers 11/01/07 10/31/09 378,343 *
Starr Cancer Consortium Dr. Van Aelst 11/01/07 10/31/09 240,000 *
Starr Cancer Consortium Dr. Wigler 11/01/07 10/31/09 120,000 *
Starr Cancer Consortium Drs. Powers/Lucito 11/01/07 10/31/09 300,000 *
Women in Science Dr. D. Spector 01/01/07 12/31/07 66,275 *
Women's Insurance Network of Dr. S. Muthuswamy 06/01/07 05/31/08 16,951 *
Long Island
*New grants awarded in 2007
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Fellowship Support
The Rita Allen Foundation Dr. Trotman 09/01/07 08/31/10 50,000 *
American Cancer Society Dr. Karginov 01/01/07 12/31/09 44,000 *
Arnold and Mabel Beckman Foundation Watson School of Biological Sciences 09/01/05 08/31/10 350,000
Arnold and Mabel Beckman Foundation Dr. Dubnau 09/01/05 08/31/08 88,000
Terri Brodeur Breast Cancer Foundation Dr. Chatterjee 01/01/07 12/31/08 50,000 *
C.J. Martin Fellowship Dr. Irvine 04/01/06 03/31/10 45,966
Carnegie Institution Dr. Timmermans 09/01/07 08/31/08 15,385 *
Cashin Family Fund Watson School of Biological Sciences 09/01/04 08/31/08 40,000
The Mary K. Chapman Foundation Dr. Stillman 12/01/07 11/30/08 85,000 *
CSHL Association Fellowship New Investigator Support 2007 280,000 *
The Danish Cancer Society Dr. Jensen 01/01/07 12/31/09 71,312 *
DFG (German Reasearch Council) Dr. Miething 01/01/07 12/31/08 55,000 *
Ellison Medical Foundation Dr. Chien 07/01/07 06/30/09 49,250 *
Francis Goelet Trust Dr. Wigler 10/01/05 09/30/08 64,028
The Allen and Lola Goldring Foundation Dr. Stillman 09/01/07 08/31/08 75,000 *
Heat and Stroke Foundation Dr. Boivin 07/01/06 06/30/08 38,870
Human Frontier Science Program Dr. Kasri 09/01/06 08/31/09 38,000
Organization
Human Frontier Science Program Dr. Schlach 08/01/07 07/31/08 38,000 *
Organization
Annette Kade Charitable Trust Watson School of Biological Sciences 03/01/07 02/28/09 50,000 *
Harvey L. Karp Foundation Dr. Krainer 04/01/07 03/31/08 50,000 *
The Leukemia & Lymphoma Society Dr. Krizhanovsky 07/01/06 06/30/09 50,000
The Lymphoma Research Foundation Dr. Kurland 07/01/06 06/30/08 55,000
Merck Career Development Award Watson School of Biological Sciences 01/01/07 12/31/07 20,000 *
Sir Keith Murdock Dr. Murchison 04/01/07 09/14/07 25,000 *
NARSAD Dr. Real 07/01/06 06/30/08 30,000
NARSAD Dr. Kuhlman 07/01/06 06/30/08 30,000
NARSAD Dr. Encinas 07/01/07 06/30/09 30,000 *
NYS Department of Health, Health Dr. Chen 01/01/06 03/31/08 60,000
Research Science Board, Breast Cancer
Research, and Education Program
The Robert Leet and Clara Guthrie Dr. Lima 01/15/07 01/14/09 46,000 *
Patterson Trust
The Sass Foundation for Medical Dr. Stillman 12/01/07 11/30/09 75,000 *
Research, Inc.
The Seraph Foundation, Inc. Watson School of Biological Sciences 10/01/04 09/30/08 45,000
Lauri Strauss Leukemia Foundation Dr. Pardee 02/01/07 01/31/08 15,000 *
Swartz Foundation Drs. Koulakov/Tsigankov 01/01/07 12/31/07 50,000 *
Swartz Foundation Dr. Mainen 01/01/07 12/31/07 333,333 *
Swartz Foundation Drs. Mainen/Felsen 01/01/07 12/31/07 50,000 *
Swartz Foundation Drs. Zador/Jaramillo 01/01/07 12/31/07 50,000 *
Swartz Foundation Dr. Zador/Neuro Seminar Support 01/01/07 12/31/07 15,000 *
Swartz Foundation Drs. Zador/Oswald-Pisarski 01/01/07 12/31/07 16,667 *
Uehara Memorial Foundation, Japan Dr. Kawakami 01/16/07 01/15/08 33,157 *
Vicom Computer Services, Inc./ Dr. Townsend 02/01/07 12/31/08 225,000 *
IBM Fellowship
Michel David-Weill Dr. Cline 09/01/06 08/31/09 200,000
Training Support
Cornelius N. Bliss Memorial Fund Undergraduate Research Program 2007 4,500 *
Howard Hughes Medical Institute Undergraduate Research Program 2007 7,000 *
Hunter College Undergraduate Research Program 2007 7,000 *
Steamboat Foundation Undergraduate Research Program 05/01/07 04/30/08 12,000 *
William Townsend Porter Foundation Undergraduate Research Program 04/01/07 03/31/08 10,000 *
John Xue Undergraduate Research Program 2007 500 *
*New grants awarded in 2007
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Course Support
Applied Biosystems Next-generation Sequencing 08/01/07 07/31/08 25,000 *
Autism Speaks, Inc. Workshop on Autism Spectrum Disorders 05/01/07 04/30/11 15,000 *
Duke University Medical Center Infectious Disease: A Challenge for 09/01/07 08/31/08 40,102 *
Biomedical Informatics
Howard Hughes Medical Institute Neurobiology Course Support 01/01/91 12/31/09 750,000
Illumina, Inc. Next-generation Sequencing 08/01/07 07/31/08 25,000 *
The Nancy Lurie Marks Family Workshop on Autism Spectrum 05/01/07 04/30/11 15,000 *
Foundation Disorders
Roche Diagnostics Next-generation Sequencing 08/01/07 07/31/08 25,000 *
The Simons Foundation Workshop on Autism Spectrum 05/01/07 04/30/11 15,000 *
Disorders
Meeting Support
Boston Biochem, Inc. The Ubiquitin Family 04/01/07 03/31/08 500 *
Burroughs Wellcome Microbial Pathogenesis and Host 07/01/07 06/30/08 12,000 *
Response
Foundation for the National Institutes Clinical Cardiovascular Genomics 03/01/07 02/29/08 18,710 *
of Health
454 Life Sciences Workshop on Honey Bee Genomics 01/01/07 12/31/07 3,000 *
and Biology
International Business Machines Computational Cell Biology 03/01/07 02/29/08 2,000 *
Corporation
International Vaccine Institute PDVI (Pediatric Dengue Vaccine 04/01/07 03/31/08 87,744 *
Initiative) Research Network Meeting
Roche Applied Science The Biology of Genomes 03/01/07 02/29/08 5,000 *
Roche Applied Science Workshop on Honey Bee Genomics 03/01/07 02/29/08 5,000 *
and Biology
Solexa, Inc. The Biology of Genomes 03/01/07 02/29/08 2,500 *
Syngenta Systems Biology: Global Regulation of 03/01/07 02/29/08 2,000 *
Gene Expression
University of Connecticut Health Center Computational Cell Biology 03/01/07 02/28/09 48,000 *
Library Support
Richard Lounsbery Foundation, Inc. Dr. Pollock 06/01/07 05/31/08 5,000 *
*New grants awarded in 2007
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DOLAN DNA LEARNING CENTER GRANTS
Duration 2007
Grantor Program of Grant Funding
FEDERAL GRANTS
National Institutes of Health Science Education Partnership Award: Nationwide Dissemination 08/07–07/09 $ 19,753
of Inside Cancer Internet Site
National Science Foundation Course, Curriculum, and Laboratory Instruction Progam: 09/07–08/09 10,973
Nationwide Dissemination of RNAi Curriculum
National Science Foundation Plant Genome Initiative Educational Outreach: Minority Fellows 09/04–08/07 58,517
and Regional Plant Genomics Footlockers
National Science Foundation Plant Genome Initiative Educational Outreach: Construction and 12/05–11/07 141,459
Nationwide Dissemination of Dynamic Gene Internet Site
AAAS/NSF National Science Digital Library: Meta-tagging DNALC Internet 10/05–09/09 50,868
Content for BiosciEdNet
Washington University/NSF Plant Genome Initiative Educational Outreach: Multimedia 11/05–10/08 18,337
Materials on Maize Genome Sequencing
Cornell University/NSF Plant Genome Initiative Educational Outreach: Minority 09/05–08/08 52,382
Fellows and Regional Plant Genomics Footlockers
USDA Systematic Determination of the Maize Gene Set: Educational 02/06–01/07 3,178
Outreach
NONFEDERAL GRANTS
Amgen Foundation Amgen Leadership Symposium 04/05–12/08 $ 85,233
Clemson University DNALC Licensing 2007 50,000
Dana Foundation Genes to Cognition (G2C) Online Internet Site Development 10/04–09/08 239,986
Dialog Gentechnik DNALC Licensing 2007 24,975
Goldman Sachs Foundation Harlem DNA Lab Planning 2007 50,000
Hewlett Foundation Genes to Cognition (G2C) Online Internet Site Evaluation 10/05–10/09 68,983
Howard Hughes Medical Institute Pre-College Science Education Initiative: NYC Teacher Training 09/07–08/08 21,878
North Shore–LIJ Health System DNALC West Operating Support 2007 50,000
Porter Foundation Scholarships for Minority and Disadvantaged Students 2007 30,000
The following schools each contributed $1000 or more for participation in the Curriculum Study Program:
Bellmore–Merrick Central High School District $1,250
Fordham Preparatory School 1,250
Garden City Union Free School District 1,250
The Green Vale School 2,750
Half Hollow Hills Central School District 1,250
Harborfields Central School District 1,500
Huntington Union Free School District 1,250
Island Trees Union Free School District 1,500
Jericho Union Free School District 1,500
Lawrence Union Free School District 1,250
Levittown Union Free School District 2,750
Locust Valley Central School District 1,500
Massapequa Union Free School District 1,500
North Shore Central School District $1,250
North Shore Hebrew Academy 1,500
Oceanside Union Free School District 1,500
Oyster Bay–East Norwich School District 1,250
Plainedge Union Free School District 1,500
Plainview–Old Bethpage Central School District 1,250
Portledge School 1,500
Port Washington Union Free School District 1,500
Ramaz School 2,750
Roslyn Union Free School District 2,750
South Huntington Union Free School District 1,500
Syosset Central School District 2,750
Yeshiva University High School for Girls 1,500
Allen Christian School $ 1,150
Bay Shore Union Free School District 4,675
Bellmore Union Free School District 5,400
Bellmore–Merrick Central School District 16,600
Bethpage Union Free School District 1,950
Deer Park Union Free School District 1,080
Eastern Middle School 4,950
East Meadow Union Free School District 2,297
East Williston Union Free School District 2,700
Elwood Union Free School District 3,820
Floral Park–Bellerose Union Free School District 5,400
Friends Academy 2,550
Garden City Union Free School District 7,005
Great Neck Union Free School District 13,380
The Green Vale School 1,200
Half Hollow Hills Central School District 7,125
Herricks Union Free School District 1,650
Huntington Union Free School District 6,925
Jericho Union Free School District 15,625
Lawrence Union Free School District 14,100
Locust Valley Central School District $ 8,587
Mamaroneck Union Free School District 3,600
Mattituck–Cutchogue Union Free School District 1,375
Merrick Union Free School District 1,200
Mott Hall V Middle School 2,000
North Bellmore Union Free School District 2,750
Northport–East Northport Union Free School District 1,187
Oceanside Union Free School District 1,125
Old Westbury School of the Holy Child 5,575
Oyster Bay–East Norwich Central School District 2,515
Park City Prep Charter School 1,350
Plainview–Old Bethpage Central School District 3,830
Port Washington Union Free School District 5,350
Roberto Clemente Middle School 1,000
Rockville Centre Union Free School District 11,100
Scarsdale Union Free School District 1,325
St. Dominic Elementary School 3,900
St. Edward the Confessor School 1,820
Syosset Central School District 29,625
Yeshiva Darchei Torah 1,900
The following schools each contributed $1000 or more for participation in the Genetics as a Model for Whole Learning Program:
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Duration 2007
Grantor Program of Grant Funding
FEDERAL SUPPORT
Centers for Disease Control and The Laboratory Diagnosis of Lyme Disease II 2007 $ 8,900*
Prevention (CDC)
NIH–National Institute of Allergy & The Laboratory Diagnosis of Lyme Disease II 2007 17,100*
Infectious Diseases
NIH–National Institute of Mental Health Fragile-X Syndrome and Mechanisms of Synaptic 2007 44,564*
(through a grant to University of Illinois) Translation
The National Science Foundation Design Principles in Biological Systems–2 2007 47,830*
The National Science Foundation Second Environment Ontology Workshop 2007 30,000
U.S. Department of Homeland Security Microbial Forensics: Enduring Research Pathways 2007 9,800*
NONFEDERAL SUPPORT
Meeting Support
AstraZeneca Pharmaceuticals Neurobiology of Depression: From Molecules to Mood 2007 5,000*
Boehringer Ingelheim Fonds Foundation Science—Get It Across! 2007 38,461*
for Basic Research in Medicine
The Champalimaud Foundation Champalimaud Foundation: Neuroscience and Cancer 2007 108,035*
Research
Greater NY Chapter of the ALS Association Drug Discovery, Biomarkers, and Clinical Trials for ALS 2007 44,787*
The W.M. Keck Foundation The Brain Architecture Project Annual Meeting 2007 23,964*
Eli Lilly & Company Neurobiology of Depression: From Molecules to Mood 2007 2,000*
Marsh & McLennan Companies–MMC Interdisciplinary Memory Symposium in Neurosciences 2007 5,000*
Matching Gifts to Education Program and the Humanities
Memory Pharmaceutical Corp. Neurobiology of Depression 2007 5,000*
Haig R. Nalbantian Interdisciplinary Memory Symposium in Neurosciences
and the Humanities 2007 5,000*
Open Biosystems Interactome Mapping Project for Human and Model
Organisms 2007 3,000*
OSI Pharmaceuticals, Inc. Epithelial Mesenchymal Transition 2007 19,748*
Mr. and Mrs. Howard Phipps, Jr. Interdisciplinary Memory Symposium in Neurosciences
and the Humanities 2007 10,000*
Private funding Cell Transplantation as a Therapy for Parkinson’s Disease 2007 45,944*
Private funding Retreat From Reason 2007 17,915*
Roche Pharmaceuticals Neurobiology of Depression: From Molecules to Mood 2007 10,000*
The Daniel and Joanna S. Rose Fund, Inc. Interdisciplinary Memory Symposium in Neurosciences 2007 10,000*
and the Humanities
Albert B. Sabin Vaccine Institute (with Protecting Public Trust in Immunization 2007 26,093*
support of the Robert Wood Johnson
Foundation)
The Satenik and Adom Ourian Educational Interdisciplinary Memory Symposium in Neurosciences 2007 3,000*
Foundation and the Humanities
The Selz Foundation, Inc. Interdisciplinary Memory Symposium in Neurosciences
and the Humanities 2007 1,000*
Sepracor Neurobiology of Depression: From Molecules to Mood 2007 5,000*
Alfred P. Sloan Foundation Using Bar-code Data in Studies of Molecular and 2007 45,000*
Evolutionary Dynamics
The Swartz Foundation New Frontiers in Studies of Nonconscious Processing 2007 35,956*
University of Georgia (with support of International Workshop on Conifer Genomics 2007 27,139*
Arborgen, Canadian Forest Service,
European Union Evoltree, Genome
British Columbia, Genome Canada,
Oregon State University, Port Blakeley
Tree Farms, Starker Forests, University of
California at Davis, University of Maine,
and USDA Forest Service)
Wyeth Pharmaceuticals Neurobiology of Depression: From Molecules to Mood 2007 5,000*
*New grants awarded in 2007
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It has been just over 1 year since the public announcement of Cold Spring Harbor Laboratory’s $200
million capital campaign. In that time, we have seen tremendous progress in the construction of six new
buildings, which now can clearly be seen from across the harbor. Work is currently focused on the inte-
rior portions of each building. Fund-raising for the campaign has been equally successful, with more
than $20 million raised since last year and over $150 million raised toward the goal.
In 2007, the Laboratory received a $25 million grant to support schizophrenia research, one of the
largest gifts in our history. This wonderful commitment from Vada and Ted Stanley has given our
researchers the necessary resources to tackle this debilitating disease. The second annual Double Helix
Medals Dinner was held on November 8 at the Mandarin Oriental and honored Dr. Michael Wigler, Dr.
Richard Axel, and David Koch for their extraordinary contributions to genetic disease research. The
event raised over $3 million in unrestricted funding for the Laboratory.
This year’s many advances in science could not have happened without the support of our donors.
Thank you for your commitment to scientific research and education at Cold Spring Harbor Laboratory.
Charles V. Prizzi, Vice President for Development
Cold Spring Harbor Laboratory is a nonprofit research and
educational institution chartered by the State of New York.
ScienceWatch, an independent ratings service, has ranked
the Laboratory’s molecular biology and genetics program
number one during the last decade. Additionally, Charity
Navigator, a philanthropic evaluator, has bestowed their
highest four-star rating on the Laboratory for 6 consecutive
years.
Less than half of the Laboratory’s annual revenues are
derived from Federal grants and contracts, and we rely
heavily on support from foundations, corporations, and
individuals. There are a variety of ways to give to the
Laboratory:
Capital and Endowment Campaign Support: Cold Spring
Harbor has embarked on a $200 million capital and
endowment campaign to speed the translation of genet-
ic discoveries into diagnostic and therapeutic treatments
and to expand Lab facilities and staff. Endowment gifts
can be directed toward supporting cancer, neuroscience,
or educational programs. Capital gifts can be made to
name laboratories and conference rooms in one of our six
new research buildings.
Annual Fund and Research Support: Donations provide
funding for some of the most determined and innovative
young researchers in science today. Your gift is an invest-
ment in some of the world’s best research in cancer, neu-
roscience, plant biology, and bioinformatics.
Science Education:Donations support programs at the Dolan
DNA Learning Center and the Watson School of Biological
Sciences, where the next generation of scientists learn about
genetics in an exciting and interactive environment.
Planned and Estate Gifts: Individuals who inform us of their
intention to make a gift to Cold Spring Harbor Laboratory
from their estate are invited to become members of The
Harbor Society. Estate gifts help to ensure that CSHL will
advance its mission for many years to come.
For additional information, please contact the Vice President for Development, Cold Spring Harbor Laboratory, One Bungtown
Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6865.
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President’s Council
The President’s Council is composed of individuals who gather together for stimulating scientific events
related to current CSHL research. Their contributions of $25,000 or more annually support research
and education at CSHL and help to fund the Cold Spring Harbor Laboratory Fellows, a group of excep-
tionally talented young scientists who show the capacity for high-level innovative research. Rather than
conducting a postdoctoral apprenticeship with a senior scientist, as is conventional, Fellows begin
independent research immediately following receipt of their Ph.D.s. This rigorous program promotes
outstanding young scientists to advance their careers at a young age so that they can promptly con-
tribute new insights to important biomedical science.
In April, President’s Council Members Diahn and Tom McGrath hosted a cocktail reception featur-
ing a talk by Professor Scott Lowe on Innovation, Integration, and Renewal in Cancer Research at
CSHL. The October President’s Council retreat brought together leaders in the field of RNA interference
(RNAi), including Nobel laureates Sydney Brenner and Phillip Sharp, as well as CSHL Professors Greg
Hannon and Marja Timmermans. President’s Council members learned about how the phenomenon of
RNAi can turn on and off genes, suggesting exciting new strategies to develop therapies for disease,
and had the opportunity to see the results of RNAi firsthand through experiments at the Dolan DNA
Learning Center.
President's Council Co-Chairman Dr. William
Haseltine (left) with Edward Epstein and David
Koch at the April 9 spring reception hosted by
Diahn and Tom McGrath.
Kathryn Davis and Dolan DNALC Executive Director
Dave Micklos during the fall President’s Council event.
President
Dr. Bruce Stillman
2007 Co-Chairs
Mr. and Mrs. John H. Friedman
Dr. William A. Haseltine
Mr. George F. Ohrstrom
Members
Mr. David G.P. Allan
Mr. and Mrs. Donald Everett Axinn
Mr. and Mrs. Yves C. de Balmann
Ms. Karen H. Bechtel
Mr. and Mrs. Hans Bosch
Dr. Gerald Chan
Dr. and Mrs. Lan Bo Chen
Mr. Richard Baron Cohen
Mr. Michel David-Weill
Mrs. Kathryn Wasserman Davis
Mr. David B. Ford
Mr. Jacob Goldfield
Dr. and Mrs. Leo Guthart
Mr. and Mrs. Charles E. Harris
Mr. and Mrs. J. Tomilson Hill III
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. David H. Koch
Mr. and Mrs. Bryan H. Lawrence
Mrs. George N. Lindsay
Mr. and Mrs. Thomas J. McGrath
Ms.Wendy Keys andMr. Donald A. Pels
Mr. and Mrs. John C. Phelan
Mr. and Mrs. Roderick N. Reed
Mr. and Mrs. Luis E. Rinaldini
Mr. and Mrs. David Rubenstein
Mr. and Mrs. Alan Seligson
Drs. Marilyn and James H. Simons
Mr. and Mrs. Erwin P. Staller
Mrs. Cynthia R. Stebbins
Dr. Charles L. Stone, Jr.
Dr. James M. Stone
Dr. and Mrs. Jerome Swartz
Mrs. Robert W. Tilney
Mr. and Mrs. Howard Tytel
Mr. and Mrs. Raymond L.M. Wong
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Cold Spring Harbor Laboratory Association (CSHLA)
We are grateful to the growing number of members of the Cold Spring Harbor Laboratory Association
who encourage young scientists as they endeavor to solve complicated biomedical problems with
ambitious approaches that are not yet eligible for government grants. In 2007, our annual fund goal of
$1.2 million was surpassed for a total of $1,260,000 raised by nearly 1000 members.
Laboratory Association members receive invitations to social and fund-raising events in support of
CSHL, subscriptions to our quarterly magazine The Harbor Transcript and our monthly net-letter, and
are encouraged to get to know our scientists and help to integrate them and their families into the com-
munity.
Directors
Pien Bosch, President
Timothy S. Broadbent, Vice
President
Lynn M. Gray, Vice
President
Michael S. O’Brien,
Treasurer
Lynn McGrath Tone,
Secretary
Joseph V. Amella
David L. Banker
Joyce Bertoldo
Maria L. Brisbane
Barbara Candee
Suzanne DiMaio
E. Richard Droesch
Linda Ferrante
Kate Seligson Friedman
Lori Garofalo
Larry E. Gelman, M.D.
Charles B. Goodwin, M.D.
Lauryl Palatnick
David Peikon
Jay C. Plourde
Scott J. Ratner, M.D.
Raymond G. Schuville
Pearl F. Staller
Cathy Cyphers Soref
John C. Stevenson, Ph.D.
Sandy Tytel
W. Fifield Whitman
Honorary Directors
John P. Cleary
George W. Cutting, Jr.
Mary D. Lindsay
Anne R. Meier
2007 CSHLA Directors
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Dolan DNA Learning Center Advisory Boards
The Corporate Advisory Board (CAB), established in 1992, serves the Dolan DNA Learning Center as a
bridge to the corporate community and assists in securing annual unrestricted funds. Composed of influ-
ential business leaders from large and small companies on Long Island and Manhattan, the CAB is a nec-
essary and vital component to the continued success and mission of the DNALC. The Dolan DNA Learning
Center Committee oversees the strategic development of the Center, including capital resource develop-
ment and the evolution of satellite locations in North America and beyond.
On June 19th, the DNALC held its 14th
annual golf tournament at Piping Rock
Country Club. Pictured at the event are
Don (left) and Arthur Saladino.
DNALC Corporate Advisory
Board
Edward A. Chernoff, Motors & Armatures
Inc., Chairman
Laurie Landeau, VMD, CSHL Trustee
Liaison
Michael Aboff, Aboff’s Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, Commerce Bank
Thomas J. Calabrese, Daniel Gale
Sothebys International Realty
Richard A. Catalano, KPMG, LLP
Marian Conway, Roslyn Savings
Foundation
James Chinitz, Population Diagnostics
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall Corporation
David Epstein, Ph.D., OSI
Pharmaceuticals, Inc.
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business
Products Centre
Lawrence Goodman, Curtis, Mallet-
Prevost, Colt & Mosle LLP
Mary Jane Helenek, Luitpold
Pharmaceuticals
Arthur D. Herman, Herman Development
Corporation
Diana Hoadley, JP Morgan
Robert Hoppenstedt, Bethpage Federal
Credit Union
Robert Isaksen, Bank of America
Neil M. Kaufman, Davidoff, Malito &
Hutcher
John C. Kean III, Kean Development
Corporation
Norman Kelker, Enzo Life Sciences
Robert Keller, Keyspan Foundation
Teresa Kemp-Zielenski, United Way of
Long Island
Scott Livingston, Axiom Capital,
Livingston Group
James E. Mattutat, Ingleside Investors,
Inc.
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sotheby’s
Real Estate
Frank Posillico, Rose Racanelli Realty/
Aireco
Christiaan B. Reynolds
William D. Roche
Charles R. Schueler, Cablevision
Lee Shuett, Nikon Instruments
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust
Robert Van Nostrand, AGI Dermatics
Hans Zobel, Festo Corporation
DNALC Committee
Lori Bressler
Edward A. Chernoff
Lola N. Grace
Suzanne Kleinknecht
Laurie Landeau
Suzanne Leeds
Peter Quick
Lawrence Scherr
Arthur M. Spiro
Peter Tilles
Edward Travaglianti
Marianne Dolan Weber
Dolan DNA Learning Center Corporate Advisory Board Chairman Eddie Chernoff
(seated, right) with friends at the 2007 golf tournament.
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Contributions of $5,000,000+ (lifetime)
Anonymous*
Anonymous*
Mr. and Mrs. Donald Everett Axinn*
Arnold and Mabel Beckman
Foundation
Mr. and Mrs. Landon T. Clay*
The Dart Foundation
Kathryn Wasserman Davis
The Shelby Cullom Davis
Foundation*
The DeMatteis Family Foundation*
Mr. and Mrs. Charles F. Dolan–The
Dolan Family Foundation
The William Stamps Farish Fund*
Gen*NY*sis grant from the New
York State Dormitory Authority*
The Lita Annenberg Hazen
Foundation
The W.M. Keck Foundation
David H. Koch*
Lucille P. Markey Charitable Trust
Nancy Abeles Marks*
The Quick Family*
The Robertson Family
Mr. and Mrs. Theodore R. Stanley*
The Starr Foundation*
Mr. and Mrs. Henry Wendt III*
Contributions of $100,000+
or $1,000,000+ (lifetime)
Anonymous*
Anonymous
Autism Speaks
The Breast Cancer Research
Foundation
Bristol-Myers Squibb Company
Cedar Hill Foundation*
The Mary K. Chapman Foundation
Mr. Edward A. Chernoff–Motors &
Armatures, Inc.*
Dr. and Mrs. Bayard D. Clarkson–
Clarkson Family Foundation*
Mr. and Mrs. John P. Cleary*
Mr. and Mrs. John H. Coleman*
The Dana Foundation
Mr. and Mrs. Norris Darrell, Jr.*
Michel David-Weill*
Mr. and Mrs. Henry P. Davison II–
The Perkin Fund*
Ira W. DeCamp Foundation
Estate of Norman K. Dorf*
New York State Empire State
Development Corporation*
Curt Engelhorn
The Samuel Freeman Trust
The Coleman Fung Foundation*
Robert B. Gardner, Jr.
Robert L. Garland
Drs. Joan Brooks and James
Garrels*
Robert A. Gay*
Genentech, Inc.*
Kenyon Gillespie
Francis Goelet Trust*
Dr. and Mrs. Philip Goelet*
Jacob D. Goldfield*
Florence Gould Foundation
The Grace Family
The Jerome L. Greene Foundation
Dr. Leo A. Guthart
Harrison Family Foundation*
The Thomas Hartman Foundation
for Parkinson's Research
Janet Strauss and Jeff Hawkins*
Jo-Ellen and Ira Hazan
William Randolph Hearst
Foundation*
Joan's Legacy: The Joan
Scarangello Foundation to
Conquer Lung Cancer
Annette Kade Charitable Trust
The Karches Foundation
Mr. and Mrs. John Klingenstein–The
Esther A. & Joseph Klingenstein
Fund, Inc.
Mr. and Mrs. Townsend J. Knight
The Koshland Foundation*
Laurie J. Landeau, VMD*
The Forrest C. and Frances H.
Lattner Foundation
Mr. and Mrs. Gerard Leeds*
The Lehrman Institute*
The Lessing Family Foundation*
Mary D. Lindsay*
Mr. and Mrs. Robert D. Lindsay and
Family*
The Litchfield Charitable Trust
Estate of Elisabeth Sloan Livingston*
Mr. and Mrs. David L. Luke III*
Josiah Macy, Jr. Foundation
Manhasset Women's Coalition
Against Breast Cancer
Dr. Thomas Maniatis*
The G. Harold & Leila Y. Mathers
Charitable Foundation
Mr. and Mrs. Thomas J. McGrath*
Gillian and Eduardo Mestre*
Mr. and Mrs. William R. Miller
The Don Monti Memorial Research
Foundation
New York State Office of Parks,
Recreation, and Historic
Preservation*
Jamie Nicholls and Fran Biondi*
Manyu Ogale
OSI Pharmaceuticals Foundation*
William and Maude Pritchard
Charitable Trust
V. Kann Rasmussen Foundation
Fannie E. Rippel Foundation
The Robertson Foundation*
Mr. and Mrs. David M. Rubenstein
The Sass Foundation for Medical
Research
Mr and Mrs. Alan Seligson*
The Seraph Foundation*
Dr. and Mrs. Phillip A. Sharp*
Herbert J. Siegel
Alfred P. Sloan Foundation
Howard Solomon*
St. Giles Foundation
Cynthia R. Stebbins*
Dr. and Mrs. James M. Stone*
Dr. and Mrs. Jerome Swartz–Swartz
Foundation
Waclaw T. Szybalski, D.Sc.*
Doris M. and Peter S. Tilles
Foundation*
Dr. and Mrs. James D. Watson
Dr. Norton D. Zinder*
The Roy J. Zuckerberg Family
Foundation*
Contributions of $50,000+
Anonymous*
Anonymous*
Cashin Family Fund
Mr. and Mrs. Roderick H. Cushman*
The Allen & Lola Goldring
Foundation
William and Flora Hewlett
Foundation
The Karp Foundation, Inc.
F.M. Kirby Foundation
Mr. and Mrs. Bryan H. Lawrence
Margaret and Richard Lipmanson
Foundation
Breast Cancer Awareness Day in
memory of Elizabeth McFarland
Louis Morin Charitable Trust
Dr. Thomas C. Nelson
Louise Parent and John Casaly
Mr. and Mrs. John C. Phelan
Mr. and Mrs. Luis E. Rinaldini*
Estate of Mary Vander Poel Russell*
Contributions of $25,000+
Arrow Electronics, Inc.
Karen H. Bechtel
Mr. and Mrs. Hans E.R. Bosch
Dr. Gerald Chan–The Morningside
Foundation
CBS Corporation
Richard Baron Cohen
Daniel Gale Sotheby's International
Realty
Mr. and Mrs. Yves C. de Balmann
The Eppley Foundation for
Research, Inc.
F.A.C.T. (Find A Cure Today)
David B. Ford
Mr. and Mrs. John H. Friedman
Joni Gladowsky Breast Cancer
Foundation
Robert I. Goldman Foundation
Mr. and Mrs. Joseph Gregory
Mr. and Mrs. Charles E. Harris II
Honor Roll of Donors
Dr. Michael Wigler (left) and Dr.
Richard Axel (right) receive their
Double Helix Medals from CSHL
Honorary Trustee Evelyn Lauder and
President Dr. Bruce Stillman.
CSHL Trustee Jamie Nicholls (cen-
ter) and her husband Fran Biondi
are pictured with Sophie Ayres at
the Double Helix Medals Dinner.
Jamie and Fran were co-chairs of
the event.
*Gift or pledge made to the Hillside Campus Campaign 2003–2007
CSHL Chairman Eduardo Mestre
with his wife Gillian (center) and
Laboratory Trustee Louise Parent at
the Double Helix Medals Dinner.
Double Helix Medal recipient David
Koch pictured with (left to right) CSHL
Honorary Trustee Evelyn Lauder,
Amanda Haynes-Dale, and Julia Koch.
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William A. Haseltine, Ph.D.
Islip Breast Cancer Coalition
Mr. and Mrs. Michael Kennedy–The
Shana Alexander Charitable
Foundation
Mr. and Mrs. Walter B. Kissinger
Lehman Brothers
The Lehman Brothers Foundation
L.I.A.B.C. (Long Islanders Against
Breast Cancer)
Long Island 2-Day Walk to Fight
Breast Cancer, Inc.
Marcia Kramer Mayer and Michael
Eisenbud
Mr. and Mrs. Douglas P. Morris
George Ohrstrom
Abby and George O'Neill Trust
OSI Pharmaceuticals, Inc.
Pall Corporation
William Townsend Porter Foundation
Dr. and Mrs. Mark Ptashne–Joe
Lewis Jefferson Foundation*
Diane Emdin Sachs Memorial Walk
Mr. and Mrs. Irwin Sicherman, O.D.
Mr. and Mrs. Erwin P. Staller
Mr. and Mrs. James F. Stebbins
Mrs. Robert W. Tilney, Jr.
Mr. and Mrs. Howard J. Tytel
Edwin S. Webster Foundation*
Mr. and Mrs. Raymond Wong
YM BioSciences, Inc.
Contributions of $10,000+
The Bahnik Foundation
Joyce Bertoldo and Michael Griffin
Breast Cancer Help, Inc.
Mr. and Mrs. Bill Bresnan
Brinkmann Instruments/Eppendorf
North America
Brownstone Agency, Inc.
Mr. and Mrs. Thomas J. Calabrese,
Jr.*
Mr. and Mrs. John P. Campbell–The
Ada Howe Kent Foundation
Canon Communications–Charles
McCurdy
Mr. and Mrs. John K. Castle
Centerbrook Architects and
Planners, LLC
Columbia University Medical Center
Cravath, Swaine & Moore LLP
The Tarrant & Laura C. Cutler
Charitable Trust
Mr. and Mrs. George W. Cutting, Jr.
Mr. and Mrs. Jack DiMaio, Jr.
Mr. and Mrs. E. Richard Droesch–
Florence Corporation
The William Ewing Foundation
Fortunato Sons Contracting, Inc.
Lori and Stephen Garofalo
Dr. and Mrs. Charles B. Goodwin
Lola and John Grace
Mr. and Mrs. Oliver R. Grace,
Jr.–OBX
Mr. and Mrs. Randall Hack
The Irving A. Hansen Memorial
Foundation
Elaine Hayes Special Effects Salon
Mr. and Mrs. Brian Higgins
Mr. and Mrs. Francis J. Ingrassia
Drs. Nancy and Ron Israeli
Thomas Campbell Jackson
The Kapp Family Foundation
Mr. and Mrs. David M. Knott
The Korein Foundation
Mr. and Mrs. Richard Leeds
Little Louie Foundation
The Litwin Foundation
Mr. and Mrs. Daniel Loeb
Luitpold Pharmaceuticals Inc.
Mrs. David Mahoney
Nancy Lurie Marks Family
Foundation
Merck Research Laboratories
Morey Family Foundation
New York Presbyterian Hospital
Mr. and Mrs. Louis J. Nicastro
Mr. and Mrs. Frank T. O'Keefe
Susanne C. Olin
John G. Passarelli, M.D.
Mr. and Mrs. Howard Phipps, Jr.
The Honorable and Mrs. Leon Polsky
Thomas C. Quick
Roderick N. Reed
Mr. and Mrs. John R. Reese*
Mr. and Mrs. Owen T. Smith
Deborah K. Solbert
Debra Parmet Sondock
Mr. and Mrs. Douglas S. Soref
Steamboat Foundation
Lauri Strauss Leukemia Foundation
Textor Family Foundation
Mr. and Mrs. Stanley S. Trotman, Jr.*
Wendy and Yichwan Wang
Fifield and Heather Whitman
Mr. and Mrs. Richard H. Witmer, Jr.
Women's Insurance Network of
Long Island
Mark and Karen Zoller
Contributions of $5,000+
Mr. and Mrs. Lee S. Ainslie III
Mr. and Mrs. Joseph V. Amella
Ashner Family Evergreen Foundation
AKF Engineers, LLP
Glenn R. August
Mr. and Mrs. W. Dillaway Ayres, Jr.
Bank of America, Long Island
Nicholas J. Bartilucci–Dvirka &
Bartilucci Consulting Engineers
Mr. and Mrs. Rodney B. Berens
Daniel Berlin
Bethpage Federal Credit Union
Maria L. Brisbane
Mrs. Harry A. Brooks
Mr. and Mrs. William J. Candee III
CSHL Chancellor Emeritus Dr.
James Watson (left) with Laboratory
Trustee David Rubenstein at the
Double Helix Medals Dinner.
On October 12, the renovation of the Carnegie building officially
began with a groundbreaking ceremony. Pictured (left to right)
are Library Director Mila Pollock, Dr. Waclaw Szybalski, Dr.
James Watson, Laurel Hollow Mayor The Honorable Harry
Anand, and Laboratory President Dr. Bruce Stillman.
On January 28, the CSHL
Association held its annual meeting,
which featured a talk by Dr. Philip
R. Reilly, author of The Strongest
Boy in the World. Pictured are
CSHLA Honorary Director George
Cutting and Laboratory Honorary
Trustee Mary Lindsay.
The 9th Annual Jazz at the Lab was held on April 14. Pictured at the event
are (left to right) CSHL Association Director Lauryl Palatnick, Kerry and Andy
Glanz, Rob Palatnick, Elizabeth and Rob Bailenson, and Saul and Lynn
Federman.
440 *Gift or pledge made to the Hillside Campus Campaign 2003–2007
421-452_LAR_grants_finances:407-442_FINANCIAL  5/28/08  11:00 AM  Page 440
441
Dr. Mary Ann Cardile and Dr. Gerald
A. Weber
Commerce Bank
Crest Hollow Country Club
Mr. and Mrs. Richard T. Cunniff
Mr. and Mrs. Mark DeGennaro
Mr. and Mrs. David H. Deming
Dilworth & Barrese, LLP
Mr. and Mrs. Michael J. DiMaio
Mr. and Mrs. Joseph T. Donohue
Mr. and Mrs. Robert W. Fagiola
Mr. and Mrs. John S. Friedman
William F. Gerry
Robert J. Glaser, M.D.*
Mr. and Mrs. William H. Grover
Mr. and Mrs. Martin D. Gruss
Mrs. John W. Hadley
Hearts for Cancer
JPMorgan Chase & Co.
Mr. and Mrs. Richard P. Kleinknecht
Mr. and Mrs. John D. Kousi–
Eastwind Maritime, Inc.
KPMG, LLP
The Fay J. Lindner Foundation*
Richard Lounsbery Foundation
Marc Lustgarten Pancreatic Cancer
Foundation
Mr. and Mrs. John Macaskill
Mr. and Mrs. Robert P. Lynn III
Carol Marcincuk Ovarian Cancer
Research Fund
Joyce and Robert Marcus
Marsh, Inc.
Gary Melius–The Elena Melius
Foundation
Mr. and Mrs. John Robinson Miller IV
Summer Hope Foundation–Ed
Mouradian
Nastech Pharmaceutical Company,
Inc.
National Maintenance Supplies, Inc.
Mr. and Mrs. Michael S. O'Brien
William C. and Joyce C. O'Neil
Charitable Trust
Mr. and Mrs. Michael C. Pascucci
Dr. and Mrs. John E. Postley–The
New York Physicians
Foundation, Inc.
Mrs. Richardson Pratt, Jr. and
Family
Preston V. Pumphrey
Lewis S. Ranieri
The Rathmann Family Foundation
Mr. and Mrs. Leonard Rivkin
Mr. and Mrs. Henry E. Salzhauer–
Salzhauer Family Fund
Judi Shesh Memorial Foundation
Walter and Monica Noel Family
Foundation–Ariane Sodi
Sovereign Bank
Mr. and Mrs. Oliver Stanton
Lee Steinberg
Mr. and Mrs. Alan C. Stephenson
Dr. and Mrs. Bruce W. Stillman
The Tilles Family Foundation
U.S. Trust Company
Mr. and Mrs. Paul A. Vermylen, Jr.
Marjorie M. von Stade
Mr. and Mrs. Albert Weis
West Islip Youth Enrichment
Services
Contributions of $2,500+
All Pro Carpet Co., Inc.
Mr. and Mrs. Robert H.B. Baldwin
The Banfi Vintners Foundation
Mr. and Mrs. David L. Banker
Richard A. Bernstein
The Cornelius N. Bliss Memorial Fund
Mr. and Mrs. Timothy S. Broadbent
Mr. and Mrs. W. Russell Byers, Jr.
Dr. Michelle Gerwin Carlson and Mr.
Scott Carlson
Mr. and Mrs. George W. Carmany III
Mr. and Mrs. Frank Castagna–Fifth
Avenue of L.I. Realty Association
Ms. Bernadette Castro and Dr. Peter
Guida
Mr. and Mrs. James J. Celestino
Jane H. Choate
Mrs. Robert L. Clarkson, Jr.
Clear Channel Worldwide–WALK 97.5
James W. Cleary
Dr. and Mrs. Struan H. Coleman
Mr. and Mrs. James C. Cook
Curtis, Mallet-Prevost, Colt & Mosle,
LLP
Andrea Rizzo Cuvelier
Robert de Rothschild
Enzo Life Sciences, Inc.
Mr. and Mrs. Frank Feinberg
Brandon Fradd
The Leonard Friedland Charitable
Foundation
Mr. and Mrs. Thomas S.T. Gimbel
Rosalyn C. Gordon
Lori Grace
Mr. and Mrs. Austen T. Gray, Jr.
The David and Alan Greene Family
Foundation, Inc.
Mr. and Mrs. Gordon S. Hargraves
Mr. and Mrs. Mitchell Hauser
Richard C. Hazlewood
Thomas and Margaret Healey–The
Healey Family Foundation
Arthur D. Herman–Herman
Development Corporation
Christopher and Cathy Hogg
Huntington Business Products
Centre, Inc.
The Stanley R. and Elisabeth G.
Jacobs Foundation
Barclay G. Jones III
Andrea B. and Peter D. Klein
Steven B. Klinsky
The Lauder Foundation–Leonard
and Evelyn Lauder Fund
The Shirley B. and Eugene J. Levitt
Fund
Mrs. Georgie W. Lewis
David M. Livingston, M.D.
Long Beach Breast Cancer Coalition
Maclean Family Trust
Mr. and Mrs. Clarence F. Michalis
Mr. and Mrs. David B. Miller
Keith M. Moffat
Nikon Instruments, Inc.
Oxford & Simpson Realty Services,
Inc.
Pabco Construction Corporation
Lauryl and Robert Palatnick
David P. Pearson
Pictured (left to right) are Bob Hussey, David Knott, and Tom Gimbel at Jazz
at the Lab.
Pictured (left to right) are Michael and Jackie Shapiro, Larry and Jessica
Glassman, Nancy and Ron Israeli, and Marcie and Jeff Kaiser at Jazz at
the Lab.
Pictured (left to right) are Norris Darrell, Charles Goodwin, Henriette Darrell,
and Anne Goodwin at the CSHL Association’s annual meeting.
*Gift or pledge made to the Hillside Campus Campaign 2003–2007
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Paintings by David Peikon, Ltd.
Mr. and Mrs. Robert S. Pitts
Frank Posillico
Mr. and Mrs. William S. Post
Drs. Marjorie Van de Stouwe and
Scott Ratner
Mr. and Mrs. Christian B. Reynolds
Mr. and Mrs. Raymond G. Schuville
Mr. and Mrs. Angelo Silveri
Mr. and Mrs. Ian Kendall Wheeler
Snow
Mr. and Mrs. Arthur M. Spiro
Kathleen and Jim Szymanski
Mr. and Mrs. Pascal Franchot Tone
United Healthcare
Vance Van Dine
Dr. and Mrs. Robert Vizza
Mr. and Mrs. John E. Welsh III
Dr. and Mrs. Reed Wickner
Marilyn Monter and Wilfried
Witthuhn
Diane and Howard Wohl Family
Foundation
Mr. and Mrs. James A. Woods
Contributions of $1,000+
Anonymous
Aboff's Paints & Wallcoverings
Advantage Title Agency, Inc.
Mr. and Mrs. Mohamed Farrag
Ahmed
Dr. Bruce Alberts
Mr. and Mrs. Robert H. Arnow
Mr. and Mrs. Henry D. Babcock
Mr. and Mrs. Carter Bales
Dr. and Mrs. Arthur M. Bernhang
Catherine Cahill and William
Bernhard
Pam and Gene Bernstein–PGJM
Foundation
Mr. and Mrs. Xerxes K. Bhote
Mr. and Mrs. John J. Bingham
Jane K. Boorstein
David Botstein and Renee Fitts
Dr. William Braden III–Porter Braden
Endowment Fund
Bressler Family Foundation
John Britton
Scott A. Broadbent, Jr.
Frank Brunckhorst
James and Barbara Brundige
Mr. and Mrs. George Bullen
Mr. and Mrs. Daniel J. Cahill
Callan, Koster, Brady & Brennan,
LLP
Ann and Peter Cannell
Robert B. Catell
Charles Henry Leach II Foundation
Mr. and Mrs. Harry Charlston
Mr. and Mrs. Robert W. Chasanoff
Mr. and Mrs. David C. Clark
Dr. and Mrs. John Coffin
Drs. Joan and Peter Cohn
Caroline V. Coleman
Cortel Business Solutions, Inc.
Mr. and Mrs. Curtis Cushman
Peter and Connie Dagher
Charles A. Dana III
Davidoff Malito & Hutcher, LLP
The Davidson Family Foundation
Mr. and Mrs. Guy L. de Chazal
Mr. and Mrs. Daniel C. de Roulet
Brenda Earl and Michael DePaola
Foundation
Dr. Lester Dubnick
Mrs. William T. Dunn, Jr.
Earle I. Mack Foundation,Inc.
Julie C. Eichenberger
Mrs. James A. Eisenman
Mrs. Duncan Elder
Electronix Systems Central Station
Alarms, Inc.
Martin Elias
John and Lisa Evans
Mr. and Mrs. Donald M. Eversoll
Farad Construction Inc.
Dr. Robert J. Feeney
Festo Corporation
Mr. and Mrs. Roger Fradin
G & M Earth Moving, Inc.
E. Maxwell Geddes, Jr.
Catherine A. Gellert
Mr. and Mrs. Edward M. Giles
Glen Cove C.A.R.E.S.
Dr. and Mrs. Walter L. Goldschmidts
Rich and Mindy Gordon
Mr. and Mrs. Robert M. Grace
Dorrance H. Hamilton–Hamilton
Family Foundation
Reverend Linda Peyton Hancock
Henry U. Harris, Jr.
Walter H. Haydock
Amanda H. Haynes-Dale
Gil and Sheila Henoch
Meghan Henson and Chris Sauer
William A. Herzog
Thomasina and Joe Heyenoort–Cold
Spring Motors
William H. Heyman and Wendy Dietze
James Hicks, Ph.D.
Dr. Mark Hoffman*
Mrs. Albert L. Hoffman
Dr. Eric Hunter
Mr. and Mrs. Robert F. Hussey
Joan M. Hutchins
Waldo and Carol Hutchins
Frederic B. Ingraham
Mr. and Mrs. Clarke Keough—
Donald and Marilyn Keough
Foundation
Geoffrey D. Kimball
Thomas Korossy
Mr. and Mrs. Cary A. Kravet
Eduardo and Consuelo Lacroze
Mr. and Mrs. Gordon E. Lamb
Mr. and Mrs. Edward M. Lamont
Carol and Jim Large
Jerome M. Le Wine
Long Island Alzheimer's Foundation
Mr. and Mrs. Patrick H. Mackay
Mr. and Mrs. Alan B. Marks
Mr. and Mrs. John Maroney
Jim Mattutat–A.C. Israel Foundation
Jennifer Jordan McCall–The Hope
and Norman Hope Foundation
Faith H. McCurdy
Carol McFadden
MetLife
Kazie Metzger and John C. Harvey
Mr. and Mrs. David A. Micklos
Mr. and Mrs. Sidney A. Miller
Mintz Levin Cohn Ferris Glovsky &
Popeo
Leo Model Foundation
Kathleen A. Mooney
Thomas J. Morley, M.D.
Moxie Pictures, Inc.
Mr. and Mrs. Stephen V. Murphy
Mr. and Mrs. Francis W. Murray III
Richard P. and Faye Nespola
Charitable Foundation
Norwood Foundation
Ruth Nussdorf
The Olian Foundation
Peter M. O'Neill
Barry M. Osborn
OSIA NYS Grand Lodge Foundation
Mr. and Mrs. Richard S. Overton
Rhoda Parmet
Mr. and Mrs. Douglas L. Paul
Mr. and Mrs. Nicholas B.
Paumgarten
Joyce and John Phelan
Philips Research USA
Mr. and Mrs. Howard Phipps III
Mr. and Mrs. Robert A. Pilkington
Mr. and Mrs. Grant A. Porter
George and Carol Pratt
Mr. and Mrs. James P. Regan
George Roche
Mr. and Mrs. Arthur M. Rogers, Jr.
Daryl and Steven Roth
Miriam K. Rothenberg
Mr. and Mrs. J. Wright Rumbough,
Jr.
Jason Gladowsky (left) with his sister Alison and father Elliott as they present a
check from the Joni Gladowsky Foundation to Laboratory scientist Dr. Senthil
Muthuswamy. The foundation was started in memory of their mother/wife, Joni,
who lost her battle against breast cancer.
*Gift or pledge made to the Hillside Campus Campaign 2003–2007
Women's Partnership for Science luncheon Co-Chairs Mary Snow, Blair Husain,
Kristina Perkin Davison, Elizabeth Ainslie, Anne Byers, and Nancy Tilghman.
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Mr. and Mrs. Daniel Salomone
Roger Hugh Samet
Mr. and Mrs. Peter G. Schiff
Howard Schliff
Steven and Eileen Schlussel
Mr. and Mrs. Enrique F. Senior
Lee and June Shuett
Mary F. Smith Family Foundation
Mr. and Mrs. James L. Spingarn
Shirley Steere
Carmella L. Stephens
Dr. and Mrs. John C. Stevenson
Mr. and Mrs. Jeffrey T. Stevenson
Ronald Swanstrom
Daniel M. Carbone–Syosset
Limousine Service
Judith and Irwin Tantleff
Ann K. Thompson and James C.
Childress
Mr. and Mrs. Harold J. Thompson
Helene P. Victor
Walter B. James Fund No. 2
Mr. and Mrs. Douglas A. Warner III
Mr. and Mrs. Richard C. Webel
Mr. and Mrs. Richard Weir III
Mr. and Mrs. Karl G. Wellner
Mrs. Taggart Whipple
Gerald I. White
Robert E. Wittes, M.D.
Mayer Wolf
Mr. and Mrs. Irwin Young
Contributions of $500+
Joan Taub Ades and Alan M. Ades
Albanese Organization, Inc.
Arne and Bonnie Arnesen
Vahan Ayvazian
Mr. and Mrs. Robert A. Bailenson
Harriet W. Bailey
Mr. and Mrs. John Barry
Kendra D. Block
Mr. and Mrs. Peter H. Blohm
Mr. and Mrs. George H. Bostwick, Jr.
Rosemary Bourne
Dr. Stephen Brand
Dr. Charles Buntschuh and Joan Caly
Mr. and Mrs. Howard Butnick
Martha M. Osterhus Carlstrom
Dr. Susan L. Carpenter
Mr. and Mrs. Piero Casalicchio
Rita Chang and Bill Quinlan
Eleanor Chernick, Ed.D.
Dr. Francois Clavel
Fred Colin–Simon and Eve Colin
Foundation, Inc.
Barry and Donna Cosel-Pieper
Michael Creem
Jerry M. Cudzil
Mr. and Mrs. Stefan H. Cushman
D. Reis Furniture Mfg. Corp.
Stewart W. Davis
Patrick S. DePippo, MD
Rosamond A. Dean
Diamondston Foundation
Carolyn C. Dilworth
Mr.and Mrs. Nelson Doubleday
Mr. and Mrs. Kostas Douzinas
Lee MacCormick Edwards, Ph.D.
Dr. John H. Elder
Mr. and Mrs. Christopher Elkus
Dr. Michael Emerman
Christopher and Lisa Engel
Thomas Eschmann
Mr. and Mrs. Saul D. Federman
Dolores Fredrich and Jeffrey Keller
Dr. and Mrs. Candido E. Fuentes-Felix
Richard Gachot
Mr. and Mrs. William C. Gay, Jr.
Harriet C. Gerard
Mr. and Mrs. Andrew Glanz
Dr. Stephen P. Goff
Mr. and Mrs. Pierre A. Gonthier
Dr. Warner C. Greene
Dr. and Mrs. Ronald J. Gulotta
Mr. and Mrs. Frank Gundersen
Mr. and Mrs. Harold W. Hawkey
Edward and Jeannine Heaney
Dr. Christopher P. Hill
Dr. and Mrs. Thomas J. Hope
Mr. and Mrs. Frank A. Huerta
The Iovino Family Foundation
Susan Isaacs and Elkan
Abramovitz
Dr. Kathryn Jones
Dr. Richard A. Kaplan
Dr. and Mrs. Norman Kelker
Mr. and Mrs. Jeffrey E. Kelter
Mr. and Mrs. Roy S. Klein
Landscapes by Jeffco, Inc.
Pamela T. LeBoutillier
Lewisy Fuel Oil, Inc.
Mr. and Mrs. Robert V. Lindsay
George N. Lindsay, Jr. and Nancy
Metz
Mr. and Mrs. Luke D. Lynch, Jr.
Mr. and Mrs. Robert G. MacLean
Kevin G. Mahony
Massachusetts Institute of
Technology
Mr. and Mrs. Mark Mayoka
Nancy Mazarin
Linda H. McLaughlin
Mr. and Mrs. Paul M. McNicol
Meenan Oil Company, L.P.
Mr. and Mrs. Arthur I. Mendolia
Dr. and Mrs. Jeffrey H. Miller
Mr. and Mrs. Phil Mittleman
Mr. and Mrs. Donald A.
Morrongiello
Mr. and Mrs. Roger T. Mullarkey
Myron M. Studner Foundation
Dr. Jeanne M. Nerbonne
Mr. and Mrs. Vincent R. Nesi, Jr.
Mr. and Mrs. Frank J. Olt, Jr.
Olmstead Family
Mr. and Mrs. Stephen Orent
The Anthony & Claire Pace
Foundation, Inc.
Mr. and Mrs. Luis J. Paniagua
Mr. and Mrs. C. Allen Parker
Dr. and Mrs. Anthony Piazza
Jeanne and Whitney Pidot
Mr. and Mrs. John Gardiner Pieper
Leila C. Pile
Praxis Public Relations, Inc.
Nicole and Charlie Prizzi
Marina S. Purcell
Mr. and Mrs. Alex Quentin
Curtis and Louise Read
The Richard Foundation
Mr. and Mrs. William D. Roche
The Rosenstiel Foundation
Pamela and Richard Rubinstein
Drs. Maria and Charles Ryan
Mr. and Mrs. Francis Scricco
Louise and Jonathan Sehring
John and Pat Sheehy
Dr. H.R. Shepherd–Sabin Vaccine
Institute
Silvercup Studios
Mary and George Simko
Mr. and Mrs. Howard R. Simpson
Keith Simpson
The Honorable and Mrs. Eliot L.
Spitzer
Mr. and Mrs. Robert E. Spring
St. John's Church
Sterling Monroe Securities, Llc
Penny Maureen Stern, M.D.
Byam K. Stevens, Jr.
Steven Stolman and Jack Young
Nancy B. Taylor
Mr. and Mrs. David H. Taylor, Jr.
Dr. Alice P. Telesnitsky
Nick Tricouros
Mr. and Mrs. Godfrey G. Truslow
John B. Vermylen
F. Skiddy von Stade III
Dr. Leslie B. Vosshall
Mr. and Mrs. Colton P. Wagner
Mr. and Mrs. Thomas J. Walsh
Mr. and Mrs. Lewis M. Warren, Jr.
Townsend U. Weekes and Diana
Collins
Dr. Kevin M. Weeks
F. Helmut Weymar
Douglas Williams
Dr. and Mrs. Eckard Wimmer
Eunice Johnson Winslow
Mr. and Mrs. John Wright
Mr. and Mrs. Frank F. Zerilli
*Gift or pledge made to the Hillside Campus Campaign 2003–2007
Breast Cancer Help and Sons of Italy present a check to CSHL scientist
Dr. Raffaella Sordella for her cancer research.
The Don Monti Memorial Foundation has been supporting Dr. Scott Lowe's
cancer research since 2006. Pictured (left to right) are CSHL Trustee Ed
Travaglianti, Richard Monti, Arthur Saladino, Caroline Monti Saladino, CSHL
President Dr. Bruce Stillman, Anna Travaglia, and Dr. Scott Lowe.
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IN HONOR OF
Sylvia Atkins
Kaila Barker
Carter Biondi
Phillipine Bosch
Jane L. Carter
Lucy and George Cutting
DNA Boot Camp Summer Class of
2004
DNALC Staff
Lynn Folley
Bernard Gartlir
Grosmami
Arthur Herman
Helene Herzig
Lisa Hufnagel
Ben Israeli
Nathan Jaitlin
Jenny Li-Chun Lin
Mary D. Lindsay
Dr. Scott Lowe
Stacy McCabe
Dr. W. Richard McCombie
Olmstead Family
David Peikon
Dr. Marcia Robbins–Wilf and Dr. Perry
Robbins
Henry Salzhauer
Jordan Siev
J. Craig Venter
Katherine Von Stade
Reverend and Mrs. David J. Ware
Dr. James D. Watson
Dr. Michael Wigler
Laurie Wolfert
JinLan Lui and Ben Ming Zhang
Dr. Yi Zhong
Phoebe, Sophia, Olivia, and Chloe
American Express
Amgen
Analect, LLC
Bristol-Myers Squibb Foundation, Inc.
Compu-Tech Software Services, Inc.
The Michael and Susan Dell Foundation
Dow Jones & Company, Inc.
Forest Laboratories, Inc. Matching Gift
Program
Honeywell Matching Gifts Program
iStar Financial, Inc.
The J.P. Morgan Chase Foundation
Marsch & McLennan
McKinsey & Company, Inc.
The Meredith Corporation Foundation
Merrill Lynch & Co., Inc.
The Millipore Foundation
David and Lucile Packard Foundation
Pfizer Foundation Matching Gifts
Program
Select Equity Group, Inc.
United Way of New York City
Verizon Foundation
WellPoint Foundation
XI Global Services, Inc.
CORPORATE AND FOUNDATION MATCHING GIFT CONTRIBUTORS
IN MEMORY OF
William Appleby
Neil and Eileen Begley
Robert Bellospirto
Cecilia Benevisto
Joseph Betz
Paul Breslow
Doris Brisbane
Gerard X. Brogan, Sr.
Christine Cataldo
Henry Clark
Thomas Doherty
Norman K. Dorf
Evelyn Emdin
Marvin E. Frankel
Nancy Slaughter Gay
Martha Gerry
Joni Gladowsky
Dr. Christopher G. Goff
Neal Goldberg
Robert I. Goldman
Allen Goldring
Father Emmanuel Gratsias
Brad Herman
Morton Hertzlinger
Peggy Hobbs
Frederick H. Janson
Harold Kammerer
Dr. Andy Kaplan
Dr. Larry Katz
Luitgard Kiefer
Edward C. Kramer
Claire Landau
Susan Leddy
Barbara Leeds
Rob Lindsey
Candido Llovera
Michael P. Lynam
Lisa MacInnes
Beatriz Madero
John Marcin
Carol Marcincuk
Dr. Egon Mayer
Elizabeth McFarland
Nancy Mitchell
Don Monti
Barbara Muney
William E. Murray
Mrs. Newmark
Donald J. Parmet
Carole Pearson
Terry Petikas
Dr. Cecile Pickart
Julie and Billy Porter
Lydia and Christopher Reeves
Mary Ellen Regan
Jack Richards
Fanny Lopez Arenas de Rinaldini
John Romer
Susan Rose
Lynn Roughgarden
Diane Emdin Sachs
Karen Sachs
Robert Schwartz
Andrew Seligson
Dr. Robert Shpuntoff
Jerry Sobelson
Mitchell Sokal
Betty Starr
Becky Stephens
Phyllis Studner-Grant
Dr. Michael Tepedino
Ruth Weinstein
Rose Marie Wilson
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CORPORATE SPONSOR PROGRAM
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory
campus or at the Banbury Center. Without the strong foundation provided by the Program, we could
neither plan with confidence for the year’s meetings nor introduce new and unusual topics. We, and all
of the scientists who attended meetings at Cold Spring Harbor Laboratory, are very grateful to our
sponsors.
The members of the Program receive special privileges in acknowledgment of their contributions. We
waive all on-site fees for 16 representatives of the Corporate Benefactors and eight representatives of the
Corporate Sponsors at our meetings. In 2007, no fewer than 24 meetings took place in Grace Auditorium.
Six and three scientists, respectively, from Benefactors and Sponsors may attend meetings at the
Banbury Center, where attendance is otherwise only by invitation of the organizers. Member companies
receive gratis copies of Cold Spring Harbor Laboratory Press publications, including the journals Genes
& Development, Learning & Memory, Protein Science, Genome Research, and RNA. We acknowledge
our Sponsors in all relevant publications, including the books of abstracts given to each of the 7000 par-
ticipants who come to the meetings each year. The names of the sponsoring companies are listed on the
poster describing the meetings, and this is mailed to approximately 17,000 scientists throughout the
world. In addition, the companies are listed on the Cold Spring Harbor Laboratory Web site on the
Meetings Office and Banbury Center pages. Members in 2007 were:
CORPORATE PATRONS
Pfizer Inc.
CORPORATE BENEFACTORS
Amgen Inc.
GlaxoSmithKline
Merck Research Laboratories
Novartis Institutes for BioMedical Research
CORPORATE SPONSORS
Applied Biosystems
AstraZeneca
BioVentures, Inc.
Bristol-Myers Squibb Company
Genentech, Inc.
Hoffmann-La Roche Inc.
Kyowa Hakko Kogyo Co., Ltd.
New England BioLabs, Inc.
OSI Pharmaceuticals, Inc.
Sanofi-Aventis
Schering-Plough Research Institute
PLANT CORPORATE ASSOCIATES
Monsanto Company
Pioneer Hi-Bred International, Inc.
FOUNDATIONS
Hudson-Alpha Institute for Biotechnology
CORPORATE AFFILIATES
Abcam Ltd.
Agilent Technologies, Inc.
USB Corporation
CORPORATE CONTRIBUTORS
Cell Signaling Technology
Epicentre Biotechnologies
Illumina Inc.
Millipore
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RESEARCH
David L. Spector
Director of Research
Walter L. Goldschmidts
Executive Director, Sponsored
Programs
Professors
Hollis Cline
Gregory Hannon,* Program
Chair, Bioinformatics/
Genetics
David Jackson
Leemor Joshua-Tor
Adrian Krainer
Yuri Lazebnik
Scott Lowe,* Program Chair,
Cancer and Molecular
Biology
Roberto Malinow, Program
Chair, Neuroscience
Robert Martienssen
W. Richard McCombie
Partha Mitra
Lincoln Stein
William Tansey
Nicholas Tonks
Linda Van Aelst
Michael Wigler
Anothony Zador
Michael Zhang
Yi Zhong
Associate Professors
Grigori Enikolopov
Z. Josh Huang
Zachary Mainen
Alea Mills
Senthil Muthuswamy
Scott Powers
Jacek Skowronski
Arne Stenlund
Marja Timmermans
Assistant Professors
Joshua Dubnau
Hiroyasu Furukawa
Adam Kepecs
Alexei Koulakov
Robert Lucito
Vivek Mittal
Jonathan Sebat
Raffaella Sordella
Lloyd Trotman
Glenn Turner
Research Assistant
Professor
Matthew Vaughn
Director, Research
Operations
Sydney Gary
Senior Computer
Scientists
Alexander Krasnitz
Lakshmi Muthuswamy
Ravi Sachidanandam
Boris Yamrom
Computer Scientist
Aleksandr Genkin
Cold Spring Harbor
Fellow
Patrick Paddison
Senior Research
Investigator
James Hicks
Research Investigators
Kenneth Chang
Eric Enemark
Diane Esposito
Tatyana Michurina
David Mu
Natalia Peunova
Michael Regulski
Mona Spector
Zhenyu Xuan
Adjunct Professors
Ann-Shyn Chiang
Peter D’Eustachio
Karel Svoboda*
Timothy Tully
Adjunct Associate
Professors
Carlos Brody
Dmitri Chklovskii
Adjunct Assistant
Professors
Wolfgang Lukowitz
Mirjana Maletic-Savatic
Doreen Ware
Visiting Professor
Matthew Ridley
Visiting Scientists/
Collaborative Scientists
Michael Caudy
Aniruddha Das
Nevenka Dimitrova
Thomas Gingeras
Hiroaki Hagiwara
Sitharthan Kamalakaran
Seung Jun Kim
Cordula Schulz
Yalin Wang
Senior Fellow
Jose Silva
Senior Clinical Fellow
Lars Zender
Postdoctoral Fellows
Victoria Aranda Calleja
Alexey Aravin
Anindya Bagchi
Martin Bayer
Yoselin Benitez Alfonso
Jennifer Bestman
Uli Bialuca
Benjamin Boettner
Benoit Boivin
Hemant Bokil
Peter Bommert
Daniel Bouyer
Julius Brennecke
Anka Bric*
Chunlin Cai
Santanu Chakraborty
Samit Chatterjee
Muhan Chen
Shuaili Chen
Agustin Chicas
Yu-Chen Chien
Anne Daulny
Stacy DeBlasio
James Demas
Ebru Demir
Ross Dickins
Juan Encinas
Christopher Faehnle
Yuda Fang
Katalin Fejes Toth*
Gidon Felsen
Cristina Fernandez Marco
DingCheng Gao
Fuqiang Geng
Vladimir Grubor
Mengjuan Guo
Xuecui Guo
Astrid Desiree Haase
Yoshitaka Hippo
Masateru Hiramoto
Emily Hodges
Tomas Hromadka
Hailan Hu
Yimin Hua
Daniel Huber*
Michael Huebner
Danielle Irvine
Santiago Jaramillo Escobar
Mads Aaboe Jensen
Robyn Johnston
Claudia Jurgensen
Erkan Karakas
Fedor Karginov
Hironori Kawakami
Helmut Kessels
William Keyes
LABORATORY MANAGEMENT
Bruce W. Stillman, President
James D. Watson, Chancellor†
W. Dillaway Ayres Jr., Chief Operating Officer
* Employee of the Howard Hughes Medical Institute
†Through 10/25/07
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Akiko Kobayashi
Valery Krizhanovsky
Sandra Kuhlman
Prakash Kumar
John Kurland
Duda Kvitsiani
Yoon-Ha Lee
Dan Levy
Bo Li
Jianli Li
Li Li
Susana Lima
Yang Liu Sullivan
Mukesh Lodha
Jiangteng Lu
Dheeraj Malhotra
Akira Mamiya
Louis Manganas
Anthony Mazurek
Shane Edward McCarthy
Kevin McDonnell
Christoph Miething
Sylvain Mitelheiser
Katharine Munckton
Masayoshi Murakami
Elizabeth Murchison
Nael Nadif Kasri
Namiko Nagasawa
Fabio Nogueira
Michaela Oswald-Pisarski
Gonzalo Hugo Otazu Aldana
Hysell Oviedo
Mario Pagani
Timothy Pardee
June Hee Park
Anirban Paul
Shilpi Paul
Hongtao Qin
Ileng Ramachandran
Kandasamy Ravi
Eleonore Real
Francesc Roca
Ananda Sarkar
Thomas Schalch
Lucio Schiapparelli
Rebecca Schwab
Ulla Schwertassek
Camile Semighini
Jihane Serkhane
Pranav Sharma
Wan Hua Shen
Yi-Jun Sheu
Khalid Siddiqui
Richard Slotkin
Matthew Smear
Andrew Smith
Vihra Sotirova
Smita Srivastava
Chunlao Tang
Hiroki Taniguchi
Milos Tanurdzic
Rajika Thakar
Vatsala Thirumalai
Dmitry Tsigankov
Daniel Valente
Haibin Wang
Liang Wang
Clinton Whipple
Caizhi Wu
Shouzhen Xia
Ning Long Xu
Hong Yang
Miguel Zaratiegui Biurrun
Lixing Zhan
Zuo Zhang
Johannes Zuber
Graduate Students
Canan Aksoy
Hiroki Asari
Hannah Bender
Claire Biot
Rebecca Bish
Allison Blum
Megan Bodnar
Francois Bolduc
Ralph Burgess
Kasandra Burgos
Joseph Calarco
Abhishek Chakraborty
An-Yun Chang
Fauzia Chaudhary
Sihem Cheloufi
Yen-Yu Chen
Yi-Chun Chen
Hsueh-Cheng Chiang
Daniel Chitwood
Shu-Ling Chiu
Hyejin Cho
Galen Collins
Michael Cressy
Monica Dus
Saya Ebbesen
Yaniv Erlich
Xin Feng
Patrick Finigan
Oliver Fregoso
Yu Fu
Angelique Girard
Eyal Gruntman
Paloma Guzzardo Tamargo
Jong Jin Han
Md Aftabul Haque
Christopher Harvey
Miao He
Xingyue He
Shun Ho
Kyle Honegger
Ikuko Hotta
Katarzyna Hrecka
Ingrid Ibarra
Keisha John
Nihan Kara
Danny Khalil
Anna Kloc
Marek Kudla
Mary Kusenda
Matthew Lazarus
Jane Lee
Amy Leung
Wangzhi Li
Wanhe Li
Guang Lin
Xiaofei Liu
Sarahjane Locke
Alexandra Lucs
Elena Lum
Hiroshi Makino
Colin Malone
Katherine McJunkin
Nicholas Navin
Daniel Nolan
Marissa Nolan
Hazeem Okunola
Hassana Okunola
Shraddha Pai
Cristian Papazoglu-Statescu
Michael Pautler
Maria Pineda
Yevgeniy Plavskin
Prem Premsrirut
Sachin Ranade
Amy Rappaport
Frederick Rollins
Avi Rosenberg
Jeffrey Rosenfeld
Marlies Rossmann
Sigal Saar
Joshua Sanders
Claudio Scuoppo
David Simpson
Rahul Sinha
Despina Siolas
Shuying Sun
Hongjae Sunwoo
Lung-Hao Tai
Oliver Tam
Deepika Vasudevan
Assaf Vestin
Zhenxun Wang
Wei Wei
Jeremy Wilusz
Xiaoyun Wu
Chunsu Xu
Bin Xue
Wen Xue
Yang Yang
Yu-Ting Yang
Hatim Zariwala
Chaolin Zhang
Jianping Zhang
Rui Zhao
Zhen Zhao
Petr Znamenskiy
Research Programmers
Peter Andrews
Abhishek Bhandari
Jason Bohland
Scott Cain
Aung Kyaw Chi
Norberto De La Cruz
Benjamin Faga
Gopalakrishnan Gopinathrao
Todd Harris
Alexander Kanapin
Jude Kendall
Sohail Khan
Lalitha Krishnan
Anthony Leotta
Chengzhi Liang
John Lin
Zhenyuan Lu
Vladimir Makarov
Steven Marks
Sheldon McKay
Apurva Narechania
Timothy O’Connor
Andrew Olson
Deepa Pai
Shiran Pasternak
Liya Ren
Michael Ronemus
Marcella Tello-Ruiz
Xuehong Wei
Guanming Wu
Seungtai Yoon
Charles Youens-Clark
Zheng Zha
Wei Zhao
Research Associates
Carmelita Bautista
Barry Burbach
Lisa Manche
Mila McCurrach
Linda Rodgers
Simone Salghetti
Patricia Wendel
Xiaoqun Zhang
Laboratory Facility
Managers
Sabrina Boettcher*
Steven Hearn
Christopher Johns
Sang Yong Kim
Pamela Moody
Timothy Mulligan
Joseph Simorowski
Spencer Teplin
Jennifer Troge
Ming Wang
* Employee of the Howard Hughes Medical Institute
447
421-452_LAR_grants_finances:407-442_FINANCIAL  5/28/08  11:00 AM  Page 447
448
Laboratory Manager
Martha Daddario
Laboratory Technicians
Ninche Alston
Claude Ambroise
Kimberly Bell
Kenneth Bergami
Surjya Bhattacharyya
Kimberly Bronson
James Byrnes
Laura Cardone
Joshua Cohen
Kerry Cook
Hilary Cox
Nancy Dawkins-Pisani
Margaret Falkowski
Silvia Fenoglio
Magdalena Gierszewska
Amy Gottesman
Mary Hahn
Inessa Hakker
Fangle Hu
Lisa Hufnagel
Taneisha James
Justyna Janas
Frederick Katzenberger
So Young Kim
Melissa Kramer
Seung Yeon Lee
Kristin Lehet
Jingjing Li
Wen Wen Lin
Trine Lindsted
Qing Liu
Ying Hsiu Liu
Beicong Ma*
Krista Marran
Jennifer Meth
Maria Mosquera
Stephanie Muller
Lidia Nascimento
Ronnie Packer
Rae Hum Paik
Kevin Pavon
Theresa Racanelli
Umamaheswari Ramu
Danea Rebolini
Michael Riggs
Patricia Roccanova
Michelle Rooks
Joseph Sarro II
Stephen Schuck
Janelle Simon*
Noriko Simorowski
Stephanie Smith
Lori Spiegel
Huaien Wang
Jing Wang
Regina Whitaker
Jason Williams
Scilla Wu
Ying Wu
Miao-Miao Yang
Lifang Zhang
Media Makers/Laboratory
Aides
Christopher Algieri
June Blanchford
Patricia Brady
Florinda Chaves
Terrance Chisum
Salvador Henriquez
Raymond Kim
Marcela Lara
Vincent Meschan
Kenny Rojas
Hong Jie Shen
Rulan Shen
Richard Suen
Amy Tang-Qiu
Margaret Wallace
Research Administration
Maureen Bell
Denise Roberts
Scientific Administrators
Paloma Anderson
Sadie Arana
Christine Bedell
Patricia Bird
Lynn Boss*
Becky Dong
Sandra Doscher
Irene Gill
Jo Leonardo*
Idee Mallardi
Barbara Matusik
Sandra Michelsen
Stephanie Peragallo
Lyzette Williams
EDUCATION
Banbury Center
Jan A. Witkowski, Executive
Director
Barbara Polakowski
Eleanor Sidorenko
Beatrice Toliver
CSHL Press
John R. Inglis, Executive
Director
Barbara Acosta
Janet Argentine
Ingrid Benirschke Perkins
Cynthia Blaut
Ann Boyle
Carol Brown
Kathleen Bubbeo
Margaret Calicchia
Jane Carter
Kathleen Cirone
Laureen Connell
Heather Cosel-Pieper
Mary Cozza
David Crotty
Judith Cuddihy
Maryliz Dickerson
Christina Dzikowski
Joan Ebert
Maria Fairchild
Corrisa Farmer
Alexander Gann
Bibiane Garite
Kaaren Hegquist
Lauren Heller
Pauline Henick
Nancy Hodson
Geraldine Jaitin
Kaaren Janssen
William Keen
Catherine Kelly
Kathryn LaForgia
Christina Lo
Kathleen MacDonald
Robert Majovski
Victor Manchiso
Wayne Manos
Jacqueline Matura
Mala Mazzullo
Mary Mulligan
Stephanie Novara
Keriaki Pollakis
Elizabeth Powers
Theodore Roeder
Nora Ruth
Mary Sabala
Roberta Salant
Susan Schaefer
Lauren Schmidt
Inez Sialiano
Marcie Siconolfi
Maria Smit
Rena Steuer
Sharon Story
Hillary Sussman
Linda Sussman
Christopher Vacca
Denise Weiss
Dolan DNA Learning
Center
David A. Micklos, Executive
Director
Stephen Blue
Charmaine Browne
Elna Carrasco
John Connolly
Jennifer Cutillo
Maria Diaz
Alina Duvall
Cornel Ghiban
Malissa Hewitt
Eun-Sook Jeong
Mary Lamont
Brian Lang
Susan Lauter
Amanda McBrien
Colleen McKechnie
Valerie Meszaros
Eric Nash
Carolyn Reid
Danielle Sixsmith
Jermel Watkins
Lauren Weidler
Chun-hua Yang
Library and Archives
Ludmila T. Pollock,
Executive Director
Paula Abisognio
Jiye Ai
Ellen Brenner
Alexander Carnevale
Clare Clark
Angela Cornwell
Anthony Dellureficio
Charles Egleston
Helena Jonson
Gail Sherman
Rhonda Veros
Carlos Viteri
Claudia Zago
Meetings and Courses
David J. Stewart, Executive
Director
Mark Beavers
Edward Campodonico
Joseph Carrieri
Reginald Cayo
Katiria Ceballos
Maoyen Chi
William Dickerson
Gerald McCloskey
Andrew Mendelsohn
Maureen Morrow
Andrea Newell
Kenneth Orff
Valerie Pakaluk
Jonathan Parsons
Lauren Postyn
Mary Smith
Margaret Stellabotte
Andrea Stephenson
Barbara Zane
* Employee of the Howard Hughes Medical Institute
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Watson School of
Biological Sciences
Leemor Joshua-Tor, Dean
Uwe Hilgert
Dawn Meehan
Alyson Kass-Eisler
Kimberley Geer
Terri I. Grodzicker, Assistant
Director of Academic Affairs
ADMINISTRATIVE
DEPARTMENTS
Comptroller’s Office
and Accounting
Lari C. Russo, Vice
President, Finance and
Comptroller
Sharon Bense
Karine Boyce
Helen Chase
Damian Desiderio
Karen Filasky
Mary Ellen Goldstein
Laura Guterman
Elizabeth Janow
Patricia Maroney
Alison McDermott
Mary Ann Miceli
Kari Pavlovsky
Patricia Penner
Grace Tomasi
Patricia Urena
Noreen Vance
Central Administration
Maureen Berejka
Karen Rodzenko
Judith Smith
Madeline Wisnewski
Culinary Services
James Hope, Director
Alexander Aguilera
Andres Alarcon
Nicholas Algios
Jeannette Amato
Ingrid Amaya
Jaime Bonilla
Reinaldo Bonilla
Francis Bowdren
Maryam Brinkwart
Guiditta Carino
William Carmona
Julio Carrasco
John Castrillon
Marvin Chavez
Joan Doxey
Piedad Echeverri
Julie Ehrlich
Suzanne Esposito
Lucy Figueroa
Andres Gonzalez
Barbara Gordon
Jennifer Gordon
Kirsten Hucke
Gloria Hurtado
Pierre Jean-Baptiste
Jesus Magana
Juan Magana
Thomas McIlvaine
Jessica Miller
Laurie Moller
Frederik Munter
Jorge Ramirez
Jose Reyes
Susana Roman
Maria Salazar
Faustino Vargas
Maria Villatoro
Jennifer Ziegler
Day Care Center
Deborah Keller, Director
Danielle Arleo
Rita Beetham
Suzanne Chitwood
Stephanie Dennis
Serena Dowd
Jennifer Filipowicz
Karen Flore
Shermin Huda
Laura LaRosa
Stephanie LaRosa
Cynthia Lyon
Deirdre McDermott
Paula Messinger
Denise Moder
Lisa Reilly
Joan Zimmermann
Development
Charles V. Prizzi, Vice
President
Jean DeForest
Diane Fagiola
Kiryn Haslinger
Karen Orzel
Wendy Schneps
Paula Smith
Jill Stone
Facilities
Arthur Brings, Vice
President, Chief Facilities
Officer
Robert Albinson
Leslie Allen
Edward Anderson
Peter Anderson
Jerry Armstrong
Damir Begonja
Santo Bellino
Edwin Bennett
John Benson
Lisa Bianco
William Bishop
Thomas Blume
Keith Brown
Amy Burrows
Michael Cahn
Jacqueline Cappellani
Frank Carberry
Dessie Carter
Ming-Kai Chan
Daniel Chapman
Christopher Clark
Jodi Coblentz
Justin Cohen
Robert Collins
Drew Comer
Gabriela Cruz
Peter Dale
Steven Daniels
Charlene De Poto
James Decker
Robert Dickerson
Glen DiMaria
Kevin Donohue
Jared Downing
Wesley Dreusike
Eileen Earl
Paul Edwards
Robert Eifert
Joseph Ellis
Susan Esposito
Rafael Estrella
Romulo Estrella
Daniella Ferreira Cunha
Albert Ferri
Yolanda Figueroa
Nelson Flores Giron
Robert Fowles
Leo Franz
Angela Garcia
Sonia Garcia
Wilman Garcia
Robert Gensel
Jeffrey Goldblum
Erick Greene
Leo Greene
Stephen Gregorovic
Kim Gronachan
Courtney Hakker
Wayne Hamilton
Evan Harmon
Adriana Hincapie
Gerard Holler
Denise Hoppe
Joseph Houser
Matthew Hoyer
Craig Hubbs
Christopher Hubert
Louis Hunter
Christine Hurson
Louis Jagoda
Domingo Jerez
Randal Jones
Daniel Jusino
Jeffrey Klaverweiden
James Knott, Jr.
Poh Sim Koh
Oscar Lastra
Walter Leute
Margarita Lopez
Charles Mandell, Jr.
Lea Manzella
Patricia McAdams
Christopher McEvoy
Tahid McCoy
Jonathan Merant
Dora Merlino
John Meyer
Daniel Miller
Tsepo Morris
Mary Muno
Louis Muno
Gustavo Munoz
Michael Murphy
Kenneth Nastri
George Newell III
Aigoul Nourjanova
Fernando Orrego
Louis Os
Wayne Pav
Michael Peluso
Jose Pineda
John Pisciotta
David Pollock
Manuel Ramones
Wilson Ramones
Steven Randall
Carla Rivas
Ronald Romani
Marlene Rubino
Frank Russo
Michael Santonastasio
John Schindler
Claudia Schmid
Charles Schneider
Herbert Schulz
Stanley Schwarz
Peter Schwind
Cesar Sisalima
Lane Smith
Peter Stahl
John Sundman
Clifford Sutkevich
Matthew Sweeney
Steven Tang
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Yew Teo
Leigh Tyrrel
James Van Wie
Eric Vazquez
Benjamin Veneable III
John Wallace
Leslie Wenzel
Graham Wildt
Jenna Williams
Dorothy Williams
Ann Williams
Curtis Williams
Wenbo Yang
Human Resources
Katherine G. Raftery, Vice
President
Patricia Crawford
Christie DeRosalia
Leslie Inglis
Barbara Purcell
Marjorie Ryan
Theresa Saia
Patricia Schoeffler
Rashmi Sinha
Kerrin Tocci
Karen Ullman
Rita Wienclaw
Paola Zaks
Information Technology
R. Michael Townsend,
Director
James Bense
Melissa Georgia Bruggemann
William Burns
Lucas Carey
Orian Diaz
Gregg Evans
Kelvin Flores
Jeffrey Goldschrafe
Eric Hansen
Todd Heywood
Derek Johnson
Jason Katz
Sean Kelly
Michael Malave
Louis Malfi
Barbara Peters
Steven Prego
Carlos Rendon
Leila Sawicki
Salvatore Serafino
Michael Skuthan
Russell Strine
David Trimboli
Peter Van Buren
Steven Zielinski
Procurement
Philip Lembo, Director
Deborah Aufiero
Margaret Brock
Carol Brower
Susan De Angelo
Jeffrey DuPree
Bruce Fahlbusch
Christopher Oravitz
Krystyna Rzonca
Barbara Santos
Leonard Sposato
Public Affairs
Dagnia Zeidlickis, Vice
President, Communications
Margot Bennett
James Bono
James Duffy
Catherine Eberstark
Joan Lui
Elizabeth Panagot
Amanda Reiss
Philip Renna
John Verity
Sponsored Programs
Walter L. Goldschmidts,
Executive Director
Wendy Crowley
Maureen Davies
Carol DuPree
Diane Errico
Jill Hemish
Joanne Janelli
Delia King
Ruta Ledins
Stacy Leotta
Susan Schultz
Kathleen Wall-Rooney
Technology Transfer
John P. Maroney, Vice
President and In-House
Counsel
Elizabeth Cherian-Samuel
Lorraine McInerny
Limin Wen
RESEARCH STAFF
DEPARTURES DURING
2007
Dean, Watson School
Lilian Clark
Professors
Tatsuya Hirano
Karel Svoboda
Timothy Tully
Associate Professor
Dmitri Chklovskii
Assistant Professors
Wolfgang Lukowitz
Michael Myers
Cold Spring Harbor Fellows
Ira Hall
Gilbert Henry
Research Investigator
Antonius Holtmaat
Visiting Professors
William Benjamin
Visiting Scientists/
Collaborative Scientists
Paulo Ferriera
Adriana Hemerly
Tetsuya Nakamara
Atmakuri Rao
Amanda Sierra
Senior Fellows
Michelle Hastings
Lin He
Postdoctoral Fellows
Nobuki Aono
Alfonso Junior Apicella
Jannic Boehm
Deirdre Buckley
Ingrid Bureau
Vincenzo DePaola
Ana Domingos
Dominik Duelli
Rebecca Ewald
Tristan Fiedler
Andrea Gallavotti
Rita Gandhi
Supriya Gangadharan
Damian Garcia
Naira Gorovits
Hongzhen He
Jill Hemish
Shanta Hinton
Maarten Hoek
Joseph Jun
Prasanth Kumar
Kannanganattu
Rotem Karni
Alla Karpova
Adam Kepecs
Charles Kopec
Byeong Ha Lee
Hong Li
Ping-I Lin
Christopher Mayer
Albert Mellick
Yuriy Mishchenko*
Amitabh Mohanty
Tal Nawy
Itay Onn
Dhruv Pant
Antonella Piccini
Michael Regulski
Xin-Ying Ren
Fabiola Rivas
Jorge Santos DaSilva
Angshuman Sarkar
Mayilvahanan Shanmugam
Keisha Shintomi
Jose Silva
Philip Smith
Takuya Takahashi
Niraj Tolia
Caronline van der Meijden
Yalin Wang
Linda Wilbrecht
Min Yu
Chih-Chi Yuan
Xiaoyue Zhao
Research Programmers
Cara Allen
Payan Canaran
Maoyen Chi
Hiren Maniar
Samar Mehta
Ankit Patel
Theodore Roeder
Joseph Trubisz
Matthew Vaughn
Vicky Zhou
* Employee of the Howard Hughes Medical Institute
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